Citrus Sinensis ID: 000715
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1335 | 2.2.26 [Sep-21-2011] | |||||||
| Q5R4M2 | 1275 | Serine/threonine-protein | yes | no | 0.191 | 0.200 | 0.409 | 8e-61 | |
| Q96C45 | 1275 | Serine/threonine-protein | yes | no | 0.191 | 0.200 | 0.409 | 1e-60 | |
| Q3V129 | 1303 | Serine/threonine-protein | yes | no | 0.194 | 0.198 | 0.398 | 9e-59 | |
| Q9NRP7 | 1315 | Serine/threonine-protein | no | no | 0.229 | 0.233 | 0.371 | 3e-51 | |
| Q69ZM6 | 1316 | Serine/threonine-protein | no | no | 0.190 | 0.193 | 0.411 | 3e-51 | |
| Q5RAJ5 | 1315 | Serine/threonine-protein | no | no | 0.190 | 0.193 | 0.408 | 3e-51 | |
| Q2QAV0 | 1322 | Serine/threonine-protein | no | no | 0.185 | 0.187 | 0.375 | 3e-44 | |
| Q55FT4 | 2247 | Probable serine/threonine | yes | no | 0.186 | 0.110 | 0.370 | 4e-41 | |
| Q4V7Q6 | 468 | Serine/threonine-protein | N/A | no | 0.198 | 0.566 | 0.357 | 1e-39 | |
| Q5ZJH6 | 468 | Serine/threonine-protein | no | no | 0.207 | 0.591 | 0.343 | 2e-39 |
| >sp|Q5R4M2|ULK4_PONAB Serine/threonine-protein kinase ULK4 OS=Pongo abelii GN=ULK4 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 236 bits (603), Expect = 8e-61, Method: Compositional matrix adjust.
Identities = 116/283 (40%), Positives = 165/283 (58%), Gaps = 27/283 (9%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
M + +YE IGRG S VYKGR+K TI + AI DK ++ ++ VR+ H + H N++
Sbjct: 1 MENFILYEEIGRGSKSVVYKGRRKGTINFVAILCTDKCKRPEITNWVRLTHEIKHKNIVT 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
F+ WYETS HLWLV+E C GG L +++ QD LPED +R+ DL+ L +LH GI++C
Sbjct: 61 FHEWYETSNHLWLVVELCTGGSLKTVIAQDENLPEDVVREFGIDLISGLHHLHKLGILFC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLAR----------KLSDASKA---------PSSMLPQAK 161
D+ P ILL+ G K +F LA+ L A + SM + K
Sbjct: 121 DISPRKILLEGPGTLKFSNFCLAKVEGENLEEFFALVAAEEGGGDSGENVLKKSMKSRVK 180
Query: 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL-SDPSP 220
G+P Y APE+ G S +SDLW +GC+LYE ++G+PPF ++L + IL DP P
Sbjct: 181 -GSPVYTAPEVV-RGAEFSISSDLWSVGCLLYEMFSGKPPFFSESISELTEKILCEDPLP 238
Query: 221 PLPGNPSRP-----FANLINSLLVKDPAQRLHWSDLCGHAFWR 258
P+P + S P F NL++ LL +DP +RL W+ L H+FW+
Sbjct: 239 PIPKDSSCPKASSDFTNLLDGLLQRDPQKRLTWTRLLQHSFWK 281
|
Pongo abelii (taxid: 9601) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q96C45|ULK4_HUMAN Serine/threonine-protein kinase ULK4 OS=Homo sapiens GN=ULK4 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 236 bits (602), Expect = 1e-60, Method: Compositional matrix adjust.
Identities = 116/283 (40%), Positives = 165/283 (58%), Gaps = 27/283 (9%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
M + +YE IGRG + VYKGR+K TI + AI DK ++ ++ VR+ + H N++
Sbjct: 1 MENFILYEEIGRGSKTVVYKGRRKGTINFVAILCTDKCKRPEITNWVRLTREIKHKNIVT 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
F+ WYETS HLWLV+E C GG L +++ QD LPED +R+ DL+ L +LH GI++C
Sbjct: 61 FHEWYETSNHLWLVVELCTGGSLKTVIAQDENLPEDVVREFGIDLISGLHHLHKLGILFC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLAR----------KLSDASKA---------PSSMLPQAK 161
D+ P ILL+ G K +F LA+ L A + SM + K
Sbjct: 121 DISPRKILLEGPGTLKFSNFCLAKVEGENLEEFFALVAAEEGGGDNGENVLKKSMKSRVK 180
Query: 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL-SDPSP 220
G+P Y APE+ G S +SDLW LGC+LYE ++G+PPF ++L + IL DP P
Sbjct: 181 -GSPVYTAPEVV-RGADFSISSDLWSLGCLLYEMFSGKPPFFSESISELTEKILCEDPLP 238
Query: 221 PLPGNPSRP-----FANLINSLLVKDPAQRLHWSDLCGHAFWR 258
P+P + SRP F NL++ LL +DP +RL W+ L H+FW+
Sbjct: 239 PIPKDSSRPKASSDFINLLDGLLQRDPQKRLTWTRLLQHSFWK 281
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3V129|ULK4_MOUSE Serine/threonine-protein kinase ULK4 OS=Mus musculus GN=Ulk4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 229 bits (585), Expect = 9e-59, Method: Compositional matrix adjust.
Identities = 114/286 (39%), Positives = 163/286 (56%), Gaps = 27/286 (9%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
M + +YE IGRG + VYKGR+K TI + AI +K ++ ++ VR+ H + H N++
Sbjct: 1 MENFVLYEEIGRGSRTVVYKGRRKGTINFVAILCTEKCKRPEITNWVRLTHEIKHKNIVT 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
F+ WYETS HLWLV+E C GG L +++ QD LPED +R+ DLV L +LH GI++C
Sbjct: 61 FHEWYETSNHLWLVVELCTGGSLETVIAQDENLPEDVVREFGVDLVTGLHHLHRLGILFC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDA-------------------SKAPSSMLPQAK 161
DL P ILL+ G K +F LA+ ++ + SM + +
Sbjct: 121 DLSPGKILLEGPGTLKFSNFCLAKVAGESLEEFFALVAAEEGGGDSGENALKKSMKTRVR 180
Query: 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL-SDPSP 220
G+ Y APE+ +G S SDLW LGC+LYE ++G+PPF ++LV+ IL DP P
Sbjct: 181 -GSLIYAAPEIV-KGTEFSVTSDLWSLGCLLYEMFSGKPPFFSETVSELVEKILYEDPLP 238
Query: 221 PLPGNPSRP-----FANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261
P+P + S P F NL++ LL KDP +R W + H FW+ L
Sbjct: 239 PIPKDSSFPKASSDFLNLLDGLLQKDPQKRFSWEGVLQHPFWKDAL 284
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NRP7|STK36_HUMAN Serine/threonine-protein kinase 36 OS=Homo sapiens GN=STK36 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 204 bits (520), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 120/323 (37%), Positives = 175/323 (54%), Gaps = 16/323 (4%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDH 55
M +YH+ E IG G + VYKGR+K + + A+K + K +S+ + +E+ ++ L H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
PN++ +ET + +V +Y G+L +L D +LPED ++ +A LV AL YLHS
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDY-AEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSH 119
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I++ D+KP NILL + G KLCDFG AR +S ++M+ + GTP YM+PEL EE
Sbjct: 120 RILHRDMKPQNILLAKGGGIKLCDFGFARAMST-----NTMVLTSIKGTPLYMSPELVEE 174
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235
+ + +DLW +GC+LYE G PPF QLV IL DP P S F N +
Sbjct: 175 RP-YDHTADLWSVGCILYELAVGTPPFYATSIFQLVSLILKDPV-RWPSTISPCFKNFLQ 232
Query: 236 SLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKGAVRQDENSMLGSTPV-RV 294
LL KDP QRL W DL H F +T + P P + + E +L R+
Sbjct: 233 GLLTKDPRQRLSWPDLLYHPFIAGHVTIITEPAGPDLGTPFTSRLPPELQVLKDEQAHRL 292
Query: 295 TPSGRKTQ--TKTSGRVFEEKQK 315
P G +++ T+ R+ EE +
Sbjct: 293 APKGNQSRILTQAYKRMAEEAMQ 315
|
Serine/threonine protein kinase which plays an important role in the sonic hedgehog (Shh) pathway by regulating the activity of GLI transcription factors. Controls the activity of the transcriptional regulators GLI1, GLI2 and GLI3 by opposing the effect of SUFU and promoting their nuclear localization. GLI2 requires an additional function of STK36 to become transcriptionally active, but the enzyme does not need to possess an active kinase catalytic site for this to occur. Required for postnatal development, possibly by regulating the homeostasis of cerebral spinal fluid or ciliary function. Essential for construction of the central pair apparatus of motile cilia. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q69ZM6|STK36_MOUSE Serine/threonine-protein kinase 36 OS=Mus musculus GN=Stk36 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 204 bits (520), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 110/267 (41%), Positives = 154/267 (57%), Gaps = 13/267 (4%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDH 55
M +YH+ E IG G + VYKGRKK + + A+K + K +S+ + +E+ ++ L H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRKKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLWH 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
PN++ +ET + +V +Y G+L +L D +LPED ++ +A LV AL YLHS
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDY-AEGELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSH 119
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I++ D+KP NILL + G KLCDFG AR +S ++M+ + GTP YM+PEL EE
Sbjct: 120 RILHRDMKPQNILLAKGGGIKLCDFGFARAMST-----NTMVLTSIKGTPLYMSPELVEE 174
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235
+ + +DLW +GC+LYE G PPF QLV IL DP P S F N +
Sbjct: 175 RP-YDHTADLWSVGCILYELAVGTPPFYTTSIFQLVSLILKDPV-RWPSTISSCFKNFLQ 232
Query: 236 SLLVKDPAQRLHWSDLCGHAFWRTKLT 262
LL KDP QRL W DL H F ++T
Sbjct: 233 GLLTKDPRQRLSWPDLLHHPFIAGRVT 259
|
Serine/threonine protein kinase which plays an important role in the sonic hedgehog (Shh) pathway by regulating the activity of GLI transcription factors. Controls the activity of the transcriptional regulators GLI1, GLI2 and GLI3 by opposing the effect of SUFU and promoting their nuclear localization. GLI2 requires an additional function of STK36 to become transcriptionally active, but the enzyme does not need to possess an active kinase catalytic site for this to occur. Required for postnatal development, possibly by regulating the homeostasis of cerebral spinal fluid or ciliary function. Essential for construction of the central pair apparatus of motile cilia. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5RAJ5|STK36_PONAB Serine/threonine-protein kinase 36 OS=Pongo abelii GN=STK36 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (520), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 109/267 (40%), Positives = 154/267 (57%), Gaps = 13/267 (4%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDH 55
M +YH+ E IG G + VYKGR+K + + A+K + K +S+ + +E+ ++ L H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
PN++ +ET + +V +Y G+L+ +L D +LPED ++ +A LV AL YLHS
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDY-AEGELLQILEDDGKLPEDQVQAIAAQLVSALYYLHSH 119
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I++ D+KP NILL + G KLCDFG AR +S ++M+ + GTP YM+PEL EE
Sbjct: 120 RILHRDMKPQNILLAKGGGIKLCDFGFARAMST-----NTMVLTSIKGTPLYMSPELVEE 174
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235
+ + +DLW +GC+LYE G PPF QLV IL DP P S F N +
Sbjct: 175 RP-YDHTADLWSVGCILYELAVGTPPFYATSIFQLVSLILKDPV-RWPSTISPCFKNFLQ 232
Query: 236 SLLVKDPAQRLHWSDLCGHAFWRTKLT 262
LL KDP QRL W DL H F +T
Sbjct: 233 GLLTKDPRQRLSWPDLLYHPFIAGHVT 259
|
Serine/threonine protein kinase which plays an important role in the sonic hedgehog (Shh) pathway by regulating the activity of GLI transcription factors. Controls the activity of the transcriptional regulators GLI1, GLI2 and GLI3 by opposing the effect of SUFU and promoting their nuclear localization. GLI2 requires an additional function of STK36 to become transcriptionally active, but the enzyme does not need to possess an active kinase catalytic site for this to occur. Required for postnatal development, possibly by regulating the homeostasis of cerebral spinal fluid or ciliary function. Essential for construction of the central pair apparatus of motile cilia. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QAV0|TIO_ARATH Serine/threonine-protein kinase TIO OS=Arabidopsis thaliana GN=TIO PE=1 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (460), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 98/261 (37%), Positives = 144/261 (55%), Gaps = 13/261 (4%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-----KVLQEVRMLHSLDH 55
+ YH+ E +G G + VYKGR+K T + A+K + K K+ + QE+ +L L H
Sbjct: 3 VEDYHVIELVGEGSFGRVYKGRRKYTGQTVAMKFIMKQGKTDKDIHSLRQEIEILRKLKH 62
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
N++ +E + +V E+ G+L +L D LPE+ ++ +A+ LV+AL YLHS
Sbjct: 63 ENIIEMLDSFENAREFCVVTEF-AQGELFEILEDDKCLPEEQVQAIAKQLVKALDYLHSN 121
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
II+ D+KP NIL+ KLCDFG AR +S ++++ ++ GTP YMAPEL +E
Sbjct: 122 RIIHRDMKPQNILIGAGSVVKLCDFGFARAMS-----TNTVVLRSIKGTPLYMAPELVKE 176
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235
+ DLW LG +LYE Y G+PPF L++ I+ DP P S F + +
Sbjct: 177 QP-YDRTVDLWSLGVILYELYVGQPPFYTNSVYALIRHIVKDPV-KYPDEMSTYFESFLK 234
Query: 236 SLLVKDPAQRLHWSDLCGHAF 256
LL K+P RL W L H F
Sbjct: 235 GLLNKEPHSRLTWPALREHPF 255
|
Plays a role in conventional modes of cytokinesis in meristems and during male gametogenesis but also acts in nonconventional modes of cytokinesis (cellularization) during female gametogenesis. Constitutes a signaling module in association with Kinesin-12 members that is required to support phragmoplast expansion and cell-plate growth in plant cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55FT4|TSUA_DICDI Probable serine/threonine-protein kinase tsuA OS=Dictyostelium discoideum GN=tsuA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (433), Expect = 4e-41, Method: Compositional matrix adjust.
Identities = 97/262 (37%), Positives = 142/262 (54%), Gaps = 13/262 (4%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDHPNV 58
Y + IG G + VYK RKK T + A K + K K++ + QE+ +L +L HPN+
Sbjct: 5 YKLIGQIGEGSFGKVYKYRKKFTGQLVACKVISKKGKNEEDILSLRQEIDILKNLSHPNI 64
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
++F S +E LV EY GDL ++ ++ L D I+ + LV AL YLH K +I
Sbjct: 65 IQFISCFENKNEFTLVTEYA-DGDLSQIISEEKTLSVDLIQSICYQLVIALNYLHYKKVI 123
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
+ D+KP NIL+ G+ K+CDFG A+ +S +S+L + GTP Y+APE+ +E
Sbjct: 124 HRDIKPQNILITSGGQIKVCDFGFAKTISS-----NSILLTSLKGTPLYLAPEIIQEQP- 177
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL-SDPSPPLPGNPSRPFANLINSL 237
+ Y +DLW LG +LY+ G PPF LV L S+ P N +L L
Sbjct: 178 YDYKADLWSLGIILYQILVGSPPFSANSLADLVHMTLESNIEIPKELNKYPDLVSLFRQL 237
Query: 238 LVKDPAQRLHWSDLCGHAFWRT 259
L K+P +R+ W DL H F ++
Sbjct: 238 LCKNPDKRIGWPDLLYHPFVKS 259
|
Plays a role in chemotaxis and seems to be involved in polarization. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q4V7Q6|ULK3_XENLA Serine/threonine-protein kinase ULK3 OS=Xenopus laevis GN=ulk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 166 bits (419), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 104/291 (35%), Positives = 153/291 (52%), Gaps = 26/291 (8%)
Query: 1 MNQYHIYEAIGRGKYSTVYKG-RKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLD 54
+ + + E +G G Y+TVYK RK+ E AIK V K +K +L E+ +L ++
Sbjct: 10 LEDFILTEKLGSGSYATVYKAYRKRNAREVVAIKCVSKKSLNKAAVENLLTEIEILKTVH 69
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HP++L + +++L+ EYC GGDL +R LPE ++ Q L AL++LH
Sbjct: 70 HPHILELKDFQWDQDYIFLITEYCAGGDLSRFIRTRRILPERIVQVFLQQLASALKFLHE 129
Query: 115 KGIIYCDLKPSNILLDENGR--TKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
K I + DLKP NILL R KL DFG A+ +S S PQA G+P YMAPE+
Sbjct: 130 KNISHLDLKPQNILLSRLDRPHLKLADFGFAQHMS------SEDAPQALRGSPLYMAPEM 183
Query: 173 FEEGGVHSYAS-DLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP--SRP 229
H A DLW +G +LYE G+ PF + F++L + ILS + LP P S
Sbjct: 184 V--CSKHYDARVDLWSVGVILYEALFGKAPFASKSFSELEEKILSHKTIELPTRPRLSPE 241
Query: 230 FANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKGAVR 280
+L+ LL +DP +R+ + + H F + L P+ ++L+ A R
Sbjct: 242 CRDLLQQLLQRDPDKRISFIEFFAHLF-------VDLEHMPSAETLEKATR 285
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5ZJH6|ULK3_CHICK Serine/threonine-protein kinase ULK3 OS=Gallus gallus GN=ULK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 165 bits (417), Expect = 2e-39, Method: Compositional matrix adjust.
Identities = 101/294 (34%), Positives = 154/294 (52%), Gaps = 17/294 (5%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGR-KKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLD 54
++ + + E +G G Y+TVYK K+ T E A+K V K ++ +L E+ +L ++
Sbjct: 11 LDGFVLTERLGTGTYATVYKAYGKRDTREVVAVKCVSKRSLNRASVENLLTEIEILKTIR 70
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HP+++ + S H++L++E+C GGDL +R LPE R Q L AL++LH
Sbjct: 71 HPHIVELKDFQWDSDHIYLIMEFCAGGDLSRFIRMRRILPEKVARIFLQQLACALKFLHD 130
Query: 115 KGIIYCDLKPSNILLD--ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
I + DLKP NILL EN + KL DFG A+ +S + G+P YMAPE+
Sbjct: 131 HNISHLDLKPQNILLSTPENPQLKLADFGFAQYMSPWDEK------HVLRGSPLYMAPEM 184
Query: 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP--SRPF 230
+ DLW +G +LYE GRPPF R F +L + I SD + LP P S
Sbjct: 185 VCRQQYDARV-DLWSVGVILYEALFGRPPFASRSFAELEEKIRSDRAIELPSRPPLSPDC 243
Query: 231 ANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKGAVRQDEN 284
+L+ LL +DP +R+ + + H F + P P A + + AV++D+
Sbjct: 244 RDLLQRLLERDPLKRISFEEFFAHPFVDMEHMPGPESFCKATNLVVEAVKKDQE 297
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1335 | ||||||
| 225432402 | 1368 | PREDICTED: serine/threonine-protein kina | 0.997 | 0.973 | 0.772 | 0.0 | |
| 356555573 | 1371 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.973 | 0.743 | 0.0 | |
| 356549052 | 1370 | PREDICTED: serine/threonine-protein kina | 0.999 | 0.973 | 0.747 | 0.0 | |
| 357447477 | 1358 | Serine/threonine protein kinase [Medicag | 0.999 | 0.982 | 0.738 | 0.0 | |
| 449495406 | 1371 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.999 | 0.973 | 0.717 | 0.0 | |
| 449432789 | 1372 | PREDICTED: serine/threonine-protein kina | 0.999 | 0.972 | 0.716 | 0.0 | |
| 297812057 | 1366 | EMB3013 [Arabidopsis lyrata subsp. lyrat | 0.990 | 0.967 | 0.673 | 0.0 | |
| 42567943 | 1366 | Protein kinase family protein with ARM r | 0.990 | 0.967 | 0.664 | 0.0 | |
| 297736922 | 1115 | unnamed protein product [Vitis vinifera] | 0.834 | 0.999 | 0.664 | 0.0 | |
| 115435762 | 1346 | Os01g0259400 [Oryza sativa Japonica Grou | 0.985 | 0.976 | 0.604 | 0.0 |
| >gi|225432402|ref|XP_002276882.1| PREDICTED: serine/threonine-protein kinase ULK4-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 2162 bits (5603), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1058/1369 (77%), Positives = 1181/1369 (86%), Gaps = 37/1369 (2%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
MNQYHIYEAIGRGKYSTVYKGRKKK+IEYFAIKSVDKSQK+K+LQEVR+LHSLDH NVL
Sbjct: 1 MNQYHIYEAIGRGKYSTVYKGRKKKSIEYFAIKSVDKSQKNKLLQEVRILHSLDHSNVLN 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
F+SWYETSAHLWLVLEYCVGGDLM+LL+QD+QLPEDS+ DLA+DLVRALQ+LHSKGIIYC
Sbjct: 61 FFSWYETSAHLWLVLEYCVGGDLMTLLQQDSQLPEDSVHDLARDLVRALQFLHSKGIIYC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKPSNILLDENG TKLCDFGLARKLSD SK PSSMLPQAK GTPCYMAPELF++GGVHS
Sbjct: 121 DLKPSNILLDENGCTKLCDFGLARKLSDISKTPSSMLPQAKRGTPCYMAPELFQDGGVHS 180
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
YASD W LGCVLYECYAGRPPFVGREFTQLVKSILSDP+P LPG PSRPF NLINSLLVK
Sbjct: 181 YASDFWALGCVLYECYAGRPPFVGREFTQLVKSILSDPTPTLPGTPSRPFVNLINSLLVK 240
Query: 241 DPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSL------------------------- 275
DPA+R+ W +LCGHAFWRTK T +PLPPQPAFD+L
Sbjct: 241 DPAERIQWPELCGHAFWRTKFTSVPLPPQPAFDNLIDLYSKLCLSERNGDKPLQNKTPPK 300
Query: 276 ------KGAVRQDENSMLG----STPVRVTPSGRKTQTKTSGRVFEEKQKDPSGTTRQVN 325
KG +QDENS+LG TPV+ GR+ QTK SGRV +EKQKDPS T VN
Sbjct: 301 YRDRDSKGTPKQDENSILGLKGYETPVKGITGGRRAQTKASGRVADEKQKDPSSATGGVN 360
Query: 326 LLRLSRIVKSNLQRENDKENYRRPLPNGSENDSEVKIENNDMELDFNENTEDETNDEPDG 385
LLRLSRI KSNLQREN+KENYRRPLPN SENDSEVKIEN DMELDFNENTEDE +DEPDG
Sbjct: 361 LLRLSRIAKSNLQRENEKENYRRPLPNNSENDSEVKIENTDMELDFNENTEDEPHDEPDG 420
Query: 386 PDNPNCASEDKLSGQPQHHEKAEETGRNGNHSGTPSAEGMPVSDESRKQDRESSPERVEV 445
D N EDKLS Q QH K EE N N T +PVSD+SR D ES + VEV
Sbjct: 421 SDTSNFTPEDKLSSQTQHQGKVEEMEDNTNQLDTAHVVSIPVSDDSRTFDHES--DHVEV 478
Query: 446 AATPPTVSPQLKTTRIREGSGPPLDSESSRSSNSLSQVLWHPSDLSVRPVMPSRKADKVS 505
AATPP+VSPQ++ R++EGSG +D +SS+SS ++S VLWHPSDLSVRPVMPSRKADK+
Sbjct: 479 AATPPSVSPQVRIQRVKEGSGSAVDFDSSKSSGNISHVLWHPSDLSVRPVMPSRKADKLP 538
Query: 506 EVFPSLPFEALKASDFVKMSKEQLDALNARILAVLNGNSSIGEKQNVIRYLEMLSSNADA 565
E PSLPF+AL ASDF+KMSKEQLD+LN RI+ + NGN++I EKQNVI+YLEMLS+NADA
Sbjct: 539 ETLPSLPFDALAASDFIKMSKEQLDSLNNRIITIFNGNTTIAEKQNVIKYLEMLSNNADA 598
Query: 566 ANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGL 625
ANILT+GPIM+V+VKMLR SK SALRVQLASLIGL IRHSTFIDDDLA+SGILGSLTDGL
Sbjct: 599 ANILTNGPIMMVIVKMLRQSKASALRVQLASLIGLLIRHSTFIDDDLASSGILGSLTDGL 658
Query: 626 RDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSS 685
RD+QEKVRRFSMAALGELLFYISTQNEHA+D+NPPESPSKD+R++SGWQV N+LISLVSS
Sbjct: 659 RDRQEKVRRFSMAALGELLFYISTQNEHAKDNNPPESPSKDSRSSSGWQVSNALISLVSS 718
Query: 686 VLRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESMRLTAGS 745
+LRKGEDD+TQ YALRTIENICSQGG+W ARFTSQDVI+NLCYI+RA GKQESMRLTAGS
Sbjct: 719 ILRKGEDDVTQQYALRTIENICSQGGNWAARFTSQDVINNLCYIFRAAGKQESMRLTAGS 778
Query: 746 CLVRLVRFNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGSQMCTNIGRN 805
CLVRLVRF+ PS+QSV+DKLS +D ++L+KGSPREQQISLNLLN+AMLGS M TNIGR+
Sbjct: 779 CLVRLVRFHPPSIQSVIDKLSFRDTVTALVKGSPREQQISLNLLNMAMLGSHMFTNIGRH 838
Query: 806 LLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNGRRWLLHFFCNSRLLSSVDRL 865
LLPLVEDKNLVPSLVSL EQGSEVLRGK LVFV+LLCKNG+RWL HFFCN+R LS+VDRL
Sbjct: 839 LLPLVEDKNLVPSLVSLIEQGSEVLRGKTLVFVALLCKNGKRWLPHFFCNARFLSAVDRL 898
Query: 866 GKEKDSFLQQCLEAFVHVVASIIPGLLDIITGDIQQMMGGRRHGQISAITSRAAPKTNVH 925
KEKDS++QQCL+AF+HVV+S IPGLL+ ITGDIQQMMGGRRHGQI+ +T+RAAPK VH
Sbjct: 899 VKEKDSYVQQCLDAFLHVVSSTIPGLLETITGDIQQMMGGRRHGQIAGLTNRAAPKIKVH 958
Query: 926 LFPVVLHLLGSSSFKNRVVSPPVLQQLANLCKVVETQFQGRDDFQITLLRILESISEESN 985
LFPVVLHLLGSSSFK+RVV+ VLQQLANL K+ E+ FQGRDDFQITLLR+LESI+EE +
Sbjct: 959 LFPVVLHLLGSSSFKHRVVNHQVLQQLANLIKLAESPFQGRDDFQITLLRVLESITEEPS 1018
Query: 986 VILGNPEIFFHEILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEPVEDEQRLQDLKS 1045
VIL + +F EILPSL VLY+GNKDGDARFLCLKIL D M+I LNEP E EQR +DLKS
Sbjct: 1019 VILESANVFIGEILPSLAVLYRGNKDGDARFLCLKILFDAMVIYLNEPSEVEQRSEDLKS 1078
Query: 1046 ISNSHFLPLYPTLIEDEDPIPMYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGDLS 1105
ISN+HFLPLYPTLIEDEDPIPMYAQK+LVM IE YI+I DILH++TVSQCFEFLLGDLS
Sbjct: 1079 ISNTHFLPLYPTLIEDEDPIPMYAQKLLVMFIEFNYIRIPDILHMETVSQCFEFLLGDLS 1138
Query: 1106 SANVSNVKLCLALASAPEMESKLLSQLKVVRRIGNLLELVYAKDMEDFLEPTLGLCRAFL 1165
SANV++VKLCLALASAPEME+KLLSQLKVVR+IGNLLE V AKDMEDFLEPTLGLCRAFL
Sbjct: 1139 SANVNSVKLCLALASAPEMETKLLSQLKVVRKIGNLLEFVNAKDMEDFLEPTLGLCRAFL 1198
Query: 1166 LRSVSSRKGFNYTKEPALLGDCSAEYGTAIDQQQSIRDIMDFSGNVGVFLKLSCSQEANV 1225
LRSV SRKGF Y+KEP L+ D E A+DQQQ IRDIMDF NV VFL+LS S EANV
Sbjct: 1199 LRSVGSRKGFIYSKEPTLICDGPTEVRGAVDQQQYIRDIMDFGSNVSVFLELSGSDEANV 1258
Query: 1226 ADVASECVVLLLKAAPREGTTGFLTNLAKVTAILESWRRGTSHLILQRVLHALGYSCRQY 1285
AD+ASECVVLLLKAAPRE TTGFLTNL+KV+A+LESWRR SHL++ R+LHALGYSCRQY
Sbjct: 1259 ADIASECVVLLLKAAPREATTGFLTNLSKVSALLESWRRAVSHLLVLRMLHALGYSCRQY 1318
Query: 1286 LSHAMILSISINEISRIEAIISEMKTSSTTTLADAALLAASELQRLPRC 1334
LSHAMILSISI EISR+E I+SE+K SS +ADAALL A ELQRLPRC
Sbjct: 1319 LSHAMILSISIPEISRLETIVSELKNSSIPGVADAALLVAKELQRLPRC 1367
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555573|ref|XP_003546105.1| PREDICTED: serine/threonine-protein kinase ULK4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 2090 bits (5414), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1020/1371 (74%), Positives = 1158/1371 (84%), Gaps = 36/1371 (2%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
MNQYHIYEAIGRG+YSTVYKGRKKKTIEYFAIKSVDKSQK+KVL+EVR+LH+LDH NVL+
Sbjct: 1 MNQYHIYEAIGRGRYSTVYKGRKKKTIEYFAIKSVDKSQKTKVLEEVRILHTLDHANVLK 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
FY WYETSAHLWLVLEYCVGGDL+S+LRQD+QLPEDS+ A +LV+ALQ+LHS IIYC
Sbjct: 61 FYDWYETSAHLWLVLEYCVGGDLLSILRQDSQLPEDSVHGFAYNLVKALQFLHSNEIIYC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKPSNILLDENG KLCDFGLARKL D SKAPSS LP+AK GTP YMAPELFE+GGVHS
Sbjct: 121 DLKPSNILLDENGCAKLCDFGLARKLKDISKAPSSSLPRAKRGTPSYMAPELFEDGGVHS 180
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
YASD W LGCVLYECYAGRPPFVGREFTQLVKSI+SDP+PPLPGNPSRPF NLINSLLVK
Sbjct: 181 YASDFWALGCVLYECYAGRPPFVGREFTQLVKSIISDPTPPLPGNPSRPFVNLINSLLVK 240
Query: 241 DPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSL------------------------- 275
DPA+R+ W +LCGHAFWRTK T +PLP QPAFD +
Sbjct: 241 DPAERIQWPELCGHAFWRTKFTLLPLPAQPAFDDMIELHAKPCLSERNGDKSSHNRTPTK 300
Query: 276 ------KGAVRQDENSMLGS----TPVRVTPSGRKTQTKTSGRVFEEKQKDPSGTTRQVN 325
KGA+R+DENS+LGS TP R TP G +TQTK SGR+ E KQKD S ++ VN
Sbjct: 301 YREKDVKGALRKDENSVLGSRGIETPARATPIGHRTQTKGSGRIHEVKQKDNSNISKGVN 360
Query: 326 LLRLSRIVKSNLQRENDKENYRRPLPNGSENDSEVKIENNDMELDFNENTEDETNDEPDG 385
LLRLSRI K+NLQREN+KENYRRPLPN SENDSEVKIEN DMELDFNENTED+ ++E DG
Sbjct: 361 LLRLSRIAKTNLQRENEKENYRRPLPNNSENDSEVKIENTDMELDFNENTEDDAHEETDG 420
Query: 386 PDNPNCASEDKLSGQPQHHEKAEETGRNGNHSGTPSAEGMPVSDESRKQDRESSPERVEV 445
+ ++K + KAEE N + TPS PVSD+ R D ES+P+ ++
Sbjct: 421 TEQTTPVPDEKTDNHFLNQGKAEEIENNTHQLDTPSVVHPPVSDDPRSFDHESTPDLPDI 480
Query: 446 AATPPTVSPQLKTTRIREGSGPPLDSESSRSSNSLSQVLWHPSDLSVRPVMPSRKADKVS 505
+A P+VSPQ+K R +E +G LD + SR SN+LSQVLWHPSDLSVRPVMPSRK DK S
Sbjct: 481 SAISPSVSPQVKKHRTKEDAGSGLDFDFSRLSNNLSQVLWHPSDLSVRPVMPSRKIDKAS 540
Query: 506 EVFPSLPFEALKASDFVKMSKEQLDALNARILAVLNGNSSIGEKQNVIRYLEMLSSNADA 565
EV PSLPFEAL+ASDFVKM KE+L+A++ RIL++LNGN+SIGEKQNVIRYLEMLSSNADA
Sbjct: 541 EVIPSLPFEALQASDFVKMPKEKLEAIHNRILSILNGNTSIGEKQNVIRYLEMLSSNADA 600
Query: 566 ANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGL 625
ANILT+GPIML+LVK+ R SK SALRVQLASLIGL IRHSTF+DD LA+SGILG+LTDGL
Sbjct: 601 ANILTNGPIMLMLVKLQRQSKASALRVQLASLIGLLIRHSTFVDDSLASSGILGALTDGL 660
Query: 626 RDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSS 685
RD+QEKVRRFSMAALGELLFYISTQN RD+N ESPSKDNRT GWQVPNSLISLVSS
Sbjct: 661 RDRQEKVRRFSMAALGELLFYISTQNADCRDNNQLESPSKDNRTTHGWQVPNSLISLVSS 720
Query: 686 VLRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESMRLTAGS 745
+LRKGEDD+TQLYALRTIENICSQGG WV R +SQ VISNLCYIYRA+GKQESMRLTAGS
Sbjct: 721 MLRKGEDDITQLYALRTIENICSQGGSWVGRLSSQYVISNLCYIYRASGKQESMRLTAGS 780
Query: 746 CLVRLVRFNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGSQMCTNIGRN 805
CLVRLVRFN PS+Q V++KLS KD+AS+L+KGSPREQQISLNLLN+AMLGS M TNIGR
Sbjct: 781 CLVRLVRFNPPSIQLVIEKLSFKDLASALVKGSPREQQISLNLLNMAMLGSHMFTNIGRC 840
Query: 806 LLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNGRRWLLHFFCNSRLLSSVDRL 865
L+ L EDKNL+PSL+ L EQGSEVLRGKALV V+LLCK+GRRWL HFFC+ +LLS VDRL
Sbjct: 841 LVSLAEDKNLIPSLLGLVEQGSEVLRGKALVLVALLCKHGRRWLPHFFCSQKLLSVVDRL 900
Query: 866 GKEKDSFLQQCLEAFVHVVASIIPGLLDIITGDIQQMMGGRRHGQISAITSRAAPKTNVH 925
GKEKD++++QCL+AFVH+VAS IPGLLDIITGD+QQMMGGRR G ISA+TSR+APKT++H
Sbjct: 901 GKEKDAYVRQCLDAFVHIVASSIPGLLDIITGDVQQMMGGRRQGHISALTSRSAPKTSIH 960
Query: 926 LFPVVLHLLGSSSFKNRVVSPPVLQQLANLCKVVETQFQGRDDFQITLLRILESISEESN 985
LFPVVLHLLG+S+FK++VV+P VL+QLANL K+VET FQGRDDFQITLLRI ES++EES
Sbjct: 961 LFPVVLHLLGTSTFKHKVVTPQVLRQLANLIKLVETPFQGRDDFQITLLRIFESLTEESP 1020
Query: 986 VILGNPEIFFHEILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEPVEDEQRLQDLKS 1045
VILGNP+IF EILPS TVLYKGNKDGDARFLCLKIL DVMIILL+EP+E+E RL+DLK
Sbjct: 1021 VILGNPDIFIREILPSSTVLYKGNKDGDARFLCLKILFDVMIILLSEPIEEEHRLKDLKF 1080
Query: 1046 ISNSHFLPLYPTLIEDEDPIPMYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGDLS 1105
+SN+HFLPLYPTLIEDEDPIP+YAQK+LVML+E +I I DILHLKT+SQCFEFLLGDLS
Sbjct: 1081 VSNTHFLPLYPTLIEDEDPIPIYAQKLLVMLMEFSFITIPDILHLKTISQCFEFLLGDLS 1140
Query: 1106 SANVSNVKLCLALASAPEMESKLLSQLKVVRRIGNLLELVYAKDMEDFLEPTLGLCRAFL 1165
+ANV+NVKLCLALASAPEMESKLLSQLKVVRRIGN LE VYAK MED L+PTLGLC+AFL
Sbjct: 1141 NANVNNVKLCLALASAPEMESKLLSQLKVVRRIGNFLEFVYAKGMEDLLDPTLGLCKAFL 1200
Query: 1166 LRSVSSRKGFNYTKEPALLGDCSAEY-GTAIDQQQSIRDIMDFSGNVGVFLKLSCSQEAN 1224
RSVS KGF+YT EP LLGDC E G A+D QQ I+DI DF NVGV L+LS S E +
Sbjct: 1201 ARSVSCTKGFSYTTEPILLGDCPPELSGGAVDPQQCIKDIADFGSNVGVLLELSASAETS 1260
Query: 1225 VADVASECVVLLLKAAPREGTTGFLTNLAKVTAILESWRRGTSHLILQRVLHALGYSCRQ 1284
+AD+ASECVVLLLKAAPRE TTG LTNL KVT ILESW RG HL++QR+LHALGY+C+Q
Sbjct: 1261 IADIASECVVLLLKAAPREATTGILTNLPKVTVILESWNRGIPHLMVQRMLHALGYACKQ 1320
Query: 1285 YLSHAMILSISINEISRIEAIISEMKTSSTTTLADAALLAASELQRLPRCL 1335
YL HAMILSIS EISR E I+SE+K+S + LA A LAA ELQRLPRC+
Sbjct: 1321 YLLHAMILSISKPEISRTEVIVSELKSSGGSALAKTAGLAALELQRLPRCI 1371
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549052|ref|XP_003542912.1| PREDICTED: serine/threonine-protein kinase ULK4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 2080 bits (5390), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1025/1371 (74%), Positives = 1157/1371 (84%), Gaps = 37/1371 (2%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
MNQYHIYEAIGRG+YSTVYKGRKKKTIEYFAIKSVDKSQK+KVL+EVR+LH+L H NVL+
Sbjct: 1 MNQYHIYEAIGRGRYSTVYKGRKKKTIEYFAIKSVDKSQKTKVLEEVRILHTLGHVNVLK 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
FY WYETSAHLWLVLEYCVGGDL+S+LRQD+QLPEDS+ D A D+V+ALQ+LHS GIIYC
Sbjct: 61 FYDWYETSAHLWLVLEYCVGGDLLSILRQDSQLPEDSVYDFAYDIVKALQFLHSNGIIYC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKPSNILLDENG KLCDFGLARKL D SKAPSS LP+AK GTP YMAPELFE+ GVHS
Sbjct: 121 DLKPSNILLDENGCAKLCDFGLARKLKDISKAPSSSLPRAKRGTPSYMAPELFEDSGVHS 180
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
YASD W LGCVLYECYAGRPPFVGREFTQLVKSI+SDP+PPLPGNPSRPF NLINSLLVK
Sbjct: 181 YASDFWALGCVLYECYAGRPPFVGREFTQLVKSIISDPTPPLPGNPSRPFVNLINSLLVK 240
Query: 241 DPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSL------------------------- 275
DPA+R+ W +LCGHAFWRTK T + LP QPAFD +
Sbjct: 241 DPAERIQWPELCGHAFWRTKFTLVSLPAQPAFDDMIGLHAKPCLSERNGDKSSHNRTPTK 300
Query: 276 ------KGAVRQDENSMLGS----TPVRVTPSGRKTQTKTSGRVFEEKQKDPSGTTRQVN 325
KG +R+DENS+LGS TP R TP G +TQTK SGR+ E KQKD S ++ VN
Sbjct: 301 YREKDVKGFLRKDENSVLGSRGIETPTRATPIGHRTQTKGSGRIHEVKQKDNSNISKGVN 360
Query: 326 LLRLSRIVKSNLQRENDKENYRRPLPNGSENDSEVKIENNDMELDFNENTEDETNDEPDG 385
LLRLSRI K+NLQREN+KENYRRPLPN SENDSEVKIEN DMELDFNEN ED+ ++E DG
Sbjct: 361 LLRLSRIAKTNLQRENEKENYRRPLPNNSENDSEVKIENTDMELDFNENAEDDAHEETDG 420
Query: 386 PDNPNCASEDKLSGQPQHHEKAEETGRNGNHSGTPSAEGMPVSDESRKQDRESSPERVEV 445
+ ++K+ + KAEE N + TPS PVSD+ R D ES+P+ ++
Sbjct: 421 AEQTTPVPDEKMVNHFLNQGKAEEVENNTHQLDTPSVHP-PVSDDPRSFDHESTPDHPDI 479
Query: 446 AATPPTVSPQLKTTRIREGSGPPLDSESSRSSNSLSQVLWHPSDLSVRPVMPSRKADKVS 505
+A P+VSPQ+K R +E SG LDS+SSR SN+LSQVLWH SDLSVRPVMPSRK DKVS
Sbjct: 480 SAISPSVSPQVKKHRTKEDSGSGLDSDSSRLSNNLSQVLWHASDLSVRPVMPSRKVDKVS 539
Query: 506 EVFPSLPFEALKASDFVKMSKEQLDALNARILAVLNGNSSIGEKQNVIRYLEMLSSNADA 565
EV PSLPFEAL+ASDFVKM KEQL+A++ RIL++LNGN+SIGEKQNVIRYLEMLSSNADA
Sbjct: 540 EVIPSLPFEALQASDFVKMPKEQLEAVHNRILSILNGNTSIGEKQNVIRYLEMLSSNADA 599
Query: 566 ANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGL 625
ANILT+GPIML+LVK+ R SK SALRVQLASLIGL IRHSTF+DD LA+SGILG+LTDGL
Sbjct: 600 ANILTNGPIMLMLVKLQRQSKASALRVQLASLIGLLIRHSTFVDDSLASSGILGALTDGL 659
Query: 626 RDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSS 685
RD+QEKVRRFSMAALGELLFYISTQN RD+N ESPSKDNR A GWQVPNSLISLVSS
Sbjct: 660 RDRQEKVRRFSMAALGELLFYISTQNADCRDNNQLESPSKDNRNAHGWQVPNSLISLVSS 719
Query: 686 VLRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESMRLTAGS 745
+LRKGEDD+TQLYALRTIENICSQGG WV R +SQDVISNLCYIYRA+GKQESMRLTAGS
Sbjct: 720 ILRKGEDDITQLYALRTIENICSQGGSWVGRLSSQDVISNLCYIYRASGKQESMRLTAGS 779
Query: 746 CLVRLVRFNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGSQMCTNIGRN 805
CLVRLVRFN PS+QSV++KLS KD++S+L+KGSPREQQISLNLLN+AMLGS M TNIGR
Sbjct: 780 CLVRLVRFNPPSIQSVIEKLSFKDLSSALVKGSPREQQISLNLLNMAMLGSHMFTNIGRY 839
Query: 806 LLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNGRRWLLHFFCNSRLLSSVDRL 865
L+ L EDKNL+PSL+ L EQGSEVLRGKALV V+LLCK+GRRWL HFFC+ +LLS VDRL
Sbjct: 840 LVSLAEDKNLIPSLLGLVEQGSEVLRGKALVLVALLCKHGRRWLPHFFCSQKLLSVVDRL 899
Query: 866 GKEKDSFLQQCLEAFVHVVASIIPGLLDIITGDIQQMMGGRRHGQISAITSRAAPKTNVH 925
GKEKD++++QCL+AFVH+VAS IPGLLDIITGDIQQMMGGRRHG ISA+TSR+APK N+H
Sbjct: 900 GKEKDAYVRQCLDAFVHIVASSIPGLLDIITGDIQQMMGGRRHGHISALTSRSAPKPNIH 959
Query: 926 LFPVVLHLLGSSSFKNRVVSPPVLQQLANLCKVVETQFQGRDDFQITLLRILESISEESN 985
LFPVVLHLLG+S+FK++VV+P VL+QLANL K+VET FQGRDDFQITLLRI ES++EES
Sbjct: 960 LFPVVLHLLGTSTFKHKVVTPQVLRQLANLIKLVETSFQGRDDFQITLLRIFESLTEESP 1019
Query: 986 VILGNPEIFFHEILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEPVEDEQRLQDLKS 1045
VI+GNP+IF EILPSLTVLYKGNKDGDARFLCLKIL DVMIILL+EP+E+EQRL DLK
Sbjct: 1020 VIIGNPDIFIREILPSLTVLYKGNKDGDARFLCLKILFDVMIILLSEPIEEEQRLTDLKF 1079
Query: 1046 ISNSHFLPLYPTLIEDEDPIPMYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGDLS 1105
+SN+ FLPLYPTLIEDEDPIP+YAQK+LVML+E +I I DILHLKT+SQCFEFLLGDLS
Sbjct: 1080 VSNTRFLPLYPTLIEDEDPIPIYAQKLLVMLMEFSFITIPDILHLKTISQCFEFLLGDLS 1139
Query: 1106 SANVSNVKLCLALASAPEMESKLLSQLKVVRRIGNLLELVYAKDMEDFLEPTLGLCRAFL 1165
+ANV+NVKLCLALASAPEMESKLLSQLKVVRRIGN LE VYAK MED LEPTLGLC+AFL
Sbjct: 1140 NANVNNVKLCLALASAPEMESKLLSQLKVVRRIGNFLEFVYAKGMEDLLEPTLGLCKAFL 1199
Query: 1166 LRSVSSRKGFNYTKEPALLGDCSAEY-GTAIDQQQSIRDIMDFSGNVGVFLKLSCSQEAN 1224
RSVS KGF+YT E LLGDC E G A+D QQ I+DI DF NVGV L+LS S E +
Sbjct: 1200 ARSVSCTKGFSYTTELILLGDCPPELSGGAVDPQQCIKDIADFGSNVGVLLELSASAETS 1259
Query: 1225 VADVASECVVLLLKAAPREGTTGFLTNLAKVTAILESWRRGTSHLILQRVLHALGYSCRQ 1284
+AD+ASECVVLLLKAAPRE TTG LTNL KVT ILESW RG HLI+QR+LHALGY+C+Q
Sbjct: 1260 IADIASECVVLLLKAAPREATTGILTNLPKVTVILESWSRGIPHLIIQRMLHALGYACKQ 1319
Query: 1285 YLSHAMILSISINEISRIEAIISEMKTSSTTTLADAALLAASELQRLPRCL 1335
YL HAMILSIS EISR E I+SE+K S LA A LAA ELQRLPRC+
Sbjct: 1320 YLLHAMILSISKPEISRTEVIVSELKNSGVPALAKTAGLAALELQRLPRCI 1370
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357447477|ref|XP_003594014.1| Serine/threonine protein kinase [Medicago truncatula] gi|355483062|gb|AES64265.1| Serine/threonine protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 2026 bits (5248), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 1003/1359 (73%), Positives = 1149/1359 (84%), Gaps = 25/1359 (1%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
MNQYHIYEAIGRG+YSTVYKGRKKKTIEYFAIKSVDKSQK+KVLQEVR+LH+LDH NVL+
Sbjct: 1 MNQYHIYEAIGRGRYSTVYKGRKKKTIEYFAIKSVDKSQKNKVLQEVRILHTLDHQNVLK 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
FYSWYETSAHLWLVLEYCVGGDL+S+LRQD+QLPEDS+ +LA DLVRALQYLHS GIIYC
Sbjct: 61 FYSWYETSAHLWLVLEYCVGGDLLSILRQDSQLPEDSVNELACDLVRALQYLHSNGIIYC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKPSNILLDENGRTKLCDFGLAR+L + SK PSS LPQAK GTP YMAPELFE+GGVHS
Sbjct: 121 DLKPSNILLDENGRTKLCDFGLARRLKEISKVPSSSLPQAKRGTPSYMAPELFEDGGVHS 180
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
YASD W LGCVLYECY GRPPFVGREFTQLVKSI+SDP+PPLPGNPS PF NLINSLLVK
Sbjct: 181 YASDFWALGCVLYECYTGRPPFVGREFTQLVKSIISDPTPPLPGNPSPPFVNLINSLLVK 240
Query: 241 DPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSL------------------------K 276
DPA+R+ W +LCGH FW+TK T + LPPQPAFD + K
Sbjct: 241 DPAERIQWHELCGHGFWKTKFTLVSLPPQPAFDDMTELHAKQCLSERNGDKSSHNRTPPK 300
Query: 277 GAVRQDENSMLGSTPVRVTPSGRKTQTKTSGRVFEEKQKDPSGTTRQVNLLRLSRIVKSN 336
+ + + TP R TP+G +TQTK SGR E KQKDPS + +NLLR+SRI KSN
Sbjct: 301 SREKDGKGARAIETPTRATPNGHRTQTKGSGRTVEAKQKDPSIIKKGLNLLRMSRIAKSN 360
Query: 337 LQRENDKENYRRPLPNGSENDSEVKIENNDMELDFNENTEDETNDEPDGPDNPNCASEDK 396
LQ+EN+KENYRRPLPNGSE D +VKIEN DMELDFNEN E++ DE DG ++ + +K
Sbjct: 361 LQKENEKENYRRPLPNGSEKDVDVKIENTDMELDFNENNEEDALDENDGSEHTPSVANEK 420
Query: 397 LSGQPQHHEKAEETGRNGNHSGTPSAEGMPVSDESRKQDRESSPERVEVAATPPTVSPQL 456
+ Q+ KA++T + + TPS P SD+SR ES+P+R +++A P+VSP +
Sbjct: 421 MESNFQNQGKADDTENDIHRLDTPSVT-TPASDDSRTFVHESTPDRSDISAISPSVSPLV 479
Query: 457 KTTRIREGSGPPLDSESSRSSNSLSQVLWHPSDLSVRPVMPSRKADKVSEVFPSLPFEAL 516
K R+++ G LDS+SSRSSN +SQV WHPSDLSVRPVMPSRK DK SEV PSLPFEAL
Sbjct: 480 KKQRLKDDLGSGLDSDSSRSSNDISQVSWHPSDLSVRPVMPSRKVDKGSEVIPSLPFEAL 539
Query: 517 KASDFVKMSKEQLDALNARILAVLNGNSSIGEKQNVIRYLEMLSSNADAANILTSGPIML 576
+A +FVKM KEQL+AL+ RI+A+LNG+++IGEKQN +RYLEMLS+NADAANILT+GPIML
Sbjct: 540 QAPEFVKMPKEQLEALHNRIIAILNGSTAIGEKQNAVRYLEMLSTNADAANILTNGPIML 599
Query: 577 VLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLRDKQEKVRRFS 636
+L+K+LR SK SALRVQLASLIGL IRHSTF+DD LANSGILGSLTDGLRD+QEKVRRFS
Sbjct: 600 ILIKLLRQSKASALRVQLASLIGLLIRHSTFVDDSLANSGILGSLTDGLRDRQEKVRRFS 659
Query: 637 MAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQ 696
MAALGELLFYISTQ+ +RD+ P ESPSKDNRTA GWQVPNSLISLVSSVLRKGEDD+TQ
Sbjct: 660 MAALGELLFYISTQSADSRDNTPLESPSKDNRTAHGWQVPNSLISLVSSVLRKGEDDITQ 719
Query: 697 LYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESMRLTAGSCLVRLVRFNAP 756
LYALRTIENICSQGG WV R SQDVISNLCYIYRA GK ESMRLTAGSCLVRLVRFN P
Sbjct: 720 LYALRTIENICSQGGAWVGRLISQDVISNLCYIYRAVGKLESMRLTAGSCLVRLVRFNPP 779
Query: 757 SMQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGSQMCTNIGRNLLPLVEDKNLV 816
S+QSV++KLS KD+AS+L+KGSPREQQISLNLLN AMLGS M TN+GR L+ L EDKNL+
Sbjct: 780 SIQSVIEKLSFKDLASALVKGSPREQQISLNLLNTAMLGSHMLTNVGRYLMQLAEDKNLI 839
Query: 817 PSLVSLTEQGSEVLRGKALVFVSLLCKNGRRWLLHFFCNSRLLSSVDRLGKEKDSFLQQC 876
PSL++ EQGS+VL+GKALVFV+LLCK+GRRWL FFC+ +LLS VDRLGKEKD+F++QC
Sbjct: 840 PSLLAFVEQGSKVLKGKALVFVALLCKHGRRWLPQFFCSHKLLSVVDRLGKEKDAFVRQC 899
Query: 877 LEAFVHVVASIIPGLLDIITGDIQQMMGGRRHGQISAITSRAAPKTNVHLFPVVLHLLGS 936
L+AF+H+VAS IPGLLDIITGDIQQMMGGRRHG IS++TSR+APK+N+HLFPVVLHLL S
Sbjct: 900 LDAFLHIVASTIPGLLDIITGDIQQMMGGRRHGHISSLTSRSAPKSNIHLFPVVLHLLES 959
Query: 937 SSFKNRVVSPPVLQQLANLCKVVETQFQGRDDFQITLLRILESISEESNVILGNPEIFFH 996
S+FK++V + PVL+QLANL K+ E FQGRDDFQITLLRILES++EES+VIL NP+IF
Sbjct: 960 SAFKHKVATLPVLRQLANLIKLAEAPFQGRDDFQITLLRILESLTEESSVILANPDIFLR 1019
Query: 997 EILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEPVEDEQRLQDLKSISNSHFLPLYP 1056
EILPSLTVLYKGNKDGDARFLCLKI DVMIILL+EP+E+EQRL DLK +SN+HFLPLYP
Sbjct: 1020 EILPSLTVLYKGNKDGDARFLCLKIFFDVMIILLSEPIEEEQRLNDLKFVSNTHFLPLYP 1079
Query: 1057 TLIEDEDPIPMYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGDLSSANVSNVKLCL 1116
TLIEDEDPIP++AQK+LVML+E +I I DILHLKT+SQCFEFLLGDLS+ANV+NVKLCL
Sbjct: 1080 TLIEDEDPIPIFAQKLLVMLLEFSFISIPDILHLKTISQCFEFLLGDLSNANVNNVKLCL 1139
Query: 1117 ALASAPEMESKLLSQLKVVRRIGNLLELVYAKDMEDFLEPTLGLCRAFLLRSVSSRKGFN 1176
ALASAPEMESKLLSQLKVVRRIGN LE V AK MED LEPTLGLCRAFL RSVS KGF+
Sbjct: 1140 ALASAPEMESKLLSQLKVVRRIGNFLEFVCAKGMEDLLEPTLGLCRAFLARSVSCTKGFS 1199
Query: 1177 YTKEPALLGDCSAEYGTAIDQQQSIRDIMDFSGNVGVFLKLSCSQEANVADVASECVVLL 1236
YT EP LLGD E A+D QQ IRDI DF NVGVFL+LS S+E +VAD+AS+CVVLL
Sbjct: 1200 YTTEPTLLGDSPPEVSGAVDPQQCIRDITDFGNNVGVFLELSGSRETSVADIASQCVVLL 1259
Query: 1237 LKAAPREGTTGFLTNLAKVTAILESWRRGTSHLILQRVLHALGYSCRQYLSHAMILSISI 1296
LKAAPRE TTG LTNL KVT ILESW +GT HL +QR+LHALGY+C+QYL HAMILSISI
Sbjct: 1260 LKAAPREATTGLLTNLPKVTVILESWSKGTPHLTVQRMLHALGYACKQYLLHAMILSISI 1319
Query: 1297 NEISRIEAIISEMKTSSTTTLADAALLAASELQRLPRCL 1335
EISRIE I++E+K+SS LA A LAA ELQRLPRC+
Sbjct: 1320 PEISRIEVIVTELKSSSVPALAKTAGLAALELQRLPRCI 1358
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449495406|ref|XP_004159831.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase ULK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 2008 bits (5203), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 984/1372 (71%), Positives = 1137/1372 (82%), Gaps = 38/1372 (2%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
MNQYHIYEAIGRGKYSTVYKGRKKKTIEY AIKSVDKSQK+K+LQEVR+LHSLDHPNVL+
Sbjct: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYSAIKSVDKSQKNKILQEVRILHSLDHPNVLK 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
FYSWYETSAHLWLVLEYCVGGDLMS+LRQD +LPEDSI DLA DLVRALQYLHSKGIIYC
Sbjct: 61 FYSWYETSAHLWLVLEYCVGGDLMSILRQDGKLPEDSIHDLASDLVRALQYLHSKGIIYC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKPSNILLDENG KLCDF LARKLS+ SK SS PQ K GTPCYMAPELF++ G+HS
Sbjct: 121 DLKPSNILLDENGHIKLCDFELARKLSEISKTNSSA-PQTKRGTPCYMAPELFKDDGIHS 179
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
YASD+W LGCVLYEC+ GRPPF+GREFTQLVKSILSDP+P LPG+PSRPF NLINSLLVK
Sbjct: 180 YASDMWALGCVLYECFVGRPPFMGREFTQLVKSILSDPTPILPGSPSRPFVNLINSLLVK 239
Query: 241 DPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSL------------------------- 275
DPA+R+ W +LCGHAFWRTK+TP+ LPPQPAF +L
Sbjct: 240 DPAERIQWPELCGHAFWRTKITPVSLPPQPAFANLINQHSKPCLSERNGEKLAPNRTPPK 299
Query: 276 ------KGAVRQDENSMLGS----TPVRVTPSGRKTQTKTSGRVFEEKQ-KDPSGTTRQV 324
KG +RQ+ENS GS T V+ TP +KTQ+K S +V EEK+ K+ ++ V
Sbjct: 300 CREKDAKGTLRQNENSAFGSSKNETLVKGTPGSQKTQSKVSSKVVEEKKLKENPSASKGV 359
Query: 325 NLLRLSRIVKSNLQRENDKENYRRPLPNGSENDSEVKIENNDMELDFNENTEDETNDEPD 384
NLLRLSRI KSNLQRENDKENYRRP+ SENDSEV+++N DMELDFNEN EDE++DEPD
Sbjct: 360 NLLRLSRIAKSNLQRENDKENYRRPVSGNSENDSEVELKNTDMELDFNENVEDESHDEPD 419
Query: 385 GPDNPNCASEDKLSGQPQHHEKAEETGRNGNHSGTPSAEGMPVSDESRKQDRESSPERVE 444
DN N EDK S E G+ S A + SD S K D+ES R E
Sbjct: 420 ESDNINGNQEDKTSNDNHQARMEEAQNMGGDLSDYSPAVNINASDLSNKHDQESPLVRTE 479
Query: 445 VAATPPTVSPQLKTTRIREGSGPPLDSESSRSSNSLSQVLWHPSDLSVRPVMPSRKADKV 504
V T P+ SPQLK R +EGS LD++SS+SSN+LS+ WH SDLSV+PVMPS+KADK+
Sbjct: 480 VVGTSPSASPQLKNQRTKEGSTYALDTDSSKSSNNLSEFFWHQSDLSVKPVMPSKKADKM 539
Query: 505 SEVFPS-LPFEALKASDFVKMSKEQLDALNARILAVLNGNSSIGEKQNVIRYLEMLSSNA 563
S+V P+ LPFE L+A DFVKM KE DA +++I+A L+GN+S+GEKQN+IRYLEMLS+NA
Sbjct: 540 SDVNPTILPFEGLQAPDFVKMPKEWQDATSSKIIATLSGNTSVGEKQNMIRYLEMLSNNA 599
Query: 564 DAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTD 623
DAANILT+GP+ML+LVKML+ SK LRVQL SLIGL IRHSTFID+DLANSG+L SLTD
Sbjct: 600 DAANILTNGPVMLMLVKMLKQSKVLQLRVQLTSLIGLLIRHSTFIDNDLANSGLLFSLTD 659
Query: 624 GLRDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLV 683
GLRDKQEKVRRFSMAALGELLFYISTQ EH ++NP ESP K+ R+ +GWQVPNSLISLV
Sbjct: 660 GLRDKQEKVRRFSMAALGELLFYISTQEEHNSNANPLESPLKETRSPTGWQVPNSLISLV 719
Query: 684 SSVLRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESMRLTA 743
SS+LRKGEDD+TQLYALRTIENICSQG W +RFTSQDVISNLCYIYRA+GK E++RLTA
Sbjct: 720 SSILRKGEDDLTQLYALRTIENICSQGAIWASRFTSQDVISNLCYIYRASGKSENIRLTA 779
Query: 744 GSCLVRLVRFNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGSQMCTNIG 803
GSCLVRLVRFN +QSV DKLS KD+A +L+KG+PREQQI+LNLLN+ M+G + T+IG
Sbjct: 780 GSCLVRLVRFNPSCIQSVTDKLSSKDMACALVKGNPREQQITLNLLNMIMVGGNVLTSIG 839
Query: 804 RNLLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNGRRWLLHFFCNSRLLSSVD 863
R LLPL+E+KNLV SL+SL EQGSEVL+GKA+VFV+ LCK+ RRWL HFFCN+RLLSSVD
Sbjct: 840 RYLLPLMEEKNLVSSLISLIEQGSEVLKGKAIVFVAFLCKSVRRWLPHFFCNARLLSSVD 899
Query: 864 RLGKEKDSFLQQCLEAFVHVVASIIPGLLDIITGDIQQMMGGRRHGQISAITSRAAPKTN 923
RL +EKD ++QQCL +H+VASI+P LLD+I GDIQQMMGGRRHG IS++TSRAAPKTN
Sbjct: 900 RLAREKDVYVQQCLTGSLHIVASIVPSLLDMIIGDIQQMMGGRRHGHISSLTSRAAPKTN 959
Query: 924 VHLFPVVLHLLGSSSFKNRVVSPPVLQQLANLCKVVETQFQGRDDFQITLLRILESISEE 983
+HLFPVVLHLLGSS+FK +VVSP VLQQL++L + +ET FQGRDDFQITLLR++ESI+EE
Sbjct: 960 IHLFPVVLHLLGSSTFKRKVVSPQVLQQLSDLIRHIETPFQGRDDFQITLLRVIESITEE 1019
Query: 984 SNVILGNPEIFFHEILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEPVEDEQRLQDL 1043
+VIL NPEIF H+ILPSL VLYKGNKDGDARFLCLKIL D M+I LNEP D QRL+DL
Sbjct: 1020 FSVILENPEIFVHKILPSLAVLYKGNKDGDARFLCLKILFDAMVIFLNEPSLDGQRLEDL 1079
Query: 1044 KSISNSHFLPLYPTLIEDEDPIPMYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGD 1103
K I+N HFLPLYP LIED+DPIPMYAQK+LVMLIE YIKISDILHLKT+SQCFEFLLGD
Sbjct: 1080 KQIANLHFLPLYPALIEDDDPIPMYAQKLLVMLIECNYIKISDILHLKTISQCFEFLLGD 1139
Query: 1104 LSSANVSNVKLCLALASAPEMESKLLSQLKVVRRIGNLLELVYAKDMEDFLEPTLGLCRA 1163
LS+ANVS+VKLCLALASAPEMES++LSQLKVVRRIG LLE VYAKDMEDFLEPTLGLCRA
Sbjct: 1140 LSNANVSSVKLCLALASAPEMESRILSQLKVVRRIGILLEFVYAKDMEDFLEPTLGLCRA 1199
Query: 1164 FLLRSVSSRKGFNYTKEPALLGDCSAEYGTAIDQQQSIRDIMDFSGNVGVFLKLSCSQEA 1223
LLRSVS RKGF Y+KEP LLGD + E ++Q + IRDI DF N+GV L+LS S EA
Sbjct: 1200 LLLRSVSCRKGFIYSKEPFLLGDGTPEQKVLVNQLECIRDISDFGNNLGVLLELSGSSEA 1259
Query: 1224 NVADVASECVVLLLKAAPREGTTGFLTNLAKVTAILESWRRGTSHLILQRVLHALGYSCR 1283
N+AD+ASECVV L+ AAPREGTTG LTNL KV+ ILESWRRG L++QR+LH+LGY+CR
Sbjct: 1260 NIADIASECVVFLVTAAPREGTTGLLTNLHKVSVILESWRRGGCLLLVQRMLHSLGYACR 1319
Query: 1284 QYLSHAMILSISINEISRIEAIISEMKTSSTTTLADAALLAASELQRLPRCL 1335
QYL+HAMILS+SI+EISRIEAIIS++K+SST LA+ A+L A ELQRL RC+
Sbjct: 1320 QYLAHAMILSLSISEISRIEAIISDIKSSSTPRLANDAMLVAMELQRLHRCI 1371
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449432789|ref|XP_004134181.1| PREDICTED: serine/threonine-protein kinase ULK4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 2004 bits (5191), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 984/1373 (71%), Positives = 1137/1373 (82%), Gaps = 39/1373 (2%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
MNQYHIYEAIGRGKYSTVYKGRKKKTIEY AIKSVDKSQK+K+LQEVR+LHSLDHPNVL+
Sbjct: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYSAIKSVDKSQKNKILQEVRILHSLDHPNVLK 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
FYSWYETSAHLWLVLEYCVGGDLMS+LRQD +LPEDSI DLA DLVRALQYLHSKGIIYC
Sbjct: 61 FYSWYETSAHLWLVLEYCVGGDLMSILRQDGKLPEDSIHDLASDLVRALQYLHSKGIIYC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKPSNILLDENG KLCDF LARKLS+ SK SS PQ K GTPCYMAPELF++ G+HS
Sbjct: 121 DLKPSNILLDENGHIKLCDFELARKLSEISKTNSSA-PQTKRGTPCYMAPELFKDDGIHS 179
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
YASD+W LGCVLYEC+ GRPPF+GREFTQLVKSILSDP+P LPG+PSRPF NLINSLLVK
Sbjct: 180 YASDMWALGCVLYECFVGRPPFMGREFTQLVKSILSDPTPILPGSPSRPFVNLINSLLVK 239
Query: 241 DPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSL------------------------- 275
DPA+R+ W +LCGHAFWRTK+TP+ LPPQPAF +L
Sbjct: 240 DPAERIQWPELCGHAFWRTKITPVSLPPQPAFANLINQHSKPCLSERNGEKLAPNRTPPK 299
Query: 276 ------KGAVRQDENSMLGS----TPVRVTPSGRKTQTKTSGRVFEEKQ-KDPSGTTRQV 324
KG +RQ+ENS GS T V+ TP +KTQ+K S +V EEK+ K+ ++ V
Sbjct: 300 CREKDAKGTLRQNENSAFGSSKNETLVKGTPGSQKTQSKVSSKVVEEKKLKENPSASKGV 359
Query: 325 NLLRLSRIVKSNLQRENDKENYRRPLPNGSENDSEVKIENNDMELDFNENTEDETNDEPD 384
NLLRLSRI KSNLQRENDKENYRRP+ SENDSEV+++N DMELDFNEN EDE++DEPD
Sbjct: 360 NLLRLSRIAKSNLQRENDKENYRRPVSGNSENDSEVELKNTDMELDFNENVEDESHDEPD 419
Query: 385 GPDNPNCASEDKLSGQPQHHEKAEETGRNGNHSGTPSAEGMPVSDESRKQDRESSPERVE 444
DN N EDK S E G+ S A + SD S K D+ES R E
Sbjct: 420 ESDNINGNQEDKTSNDNHQARMEEAQNMGGDLSDYSPAVNINASDLSNKHDQESPLVRTE 479
Query: 445 VAATPPTVSPQLKTTRIREGSGPPLDSESSRSSNSLSQVLWHPSDLSVRPVMPSRKADKV 504
V T P+ SPQLK R +EGS LD++SS+SSN+LS+ WH SDLSV+PVMPS+KADK+
Sbjct: 480 VVGTSPSASPQLKNQRTKEGSTYALDTDSSKSSNNLSEFFWHQSDLSVKPVMPSKKADKM 539
Query: 505 SEVFPS-LPFEALKASDFVKMSKEQLDALNARILAVLNGNSSIGEKQNVIRYLEMLSSNA 563
S+V P+ LPFE L+A DFVKM KE DA +++I+A L+GN+S+GEKQN+IRYLEMLS+NA
Sbjct: 540 SDVNPTILPFEGLQAPDFVKMPKEWQDATSSKIIATLSGNTSVGEKQNMIRYLEMLSNNA 599
Query: 564 DAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTD 623
DAANILT+GP+ML+LVKML+ SK LRVQL SLIGL IRHSTFID+DLANSG+L SLTD
Sbjct: 600 DAANILTNGPVMLMLVKMLKQSKVLQLRVQLTSLIGLLIRHSTFIDNDLANSGLLFSLTD 659
Query: 624 GLRDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLV 683
GLRDKQEKVRRFSMAALGELLFYISTQ EH ++NP ESP K+ R+ +GWQVPNSLISLV
Sbjct: 660 GLRDKQEKVRRFSMAALGELLFYISTQEEHNSNANPLESPLKETRSPTGWQVPNSLISLV 719
Query: 684 SSVLRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESMRLTA 743
SS+LRKGEDD+TQLYALRTIENICSQG W +RFTSQDVISNLCYIYRA+GK E++RLTA
Sbjct: 720 SSILRKGEDDLTQLYALRTIENICSQGAIWASRFTSQDVISNLCYIYRASGKSENIRLTA 779
Query: 744 GSCLVRLVRFNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGSQMCTNIG 803
GSCLVRLVRFN +QSV DKLS KD+A +L+KG+PREQQI+LNLLN+ M+G + T+IG
Sbjct: 780 GSCLVRLVRFNPSCIQSVTDKLSSKDMACALVKGNPREQQITLNLLNMIMVGGNVLTSIG 839
Query: 804 RNLLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNGRRWLLHFFCNSRLLSSVD 863
R LLPL+E+KNLV SL+SL EQGSEVL+GKA+VFV+ LCK+ RRWL HFFCN+RLLSSVD
Sbjct: 840 RYLLPLMEEKNLVSSLISLIEQGSEVLKGKAIVFVAFLCKSVRRWLPHFFCNARLLSSVD 899
Query: 864 RLGKEKDSFLQQCLEAFVHVVASIIPGLLDIITGDIQQMMGGRRHGQISA-ITSRAAPKT 922
RL +EKD ++QQCL +H+VASI+P LLD+I GDIQQMMGGRRHG IS+ +TSRAAPKT
Sbjct: 900 RLAREKDVYVQQCLTGSLHIVASIVPSLLDMIIGDIQQMMGGRRHGHISSPLTSRAAPKT 959
Query: 923 NVHLFPVVLHLLGSSSFKNRVVSPPVLQQLANLCKVVETQFQGRDDFQITLLRILESISE 982
N+HLFPVVLHLLGSS+FK +VVSP VLQQL++L + +ET FQGRDDFQITLLR++ESI+E
Sbjct: 960 NIHLFPVVLHLLGSSTFKRKVVSPQVLQQLSDLIRHIETPFQGRDDFQITLLRVIESITE 1019
Query: 983 ESNVILGNPEIFFHEILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEPVEDEQRLQD 1042
E +VIL NPEIF H+ILPSL VLYKGNKDGDARFLCLKIL D M+I LNEP D QRL+D
Sbjct: 1020 EFSVILENPEIFVHKILPSLAVLYKGNKDGDARFLCLKILFDAMVIFLNEPSLDGQRLED 1079
Query: 1043 LKSISNSHFLPLYPTLIEDEDPIPMYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLG 1102
LK I+N HFLPLYP LIED+DPIPMYAQK+LVMLIE YIKISDILHLKT+SQCFEFLLG
Sbjct: 1080 LKQIANLHFLPLYPALIEDDDPIPMYAQKLLVMLIECNYIKISDILHLKTISQCFEFLLG 1139
Query: 1103 DLSSANVSNVKLCLALASAPEMESKLLSQLKVVRRIGNLLELVYAKDMEDFLEPTLGLCR 1162
DLS+ANVS+VKLCLALASAPEMES++LSQLKVVRRIG LLE VYAKDMEDFLEPTLGLCR
Sbjct: 1140 DLSNANVSSVKLCLALASAPEMESRILSQLKVVRRIGILLEFVYAKDMEDFLEPTLGLCR 1199
Query: 1163 AFLLRSVSSRKGFNYTKEPALLGDCSAEYGTAIDQQQSIRDIMDFSGNVGVFLKLSCSQE 1222
A LLRSVS RKGF Y+KEP LLGD + E ++Q + IRDI DF N+GV L+LS S E
Sbjct: 1200 ALLLRSVSCRKGFIYSKEPFLLGDGTPEQKVLVNQLECIRDISDFGNNLGVLLELSGSSE 1259
Query: 1223 ANVADVASECVVLLLKAAPREGTTGFLTNLAKVTAILESWRRGTSHLILQRVLHALGYSC 1282
AN+AD+ASECVV L+ AAPREGTTG LTNL KV+ ILESWRRG L++QR+LH+LGY+C
Sbjct: 1260 ANIADIASECVVFLVTAAPREGTTGLLTNLHKVSVILESWRRGGCLLLVQRMLHSLGYAC 1319
Query: 1283 RQYLSHAMILSISINEISRIEAIISEMKTSSTTTLADAALLAASELQRLPRCL 1335
RQYL+HAMILS+SI+EISRIEAIIS++K+SST LA+ A+L A ELQRL RC+
Sbjct: 1320 RQYLAHAMILSLSISEISRIEAIISDIKSSSTPRLANDAMLVAMELQRLHRCI 1372
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297812057|ref|XP_002873912.1| EMB3013 [Arabidopsis lyrata subsp. lyrata] gi|297319749|gb|EFH50171.1| EMB3013 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1845 bits (4779), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 928/1377 (67%), Positives = 1088/1377 (79%), Gaps = 55/1377 (3%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
MNQYHIYEAIG GK STVYKGRKKKTIEYFA KSVDKS+KSKVLQEVR+LHSL+HPNVL+
Sbjct: 1 MNQYHIYEAIGHGKCSTVYKGRKKKTIEYFACKSVDKSRKSKVLQEVRILHSLNHPNVLK 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
FY+WYETSAH+WLVLEYCVGGDL +LL+QD +LPE+SI A DLV ALQYLHSKGIIYC
Sbjct: 61 FYAWYETSAHMWLVLEYCVGGDLRTLLQQDCKLPEESIYGFAFDLVIALQYLHSKGIIYC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKPSNILLDENG KLCDFGL+RKL D SK+PS+ K GTP YMAPEL+E+GG+HS
Sbjct: 121 DLKPSNILLDENGHIKLCDFGLSRKLDDISKSPST----GKRGTPYYMAPELYEDGGIHS 176
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
+ASDLW LGCVLYECY GRPPFV REFTQLVKSI SDP+PPLPGN SR F NLI SLL+K
Sbjct: 177 FASDLWALGCVLYECYTGRPPFVAREFTQLVKSIHSDPTPPLPGNASRSFVNLIESLLIK 236
Query: 241 DPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSL------------------------- 275
DPAQR+ W+DLCGHAFW++K+ + LP QPAFD++
Sbjct: 237 DPAQRIQWADLCGHAFWKSKINLVQLPTQPAFDNMIGIYTKPCLSERNGDRPNKTPPKYR 296
Query: 276 ----KGAVRQDENSMLGS----TPVRVTPSGRKTQTKTSGRVFEEKQKDPSGTTRQVNLL 327
KG +Q+ENS+ GS TP++ TP G K QTK R EEK G RQ+N+L
Sbjct: 297 EKDPKGGSKQNENSVQGSKGHETPIKGTPGGSKAQTKLPSRATEEKHGGRPGANRQMNIL 356
Query: 328 RLSRIVKSNLQRENDKENYRRPLPNGSENDSEVKIENNDMELDFNENTEDETNDEPDGPD 387
RLSRI K+NLQ+EN+KENYRRPLPN +EN +EVKIEN DMELDF+EN +DE DE +G +
Sbjct: 357 RLSRIAKANLQKENEKENYRRPLPNSNENCAEVKIENTDMELDFDENNDDEGPDESEGTE 416
Query: 388 NPNCASEDKLSGQPQHHEKAEETGRNGNHSGTPSAEGMPVSDESRKQDRESSPERVEVAA 447
N +CA E+++ Q + H + N + SA P+S E+R E S E ++V+A
Sbjct: 417 NTSCAQEERVVSQNESHRRQGVLSSNVPDENS-SANETPISGEARDCHEEQS-EPMDVSA 474
Query: 448 TPPTVSPQLKTTRIREGSGPPLDSESSRSSNSLSQVLWHPSDLSVRPVMPSRKADKVSEV 507
PP+ SPQLKT R RE SG ++ +SS++ SL+ VLWH +DLSVRPVMPSRK+DK E
Sbjct: 475 APPSASPQLKTHRGREISGVAVNHDSSKTPTSLTDVLWHIADLSVRPVMPSRKSDK--EA 532
Query: 508 FPSLPFEALKASDFVKMSKEQLDALNARILAV-LNGNSSIGEKQNVIRYLEMLSSNADAA 566
PSL FE + SDF KM K++L+ LN RI+ V +S + EKQN+IRYLE LSSNADAA
Sbjct: 533 VPSLSFETPQPSDFGKMGKQELEPLNTRIITVLSGSSSGLSEKQNLIRYLETLSSNADAA 592
Query: 567 NILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLR 626
NILT+GPIMLVLVK+LRLSKT A RVQ+ASLIGL IRHST I+DDLANSGIL SLT+GLR
Sbjct: 593 NILTNGPIMLVLVKVLRLSKTPAFRVQIASLIGLLIRHSTSIEDDLANSGILDSLTNGLR 652
Query: 627 DKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSSV 686
DK EKVRRFSMAALGELLFYISTQNEH +D PPESPSK+ R+ASGWQV N+LISLVSSV
Sbjct: 653 DKHEKVRRFSMAALGELLFYISTQNEH-KDFKPPESPSKETRSASGWQVSNALISLVSSV 711
Query: 687 LRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESMRLTAGSC 746
LRKGEDD+TQLYALRTIENICSQG +W RF+SQD+ISNLCYIYRATGKQESMR TAGSC
Sbjct: 712 LRKGEDDLTQLYALRTIENICSQGAYWATRFSSQDLISNLCYIYRATGKQESMRQTAGSC 771
Query: 747 LVRLVRFNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGSQMCTNIGRNL 806
LVRL RFN P +Q+V++KLS+K+IASS +KGS REQQ+ LNLLN+AM+GS T+ GR+L
Sbjct: 772 LVRLARFNPPCIQTVVEKLSLKEIASSFVKGSAREQQVCLNLLNMAMIGSHTFTSFGRHL 831
Query: 807 LPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNGRRWLLHFFCNSRLLSSVDRLG 866
+ L E+KNL PSL+S+ EQG+EVLRGKAL+FV+LLCKN RRWL +FFCN+R L VDRL
Sbjct: 832 VTLTEEKNLFPSLLSIIEQGTEVLRGKALLFVALLCKNSRRWLTNFFCNARFLPVVDRLA 891
Query: 867 KEKDSFLQQCLEAFVHVVASIIPGLLDIITGDIQQMMGGRRHGQISAITSRAAPKTNVHL 926
KEKDS++QQCLEAFV+V+ASIIPGLLD IT DIQQ+M GRRHG +S + SRA KTN HL
Sbjct: 892 KEKDSYVQQCLEAFVNVIASIIPGLLDTITNDIQQLMTGRRHGPVSPLNSRAPLKTNAHL 951
Query: 927 FPVVLHLLGSSSFKNRVVSPPVLQQLANLCKVVETQFQGRDDFQITLLRILESISEESNV 986
FPVVLHLLGSSSFKN++V+P V++QLANL K+VE FQGRDDF+ITLL++LE I+ ++ +
Sbjct: 952 FPVVLHLLGSSSFKNKMVTPQVVRQLANLTKLVEASFQGRDDFRITLLQVLECIAGDAPL 1011
Query: 987 ILGNPEIFFHEILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEPVEDEQRL-QDLKS 1045
+ N EI EILPSL +Y GNKDGDARFLCLKI D M ILL E E EQ+ +DLKS
Sbjct: 1012 VTQNGEIIIREILPSLAAIYNGNKDGDARFLCLKIWFDSMTILLTECTEIEQQTSEDLKS 1071
Query: 1046 ISNSHFLPLYPTLIEDEDPIPMYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGDLS 1105
ISNSHFLPLYP LI+DEDPIP YAQK+LVML+E YIKIS++LH TVSQCFEFLLGDLS
Sbjct: 1072 ISNSHFLPLYPALIQDEDPIPAYAQKLLVMLVEFDYIKISNLLHHNTVSQCFEFLLGDLS 1131
Query: 1106 SANVSNVKLCLALASAPEMESKLLSQLKVVRRIGNLLELVYAKDMEDFLEPTLGLCRAFL 1165
SANV+NVKLCLALASAPEME+KLLSQLKVVRRIGNLLE V AKDMEDFLEPTL LCRAFL
Sbjct: 1132 SANVNNVKLCLALASAPEMETKLLSQLKVVRRIGNLLEFVNAKDMEDFLEPTLSLCRAFL 1191
Query: 1166 LRSVSSRKGF--NYTKEPALLGDCSAEYGTAIDQQQSIRDIMDFSGNVGVFLKLSCSQEA 1223
LRS+ ++KG NYTKEP LL + S + +D Q+ IRDI DF N+G+FL + +
Sbjct: 1192 LRSLGNKKGLSSNYTKEPTLLSETSFTF--EVDPQECIRDIADFGSNIGLFLHFAGLDDD 1249
Query: 1224 N---VADVASECVVLLLKAAPREGTTGFLTNLAKVTAILESWRRGTSH----LILQRVLH 1276
VAD+ASECVVLLLKAA RE TTGFLTNL K+T IL+SWRR S L+L+RVLH
Sbjct: 1250 TSIAVADIASECVVLLLKAASREATTGFLTNLPKITPILDSWRRRKSTELHLLVLKRVLH 1309
Query: 1277 ALGYSCRQYLSHAMILSISINEISRIEAIISEMKTSSTTTLADAALLAASELQRLPR 1333
LGY+C+QYLS AMILSIS +++S+I I+SEMK S T L A L A ELQRLPR
Sbjct: 1310 CLGYACKQYLSQAMILSISGHDVSKINTIVSEMKNSDVTGLNSVATLVAMELQRLPR 1366
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42567943|ref|NP_197371.2| Protein kinase family protein with ARM repeat domain [Arabidopsis thaliana] gi|332005217|gb|AED92600.1| Protein kinase family protein with ARM repeat domain [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1821 bits (4717), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 915/1377 (66%), Positives = 1080/1377 (78%), Gaps = 55/1377 (3%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
MNQYHIYEAIG GK STVYKGRKKKTIEYFA KSVDKS+K+KVLQEVR+LHSL+HPNVL+
Sbjct: 1 MNQYHIYEAIGHGKCSTVYKGRKKKTIEYFACKSVDKSRKNKVLQEVRILHSLNHPNVLK 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
FY+WYETSAH+WLVLEYCVGGDL +LL+QD +LPE+SI LA DLV ALQYLHSKGIIYC
Sbjct: 61 FYAWYETSAHMWLVLEYCVGGDLRTLLQQDCKLPEESIYGLAYDLVIALQYLHSKGIIYC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKPSNILLDENG KLCDFGL+RKL D SK+PS+ K GTP YMAPEL+E+GG+HS
Sbjct: 121 DLKPSNILLDENGHIKLCDFGLSRKLDDISKSPST----GKRGTPYYMAPELYEDGGIHS 176
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
+ASDLW LGCVLYECY GRPPFV REFTQLVKSI SDP+PPLPGN SR F NLI SLL+K
Sbjct: 177 FASDLWALGCVLYECYTGRPPFVAREFTQLVKSIHSDPTPPLPGNASRSFVNLIESLLIK 236
Query: 241 DPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSL------------------------- 275
DPAQR+ W+DLCGHAFW++K+ + LP QPAFD +
Sbjct: 237 DPAQRIQWADLCGHAFWKSKINLVQLPTQPAFDDMIGINTKPCLSERNGDRPNKTPPKYR 296
Query: 276 ----KGAVRQDENSMLGS----TPVRVTPSGRKTQTKTSGRVFEEKQKDPSGTTRQVNLL 327
KG +Q+ENS+ GS TP++ TP G K Q K R EEK RQVN+L
Sbjct: 297 EKDRKGGSKQNENSIQGSKGHETPIKGTPGGSKAQAKLPSRATEEKHGGRPAANRQVNIL 356
Query: 328 RLSRIVKSNLQRENDKENYRRPLPNGSENDSEVKIENNDMELDFNENTEDETNDEPDGPD 387
RLSRI K+NLQ+EN+KENYRRPLPN +EN +EVKI+N DMELDF+EN +DE DE +G +
Sbjct: 357 RLSRIAKANLQKENEKENYRRPLPNSNENCAEVKIDNTDMELDFDENNDDEGPDESEGTE 416
Query: 388 NPNCASEDKLSGQPQHHEKAEETGRNGNHSGTPSAEGMPVSDESRKQDRESSPERVEVAA 447
N +CA E+++ ++H + N + SA P E+R + S E ++++A
Sbjct: 417 NTSCAQEERVMSHNENHRRQRVVSSNVPDENS-SANETPTLGEARDCHEDQS-EPMDMSA 474
Query: 448 TPPTVSPQLKTTRIREGSGPPLDSESSRSSNSLSQVLWHPSDLSVRPVMPSRKADKVSEV 507
PP+ SPQLKT R RE SG ++ +SS++ SL+ V WH SDLSVRPVMPSRK+DK E
Sbjct: 475 APPSASPQLKTHRGRETSGVAVNHDSSKAPTSLTDVFWHISDLSVRPVMPSRKSDK--EA 532
Query: 508 FPSLPFEALKASDFVKMSKEQLDALNARILAV-LNGNSSIGEKQNVIRYLEMLSSNADAA 566
SL FE + SDF K K++L+ LN RI+ V +S + EKQN+IRYLE LS+NADAA
Sbjct: 533 VHSLSFETPQPSDFSKKGKQELEPLNNRIITVLSGSSSGLSEKQNLIRYLETLSTNADAA 592
Query: 567 NILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLR 626
NILT+GPIMLVLVK+LRLSKT A RVQ+ASLIGL IRHST I+DDLANSGIL SLT+GLR
Sbjct: 593 NILTNGPIMLVLVKVLRLSKTPAFRVQIASLIGLLIRHSTSIEDDLANSGILDSLTNGLR 652
Query: 627 DKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSSV 686
DK EKVRRFSMAALGELLFYISTQNEH +D PPESPSK+ R+ASGWQV N+LISLVSSV
Sbjct: 653 DKHEKVRRFSMAALGELLFYISTQNEH-KDFKPPESPSKETRSASGWQVSNALISLVSSV 711
Query: 687 LRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESMRLTAGSC 746
LRKGEDD+TQ+YALRTIENICSQG +W RF+SQD+ISNLCYIY+ATGKQESMR TAGSC
Sbjct: 712 LRKGEDDLTQVYALRTIENICSQGAYWATRFSSQDLISNLCYIYKATGKQESMRQTAGSC 771
Query: 747 LVRLVRFNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGSQMCTNIGRNL 806
LVRL RFN P +Q+V++KLS+K+IASS +KGS REQQ+ LNLLN+AM+GS T+ GR+L
Sbjct: 772 LVRLARFNPPCIQTVVEKLSLKEIASSFVKGSAREQQVCLNLLNMAMIGSHTFTSFGRHL 831
Query: 807 LPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNGRRWLLHFFCNSRLLSSVDRLG 866
+ L E+KNL PSL+S+ EQG+EVLRGKAL+FV+ LCKN RRWL +FFCN+R L VDRL
Sbjct: 832 VTLTEEKNLFPSLLSIIEQGTEVLRGKALLFVAFLCKNSRRWLTNFFCNARFLPVVDRLA 891
Query: 867 KEKDSFLQQCLEAFVHVVASIIPGLLDIITGDIQQMMGGRRHGQISAITSRAAPKTNVHL 926
KEKDS+LQQCLEAFV+V+ASIIPG+LD IT DIQQ+M GRRHG +S + SRA KTN HL
Sbjct: 892 KEKDSYLQQCLEAFVNVIASIIPGMLDTITNDIQQLMTGRRHGPVSPLNSRAPVKTNAHL 951
Query: 927 FPVVLHLLGSSSFKNRVVSPPVLQQLANLCKVVETQFQGRDDFQITLLRILESISEESNV 986
FPVVLHLLGSSSFKN++V+P VL+QLANL K+VE FQGRDDF++TLL++LE I+ ++ +
Sbjct: 952 FPVVLHLLGSSSFKNKMVTPQVLRQLANLTKLVEASFQGRDDFRVTLLQVLECITGDAPL 1011
Query: 987 ILGNPEIFFHEILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEPVEDEQRL-QDLKS 1045
+ N EI EILPSL +Y GNKDGDARFLCLKI D + ILL E E EQ++ +DLKS
Sbjct: 1012 VTQNGEIIIREILPSLAAIYNGNKDGDARFLCLKIWFDSLTILLTECTEIEQQISEDLKS 1071
Query: 1046 ISNSHFLPLYPTLIEDEDPIPMYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGDLS 1105
ISNSHFLPLYP LI+DEDPIP YAQK+LVML+E YIKIS++L TVSQCFEFLLGDLS
Sbjct: 1072 ISNSHFLPLYPALIQDEDPIPAYAQKLLVMLVEFDYIKISNLLRHNTVSQCFEFLLGDLS 1131
Query: 1106 SANVSNVKLCLALASAPEMESKLLSQLKVVRRIGNLLELVYAKDMEDFLEPTLGLCRAFL 1165
SANV+NVKLCLALASAPEMESKLLSQLKVVRRIGNLLE V AKDMEDFLEPTL LCRAFL
Sbjct: 1132 SANVNNVKLCLALASAPEMESKLLSQLKVVRRIGNLLEFVNAKDMEDFLEPTLSLCRAFL 1191
Query: 1166 LRSVSSRKGF--NYTKEPALLGDCSAEYGTAIDQQQSIRDIMDFSGNVGVFLKLSCSQEA 1223
LRS+ ++KG NYTKEP LL + A + +D Q+ IRDI DF N+G+FL + +
Sbjct: 1192 LRSLGNKKGLSSNYTKEPTLLSE--ASFTFEVDPQECIRDIADFGSNIGLFLHFAGLDDD 1249
Query: 1224 N---VADVASECVVLLLKAAPREGTTGFLTNLAKVTAILESWRRGTSH----LILQRVLH 1276
VAD+ASECVVLLLKAA RE TTGFLTNL K+T IL+SWRR S L+L+RVLH
Sbjct: 1250 TSIAVADIASECVVLLLKAASREATTGFLTNLPKITPILDSWRRRKSTELHLLVLKRVLH 1309
Query: 1277 ALGYSCRQYLSHAMILSISINEISRIEAIISEMKTSSTTTLADAALLAASELQRLPR 1333
LGY+C+QYLS AMILSIS +++S+I AI+SEMK S L A L A ELQRLPR
Sbjct: 1310 CLGYACKQYLSQAMILSISGHDVSKINAIVSEMKNSDAAGLNSIASLVAMELQRLPR 1366
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736922|emb|CBI26123.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1704 bits (4413), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 887/1334 (66%), Positives = 985/1334 (73%), Gaps = 220/1334 (16%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
MNQYHIYEAIGRGKYSTVYKGRKKK+IEYFAIKSVDKSQK+K+LQEVR+LHSLDH NVL
Sbjct: 1 MNQYHIYEAIGRGKYSTVYKGRKKKSIEYFAIKSVDKSQKNKLLQEVRILHSLDHSNVLN 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
F+SWYETSAHLWLVLEYCVGGDLM+LL+QD+QLPEDS+ DLA+DLVRALQ+LHSKGIIYC
Sbjct: 61 FFSWYETSAHLWLVLEYCVGGDLMTLLQQDSQLPEDSVHDLARDLVRALQFLHSKGIIYC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKPSNILLDENG TKLCDFGLARKLSD SK PSSMLPQAK GTPCYMAPELF++GGVHS
Sbjct: 121 DLKPSNILLDENGCTKLCDFGLARKLSDISKTPSSMLPQAKRGTPCYMAPELFQDGGVHS 180
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
YASD W LGCVLYECYAGRPPFVGREFTQLVKSILSDP+P LPG PSRPF NLINSLLVK
Sbjct: 181 YASDFWALGCVLYECYAGRPPFVGREFTQLVKSILSDPTPTLPGTPSRPFVNLINSLLVK 240
Query: 241 DPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKGAVRQDENSMLGSTPVRVTPSGRK 300
DPA+R+ W +LCGHAFWRTK T +PLPPQPAFD+L D S L GR+
Sbjct: 241 DPAERIQWPELCGHAFWRTKFTSVPLPPQPAFDNLI-----DLYSKL---------CGRR 286
Query: 301 TQTKTSGRVFEEKQKDPSGTTRQVNLLRLSRIVKSNLQRENDKENYRRPLPNGSENDSEV 360
QTK SGRV +EKQKDPS T VNLLRLSRI KSNLQREN+KENYRRPLPN SENDSE
Sbjct: 287 AQTKASGRVADEKQKDPSSATGGVNLLRLSRIAKSNLQRENEKENYRRPLPNNSENDSE- 345
Query: 361 KIENNDMELDFNENTEDETNDEPDGPDNPNCASEDKLSGQPQHHEKAEETGRNGNHSGTP 420
H K EE N N T
Sbjct: 346 ------------------------------------------HQGKVEEMEDNTNQLDTA 363
Query: 421 SAEGMPVSDESRKQDRESSPERVEVAATPPTVSPQLKTTRIREGSGPPLDSESSRSSNSL 480
+PVSD+SR D ES + VEVAATPP+VSPQ++ R++EGS
Sbjct: 364 HVVSIPVSDDSRTFDHES--DHVEVAATPPSVSPQVRIQRVKEGS--------------- 406
Query: 481 SQVLWHPSDLSVRPVMPSRKADKVSEVFPSLPFEALKASDFVKMSKEQLDALNARILAVL 540
ADK+ E PSLPF+AL ASDF+KMSKEQLD+LN RI+ +
Sbjct: 407 --------------------ADKLPETLPSLPFDALAASDFIKMSKEQLDSLNNRIITIF 446
Query: 541 NGNSSIGEKQNVIRYLEMLSSNADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGL 600
NGN++I EKQNVI+YLEMLS+NADAANILT+GPIM+V+VKMLR SK SALRVQLASLIGL
Sbjct: 447 NGNTTIAEKQNVIKYLEMLSNNADAANILTNGPIMMVIVKMLRQSKASALRVQLASLIGL 506
Query: 601 FIRHSTFIDDDLANSGILGSLTDGLRDKQEKVRRFSMAALGELLFYISTQNEHARDSNPP 660
IRHSTFIDDDLA+SGILGSLTDGLRD+QEKVRRFSMAALGELLFYISTQNEHA+D+NPP
Sbjct: 507 LIRHSTFIDDDLASSGILGSLTDGLRDRQEKVRRFSMAALGELLFYISTQNEHAKDNNPP 566
Query: 661 ESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTIENICSQGGHWVARFTSQ 720
ESPSKD+R++SGWQV N+LISLVSS+LRKGEDD+TQ YALRTIENICSQGG+W ARFTSQ
Sbjct: 567 ESPSKDSRSSSGWQVSNALISLVSSILRKGEDDVTQQYALRTIENICSQGGNWAARFTSQ 626
Query: 721 DVISNLCYIYRATGKQESMRLTAGSCLVRLVRFNAPSMQSVMDKLSIKDIASSLIKGSPR 780
DVI+NLCYI+RA GKQESMRLTAGSC SPR
Sbjct: 627 DVINNLCYIFRAAGKQESMRLTAGSC-------------------------------SPR 655
Query: 781 EQQISLNLLNLAMLGSQMCTNIGRNLLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSL 840
EQQISLNLLN+AMLGS M TNIGR+LLPL PS V +
Sbjct: 656 EQQISLNLLNMAMLGSHMFTNIGRHLLPL-------PSFVRMC----------------- 691
Query: 841 LCKNGRRWLLHFFCNSRLLSSVDRLGKEKDSFLQQCLEAFVHVVASIIPGLLDIITGDIQ 900
D+FL HVV+S IPGLL+ ITGDIQ
Sbjct: 692 ----------------------------LDAFL--------HVVSSTIPGLLETITGDIQ 715
Query: 901 QMMGGRRHGQISAITSRAAPKTNVHLFPVVLHLLGSSSFKNRVVSPPVLQQLANLCKVVE 960
QMMGGRRHGQI+ +T+RAAPK VHLFPVVLHLLGSSSFK+RVV+ VLQQLANL K+ E
Sbjct: 716 QMMGGRRHGQIAGLTNRAAPKIKVHLFPVVLHLLGSSSFKHRVVNHQVLQQLANLIKLAE 775
Query: 961 TQFQGRDDFQITLLRILESISEESNVILGNPEIFFHEILPSLTVLYKGNKDGDARFLCLK 1020
+ FQGRDDFQITLLR+LESI+EE +VIL + +F EILPSL VLY+GNKDGDARFLCLK
Sbjct: 776 SPFQGRDDFQITLLRVLESITEEPSVILESANVFIGEILPSLAVLYRGNKDGDARFLCLK 835
Query: 1021 ILSDVMIILLNEPVEDEQRLQDLKSISNSHFLPLYPTLIEDEDPIPMYAQKVLVMLIESG 1080
IL D M+I LNEP E EQR +DLKSISN+HFLPLYPTLIEDEDPIPMYAQK+LVM IE
Sbjct: 836 ILFDAMVIYLNEPSEVEQRSEDLKSISNTHFLPLYPTLIEDEDPIPMYAQKLLVMFIEFN 895
Query: 1081 YIKISDILHLKTVSQCFEFLLGDLSSANVSNVKLCLALASAPEMESKLLSQLKVVRRIGN 1140
YI+I DILH++T LLSQLKVVR+IGN
Sbjct: 896 YIRIPDILHMET-----------------------------------LLSQLKVVRKIGN 920
Query: 1141 LLELVYAKDMEDFLEPTLGLCRAFLLRSVSSRKGFNYTKEPALLGDCSAEYGTAIDQQQS 1200
LLE V AKDMEDFLEPTLGLCRAFLLRSV SRKGF Y+KEP L+ D E A+DQQQ
Sbjct: 921 LLEFVNAKDMEDFLEPTLGLCRAFLLRSVGSRKGFIYSKEPTLICDGPTEVRGAVDQQQY 980
Query: 1201 IRDIMDFSGNVGVFLKLSCSQEANVADVASECVVLLLKAAPREGTTGFLTNLAKVTAILE 1260
IRDIMDF NV VFL+LS S EANVAD+ASECVVLLLKAAPRE TTGFLTNL+KV+A+LE
Sbjct: 981 IRDIMDFGSNVSVFLELSGSDEANVADIASECVVLLLKAAPREATTGFLTNLSKVSALLE 1040
Query: 1261 SWRRGTSHLILQRVLHALGYSCRQYLSHAMILSISINEISRIEAIISEMKTSSTTTLADA 1320
SWRR SHL++ R+LHALGYSCRQYLSHAMILSISI EISR+E I+SE+K SS +ADA
Sbjct: 1041 SWRRAVSHLLVLRMLHALGYSCRQYLSHAMILSISIPEISRLETIVSELKNSSIPGVADA 1100
Query: 1321 ALLAASELQRLPRC 1334
ALL A ELQRLPRC
Sbjct: 1101 ALLVAKELQRLPRC 1114
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|115435762|ref|NP_001042639.1| Os01g0259400 [Oryza sativa Japonica Group] gi|56783970|dbj|BAD81407.1| putative FUSED serine/threonine kinase [Oryza sativa Japonica Group] gi|56783973|dbj|BAD81428.1| putative FUSED serine/threonine kinase [Oryza sativa Japonica Group] gi|113532170|dbj|BAF04553.1| Os01g0259400 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 1693 bits (4385), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 825/1364 (60%), Positives = 1033/1364 (75%), Gaps = 49/1364 (3%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
MN +H+YEAIGRGK+STVYKGRKKK+IEYFA+KSVDKSQ+SKVL EVRMLHSLDHPNVL+
Sbjct: 1 MNNFHVYEAIGRGKHSTVYKGRKKKSIEYFAVKSVDKSQRSKVLNEVRMLHSLDHPNVLK 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
FYSWYETSAH WL+LEYCVGGDL LL QD +LPE+SI DLA DLV+ALQ+LHS+GIIYC
Sbjct: 61 FYSWYETSAHFWLILEYCVGGDLKGLLEQDKKLPENSIHDLAYDLVKALQFLHSQGIIYC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKPSN+LLDE+G KLCDFGLAR+L D K +PQ GTPCYMAPELF+EGGVHS
Sbjct: 121 DLKPSNVLLDESGCMKLCDFGLARRLKDIEKTNPGDVPQPLKGTPCYMAPELFQEGGVHS 180
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
YASD W LGCVLYECY+GRPPFV EFTQLVKSI+SDP+PPLP NPSR F NLIN LL+K
Sbjct: 181 YASDFWALGCVLYECYSGRPPFVANEFTQLVKSIISDPTPPLPDNPSRSFQNLINCLLMK 240
Query: 241 DPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSL------------------------- 275
DPA+RL WS+LC H FWR++++ +PLPPQPAFD++
Sbjct: 241 DPAERLQWSELCEHHFWRSRMSIIPLPPQPAFDNMVDLSATPYLVERNGDKPSRQSTPPK 300
Query: 276 --KGAVRQDENSMLGSTPVRVTPSGRKTQTKTSGRVFEEKQKDPSGTTRQVNLLRLSRIV 333
G ++DENS TPV+ SG+K K S + + + VN+LR+SR+
Sbjct: 301 PRDGLRKKDENSAKVFTPVKNMLSGKKNNAKPSCK---------ADGLKGVNILRMSRVA 351
Query: 334 KSNLQRENDKENYRRPLPNGSENDSEVKIENNDMELDFNENTEDETNDEPDGPDNPNCAS 393
K NLQRE DKENYRR SEND+EVKIENNDMELDF EN E + D+ DG DNP A
Sbjct: 352 KRNLQREKDKENYRRHPTEASENDTEVKIENNDMELDFGENPEGDAPDDNDGSDNPGSAE 411
Query: 394 EDKLSGQPQHHEKAEETGRNGNHSGTPSAEGMPVSDESRKQDRESSPERVEVAATPPTVS 453
++KLS Q E N + EG PV E+ + + E ++V ATPP++
Sbjct: 412 DEKLSTQ---GTDGNEENCMSNQMDMLTDEG-PVKAETMIKTEHNCSENLDVVATPPSIC 467
Query: 454 PQLKTTRIREGSGPPLDSESSRSSNSLSQVLWHPSDLSVRPVMPSRKADKVSEVFPSLPF 513
+ K R + SG SE S +S WHP+DL+V+PVMP RK DK E P LPF
Sbjct: 468 MR-KAQRAKTTSGAAAGSEPS----DISAAFWHPTDLAVKPVMPGRKGDKAVETVPMLPF 522
Query: 514 EALKASDFVKMSKEQLDALNARILAVLNGNSSIGEKQNVIRYLEMLSSNADAANILTSGP 573
EAL A D++K+ +EQ++A N++IL L+G + EKQN+I+YLEMLS N+DAANI+T+GP
Sbjct: 523 EALPAVDYIKLPREQMNAFNSQILQSLSGTFQVSEKQNIIKYLEMLSINSDAANIITNGP 582
Query: 574 IMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLRDKQEKVR 633
IML+L+KMLRLSKTS LRVQ+ASL+GL IR+ST +D +LA+SGI +L+DGLRDK +K+R
Sbjct: 583 IMLLLIKMLRLSKTSVLRVQIASLMGLLIRYSTILDIELASSGIFNALSDGLRDKHDKLR 642
Query: 634 RFSMAALGELLFYISTQNEH-ARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGED 692
RF MA LGELLFYISTQ++ ++ N ESP KDNR + WQVP+S+I+LVSS+LRKGED
Sbjct: 643 RFCMATLGELLFYISTQSDQDTKEINAQESPLKDNRATASWQVPSSVIALVSSILRKGED 702
Query: 693 DMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESMRLTAGSCLVRLVR 752
D+ QLYALRTI+NICSQG W +RF SQDVIS+LCYIYRATGKQE+ RL AGSCL RL R
Sbjct: 703 DLAQLYALRTIDNICSQGTDWTSRFASQDVISHLCYIYRATGKQENTRLIAGSCLARLAR 762
Query: 753 FNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGSQMCTNIGRNLLPLVED 812
F++ + ++++L+ KDIA +LIKG+ REQQISLNLLN A++ SQ+ + R + L E+
Sbjct: 763 FSSSCIHLILERLAFKDIACTLIKGNSREQQISLNLLNSALVNSQIIPTMNRYIQSLTEE 822
Query: 813 KNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNGRRWLLHFFCNSRLLSSVDRLGKEKDSF 872
K LVP L+SL EQG++VLRGK L+FV+LLCKN RRWL HFFCN++LLS+VDRLGKEK+ F
Sbjct: 823 KQLVPGLISLIEQGTDVLRGKTLLFVALLCKNSRRWLPHFFCNAKLLSAVDRLGKEKEGF 882
Query: 873 LQQCLEAFVHVVASIIPGLLDIITGDIQQMMGGRRHGQISAITSRAAPKTNVHLFPVVLH 932
+ QC EAFV +VAS++PG+LD ++ DIQQ+MGG+RHG +A+T RA PK+ +HLFPV+LH
Sbjct: 883 IHQCTEAFVQLVASLVPGILDTVSSDIQQVMGGKRHGAATALTGRAHPKSIIHLFPVILH 942
Query: 933 LLGSSSFKNRVVSPPVLQQLANLCKVVETQFQGRDDFQITLLRILESISEESNVILGNPE 992
LLGS SF +RVV+ VL QLANL K++E FQ RDDFQ+TLLR+LE+ +EE +VIL +
Sbjct: 943 LLGSVSFNHRVVTSHVLLQLANLMKILEAPFQARDDFQMTLLRVLEAATEEPSVILNEHK 1002
Query: 993 IFFHEILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEP--VEDEQRLQDLKSISNSH 1050
IF ILPSL+VLYKGNKDGDARFLCLKILSDVMI++ ++ +EQ + DL+ IS +
Sbjct: 1003 IFTSRILPSLSVLYKGNKDGDARFLCLKILSDVMIVIFSDSSLTSNEQTVSDLEKISQKY 1062
Query: 1051 FLPLYPTLIEDEDPIPMYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGDLSSANVS 1110
FLP+YP+ EDEDPIP+YAQK+LVML+E Y+K+SDIL+ TVS+CFEFLLGDLS+ANVS
Sbjct: 1063 FLPMYPSFAEDEDPIPIYAQKLLVMLMEHDYVKVSDILNEATVSRCFEFLLGDLSNANVS 1122
Query: 1111 NVKLCLALASAPEMESKLLSQLKVVRRIGNLLELVYAKDMEDFLEPTLGLCRAFLLRSVS 1170
NVKLC ALASAP+M++ +LSQL+VVRRIGNLLE V AKDM+DFLEPTL LCRAF++R +S
Sbjct: 1123 NVKLCFALASAPDMDTDILSQLQVVRRIGNLLEFVTAKDMDDFLEPTLELCRAFIIRGIS 1182
Query: 1171 SRKGFNYTKEPALLGDCSAEYGTAIDQQQSIRDIMDFSGNVGVFLKLSCSQEANVADVAS 1230
S K +KEPALL D + A+DQQ + DI DF GN+G+FL L S + +++D+AS
Sbjct: 1183 SDKIVALSKEPALLVDSAFSMSIAVDQQSCVMDICDFGGNMGIFLDLVGSSDPHISDLAS 1242
Query: 1231 ECVVLLLKAAPREGTTGFLTNLAKVTAILESWRRGTSHLILQRVLHALGYSCRQYLSHAM 1290
+C+VLLLKAAPRE T G LTNL K++ +L+ + GT L L R+L+ L +SCRQYL+ M
Sbjct: 1243 DCLVLLLKAAPREATVGLLTNLPKLSVVLDLLKHGTC-LRLTRLLYCLAFSCRQYLAQGM 1301
Query: 1291 ILSISINEISRIEAIISEMKTSSTTTLADAALLAASELQRLPRC 1334
I+SIS++ + R+EA++S K S LADAA +ELQRLPRC
Sbjct: 1302 IVSISLSALMRVEALVSAFKGSHDGCLADAASYLGAELQRLPRC 1345
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1335 | ||||||
| TAIR|locus:2180044 | 1366 | RUK [Arabidopsis thaliana (tax | 0.797 | 0.778 | 0.633 | 0.0 | |
| UNIPROTKB|E2RMM8 | 1274 | ULK4 "Uncharacterized protein" | 0.582 | 0.610 | 0.225 | 4e-82 | |
| MGI|MGI:1921622 | 1303 | Ulk4 "unc-51-like kinase 4" [M | 0.575 | 0.589 | 0.219 | 2.1e-77 | |
| UNIPROTKB|Q96C45 | 1275 | ULK4 "Serine/threonine-protein | 0.107 | 0.112 | 0.444 | 2.8e-75 | |
| ZFIN|ZDB-GENE-100922-243 | 1048 | ulk4 "unc-51-like kinase 4 (C. | 0.397 | 0.506 | 0.286 | 2.5e-73 | |
| TAIR|locus:2203822 | 497 | AT1G33940 "AT1G33940" [Arabido | 0.142 | 0.382 | 0.685 | 2.9e-73 | |
| RGD|1565726 | 1185 | Ulk4 "unc-51-like kinase 4 (C. | 0.522 | 0.589 | 0.228 | 7.7e-67 | |
| UNIPROTKB|D4A8P3 | 1188 | Stk36 "Protein Stk36" [Rattus | 0.244 | 0.275 | 0.362 | 6e-47 | |
| UNIPROTKB|E1B793 | 1317 | STK36 "Uncharacterized protein | 0.233 | 0.236 | 0.373 | 3.9e-46 | |
| UNIPROTKB|C9JDA4 | 279 | STK36 "Serine/threonine-protei | 0.196 | 0.939 | 0.4 | 7.6e-46 |
| TAIR|locus:2180044 RUK [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3348 (1183.6 bits), Expect = 0., Sum P(2) = 0.
Identities = 688/1086 (63%), Positives = 817/1086 (75%)
Query: 263 PMPLPPQPAFDSLKGAVRQDENSMLGS----TPVRVTPSGRKTQTKTSGRVFEEKQKDPS 318
P PP+ KG +Q+ENS+ GS TP++ TP G K Q K R EEK
Sbjct: 288 PNKTPPKYREKDRKGGSKQNENSIQGSKGHETPIKGTPGGSKAQAKLPSRATEEKHGGRP 347
Query: 319 GTTRQVNLLRLSRIVKSNLQRENDKENYRRPLPNGSENDSEVKIENNDMXXXXXXXXXXX 378
RQVN+LRLSRI K+NLQ+EN+KENYRRPLPN +EN +EVKI+N DM
Sbjct: 348 AANRQVNILRLSRIAKANLQKENEKENYRRPLPNSNENCAEVKIDNTDMELDFDENNDDE 407
Query: 379 XXXXXXXXXXXXCASEDKLSGQPQHHEKAEETGRNGNHSGTPSAEGMPVSDESRKQDRES 438
CA E+++ ++H + N + SA P E+R +
Sbjct: 408 GPDESEGTENTSCAQEERVMSHNENHRRQRVVSSNVPDENS-SANETPTLGEARDCHEDQ 466
Query: 439 SPERVEVAATPPTVSPQLKTTRIREGSGPPLDXXXXXXXXXXXQVLWHPSDLSVRPVMPS 498
S E ++++A PP+ SPQLKT R RE SG ++ V WH SDLSVRPVMPS
Sbjct: 467 S-EPMDMSAAPPSASPQLKTHRGRETSGVAVNHDSSKAPTSLTDVFWHISDLSVRPVMPS 525
Query: 499 RKADKVSEVFPSLPFEALKASDFVKMSKEQLDALNARILAVLNGNSS-IGEKQNVIRYLE 557
RK+DK E SL FE + SDF K K++L+ LN RI+ VL+G+SS + EKQN+IRYLE
Sbjct: 526 RKSDK--EAVHSLSFETPQPSDFSKKGKQELEPLNNRIITVLSGSSSGLSEKQNLIRYLE 583
Query: 558 MLSSNADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGI 617
LS+NADAANILT+GPIMLVLVK+LRLSKT A RVQ+ASLIGL IRHST I+DDLANSGI
Sbjct: 584 TLSTNADAANILTNGPIMLVLVKVLRLSKTPAFRVQIASLIGLLIRHSTSIEDDLANSGI 643
Query: 618 LGSLTDGLRDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPN 677
L SLT+GLRDK EKVRRFSMAALGELLFYISTQNEH +D PPESPSK+ R+ASGWQV N
Sbjct: 644 LDSLTNGLRDKHEKVRRFSMAALGELLFYISTQNEH-KDFKPPESPSKETRSASGWQVSN 702
Query: 678 SLISLVSSVLRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQE 737
+LISLVSSVLRKGEDD+TQ+YALRTIENICSQG +W RF+SQD+ISNLCYIY+ATGKQE
Sbjct: 703 ALISLVSSVLRKGEDDLTQVYALRTIENICSQGAYWATRFSSQDLISNLCYIYKATGKQE 762
Query: 738 SMRLTAGSCLVRLVRFNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGSQ 797
SMR TAGSCLVRL RFN P +Q+V++KLS+K+IASS +KGS REQQ+ LNLLN+AM+GS
Sbjct: 763 SMRQTAGSCLVRLARFNPPCIQTVVEKLSLKEIASSFVKGSAREQQVCLNLLNMAMIGSH 822
Query: 798 MCTNIGRNLLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNGRRWLLHFFCNSR 857
T+ GR+L+ L E+KNL PSL+S+ EQG+EVLRGKAL+FV+ LCKN RRWL +FFCN+R
Sbjct: 823 TFTSFGRHLVTLTEEKNLFPSLLSIIEQGTEVLRGKALLFVAFLCKNSRRWLTNFFCNAR 882
Query: 858 LLSSVDRLGKEKDSFLQQCLEAFVHVVASIIPGLLDIITGDIQQMMGGRRHGQISAITSR 917
L VDRL KEKDS+LQQCLEAFV+V+ASIIPG+LD IT DIQQ+M GRRHG +S + SR
Sbjct: 883 FLPVVDRLAKEKDSYLQQCLEAFVNVIASIIPGMLDTITNDIQQLMTGRRHGPVSPLNSR 942
Query: 918 AAPKTNVHLFPVVLHLLGSSSFKNRVVSPPVLQQLANLCKVVETQFQGRDDFQITLLRIL 977
A KTN HLFPVVLHLLGSSSFKN++V+P VL+QLANL K+VE FQGRDDF++TLL++L
Sbjct: 943 APVKTNAHLFPVVLHLLGSSSFKNKMVTPQVLRQLANLTKLVEASFQGRDDFRVTLLQVL 1002
Query: 978 ESISEESNVILGNPEIFFHEILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEPVEDE 1037
E I+ ++ ++ N EI EILPSL +Y GNKDGDARFLCLKI D + ILL E E E
Sbjct: 1003 ECITGDAPLVTQNGEIIIREILPSLAAIYNGNKDGDARFLCLKIWFDSLTILLTECTEIE 1062
Query: 1038 QRL-QDLKSISNSHFLPLYPTLIEDEDPIPMYAQKVLVMLIESGYIKISDILHLKTVSQC 1096
Q++ +DLKSISNSHFLPLYP LI+DEDPIP YAQK+LVML+E YIKIS++L TVSQC
Sbjct: 1063 QQISEDLKSISNSHFLPLYPALIQDEDPIPAYAQKLLVMLVEFDYIKISNLLRHNTVSQC 1122
Query: 1097 FEFLLGDLSSANVSNVKLCLALASAPEMESKLLSQLKVVRRIGNLLELVYAKDMEDFLEP 1156
FEFLLGDLSSANV+NVKLCLALASAPEMESKLLSQLKVVRRIGNLLE V AKDMEDFLEP
Sbjct: 1123 FEFLLGDLSSANVNNVKLCLALASAPEMESKLLSQLKVVRRIGNLLEFVNAKDMEDFLEP 1182
Query: 1157 TLGLCRAFLLRSVSSRKGF--NYTKEPALLGDCSAEYGTAIDQQQSIRDIMDFSGNVGVF 1214
TL LCRAFLLRS+ ++KG NYTKEP LL + S + +D Q+ IRDI DF N+G+F
Sbjct: 1183 TLSLCRAFLLRSLGNKKGLSSNYTKEPTLLSEASFTF--EVDPQECIRDIADFGSNIGLF 1240
Query: 1215 LK---LSCSQEANVADVASECVVLLLKAAPREGTTGFLTNLAKVTAILESWRRGTS---H 1268
L L VAD+ASECVVLLLKAA RE TTGFLTNL K+T IL+SWRR S H
Sbjct: 1241 LHFAGLDDDTSIAVADIASECVVLLLKAASREATTGFLTNLPKITPILDSWRRRKSTELH 1300
Query: 1269 L-ILQRVLHALGYSCRQYLSHAMILSISINEISRIEAIISEMKXXXXXXXXXXXXXXXXE 1327
L +L+RVLH LGY+C+QYLS AMILSIS +++S+I AI+SEMK E
Sbjct: 1301 LLVLKRVLHCLGYACKQYLSQAMILSISGHDVSKINAIVSEMKNSDAAGLNSIASLVAME 1360
Query: 1328 LQRLPR 1333
LQRLPR
Sbjct: 1361 LQRLPR 1366
|
|
| UNIPROTKB|E2RMM8 ULK4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 412 (150.1 bits), Expect = 4.0e-82, Sum P(3) = 4.0e-82
Identities = 192/851 (22%), Positives = 378/851 (44%)
Query: 482 QVLWHPSDLSVRPVMPSRKADKVSEV-F-PS---LPFEALKASDFVKMS--KEQLDALNA 534
++++ SDL V P++ + K K + F P LP ++ F+K E L + +
Sbjct: 410 KLIYMDSDLVVTPIIDNPKIMKQPPIKFDPKILHLPAHSVDKLVFLKDQDWNEFLQQVCS 469
Query: 535 RILAVLNGNSSIGEKQNVIRYLEMLSSNADAANILTSGPIMLVLVKMLRLSKTSALRVQL 594
+I + + K N++ YL +L+ + + A L P+ +L++ LR++ +R ++
Sbjct: 470 QIDSTEKSTGASRAKLNLLCYLCVLAGHREVATRLLHSPLFQLLIQHLRIAPNWDIRAKV 529
Query: 595 ASLIGLFIRHSTFIDDDLANSGILGSLTDGLRD--KQEKVRRFSMAALGELLFYISTQNE 652
A +IGL H+T + ++ + + LT+ +R+ + K+++ + LGEL++ ++TQ E
Sbjct: 530 ARVIGLLALHTTELQENTPVTEAITVLTELIRENFRNSKLKQCLLPTLGELIYLVATQEE 589
Query: 653 HARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTIENICSQGGH 712
+ NP E W VP + +++ LR+GE+ + A + IEN+C+
Sbjct: 590 --KKKNPREC----------WAVPLAAYTVLMRCLREGEERVVNHMAAKIIENVCTTFSA 637
Query: 713 WVARFTSQDVISNLCYIYRATGKQESMRLTAGSCLVRLVRFNAPSMQSVMDKLSIKDIAS 772
F + ++ L Y++R + +S+R+TA S L R+ R + + Q+V++K+ + + +
Sbjct: 638 QAQGFITGEIGPVLWYLFRHS-TIDSLRITAISALCRITRHSPTAFQNVIEKVGLNSVIN 696
Query: 773 SLIKGSPREQQISLNLLNLAMLGSQMCTNIGRNLLPLVEDKNLVPSLVSLTEQGSEVLRG 832
SL + QQ L L AML C + L+ + + + L+
Sbjct: 697 SLATAICKVQQYMLTLFT-AMLS---CGIHLQRLIQEKDFVSTIIRLLDSPSTSIRAKAF 752
Query: 833 KALVFV------SLLCKNGRRWLLHFFCNSRLLSSVDRLGKEKDS---FLQQCLEAFVHV 883
L+++ LL R +++ +SR + GKE+ S +L +CL+ +
Sbjct: 753 LVLLYILIHNHEMLLLSCQARLVMYIERDSRKTTP----GKEQQSSNEYLSRCLDLLIRH 808
Query: 884 VASIIPGLLDIITGDIQQMMGGRRHGQISAITSRAAPKTNVHLFPVVLHLLGSSSFKNRV 943
+ +P +L I + + GR+H S + ++ K + L +VLHL+ S F+ +V
Sbjct: 809 IVQELPRILGDILNALANV-SGRKHP--STVQAKQL-KMYLPLMTIVLHLVTSQVFRPQV 864
Query: 944 VSPPVLQQLANLCKVV------ETQFQGR------DDFQITLLRILESISEESNVILGNP 991
V+ L L + ET G ++F L E+I + ++
Sbjct: 865 VTEEFLFSYGTLLSHIKSVDSGETNIDGAIGLMASEEFIKITLSAFEAIIQYPILLKDYC 924
Query: 992 EIFFHEILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEPVEDEQRLQD------LKS 1045
ILP L L + +++ + R L++LS+ +L+N+ V D ++ + L +
Sbjct: 925 STVVDYILPPLVSLVQ-SQNVEWRLFSLRLLSETTSLLVNQEVGDGKKEANVNFDSSLLA 983
Query: 1046 ISNSHFLPLYPTLIEDEDPIPMYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGD-- 1103
+ LP Y ++ + DP+P YA K+LV + E + K + FE +L
Sbjct: 984 LIRDVLLPQYEHILTEPDPVPAYALKLLVAMTEHNPTFTRLVEESKLIPLIFEVILEHQE 1043
Query: 1104 --LSSANVSNVKLCLALASAPEMESKLLSQLKVVRRIGNLLELVYAKDMEDFLEPTLGLC 1161
L + S + L L + + KLL + +VR + +L ++ +
Sbjct: 1044 NILGNTMQSVIALLNNLVACKDSNMKLLYEQGLVRHVCDLFTETATLCLDVDNKNNNETA 1103
Query: 1162 RAFLLRSVSSRKGF-NYTKEPALLGDCSAEYGTAIDQQQSIRDIMDFSGN----VGVFLK 1216
A L + G YT L + + G+ D Q + D++ S + + +
Sbjct: 1104 AALLFSLLDILHGMLTYTSSVVRLALQAQKSGSGGDTQAA-EDLLLLSKPLTDLISLLIP 1162
Query: 1217 LSCSQEANVADVASECVVLLLKAAPREGTTGFLTNLAKVTA-ILESWRRGTSHLILQRVL 1275
L S++ + +V+S+C+ +L++ E A+ A +L S +L ++L
Sbjct: 1163 LLPSEDPEIFEVSSKCLSILVQLYGGENPDSLSPENAENFADLLTSKEDPKEQKLLLKIL 1222
Query: 1276 HALGYSCRQYL 1286
+ S ++L
Sbjct: 1223 RRMVTSNEKHL 1233
|
|
| MGI|MGI:1921622 Ulk4 "unc-51-like kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 378 (138.1 bits), Expect = 2.1e-77, Sum P(3) = 2.1e-77
Identities = 186/846 (21%), Positives = 373/846 (44%)
Query: 437 ESSPERVEVAATPPTVSPQLKTTRIREGSGPPLDXXXXXXXXXXXQVLWHPSDLSVRPVM 496
E +P E ++P SP K T SG ++++ SDL + P++
Sbjct: 374 ELNPGEGEDPSSPQKTSPLSKMT-----SG---HLSQGALESQMRELIYTDSDLVITPII 425
Query: 497 PSRKADKVSEV-F-PSLPFEALKASDFVKMSKEQ-----LDALNARILAVLNGNSSIGEK 549
+ K K + F P + + + + + K+Q L + ++I + ++ K
Sbjct: 426 DNPKIMKQPAIKFDPKILHLPAYSVEKLLVLKDQDWNDFLQQVCSQIDSSEKSTGALRAK 485
Query: 550 QNVIRYLEMLSSNADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFID 609
N++ YL +++++ + A L P+ +L++ LR++ +R ++A ++G+ H+T +
Sbjct: 486 LNLLCYLCVVATHKEVATRLLHSPLFQLLIQHLRIAPNWDIRSKVARVVGMLALHTTELQ 545
Query: 610 DDLANSGILGSLTDGLRD--KQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDN 667
+++ + LT+ +R+ + K+++ + LG+LL+ ++TQ E K+
Sbjct: 546 ENVPVIEAITLLTELIRENFRSGKLKQCLLPTLGQLLYLVATQEE------------KNQ 593
Query: 668 RTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLC 727
+ W VP + +++ LR+GE+ + A + IEN+C+ FT+ ++ L
Sbjct: 594 HSRDCWAVPLAAYTVLMRCLREGEERVVNHMAAKIIENVCTTFSAQAQGFTTGEIGPVLW 653
Query: 728 YIYRATGKQESMRLTAGSCLVRLVRFNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLN 787
+++R + +++R+TA S L R+ R + + Q+V++K+ + + SSL + QQ L
Sbjct: 654 HLFRHS-TVDALRITAISALCRITRQSPTAFQNVIEKVGLNAVISSLASAICKVQQYMLT 712
Query: 788 LLNLAMLGSQMCTNIGRNLLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFV------SLL 841
L AML C + L+ + + V L+ L+++ LL
Sbjct: 713 LFT-AMLS---CGIHLQRLIQEKDFVSTVIRLLDSPSTPIRAKAFLVLLYILIHNRDMLL 768
Query: 842 CKNGRRWLLHFFCNSRLLSSVDRLGKEKDS---FLQQCLEAFVHVVASIIPGLLDIITGD 898
R +++ +SR S GKE+ S +L +CL+ + + P +L I
Sbjct: 769 LSCQARLVMYIERDSRKTSP----GKEQQSGNEYLARCLDLLIQHMVQEPPRILGDILNA 824
Query: 899 IQQMMGGRRHGQISAITSRAAPKTNVHLFPVVLHLLGSSSFKNRVVSPPVLQQLANLCKV 958
+ + GR+H S + + K + + PVVLHL+ S F+ +VV+ L +
Sbjct: 825 LANV-SGRKHP--STVQGKQL-KMCLPMMPVVLHLVMSQVFRPQVVTEEFLFSYGTILSH 880
Query: 959 V------ETQFQGR------DDFQITLLRILESISEESNVILGNPEIFFHEILPSLTVLY 1006
+ ET G ++F L E++ + ++ ILP L L
Sbjct: 881 IKSIDLGETNIDGAIGIVASEEFIKVTLSAFEAVIQYPVLLADYRSTVMDYILPPLVSLV 940
Query: 1007 KGNKDGDARFLCLKILSDVMIILLN-EPVE-DEQRLQD----LKSISNSHFLPLYPTLIE 1060
+ +++ + R L++LS+ +L++ EP + DE+ D L ++ LP Y ++
Sbjct: 941 Q-SQNVEWRLFSLRLLSETTTLLVSQEPEDGDEEASCDSDSSLLALIRDELLPQYEHILM 999
Query: 1061 DEDPIPMYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGDLSS--ANV--SNVKLCL 1116
+ DP+P YA K+LV + E + K V FE +L S N S + L
Sbjct: 1000 EPDPVPAYALKLLVAMTEHNPAFTRLVEESKLVPLIFEVILEHQESILGNTMQSVIALLN 1059
Query: 1117 ALASAPEMESKLLSQLKVVRRIGNLLE----LVYAKDMEDFLEPTLGLCRAFLLRSVSSR 1172
L + + +LL + +V + N+ L +D + EP L + L +
Sbjct: 1060 NLVAYKDSNMQLLYEQGLVGHVCNMFTETATLCLDRDNKTNTEPASTLLASLLDILLGML 1119
Query: 1173 KGFNYTKEPALLGDCSAEYGTAIDQQQSIRDIMDFSGNVGVFLKLSCSQEANVADVASEC 1232
+ AL S G + + + + + + L S++ +++V+S+C
Sbjct: 1120 TYTSRIVRQALQVQKSGSRGDTQAAEDLLLLSKPLTDLISLLIPLLPSEDPEISEVSSKC 1179
Query: 1233 VVLLLK 1238
+ +L++
Sbjct: 1180 LSILVQ 1185
|
|
| UNIPROTKB|Q96C45 ULK4 "Serine/threonine-protein kinase ULK4" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 362 (132.5 bits), Expect = 2.8e-75, Sum P(3) = 2.8e-75
Identities = 64/144 (44%), Positives = 92/144 (63%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
M + +YE IGRG + VYKGR+K TI + AI DK ++ ++ VR+ + H N++
Sbjct: 1 MENFILYEEIGRGSKTVVYKGRRKGTINFVAILCTDKCKRPEITNWVRLTREIKHKNIVT 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
F+ WYETS HLWLV+E C GG L +++ QD LPED +R+ DL+ L +LH GI++C
Sbjct: 61 FHEWYETSNHLWLVVELCTGGSLKTVIAQDENLPEDVVREFGIDLISGLHHLHKLGILFC 120
Query: 121 DLKPSNILLDENGRTKLCDFGLAR 144
D+ P ILL+ G K +F LA+
Sbjct: 121 DISPRKILLEGPGTLKFSNFCLAK 144
|
|
| ZFIN|ZDB-GENE-100922-243 ulk4 "unc-51-like kinase 4 (C. elegans)" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 452 (164.2 bits), Expect = 2.5e-73, Sum P(3) = 2.5e-73
Identities = 170/594 (28%), Positives = 285/594 (47%)
Query: 483 VLWHPSDLSVRPVMPSRKADKVSEV-F-P-SLPFEALKASDFVKMSKEQLDALNARILAV 539
+L+ DL+V P+M + K K + V F P +L A A +S E ++ AV
Sbjct: 419 LLYTDCDLTVTPIMDNPKILKTAPVRFDPKTLCVPAHSAERLSCLSSEDWSQFLQQVCAV 478
Query: 540 LNGNSSIGE--------KQNVIRYLEMLSSNADAANILTSGPIMLVLVKMLRLSKTSALR 591
L G K N++ YL + ++ D A L + VLV+ +R + +R
Sbjct: 479 LESVDRAGSANATAPRAKLNLLCYLCTVCNHRDTATRLIHSELFPVLVQQMRQAPNWDIR 538
Query: 592 VQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLRD--KQEKVRRFSMAALGELLFYIST 649
++ IGL H T + D S + T+ +R+ + K+++ + +GELL+ I+T
Sbjct: 539 SKVMRAIGLLASHCTELRDHAPVSEAVAMFTELIRENFRSSKLKQCLIPPMGELLYLIAT 598
Query: 650 QNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTIENICSQ 709
Q E K R W VP + +++ LR+GED + A +TIEN+CS+
Sbjct: 599 QEE------------KKERPGGLWVVPAAAYTVLMRCLREGEDLVVNHMAAKTIENVCSR 646
Query: 710 GGHWVARFTSQDVISNLCYIYRATGKQESMRLTAGSCLVRLVRFNAPSMQSVMDKLSIKD 769
F + +V L Y++ + +++R++A S L ++ R +A + QSV+DK+ +
Sbjct: 647 ESQSAQGFITAEVGPALWYLFTHS-TVDALRVSAISALCKITRQSAGAFQSVIDKVGLPS 705
Query: 770 IASSLIKGSPREQQISLNLLNLAMLGSQMCTNIGRNLLPLVEDKNLVPSLVSLTEQGSEV 829
I S L+ G R QQ L + AML S G + LV+D++ V ++ E S V
Sbjct: 706 ILSCLVSGISRVQQHMLTMF-AAMLAS------GAHSHRLVQDRDFVMKIIRSLESPSSV 758
Query: 830 LRGKALVFVSLLCKNGRRWLLHFFCNSRLLSSVDR------LGKEKDS---FLQQCLEAF 880
+R KA + + + N R LL CNSRL+ ++R GKE+ S +L +CL F
Sbjct: 759 IRAKAFLVLLQVLMNNREMLL-LCCNSRLVMYIERDVRKATPGKEQQSGNEYLSKCLTLF 817
Query: 881 VHVVASIIPGLLDIITGDIQQMMGGRRHGQISAITSRAAPKTNVHLFPVVLHLLGSSSFK 940
+ +P +LD I + ++G R+H S SR K ++ + VVLHLL S F+
Sbjct: 818 IRHTVRELPAILDDILSVLGSIVG-RKHP--SPTQSRQL-KQSLPMMAVVLHLLTSQIFR 873
Query: 941 NRVVSPPVLQQLANLCKVV------ETQF-------QGRDDFQI-TLLRILESISEESNV 986
+VV+ L + L + ET Q + I L +E+IS+ +
Sbjct: 874 PQVVTEAFLIKFGKLLNHITSIDSNETSLGSAIGTGQASSEELIRNTLSAVEAISQHPAL 933
Query: 987 ILGNPEIFFHEILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEP-VEDEQR 1039
+ P I I+P L L +K+ + R + L++LS++ ++LL++ VE+ +R
Sbjct: 934 LSLYPFIVVDLIVPPLASL-AFSKNVEWRIVSLRVLSEITLLLLSQDEVEERER 986
|
|
| TAIR|locus:2203822 AT1G33940 "AT1G33940" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 671 (241.3 bits), Expect = 2.9e-73, Sum P(2) = 2.9e-73
Identities = 131/191 (68%), Positives = 157/191 (82%)
Query: 775 IKGSPREQQISLNLLNLAMLGSQMC-TNIGRNLLPLVEDKNLVPSLVSLTEQGSEVLRGK 833
I GS REQQ+ LNLLN+AM+GS T+ GR+L+ L E+KNL PSL+S+ EQG+EVLRGK
Sbjct: 96 ISGSAREQQVCLNLLNMAMIGSHHTFTSFGRHLVTLTEEKNLFPSLLSIIEQGTEVLRGK 155
Query: 834 ALVFVSLLCKNGRRWLLHFFCNSRLLSSVDRLGKEKDSFLQQCLEAFVHVVASIIPGLLD 893
A +FV+ LCKN RRWL +FFCN+R L VDRL KEKDS+LQQCLEAFV+V+ SIIPGLLD
Sbjct: 156 APLFVAFLCKNSRRWLTNFFCNARFLPVVDRLAKEKDSYLQQCLEAFVNVITSIIPGLLD 215
Query: 894 IITGDIQQMMGGRRHGQISAITSRAAPKTNVHLFPVVLHLLGSSSFKNRVVSPPVLQQLA 953
IT DIQQ+M GRRHG +S + SRA+ KTN HLFPVVLHLLGSS FKN++V+P VL+QLA
Sbjct: 216 TITNDIQQLMTGRRHGPVSPLNSRASVKTNAHLFPVVLHLLGSSLFKNKMVTPQVLRQLA 275
Query: 954 NLCKVVETQFQ 964
NL K+VE FQ
Sbjct: 276 NLTKLVEASFQ 286
|
|
| RGD|1565726 Ulk4 "unc-51-like kinase 4 (C. elegans)" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 361 (132.1 bits), Expect = 7.7e-67, Sum P(3) = 7.7e-67
Identities = 176/770 (22%), Positives = 334/770 (43%)
Query: 437 ESSPERVEVAATPPTVSPQLKTTRIREGSGPPLDXXXXXXXXXXXQVLWHPSDLSVRPVM 496
E +P E ++P SP K T SG ++++ SDL + P++
Sbjct: 374 ELNPGEGEDPSSPQKTSPLSKMT-----SG---HLSQGALESQMRELIYTDSDLVITPII 425
Query: 497 PSRKADKVSEV-F-PS-LPFEALKASDFVKMSKEQL-DALNARILAVLNGNSSIGE---K 549
+ K K + F P L A + + + D L V + S G K
Sbjct: 426 DNPKIMKQPAIKFDPKILHLPAYSVEKLLALKDQDWSDFLQQLCSHVDSSEKSTGALRAK 485
Query: 550 QNVIRYLEMLSSNADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFID 609
N++ YL +++++ + A L P+ +L++ LR++ +R ++A ++G+ H+ +
Sbjct: 486 LNLLCYLCVVATHKEVATRLLHSPLFQLLIQHLRIAPNWDIRSKVARVVGMLALHTAELQ 545
Query: 610 DDLANSGILGSLTDGLRD--KQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDN 667
+ + + LT+ +R+ + K+++ + LG+LL+ ++TQ E K
Sbjct: 546 ESVPVIEAITLLTELIRENFRSGKLKQCLLPTLGQLLYLVATQEE------------KTQ 593
Query: 668 RTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLC 727
+ W VP + +++ LR+GE+ + A + IEN+C+ FT+ ++ L
Sbjct: 594 HSRECWSVPLAAYTVLMRCLREGEERVVNHMAAKIIENVCTTFSAQAQGFTTGEIGPVLW 653
Query: 728 YIYRATGKQESMRLTAGSCLVRLVRFNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLN 787
+++R + +++R+TA S L R+ R + + Q+V++K+ + + SSL + QQ L
Sbjct: 654 HLFRHS-TVDALRITAISALCRITRQSPTAFQNVIEKVGLNAVISSLASAICKVQQYMLT 712
Query: 788 LLNLAMLGSQMCTNIGRNLLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFV------SLL 841
L AML C + L+ + + V L+ L++V LL
Sbjct: 713 LFT-AMLS---CGIHLQRLIQEKDFVSTVIRLLDSPSTPIRAKAFLVLLYVLIHNRDMLL 768
Query: 842 CKNGRRWLLHFFCNSRLLSSVDRLGKEKDSFLQQCLEAFVHVVASIIPGLLDIITGDIQQ 901
R +++ +SR S L + + +L +CL+ + + P +L I +
Sbjct: 769 LSCQARLVMYIERDSRKTSPGKEL-QSGNEYLARCLDLLIQHMVQESPRILGDILNALAN 827
Query: 902 MMGGRRHGQISAITSRAAPKTNVHLFPVVLHLLGSSSFKNRVVSPPVLQQLANLCKVV-- 959
+ GR+H S + + K + + PVVLHL+ S F+ +VV+ L + +
Sbjct: 828 V-SGRKHP--STVQGKQL-KMCLPMMPVVLHLVMSQVFRPQVVTEEFLFSYGTILSHIKS 883
Query: 960 ----ETQFQGR------DDFQITLLRILESISEESNVILGNPEIFFHEILPSLTVLYKGN 1009
ET G ++F L E++ + ++ ILP L L + +
Sbjct: 884 IDLGETNIDGAIGIVASEEFIKITLSAFEAVIQYPVLLADYRATVVDYILPPLVSLVQ-S 942
Query: 1010 KDGDARFLCLKILSDVMIILLN-EPVE-DEQRLQD----LKSISNSHFLPLYPTLIEDED 1063
++ + R L++LS+ +L++ EP + DE+ D L ++ LP Y ++ + D
Sbjct: 943 QNVEWRLFSLRLLSETTTLLVSQEPEDGDEEASCDSDSGLLALIRDELLPQYEHILMEPD 1002
Query: 1064 PIPMYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGDLSS--ANV--SNVKLCLALA 1119
P+P YA K+LV + E + K V FE +L S N S + L L
Sbjct: 1003 PVPAYALKLLVAMTEHNPAFTRLVAESKLVPLIFEVILEHQESILGNTMQSVIALLNNLV 1062
Query: 1120 SAPEMESKLLSQLKVVRRIGNLLE----LVYAKDMEDFLEPTLGLCRAFL 1165
+ + +LL + +V + N+ L +D + EP L + L
Sbjct: 1063 AYKDSNMQLLYEQGLVGHVCNMFTETATLCLDRDNKTNTEPAATLLASLL 1112
|
|
| UNIPROTKB|D4A8P3 Stk36 "Protein Stk36" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 505 (182.8 bits), Expect = 6.0e-47, Sum P(2) = 6.0e-47
Identities = 125/345 (36%), Positives = 183/345 (53%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK---SQKS-KVLQ-EVRMLHSLDH 55
M +YH+ E IG G + VYKGRKK + + A+K + K S+K + LQ E+ ++ L H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRKKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLWH 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
PN++ +ET + +V +Y G +L +L D +LPE+ ++ +A LV AL YLHS
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDYAEG-ELFQILEDDGKLPEEQVQAIAAQLVSALYYLHSH 119
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I++ D+KP NILL + G KLCDFG AR +S + +L K GTP YM+PEL EE
Sbjct: 120 RILHRDMKPQNILLAKGGGIKLCDFGFARAMS----TNTMVLTSIK-GTPLYMSPELVEE 174
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILXXXXXXXXXXXXXXFANLIN 235
+ + +DLW +GC+LYE G PPF QLV S++ F N +
Sbjct: 175 RP-YDHTADLWSVGCILYELAVGTPPFYTTSIFQLV-SLILKDPVRWPSTITSCFKNFLQ 232
Query: 236 SLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKGAVRQDENSMLGSTPV-RV 294
LL KDP QRL W DL H F ++T + P + + E +L R+
Sbjct: 233 GLLTKDPRQRLSWPDLLHHPFIAGRVTIITEPAGSNLGTPFTSRLPPELQVLKDEQAHRL 292
Query: 295 TPSGRKTQT--KTSGRVFEE-KQKDPSGTTRQVNL-LRLSRIVKS 335
P G +++ + R+ EE KQK+ T ++ RLS++ S
Sbjct: 293 APKGNQSRILRQACKRMAEEAKQKEDQNTGSTLDQEARLSKVTPS 337
|
|
| UNIPROTKB|E1B793 STK36 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 508 (183.9 bits), Expect = 3.9e-46, Sum P(2) = 3.9e-46
Identities = 123/329 (37%), Positives = 175/329 (53%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK---SQKS-KVLQ-EVRMLHSLDH 55
M +YH+ E IG G + VYKGR+K + + A+K + K S+K + LQ E+ ++ L H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
PN++ +ET + +V +Y G +L +L D +LPED ++ +A LV AL YLHS
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDYAEG-ELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSH 119
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I++ D+KP NILL + G KLCDFG AR +S + +L K GTP YM+PEL EE
Sbjct: 120 RILHRDMKPQNILLAKGGGIKLCDFGFARAMS----TNTMVLTSIK-GTPLYMSPELVEE 174
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILXXXXXXXXXXXXXXFANLIN 235
+ + +DLW +GC+LYE G PPF QLV S++ F N +
Sbjct: 175 RP-YDHTADLWSVGCILYELAVGTPPFYTTSIFQLV-SLILKDPVRWPPTISPCFKNFLQ 232
Query: 236 SLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKGAVRQDENSMLGSTPV-RV 294
LL KDP QRL W DL H F ++T + P P F + + E +L R+
Sbjct: 233 GLLTKDPRQRLSWPDLLHHPFIAGRVTILTEPAGPDFGTPFTSRLPPELQVLKDQQAHRL 292
Query: 295 TPSGRKTQT--KTSGRVFEE-KQKDPSGT 320
P G ++ + R+ EE KQK T
Sbjct: 293 APKGNRSHILRQACKRMAEEAKQKKHQNT 321
|
|
| UNIPROTKB|C9JDA4 STK36 "Serine/threonine-protein kinase 36" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 493 (178.6 bits), Expect = 7.6e-46, P = 7.6e-46
Identities = 110/275 (40%), Positives = 153/275 (55%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK---SQKS-KVLQ-EVRMLHSLDH 55
M +YH+ E IG G + VYKGR+K + + A+K + K S+K + LQ E+ ++ L H
Sbjct: 1 MEKYHVLEMIGEGSFGRVYKGRRKYSAQVVALKFIPKLGRSEKELRNLQREIEIMRGLRH 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
PN++ +ET + +V +Y G +L +L D +LPED ++ +A LV AL YLHS
Sbjct: 61 PNIVHMLDSFETDKEVVVVTDYAEG-ELFQILEDDGKLPEDQVQAIAAQLVSALYYLHSH 119
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I++ D+KP NILL + G KLCDFG AR +S + +L K GTP YM+PEL EE
Sbjct: 120 RILHRDMKPQNILLAKGGGIKLCDFGFARAMS----TNTMVLTSIK-GTPLYMSPELVEE 174
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILXXXXXXXXXXXXXXFANLIN 235
+ + +DLW +GC+LYE G PPF QLV S++ F N +
Sbjct: 175 RP-YDHTADLWSVGCILYELAVGTPPFYATSIFQLV-SLILKDPVRWPSTISPCFKNFLQ 232
Query: 236 SLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQP 270
LL KDP QRL W DL H F +T + P P
Sbjct: 233 GLLTKDPRQRLSWPDLLYHPFIAGHVTIITEPAGP 267
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00019833001 | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (1267 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1335 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-90 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-80 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-71 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-69 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-68 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-65 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-62 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-59 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-59 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-57 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-57 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-55 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-53 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-51 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-51 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-51 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-51 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-50 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-49 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-49 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-49 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-48 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-47 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-46 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-46 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-46 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-45 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 9e-45 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-45 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-43 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-43 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-43 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-43 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-42 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-42 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-42 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-41 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-41 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-41 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-40 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-39 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-39 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-39 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-39 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-39 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-38 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-38 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-38 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-38 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-38 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-38 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-38 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-38 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-38 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-38 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-37 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-37 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-37 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-37 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-37 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-37 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-37 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-37 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-37 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-37 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-37 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-37 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-37 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-36 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-35 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-35 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-35 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-35 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-35 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-35 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-35 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-35 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-35 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-35 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-35 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-34 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-34 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-34 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-34 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-34 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-34 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-34 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-34 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-33 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-33 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-33 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-33 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-33 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-33 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-33 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-32 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-32 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-32 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-32 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-32 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-32 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-32 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-32 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-32 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-32 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-32 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-32 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-31 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-31 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-31 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-31 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-30 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-30 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-30 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-30 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-30 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-30 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-30 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-30 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-30 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-29 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-29 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-29 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-29 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-29 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-29 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-29 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-29 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-29 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-29 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-28 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-28 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-28 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-28 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-28 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-28 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-28 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-28 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-28 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-27 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-27 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-27 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-27 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-27 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-27 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-27 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-27 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-27 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-26 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-26 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-26 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-26 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-26 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-26 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-26 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-26 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-26 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-25 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-25 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-25 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-25 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-25 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-25 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-25 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-25 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-25 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-25 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-25 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-25 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-24 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-24 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-24 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-23 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-23 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-23 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-22 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-22 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-22 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-22 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-22 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-22 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-22 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-21 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-21 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-21 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-21 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-21 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-20 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-20 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-17 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-17 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-16 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-14 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-12 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 9e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-08 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 4e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 5e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 9e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 8e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.001 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 0.002 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 291 bits (747), Expect = 5e-90
Identities = 111/260 (42%), Positives = 149/260 (57%), Gaps = 14/260 (5%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK----VLQEVRMLHSLDHPNVL 59
Y I E +G G + VY R KKT + AIK + K + K +L+E+++L L HPN++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
R Y +E L+LV+EYC GGDL LL++ +L ED R + ++ AL+YLHSKGI++
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
DLKP NILLDE+G KL DFGLAR+L K + GTP YMAPE+ G +
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF------VGTPEYMAPEVLLGKG-Y 173
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP---SRPFANLINS 236
A D+W LG +LYE G+PPF G + + + P PP P S +LI
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233
Query: 237 LLVKDPAQRLHWSDLCGHAF 256
LLVKDP +RL + H F
Sbjct: 234 LLVKDPEKRLTAEEALQHPF 253
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 265 bits (680), Expect = 1e-80
Identities = 103/265 (38%), Positives = 147/265 (55%), Gaps = 16/265 (6%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDHPNV 58
Y + +G G + TVYK + K T + A+K + K + +E+R+L L HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+R +E HL+LV+EYC GGDL L + L ED + +A ++R L+YLHS GII
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
+ DLKP NILLDENG K+ DFGLA+KL +S + ++ GTP YMAPE+ G
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF-----VGTPWYMAPEVLLGGNG 175
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVGREFT---QLVKSILSDP---SPPLPGNPSRPFAN 232
+ D+W LG +LYE G+PPF G QL++ IL P P + S +
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 233 LINSLLVKDPAQRLHWSDLCGHAFW 257
LI L KDP++R ++ H ++
Sbjct: 236 LIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 237 bits (608), Expect = 5e-71
Identities = 93/252 (36%), Positives = 142/252 (56%), Gaps = 15/252 (5%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-----KSQKSKVLQEVRMLHSLDHPN 57
+Y I + IG+G + VY R+K + + +K +D + ++ L EV++L L+HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ----LPEDSIRDLAQDLVRALQYLH 113
++++Y +E L +V+EY GGDL +++ + PE+ I D L AL+YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
S+ I++ D+KP NI L NG KL DFG+++ LS ++ GTP Y++PEL
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-----VGTPYYLSPELC 175
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233
+ ++Y SD+W LGCVLYE + PF G +L IL PP+P S NL
Sbjct: 176 QNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL 234
Query: 234 INSLLVKDPAQR 245
++SLL KDP +R
Sbjct: 235 VSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 2e-69
Identities = 98/257 (38%), Positives = 146/257 (56%), Gaps = 16/257 (6%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQ---EVRMLHSLDHPNVLRFYS 63
+G+G + V RKK T + +A+K + K ++ +V E +L ++HP +++ +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
++T L+LVLEY GG+L S L ++ + E+ R A ++V AL+YLHS GIIY DLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYAS 183
P NILLD +G KL DFGLA++LS ++ CGTP Y+APE+ G + A
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTF-----CGTPEYLAPEVLLGKG-YGKAV 174
Query: 184 DLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPA 243
D W LG +LYE G+PPF + ++ + IL DP P S +LI+ LL KDP
Sbjct: 175 DWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP-LRFPEFLSPEARDLISGLLQKDPT 233
Query: 244 QRLHW---SDLCGHAFW 257
+RL ++ H F+
Sbjct: 234 KRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 227 bits (581), Expect = 5e-68
Identities = 91/251 (36%), Positives = 128/251 (50%), Gaps = 43/251 (17%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQ----EVRMLHSLDHPNVLRFYSWY 65
+G G + TVY R KKT + AIK + K S +L+ E+ +L L+HPN+++ Y +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLHSKGIIYCDLKP 124
E HL+LV+EYC GG L LL+++ L ED I + ++ L+YLHS GII+ DLKP
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120
Query: 125 SNILLDE-NGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYAS 183
NILLD NG+ KL DFGL++ L+ + GTP YMAPE+ G +S S
Sbjct: 121 ENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-----IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 184 DLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPA 243
D+W LG +LYE +LI +L KDP
Sbjct: 176 DIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPE 203
Query: 244 QRLHWSDLCGH 254
+R ++ H
Sbjct: 204 KRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 7e-65
Identities = 95/258 (36%), Positives = 141/258 (54%), Gaps = 13/258 (5%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDHPNVLRFY 62
E +GRG + +VY K T E A+KSV+ S S+ + +E+R+L SL HPN++R+Y
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 63 --SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
E L + LEY GG L SLL++ +LPE IR + ++ L YLHS GI++
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
D+K +NIL+D +G KL DFG A++L D + + GTP +MAPE+ G +
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVR---GTPYWMAPEVI-RGEEYG 181
Query: 181 YASDLWGLGCVLYECYAGRPPF--VGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLL 238
A+D+W LGC + E G+PP+ +G L K S P +P + S + + L
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCL 241
Query: 239 VKDPAQRLHWSDLCGHAF 256
+DP +R +L H F
Sbjct: 242 RRDPKKRPTADELLQHPF 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 7e-62
Identities = 97/268 (36%), Positives = 140/268 (52%), Gaps = 26/268 (9%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSK-VLQEVRMLHSLD- 54
+ + + IG G +STV ++K+T + +AIK +DK Q K K V E +L L+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HP +++ Y ++ +L+ VLEY G+L+ +R+ L E R A +++ AL+YLHS
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK------------- 161
KGII+ DLKP NILLD++ K+ DFG A K+ D + +P S A
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTA-KVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 162 ---CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP 218
GT Y++PEL E +SDLW LGC++Y+ G+PPF G + IL
Sbjct: 180 ASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238
Query: 219 SPPLPGNPSRPFANLINSLLVKDPAQRL 246
P P +LI LLV DP RL
Sbjct: 239 YSFPPNFPPD-AKDLIEKLLVLDPQDRL 265
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 3e-59
Identities = 91/258 (35%), Positives = 139/258 (53%), Gaps = 13/258 (5%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDHPN 57
Y + + IGRG + VYKG +T ++ AIK + + + ++QE+ +L +L HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPED-SIRDLAQDLVRALQYLHSKG 116
++++ ETS L+++LEY G L ++++ PE + Q L + L YLH +G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL-QGLAYLHEQG 119
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
+I+ D+K +NIL ++G KL DFG+A KL+D SK +S++ GTP +MAPE+ E
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-----GTPYWMAPEVIEMS 174
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
G S ASD+W LGC + E G PP+ + I+ D PPLP S + +
Sbjct: 175 GA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQ 233
Query: 237 LLVKDPAQRLHWSDLCGH 254
KDP R L H
Sbjct: 234 CFQKDPNLRPTAKQLLKH 251
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 5e-59
Identities = 96/259 (37%), Positives = 146/259 (56%), Gaps = 13/259 (5%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD---KSQKSKVLQEVRMLHSLDHPNVLR 60
+ I E IG+G + VYK R K+T + AIK + K +K K++ E+++L HPN+++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLHSKGIIY 119
+Y Y LW+V+E+C GG L LL+ NQ L E I + ++L++ L+YLHS GII+
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
D+K +NILL +G KL DFGL+ +LSD +KA ++M GTP +MAPE+ G +
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSD-TKARNTM-----VGTPYWMAPEVI-NGKPY 174
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN--PSRPFANLINSL 237
Y +D+W LG E G+PP+ + + I ++ P L S F + +
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKC 234
Query: 238 LVKDPAQRLHWSDLCGHAF 256
L K+P +R L H F
Sbjct: 235 LQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 2e-57
Identities = 99/247 (40%), Positives = 135/247 (54%), Gaps = 11/247 (4%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYS 63
I +G Y V+ +KK T + +AIK + K+ Q +VL E +L P V++ Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
++ +L+LV+EY GGDL SLL L ED R ++V AL+YLHS GII+ DLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 124 PSNILLDENGRTKLCDFGLARK-LSDASKAPSSMLPQAK--CGTPCYMAPELFEEGGVHS 180
P NIL+D NG KL DFGL++ L + + K GTP Y+APE+ G HS
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HS 179
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPSPPLPGNPSRPFANLINSLLV 239
D W LGC+LYE G PPF G ++ ++IL+ P S +LI+ LLV
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 240 KDPAQRL 246
DP +RL
Sbjct: 240 PDPEKRL 246
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 5e-57
Identities = 84/246 (34%), Positives = 128/246 (52%), Gaps = 16/246 (6%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYS 63
+G G + V + K FA+K V K Q+ + E +L +HP +++ Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
++ ++++++EYC+GG+L ++LR E + R +V A +YLH++GIIY DLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYAS 183
P N+LLD NG KL DFG A+KL K + CGTP Y+APE+ G + ++
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF------CGTPEYVAPEIILNKG-YDFSV 173
Query: 184 DLWGLGCVLYECYAGRPPFVGREFTQLV--KSILSDPSP-PLPGNPSRPFANLINSLLVK 240
D W LG +LYE GRPPF + + IL P + +LI LL +
Sbjct: 174 DYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233
Query: 241 DPAQRL 246
+P +RL
Sbjct: 234 NPEERL 239
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 6e-55
Identities = 89/261 (34%), Positives = 132/261 (50%), Gaps = 26/261 (9%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPN 57
Y + E IG+G + TV K R+K + K +D K +++ EV +L L HPN
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60
Query: 58 VLRFYSWY--ETSAHLWLVLEYCVGGDLMSLL---RQDNQ-LPEDSIRDLAQDLVRALQY 111
++R+Y ++ L++V+EYC GGDL L+ +++ + + E+ I + L+ AL
Sbjct: 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 112 LHSKG-----IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC 166
H++ +++ DLKP+NI LD N KL DFGLA+ L S + GTP
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-----DSSFAKTYVGTPY 175
Query: 167 YMAPELFEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPG 224
YM+PE SY SD+W LGC++YE A PPF R QL I +P
Sbjct: 176 YMSPEQLNH---MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPY 232
Query: 225 NPSRPFANLINSLLVKDPAQR 245
S +I S+L DP +R
Sbjct: 233 RYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 4e-53
Identities = 93/255 (36%), Positives = 138/255 (54%), Gaps = 24/255 (9%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSK----VLQEVRMLHSLDH 55
+ + + +G G + V R K + +Y+A+K + K++ K K VL E R+L S+ H
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
P ++ Y ++ ++L+LV+EY GG+L S LR+ + PE R A +V AL+YLHS
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I+Y DLKP N+LLD +G K+ DFG A+++ + L CGTP Y+APE+
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY----TL----CGTPEYLAPEIILS 172
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----PSPPLPGNPSRPFA 231
G + A D W LG ++YE AG PPF Q+ + IL PS S
Sbjct: 173 KG-YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF-----FSPDAK 226
Query: 232 NLINSLLVKDPAQRL 246
+LI +LL D +RL
Sbjct: 227 DLIRNLLQVDLTKRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 3e-51
Identities = 104/307 (33%), Positives = 144/307 (46%), Gaps = 44/307 (14%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHPNVLRFYS 63
+G+G V+ R K T + FA+K +DK + K VL E +L +LDHP + Y+
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68
Query: 64 WYETSAHLWLVLEYCVGGDLMSLL--RQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
++T +L LV++YC GG+L LL + L E+ R A +++ AL+YLH GI+Y D
Sbjct: 69 SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRD 128
Query: 122 LKPSNILLDENGRTKLCDFGL--------------ARKLSDASKAPSSMLPQAKC----- 162
LKP NILL E+G L DF L RK S S S
Sbjct: 129 LKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR 188
Query: 163 -----GTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD 217
GT Y+APE+ G H A D W LG +LYE G PF G + +IL
Sbjct: 189 SNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKK 247
Query: 218 PSPPLPGNPSRPFA--NLINSLLVKDPAQRLHW----SDLCGHAFWRT----KLTPMPLP 267
PG+P + +LI LLVKDP++RL +++ H F+R + P
Sbjct: 248 E-VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPP 306
Query: 268 PQPAFDS 274
P D
Sbjct: 307 IIPRPDD 313
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 3e-51
Identities = 82/262 (31%), Positives = 134/262 (51%), Gaps = 17/262 (6%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-----KSQKSKVLQEVRMLHSLDHPN 57
+ + + +G+G Y +VYK ++ +++A+K VD + ++ + E+R+L S++HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQD----NQLPEDSIRDLAQDLVRALQYLH 113
++ + + L +V+EY GDL + + +PE I + L+R LQ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
+ I++ DLK +NILL N K+ D G+ SK + + + GTP YMAPE++
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGI-------SKVLKKNMAKTQIGTPHYMAPEVW 173
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233
+ G +SY SD+W LGC+LYE PPF R L + PP+P S+ N
Sbjct: 174 K-GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNF 232
Query: 234 INSLLVKDPAQRLHWSDLCGHA 255
I S+L P R + +
Sbjct: 233 IRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 3e-51
Identities = 87/256 (33%), Positives = 146/256 (57%), Gaps = 15/256 (5%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
+G+G VYK R K T + +A+K + D+ + ++L+E++ L S + P V++ Y +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLKP 124
+ +VLEY GG L LL++ ++PE + +A+ +++ L YLH+K II+ D+KP
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKP 128
Query: 125 SNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASD 184
SN+L++ G K+ DFG+++ L + ++ GT YM+PE +G +SYA+D
Sbjct: 129 SNLLINSKGEVKIADFGISKVLENTLDQCNTF-----VGTVTYMSPERI-QGESYSYAAD 182
Query: 185 LWGLGCVLYECYAGRPPFVGRE---FTQLVKSILSDPSPPLPGNP-SRPFANLINSLLVK 240
+W LG L EC G+ PF+ F +L+++I P P LP S F + I++ L K
Sbjct: 183 IWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQK 242
Query: 241 DPAQRLHWSDLCGHAF 256
DP +R ++L H F
Sbjct: 243 DPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 4e-51
Identities = 86/254 (33%), Positives = 133/254 (52%), Gaps = 17/254 (6%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK-------SKVLQEVRMLHSLDH 55
+ + IG+G + V +K+ T + FA+K ++K QK VL E R+L L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNK-QKCVEKGSVRNVLNERRILQELNH 59
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
P ++ + ++ +++LV++ +GGDL L Q + E+ ++ ++V AL+YLHSK
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
GII+ D+KP NILLDE G + DF +A K++ + S GTP YMAPE+
Sbjct: 120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS------TSGTPGYMAPEVL-C 172
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVG--REFTQLVKSILSDPSPPLPGNPSRPFANL 233
+S A D W LG YEC G+ P+ G R +++ P S +
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDA 232
Query: 234 INSLLVKDPAQRLH 247
IN LL +DP +RL
Sbjct: 233 INKLLERDPQKRLG 246
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 1e-50
Identities = 86/261 (32%), Positives = 140/261 (53%), Gaps = 14/261 (5%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-KSQKSKVLQEVRMLHSLDHPNVLR 60
+ I E +G G Y +VYK K+T + AIK V + ++++E+ +L D P +++
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 61 FYSWYETSAHLWLVLEYCVGG---DLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+Y Y + LW+V+EYC G D+M + + L E+ I + ++ L+YLHS
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNKK 120
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
I+ D+K NILL+E G+ KL DFG++ +L+D ++++ GTP +MAPE+ +E G
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-----GTPFWMAPEVIQEIG 175
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGNPSRPFANLIN 235
++ +D+W LG E G+PP+ + + I + P P L P S F + +
Sbjct: 176 -YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234
Query: 236 SLLVKDPAQRLHWSDLCGHAF 256
LVKDP +R L H F
Sbjct: 235 KCLVKDPEERPSAIQLLQHPF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 4e-49
Identities = 82/263 (31%), Positives = 139/263 (52%), Gaps = 12/263 (4%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK----VLQEVRMLHSLDHPN 57
+ + E IG+G + VYK K+T + AIK +D + + QE++ L P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+ ++Y + + LW+++EYC GG + LL+ +L E I + ++++ L+YLH +G
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEGK 119
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
I+ D+K +NILL E G KL DFG++ +L+ ++ + GTP +MAPE+ ++ G
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFWMAPEVIKQSG 174
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP-SRPFANLINS 236
+ +D+W LG E G PP +++ I + P L GN S+PF + ++
Sbjct: 175 -YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL 233
Query: 237 LLVKDPAQRLHWSDLCGHAFWRT 259
L KDP +R +L H F +
Sbjct: 234 CLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 4e-49
Identities = 91/275 (33%), Positives = 139/275 (50%), Gaps = 26/275 (9%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIK--SVDKSQKSKVLQEVRMLHSL-DHPNV 58
+ + E IG G Y VYK R KKT + AIK + + ++ ++ +E +L +HPN+
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 59 LRFYSWYETSAH------LWLVLEYCVGG---DLM-SLLRQDNQLPEDSIRDLAQDLVRA 108
FY + LWLV+E C GG DL+ L ++ +L E+ I + ++ +R
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG 125
Query: 109 LQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC-GTPCY 167
L YLH +I+ D+K NILL +N KL DFG++ +L S++ + GTP +
Sbjct: 126 LAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------STLGRRNTFIGTPYW 179
Query: 168 MAPELF--EEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL- 222
MAPE+ +E SY SD+W LG E G+PP + + I +P P L
Sbjct: 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK 239
Query: 223 -PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
P N S+ F + I+ L+K+ QR +L H F
Sbjct: 240 SPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 9e-49
Identities = 91/265 (34%), Positives = 137/265 (51%), Gaps = 27/265 (10%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLH-SLDHPNVLRFY 62
+G+G + V K T E +A+K + K Q V + E R+L + HP + + +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
S ++T L+ V+EY GGDLM +++ + E R A ++V LQ+LH +GIIY DL
Sbjct: 63 SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK----CGTPCYMAPELFEEGGV 178
K N+LLD G K+ DFG+ ++ +L CGTP Y+APE+
Sbjct: 123 KLDNVLLDSEGHIKIADFGMCKE---------GILGGVTTSTFCGTPDYIAPEILSYQP- 172
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLL 238
+ A D W LG +LYE AG+ PF G + +L +SIL D P S+ +++ S L
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-VRYPRWLSKEAKSILKSFL 231
Query: 239 VKDPAQRLHWS-----DLCGHAFWR 258
K+P +RL D+ GH F+R
Sbjct: 232 TKNPEKRLGCLPTGEQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 4e-48
Identities = 87/259 (33%), Positives = 134/259 (51%), Gaps = 19/259 (7%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV------DKSQKSKVLQEVRMLHSLD 54
+ + I + IG+G++S VYK A+K V D + L+E+ +L LD
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLR----QDNQLPEDSIRDLAQDLVRALQ 110
HPNV+++ + + + L +VLE GDL +++ Q +PE +I L AL+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 111 YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAP 170
++HSK I++ D+KP+N+ + G KL D GL R S + A S GTP YM+P
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-----LVGTPYYMSP 175
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT--QLVKSILSDPSPPLPGNP-S 227
E E G +++ SD+W LGC+LYE A + PF G + L K I PPLP + S
Sbjct: 176 ERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234
Query: 228 RPFANLINSLLVKDPAQRL 246
+L++ + DP +R
Sbjct: 235 EELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 8e-48
Identities = 114/380 (30%), Positives = 168/380 (44%), Gaps = 30/380 (7%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHP- 56
Y I +G G + VY R +K A+K + K +SK L+E+++L SL+HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQD---NQLPEDSIRDLAQDLVRALQYLH 113
N+++ Y +++ L+LV+EY GG L LL++ L E + ++ AL+YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 114 SKGIIYCDLKPSNILLDENG-RTKLCDFGLARKLSDA-SKAPSSMLPQAKCGTPCYMAPE 171
SKGII+ D+KP NILLD +G KL DFGLA+ L D S + LP GTP YMAPE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 172 LFEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGR----EFTQLVKSILSDPSPPLPGN 225
+ + +SD+W LG LYE G PPF G +Q +K IL P+P L
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238
Query: 226 PSRP--------FANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKG 277
S ++L+ LL KDP RL S H
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSA 298
Query: 278 AVRQDE-NSMLGSTPVRVTPSGRKTQTKTSGRVFEEKQKDPSGTTRQVNLLRLSRIVKSN 336
+R S+ + + + K F ++ ++ N L S+
Sbjct: 299 PLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASS 358
Query: 337 LQRENDKENYRRPLPNGSEN 356
+ K + R + S +
Sbjct: 359 KRSSLPKISARSSPSSLSSS 378
|
Length = 384 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 4e-47
Identities = 89/247 (36%), Positives = 132/247 (53%), Gaps = 20/247 (8%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSL-DHPNVLRFY 62
I +G + +VY +K+ T +YFAIK + KS Q + V E ++ + P V + Y
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
+++ +L+LV+EY GGD SL++ LPED + ++V ++ LH +GII+ D+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
KP N+L+D+ G KL DFGL+R + + + GTP Y+APE G
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSR---------NGLENKKFVGTPDYLAPETI-LGVGDDKM 173
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPSPPLPGNPS-RPFA-NLINSLLV 239
SD W LGCV++E G PPF + +ILS + P P A +LIN LL
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233
Query: 240 KDPAQRL 246
DPA+RL
Sbjct: 234 MDPAKRL 240
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 84/258 (32%), Positives = 136/258 (52%), Gaps = 15/258 (5%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV---DKSQKSK-----VLQEVRMLHSLDHPNVL 59
E +G G + +VY+G ++FA+K V D Q + + QE+ +L L HPN++
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
++ +L++ LE GG L LL++ PE IR + ++ L+YLH + ++
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
D+K +NIL+D NG KL DFG+A+++ + S A S G+P +MAPE+ + G +
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK------GSPYWMAPEVIAQQGGY 179
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS-PPLPGNPSRPFANLINSLL 238
A+D+W LGC + E G+PP+ E V I PP+P + S + I L
Sbjct: 180 GLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCL 239
Query: 239 VKDPAQRLHWSDLCGHAF 256
+DP+ R ++L H F
Sbjct: 240 QRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-46
Identities = 81/249 (32%), Positives = 128/249 (51%), Gaps = 13/249 (5%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-----KSQKSKVLQEVRMLHSLDHPNV 58
+ I IG+G + V+K +K +A+K +D + ++ + + E R+L LD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLR--QDNQLPEDSIRDLAQDLVRALQYLHSKG 116
+R+Y + L +V+EY GDL LL+ + LPED + ++ L +LHSK
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
I++ D+K N+ LD K+ D G+A+ LS ++ GTP Y++PEL E+
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-----DNTNFANTIVGTPYYLSPELCEDK 176
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
++ SD+W LG VLYEC G+ PF L+ I+ PP+ S+ A LI+
Sbjct: 177 P-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ 235
Query: 237 LLVKDPAQR 245
L KD QR
Sbjct: 236 CLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 7e-46
Identities = 86/250 (34%), Positives = 127/250 (50%), Gaps = 16/250 (6%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKS------VDKSQKSKVLQEVRMLHSLDHP 56
+ +G G + V+ R + + Y+A+K + Q+ V E R+L + HP
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
++R + L++++EY GG+L S LR + + A ++V AL+YLHSK
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE 121
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
I+Y DLKP NILLD+ G KL DFG A+KL D + CGTP Y+APE+ +
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT--------WTLCGTPEYLAPEVIQSK 173
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
G H+ A D W LG ++YE G PPF + + IL+ P + +LI
Sbjct: 174 G-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-KLEFPRHLDLYAKDLIKK 231
Query: 237 LLVKDPAQRL 246
LLV D +RL
Sbjct: 232 LLVVDRTRRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 88/258 (34%), Positives = 132/258 (51%), Gaps = 13/258 (5%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSKVLQ---EVRMLHSLDHPNVLRFYSW 64
IG G + VY T E A+K + + + + E+++L L HPN++++Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 65 YETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKP 124
+++ +EYC GG L LL L E IR L+ L YLHS GI++ D+KP
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKP 127
Query: 125 SNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSY--A 182
+NI LD NG KL DFG A KL + + + Q+ GTP YMAPE+ G + A
Sbjct: 128 ANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV-QSLAGTPAYMAPEVITGGKGKGHGRA 186
Query: 183 SDLWGLGCVLYECYAGRPPFVG--REFTQLVKSILSDPSPPLPGN--PSRPFANLINSLL 238
+D+W LGCV+ E G+ P+ EF Q++ + + PP+P + S + ++ L
Sbjct: 187 ADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCL 245
Query: 239 VKDPAQRLHWSDLCGHAF 256
DP +R S+L H F
Sbjct: 246 ESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 83/259 (32%), Positives = 137/259 (52%), Gaps = 20/259 (7%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK----VLQEVRMLHSLDHPNVLRFYSWY 65
+G G V K + T + A+K++ +L+E+ +LH + P ++ FY +
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLK 123
+ + + +EY GG L +L++ ++PE + +A +++ L YLH K II+ D+K
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVK 128
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYAS 183
PSNIL++ G+ KLCDFG++ +L + S A + GT YMAPE +G +S S
Sbjct: 129 PSNILVNSRGQIKLCDFGVSGQLVN-SLA------KTFVGTSSYMAPERI-QGNDYSVKS 180
Query: 184 DLWGLGCVLYECYAGRPPFVGREFT-----QLVKSILSDPSPPLPGNP-SRPFANLINSL 237
D+W LG L E GR P+ +L++ I+++P P LP S F + +N
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLC 240
Query: 238 LVKDPAQRLHWSDLCGHAF 256
L+KDP +R + +L H F
Sbjct: 241 LIKDPRERPSYKELLEHPF 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 9e-45
Identities = 88/279 (31%), Positives = 126/279 (45%), Gaps = 44/279 (15%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK-----SKVLQEVRMLHSLDHPNV 58
Y E +G G Y VYK R KKT E A+K + + S L+E+ +L L HPN+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGI 117
++ T L+LV EYC DL L + L + I+ + L+R L Y HS I
Sbjct: 61 VKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA--PSSMLPQAKCGTPCYMAPELFEE 175
++ DLKP NIL++ +G KL DFGLAR + + T Y APE+
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-------TLWYRAPEILLG 172
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK----------------SILSDP 218
+S A D+W +GC+ E G+P F G E QL K + L D
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232
Query: 219 SPPLPGNPSRPFA-----------NLINSLLVKDPAQRL 246
P P P + +L++ +L +PA+R+
Sbjct: 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI 271
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 9e-45
Identities = 81/257 (31%), Positives = 132/257 (51%), Gaps = 14/257 (5%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDH--- 55
Y E IGRG Y VY+G+ T A+K + S + +EV +L L
Sbjct: 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQP 61
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
PN+ ++Y Y LW+++EY GG + +L++ + E I + ++++ AL+Y+H
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKV 120
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
G+I+ D+K +NIL+ G KLCDFG+A L+ S S+ + GTP +MAPE+ E
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-----GTPYWMAPEVITE 175
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP-SRPFANLI 234
G + +D+W LG +YE G PP+ + + + I P L N S+ +
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFV 235
Query: 235 NSLLVKDPAQRLHWSDL 251
+ L ++P +RL +L
Sbjct: 236 AACLDEEPKERLSAEEL 252
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 83/270 (30%), Positives = 137/270 (50%), Gaps = 19/270 (7%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD--KSQKS--KVLQEVRMLHSLDHPN 57
+ Y + E IG G + VY E AIK +D K Q S ++ +EV+ + +HPN
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ---LPEDSIRDLAQDLVRALQYLHS 114
V+++Y+ + LWLV+ Y GG L+ +++ L E I + +++++ L+YLHS
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK---CGTPCYMAPE 171
G I+ D+K NILL E+G K+ DFG++ L+D + + GTPC+MAPE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD----GGDRTRKVRKTFVGTPCWMAPE 176
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP----- 226
+ E+ + + +D+W G E G P+ +++ L + P L
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY 236
Query: 227 SRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
S+ F +I+ L KDP++R +L H F
Sbjct: 237 SKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 71/260 (27%), Positives = 121/260 (46%), Gaps = 20/260 (7%)
Query: 5 HIYEAIGRGKYSTVYKGRKKKTIEYF----AIKSV----DKSQKSKVLQEVRMLHSLDHP 56
+ + +G G + VYKG K E A+K++ + ++ + L+E ++ L HP
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHP 61
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSK 115
N++R L++V EY GGDL+ LR+ +L + +A + + ++YL SK
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESK 121
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSMLPQAKCGTPCYMAPEL 172
++ DL N L+ EN K+ DFGL+R + + K LP +MAPE
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP------IKWMAPES 175
Query: 173 FEEGGVHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFA 231
++ G + SD+W G +L+E G P+ G ++++ + P P N
Sbjct: 176 LKD-GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELY 234
Query: 232 NLINSLLVKDPAQRLHWSDL 251
L+ DP R +S+L
Sbjct: 235 ELMLQCWAYDPEDRPTFSEL 254
|
Length = 258 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 3e-43
Identities = 88/252 (34%), Positives = 130/252 (51%), Gaps = 16/252 (6%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK------SQKSKVLQEVRMLHSLD 54
++ + + E +G G + V + K T EY+AIK + K Q V QE +L L
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HP ++ ++ ++ +LE+ VGG+L + LR+ + P D + +LV A +YLHS
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
K IIY DLKP N+LLD G K+ DFG A+K+ D + CGTP Y+APE+ +
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--------FTLCGTPEYLAPEVIQ 188
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
G H A D W +G +LYE AG PPF ++ + IL+ P +L+
Sbjct: 189 SKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG-RLKFPNWFDGRARDLV 246
Query: 235 NSLLVKDPAQRL 246
LL D +RL
Sbjct: 247 KGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 3e-43
Identities = 85/271 (31%), Positives = 138/271 (50%), Gaps = 16/271 (5%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD--KSQKSKVLQEVRMLHSLDHPNVLRF 61
Y E IG G VYK + T + AIK + K K ++ E+ ++ HPN++ +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
Y Y LW+V+EY GG L ++ Q ++ E I + +++++ L+YLHS+ +I+
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
D+K NILL ++G KL DFG A +L+ +S++ GTP +MAPE+ + +
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-----GTPYWMAPEVI-KRKDYG 194
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGNPSRPFANLINSLL 238
D+W LG + E G PP++ + + I + PPL P S F + +N L
Sbjct: 195 PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCL 254
Query: 239 VKDPAQRLHWSDLCGHAF-----WRTKLTPM 264
VKDP +R +L H F + + P+
Sbjct: 255 VKDPEKRPSAEELLQHPFLKKACPKEEFAPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 5e-43
Identities = 74/256 (28%), Positives = 121/256 (47%), Gaps = 27/256 (10%)
Query: 10 IGRGKYSTVYKGRKKKTIEYF---AIKSV----DKSQKSKVLQEVRMLHSLDHPNVLRFY 62
+G G + VYKG+ K A+K++ + ++ L+E R++ L HPNV+R
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQ------DNQLPEDSIRDL---AQDLVRALQYLH 113
L+LVLEY GGDL+ LR+ + S++DL A + + ++YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSD---ASKAPSSMLPQAKCGTPCYMAP 170
SK ++ DL N L+ E+ K+ DFGL+R + D K LP + +MAP
Sbjct: 123 SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP-IR-----WMAP 176
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRP 229
E ++ G+ + SD+W G +L+E + G P+ G ++++ + P P
Sbjct: 177 ESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDE 235
Query: 230 FANLINSLLVKDPAQR 245
L+ S DP R
Sbjct: 236 LYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 6e-43
Identities = 94/292 (32%), Positives = 143/292 (48%), Gaps = 38/292 (13%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDH 55
+ + + + IGRG + V+ R K T + +A+K + KS Q + V E +L D
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 56 PNVLR-FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
P +++ +YS+ + HL+LV+EY GGDLM+LL + + PE++ R +LV AL +H
Sbjct: 61 PWIVKLYYSFQDEE-HLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS------------------SM 156
G I+ D+KP NIL+D +G KL DFGL +K++ A
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 157 LPQAKC------GTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQL 210
Q + GTP Y+APE+ G + D W LG +LYE G PPF +
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVL-RGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238
Query: 211 VKSILS-DPSPPLPGNP--SRPFANLINSLLVKDPAQRL-HWSDLCGHAFWR 258
I++ S P +P S +LI LL DP RL + ++ H F++
Sbjct: 239 YNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 88/291 (30%), Positives = 133/291 (45%), Gaps = 43/291 (14%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDHPNV 58
Y IG G Y VYK R KKT E A+K + + + ++E+++L L HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 59 LRFYSWYETSAH--LWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSK 115
+R + +++V EY DL LL + + E I+ + L+ LQYLHS
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYM-DHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
GI++ D+K SNIL++ +G KL DFGLAR + + A + + T Y PEL
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT----NRVITLWYRPPELLLG 175
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDPSP---P----LPGN 225
+ D+W +GC+L E + G+P F G E QL K + P+ P LP
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235
Query: 226 ----PSRPFAN----------------LINSLLVKDPAQRLHWSDLCGHAF 256
P +P+ L++ LL DP +R+ H +
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 86/288 (29%), Positives = 124/288 (43%), Gaps = 41/288 (14%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKV-----LQEVRMLHSLDHPNV 58
Y IG G Y VYK R K T E AIK + +S+ L+E+++L L+HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLHSKGI 117
++ + L+LV E+ DL L++ + LPE I+ L++ L + HS GI
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
++ DLKP N+L++ G KL DFGLAR T Y APEL
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSF-----GSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDPSP---------PLPGN 225
+S D+W +GC+ E + RP F G+ E QL K L P P
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234
Query: 226 PSRPFAN-----------------LINSLLVKDPAQRLHWSDLCGHAF 256
S P L++ +L DP +R+ H +
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 8e-42
Identities = 97/283 (34%), Positives = 145/283 (51%), Gaps = 34/283 (12%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLHSLDHPNVLRFYS 63
+G+G + V R+K T +Y+A+K + K K +V L E R+L + HP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
++T L V+EY GG+L L ++ ED R ++V AL YLHS ++Y DLK
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLK 122
Query: 124 PSNILLDENGRTKLCDFGLARK-LSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSY- 181
N++LD++G K+ DFGL ++ +SD + + CGTP Y+APE+ E+ + Y
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKTF------CGTPEYLAPEVLED---NDYG 173
Query: 182 -ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
A D WGLG V+YE GR PF ++ +L + IL + P S +L+ LL K
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLAGLLKK 232
Query: 241 DPAQRL-----HWSDLCGHAFWRT---------KLTPMPLPPQ 269
DP QRL ++ H F+ + KL P P PQ
Sbjct: 233 DPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEP-PFKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 8e-42
Identities = 78/255 (30%), Positives = 125/255 (49%), Gaps = 19/255 (7%)
Query: 10 IGRGKYSTVYKGR----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNVLRF 61
+G G + VYKG+ K A+K++ + Q + L+E R++ LDHPNV++
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
L++V+EY GGDL+S LR+ +L + A + R ++YL SK I+
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHR 126
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDAS--KAPSSMLPQAKCGTPCYMAPELFEEGGV 178
DL N L+ EN K+ DFGL+R L D + LP +MAPE +E G
Sbjct: 127 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR------WMAPESLKE-GK 179
Query: 179 HSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237
+ SD+W G +L+E + G P+ G ++++ + + P P N +L+
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQC 239
Query: 238 LVKDPAQRLHWSDLC 252
+DP R +S+L
Sbjct: 240 WAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 88/268 (32%), Positives = 124/268 (46%), Gaps = 23/268 (8%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV---DKSQKSKVLQEVRMLHSLDHPNVL 59
Y + + IG G Y VYK R T E AIK + + QE+ ML HPN++
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 60 RFYSWYETSAHLWLVLEYCVGG---DLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
++ Y LW+V+EYC GG D+ + R L E I + ++ ++ L YLH G
Sbjct: 64 AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG 121
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
I+ D+K +NILL E+G KL DFG++ +L+ S + GTP +MAPE+
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAAVE 176
Query: 177 GVHSYAS--DLWGLGCVLYECYAGRPPFVG----REFTQLVKSILSDPSPPL--PGNPSR 228
Y D+W LG E +PP R + KS + P P L S
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS--NFPPPKLKDKEKWSP 234
Query: 229 PFANLINSLLVKDPAQRLHWSDLCGHAF 256
F + I L KDP +R + L H F
Sbjct: 235 VFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 4e-41
Identities = 87/244 (35%), Positives = 130/244 (53%), Gaps = 14/244 (5%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS-------QKSKVLQEVRMLHSLDHPNVLRFY 62
IG+G + V + K +++A+K + K QK + + +L ++ HP ++ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
++T+ L+ VL+Y GG+L L+++ PE R A ++ AL YLHS IIY DL
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
KP NILLD G L DFGL ++ + SK S+ CGTP Y+APE+ + +
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF-----CGTPEYLAPEVLRKQP-YDRT 176
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDP 242
D W LG VLYE G PPF R+ ++ +IL+ P L N S +L+ LL KD
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-RLKPNISVSARHLLEGLLQKDR 235
Query: 243 AQRL 246
+RL
Sbjct: 236 TKRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 4e-41
Identities = 93/274 (33%), Positives = 147/274 (53%), Gaps = 25/274 (9%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQ---------EVRMLH-SLDHPNVL 59
+G+G + V K T E+FAIK++ +K VL+ E R+L + +HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKAL---KKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ ++T HL+ V+EY GGDLM ++ + E R A +++ LQ+LH KGIIY
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
DLK N+LLD++G K+ DFG+ ++ + S+ CGTP Y+APE+ +G +
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF-----CGTPDYIAPEIL-KGQKY 173
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLV 239
+ + D W G +LYE G+ PF G + +L SIL+D P P S+ + ++ L
Sbjct: 174 NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRWISKEAKDCLSKLFE 232
Query: 240 KDPAQRLHWS-DLCGHAFWRT----KLTPMPLPP 268
+DP +RL D+ H F+R +L +PP
Sbjct: 233 RDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPP 266
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 90/291 (30%), Positives = 125/291 (42%), Gaps = 40/291 (13%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSLDHP 56
N+Y + +G G Y V K R K T E AIK D+ K L+EV++L L H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
N++ + L+LV EY L L LP D++R L++A+ Y HS
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
II+ D+KP NIL+ E+G KLCDFG AR L +P + T Y APEL
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT----DYVATRWYRAPELLVGD 176
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK----------------------- 212
+ D+W +GC++ E G P F G + QL
Sbjct: 177 TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 213 -SILSDPSPP------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
+PS P PG S P + + + L DP +RL +L H +
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 80/257 (31%), Positives = 122/257 (47%), Gaps = 22/257 (8%)
Query: 10 IGRGKYSTVYKGR----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNVLRF 61
+G G + VYKG A+K++ + Q + L+E R++ LDHPN+++
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDL---AQDLVRALQYLHSKGII 118
L +V+EY GGDL+ LR N+ E S+ DL A + R ++YL SK I
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLESKNFI 125
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDAS--KAPSSMLPQAKCGTPCYMAPELFEEG 176
+ DL N L+ EN K+ DFGL+R L D K LP +MAPE +E
Sbjct: 126 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR------WMAPESLKE- 178
Query: 177 GVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235
G + SD+W G +L+E + G P+ G ++++ + P P N L+
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLML 238
Query: 236 SLLVKDPAQRLHWSDLC 252
+DP R +S+L
Sbjct: 239 QCWAEDPEDRPTFSELV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 2e-39
Identities = 84/253 (33%), Positives = 133/253 (52%), Gaps = 11/253 (4%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVD----KSQKSKVLQEVRMLHSLDHPNVLRFYS 63
E IG+G + VYKG +T E AIK +D + + + QE+ +L D P + R+Y
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
Y LW+++EY GG + LL+ L E I + +++++ L YLHS+ I+ D+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYAS 183
+N+LL E G KL DFG+A +L+D ++ + GTP +MAPE+ ++ + + +
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVIKQSA-YDFKA 182
Query: 184 DLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPA 243
D+W LG E G PP +++ I + P L G S+PF + + L KDP
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPR 242
Query: 244 QRLHWSDLCGHAF 256
R +L H F
Sbjct: 243 FRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 2e-39
Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 42/288 (14%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKS------VDKSQKSKVLQEVRML---HSLDHPNVLR 60
+GRG + V KKT E +AIK+ + + + ++ E R+ +S HP ++
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
++ ++T H+ V+EY GGDLM + + E A +V LQYLH I+Y
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK----CGTPCYMAPELFEEG 176
DLK N+LLD G K+ DFGL ++ M + CGTP ++APE+ E
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLCKE---------GMGFGDRTSTFCGTPEFLAPEVLTE- 175
Query: 177 GVHSY--ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
SY A D WGLG ++YE G PF G + ++ SI++D P SR +++
Sbjct: 176 --TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND-EVRYPRFLSREAISIM 232
Query: 235 NSLLVKDPAQRLHWS-----DLCGHAFWRT--------KLTPMPLPPQ 269
LL ++P +RL D+ F+R + P P
Sbjct: 233 RRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPT 280
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 3e-39
Identities = 87/292 (29%), Positives = 132/292 (45%), Gaps = 46/292 (15%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV------DKSQKSKVLQEVRMLHSLDHP 56
+Y I IG G + V+K + ++T E A+K V L+E++ L + HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQ-ALREIKALQACQHP 59
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSK 115
V++ + + LV+EY DL +LR + LPE ++ + L++ + Y+H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
GI++ DLKP+N+L+ +G K+ DFGLAR S + P Q T Y APEL
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFS--EEEPRLYSHQ--VATRWYRAPELLY- 173
Query: 176 GGVHSY--ASDLWGLGCVLYECYAGRPPFVGR-EFTQL--VKSILSDPS----------- 219
G Y DLW +GC+ E G P F G + QL V L P+
Sbjct: 174 -GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232
Query: 220 -------PPLPGNPSR---PFA-----NLINSLLVKDPAQRLHWSDLCGHAF 256
P P P A +L+ LLV DP++RL ++ H +
Sbjct: 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 4e-39
Identities = 98/322 (30%), Positives = 158/322 (49%), Gaps = 51/322 (15%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----------QKSKVLQEVRMLHSLDHPNV 58
IGRG Y+ V KKT +A+K + K Q K + E + +HP +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFET----ASNHPFL 58
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ +S ++T + L+ V+E+ GGDLM +++ +LPE+ R + ++ AL +LH +GII
Sbjct: 59 VGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGII 118
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
Y DLK N+LLD G KL D+G+ ++ S+ CGTP Y+APE+ G
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF-----CGTPNYIAPEIL-RGED 172
Query: 179 HSYASDLWGLGCVLYECYAGRPPF--VG-----REFTQ--LVKSILSDPSPPLPGNPSRP 229
+ ++ D W LG +++E AGR PF VG + T+ L + IL +P + S
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-RIPRSLSVK 231
Query: 230 FANLINSLLVKDPAQRL------HWSDLCGHAFWRT---------KLTPMPLPPQPAFDS 274
++++ L KDP +RL + D+ H F+R ++ P P +P +S
Sbjct: 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLP---PYKPNIES 288
Query: 275 LKGAVRQDENSMLGSTPVRVTP 296
+ D PV++TP
Sbjct: 289 DRDLDNFD--PQFTDEPVQLTP 308
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 8e-39
Identities = 87/268 (32%), Positives = 130/268 (48%), Gaps = 22/268 (8%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV----------DKSQKSKVL---QEVRMLHSLD 54
E IG+G Y VY T E A+K V D QK V E+ L LD
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
H N++++ + T +L + LEY GG + S LR + E +R + ++ L YLHS
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
KGI++ DLK N+L+D +G K+ DFG+++K D +M Q G+ +MAPE+
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---GSVFWMAPEVIH 183
Query: 175 -EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS-PPLP----GNPSR 228
+S D+W LGCV+ E +AGR P+ E + + + S PP+P N S
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSP 243
Query: 229 PFANLINSLLVKDPAQRLHWSDLCGHAF 256
+ +N+ +P R +L H F
Sbjct: 244 VALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 1e-38
Identities = 84/271 (30%), Positives = 134/271 (49%), Gaps = 20/271 (7%)
Query: 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVD--KSQKSKVL-QEVRMLHSLDHPNVLRFYS 63
+ IG G V K T A+K +D K Q+ ++L EV ++ HPN++ YS
Sbjct: 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
Y LW+V+E+ GG L ++ + E+ I + +++AL +LH++G+I+ D+K
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK--CGTPCYMAPELFEEGGVHSY 181
+ILL +GR KL DFG ++S +P+ K GTP +MAPE+ Y
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKE-------VPRRKSLVGTPYWMAPEVISR---LPY 192
Query: 182 AS--DLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGNPSRPFANLINSL 237
+ D+W LG ++ E G PP+ Q +K I + P L S + ++ +
Sbjct: 193 GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252
Query: 238 LVKDPAQRLHWSDLCGHAFWRTKLTPMPLPP 268
LV+DPAQR ++L H F P + P
Sbjct: 253 LVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 85/253 (33%), Positives = 133/253 (52%), Gaps = 11/253 (4%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVD----KSQKSKVLQEVRMLHSLDHPNVLRFYS 63
E IG+G + V+KG +T + AIK +D + + + QE+ +L D P V ++Y
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
Y LW+++EY GG + LLR E I + +++++ L YLHS+ I+ D+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYAS 183
+N+LL E G KL DFG+A +L+D ++ + GTP +MAPE+ ++ S A
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVIQQSAYDSKA- 182
Query: 184 DLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPA 243
D+W LG E G PP +++ I + P L G S+PF I++ L KDP+
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPS 242
Query: 244 QRLHWSDLCGHAF 256
R +L H F
Sbjct: 243 FRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 82/257 (31%), Positives = 127/257 (49%), Gaps = 15/257 (5%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVD---KSQKSKVLQEVRMLHSLDHPNVLRFYSWYE 66
+G G + VYK + K+T + A K + + + + E+ +L HPN++ Y Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 67 TSAHLWLVLEYCVGGDLMSL-LRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPS 125
LW+++E+C GG L S+ L + L E IR + + ++ AL +LHS +I+ DLK
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAG 132
Query: 126 NILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF----EEGGVHSY 181
NILL +G KL DFG++ K + + + GTP +MAPE+ + + Y
Sbjct: 133 NILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAPEVVACETFKDNPYDY 187
Query: 182 ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGNPSRPFANLINSLLV 239
+D+W LG L E PP +++ IL P L P S F + + S LV
Sbjct: 188 KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLV 247
Query: 240 KDPAQRLHWSDLCGHAF 256
KDP R ++L H F
Sbjct: 248 KDPDDRPTAAELLKHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 81/249 (32%), Positives = 123/249 (49%), Gaps = 20/249 (8%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHPNVLRFYS 63
+G+G + V + K T + +A K +DK + K L E ++L + ++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
+ET L LV+ GGDL + + PE A ++ L++LH + I+Y D
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSY 181
LKP N+LLD++G ++ D GLA +L K + + GTP YMAPE+ +G V+ +
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKK------IKGRAGTPGYMAPEVL-QGEVYDF 173
Query: 182 ASDLWGLGCVLYECYAGRPPFVGR----EFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237
+ D + LGC LYE AGR PF R E +L + L P S +L +L
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV-EYPDKFSPEAKDLCEAL 232
Query: 238 LVKDPAQRL 246
L KDP +RL
Sbjct: 233 LQKDPEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 2e-38
Identities = 89/263 (33%), Positives = 134/263 (50%), Gaps = 19/263 (7%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK------SQKSKVLQEVRMLHSLDH 55
+ + I G Y VY R K+T + FA+K ++K +Q +V E +L ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
P V+ + +ET HL +V+EY GGD +LL+ LP D R + V AL+YLH+
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLAR--------KLSDAS--KAPSSMLPQAKCGTP 165
GI++ DLKP N+L+ G KL DFGL++ L + K L + CGTP
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 166 CYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN 225
Y+APE+ G + D W +G +LYE G PF G +L ++SD G+
Sbjct: 181 EYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239
Query: 226 PSRP--FANLINSLLVKDPAQRL 246
+ P +LI+ LL ++P +RL
Sbjct: 240 EALPADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 87/251 (34%), Positives = 133/251 (52%), Gaps = 14/251 (5%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-----KSQKSKVLQEVRMLHSLDHPN 57
+Y I + IG G + +Y + K E+ IK +D +K +EV +L + HPN
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLL-RQDNQL-PEDSIRDLAQDLVRALQYLHSK 115
++ F++ ++ + L++V+EYC GGDLM + RQ L ED I + L+++H +
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 116 GIIYCDLKPSNILLDENGR-TKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
I++ D+K NI L +NG KL DFG+AR+L+D S L GTP Y++PE+ +
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND-----SMELAYTCVGTPYYLSPEICQ 175
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
++ +D+W LGCVLYE + PF G QLV I P+ N SR +LI
Sbjct: 176 NRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLI 234
Query: 235 NSLLVKDPAQR 245
+ L P R
Sbjct: 235 SQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 87/261 (33%), Positives = 135/261 (51%), Gaps = 15/261 (5%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDHPN 57
+Y +GRG + V+ R+K + IK + Q +K E ++L L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLL--RQDNQLPEDSIRDLAQDLVRALQYLHSK 115
++ +Y + L +V+EY GG L + R ++ L ED+I ++ AL ++H+K
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 116 GIIYCDLKPSNILLDENGRT-KLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
I++ DLK NILLD++ K+ DFG+++ LS SKA + + GTPCY++PEL E
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV------GTPCYISPELCE 174
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
G ++ SD+W LGCVLYE + + F LV I+S P+ S LI
Sbjct: 175 -GKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLI 233
Query: 235 NSLLVKDPAQRLHWSDLCGHA 255
S+L DP++R S +
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-38
Identities = 84/244 (34%), Positives = 128/244 (52%), Gaps = 14/244 (5%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDK-------SQKSKVLQEVRMLHSLDHPNVLRFY 62
IG+G + V ++K ++A+K + K Q + + +L +L HP ++ +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
++T+ L+ VL+Y GG+L L+++ E R A ++ A+ YLHS IIY DL
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
KP NILLD G L DFGL ++ + + S+ CGTP Y+APE+ + +
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF-----CGTPEYLAPEVLRKEP-YDRT 176
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDP 242
D W LG VLYE G PPF R+ +Q+ +IL P LPG + +L+ LL KD
Sbjct: 177 VDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL-QLPGGKTVAACDLLVGLLHKDQ 235
Query: 243 AQRL 246
+RL
Sbjct: 236 RRRL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 6e-38
Identities = 92/295 (31%), Positives = 140/295 (47%), Gaps = 30/295 (10%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDH 55
+ + +GRG + V R+K T + +A+K + KS S +E +L +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLL-RQDNQLPEDSIRDLAQDLVRALQYLHS 114
P + + ++ +L+LV+EY GGDL+SLL R ++Q ED + +LV A+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
G ++ D+KP N+L+D G KL DFG A +L A+K +S LP GTP Y+APE+
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLP---VGTPDYIAPEVLT 176
Query: 175 -----EGGVHSYASDLWGLGCVLYECYAGRPPF----VGREFTQLV--KSILSDPSPPLP 223
G + D W LG + YE GR PF + + ++ + L P P
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP-- 234
Query: 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRT----KLTPMPLPPQPAFDS 274
S F +LI SLL +RL + LC H F+ + P P S
Sbjct: 235 -KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKS 287
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 6e-38
Identities = 80/250 (32%), Positives = 128/250 (51%), Gaps = 14/250 (5%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-----KSQKSKVLQEVRMLHSLDHPNV 58
Y +G+G Y V R + + + IK ++ + ++ QE ++L L HPN+
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 59 LRFY-SWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHSK 115
+ + SW L++V+ +C GGDL L++ LPE+ + + + ALQYLH K
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I++ DLK N+ L K+ D G+AR L + S+++ GTP YM+PELF
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-----GTPYYMSPELFSN 176
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235
++Y SD+W LGC +YE + F ++ LV I+ PP+P + S LI
Sbjct: 177 KP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235
Query: 236 SLLVKDPAQR 245
++L K P +R
Sbjct: 236 TMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 2e-37
Identities = 82/244 (33%), Positives = 126/244 (51%), Gaps = 14/244 (5%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLH-SLDHPNVLRFY 62
+G+G + V K T E +AIK + K Q V + E R+L + HP + +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
++T L+ V+EY GGDLM +++ + E R A ++ AL +LH G+IY DL
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
K NILLD G KL DFG+ ++ + + CGTP Y+APE+ +E + +
Sbjct: 123 KLDNILLDAEGHCKLADFGMCKE-----GILNGVTTTTFCGTPDYIAPEILQELE-YGPS 176
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDP 242
D W LG ++YE AG+PPF L +SIL D P S+ +++ + + K+P
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD-DVLYPVWLSKEAVSILKAFMTKNP 235
Query: 243 AQRL 246
+RL
Sbjct: 236 NKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 2e-37
Identities = 104/335 (31%), Positives = 163/335 (48%), Gaps = 49/335 (14%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----------QKSKVLQEVRMLHSLDHPNV 58
IGRG Y+ V R KK + +A+K V K Q K + E + +P +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFE----QASSNPFL 58
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ +S ++T++ L+LV+EY GGDLM +++ +LPE+ R A ++ AL +LH +GII
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGII 118
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
Y DLK N+LLD +G KL D+G+ ++ S+ CGTP Y+APE+ G
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTF-----CGTPNYIAPEIL-RGEE 172
Query: 179 HSYASDLWGLGCVLYECYAGRPPF--------VGREFTQLVKSILSDPSPPLPGNPSRPF 230
+ ++ D W LG +++E AGR PF + E L + IL P +P S
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTE-DYLFQVILEKPI-RIPRFLSVKA 230
Query: 231 ANLINSLLVKDPAQRL------HWSDLCGHAFWRT--------KLTPMPLPPQPAFDSLK 276
++++ L KDP +RL +SD+ H F+R+ K P PQ D
Sbjct: 231 SHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDY-- 288
Query: 277 GAVRQDENSMLGSTPVRVTPSGRKTQTKTSGRVFE 311
++ ++ S PV++TP + FE
Sbjct: 289 --GLENFDTQFTSEPVQLTPDDEDVIKRIDQSEFE 321
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 88/261 (33%), Positives = 141/261 (54%), Gaps = 23/261 (8%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLH-SLDHPNVLRFY 62
+G+G + V+ K T ++FAIK++ K + E R+L + +HP + Y
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
++T +L+ V+EY GGDLM ++ ++ A +++ LQ+LHSKGI+Y DL
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK----CGTPCYMAPELFEEGGV 178
K NILLD +G K+ DFG+ ++ +ML AK CGTP Y+APE+ G
Sbjct: 123 KLDNILLDTDGHIKIADFGMCKE---------NMLGDAKTCTFCGTPDYIAPEIL-LGQK 172
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLL 238
++ + D W G +LYE G+ PF G + +L +SI D +P P +R +++ L
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-NPCYPRWLTREAKDILVKLF 231
Query: 239 VKDPAQRLHW-SDLCGHAFWR 258
V++P +RL D+ H F+R
Sbjct: 232 VREPERRLGVKGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 2e-37
Identities = 83/260 (31%), Positives = 138/260 (53%), Gaps = 23/260 (8%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGR--------KKKTIEYFAIKSVDKSQKSKVLQEVRMLHS 52
+ + I + IGRG++S VY+ K ++ F + +D ++ ++E+ +L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL--MDAKARADCIKEIDLLKQ 58
Query: 53 LDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLR----QDNQLPEDSIRDLAQDLVRA 108
L+HPNV+++Y+ + L +VLE GDL +++ Q +PE ++ L A
Sbjct: 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 109 LQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
L+++HS+ +++ D+KP+N+ + G KL D GL R S + A S++ GTP YM
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-----GTPYYM 173
Query: 169 APELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT--QLVKSILSDPSPPLPGNP 226
+PE E G +++ SD+W LGC+LYE A + PF G + L K I PPLP +
Sbjct: 174 SPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDH 232
Query: 227 -SRPFANLINSLLVKDPAQR 245
S L+N + DP +R
Sbjct: 233 YSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 2e-37
Identities = 93/281 (33%), Positives = 144/281 (51%), Gaps = 24/281 (8%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---KSKV---LQEVRMLHSLDHPNVLRFYS 63
IG+G + V + RK+ T +A+K++ K+ +S+V L E +L ++ P ++
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
+++ L+LVL + GG+L L+++ + R +L+ AL+ LH +IY DLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 124 PSNILLDENGRTKLCDFGLAR-KLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
P NILLD G LCDFGL + + D K + CGTP Y+APEL G ++ A
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKDDDKTNTF------CGTPEYLAPELLLGHG-YTKA 173
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDP 242
D W LG +LYE G PPF ++ + IL +P P R +L+ LL +DP
Sbjct: 174 VDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL-RFPDGFDRDAKDLLIGLLSRDP 232
Query: 243 AQRLHWS---DLCGHAF-----WRTKLTPMPLPP-QPAFDS 274
+RL ++ ++ H F W+ L PP +PA S
Sbjct: 233 TRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSS 273
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 91/281 (32%), Positives = 144/281 (51%), Gaps = 30/281 (10%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKS------VDKSQKSKVLQEVRMLHSLDHPNVLRFYS 63
+G+G + V R+K T Y+A+K + K + + + E R+L + HP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
++T L V+EY GG+L L ++ E+ R ++V AL+YLHS+ ++Y D+K
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122
Query: 124 PSNILLDENGRTKLCDFGLARK-LSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
N++LD++G K+ DFGL ++ +SD + + CGTP Y+APE+ E+ + A
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATM------KTFCGTPEYLAPEVLEDND-YGRA 175
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDP 242
D WGLG V+YE GR PF ++ +L + IL + P S +L+ LL KDP
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRFPRTLSPEAKSLLAGLLKKDP 234
Query: 243 AQRL-----HWSDLCGHAFW---------RTKLTPMPLPPQ 269
QRL ++ H F+ + KL P P PQ
Sbjct: 235 KQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLP-PFKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-37
Identities = 101/306 (33%), Positives = 144/306 (47%), Gaps = 55/306 (17%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHPNVLRFYS 63
IG G Y VY+ R + E A+K V + + L+E+ +L +L HPN++
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV-RMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 64 WYETSAHL---WLVLEYCVGGDLMSLLRQDNQ---LPEDSIRDLAQDLVRALQYLHSKGI 117
HL +LV+EYC DL SLL DN E ++ L L+R LQYLH I
Sbjct: 74 -VVVGKHLDSIFLVMEYC-EQDLASLL--DNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
I+ DLK SN+LL + G K+ DFGLAR +K M P K T Y APEL
Sbjct: 130 IHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK---PMTP--KVVTLWYRAPELLLGCT 184
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGR---EFTQLVKSILSDPSP---------PLPGN 225
++ A D+W +GC+L E A +P G+ E L+ +L P+ PL G
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244
Query: 226 ---PSRPFAN--------------LINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPP 268
P +P+ N L+N LL+ DP +R + ++++ K P+P P
Sbjct: 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK--PLPCEP 302
Query: 269 Q--PAF 272
+ P F
Sbjct: 303 EMMPTF 308
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 94/281 (33%), Positives = 147/281 (52%), Gaps = 30/281 (10%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKS------VDKSQKSKVLQEVRMLHSLDHPNVLRFYS 63
+G+G + V R+K + +Y+A+K + K + + L E R+L + HP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
++T L V+EY GG+L L ++ ED R ++V AL YLHS I+Y DLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 124 PSNILLDENGRTKLCDFGLARK-LSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
N++LD++G K+ DFGL ++ ++DA+ + CGTP Y+APE+ E+ + A
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGITDAATM------KTFCGTPEYLAPEVLEDND-YGRA 175
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDP 242
D WGLG V+YE GR PF ++ +L + IL + P S +L++ LL+KDP
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-DIKFPRTLSADAKSLLSGLLIKDP 234
Query: 243 AQRL-----HWSDLCGHAF-----WR----TKLTPMPLPPQ 269
+RL ++ H+F W+ KL P P PQ
Sbjct: 235 NKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVP-PFKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 4e-37
Identities = 101/326 (30%), Positives = 152/326 (46%), Gaps = 39/326 (11%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLHSLDHPNVL-RFY 62
+G+G + V +K T E +AIK + K Q V + E R+L P L + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
S ++T L+ V+EY GGDLM ++Q + E A ++ L +LHSKGIIY DL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK----CGTPCYMAPE--LFEEG 176
K N++LD G K+ DFG+ ++ ++ CGTP Y+APE ++
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCKE---------NIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
G + D W G +LYE AG+PPF G + +L +SI+ + + P + S+ ++
Sbjct: 179 G---KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM-EHNVSYPKSLSKEAVSICKG 234
Query: 237 LLVKDPAQRLHWS-----DLCGHAFWR----TKLTPMPLPPQPAFDSLKGAVRQDEN--S 285
LL K PA+RL D+ HAF+R KL + QP F R EN
Sbjct: 235 LLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREI--QPPFKPKVKGRRSAENFDK 292
Query: 286 MLGSTPVRVTPSGRKTQTKTSGRVFE 311
P +TP + F+
Sbjct: 293 FFTREPPVLTPPDKLVIANIDQSEFQ 318
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 4e-37
Identities = 83/253 (32%), Positives = 134/253 (52%), Gaps = 11/253 (4%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVD----KSQKSKVLQEVRMLHSLDHPNVLRFYS 63
E IG+G + V+KG +T + AIK +D + + + QE+ +L D P V ++Y
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
Y LW+++EY GG + LL + L E I + +++++ L YLHS+ I+ D+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYAS 183
+N+LL E+G KL DFG+A +L+D ++ + GTP +MAPE+ ++ S A
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVIKQSAYDSKA- 182
Query: 184 DLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPA 243
D+W LG E G PP +++ I + P L GN S+P + + L K+P+
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPS 242
Query: 244 QRLHWSDLCGHAF 256
R +L H F
Sbjct: 243 FRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 6e-37
Identities = 92/271 (33%), Positives = 140/271 (51%), Gaps = 22/271 (8%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVR-MLHSLDHP 56
N IG G VYK R KKT A+K + ++ ++L ++ +L S D P
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLHSK 115
+++ Y ++ T + +++ +E + L LL++ +PED + + +V+AL YL K
Sbjct: 75 YIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK 133
Query: 116 -GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
G+I+ D+KPSNILLD +G KLCDFG++ +L D SKA + A C YMAPE +
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD-SKAKTR---SAGC--AAYMAPERID 187
Query: 175 EGGVHS-Y--ASDLWGLGCVLYECYAGRPPFVG--REFTQLVKSILSDPSPPLPGNP--S 227
+ Y +D+W LG L E G+ P+ EF L K IL + P LP N S
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK-ILQEEPPSLPPNEGFS 246
Query: 228 RPFANLINSLLVKDPAQRLHWSDLCGHAFWR 258
F + ++ L KD +R + +L H F R
Sbjct: 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 8e-37
Identities = 92/274 (33%), Positives = 144/274 (52%), Gaps = 35/274 (12%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----------QKSKVLQEVRMLHSLDHPNV 58
IGRG Y+ V R KKT +A+K V K Q K + E + +HP +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFE----QASNHPFL 58
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ +S ++T + L+ V+EY GGDLM +++ +LPE+ R + ++ AL YLH +GII
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGII 118
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
Y DLK N+LLD G KL D+G+ ++ S+ CGTP Y+APE+ G
Sbjct: 119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-----CGTPNYIAPEIL-RGED 172
Query: 179 HSYASDLWGLGCVLYECYAGRPPF--VG------REFTQLVKSILSDPSPPLPGNPSRPF 230
+ ++ D W LG +++E AGR PF VG + + ++ + +P + S
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 232
Query: 231 ANLINSLLVKDPAQRL------HWSDLCGHAFWR 258
A+++ S L KDP +RL ++D+ GH F+R
Sbjct: 233 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 9e-37
Identities = 72/209 (34%), Positives = 107/209 (51%), Gaps = 15/209 (7%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDH 55
+ I +G+G Y V+ +KK T E A+K + KS + VL E +L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
+++ ++ +L+L +EY GGD +LL L ED R ++ A+ LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
G I+ DLKP N L+D +G KL DFGL++ + + A S + G+P YMAPE+
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGI--VTYANSVV------GSPDYMAPEVLRG 172
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVG 204
G + + D W LGC+LYE G PPF G
Sbjct: 173 KG-YDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 139 bits (350), Expect = 2e-36
Identities = 81/258 (31%), Positives = 136/258 (52%), Gaps = 19/258 (7%)
Query: 1 MNQYHIYEAIGRGKYSTVYKG-----RKKKTIEYFAI-KSVDKSQKSKVLQEVRMLHSLD 54
+ + I + IGRG++S VY+ RK ++ I + +D + ++E+ +L L+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLL----RQDNQLPEDSIRDLAQDLVRALQ 110
HPNV+++ + L +VLE GDL ++ +Q +PE ++ L A++
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 111 YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAP 170
++HS+ +++ D+KP+N+ + G KL D GL R S + A S++ GTP YM+P
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-----GTPYYMSP 175
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT--QLVKSILSDPSPPLPG-NPS 227
E E G +++ SD+W LGC+LYE A + PF G + L + I PPLP + S
Sbjct: 176 ERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234
Query: 228 RPFANLINSLLVKDPAQR 245
L++ + DP QR
Sbjct: 235 EKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-35
Identities = 74/249 (29%), Positives = 128/249 (51%), Gaps = 12/249 (4%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVR----MLHSLDHPNV 58
QY++ +G G + + + + +A+K + + S +++ R +L + HPN+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHSKG 116
+ F +E HL++V+EYC GGDLM ++ PED+I + +Q++H K
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
+++ D+K NI L +NG+ KL DFG AR L+ + + GTP Y+ PE++E
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-----GTPYYVPPEIWENM 175
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
++ SD+W LGC+LYE + PF + L+ + PLP + S +LI
Sbjct: 176 P-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234
Query: 237 LLVKDPAQR 245
+ ++P R
Sbjct: 235 MFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 1e-35
Identities = 83/260 (31%), Positives = 139/260 (53%), Gaps = 15/260 (5%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLH-SLDHPNVLR 60
+ +G+G + V K EYFA+K++ K + E R+L + ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
Y ++T HL+ V+E+ GGDLM ++ + A ++V LQ+LHSKGIIY
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLK N++LD +G K+ DFG+ ++ S+ CGTP Y+APE+ +G ++
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF-----CGTPDYIAPEIL-QGLKYT 174
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
++ D W G +LYE G+ PF G + +L +SI D +P P ++ +++ L +
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHYPRWITKESKDILEKLFER 233
Query: 241 DPAQRLHWS-DLCGHAFWRT 259
DP +RL ++ GH F++T
Sbjct: 234 DPTRRLGVVGNIRGHPFFKT 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 93/286 (32%), Positives = 132/286 (46%), Gaps = 32/286 (11%)
Query: 10 IGRGKYSTVYKGRK---KKTIEYFAIKSVDKS---QKSKVLQEVRMLHS-LDH----PNV 58
+G G Y V+ RK + +A+K + K+ QK+K + R L+ P +
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ + ++T L L+L+Y GG+L + L Q E +R ++V AL +LH GII
Sbjct: 68 VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGII 127
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG-G 177
Y D+K NILLD G L DFGL+++ A + CGT YMAPE+ G G
Sbjct: 128 YRDIKLENILLDSEGHVVLTDFGLSKEFL----AEEEERAYSFCGTIEYMAPEVIRGGSG 183
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFV--GREFTQ--LVKSILSDPSPPLPGNPSRPFANL 233
H A D W LG + +E G PF G + +Q + + IL PP P S +
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-KPPFPKTMSAEARDF 242
Query: 234 INSLLVKDPAQRLHW---SDLCGHAF-----W---RTKLTPMPLPP 268
I LL KDP +RL ++ H F W K P P P
Sbjct: 243 IQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 93/286 (32%), Positives = 129/286 (45%), Gaps = 24/286 (8%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHPNVLRFYS 63
IG G + VY R +T E AIK + S K +++EVR L L HPN + +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 64 WYETSAHLWLVLEYCVG--GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
Y WLV+EYC+G D++ + ++ L E I + ++ L YLHS I+ D
Sbjct: 83 CYLREHTAWLVMEYCLGSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHERIHRD 140
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE--LFEEGGVH 179
+K NILL E G KL DFG A +S A + GTP +MAPE L + G +
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASLVSPA---------NSFVGTPYWMAPEVILAMDEGQY 191
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP-SRPFANLINSLL 238
D+W LG E +PP + I + SP L N S F N ++S L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCL 251
Query: 239 VKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKGAVRQDEN 284
K P R +L H F + P + K AVR+ +N
Sbjct: 252 QKIPQDRPSSEELLKHRFVLRERPPTVI--IDLIQRTKDAVRELDN 295
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-35
Identities = 86/289 (29%), Positives = 128/289 (44%), Gaps = 43/289 (14%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK----VLQEVRMLHSL-DHPNV 58
Y + + +G G + +VY R K+T E AIK + K S L+EV+ L L +HPN+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 59 LRFYSWYETSAHLWLVLEYCVGG--DLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
++ + + L+ V EY G LM R+ E IR + +++ L ++H G
Sbjct: 61 VKLKEVFRENDELYFVFEYMEGNLYQLMKD-RKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
+ DLKP N+L+ K+ DFGLAR++ S+ P + T Y APE+
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREI--RSRPPYT----DYVSTRWYRAPEILLRS 173
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDPS-------------- 219
+S D+W LGC++ E Y RP F G E QL K S+L P+
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233
Query: 220 ----PPLPG--------NPSRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
P N S +LI +L DP +R S H +
Sbjct: 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 2e-35
Identities = 84/262 (32%), Positives = 135/262 (51%), Gaps = 20/262 (7%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLH-SLDHPNVLRFY 62
+G+G + V R K++ +A+K + K Q V + E R+L + +HP + + Y
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
++T L+ V+E+ GGDLM +++ + E R A ++ AL +LH KGIIY DL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
K N+LLD G KL DFG+ ++ K S+ CGTP Y+APE+ +E ++ +
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF-----CGTPDYIAPEILQE-MLYGPS 176
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDP 242
D W +G +LYE G PF L ++IL+D P S+ +++ + + K+P
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-EVVYPTWLSQDAVDILKAFMTKNP 235
Query: 243 AQRLHWSDLCG------HAFWR 258
RL L G H F++
Sbjct: 236 TMRLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 101/321 (31%), Positives = 155/321 (48%), Gaps = 33/321 (10%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKS------VDKSQKSKVLQEVRMLHSLDHPNVLRFYS 63
+G+G + V ++K T Y+A+K V K + + L E R+L + HP +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDL 122
++T L V+EY GG+L L ++ ED R ++V AL YLHS K ++Y DL
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
K N++LD++G K+ DFGL + + K ++M + CGTP Y+APE+ E+ + A
Sbjct: 123 KLENLMLDKDGHIKITDFGLCK---EGIKDGATM--KTFCGTPEYLAPEVLEDND-YGRA 176
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDP 242
D WGLG V+YE GR PF ++ +L + IL + P S +L++ LL KDP
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLSGLLKKDP 235
Query: 243 AQRL-----HWSDLCGHAF-----WR----TKLTPMPLPPQPAFDSLKGAVRQDENSMLG 288
QRL ++ H F W+ KL P P +P S DE
Sbjct: 236 KQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVP---PFKPQVTSETDTRYFDEE--FT 290
Query: 289 STPVRVTPSGRKTQTKTSGRV 309
+ + +TP + +T
Sbjct: 291 AQMITITPPDQDDSMETVDNE 311
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 85/250 (34%), Positives = 134/250 (53%), Gaps = 25/250 (10%)
Query: 10 IGRGKYSTVYKGRKKK---TIEYFAIKSVDKSQKSKVLQEVR------MLHSLDHPNVLR 60
+G+G + V+ RK + +A+K V K KV VR +L ++HP +++
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMK-VLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
+ ++T L+L+L++ GGDL + L ++ E+ ++ +L AL +LHS GIIY
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYR 122
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKP NILLDE G KL DFGL+++ D K S CGT YMAPE+ G H+
Sbjct: 123 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-----CGTVEYMAPEVVNRRG-HT 176
Query: 181 YASDLWGLGCVLYECYAGRPPFVGRE----FTQLVKSILSDPSPPLPGNPSRPFANLINS 236
++D W G +++E G PF G++ T ++K+ L +P S +L+ +
Sbjct: 177 QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG-----MPQFLSPEAQSLLRA 231
Query: 237 LLVKDPAQRL 246
L ++PA RL
Sbjct: 232 LFKRNPANRL 241
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 87/268 (32%), Positives = 135/268 (50%), Gaps = 28/268 (10%)
Query: 10 IGRGKYSTVYKGRK---KKTIEYFAIKSVDK-----SQK--SKVLQEVRMLHSLDHPNVL 59
+G+G Y V++ RK T + FA+K + K +QK + E +L ++ HP ++
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
++T L+L+LEY GG+L L ++ ED+ ++ AL++LH +GIIY
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIY 123
Query: 120 CDLKPSNILLDENGRTKLCDFGLARK-LSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
DLKP NILLD G KL DFGL ++ + + + CGT YMAPE+ G
Sbjct: 124 RDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT------HTFCGTIEYMAPEILMRSG- 176
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP--SPPLPGNPSRPFANLINS 236
H A D W LG ++Y+ G PPF + + IL PP +R +L+
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEAR---DLLKK 233
Query: 237 LLVKDPAQRL-----HWSDLCGHAFWRT 259
LL ++P+ RL +++ H F+R
Sbjct: 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRH 261
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 6e-35
Identities = 77/250 (30%), Positives = 132/250 (52%), Gaps = 13/250 (5%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDHPN 57
+Y + IG G + + K+ + + IK ++ S+ S +EV +L ++ HPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQL--PEDSIRDLAQDLVRALQYLHSK 115
++++ +E + +L++V++YC GGDL + + PED I D + AL+++H +
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I++ D+K NI L ++G KL DFG+AR L+ + L + GTP Y++PE+ E
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-----LARTCIGTPYYLSPEICEN 175
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235
++ SD+W LGCVLYE + F LV I+ PP+ + S NL++
Sbjct: 176 RP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234
Query: 236 SLLVKDPAQR 245
L ++P R
Sbjct: 235 QLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 7e-35
Identities = 72/249 (28%), Positives = 121/249 (48%), Gaps = 16/249 (6%)
Query: 7 YEAI---GRGKYSTVYKGRKKKTIEYFAIKSVD-----KSQKSKVLQEVRMLHSLDHPNV 58
Y I G+G + R+ + K V+ + ++ L E+ +L L HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLL--RQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
+ +Y+ + L + +EY GG L + ++ E+ + +V A+ Y+H G
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
I++ D+K NI L + G KL DFG+++ L +++ GTP YM+PEL +G
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-----GTPYYMSPELC-QG 175
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
+++ SD+W LGCVLYE + F LV I+ P+ S +L++S
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS 235
Query: 237 LLVKDPAQR 245
LL +DP +R
Sbjct: 236 LLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 92/277 (33%), Positives = 134/277 (48%), Gaps = 39/277 (14%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIK-----SVDKSQKSKVLQEVR-MLHSLDHPNVLRF 61
IGRG + TV K K + A+K +K QK ++L ++ ++ S D P +++F
Sbjct: 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQK-RLLMDLDVVMRSSDCPYIVKF 68
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSL----------LRQDNQLPEDSIRDLAQDLVRALQY 111
Y W+ +E LM + + +PE+ + +A V+AL Y
Sbjct: 69 YGALFREGDCWICME------LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122
Query: 112 LHSK-GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAP 170
L + II+ D+KPSNILLD NG KLCDFG++ +L D S A + A C P YMAP
Sbjct: 123 LKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-SIAKTR---DAGC-RP-YMAP 176
Query: 171 ELFEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGRE--FTQLVKSILSDPSPPLPGNP 226
E + Y SD+W LG LYE G+ P+ F QL + + DP P L +
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP-PILSNSE 235
Query: 227 ----SRPFANLINSLLVKDPAQRLHWSDLCGHAFWRT 259
S F N IN L+KD ++R + +L H F +
Sbjct: 236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 85/269 (31%), Positives = 134/269 (49%), Gaps = 21/269 (7%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDH-PNVLR 60
+ + E +G G Y VYKGR KT + AIK +D + ++ ++ QE+ ML H N+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 61 FYSWY------ETSAHLWLVLEYCVGGDLMSLLR--QDNQLPEDSIRDLAQDLVRALQYL 112
+Y + LWLV+E+C G + L++ + N L E+ I + ++++R L +L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
H +I+ D+K N+LL EN KL DFG++ +L ++ + GTP +MAPE+
Sbjct: 128 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEV 182
Query: 173 F----EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP-S 227
+ + SDLW LG E G PP + + I +P+P L S
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS 242
Query: 228 RPFANLINSLLVKDPAQRLHWSDLCGHAF 256
+ F + I S LVK+ +QR L H F
Sbjct: 243 KKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 84/269 (31%), Positives = 133/269 (49%), Gaps = 21/269 (7%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD--KSQKSKVLQEVRMLHSLDH-PNVLR 60
+ + E +G G Y VYKGR KT + AIK +D + ++ ++ E+ ML H N+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 61 FYSWYETSA------HLWLVLEYCVGGDLMSLLR--QDNQLPEDSIRDLAQDLVRALQYL 112
+Y + + LWLV+E+C G + L++ + N L ED I + ++++R L +L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
H+ +I+ D+K N+LL EN KL DFG++ +L ++ + GTP +MAPE+
Sbjct: 138 HAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEV 192
Query: 173 F--EEG--GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP-S 227
+E + Y SD+W LG E G PP + + I +P P L S
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWS 252
Query: 228 RPFANLINSLLVKDPAQRLHWSDLCGHAF 256
+ F + I LVK+ R L H F
Sbjct: 253 KKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-34
Identities = 80/259 (30%), Positives = 135/259 (52%), Gaps = 22/259 (8%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
IG G TVYK + T +A+K + + + + ++ +E+ +L ++HPNV++ + +
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPS 125
+ + + ++LE+ GG L D E + D+A+ ++ + YLH + I++ D+KPS
Sbjct: 142 DHNGEIQVLLEFMDGGSLEGTHIAD----EQFLADVARQILSGIAYLHRRHIVHRDIKPS 197
Query: 126 NILLDENGRTKLCDFGLARKLSDASKAPSSMLP-QAKCGTPCYMAPEL----FEEGGVHS 180
N+L++ K+ DFG++R L+ +M P + GT YM+PE G
Sbjct: 198 NLLINSAKNVKIADFGVSRILA------QTMDPCNSSVGTIAYMSPERINTDLNHGAYDG 251
Query: 181 YASDLWGLGCVLYECYAGRPPF-VGRE--FTQLVKSILSDPSPPLPGNPSRPFANLINSL 237
YA D+W LG + E Y GR PF VGR+ + L+ +I P P SR F + I+
Sbjct: 252 YAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCC 311
Query: 238 LVKDPAQRLHWSDLCGHAF 256
L ++PA+R L H F
Sbjct: 312 LQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 86/274 (31%), Positives = 137/274 (50%), Gaps = 35/274 (12%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYS 63
+G G +V K R K T FA+K++ + ++L+E+ + S P ++++Y
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 64 WY--ETSAHLWLVLEYCVGGDLMSL----LRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+ E+S+ + + +EYC GG L S+ ++ ++ E + +A+ +++ L YLHS+ I
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKI 126
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC--GTPCYMAPELFEE 175
I+ D+KPSNILL G+ KLCDFG++ +L + A GT YMAPE +
Sbjct: 127 IHRDIKPSNILLTRKGQVKLCDFGVSGEL---------VNSLAGTFTGTSFYMAPERI-Q 176
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ------LVKSILSDPSPPLPGNP--- 226
G +S SD+W LG L E R PF E L+ I++ P+P L P
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFPFPP-EGEPPLGPIELLSYIVNMPNPELKDEPGNG 235
Query: 227 ---SRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257
S F + I L KDP +R D+ H +
Sbjct: 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 87/276 (31%), Positives = 138/276 (50%), Gaps = 22/276 (7%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDK-------SQKSKVLQEVRMLHSLDHPNVLR 60
+ IG+G + V ++K + +A+K + K QK + + +L ++ HP ++
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
+ ++T+ L+ VL++ GG+L L+++ PE R A ++ AL YLHS I+Y
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKP NILLD G L DFGL ++ S ++ CGTP Y+APE+ + +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF-----CGTPEYLAPEVIRKQP-YD 174
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
D W LG VLYE G PPF R+ ++ +IL P PG ++ ++ LL K
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWS-ILEELLEK 233
Query: 241 DPAQRLHWSD----LCGHAFWR----TKLTPMPLPP 268
D +RL + + H F+ T L +PP
Sbjct: 234 DRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-34
Identities = 81/288 (28%), Positives = 128/288 (44%), Gaps = 53/288 (18%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSLDHPNV 58
Y + + IG G Y V K+T AIK + D ++L+E+++L L H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 59 LRFYS-----WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLH 113
+ E +++V E + DL +++ L +D I+ ++R L+YLH
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTEL-METDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTP-----CYM 168
S +I+ DLKPSNIL++ N K+CDFGLAR + + T Y
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-------TEYVVTRWYR 173
Query: 169 APELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT-QL--------------VKS 213
APEL ++ A D+W +GC+ E +P F GR++ QL +K
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233
Query: 214 ILSD----------PSPPLPGNPSRPFAN-----LINSLLVKDPAQRL 246
I S+ P P + P A+ L+ +LV DP +R+
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI 281
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-34
Identities = 84/250 (33%), Positives = 131/250 (52%), Gaps = 14/250 (5%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIK-----SVDKSQKSKVLQEVR--MLHSLDHPNVLR 60
+ IG+G + V R K +++A+K ++ K ++ K + R +L ++ HP ++
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
+ ++T+ L+ VL+Y GG+L L+++ E R A ++ AL YLHS I+Y
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKP NILLD G L DFGL ++ + + S+ CGTP Y+APE+ + +
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF-----CGTPEYLAPEVLHKQP-YD 174
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
D W LG VLYE G PPF R ++ +IL+ P P N + +L+ LL K
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP-NITNSARHLLEGLLQK 233
Query: 241 DPAQRLHWSD 250
D +RL D
Sbjct: 234 DRTKRLGAKD 243
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 82/262 (31%), Positives = 124/262 (47%), Gaps = 14/262 (5%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK---SKVLQEVRMLHSLDHPNVLR 60
Y + + +G G Y VYK R T E A+K + S + QE+ M+ H N++
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
++ Y + LW+ +EYC GG L + L E I + ++ ++ L YLHSKG ++
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL--FEEGGV 178
D+K +NILL +NG KL DFG+A K++ S + GTP +MAPE+ E+ G
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-----GTPYWMAPEVAAVEKNGG 185
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVG----REFTQLVKSILSDPSPPLPGNPSRPFANLI 234
++ D+W +G E +PP R + KS P S F N +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFV 245
Query: 235 NSLLVKDPAQRLHWSDLCGHAF 256
L K+P +R L H F
Sbjct: 246 KISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 91/294 (30%), Positives = 145/294 (49%), Gaps = 33/294 (11%)
Query: 4 YHIYEAIGRGKYSTVYKGRK---KKTIEYFAIKSVDKS---QKSKVLQEVRMLHS-LDH- 55
+ + + +G G Y V+ RK T + +A+K + K+ QK+K ++ R + L+H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 56 ---PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
P ++ + ++T A L L+L+Y GG++ + L Q + ED +R + +++ AL++L
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
H GI+Y D+K NILLD G L DFGL+++ K + CGT YMAPE+
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF----CGTIEYMAPEI 177
Query: 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFV--GREFTQ--LVKSILSDPSPPLPGNPSR 228
G H A D W LG +++E G PF G TQ + + IL PP P
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPSFIGP 236
Query: 229 PFANLINSLLVKDPAQRL-----HWSDLCGHAFWR--------TKLTPMPLPPQ 269
+L++ LL KDP +RL S++ H F++ + P P
Sbjct: 237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPS 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 85/286 (29%), Positives = 136/286 (47%), Gaps = 36/286 (12%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSW----- 64
IG+G + VY+ RKK T +A+K + K + ++ + + H++ N+L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE---IVAKKEVAHTIGERNILVRTLLDESPF 57
Query: 65 -------YETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
++T + L+LV +Y GG+L L+++ + ED + +LV AL++LH I
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDI 117
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE-LFEEG 176
+Y DLKP NILLD G LCDFGL++ +K ++ CGT Y+APE L +E
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF-----CGTTEYLAPEVLLDEK 172
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
G ++ D W LG +++E G PF + Q+ ++I S +
Sbjct: 173 G-YTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKG 231
Query: 237 LLVKDPAQRLHWSD----LCGHAF-----W----RTKLTPMPLPPQ 269
LL ++P RL L H F W + ++TP P P
Sbjct: 232 LLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITP-PFKPI 276
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-33
Identities = 73/241 (30%), Positives = 111/241 (46%), Gaps = 40/241 (16%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDH 55
+ + + IGRG + V +KK T +A+K + KS Q + V E +L D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
P V++ Y ++ +L+L++EY GGD+M+LL + + E+ R + + A+ +H
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLS---------DASKAPSSMLPQAKC---- 162
G I+ D+KP N+LLD G KL DFGL L S A S
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 163 --------------------GTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPF 202
GTP Y+APE+F + G ++ D W LG ++YE G PPF
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPPF 239
Query: 203 V 203
Sbjct: 240 C 240
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 89/301 (29%), Positives = 133/301 (44%), Gaps = 63/301 (20%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSLD---H 55
Y IG G Y TVYK R T + A+K V ++ L+E+ +L L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 56 PNVLRFY-----SWYETSAHLWLVLEYCVGGDLMSLLRQ--DNQLPEDSIRDLAQDLVRA 108
PN++R + L LV E+ V DL + L + LP ++I+DL + L+R
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 109 LQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC-- 166
+ +LHS I++ DLKP NIL+ +G+ K+ DFGLAR S T
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL-----------TSVVV 168
Query: 167 ---YMAPELFEEGGVHSYAS--DLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDP 218
Y APE+ + SYA+ D+W +GC+ E + RP F G E QL K ++ P
Sbjct: 169 TLWYRAPEVLLQS---SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP 225
Query: 219 S----PPL--------PGNPSRPF-----------ANLINSLLVKDPAQRLHWSDLCGHA 255
S P P R F +L+ +L +P +R+ + H
Sbjct: 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285
Query: 256 F 256
+
Sbjct: 286 Y 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 78/255 (30%), Positives = 129/255 (50%), Gaps = 19/255 (7%)
Query: 3 QYHIYEAIGRGKYSTVY--------KGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLD 54
+Y + + +G+G + TVY + K ++ + ++ ++ + QE ++L LD
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ----LPEDSIRDLAQDLVRALQ 110
HP +++F++ + ++ EYC G DL L + L E+ + + L+ +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 111 YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAP 170
Y+H + I++ DLK NI L N K+ DFG++R L S L GTP YM+P
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMG-----SCDLATTFTGTPYYMSP 174
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPF 230
E + G S SD+W LGC+LYE F G+ F +V I+ P+P LP SR
Sbjct: 175 EALKHQGYDS-KSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQL 233
Query: 231 ANLINSLLVKDPAQR 245
+++ S+L KDP+ R
Sbjct: 234 NSIMQSMLNKDPSLR 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 8e-33
Identities = 86/260 (33%), Positives = 135/260 (51%), Gaps = 23/260 (8%)
Query: 4 YHIYEAIGRGKYSTVYKGRK---KKTIEYFAIKSVDKS---QKSKVLQEVR-----MLHS 52
+ + + +G G Y V+ RK + + +A+K + K+ QK+K + R + H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 53 LDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
P ++ + ++T L L+L+Y GG+L + L Q + E ++ + ++V AL++L
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARK-LSDASKAPSSMLPQAKCGTPCYMAPE 171
H GIIY D+K NILLD NG L DFGL+++ D + S CGT YMAP+
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF-----CGTIEYMAPD 176
Query: 172 LFEEG-GVHSYASDLWGLGCVLYECYAGRPPFV--GREFTQ--LVKSILSDPSPPLPGNP 226
+ G G H A D W +G ++YE G PF G + +Q + + IL PP P
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-EPPYPQEM 235
Query: 227 SRPFANLINSLLVKDPAQRL 246
S ++I LL+KDP +RL
Sbjct: 236 SALAKDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-32
Identities = 88/306 (28%), Positives = 134/306 (43%), Gaps = 52/306 (16%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--------VLQEVRMLHSLD 54
+Y + +G G Y+ VYK R K+T AIK + ++ + L+E+++L L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQL---PEDSIRDLAQDLVRALQY 111
HPN++ + +++ LV E+ DL +++ D + P D I+ +R L+Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIK-DKSIVLTPAD-IKSYMLMTLRGLEY 117
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
LHS I++ DLKP+N+L+ +G KL DFGLAR M Q T Y APE
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS---PNRKMTHQVV--TRWYRAPE 172
Query: 172 LFEEGGVHSYAS--DLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDPSP------ 220
L G Y D+W +GC+ E P G + QL K L P+
Sbjct: 173 LLF--GARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230
Query: 221 ----------PLPGNPSR---PFA-----NLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262
P P P + P A +L+ LL +P +R+ H ++
Sbjct: 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND-- 288
Query: 263 PMPLPP 268
P P PP
Sbjct: 289 PAPTPP 294
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 83/268 (30%), Positives = 132/268 (49%), Gaps = 14/268 (5%)
Query: 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVD--KSQKSKVL-QEVRMLHSLDHPNVLRFYS 63
Y IG G V R+K + A+K +D K Q+ ++L EV ++ H NV+ Y
Sbjct: 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
Y LW+++E+ GG L ++ Q +L E+ I + + +++AL YLHS+G+I+ D+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYAS 183
+ILL +GR KL DFG ++S S++ GTP +MAPE+ +
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISR-TPYGTEV 198
Query: 184 DLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRP---FANLINSLLVK 240
D+W LG ++ E G PP+ Q +K L D PP N + + + +L +
Sbjct: 199 DIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRDSPPPKLKNAHKISPVLRDFLERMLTR 257
Query: 241 DPAQRLHWSDLCGHAFWRTKLTPMPLPP 268
+P +R +L H F P L P
Sbjct: 258 EPQERATAQELLDHPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 19/261 (7%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLHSLDHPNVL-RFY 62
+G+G + V +K T E +AIK + K Q V + E R+L D P L + +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
S ++T L+ V+EY GGDLM ++Q + E A ++ L +LH +GIIY DL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
K N++LD G K+ DFG+ ++ + + CGTP Y+APE+ + +
Sbjct: 128 KLDNVMLDSEGHIKIADFGMCKE-----HMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKS 181
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDP 242
D W G +LYE AG+PPF G + +L +SI+ + + P + S+ ++ L+ K P
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM-EHNVSYPKSLSKEAVSICKGLMTKHP 240
Query: 243 AQRLHWS-----DLCGHAFWR 258
++RL D+ HAF+R
Sbjct: 241 SKRLGCGPEGERDIREHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 90/273 (32%), Positives = 130/273 (47%), Gaps = 23/273 (8%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD--KSQKSKVLQEVRMLHSL-DHPNV 58
+ + I E IG+G Y VYK KK A+K +D ++ E +L SL +HPNV
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV 81
Query: 59 LRFYSWYETSAH-----LWLVLEYCVGGDLMSL----LRQDNQLPEDSIRDLAQDLVRAL 109
++FY + + LWLVLE C GG + L L +L E I + + L
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
Q+LH+ II+ D+K +NILL G KL DFG++ +L+ + GTP +MA
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST-----RLRRNTSVGTPFWMA 196
Query: 170 PELF--EEGGVHSYAS--DLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--P 223
PE+ E+ +SY + D+W LG E G PP + + I +P P L P
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP 256
Query: 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
R F + I+ L+KD R + L H F
Sbjct: 257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 3e-32
Identities = 79/262 (30%), Positives = 122/262 (46%), Gaps = 14/262 (5%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK---VLQEVRMLHSLDHPNVLR 60
+ + + IG G Y VYK R T E AIK + V QE+ M+ H N++
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
++ Y LW+ +E+C GG L + L E I ++++ ++ L YLHSKG ++
Sbjct: 71 YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHR 130
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL--FEEGGV 178
D+K +NILL +NG KL DFG++ +++ S + GTP +MAPE+ E G
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-----GTPYWMAPEVAAVERKGG 185
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVG----REFTQLVKSILSDPSPPLPGNPSRPFANLI 234
++ D+W +G E +PP R + KS P S F + +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245
Query: 235 NSLLVKDPAQRLHWSDLCGHAF 256
L K+P +R L H F
Sbjct: 246 KMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 79/272 (29%), Positives = 135/272 (49%), Gaps = 17/272 (6%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK---VLQEVRMLHSLDHPNVL 59
+Y +E IG+G TVY T + AIK ++ Q+ K ++ E+ ++ HPN++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ Y LW+V+EY GG L ++ + + E I + ++ ++AL++LHS +I+
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIH 138
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
D+K NILL +G KL DFG +++ S+M+ GTP +MAPE+ +
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKA-Y 192
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPG--NPSRPFANLINSL 237
D+W LG + E G PP++ + + I ++ +P L S F + +N
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252
Query: 238 LVKDPAQRLHWSDLCGHAFWR-----TKLTPM 264
L D +R +L H F + + LTP+
Sbjct: 253 LEMDVEKRGSAKELLQHPFLKIAKPLSSLTPL 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 78/290 (26%), Positives = 127/290 (43%), Gaps = 41/290 (14%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNV 58
+ E +G G Y+TVYKGR + T E A+K + ++ S ++E+ ++ L H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDL---MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
+R + T L LV EY DL M L ++++ L++ + + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
+++ DLKP N+L+++ G KL DFGLAR S+ + T Y AP++
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN-----EVVTLWYRAPDVLLG 174
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFT-QLVK--SILSDPS------------- 219
+S + D+W +GC++ E GRP F G QL+K I+ P+
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234
Query: 220 -PPLPGNPSRPFANLINS-----------LLVKDPAQRLHWSDLCGHAFW 257
P P P + L LL +P R+ D H ++
Sbjct: 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-32
Identities = 91/284 (32%), Positives = 137/284 (48%), Gaps = 46/284 (16%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-DKSQKSKVLQ----EVRMLHSL-DHPN 57
Y I + +G+G Y V+K ++T E A+K + D + + Q E+ L L DHPN
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPN 68
Query: 58 VLRFYSWY--ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
+++ + E ++LV EY + DL +++R N L + R + L++AL+Y+HS
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEY-METDLHAVIRA-NILEDVHKRYIMYQLLKALKYIHSG 126
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE-LFE 174
+I+ DLKPSNILL+ + R KL DFGLAR LS+ + P + + T Y APE L
Sbjct: 127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILL- 185
Query: 175 EGGVHSY--ASDLWGLGCVLYECYAGRPPFVGR--------------------------E 206
G Y D+W +GC+L E G+P F G
Sbjct: 186 --GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSP 243
Query: 207 FT-QLVKSILSDPSPPLP---GNPSRPFANLINSLLVKDPAQRL 246
F ++ S+ S P PL S +L+ LLV +P +RL
Sbjct: 244 FAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 85/282 (30%), Positives = 125/282 (44%), Gaps = 40/282 (14%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSW 64
IG G Y V+K R ++T + AIK +S+ K L+E+RML L HPN++
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 65 YETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKP 124
+ L LV EYC L L + +PE I+ + ++A+ + H I+ D+KP
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKP 128
Query: 125 SNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASD 184
NIL+ + G+ KLCDFG AR L+ + + T Y APEL + D
Sbjct: 129 ENILITKQGQIKLCDFGFARILTGPGDDYTDYV-----ATRWYRAPELLVGDTQYGPPVD 183
Query: 185 LWGLGCVLYECYAGRPPFVGR-EFTQLV-------------KSILSD---------PSP- 220
+W +GCV E G+P + G+ + QL + I S P P
Sbjct: 184 VWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPE 243
Query: 221 ---PLPG---NPSRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
PL N S P + + L DP +RL +L H +
Sbjct: 244 TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 7e-32
Identities = 87/285 (30%), Positives = 141/285 (49%), Gaps = 34/285 (11%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSL----DHPNVL 59
IGRG + VY RK T + +A+K +DK + ++ L E R++ SL D P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 60
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ T L +L+ GGDL L Q E +R A +++ L+++H++ ++Y
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
DLKP+NILLDE+G ++ D GLA D SK P A GT YMAPE+ ++G +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA---CDFSKKK----PHASVGTHGYMAPEVLQKGVAY 173
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREF--TQLVKSILSDPSPPLPGNPSRPFANLINSL 237
++D + LGC+L++ G PF + + + + LP + S +L+ L
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGL 233
Query: 238 LVKDPAQRLHW-----SDLCGHAFWRT---------KLTPMPLPP 268
L +D +RL ++ H F+R+ K P +PP
Sbjct: 234 LQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPLIPP 278
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 7e-32
Identities = 86/269 (31%), Positives = 133/269 (49%), Gaps = 23/269 (8%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLHSLDHPN 57
++ +G+G + V +K T E +AIK + K Q V + E R+L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 58 VL-RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
L + +S ++T L+ V+EY GGDLM ++Q + E A ++ L +LHSKG
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
IIY DLK N++LD G K+ DFG+ ++ + + CGTP Y+APE+
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKE-----NMWDGVTTKTFCGTPDYIAPEII--- 173
Query: 177 GVHSYAS--DLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
Y D W G +LYE AG+ PF G + +L +SI+ + + P + S+ +
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM-EHNVAYPKSMSKEAVAIC 232
Query: 235 NSLLVKDPAQRLHWS-----DLCGHAFWR 258
L+ K P +RL D+ HAF+R
Sbjct: 233 KGLMTKHPGKRLGCGPEGERDIKEHAFFR 261
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 86/270 (31%), Positives = 130/270 (48%), Gaps = 34/270 (12%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSLDHPNVLRFY 62
E +GRG Y V K R T A+K + + QK ++ + S+D P + FY
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 63 SWYETSAHLWLVLEYCVGGDLMS---------LLRQDNQLPEDSIRDLAQDLVRALQYLH 113
+W+ +E +M + + +PED + +A +V+AL+YLH
Sbjct: 67 GALFREGDVWICME------VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 114 SK-GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
SK +I+ D+KPSN+L++ NG+ KLCDFG++ L D S+ G YMAPE
Sbjct: 121 SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD------SVAKTIDAGCKPYMAPER 174
Query: 173 FE-EGGVHSY--ASDLWGLGCVLYECYAGRPPFV--GREFTQLVKSILSDPSPPLPGNP- 226
E Y SD+W LG + E GR P+ F QL K ++ +PSP LP
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL-KQVVEEPSPQLPAEKF 233
Query: 227 SRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
S F + +N L K+ +R ++ +L H F
Sbjct: 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPF 263
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 1e-31
Identities = 77/262 (29%), Positives = 129/262 (49%), Gaps = 16/262 (6%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVD---------KSQKSKVLQEVRMLHSLDHPNV 58
E +G+G Y TVY G + A+K V+ + + K+ +EV +L SL H N+
Sbjct: 6 EVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+++ + + +E+ GG + S+L + LPE + ++ + YLH+ ++
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLS--DASKAPSSMLPQAKCGTPCYMAPELFEEG 176
+ D+K +N++L NG KL DFG AR+L+ S+ML GTP +MAPE+ E
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH-GTPYWMAPEVINES 183
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS--DPSPPLPGNPSRPFANLI 234
G + SD+W +GC ++E G+PP + + I + P LP + S + +
Sbjct: 184 G-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242
Query: 235 NSLLVKDPAQRLHWSDLCGHAF 256
S L +D +R L H F
Sbjct: 243 TSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 77/261 (29%), Positives = 134/261 (51%), Gaps = 16/261 (6%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVD--------KSQKSKVL----QEVRMLHSLDHPN 57
IG G + +VY G + E A+K V+ K +K +L +E+ +L L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
++++ + HL + LEY GG + +LL E +R+ + +++ L YLH++GI
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKL--SDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I+ D+K +NIL+D G K+ DFG+++KL + S + P + G+ +MAPE+ ++
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ-GSVFWMAPEVVKQ 186
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235
++ +D+W LGC++ E G+ PF Q + I + SP +P N S + +
Sbjct: 187 -TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLE 245
Query: 236 SLLVKDPAQRLHWSDLCGHAF 256
D +R ++L H F
Sbjct: 246 KTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 79/266 (29%), Positives = 135/266 (50%), Gaps = 25/266 (9%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNVLRFYS 63
+ +G+G Y +VYK + T A+K + D+S+ ++++ E+ +LH P ++ FY
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 64 WYETSAHLWLVLEYCVGGDLMSLL---RQDNQLPEDSIRDLAQDLVRALQYLHSK-GIIY 119
+ +++ +EY G L L +PED +R + +V+ L++L + II+
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG-- 177
D+KP+N+L++ NG+ KLCDFG++ L AS A +++ G YMAPE + GG
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNI------GCQSYMAPERIKSGGPN 179
Query: 178 ---VHSYASDLWGLGCVLYECYAGRPPFVGRE----FTQLVKSILSDPSPPLPGNPSRPF 230
++ SD+W LG + E GR P+ F QL +I+ P LP S
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL-SAIVDGDPPTLPSGYSDDA 238
Query: 231 ANLINSLLVKDPAQRLHWSDLCGHAF 256
+ + L K P +R ++ L H +
Sbjct: 239 QDFVAKCLNKIPNRRPTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 72/219 (32%), Positives = 112/219 (51%), Gaps = 16/219 (7%)
Query: 4 YHIYEAIGRGKYSTVYKGR-KKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHP 56
++ +G G + V K + AIK +KS Q V E ++L+ ++HP
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
+ Y ++ ++L+LVLE+ +GG+ + LR++ + P D A +V +YL S
Sbjct: 92 FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN 151
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
I+Y DLKP N+LLD++G K+ DFG A+ + + CGTP Y+APE+
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT--------YTLCGTPEYIAPEILLNV 203
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL 215
G H A+D W LG +YE G PPF E + + IL
Sbjct: 204 G-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL 241
|
Length = 340 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 9e-31
Identities = 90/288 (31%), Positives = 128/288 (44%), Gaps = 28/288 (9%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS------KVLQEVRMLHSLDHPNVLRFYS 63
IG G + VY T E A+K + S K +++EV+ L L HPN + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
Y WLV+EYC+G L L E I + ++ L YLHS +I+ D+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE--LFEEGGVHSY 181
NILL E G+ KL DFG A K S A+ + GTP +MAPE L + G +
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPAN---------SFVGTPYWMAPEVILAMDEGQYDG 199
Query: 182 ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP-SRPFANLINSLLVK 240
D+W LG E +PP + I + SP L N + F ++ L K
Sbjct: 200 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQK 259
Query: 241 DPAQRLHWSDLCGHAF-WRTKLTPMPLPPQPAFDSL---KGAVRQDEN 284
P +R ++L H F R + P + D + K AVR+ +N
Sbjct: 260 IPQERPASAELLRHDFVRRDR------PARVLIDLIQRTKDAVRELDN 301
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 89/273 (32%), Positives = 131/273 (47%), Gaps = 23/273 (8%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK--SKVLQEVRMLHSL-DHPNV 58
+ + I E IG+G Y V+K KK A+K +D ++ E +L +L DHPNV
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77
Query: 59 LRFYSWY-----ETSAHLWLVLEYCVGGDLMSL----LRQDNQLPEDSIRDLAQDLVRAL 109
++FY Y + LWLVLE C GG + L L++ ++ E I + + + L
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
Q+LH I+ D+K +NILL G KL DFG++ +L+ + + GTP +MA
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-----TRLRRNTSVGTPFWMA 192
Query: 170 PELF--EEGGVHSYAS--DLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--P 223
PE+ E+ +Y + D+W LG E G PP + + I +P P L P
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP 252
Query: 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
S F + I L KD +R SDL H F
Sbjct: 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 79/240 (32%), Positives = 122/240 (50%), Gaps = 19/240 (7%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHP 56
N++ + +G G Y V K R K+T E AIK S+ K L+E++ML +L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSK 115
N++ + L+LV EY V +++ LL + N +P + +R L++A+ + H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEY-VEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I++ D+KP N+L+ N KLCDFG AR LS+ S A + T Y +PEL
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT----EYVATRWYRSPELL-L 174
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQL--VKSILSDPSPPLPGNPSRPFAN 232
G + A D+W +GC+L E G+P F G E QL ++ +L PLP + F +
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLG----PLPAEQMKLFYS 230
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-30
Identities = 83/300 (27%), Positives = 130/300 (43%), Gaps = 52/300 (17%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYS 63
IG G + V RK T +A+K++ K+ Q + V E +L D+ V++ Y
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
++ +L+ V++Y GGD+MSLL + ED R +L A++ +H G I+ D+K
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIK 128
Query: 124 PSNILLDENGRTKLCDFGL------------------ARK--------LSDASKAPSSML 157
P NIL+D +G KL DFGL R+ S+ + L
Sbjct: 129 PDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPL 188
Query: 158 P------QAKC------GTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR 205
+C GTP Y+APE+ G ++ D W +G +LYE G+PPF+
Sbjct: 189 ERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPFLAD 247
Query: 206 ---EFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRL---HWSDLCGHAFWRT 259
E V + + P SR ++LI L RL ++ H F++
Sbjct: 248 TPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFFKG 306
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-30
Identities = 84/313 (26%), Positives = 138/313 (44%), Gaps = 51/313 (16%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-----KVLQEVRMLHSLDHP 56
++Y +G G Y V KT AIK + + +S + +E+R+L +DH
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 57 NVLRFYSWYETSAHL------WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQ 110
NV+ + ++ L +LV +G DL ++++ +L +D I+ L ++R L+
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHL-MGADLNNIVKC-QKLSDDHIQFLVYQILRGLK 132
Query: 111 YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAP 170
Y+HS GII+ DLKPSNI ++E+ K+ DFGLAR D M T Y AP
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD------EM--TGYVATRWYRAP 184
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS---DPSPP------ 221
E+ ++ D+W +GC++ E G+ F G + +K I++ P
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244
Query: 222 ----------LPGNPSRPFAN-----------LINSLLVKDPAQRLHWSDLCGHAFWRTK 260
LP P + F L+ +LV DP +R+ ++ H +
Sbjct: 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304
Query: 261 LTPMPLPPQPAFD 273
P P P +D
Sbjct: 305 HDPEDEPVAPPYD 317
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 84/292 (28%), Positives = 128/292 (43%), Gaps = 57/292 (19%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHPNVLRFYS 63
I G Y VY+ R KKT E A+K + K +K K L+E+ +L L HPN++
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKL-KMEKEKEGFPITSLREINILLKLQHPNIVTVK- 70
Query: 64 WYE-----TSAHLWLVLEYCVGGDLMSLL---RQDNQLPEDSIRDLAQDLVRALQYLHSK 115
E +++V+EY V DL SL+ +Q E ++ L L+ + +LH
Sbjct: 71 --EVVVGSNLDKIYMVMEY-VEHDLKSLMETMKQPFLQSE--VKCLMLQLLSGVAHLHDN 125
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I++ DLK SN+LL+ G K+CDFGLAR+ K + ++ T Y APEL
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-----TLWYRAPELLLG 180
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGR----------------------EFTQLVKS 213
+S A D+W +GC+ E +P F G+ F++L +
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240
Query: 214 ILSDPSPPLPGNPSRPFAN---------LINSLLVKDPAQRLHWSDLCGHAF 256
+ + F L+N LL DPA+R+ D H +
Sbjct: 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 89/290 (30%), Positives = 132/290 (45%), Gaps = 41/290 (14%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSLDHPN 57
+Y E IG G Y TV+K + ++T E A+K V D+ S L+E+ +L L H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSI-RDLAQDLVRALQYLHSKG 116
++R Y + L LV EYC DL N + I + L++ L + HS
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
+++ DLKP N+L+++NG KL DFGLAR + S A+ T Y P++
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS-----AEVVTLWYRPPDVLFGA 174
Query: 177 GVHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKSI-----------------LSD- 217
++S + D+W GC+ E AGRP F G + +K I L D
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234
Query: 218 -PSPPLPGNPSR----PFAN-----LINSLLVKDPAQRLHWSDLCGHAFW 257
P P P S P N L+ +LLV +P QR+ + H ++
Sbjct: 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 81/250 (32%), Positives = 134/250 (53%), Gaps = 22/250 (8%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSL----DHPNVL 59
IGRG + VY RK T + +A+K +DK + ++ L E R++ SL D P ++
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 60
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ T L +L+ GGDL L Q E +R A +++ L+++H++ ++Y
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
DLKP+NILLDE+G ++ D GLA D SK P A GT YMAPE+ ++G +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA---CDFSKKK----PHASVGTHGYMAPEVLQKGTAY 173
Query: 180 SYASDLWGLGCVLYECYAGRPPF---VGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
++D + LGC+L++ G PF ++ ++ + L+ + LP + S +L+
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-VNVELPDSFSPELKSLLEG 232
Query: 237 LLVKDPAQRL 246
LL +D ++RL
Sbjct: 233 LLQRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 75/293 (25%), Positives = 130/293 (44%), Gaps = 41/293 (13%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPN 57
+Y E IG G Y V ++ + AIK + + + L+E+++L H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 58 VLRFYSWYETSA----HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLH 113
++ +++V++ + DL ++ D L E+ IR L+R L+Y+H
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
S +I+ DLKPSN+L++E+ ++ DFG+AR LS + + + T Y APEL
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE-YVATRWYRAPELL 183
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT---QLVKSILSDPSPP--------- 221
++ A D+W +GC+ E R F G+ + +L+ S+L PS
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243
Query: 222 -------LPGNPSRPFA-----------NLINSLLVKDPAQRLHWSDLCGHAF 256
LP P++ +L++ +L DP +R+ H F
Sbjct: 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF 296
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 86/258 (33%), Positives = 121/258 (46%), Gaps = 22/258 (8%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHPNVLRFYS 63
IG G + VY R +T E AIK + S K +++EV+ L + HPN + +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 64 WYETSAHLWLVLEYCVG--GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
Y WLV+EYC+G DL+ + ++ L E I + ++ L YLHS +I+ D
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE--LFEEGGVH 179
+K NILL E G+ KL DFG A S A+ + GTP +MAPE L + G +
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPAN---------SFVGTPYWMAPEVILAMDEGQY 201
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP-SRPFANLINSLL 238
D+W LG E +PP + I + SP L N S F N ++S L
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCL 261
Query: 239 VKDPAQRLHWSDLCGHAF 256
K P R +L H F
Sbjct: 262 QKIPQDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 84/311 (27%), Positives = 143/311 (45%), Gaps = 56/311 (18%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVR----MLHSLDH 55
+H + IG+G + V +KK T + +A+K++ KS+ K L V+ +L D
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
P V+ Y ++ + +L+L++E+ GGDLM++L + + ED R + V A++ +H
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLA------------RKL--SDASKAPSS------ 155
G I+ D+KP NIL+D G KL DFGL+ +KL ++K
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 156 ----------------------MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLY 193
++ + GTP Y+APE+F + G + D W LG +++
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMF 239
Query: 194 ECYAGRPPFVGREFTQLVKSILS-DPSPPLPGNP--SRPFANLINSLLVKDPAQRL---H 247
EC G PPF + + I++ + P + S +LI L+ + RL
Sbjct: 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298
Query: 248 WSDLCGHAFWR 258
++ H F+R
Sbjct: 299 AHEIKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 86/296 (29%), Positives = 132/296 (44%), Gaps = 41/296 (13%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHPN 57
+ Y +G+G + V + + T + +A K ++K + K L E ++L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHSK 115
V+ YET L LVL GGDL + E+ A ++ L+ LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I+Y DLKP NILLD+ G ++ D GLA ++ P + + GT YMAPE+ +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEI------PEGETIRGRVGTVGYMAPEVVKN 175
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGR-------EFTQLVKSILSDPSPPLPGNPSR 228
++++ D WGLGC++YE G+ PF R E + VK + S S
Sbjct: 176 ER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKF----SE 230
Query: 229 PFANLINSLLVKDPAQRL-----HWSDLCGHAFWRT---------KLTPMPLPPQP 270
++ LL KDP RL ++ H F+RT L P P P P
Sbjct: 231 AARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEP-PFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 79/264 (29%), Positives = 132/264 (50%), Gaps = 12/264 (4%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVD--KSQKSKVL-QEVRMLHSLDHPNVLRFYSWYE 66
IG G V +K T + A+K +D K Q+ ++L EV ++ H NV+ Y+ Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 67 TSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSN 126
LW+V+E+ GG L ++ ++ E+ I + ++RAL YLH++G+I+ D+K +
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148
Query: 127 ILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLW 186
ILL +GR KL DFG ++S S++ GTP +MAPE+ + D+W
Sbjct: 149 ILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-----GTPYWMAPEVISRLP-YGTEVDIW 202
Query: 187 GLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPG--NPSRPFANLINSLLVKDPAQ 244
LG ++ E G PP+ Q ++ I + P + S ++ +LV++P+Q
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQ 262
Query: 245 RLHWSDLCGHAFWRTKLTPMPLPP 268
R +L H F + P + P
Sbjct: 263 RATAQELLQHPFLKLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 3e-29
Identities = 81/280 (28%), Positives = 139/280 (49%), Gaps = 19/280 (6%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK---VLQEVRMLHSLDHPNVL 59
+Y +E IG+G TVY T + AIK ++ Q+ K ++ E+ ++ +PN++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ Y LW+V+EY GG L ++ + + E I + ++ ++AL +LHS +I+
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALDFLHSNQVIH 138
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
D+K NILL +G KL DFG +++ S+M+ GTP +MAPE+ +
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKA-Y 192
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSR---PFANLINS 236
D+W LG + E G PP++ + + I ++ +P L NP R F + +N
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ-NPERLSAVFRDFLNR 251
Query: 237 LLVKDPAQRLHWSDLCGHAFWR-----TKLTPMPLPPQPA 271
L D +R +L H F + + LTP+ + + A
Sbjct: 252 CLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIAAKEA 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 21/276 (7%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKV---LQEVRMLHSLDHPNVLR 60
+ I +G G + VYK + K+T A K ++ + ++ + E+ +L + +HP +++
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 61 FYSWYETSAHLWLVLEYCVGGDL-MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ LW+++E+C GG + +L D L E I+ + + ++ ALQYLHS II+
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF----EE 175
DLK N+LL +G KL DFG++ K + S + GTP +MAPE+ +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMK 188
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ---LVKSILSDPSPPL--PGNPSRPF 230
+ Y +D+W LG L E PP E L+K S+P P L P S F
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPH--HELNPMRVLLKIAKSEP-PTLSQPSKWSMEF 245
Query: 231 ANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPL 266
+ + + L K P R + L H F + + PL
Sbjct: 246 RDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPL 281
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 78/272 (28%), Positives = 136/272 (50%), Gaps = 17/272 (6%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK---VLQEVRMLHSLDHPNVL 59
+Y +E IG+G TVY T + AI+ ++ Q+ K ++ E+ ++ +PN++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ Y LW+V+EY GG L ++ + + E I + ++ ++AL++LHS +I+
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
D+K NILL +G KL DFG +++ S+M+ GTP +MAPE+ +
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKA-Y 193
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGNPSRPFANLINSL 237
D+W LG + E G PP++ + + I ++ +P L P S F + +N
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 238 LVKDPAQRLHWSDLCGHAFWR-----TKLTPM 264
L D +R +L H F + + LTP+
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKIAKPLSSLTPL 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-29
Identities = 83/305 (27%), Positives = 125/305 (40%), Gaps = 50/305 (16%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-DKSQKS----KVLQEVRMLHSLDH 55
+ Y I +G G + VYK R+ KT A+K + ++K L+E+++L L H
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKH 66
Query: 56 PNVLR----FYSWYETSAHL----WLVLEYCVGGDLMSLLRQDN-QLPEDSIRDLAQDLV 106
PNV+ + S ++V Y DL LL + +L E I+ L+
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLL 125
Query: 107 RALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCG-TP 165
+ YLH I++ D+K +NIL+D G K+ DFGLAR P T
Sbjct: 126 EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 166 C-----YMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVG---REFTQLVKSILSD 217
Y PEL ++ A D+WG+GCV E + RP G + L+ +
Sbjct: 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245
Query: 218 PSPP-------LPG------NPSRP-------------FANLINSLLVKDPAQRLHWSDL 251
P+ LPG + P +L++ LL DP +RL SD
Sbjct: 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305
Query: 252 CGHAF 256
H +
Sbjct: 306 LEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 80/263 (30%), Positives = 130/263 (49%), Gaps = 28/263 (10%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIE-YFAIKSV---------DKSQKSK----VLQEVRM 49
Y + E +G G + VYK RKK + A+K + DK ++ K ++ EV +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 50 L-HSLDHPNVLRFYSWYETSAHLWLVLEYCVG---GDLMSLLRQDNQ-LPEDSIRDLAQD 104
+ L HPN++R+Y + + L++V++ G G+ + L++ Q E+ I ++
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 105 LVRALQYLH-SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCG 163
+V AL+YLH K I++ DL P+NI+L E+ + + DFGLA++ SK S G
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS------VVG 175
Query: 164 TPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLP 223
T Y PE+ + + +D+W GC+LY+ +PPF L I+ PLP
Sbjct: 176 TILYSCPEIV-KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP 234
Query: 224 -GNPSRPFANLINSLLVKDPAQR 245
G S ++I S L D R
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 9e-29
Identities = 85/258 (32%), Positives = 118/258 (45%), Gaps = 22/258 (8%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHPNVLRFYS 63
IG G + VY R + E AIK + S K +++EVR L L HPN +++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 64 WYETSAHLWLVLEYCVG--GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
Y WLV+EYC+G DL+ + ++ L E I + ++ L YLHS +I+ D
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE--LFEEGGVH 179
+K NILL E G KL DFG A ++ A+ GTP +MAPE L + G +
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPAN---------XFVGTPYWMAPEVILAMDEGQY 191
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP-SRPFANLINSLL 238
D+W LG E +PP + I + SP L S F N ++S L
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251
Query: 239 VKDPAQRLHWSDLCGHAF 256
K P R L H F
Sbjct: 252 QKIPQDRPTSEVLLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 82/291 (28%), Positives = 126/291 (43%), Gaps = 47/291 (16%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSLDHPNV 58
Y E IG G Y VYK R K T E A+K + D+ S ++E+ +L L+HPN+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDS-----IRDLAQDLVRALQYLH 113
+R + L+LV E+ D + L + + P I+ L++ + Y H
Sbjct: 61 VRLLDVVHSENKLYLVFEFL---D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
S +++ DLKP N+L+D G KL DFGLAR + + + T Y APE+
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH-----EVVTLWYRAPEIL 171
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVG-REFTQLVK----------------SILS 216
+S D+W +GC+ E RP F G E QL + + L
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231
Query: 217 DPSPPLPGNPSRPFA-----------NLINSLLVKDPAQRLHWSDLCGHAF 256
D P P + + +L++ +LV DPA+R+ H +
Sbjct: 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 81/267 (30%), Positives = 131/267 (49%), Gaps = 12/267 (4%)
Query: 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVD--KSQKSKVL-QEVRMLHSLDHPNVLRFYS 63
+ IG G V K + + A+K +D K Q+ ++L EV ++ H NV+ Y+
Sbjct: 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
Y LW+V+E+ GG L ++ ++ E+ I + +++AL LH++G+I+ D+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYAS 183
+ILL +GR KL DFG ++S S++ GTP +MAPEL +
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPELISRLP-YGPEV 197
Query: 184 DLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPG--NPSRPFANLINSLLVKD 241
D+W LG ++ E G PP+ + +K I + P L S ++ LLV+D
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257
Query: 242 PAQRLHWSDLCGHAFWRTKLTPMPLPP 268
PAQR ++L H F P + P
Sbjct: 258 PAQRATAAELLKHPFLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 91/304 (29%), Positives = 130/304 (42%), Gaps = 55/304 (18%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDHP 56
++Y IG+G + V+K R KKT + A+K V + + L+E+++L L H
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 57 NVLRFYSWYETSA--------HLWLVLEYCVGGDLMSLLRQDN---QLPEDSIRDLAQDL 105
NV+ T A +LV E+C DL LL N L E I+ + + L
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFC-EHDLAGLLSNKNVKFTLSE--IKKVMKML 128
Query: 106 VRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTP 165
+ L Y+H I++ D+K +NIL+ ++G KL DFGLAR S SK + T
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS-LSKNSKPNRYTNRVVTL 187
Query: 166 CYMAPELFEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGRE-------FTQLVKSILS 216
Y PEL G Y D+WG GC++ E + P G +QL SI
Sbjct: 188 WYRPPELLL--GERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245
Query: 217 DPSP-----------PLPGNPSR-------PFAN------LINSLLVKDPAQRLHWSDLC 252
+ P LP R P+ LI+ LLV DPA+R+
Sbjct: 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305
Query: 253 GHAF 256
H F
Sbjct: 306 NHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 1e-28
Identities = 79/282 (28%), Positives = 141/282 (50%), Gaps = 17/282 (6%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK---VLQEVRMLHSLDHPNVL 59
+Y YE IG+G TV+ T + AIK ++ ++ K ++ E+ ++ L +PN++
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
F + L++V+EY GG L ++ + + E I + ++ ++AL++LH+ +I+
Sbjct: 80 NFLDSFLVGDELFVVMEYLAGGSLTDVV-TETCMDEAQIAAVCRECLQALEFLHANQVIH 138
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
D+K N+LL +G KL DFG +++ S+M+ GTP +MAPE+ +
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKA-Y 192
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGNPSRPFANLINSL 237
D+W LG + E G PP++ + + I ++ +P L P S F + +N
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252
Query: 238 LVKDPAQRLHWSDLCGHAFWR-----TKLTPMPLPPQPAFDS 274
L D +R +L H F + + LTP+ L + A S
Sbjct: 253 LEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLILAAKEAMKS 294
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 75/227 (33%), Positives = 116/227 (51%), Gaps = 14/227 (6%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHP 56
+ Y + +G G Y+TV+KGR K T A+K + ++ ++EV +L +L H
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHA 63
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSK 115
N++ + T L LV EY + DL L N + +++ L+R L Y H +
Sbjct: 64 NIVTLHDIIHTERCLTLVFEY-LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I++ DLKP N+L++E G KL DFGLAR S +K S+ + T Y P++
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN-----EVVTLWYRPPDVLLG 177
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVG---REFTQLVKSILSDPS 219
+S D+WG+GC+LYE GRP F G +E L+ +L P+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPT 224
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 69/256 (26%), Positives = 118/256 (46%), Gaps = 12/256 (4%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVL--------QEVRMLHSLDHPNVLRF 61
+G+G + VY T A+K V S E+++L +L H ++++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
Y L + +EY GG + L+ L E R + ++ ++YLHS I++ D
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSY 181
+K +NIL D G KL DFG +++L + + M GTP +M+PE+ G +
Sbjct: 130 IKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT--GTPYWMSPEVI-SGEGYGR 186
Query: 182 ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS-PPLPGNPSRPFANLINSLLVK 240
+D+W +GC + E +PP+ E + I + P+ P LP + S N + V+
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVE 246
Query: 241 DPAQRLHWSDLCGHAF 256
+ +R +L H F
Sbjct: 247 NAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 68/228 (29%), Positives = 119/228 (52%), Gaps = 17/228 (7%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQ----EVRMLHSLDHPNV 58
+ +G G +S+ Y+ R KT A+K V S++ +V++ E+R++ L+HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+R +H L +E+ GG + LL + E I + + L+R L YLH II
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQII 125
Query: 119 YCDLKPSNILLDENGR-TKLCDFGLARKLSDASKAPSSMLPQAK-CGTPCYMAPELFEEG 176
+ D+K +N+L+D G+ ++ DFG A +L A+K + Q + GT +MAPE+ G
Sbjct: 126 HRDVKGANLLIDSTGQRLRIADFGAAARL--AAKGTGAGEFQGQLLGTIAFMAPEVL-RG 182
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFT---QLVKSILSDPSPP 221
+ + D+W +GCV+ E +PP+ + + L+ I S + P
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 70/265 (26%), Positives = 130/265 (49%), Gaps = 25/265 (9%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
+G G +V K + T A K V S + ++L+E++++H P ++ FY +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLKP 124
++ + +E+ G L + ++ +P + + +A +V L YL++ I++ D+KP
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKP 132
Query: 125 SNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASD 184
SNIL++ G+ KLCDFG++ +L ++ + GT YM+PE +GG ++ SD
Sbjct: 133 SNILVNSRGQIKLCDFGVSGELINS-------IADTFVGTSTYMSPERI-QGGKYTVKSD 184
Query: 185 LWGLGCVLYECYAGRPPFVGRE-----------FTQLVKSILSDPSPPLPGNPSRPFA-N 232
+W LG + E G+ PF L++ I+ +P P LP + +
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD 244
Query: 233 LINSLLVKDPAQRLHWSDLCGHAFW 257
+++ L+KDP +R LC +
Sbjct: 245 FVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 76/260 (29%), Positives = 124/260 (47%), Gaps = 21/260 (8%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDK--SQKSKVLQEVRMLHS-LDHPNVLRFYSWYE 66
+G+G Y VY R T AIK + + S+ + L E LHS L H N++++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 67 TSAHLWLVLEYCVGGDLMSLLR------QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
+ + +E GG L +LLR +DN E +I + ++ L+YLH I++
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 121 DLKPSNILLDE-NGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV- 178
D+K N+L++ +G K+ DFG +++L+ + + GT YMAPE+ ++G
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-----TGTLQYMAPEVIDKGPRG 187
Query: 179 HSYASDLWGLGCVLYECYAGRPPFV--GREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
+ +D+W LGC + E G+PPF+ G + K + P +P + S N I
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247
Query: 237 LLVKDPAQRLHWSDLCGHAF 256
DP +R DL F
Sbjct: 248 CFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 10/208 (4%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSLDHP 56
+Y +G G Y V K + K+T + AIK DK K ++E+RML L H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
N++ + L+LV E+ L L + N L E +R ++R +++ HS
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
II+ D+KP NIL+ ++G KLCDFG AR L+ + + + T Y APEL
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELLVGD 175
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVG 204
+ A D+W +GC++ E G P F G
Sbjct: 176 TKYGRAVDIWAVGCLVTEMLTGEPLFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-28
Identities = 75/295 (25%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTI--EYFAIKSV----DKSQKSK-VLQEVRMLHSL-DH 55
Y + + +G+G Y V R +T E AIK + K +K L+E+++L H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 56 PNVLRFYS----WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
N+ Y + L+L E + DL ++R L + + ++ L+Y
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEEL-MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKY 120
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
+HS +++ DLKP N+L++ + K+CDFGLAR S+ + + + T Y APE
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEY-VATRWYRAPE 179
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP---------- 221
+ ++ A D+W +GC+L E +P F G+++ + IL P
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239
Query: 222 ---------LPGNPSRPFA-----------NLINSLLVKDPAQRLHWSDLCGHAF 256
LP P +PF +L+ LL DP +R+ + H +
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 79/264 (29%), Positives = 128/264 (48%), Gaps = 17/264 (6%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKV---LQEVRMLHSLDHPNVLR 60
+ I +G G + VYK + K+T A K +D + ++ + E+ +L S DHPN+++
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMS-LLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ +LW+++E+C GG + + +L + L E IR + + + AL YLH II+
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF----EE 175
DLK NIL +G KL DFG++ K + + S + GTP +MAPE+ +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 181
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSR---PFAN 232
+ Y +D+W LG L E PP +++ I + PP PSR F +
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSEPPTLAQPSRWSSEFKD 240
Query: 233 LINSLLVKDPAQRLHWSDLCGHAF 256
+ L K+ R + L H F
Sbjct: 241 FLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 85/279 (30%), Positives = 128/279 (45%), Gaps = 44/279 (15%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKV----LQEVRMLHSL-DHPNV 58
Y I IG G +S V K + +KT +Y+AIK + K KS L+E++ L L HPN+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 59 LRFYS--WYETSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLHSK 115
LR + + L LV E + +L L++ + LPE ++ L+++L ++H
Sbjct: 61 LRLIEVLFDRKTGRLALVFEL-MDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
GI + D+KP NIL+ ++ KL DFG R SK P + T Y APE
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYT----EYISTRWYRAPECLLT 172
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDPSPPL-----PGN-- 225
G + D+W +GCV +E + P F G E Q+ K +L P +
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232
Query: 226 ----PSR---------PFAN-----LINSLLVKDPAQRL 246
PS+ P A+ L+ LL DP +R+
Sbjct: 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI 271
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 78/263 (29%), Positives = 127/263 (48%), Gaps = 28/263 (10%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIK----SVDKSQKSKVLQEVRMLHSLDHPNVLRFYS 63
E +G G TVYK T A+K + + +++ E+ +L+ D P ++ FY
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
+ + + E+ GG L + +PE + +A +V+ L YL S I++ D+K
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRK----IPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE--LFEEGGVHSY 181
PSN+L++ G+ KLCDFG++ +L ++ + + GT YMAPE E+ G+H
Sbjct: 123 PSNMLVNTRGQVKLCDFGVSTQLVNS-------IAKTYVGTNAYMAPERISGEQYGIH-- 173
Query: 182 ASDLWGLGCVLYECYAGRPPFVGREFT-------QLVKSILSDPSPPLP-GNPSRPFANL 233
SD+W LG E GR P+ + QL++ I+ + P LP G S F +
Sbjct: 174 -SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF 232
Query: 234 INSLLVKDPAQRLHWSDLCGHAF 256
I + K P +R +L H F
Sbjct: 233 ITQCMRKQPKERPAPENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 77/252 (30%), Positives = 121/252 (48%), Gaps = 20/252 (7%)
Query: 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLR 60
Y +G+G + V + + T + +A K ++K + +S L E ++L ++ V+
Sbjct: 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 61 FYSWYETSAHLWLVLEYCVGGDL-MSLLRQDNQ-LPEDSIRDLAQDLVRALQYLHSKGII 118
YET L LVL GGDL + N E+ A +++ L+ LH + +
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV 124
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
Y DLKP NILLD+ G ++ D GLA K+ P + + GT YMAPE+
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGLAVKI------PEGESIRGRVGTVGYMAPEVLNNQR- 177
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVGR----EFTQLVKSILSDPSPPLPGNPSRPFANLI 234
++ + D WGLGC++YE G+ PF GR + ++ + +L S ++
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET-EEVYSAKFSEEAKSIC 236
Query: 235 NSLLVKDPAQRL 246
LL KDP QRL
Sbjct: 237 KMLLTKDPKQRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-27
Identities = 83/282 (29%), Positives = 143/282 (50%), Gaps = 44/282 (15%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-----KSQKSKVLQEVRMLHSLDH 55
+N+Y + + IG G++ V+ + K+T E+F K++ + +KS+++ EV ++ L H
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71
Query: 56 PNVLRFYSWYETSAH--LWLVLEYCVGGDL----MSLLRQDNQLPEDSIRDLAQDLVRAL 109
N++R+ + A+ L++++E+C GDL + ++ E +I D+ + L+ AL
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 110 QYLHS-------KGIIYCDLKPSNILLDE---------------NGR--TKLCDFGLARK 145
Y H+ + +++ DLKP NI L NGR K+ DFGL++
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 146 LSDASKAPSSMLPQAKCGTPCYMAPELF-EEGGVHSYASDLWGLGCVLYECYAGRPPF-V 203
+ S A S + GTP Y +PEL E + SD+W LGC++YE +G+ PF
Sbjct: 192 IGIESMAHSCV------GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245
Query: 204 GREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQR 245
F+QL+ + P P+ G S+ LI +LL +R
Sbjct: 246 ANNFSQLISELKRGPDLPIKGK-SKELNILIKNLLNLSAKER 286
|
Length = 1021 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 75/251 (29%), Positives = 118/251 (47%), Gaps = 23/251 (9%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHPNVLRFYS 63
+G+G + V + K T + +A K +DK + K L E +L ++ P ++
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDL--AQDLVRALQYLHSKGIIYCD 121
+E+ HL LV+ GGDL + + + R + + + + +LHS I+Y D
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSY 181
+KP N+LLD+ G +L D GLA +L D + GT YMAPE+ +E +SY
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ------RAGTNGYMAPEILKE-EPYSY 173
Query: 182 ASDLWGLGCVLYECYAGRPPF------VGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235
D + +GC +YE AGR PF V +E +L + L D N + ++
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLEDEVKFEHQNFTEESKDICR 231
Query: 236 SLLVKDPAQRL 246
L K P RL
Sbjct: 232 LFLAKKPEDRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 68/226 (30%), Positives = 118/226 (52%), Gaps = 15/226 (6%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK------SQKSKVLQEVRMLHSLDH 55
+ + I + IGRG + V + K T +A+K ++K ++ + +E +L + D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHS 114
+ + ++ +L+LV++Y VGGDL++LL + +++LPED R ++V A+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
++ D+KP N+LLD NG +L DFG K++ SS+ GTP Y++PE+ +
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV----AVGTPDYISPEILQ 176
Query: 175 --EGGVHSYAS--DLWGLGCVLYECYAGRPPFVGREFTQLVKSILS 216
E G+ Y D W LG +YE G PF + I++
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 82/302 (27%), Positives = 136/302 (45%), Gaps = 43/302 (14%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHP 56
M Y E +G G Y+TV+KGR K T A+K + ++ ++EV +L L H
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSK 115
N++ + T L LV EY + DL + N + +++ ++R L Y H +
Sbjct: 65 NIVTLHDIVHTDKSLTLVFEY-LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
+++ DLKP N+L++E G KL DFGLAR S +K S+ + T Y P++
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN-----EVVTLWYRPPDVLLG 178
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVG---REFTQLVKSILSDPSPP----------- 221
+S D+WG+GC+ +E +GRP F G + L+ +L P+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238
Query: 222 ----LPGNPSRPFAN-----------LINSLLVKDPAQRLHWSDLCGHAFWR---TKLTP 263
P +P N L+ L + +R+ + HA++R T++
Sbjct: 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHS 298
Query: 264 MP 265
+P
Sbjct: 299 LP 300
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-27
Identities = 74/227 (32%), Positives = 112/227 (49%), Gaps = 14/227 (6%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHP 56
+ Y + +G G Y+TVYKGR K T A+K + ++ ++EV +L L H
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSK 115
N++ + T L LV EY + DL L N + +++ L+R L Y H +
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEY-LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
+++ DLKP N+L++E G KL DFGLAR S +K S+ + T Y P++
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN-----EVVTLWYRPPDILLG 178
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVG---REFTQLVKSILSDPS 219
+S D+WG+GC+ YE GRP F G E + IL P+
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT 225
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 85/283 (30%), Positives = 131/283 (46%), Gaps = 31/283 (10%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHPNVLRFYS 63
+G+G + V + + T + +A K ++K + K + E R+L + ++
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 64 WYETSAHLWLVLEYCVGGDL---MSLLRQDNQ-LPEDSIRDLAQDLVRALQYLHSKGIIY 119
++T L LV+ GGDL + + ++N PE ++ L++LH + IIY
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
DLKP N+LLD +G ++ D GLA +L D + GTP +MAPEL +G +
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-----TKGYAGTPGFMAPELL-QGEEY 174
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGR----EFTQLVKSILSDPSPPLPGNPSRPFANLIN 235
++ D + LG LYE A R PF R E +L + IL+D P S +
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV-TYPDKFSPASKSFCE 233
Query: 236 SLLVKDPAQRLHWSD-----LCGHAF-----WRTKLTPMPLPP 268
+LL KDP +RL + D L H WR M PP
Sbjct: 234 ALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 7e-27
Identities = 77/283 (27%), Positives = 131/283 (46%), Gaps = 43/283 (15%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS----KVLQEVRMLHSLDHPNV 58
+Y IG G Y V K T AIK + + + L+E+++L H N+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 59 LRFY-----SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLH 113
+ +E+ +++V E + DL L++ + L D I+ ++R L+Y+H
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQEL-METDLYKLIKTQH-LSNDHIQYFLYQILRGLKYIH 123
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
S +++ DLKPSN+LL+ N K+CDFGLAR ++D + L + T Y APE+
Sbjct: 124 SANVLHRDLKPSNLLLNTNCDLKICDFGLAR-IADPEHDHTGFLTEY-VATRWYRAPEIM 181
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ---LVKSILSDPS----------- 219
++ A D+W +GC+L E + RP F G+++ L+ +L PS
Sbjct: 182 LNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241
Query: 220 -----PPLPGNPSRPFA-----------NLINSLLVKDPAQRL 246
LP P P+ +L++ +L +P +R+
Sbjct: 242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 80/255 (31%), Positives = 123/255 (48%), Gaps = 26/255 (10%)
Query: 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLR 60
Y +G+G + V + + T + +A K ++K + +S L E ++L ++ V+
Sbjct: 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYLHSKGII 118
YET L LVL GGDL + + E A ++ L+ LH + I+
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV 124
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
Y DLKP NILLD++G ++ D GLA + P + + GT YMAPE+ +
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGLAVHV------PEGQTIKGRVGTVGYMAPEVVKNER- 177
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVGR-------EFTQLVKSILSDPSPPLPGNPSRPFA 231
++++ D W LGC+LYE AG+ PF R E +LVK + + S S
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKF----SPDAR 233
Query: 232 NLINSLLVKDPAQRL 246
+L LL KDP +RL
Sbjct: 234 SLCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVR--MLHSLDHP 56
+ + + IGRG + V R K + + +A+K + K + S E R M H+ +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSE 103
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
+++ + ++ +L++V+EY GGDL++L+ + +PE R ++V AL +HS G
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDAIHSMG 162
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
I+ D+KP N+LLD++G KL DFG K+ GTP Y++PE+ +
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD----TAVGTPDYISPEVLKSQ 218
Query: 177 GVHSY---ASDLWGLGCVLYECYAGRPPF 202
G Y D W +G LYE G PF
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 73/227 (32%), Positives = 110/227 (48%), Gaps = 30/227 (13%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKK--KTIEYFAIKSV--DKSQKSKVLQ----EVRMLHSLD 54
+Y I IGRG Y VYK ++K K + +AIK DK Q + + Q E+ +L L
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 55 HPNVLR----FYSWYETSAHLWLVLEYCVGGDLMSLLR-----QDNQLPEDSIRDLAQDL 105
H NV+ F + S ++L+ +Y DL +++ + +P ++ L +
Sbjct: 61 HENVVSLVEVFLEHADKS--VYLLFDYA-EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 106 VRALQYLHSKGIIYCDLKPSNILL----DENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161
+ + YLHS +++ DLKP+NIL+ E G K+ D GLAR + K + + P
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 162 CGTPCYMAPELFEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGRE 206
T Y APEL G Y A D+W +GC+ E P F GRE
Sbjct: 178 --TIWYRAPELLL--GARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 74/239 (30%), Positives = 111/239 (46%), Gaps = 24/239 (10%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDH 55
++++ I IG G Y VYK R K T E A+K V + + ++E+++L L+H
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 56 PNVLRFYS----------WYETSAHLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQD 104
N++ + + +LV EY + DLM LL ED I+ +
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEY-MDHDLMGLLESGLVHFSEDHIKSFMKQ 124
Query: 105 LVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGT 164
L+ L Y H K ++ D+K SNILL+ G+ KL DFGLAR + P + K T
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT----NKVIT 180
Query: 165 PCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVG-REFTQL--VKSILSDPSP 220
Y PEL + A D+W GC+L E + +P F +E QL + + P P
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 82/285 (28%), Positives = 125/285 (43%), Gaps = 41/285 (14%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSLDHPNVLRFY 62
E IG G Y VYK R K T E A+K + + S ++E+ +L L+HPN+++
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLL--RQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
T L+LV E+ + DL + + +P I+ L++ L + HS +++
Sbjct: 66 DVIHTENKLYLVFEF-LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DLKP N+L++ G KL DFGLAR A P + T Y APE+ +S
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLAR----AFGVPVRTYTH-EVVTLWYRAPEILLGCKYYS 179
Query: 181 YASDLWGLGCVLYECYAGRPPFVG-REFTQLVK----------------SILSDPSPPLP 223
A D+W LGC+ E R F G E QL + + L D P P
Sbjct: 180 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239
Query: 224 GNPSRPFA-----------NLINSLLVKDPAQRLHWSDLCGHAFW 257
+ F+ +L++ +L DP +R+ H F+
Sbjct: 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-26
Identities = 69/235 (29%), Positives = 119/235 (50%), Gaps = 23/235 (9%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK-----SQKSKVLQEVRMLHSLDHPN 57
+Y I E IG+G Y V T E AIK ++ S +++L+E+++L L HP+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 58 VLRFYSWYETSAH-----LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
++ + +++V E + DL +++ ++ L + + L+RAL+Y+
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQFFLYQLLRALKYI 119
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
H+ + + DLKP NIL + + + K+CDFGLAR + P+++ T Y APEL
Sbjct: 120 HTANVFHRDLKPKNILANADCKLKICDFGLAR--VAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 173 ----FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT---QLVKSILSDPSP 220
F + ++ A D+W +GC+ E G+P F G+ L+ +L PSP
Sbjct: 178 CGSFFSK---YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 82/265 (30%), Positives = 125/265 (47%), Gaps = 43/265 (16%)
Query: 3 QYHIYEAIGRGKYSTVYKGRK-KKTIEYFAIKSV-----DKSQKSKVLQEV---RMLHSL 53
QY IG G Y V+K R K + A+K V ++ ++EV R L +
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 54 DHPNVLRFY-----SWYETSAHLWLVLEYCVGGDLMSLLRQ--DNQLPEDSIRDLAQDLV 106
+HPNV+R + S + L LV E+ V DL + L + + +P ++I+D+ L+
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 107 RALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC 166
R L +LHS +++ DLKP NIL+ +G+ KL DFGLAR S M + T
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS------FQMALTSVVVTLW 174
Query: 167 YMAPELFEEGGVHSYAS--DLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDPSPP 221
Y APE+ + SYA+ DLW +GC+ E + +P F G + QL K ++ P
Sbjct: 175 YRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231
Query: 222 -------LPGN-----PSRPFANLI 234
LP ++P +
Sbjct: 232 DWPRDVALPRQAFHSKSAQPIEKFV 256
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-26
Identities = 67/210 (31%), Positives = 114/210 (54%), Gaps = 15/210 (7%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK------SQKSKVLQEVRMLHSLDHPN 57
+ I + IGRG + V + K T + +A+K ++K ++ + +E +L + D
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKG 116
+ + ++ +L+LV++Y VGGDL++LL + +++LPED R ++V A+ +H G
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE-- 174
++ D+KP N+LLD+NG +L DFG +L S++ GTP Y++PE+ +
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV----AVGTPDYISPEILQAM 178
Query: 175 EGGVHSYAS--DLWGLGCVLYECYAGRPPF 202
E G Y D W LG +YE G PF
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 9e-26
Identities = 78/297 (26%), Positives = 137/297 (46%), Gaps = 58/297 (19%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIK----SVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
+G G V+K K + A K + + ++++++E+++LH + P ++ FY +
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLKP 124
+ + + +E+ GG L +L++ ++PE + ++ +++ L YL K I++ D+KP
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKP 132
Query: 125 SNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASD 184
SNIL++ G KLCDFG++ +L D+ + + GT YM+PE +G +S SD
Sbjct: 133 SNILVNSRGEIKLCDFGVSGQLIDS-------MANSFVGTRSYMSPERL-QGTHYSVQSD 184
Query: 185 LWGLGCVLYECYAGR---PPFVGREFTQLV-KSILSDPS----PPLPGNPSRP------- 229
+W +G L E GR PP +E + + DP+ P P P RP
Sbjct: 185 IWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPD 244
Query: 230 ------------------------------FANLINSLLVKDPAQRLHWSDLCGHAF 256
F + +N L+K+PA+R L HAF
Sbjct: 245 SRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 80/299 (26%), Positives = 137/299 (45%), Gaps = 60/299 (20%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIK----SVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
+G G V K + K + A K + + ++++++E+++LH + P ++ FY +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLKP 124
+ + + +E+ GG L +L++ ++PE+ + ++ ++R L YL K I++ D+KP
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKP 132
Query: 125 SNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASD 184
SNIL++ G KLCDFG++ +L D+ + + GT YM+PE +G +S SD
Sbjct: 133 SNILVNSRGEIKLCDFGVSGQLIDS-------MANSFVGTRSYMSPERL-QGTHYSVQSD 184
Query: 185 LWGLGCVLYECYAGR---PPFVGREFTQLVKSILSD----------PSPPLPGNP----- 226
+W +G L E GR PP +E + + D P P PG P
Sbjct: 185 IWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHG 244
Query: 227 --SRP---------------------------FANLINSLLVKDPAQRLHWSDLCGHAF 256
SRP F +N L+K+PA+R L H F
Sbjct: 245 MDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 69/224 (30%), Positives = 117/224 (52%), Gaps = 15/224 (6%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK------SQKSKVLQEVRMLHSLDHPN 57
+ I + IGRG + V + K + FA+K ++K ++ + +E +L + D+
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKG 116
+ + ++ +L+LV++Y VGGDL++LL + +++LPED R ++V A+ +H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE-- 174
++ D+KP NIL+D NG +L DFG KL + SS+ GTP Y++PE+ +
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV----AVGTPDYISPEILQAM 178
Query: 175 EGGVHSYAS--DLWGLGCVLYECYAGRPPFVGREFTQLVKSILS 216
E G Y D W LG +YE G PF + I++
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 91/298 (30%), Positives = 131/298 (43%), Gaps = 53/298 (17%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVL-----QEVRMLHSL---D 54
QY IG G Y TVYK R + + A+KSV L +EV +L L D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 55 HPNVLRFYSWYETS-----AHLWLVLEYCVGGDLMSLLRQ--DNQLPEDSIRDLAQDLVR 107
HPN++R TS + LV E+ V DL + L + LP ++I+DL + +R
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 108 ALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCY 167
L +LH+ I++ DLKP NIL+ G+ KL DFGLAR S M T Y
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS------CQMALTPVVVTLWY 173
Query: 168 MAPELFEEGGVHSYAS--DLWGLGCVLYECYAGRPPFVG-REFTQLVK--SILSDPS--- 219
APE+ + +YA+ D+W +GC+ E + +P F G E QL K ++ P
Sbjct: 174 RAPEVLLQS---TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230
Query: 220 ------------PPLPGNPSRPF--------ANLINSLLVKDPAQRLHWSDLCGHAFW 257
P P + A L+ +L +P +R+ H F+
Sbjct: 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-25
Identities = 70/231 (30%), Positives = 112/231 (48%), Gaps = 37/231 (16%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIK------SVDKSQKSKVLQEVRMLHSLDHPNVLRF 61
+ IGRG + V +KK T +A+K ++K Q + + E +L D V++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
+ ++ +L+L++E+ GGD+M+LL + + L E++ + + V A+ +H G I+ D
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRD 126
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASKA----------PSSM--------------- 156
+KP N+LLD G KL DFGL L A + PS
Sbjct: 127 IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWK 186
Query: 157 -----LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPF 202
L + GTP Y+APE+F + G ++ D W LG ++YE G PPF
Sbjct: 187 KNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 71/245 (28%), Positives = 115/245 (46%), Gaps = 37/245 (15%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIK------SVDKSQKSKVLQEVRMLHSLDHPNVLRF 61
+ IGRG + V +KK T +A+K ++K Q + E +L D V++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
+ ++ +L+L++E+ GGD+M+LL + + L E+ + + V A+ +H G I+ D
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRD 126
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASKA----------PSSMLPQ------------ 159
+KP N+LLD G KL DFGL L A + PS Q
Sbjct: 127 IKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWK 186
Query: 160 --------AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLV 211
+ GTP Y+APE+F + G ++ D W LG ++YE G PPF +
Sbjct: 187 RNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETY 245
Query: 212 KSILS 216
K +++
Sbjct: 246 KKVMN 250
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 79/239 (33%), Positives = 114/239 (47%), Gaps = 16/239 (6%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKV----LQEVRMLHSLDHP 56
+ Y + +G G Y+TVYKGR K T + A+K + + ++E +L L H
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA 63
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSK 115
N++ + T L LV EY DL + L ++R L+R L Y H +
Sbjct: 64 NIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
+++ DLKP N+L+ E G KL DFGLAR S SK S+ + T Y P++
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN-----EVVTLWYRPPDVLLG 177
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFT--QLVK--SILSDPSPPL-PGNPSRP 229
+S + D+WG+GC+ YE GRP F G QL K +L P+ PG S P
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 75/251 (29%), Positives = 117/251 (46%), Gaps = 13/251 (5%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYS 63
E IG+G + VYKG K E A+K+ + K K LQE +L DHPN+++
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
+++V+E GG L++ LR+ N+L + ++ D ++YL SK I+ DL
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC-YMAPELFEEGGVHSY 181
N L+ EN K+ DFG++R+ S L Q P + APE G ++
Sbjct: 120 AARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ----IPIKWTAPEALNYGR-YTS 174
Query: 182 ASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
SD+W G +L+E ++ G P+ G Q + I S P P L+
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAY 234
Query: 241 DPAQRLHWSDL 251
DP R +S++
Sbjct: 235 DPENRPSFSEI 245
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 74/227 (32%), Positives = 121/227 (53%), Gaps = 9/227 (3%)
Query: 23 KKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGD 82
K+K + F + + D+ Q + E+ L + DH +++ + +++ L L++EY GGD
Sbjct: 93 KEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD 151
Query: 83 LMSLLRQ--DNQLP--EDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLC 138
L ++Q LP E + L +V AL +HS+ +++ DLK +NI L G KL
Sbjct: 152 LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211
Query: 139 DFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAG 198
DFG +++ SD+ S + + CGTP Y+APEL+E +S +D+W LG +LYE
Sbjct: 212 DFGFSKQYSDSV---SLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTL 267
Query: 199 RPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQR 245
PF G ++++ +L P P S L++ LL K+PA R
Sbjct: 268 HRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 76/244 (31%), Positives = 114/244 (46%), Gaps = 24/244 (9%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSLDH 55
M+QY E IG G Y VYK R + T E A+K + D+ S ++E+ +L + H
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDS-----IRDLAQDLVRALQ 110
N++R + L+LV EY DL L + + P+ + I+ ++R +
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYL---DL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 111 YLHSKGIIYCDLKPSNILLDENGRT-KLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
Y HS +++ DLKP N+L+D KL DFGLAR + + + T Y A
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH-----EVVTLWYRA 171
Query: 170 PELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVG-REFTQLVK--SILSDPSPPL-PGN 225
PE+ +S D+W +GC+ E +P F G E +L K IL P+ PG
Sbjct: 172 PEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231
Query: 226 PSRP 229
S P
Sbjct: 232 TSLP 235
|
Length = 294 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 80/286 (27%), Positives = 130/286 (45%), Gaps = 42/286 (14%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIK-----SVDKSQKSKVLQEVRMLHSLDHPNVLRFY 62
E IG G Y VYKGR KKT + A+K S ++ S ++E+ +L L HPN++
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 63 SWYETSAHLWLVLEYCVGGDL---MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ L+L+ E+ + DL + L + + + ++ +++ + + HS+ +++
Sbjct: 66 DVLMQESRLYLIFEF-LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH 124
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
DLKP N+L+D G KL DFGLAR A P + + T Y APE+ +
Sbjct: 125 RDLKPQNLLIDNKGVIKLADFGLAR----AFGIPVRVYTH-EVVTLWYRAPEVLLGSPRY 179
Query: 180 SYASDLWGLGCVLYECYAGRPPFVG-REFTQLVK--SILSDPSPPL-PGNPSRP-----F 230
S D+W +G + E +P F G E QL + IL P+ + PG S P F
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239
Query: 231 AN-------------------LINSLLVKDPAQRLHWSDLCGHAFW 257
L+ +L+ DPA+R+ H ++
Sbjct: 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 63/208 (30%), Positives = 108/208 (51%), Gaps = 14/208 (6%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK------SQKSKVLQEVRMLHSLDHPN 57
Y + + IGRG + V R K + + +A+K + K S + +E ++ + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
V++ + ++ +L++V+EY GGDL++L+ + +PE + ++V AL +HS G+
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDAIHSMGL 163
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
I+ D+KP N+LLD++G KL DFG K+ + GTP Y++PE+ + G
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD----TAVGTPDYISPEVLKSQG 219
Query: 178 VHSY---ASDLWGLGCVLYECYAGRPPF 202
Y D W +G L+E G PF
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-25
Identities = 82/287 (28%), Positives = 133/287 (46%), Gaps = 46/287 (16%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKV-----LQEVRMLHSLDHPNVLRFYSW 64
IGRG Y V + +T E AIK + + +++ L+E+++L LDH NV+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 65 Y-----ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
E +++V E + DL ++R L +D + L+R L+Y+HS +++
Sbjct: 73 MPPPHREAFNDVYIVYEL-MDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLH 131
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
DLKPSN+LL+ N K+CDFGLAR S+ + + T Y APEL +
Sbjct: 132 RDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-----TRWYRAPELLLNCSEY 186
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQ---LVKSILSDPSPP--------------- 221
+ A D+W +GC+ E +P F G+++ L+ +L PS
Sbjct: 187 TTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIR 246
Query: 222 -LPGNPSRPFAN-----------LINSLLVKDPAQRLHWSDLCGHAF 256
LP P + FA L+ +LV DP++R+ + H +
Sbjct: 247 SLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-25
Identities = 73/247 (29%), Positives = 120/247 (48%), Gaps = 17/247 (6%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK------SQKSKVLQEVRMLHSLDHPN 57
Y + + IGRG + V R K T + +A+K + K S + +E ++ + P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
V++ + ++ +L++V+EY GGDL++L+ + +PE R ++V AL +HS G
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGF 163
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
I+ D+KP N+LLD++G KL DFG K++ GTP Y++PE+ + G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD----TAVGTPDYISPEVLKSQG 219
Query: 178 VHSY---ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP---PLPGNPSRPFA 231
Y D W +G LYE G PF I++ + P + S+
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 279
Query: 232 NLINSLL 238
NLI + L
Sbjct: 280 NLICAFL 286
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 9e-25
Identities = 75/289 (25%), Positives = 135/289 (46%), Gaps = 50/289 (17%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKS----VDKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
+G G V K + + A K + + ++++++E+++LH + P ++ FY +
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLKP 124
+ + + +E+ GG L +L++ ++PE+ + ++ ++R L YL K I++ D+KP
Sbjct: 69 YSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKP 128
Query: 125 SNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASD 184
SNIL++ G KLCDFG++ +L D S A S + GT YM+PE +G ++ SD
Sbjct: 129 SNILVNSRGEIKLCDFGVSGQLID-SMANSFV------GTRSYMSPERL-QGTHYTVQSD 180
Query: 185 LWGLGCVLYECYAGR------------------------------PPFVGREFTQ----- 209
+W LG L E GR + +
Sbjct: 181 IWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIF 240
Query: 210 -LVKSILSDPSPPLPGNP-SRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
L+ I+++P P LP S F + ++ L K+P +R +L H F
Sbjct: 241 ELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 70/258 (27%), Positives = 122/258 (47%), Gaps = 15/258 (5%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQ----EVRMLHSLDHPNVLRF 61
+G+G + VY T A K V + + SK + E+++L +L H ++++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 62 YSWYETSAH--LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
Y A L + +EY GG + L+ L E R + ++ + YLHS I++
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
D+K +NIL D G KL DFG +++L + + + ++ GTP +M+PE+ G +
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI--RSVTGTPYWMSPEVISGEG-Y 186
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS-PPLPGNPSRPFANLINSLL 238
+D+W LGC + E +PP+ E + I + P+ P LP + S + + +
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIF 246
Query: 239 VKDPAQRLHWSDLCGHAF 256
V + R +L H F
Sbjct: 247 V-EARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 78/311 (25%), Positives = 136/311 (43%), Gaps = 51/311 (16%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVL-----QEVRMLHSLDHPNV 58
Y + +G G Y TV ++T AIK + + +S++ +E+R+L + H NV
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 59 LRFYSWYETSAHL------WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
+ + L +LV+ + +G DL L++ + +L ED I+ L +++ L+Y+
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPF-MGTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYI 134
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
H+ GII+ DLKP N+ ++E+ K+ DFGLAR+ S M T Y APE+
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ------TDSEM--TGYVVTRWYRAPEV 186
Query: 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP----------- 221
++ D+W +GC++ E G+P F G + + I+ P
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246
Query: 222 --------LPGNPSRPFA-----------NLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262
LP + F N++ +LV D R+ ++ H ++
Sbjct: 247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306
Query: 263 PMPLPPQPAFD 273
P P +D
Sbjct: 307 PEDETEAPPYD 317
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 6e-24
Identities = 77/255 (30%), Positives = 120/255 (47%), Gaps = 26/255 (10%)
Query: 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLR 60
Y +G+G + V + + T + +A K ++K + ++ L E R+L ++ V+
Sbjct: 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDL--AQDLVRALQYLHSKGII 118
YET L LVL GGDL + D R + A +L L+ L + I+
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV 124
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
Y DLKP NILLD+ G ++ D GLA ++ P + + GT YMAPE+
Sbjct: 125 YRDLKPENILLDDRGHIRISDLGLAVQI------PEGETVRGRVGTVGYMAPEVINNEK- 177
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVGR-------EFTQLVKSILSDPSPPLPGNPSRPFA 231
++++ D WGLGC++YE G+ PF R E + VK + S S
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKF----SEDAK 233
Query: 232 NLINSLLVKDPAQRL 246
++ LL K+P +RL
Sbjct: 234 SICRMLLTKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-23
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 11/213 (5%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS----KVLQEVRMLHSLDHPN 57
+ Y E +G G Y+TVYKG+ K + A+K + ++ ++E +L L H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLL-RQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
++ + T L LV EY V DL + + L ++++ L+R L Y+H +
Sbjct: 65 IVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
I++ DLKP N+L+ + G KL DFGLAR S S S+ + T Y P++
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN-----EVVTLWYRPPDVLLGS 178
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ 209
+S D+WG+GC+ E G F G + Q
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 81/294 (27%), Positives = 128/294 (43%), Gaps = 52/294 (17%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVL-----QEVRMLHSLDHP 56
N+Y + +G G + V R + T + AIK + K + VL +E+++L L H
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 57 NVLR----FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
N++ F S E ++ V E +G DL LL L + I+ ++R L+Y+
Sbjct: 70 NIISLSDIFISPLED---IYFVTEL-LGTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYV 124
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
HS G+++ DLKPSNIL++EN K+CDFGLAR T Y APE+
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLAR--------IQDPQMTGYVSTRYYRAPEI 176
Query: 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ---LVKSILSDPSP--------- 220
+ D+W GC+ E G+P F G++ ++ +L P
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236
Query: 221 -------PLPGNPSRPFAN-----------LINSLLVKDPAQRLHWSDLCGHAF 256
LP PF+ L+ +LV DP +R+ ++ H +
Sbjct: 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-23
Identities = 71/248 (28%), Positives = 115/248 (46%), Gaps = 10/248 (4%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYS 63
E IGRG + V+ GR + A+KS ++ K+K LQE R+L HPN++R
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
+++V+E GGD ++ LR + +L + + ++ ++YL SK I+ DL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
N L+ E K+ DFG++R+ D A + + Q + APE G +S
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVK---WTAPEALNYGR-YSSE 176
Query: 183 SDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKD 241
SD+W G +L+E ++ G P+ Q ++I P P L+ D
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYD 236
Query: 242 PAQRLHWS 249
P QR +S
Sbjct: 237 PGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-23
Identities = 72/246 (29%), Positives = 112/246 (45%), Gaps = 49/246 (19%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDK------SQKSKVLQEVRMLHSLDHPNVLRF 61
+ +G G + V RK T +A+K++ K +Q + V E +L D+ V+R
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
Y ++ +L+ V++Y GGD+MSLL + PED R +L A++ +H G I+ D
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 122 LKPSNILLDENGRTKLCDFGLA---RKLSD------------------------------ 148
+KP NIL+D +G KL DFGL R D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 149 ---------ASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGR 199
A++ L + GTP Y+APE+ G ++ D W +G +LYE G+
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQ 245
Query: 200 PPFVGR 205
PPF+ +
Sbjct: 246 PPFLAQ 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 81/322 (25%), Positives = 135/322 (41%), Gaps = 57/322 (17%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----------------VLQEVRMLHS 52
+G G Y V K T + AIK V + S L+E+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 53 LDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
+ H N++ Y + LV++ + DL ++ + +L E ++ + ++ L L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDI-MASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARK---------LSDASKAPSSMLPQAKCG 163
H ++ DL P+NI ++ G K+ DFGLAR+ LS +K
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVV 195
Query: 164 TPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVG-REFTQLVK--SILSDPSP 220
T Y APEL + +A D+W +GC+ E G+P F G E QL + +L P+
Sbjct: 196 TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNE 255
Query: 221 ---------PL-----PGNPSR-----PFAN-----LINSLLVKDPAQRLHWSDLCGHAF 256
PL P P P A+ L+ SLL +P +R+ + H +
Sbjct: 256 DNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315
Query: 257 WRTKLTPMPL-PPQPAFDSLKG 277
+++ P+P P Q F+ L
Sbjct: 316 FKSD--PLPCDPSQLPFNFLTK 335
|
Length = 335 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 81/254 (31%), Positives = 117/254 (46%), Gaps = 16/254 (6%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKV----LQEVRMLHSLDHPNVLRFYS 63
E +G G Y+TVYKG + + A+K + + V ++E +L L H N++ +
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
T L V EY + DL + Q L ++R L+R L Y+H + I++ DL
Sbjct: 71 IIHTKETLTFVFEY-MHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
KP N+L+ G KL DFGLAR S S+ SS + T Y P++ +S A
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSS-----EVVTLWYRPPDVLLGATDYSSA 184
Query: 183 SDLWGLGCVLYECYAGRPPFVGRE--FTQLVK--SILSDPSPPL-PGNPSRPFANLINSL 237
D+WG GC+ E G+P F G F QL K ++L P+ PG P L
Sbjct: 185 LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFL 244
Query: 238 LVKDPAQRLHWSDL 251
K R+ W L
Sbjct: 245 PCKPQQLRVVWKRL 258
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 1 MNQYHIYEAIGRGKYSTVYKG--RKKKTIEYFAIKSV--DKSQKSKVLQEVRMLHSLDHP 56
+ + IG+G++ V G R +K A+K + D + L E ++ +L HP
Sbjct: 5 SKELKLGATIGKGEFGDVMLGDYRGQKV----AVKCLKDDSTAAQAFLAEASVMTTLRHP 60
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHS 114
N+++ L++V EY G L+ LR + + A D+ ++YL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE 120
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLS---DASKAPSSMLPQAKCGTPCYMAPE 171
K ++ DL N+L+ E+ K+ DFGLA++ S D+ K P + APE
Sbjct: 121 KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK-----------WTAPE 169
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYA-GRPPF 202
E S SD+W G +L+E Y+ GR P+
Sbjct: 170 ALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 76/300 (25%), Positives = 123/300 (41%), Gaps = 50/300 (16%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIK-----SVDKSQKSKVLQEVRMLHSLDH- 55
+ Y E IG G Y VYK R K T + A+K ++ L+E+ +L L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 56 PNVLRFYSWYET-----SAHLWLVLEYCVGGDLMSLL-----RQDNQLPEDSIRDLAQDL 105
++R L+LV EY + DL + LP +I+ L
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEY-LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 106 VRALQYLHSKGIIYCDLKPSNILLD-ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGT 164
++ + + H G+++ DLKP N+L+D + G K+ D GL R S K+ + + T
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-----T 174
Query: 165 PCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVG-REFTQLVK--SILSDPSPP 221
Y APE+ +S D+W +GC+ E +P F G E QL+ +L P+
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234
Query: 222 L-----------------PGNPSRPFAN-------LINSLLVKDPAQRLHWSDLCGHAFW 257
+ P + SR + L+ +L DPA+R+ H ++
Sbjct: 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 68/258 (26%), Positives = 123/258 (47%), Gaps = 15/258 (5%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQ----EVRMLHSLDHPNVLRF 61
+G+G + VY T A+K V + + SK + E+++L +L H ++++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 62 YSWYETSAH--LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
Y L + +E+ GG + L+ L E+ R + ++ + YLHS I++
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
D+K +NIL D G KL DFG +++L + + M ++ GTP +M+PE+ G +
Sbjct: 130 RDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM--KSVTGTPYWMSPEVISGEG-Y 186
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS-PPLPGNPSRPFANLINSLL 238
+D+W +GC + E +PP+ E + I + P+ P LP + S + + +
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF 246
Query: 239 VKDPAQRLHWSDLCGHAF 256
V + R +L H F
Sbjct: 247 V-EAKLRPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 68/222 (30%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 8 EAIGRGKYSTVYKGRKK----KTIEYFAIKSVDKSQKSKV----LQEVRMLHSLDHPNVL 59
+ +G G + V +G K I A+K + + S + L+E ++HSLDH N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIP-VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHSKGI 117
R Y T L +V E G L+ LR+D ++ D A + ++YL SK
Sbjct: 60 RLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF 118
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASK----APSSMLPQAKCGTPCYMAPELF 173
I+ DL NILL + + K+ DFGL R L +P A C APE
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC------APESL 172
Query: 174 EEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
S+ASD+W G L+E + G P+ G +Q++K I
Sbjct: 173 RTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 68/258 (26%), Positives = 123/258 (47%), Gaps = 15/258 (5%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQ----EVRMLHSLDHPNVLRF 61
+GRG + VY T A+K V D + SK + E+++L +L H ++++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 62 YSWYE--TSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
Y L + +EY GG + L+ L E+ R + +++ + YLHS I++
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
D+K +NIL D G KL DFG ++++ + + + ++ GTP +M+PE+ G +
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI--KSVTGTPYWMSPEVISGEG-Y 186
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP-LPGNPSRPFANLINSLL 238
+D+W + C + E +PP+ E + I + P+ P LP S + + +
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIF 246
Query: 239 VKDPAQRLHWSDLCGHAF 256
V++ +R L H F
Sbjct: 247 VEE-KRRPTAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-22
Identities = 75/264 (28%), Positives = 129/264 (48%), Gaps = 29/264 (10%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-----KSQKSKVLQEVRMLHSLDHPN 57
+Y I +G G TV ++ E FA+K VD ++ K++ EV L + D +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFS 92
Query: 58 VLRFYSWY--------ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQ------ 103
+++ + + E + LVL+Y GDL RQ+ + + R +
Sbjct: 93 IVKCHEDFAKKDPRNPENVLMIALVLDYANAGDL----RQEIKSRAKTNRTFREHEAGLL 148
Query: 104 --DLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161
++ A+ ++HSK +I+ D+K +NILL NG KL DFG ++ + S + +
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATV---SDDVGRTF 205
Query: 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP 221
CGTP Y+APE++ +S +D++ LG +LYE + PF G +++ L+ P
Sbjct: 206 CGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264
Query: 222 LPGNPSRPFANLINSLLVKDPAQR 245
LP + S ++ +LL DP +R
Sbjct: 265 LPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 4e-22
Identities = 80/312 (25%), Positives = 133/312 (42%), Gaps = 51/312 (16%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-----KVLQEVRMLHSLDHPN 57
+Y +G G Y +V KT A+K + + +S + +E+R+L + H N
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 58 VLRFYSWYETSAHL------WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
V+ + + L +LV + +G DL ++++ +L +D ++ L ++R L+Y
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLV-THLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 135
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
+HS II+ DLKPSN+ ++E+ K+ DFGLAR D T Y APE
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--------GYVATRWYRAPE 187
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP---------- 221
+ ++ D+W +GC++ E GR F G + +K IL P
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247
Query: 222 ---------LPGNPSRPFAN-----------LINSLLVKDPAQRLHWSDLCGHAFWRTKL 261
L P FAN L+ +LV D +R+ + HA++
Sbjct: 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307
Query: 262 TPMPLPPQPAFD 273
P P +D
Sbjct: 308 DPDDEPVADPYD 319
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 5e-22
Identities = 77/312 (24%), Positives = 139/312 (44%), Gaps = 51/312 (16%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-----KVLQEVRMLHSLDHPN 57
+Y +G G Y +V + + A+K + + +S + +E+R+L + H N
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 58 VLRFYSWYETSAHL------WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
V+ + + + +LV +G DL ++++ +L ++ ++ L L+R L+Y
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNL-MGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKY 133
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
+HS GII+ DLKPSN+ ++E+ ++ DFGLAR+ D T Y APE
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT--------GYVATRWYRAPE 185
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS---DPSP-------- 220
+ ++ D+W +GC++ E G+ F G ++ +K I+ PSP
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245
Query: 221 --------PLPGNPSR----------PFA-NLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261
LP P + P A +L+ +LV D +R+ S+ H ++
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305
Query: 262 TPMPLPPQPAFD 273
P P +D
Sbjct: 306 DPEDEPEAEPYD 317
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 9e-22
Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 10 IGRGKYSTVYKGRKK--KTIEYFAIKSVDKSQKS-KVLQEVRMLHSLDHPNVLRFYSWY- 65
+GRG Y VYK ++K K + +A+K ++ + S +E+ +L L HPNV+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 66 -ETSAHLWLVLEYCVGGDLMSLLR---------QDNQLPEDSIRDLAQDLVRALQYLHSK 115
+ +WL+ +Y DL +++ + QLP ++ L ++ + YLH+
Sbjct: 69 SHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 116 GIIYCDLKPSNILL----DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
+++ DLKP+NIL+ E GR K+ D G AR + K + + P T Y APE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYRAPE 185
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE 206
L ++ A D+W +GC+ E P F R+
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-21
Identities = 67/245 (27%), Positives = 110/245 (44%), Gaps = 49/245 (20%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV------DKSQKSKVLQEVRMLHSLDHPNVLRF 61
+ +G G + V K T +A+K++ +++Q + V E +L D+ V++
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
Y ++ +L+ V++Y GGD+MSLL + PE R +L A++ +H G I+ D
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 122 LKPSNILLDENGRTKLCDFGL---------------ARKLSDASKAPSSM---------- 156
+KP NIL+D +G KL DFGL + S PS +
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 157 -----------------LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGR 199
L + GTP Y+APE+ G ++ D W +G +L+E G+
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILFEMLVGQ 245
Query: 200 PPFVG 204
PPF+
Sbjct: 246 PPFLA 250
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-21
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 10 IGRGKYSTVYKGRKK--KTIEYFAIKSVDKSQKS-KVLQEVRMLHSLDHPNVLRFYSWYE 66
+GRG Y VYK ++K K +A+K ++ + S +E+ +L L HPNV+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 67 TSA--HLWLVLEYCVGGDLMSLLR---------QDNQLPEDSIRDLAQDLVRALQYLHSK 115
+ A +WL+ +Y DL +++ + QLP ++ L ++ + YLH+
Sbjct: 69 SHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 116 GIIYCDLKPSNILL----DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
+++ DLKP+NIL+ E GR K+ D G AR + K + + P T Y APE
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYRAPE 185
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE 206
L ++ A D+W +GC+ E P F R+
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 2e-21
Identities = 74/257 (28%), Positives = 119/257 (46%), Gaps = 30/257 (11%)
Query: 13 GKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSL--DHPNVLR-FYSWYETSA 69
GK+ V + K T + F K + + + E M+H L D+PN ++ +YS
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EP-MVHQLMKDNPNFIKLYYSVTTLKG 83
Query: 70 HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILL 129
H+ +++Y GDL LL+++ +L E ++ + + LV AL LH II+ D+K N+L
Sbjct: 84 HVL-IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY 142
Query: 130 DEN-GRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYAS--DLW 186
D R LCD+GL + PS GT Y +PE + H+Y D W
Sbjct: 143 DRAKDRIYLCDYGLCK----IIGTPSCY-----DGTLDYFSPEKIKG---HNYDVSFDWW 190
Query: 187 GLGCVLYECYAGRPPF---VGREFTQLVKSILSDPSPPLPGNPSR-PFAN-LINSLLVKD 241
+G + YE G+ PF E ++S+L LP + AN + S+L +
Sbjct: 191 AVGVLTYELLTGKHPFKEDEDEELD--LESLLKRQQKKLPFIKNVSKNANDFVQSMLKYN 248
Query: 242 PAQRLH-WSDLCGHAFW 257
RL ++++ H F
Sbjct: 249 INYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-21
Identities = 72/291 (24%), Positives = 122/291 (41%), Gaps = 51/291 (17%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKV---LQEVRMLHSLDHPNVL 59
+Y +G G V+ + A+K + + V L+E++++ LDH N++
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65
Query: 60 RFYSWYETSAH--------------LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDL 105
+ Y S +++V EY + DL ++L Q L E+ R L
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEY-METDLANVLEQ-GPLSEEHARLFMYQL 123
Query: 106 VRALQYLHSKGIIYCDLKPSNILLD-ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGT 164
+R L+Y+HS +++ DLKP+N+ ++ E+ K+ DFGLAR + D + L + T
Sbjct: 124 LRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV-DPHYSHKGYLSEGLV-T 181
Query: 165 PCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-------- 216
Y +P L ++ A D+W GC+ E G+P F G + ++ IL
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241
Query: 217 --------DPSPPLP--GNPSRPFA-----------NLINSLLVKDPAQRL 246
PS G P RP + + +L +P RL
Sbjct: 242 DRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-21
Identities = 82/313 (26%), Positives = 142/313 (45%), Gaps = 57/313 (18%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVL-----QEVRMLHSLDHPNVLRFYSW 64
+G G Y +V K+T E AIK + + +S++ +E+ +L + H NV+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 65 YETSA-------HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+ TSA +LV+ Y + DL ++ + L ED ++ L ++ L+Y+HS GI
Sbjct: 83 F-TSAVSGDEFQDFYLVMPY-MQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGI 138
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
I+ DLKP N+ ++E+ K+ DFGLAR +DA + T Y APE+
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLARH-ADAEMTGYVV-------TRWYRAPEVILNWM 190
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGREF----TQLVKSILSDPSP------------- 220
++ D+W +GC++ E G+ F G+++ TQ++K + P P
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK-VTGVPGPEFVQKLEDKAAKS 249
Query: 221 ---PLPGNPSRPF-----------ANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPL 266
LP P + F +L+ +L D +RL ++ H ++ +
Sbjct: 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE 309
Query: 267 PPQPAF-DSLKGA 278
Q + DSL+
Sbjct: 310 TEQQPYDDSLENE 322
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-20
Identities = 73/224 (32%), Positives = 112/224 (50%), Gaps = 20/224 (8%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYS 63
Y + IG G + VY+ T E AIK V + + K +E+ ++ +L+H N++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN-RELLIMKNLNHINIIFLKD 126
Query: 64 WY--------ETSAHLWLVLEY---CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
+Y E + L +V+E+ V + R ++ LP ++ + L RAL Y+
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 113 HSKGIIYCDLKPSNILLDENGRT-KLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
HSK I + DLKP N+L+D N T KLCDFG A+ L ++ S + + Y APE
Sbjct: 187 HSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF------YRAPE 240
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVKSI 214
L ++ DLW LGC++ E G P F G+ QLV+ I
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284
|
Length = 440 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 74/258 (28%), Positives = 120/258 (46%), Gaps = 25/258 (9%)
Query: 8 EAIGRGKYSTVYKG----RKKKTIEYFAIKS----VDKSQKSKVLQEVRMLHSLDHPNVL 59
IG G++ VY+G + + I A+K+ S + K LQE ++ DHP+++
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIA-VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ + +W+V+E G+L S L+ + L S+ + L AL YL SK +
Sbjct: 71 KLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV 129
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDAS--KAPSSMLPQAKCGTPCYMAPEL--FE 174
+ D+ N+L+ KL DFGL+R L D S KA LP +MAPE F
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK------WMAPESINFR 183
Query: 175 EGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233
+ ASD+W G ++E G PF G + ++ I + P+P N +L
Sbjct: 184 R---FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 240
Query: 234 INSLLVKDPAQRLHWSDL 251
+ DP++R +++L
Sbjct: 241 MTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 45/277 (16%)
Query: 10 IGRGKYSTVYKGR----KKKTIEYFAIKSVDKSQKSKVL----QEVRMLHSLDHPNVLRF 61
+G G + V R T E A+KS++ S + + +E+ +L +LDH N++++
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 62 YSWYETSAH--LWLVLEYCVGGDLMSLLR--QDNQLPEDSIRDL--AQDLVRALQYLHSK 115
E L L++EY G L L+ +D + R L + + + + YL S+
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI---NLKRLLLFSSQICKGMDYLGSQ 128
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC-YMAPELFE 174
I+ DL NIL++ K+ DFGLA+ L + P +P + APE
Sbjct: 129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGE---SPIFWYAPECLR 185
Query: 175 EGGVHSYASDLWGLGCVLYECYA-GRPPFV--------------GREFTQLVKSILSDPS 219
S ASD+W G LYE + G P T+L++ L
Sbjct: 186 T-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE--LLKEG 242
Query: 220 PPLPGNPSRPFANLINSLLVK----DPAQRLHWSDLC 252
LP PS P + + L+ +P R ++DL
Sbjct: 243 ERLPRPPSCP--DEVYDLMKLCWEAEPQDRPSFADLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 5e-20
Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 8 EAIGRGKYSTVYKGR-KKKTIEYFAIKS----VDKSQKSKVLQEVRMLHSLDHPNVLRFY 62
E +G+G + V+KG K KT A+K+ + + K K L E R+L DHPN+++
Sbjct: 1 ELLGKGNFGEVFKGTLKDKT--PVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
+++V+E GGD +S LR + ++L + A D + YL SK I+ D
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSY 181
L N L+ EN K+ DFG++R+ D + SS L Q + APE G +S
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIK---WTAPEALNYGR-YSS 173
Query: 182 ASDLWGLGCVLYECYA-GRPPFVG 204
SD+W G +L+E ++ G P+ G
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 7e-20
Identities = 64/276 (23%), Positives = 115/276 (41%), Gaps = 34/276 (12%)
Query: 1 MNQYHIYEAIGRGKYSTVYKG-----RKKKTIEYFAIKSVDK----SQKSKVLQEVRMLH 51
+ + +G+G + VY+G K + AIK+V++ ++ + L E ++
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMK 64
Query: 52 SLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQ--DLVRAL 109
+ +V+R T +V+E GDL S LR + PE L + +
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRS--RRPEAENNPGLGPPTLQKFI 122
Query: 110 Q----------YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSM 156
Q YL +K ++ DL N ++ E+ K+ DFG+ R + + K +
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKSIL 215
LP +MAPE ++ GV + SD+W G VL+E P+ G +++K ++
Sbjct: 183 LPVR------WMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235
Query: 216 SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDL 251
LP N L+ +P R + ++
Sbjct: 236 DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 24 KKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDL 83
+T + F +K + KS + + + H + + L Y E S ++LVL++ GG L
Sbjct: 15 TRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDS--VFLVLQHAEGGKL 72
Query: 84 MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143
S + + +PE+ ++ A ++V AL LH +GI+ DL P+NILLD+ G +L F
Sbjct: 73 WSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRW 132
Query: 144 RKLSDA--SKAPSSMLPQAKCGTPCYMAPELFEEGGV--HSYASDLWGLGCVLYECYAGR 199
++ D+ +A +M Y APE+ GG+ + A D W LG +L+E G
Sbjct: 133 SEVEDSCDGEAVENM----------YCAPEV---GGISEETEACDWWSLGAILFELLTG- 178
Query: 200 PPFVGREFTQLVKS----ILSDPSPPLPGNPSRPFANLINSLLVKDPAQRL 246
LV+ I + + +P S +L+ LL +P +RL
Sbjct: 179 --------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 2e-19
Identities = 51/145 (35%), Positives = 78/145 (53%), Gaps = 6/145 (4%)
Query: 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSV------DKSQKSKVLQEVRMLHSLDHPNVL 59
I + I RG + VY GRKK + +A+K V +K+ +V E L P ++
Sbjct: 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIV 67
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
Y +++ +++LV+EY +GGD+ SLL E+ ++ AL YLH GII+
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIH 127
Query: 120 CDLKPSNILLDENGRTKLCDFGLAR 144
DLKP N+L+ G KL DFGL++
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 7e-19
Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 14/222 (6%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYF--AIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
+G G + V++G K + +KS D ++ +EV+ L L H +++ ++
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 66 ETSAHLWLVLEYCVGGDLMSLLR--QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
++++ E G L++ LR + LP S+ D+A + + YL + I+ DL
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLA 131
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYAS 183
NIL+ E+ K+ DFGLAR + + S K + APE G S S
Sbjct: 132 ARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-----WTAPEAASH-GTFSTKS 185
Query: 184 DLWGLGCVLYECYA-GRPPFVGR---EFTQLVKSILSDPSPP 221
D+W G +LYE + G+ P+ G E + + P P
Sbjct: 186 DVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPA 227
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 65/245 (26%), Positives = 122/245 (49%), Gaps = 16/245 (6%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--VLQEVRMLHSLDHPNVLRFYSWY 65
+ +G G++ V+ G+ + I+ AIK + + S+ ++E +++ L HPN+++ Y
Sbjct: 10 KELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKP 124
+++V EY G L++ LR+ +L + + D+ D+ A++YL S G I+ DL
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAA 128
Query: 125 SNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGT--PC-YMAPELFEEGGVHSY 181
N L+ E+ K+ DFGLAR + D S GT P + PE+F+ S
Sbjct: 129 RNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ-------GTKFPVKWAPPEVFDYSR-FSS 180
Query: 182 ASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
SD+W G +++E ++ G+ P+ +++V+S+ + P ++ S +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHE 240
Query: 241 DPAQR 245
P R
Sbjct: 241 KPEDR 245
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-18
Identities = 71/258 (27%), Positives = 114/258 (44%), Gaps = 16/258 (6%)
Query: 6 IYEAIGRGKYSTVYKGRKK---KTIEYFAIKSVD----KSQKSKVLQEVRMLHSLDHPNV 58
I E IG G++ V +GR K K + AIK++ + Q+ L E ++ DHPN+
Sbjct: 8 IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+ S + ++ E+ G L S LRQ D Q + + + + ++YL
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNY 127
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP--SSMLPQAKCGTPC-YMAPELFE 174
++ DL NIL++ N K+ DFGL+R L D + P +S L P + APE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSL---GGKIPIRWTAPEAIA 184
Query: 175 EGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233
S ASD+W G V++E + G P+ ++ +I D P P + L
Sbjct: 185 YRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQL 243
Query: 234 INSLLVKDPAQRLHWSDL 251
+ KD R + +
Sbjct: 244 MLDCWQKDRNARPKFGQI 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 14/211 (6%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--VLQEVRMLHSLDHPNVLRFYSWYET 67
+G G++ V+ G+ + I+ AIK++++ S+ ++E +++ L HP +++ Y
Sbjct: 12 LGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 68 SAHLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSN 126
L++V E+ G L++ LRQ +L +D + + QD+ ++YL I+ DL N
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARN 130
Query: 127 ILLDENGRTKLCDFGLARKLSDASKAPSS--MLPQAKCGTPCYMAPELFEEGGVHSYASD 184
L+ G K+ DFG+ R + D SS P PE+F +S SD
Sbjct: 131 CLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS------PPEVFNFSK-YSSKSD 183
Query: 185 LWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
+W G +++E + G+ PF + ++V+ I
Sbjct: 184 VWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-17
Identities = 70/254 (27%), Positives = 110/254 (43%), Gaps = 47/254 (18%)
Query: 42 KVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLM-----SLLRQDNQLPED 96
+V +E++ML H NVL + H+ E V +LM ++ L D
Sbjct: 45 RVFRELKMLCFFKHDNVLSALDILQP-PHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSD 103
Query: 97 SIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLS-DASKAPSS 155
++ ++R L+YLHS GI++ D+KP N+L++ N K+CDFGLAR D SK +
Sbjct: 104 HVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT- 162
Query: 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR---EFTQLVK 212
+ T Y APE+ ++ A D+W +GC+ E R F + + L+
Sbjct: 163 ----QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
Query: 213 SILSDPS------------------PPLPGNPSRPF------------ANLINSLLVKDP 242
+L PS P P PS P +L+ +LV DP
Sbjct: 219 DLLGTPSLEAMRSACEGARAHILRGPHKP--PSLPVLYTLSSQATHEAVHLLCRMLVFDP 276
Query: 243 AQRLHWSDLCGHAF 256
+R+ +D H +
Sbjct: 277 DKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 65/253 (25%), Positives = 111/253 (43%), Gaps = 19/253 (7%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--VLQEVRMLHSLDHPNVL 59
+ +G G++ V+ G T + A+K++ S LQE +++ L H ++
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGI 117
+ Y+ +++V EY G L+ L+ +L + D+A + + YL S+
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY 124
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP--SSMLPQAKCGTPCYMAPE--LF 173
I+ DL NIL+ EN K+ DFGLAR + D + P + APE +
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK------WTAPEAANY 178
Query: 174 EEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232
G + SD+W G +L E GR P+ G ++++ + P P N +
Sbjct: 179 ---GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235
Query: 233 LINSLLVKDPAQR 245
L+ KDP +R
Sbjct: 236 LMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 70/243 (28%), Positives = 117/243 (48%), Gaps = 34/243 (13%)
Query: 9 AIGRGKYSTVYKG----RKKKTIEY-FAIKSVDKSQK----SKVLQEVRMLHSLDHPNVL 59
A+G G + VY+G R +E A+K++ +S S L E ++ +H N++
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPED----SIRDL---AQDLVRALQYL 112
R +++LE GGDL S LR++ PE +++DL A+D+ + +YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 113 HSKGIIYCDLKPSNILLDENGR---TKLCDFGLARKLSDAS---KAPSSMLPQAKCGTPC 166
I+ D+ N LL G K+ DFG+AR + AS K +MLP
Sbjct: 133 EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK------ 186
Query: 167 YMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILS----DPSPP 221
+M PE F + G+ + +D+W G +L+E ++ G P+ GR ++++ + DP
Sbjct: 187 WMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKG 245
Query: 222 LPG 224
PG
Sbjct: 246 CPG 248
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 5e-17
Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 37/279 (13%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQ----KSKVLQEVRMLHSLD 54
M +Y I IG+G VY A+K + D S+ K + L+E ++ L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSI-RDLA-QDLVRAL--- 109
HP ++ YS ++ + Y G L SLL+ Q ++S+ ++LA + V A
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQ--KESLSKELAEKTSVGAFLSI 118
Query: 110 --------QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR------------KLSDA 149
+Y+HSKG+++ DLKP NILL G + D+G A + +
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 150 SKAPSSM-LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT 208
+ SSM +P GTP YMAPE G S ++D++ LG +LY+ P+ ++
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERL-LGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237
Query: 209 QLV-KSILSDPSPPLPGNPSRPFANLIN-SLLVKDPAQR 245
++ + ++ P P PF + I L DPA+R
Sbjct: 238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 67/259 (25%), Positives = 115/259 (44%), Gaps = 21/259 (8%)
Query: 6 IYEAIGRGKYSTVYKGR----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPN 57
I + IG G++ V +GR KK I+ AIK++ Q+ L E ++ DHPN
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEID-VAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKG 116
++R S + ++ EY G L LR+ D + + + + + ++YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM---LPQAKCGTPCYMAPELF 173
++ DL NIL++ N K+ DFGL+R+L D+ ++ +P + APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR------WTAPEAI 180
Query: 174 EEGGVHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232
S ASD+W G V++E G P+ ++K++ P P +
Sbjct: 181 AYRKFTS-ASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239
Query: 233 LINSLLVKDPAQRLHWSDL 251
L+ KD +R +S +
Sbjct: 240 LMLDCWQKDRNERPTFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 73/314 (23%), Positives = 121/314 (38%), Gaps = 54/314 (17%)
Query: 7 YEAIGRGKYS--TVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDHPNVL 59
IG+ V+ + K T A+K ++ SK + QE+ L HPN+L
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGI 117
+ + + + L++V G LL+ LPE +I + +D++ AL Y+HSKG
Sbjct: 63 PYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF 122
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKL--SDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I+ +K S+ILL +G+ L + + + P++ +++PE+ ++
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182
Query: 176 GGVHSY--ASDLWGLGCVLYECYAGRPPFVGREFTQ-------------LVKSIL----S 216
+ Y SD++ +G E G PF TQ L KS
Sbjct: 183 -NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241
Query: 217 DPSPPLPGNP----------------SRPFANLINSLLVKDPAQRLHWSDLCGHAFWR-- 258
S N S F + L +DP R S L H+F++
Sbjct: 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301
Query: 259 ----TKLTPMPLPP 268
T L + L P
Sbjct: 302 KRRNTSLLDL-LKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 62/244 (25%), Positives = 111/244 (45%), Gaps = 14/244 (5%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS--KVLQEVRMLHSLDHPNVLRFYSWY 65
+ +G G++ V+ G + AIKS+ + S L E ++ L HP ++R Y+
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYA-V 69
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
T ++++ EY G L+ L+ +L + + D+A + + ++ K I+ DL+
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLR 129
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC-YMAPELFEEGGVHSYA 182
+NIL+ E K+ DFGLAR + D + + P + APE G +
Sbjct: 130 AANILVSETLCCKIADFGLARLIED-----NEYTAREGAKFPIKWTAPEAINY-GTFTIK 183
Query: 183 SDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKD 241
SD+W G +L E GR P+ G ++++++ P P N L+ +
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEK 243
Query: 242 PAQR 245
P +R
Sbjct: 244 PEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 64/248 (25%), Positives = 114/248 (45%), Gaps = 20/248 (8%)
Query: 10 IGRGKYSTVYKG----RKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNVLRF 61
+G G + +V KG + K +E A+K++ + K + L+E ++ LDHP ++R
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVE-VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
+ L LV+E G L+ L++ ++P +++LA + + YL SK ++ D
Sbjct: 62 IGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRD 120
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGT--PC-YMAPELFEEGGV 178
L N+LL + K+ DFG++R L S +A P + APE G
Sbjct: 121 LAARNVLLVNRHQAKISDFGMSRALG-----AGSDYYRATTAGRWPLKWYAPECINY-GK 174
Query: 179 HSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237
S SD+W G L+E ++ G P+ + +++ + S P P + +++ S
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSC 234
Query: 238 LVKDPAQR 245
P R
Sbjct: 235 WKYRPEDR 242
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 64/265 (24%), Positives = 120/265 (45%), Gaps = 33/265 (12%)
Query: 10 IGRGKYSTVYKGRKKKTIEY------FAIKSVDK----SQKSKVLQEVRMLHSLDHPNVL 59
+G G + VY+G + A+K++ K +K + L+E ++ + +HPN++
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLR----QDNQLPEDSIRDLAQ---DLVRALQYL 112
+ + ++++E GGDL+S LR + P ++++L D+ + YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 113 HSKGIIYCDLKPSNILLDENGRT-----KLCDFGLARKL--SD-ASKAPSSMLPQAKCGT 164
I+ DL N L+ E G K+ DFGLAR + SD K +LP
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR---- 178
Query: 165 PCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLP 223
+MAPE + G + SD+W G +++E G+ P+ ++++ + + P
Sbjct: 179 --WMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP 235
Query: 224 GNPSRPFANLINSLLVKDPAQRLHW 248
N L+ + +DP++R +
Sbjct: 236 ENCPDKIYQLMTNCWAQDPSERPTF 260
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-16
Identities = 76/273 (27%), Positives = 111/273 (40%), Gaps = 31/273 (11%)
Query: 36 DKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETS-AHLWLVLEYCVGGDLMSLLRQDNQLP 94
++ Q+++ +E + L HPN++ E L+ V EY G L +L D LP
Sbjct: 18 EEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALP 77
Query: 95 -EDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRT---KLCDFGLARKLSDAS 150
++ R + Q L AL H++GI++ DLKP NI++ + G K+ DFG+ L
Sbjct: 78 AGETGRLMLQVL-DALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVR 136
Query: 151 KAPSSMLPQAK--CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT 208
A + L + GTP Y APE G + SDL+ G + EC G+ G
Sbjct: 137 DADVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVA 195
Query: 209 QLVKSILSDPSPPLPGN-PSRPFANLINSLLVKDPAQR-------------LHWSDLCGH 254
+++ LS LP P ++ L KDP QR L L G
Sbjct: 196 EILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAPALAERFRALELCALVGI 255
Query: 255 AFWRT------KLTPMPLPPQPAFDSLKGAVRQ 281
R + PL D G RQ
Sbjct: 256 --LRMGEGAGREAIAAPLVASGTLDGETGERRQ 286
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 55/211 (26%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--VLQEVRMLHSLDHPNVLRFYSWYET 67
IG G++ V+ G + + AIK++ + S+ ++E +++ L HP +++ Y
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 68 SAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSN 126
+ + LV E+ G L LR Q + ++++ + D+ + YL S +I+ DL N
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARN 130
Query: 127 ILLDENGRTKLCDFGLARKLSDASKAPS--SMLPQAKCGTPCYMAPELFEEGGVHSYASD 184
L+ EN K+ DFG+ R + D S + P + +PE+F +S SD
Sbjct: 131 CLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK------WSSPEVFSFSK-YSSKSD 183
Query: 185 LWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
+W G +++E ++ G+ P+ R +++V++I
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 4e-16
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSKVLQEVRMLHSLDHPNVLRFYSWYET 67
+G G+Y VY+G KK A+K++ D + + L+E ++ + HPN+++
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 68 SAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPS 125
+++ E+ G+L+ LR+ N+ + + +A + A++YL K I+ DL
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 133
Query: 126 NILLDENGRTKLCDFGLARKLS-DASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASD 184
N L+ EN K+ DFGL+R ++ D A + K P +A F S SD
Sbjct: 134 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF------SIKSD 187
Query: 185 LWGLGCVLYECYA-GRPPFVGREFTQL 210
+W G +L+E G P+ G + +Q+
Sbjct: 188 VWAFGVLLWEIATYGMSPYPGIDLSQV 214
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 59/221 (26%), Positives = 110/221 (49%), Gaps = 24/221 (10%)
Query: 9 AIGRGKYSTVYKGRKKKTIEYFAIK----SVDKSQKSKVLQEVRMLHSL-DHPNVLRFYS 63
A G+ +T Y K + A+K + S++ ++ E++++ L +H N++
Sbjct: 47 AFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLG 106
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
+ ++ EYC GDL++ LR+ + L + + + + + + +L SK I+ D
Sbjct: 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRD 166
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASK---APSSMLPQAKCGTPCYMAPE-LFEEGG 177
L N+LL K+CDFGLAR + + S ++ LP +MAPE +F
Sbjct: 167 LAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK------WMAPESIFN--C 218
Query: 178 VHSYASDLWGLGCVLYECYA-GRPPF----VGREFTQLVKS 213
V+++ SD+W G +L+E ++ G P+ V +F +L+K
Sbjct: 219 VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 53/199 (26%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--VLQEVRMLHSLDHPNVLRFYSWYET 67
+G G++ V G+ + + AIK + + S+ ++E +++ L H +++ Y
Sbjct: 12 LGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 68 SAHLWLVLEYCVGGDLMSLLRQDNQLPEDS-IRDLAQDLVRALQYLHSKGIIYCDLKPSN 126
+++V EY G L++ LR+ + + S + ++ +D+ + YL SK I+ DL N
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARN 130
Query: 127 ILLDENGRTKLCDFGLARKLSDASKAPS--SMLPQAKCGTPCYMAPELFEEGGVHSYASD 184
L+D+ G K+ DFGL+R + D S S P + PE+ S SD
Sbjct: 131 CLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR------WSPPEVLLYSK-FSSKSD 183
Query: 185 LWGLGCVLYECYA-GRPPF 202
+W G +++E Y+ G+ P+
Sbjct: 184 VWAFGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 70/250 (28%), Positives = 114/250 (45%), Gaps = 32/250 (12%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKV-----LQEVRMLHSLDHPNVLRFY 62
E IG G++ V +G EY K K+ K V L+E ++ L H N++R
Sbjct: 12 EIIGEGEFGAVLQG------EYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLL 65
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHSKGIIYC 120
+ L++V+E G+L++ LR + + + + D+ ++YL SK +++
Sbjct: 66 GVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHR 124
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DL NIL+ E+G K+ DFGLAR S +S LP + APE + S
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVK------WTAPEALKHKKFSS 176
Query: 181 YASDLWGLGCVLYECYA-GRPPFVG---REFTQLV-KSILSDPSPPLPGNPSRPFANLIN 235
SD+W G +L+E ++ GR P+ +E + V K +P P L+
Sbjct: 177 -KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPA----DVYVLMT 231
Query: 236 SLLVKDPAQR 245
S +P +R
Sbjct: 232 SCWETEPKKR 241
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 67/270 (24%), Positives = 118/270 (43%), Gaps = 41/270 (15%)
Query: 10 IGRGKYSTVYKGR---KKKTIEY-FAIKSV--DKSQKS--KVLQEVRMLHSLDHPNVLRF 61
+G G + TVYKG + + ++ AIK + + S K+ ++L E ++ S+DHP+V+R
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
+S L+ + G L+ +R + + + + + + + YL K +++
Sbjct: 75 LGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR 133
Query: 121 DLKPSNILLDENGRTKLCDFGLARKL---SDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
DL N+L+ K+ DFGLA+ L A +P +MA E
Sbjct: 134 DLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK------WMALESILH-R 186
Query: 178 VHSYASDLWGLGCVLYECYA-GRPPFVG---REFTQLVKSILSDPSPP------------ 221
++++ SD+W G ++E G P+ G E L++ P PP
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVK 246
Query: 222 --LPGNPSRP-FANLINSL--LVKDPAQRL 246
+ SRP F LIN + +DP + L
Sbjct: 247 CWMIDAESRPTFKELINEFSKMARDPQRYL 276
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 6e-15
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 6 IYEAIGRGKYSTVYKGRKK---KTIEYFAIKSVD----KSQKSKVLQEVRMLHSLDHPNV 58
I + IG G++ V GR K K AIK++ + Q+ L E ++ DHPN+
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+ S + +V EY G L + LR+ D Q + + + + ++YL G
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC-YMAPELFEEG 176
++ DL NIL++ N K+ DFGL+R L D P + P + APE
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLED---DPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 177 GVHSYASDLWGLGCVLYEC--YAGRP 200
S ASD+W G V++E Y RP
Sbjct: 185 KFTS-ASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-15
Identities = 56/230 (24%), Positives = 104/230 (45%), Gaps = 29/230 (12%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS--KVLQEVRMLHSLDHPNVLRFYSWYET 67
+G G++ V+ G + + A+K++ S L+E ++ +L H ++R Y+
Sbjct: 14 LGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 68 SAHLWLVLEYCVGGDLMSLLRQDN----QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
++++ EY G L+ L+ D LP+ + D + + + Y+ K I+ DL+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK--LIDFSAQIAEGMAYIERKNYIHRDLR 130
Query: 124 PSNILLDENGRTKLCDFGLARKLSD-------ASKAPSSMLPQAKCGTPCYMAPELFEEG 176
+N+L+ E+ K+ DFGLAR + D +K P + APE G
Sbjct: 131 AANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIK-----------WTAPEAINFG 179
Query: 177 GVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGN 225
+ SD+W G +LYE G+ P+ G + ++ ++ P N
Sbjct: 180 SF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN 228
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 1 MNQYHIYEAIGRGKYSTV----YKGRKKKTIEYFAIKSVDKSQKSKV-LQEVRMLHSLDH 55
M + + + IG+G++ V Y+G K A+K + ++ L E ++ L H
Sbjct: 5 MKELKLLQTIGKGEFGDVMLGDYRGNK------VAVKCIKNDATAQAFLAEASVMTQLRH 58
Query: 56 PNVLRFYS-WYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYL 112
N+++ E L++V EY G L+ LR + L D + + D+ A++YL
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLS---DASKAPSSMLPQAKCGTPCYMA 169
+ ++ DL N+L+ E+ K+ DFGL ++ S D K P + A
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-----------WTA 167
Query: 170 PELFEEGGVHSYASDLWGLGCVLYECYA-GRPPF 202
PE E S SD+W G +L+E Y+ GR P+
Sbjct: 168 PEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 8 EAIGRGKYSTVYKGR-----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNV 58
IG+G + VY G +K + A+KS+ D + + L+E ++ HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKI--HCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 59 LRFY--SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDL---AQDLVRALQYLH 113
L + L +VL Y GDL + +R + P +++DL + + ++YL
Sbjct: 59 LSLLGICLPSEGSPL-VVLPYMKHGDLRNFIRSETHNP--TVKDLIGFGLQVAKGMEYLA 115
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
SK ++ DL N +LDE+ K+ DFGLAR + D AK +MA E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK-WMALESL 174
Query: 174 EEGGVHSYASDLWGLGCVLYECYA-GRPPF 202
+ + SD+W G +L+E G PP+
Sbjct: 175 QTQKFTT-KSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 61/247 (24%), Positives = 111/247 (44%), Gaps = 18/247 (7%)
Query: 10 IGRGKYSTVYKG--RKKKTIEYFAIK-----SVDKSQKSKVLQEVRMLHSLDHPNVLRFY 62
+G G + TV KG + KK+ + A+K + D + K ++L+E ++ LD+P ++R
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
E + LV+E G L L+++ + E +I +L + ++YL ++ DL
Sbjct: 63 GICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDL 121
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
N+LL K+ DFGL++ L KA + K + APE
Sbjct: 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK-----WYAPECMNYYKFS 176
Query: 180 SYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLL 238
S SD+W G +++E ++ G+ P+ G + ++ + I S P +L+
Sbjct: 177 S-KSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCW 235
Query: 239 VKDPAQR 245
+R
Sbjct: 236 TYGVDER 242
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 57/194 (29%), Positives = 95/194 (48%), Gaps = 30/194 (15%)
Query: 41 SKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ---------- 89
S ++ E+ M+ + H N++ L++V+EY G+L LR
Sbjct: 60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP 119
Query: 90 -DNQLPEDSI--RDL---AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143
D + PE+++ +DL A + R +++L SK I+ DL N+L+ E+ K+ DFGLA
Sbjct: 120 DDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
Query: 144 RKLSDAS---KAPSSMLPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-G 198
R + K + LP +MAPE LF+ V+++ SD+W G +L+E + G
Sbjct: 180 RDIHHIDYYRKTTNGRLPVK------WMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLG 231
Query: 199 RPPFVGREFTQLVK 212
P+ G +L K
Sbjct: 232 GSPYPGIPVEELFK 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 7e-14
Identities = 73/269 (27%), Positives = 121/269 (44%), Gaps = 41/269 (15%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQK--SKVLQEVRMLHSL-DHPN 57
Q + EAIG K K + A+K + D ++K S ++ E+ M+ + H N
Sbjct: 33 QVVMAEAIGLDK-------EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLR-----------QDNQLPED--SIRDL--- 101
++ L++++EY G+L LR Q+PE+ S +DL
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 102 AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA---SKAPSSMLP 158
A + R ++YL SK I+ DL N+L+ E+ K+ DFGLAR + K + LP
Sbjct: 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 205
Query: 159 QAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILS 216
+MAPE LF+ ++++ SD+W G +L+E + G P+ G +L K +
Sbjct: 206 VK------WMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 257
Query: 217 DPSPPLPGNPSRPFANLINSLLVKDPAQR 245
P N + ++ P+QR
Sbjct: 258 GHRMDKPSNCTNELYMMMRDCWHAVPSQR 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 65/248 (26%), Positives = 109/248 (43%), Gaps = 45/248 (18%)
Query: 8 EAIGRGKYSTVYKGR-----KKKTIEYFAIKSVDKSQKSKVLQEVR----MLHSLDHPNV 58
E +G G + VYKG ++ + AIK++ ++ + KV QE R ++ L HPN+
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLL--RQDNQLPEDSIRD--------------LA 102
+ ++ EY GDL L + D +A
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 103 QDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKL--SDASKAPS-SMLPQ 159
+ ++YL S ++ DL N L+ E K+ DFGL+R + +D + S S+LP
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 160 AKCGTPCYMAPE--LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVG---REFTQLVKS 213
+M PE L+ G + SD+W G VL+E ++ G P+ G +E ++++S
Sbjct: 191 R------WMPPEAILY---GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS 241
Query: 214 --ILSDPS 219
+L P
Sbjct: 242 RQLLPCPE 249
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 80/320 (25%), Positives = 126/320 (39%), Gaps = 84/320 (26%)
Query: 10 IGRG--KYSTVYKGRKKKTIEYFAIKSVD----KSQKSKVLQ-EVRMLHSLDHPNVLRFY 62
IGRG ++VY R T ++ D + K LQ EV + H HPN++ +
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDS----IRDLAQDLVRALQYLHSKGII 118
+ + T + LW++ + G SLL+ PE I ++ +R L YLH G I
Sbjct: 66 TVFTTGSWLWVISPFMAYGSANSLLK--TYFPEGMSEALIGNILFGALRGLNYLHQNGYI 123
Query: 119 YCDLKPSNILLDENGRTKLCDFGL------------ARKLSDASKAPSSMLPQAKCGTPC 166
+ ++K S+IL+ +G L GL A+ + D + +S+LP
Sbjct: 124 HRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-------- 173
Query: 167 YMAPELFEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP--SP-- 220
+++PEL + ++ Y SD++ +G E GR PF TQ++ L P SP
Sbjct: 174 WLSPELLRQ-DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLD 232
Query: 221 ------------------------------------------PLPGNPSRPFANLINSLL 238
P S F NL+ L
Sbjct: 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCL 292
Query: 239 VKDPAQRLHWSDLCGHAFWR 258
+DP +R S L HAF++
Sbjct: 293 QQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 59/274 (21%), Positives = 109/274 (39%), Gaps = 34/274 (12%)
Query: 5 HIYEAIGRGKYSTVYKGR-----KKKTIEYFAIK----SVDKSQKSKVLQEVRMLHSLDH 55
+ +G G + V+ G + E A+K + + +E +L + H
Sbjct: 8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH 67
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDN--------------QLPEDSIRDL 101
N+++FY +V EY GDL LR +L + +
Sbjct: 68 ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 102 AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKL--SDASK-APSSMLP 158
A + + YL S+ ++ DL N L+ + K+ DFG++R + +D + +MLP
Sbjct: 128 AVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD 217
+M PE + SD+W G VL+E + G+ P+ G ++++ I
Sbjct: 188 IR------WMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240
Query: 218 PSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDL 251
P +++ +DP QR++ D+
Sbjct: 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-13
Identities = 65/239 (27%), Positives = 99/239 (41%), Gaps = 35/239 (14%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQ--------EVRMLHSL 53
N + IG G + V K R KK + + + K K + E+ +L L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKK--DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64
Query: 54 -DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPED---------------- 96
HPN++ E +L+L +EY G+L+ LR+ L D
Sbjct: 65 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124
Query: 97 SIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156
+ A D+ R + YL K I+ DL NIL+ EN K+ DFGL+R K
Sbjct: 125 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 184
Query: 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
LP +MA E V++ SD+W G +L+E + G P+ G +L + +
Sbjct: 185 LPVR------WMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 61/248 (24%), Positives = 113/248 (45%), Gaps = 25/248 (10%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSKVLQEVRMLHSLDHPNVLRFYSWYET 67
+G G++ V++G T A+K++ L E +++ L HP +++ Y+
Sbjct: 14 LGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 68 SAHLWLVLEYCVGGDLMSLLRQDN----QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
+++V E G L+ L+ +LP+ + D+A + + YL ++ I+ DL
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQ--LIDMAAQVASGMAYLEAQNYIHRDLA 130
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGT--PC-YMAPE--LFEEGGV 178
N+L+ EN K+ DFGLAR + + + +A+ G P + APE L+
Sbjct: 131 ARNVLVGENNICKVADFGLARVIKED-------IYEAREGAKFPIKWTAPEAALYNR--- 180
Query: 179 HSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237
S SD+W G +L E GR P+ G ++++ + P P + +++
Sbjct: 181 FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDC 240
Query: 238 LVKDPAQR 245
+DP R
Sbjct: 241 WKEDPDDR 248
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 6e-13
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 32/204 (15%)
Query: 10 IGRGKYSTV----YKGRKKKTIEYFAIKSVDK----SQKSKVLQEVRMLHSLDHPNVLRF 61
+G G + V Y T E A+K++ + S +E+ +L +L H N++++
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 62 YSWYETSAH--LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
L L++EY G L L + ++L + AQ + + YLHS+ I+
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIH 130
Query: 120 CDLKPSNILLDENGRTKLCDFGLAR---------KLSDASKAPSSMLPQAKCGTPCYMAP 170
DL N+LLD + K+ DFGLA+ ++ + +P + A
Sbjct: 131 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----------WYAV 179
Query: 171 ELFEEGGVHSYASDLWGLGCVLYE 194
E +E SYASD+W G LYE
Sbjct: 180 ECLKENKF-SYASDVWSFGVTLYE 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 7e-13
Identities = 53/194 (27%), Positives = 95/194 (48%), Gaps = 30/194 (15%)
Query: 41 SKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQD--------- 90
S ++ E+ M+ + H N++ L++++EY G+L LR
Sbjct: 65 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124
Query: 91 --NQLPED--SIRDLAQ---DLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143
++P++ + +DL + R ++YL S+ I+ DL N+L+ EN K+ DFGLA
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 184
Query: 144 RKLSDA---SKAPSSMLPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-G 198
R +++ K + LP +MAPE LF+ V+++ SD+W G +++E + G
Sbjct: 185 RDVNNIDYYKKTTNGRLPVK------WMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLG 236
Query: 199 RPPFVGREFTQLVK 212
P+ G +L K
Sbjct: 237 GSPYPGIPVEELFK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 8e-13
Identities = 55/234 (23%), Positives = 106/234 (45%), Gaps = 21/234 (8%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSLDH 55
+ +Y + IG G V AIK + +++ + +E+ ++ ++H
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 56 PNVLRFYSWY------ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRAL 109
N++ + + E +++V+E + +L +++ +L + + L ++ +
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCGI 139
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
++LHS GII+ DLKPSNI++ + K+ DFGLAR A +S + T Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVTRYYRA 193
Query: 170 PELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLP 223
PE+ G + D+W +GC++ E G F G + ++ P P
Sbjct: 194 PEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-13
Identities = 53/177 (29%), Positives = 79/177 (44%), Gaps = 24/177 (13%)
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPED-------------SIRDL 101
HPN++ E +L+L +EY G+L+ LR+ L D S + L
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 102 ---AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158
A D+ R + YL K I+ DL NIL+ EN K+ DFGL+R K LP
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 174
Query: 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
+MA E V++ SD+W G +L+E + G P+ G +L + +
Sbjct: 175 VR------WMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 62/207 (29%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 10 IGRGKYSTVYKG---RKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNVLRFY 62
+G G + V KG +KK I+ AIK + +KS + ++++E ++H LD+P ++R
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQID-VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
E A L LV+E GG L L + +++ ++ +L + ++YL K ++ D
Sbjct: 62 GVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRD 120
Query: 122 LKPSNILLDENGRTKLCDFGLARKL-SDAS--KAPSSMLPQAKCGTPCYMAPE--LFEEG 176
L N+LL K+ DFGL++ L +D S KA S+ K + APE F +
Sbjct: 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK-----WYAPECINFRK- 174
Query: 177 GVHSYASDLWGLGCVLYECYA-GRPPF 202
S SD+W G ++E ++ G+ P+
Sbjct: 175 --FSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 9e-13
Identities = 63/272 (23%), Positives = 109/272 (40%), Gaps = 44/272 (16%)
Query: 10 IGRGKYSTVYKGRKKKTIEY--FAIKSVD--KSQKSKVLQ-----EVRMLHSLDHPNVLR 60
IG+G + V++ R + Y F + +V K + S +Q E ++ DHPN+++
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDN----------------------QLPEDSI 98
+ L+ EY GDL LR + L
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 99 RDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKL--SDASKAPSSM 156
+A+ + + YL + ++ DL N L+ EN K+ DFGL+R + +D KA +
Sbjct: 133 LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEND 192
Query: 157 LPQAKCGTPCYMAPE--LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKS 213
+ +M PE + ++ SD+W G VL+E ++ G P+ G +++
Sbjct: 193 AIPIR-----WMPPESIFYNR---YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYY 244
Query: 214 ILSDPSPPLPGNPSRPFANLINSLLVKDPAQR 245
+ P N NL+ K P+ R
Sbjct: 245 VRDGNVLSCPDNCPLELYNLMRLCWSKLPSDR 276
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-12
Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 30/227 (13%)
Query: 41 SKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDN-------- 91
S ++ E+ M+ + H N++ L++++EY G+L LR
Sbjct: 62 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121
Query: 92 ---QLPEDSI--RDL---AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143
+LPE+ + +DL A + R ++YL S+ I+ DL N+L+ E+ K+ DFGLA
Sbjct: 122 DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 144 RKLSDA---SKAPSSMLPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-G 198
R + + K + LP +MAPE LF+ V+++ SD+W G +L+E + G
Sbjct: 182 RDVHNIDYYKKTTNGRLPVK------WMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLG 233
Query: 199 RPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQR 245
P+ G +L K + P N + ++ P+QR
Sbjct: 234 GSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQR 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 68/278 (24%), Positives = 123/278 (44%), Gaps = 42/278 (15%)
Query: 10 IGRGKYSTVYKG-----RKKKTIEYFAIKSVDKSQKS----KVLQEVRMLHSLDHPNVLR 60
+G G++ V K + + A+K + ++ S +L E +L ++HP+V++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ----------------LPEDSIRDL--- 101
Y L L++EY G L S LR+ + L R L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 102 -----AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156
A + R +QYL +++ DL N+L+ E + K+ DFGL+R + + S
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE----DSY 183
Query: 157 LPQAKCGTPC-YMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKS 213
+ ++K P +MA E LF+ +++ SD+W G +L+E G P+ G +L
Sbjct: 184 VKRSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL 241
Query: 214 ILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDL 251
+ + P N S NL+ + ++P +R ++D+
Sbjct: 242 LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 37/209 (17%)
Query: 10 IGRGKYSTV----YKGRKKKTIEYFAIKSVDKSQKSKVL---QEVRMLHSLDHPNVLRF- 61
+G+G + +V Y + T E A+K + S + +E+ +L SL H N++++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 62 ---YSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDL--AQDLVRALQYLHSKG 116
YS + L LV+EY G L L Q ++ D + L A + + ++YL SK
Sbjct: 72 GVCYSAGRRN--LRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYLGSKR 128
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK--------CGTPCY- 167
++ DL NIL++ R K+ DFGL + +LPQ K +P +
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTK-----------VLPQDKEYYKVREPGESPIFW 177
Query: 168 MAPELFEEGGVHSYASDLWGLGCVLYECY 196
APE E S ASD+W G VLYE +
Sbjct: 178 YAPESLTE-SKFSVASDVWSFGVVLYELF 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 60/263 (22%), Positives = 117/263 (44%), Gaps = 30/263 (11%)
Query: 6 IYEAIGRGKYSTVYKGRKKKTIE-----YFAIKSVDKS----QKSKVLQEVRMLHSLDHP 56
+ +G+G + VY+G + I+ A+K+V++S ++ + L E ++
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLR------QDNQ-LPEDSIRDLAQ---DLV 106
+V+R +V+E GDL S LR ++N P +++++ Q ++
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 107 RALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSMLPQAKCG 163
+ YL++K ++ DL N ++ + K+ DFG+ R + + K +LP
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR--- 186
Query: 164 TPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPL 222
+MAPE ++G + SD+W G VL+E + P+ G Q++K ++
Sbjct: 187 ---WMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ 242
Query: 223 PGNPSRPFANLINSLLVKDPAQR 245
P N +L+ +P R
Sbjct: 243 PDNCPERVTDLMRMCWQFNPKMR 265
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 62/245 (25%), Positives = 111/245 (45%), Gaps = 20/245 (8%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS--KVLQEVRMLHSLDHPNVLRFYSWYET 67
+G+G + V+ G T + AIK++ LQE +++ L H ++ Y+ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVS 71
Query: 68 SAHLWLVLEYCVGGDLMSLLRQDN----QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
+++V E+ G L+ L++ + +LP+ + D+A + + Y+ I+ DL+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ--LVDMAAQIADGMAYIERMNYIHRDLR 129
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE--LFEEGGVHSY 181
+NIL+ +N K+ DFGLAR + D Q + APE L+ G +
Sbjct: 130 AANILVGDNLVCKIADFGLARLIEDNEYTAR----QGAKFPIKWTAPEAALY---GRFTI 182
Query: 182 ASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
SD+W G +L E GR P+ G ++++ + P P L+ K
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKK 242
Query: 241 DPAQR 245
DP +R
Sbjct: 243 DPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-12
Identities = 56/234 (23%), Positives = 108/234 (46%), Gaps = 21/234 (8%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSLDH 55
+ +Y + IG G V AIK + +++ + +E+ ++ ++H
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 56 PNVLRFYSWY------ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRAL 109
N++ + + E ++LV+E + +L +++ +L + + L ++ +
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMSYLLYQMLCGI 132
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
++LHS GII+ DLKPSNI++ + K+ DFGLAR A +S + T Y A
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVTRYYRA 186
Query: 170 PELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLP 223
PE+ G + D+W +GC++ E + F GR++ ++ P P
Sbjct: 187 PEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 62/260 (23%), Positives = 109/260 (41%), Gaps = 41/260 (15%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK-SKVL-----QEVRMLHSLDH 55
+Q IY +G ++ K+ I I++ K K KVL E++ L +D
Sbjct: 32 DQNSIY----KGIFNN------KEVI----IRTFKKFHKGHKVLIDITENEIKNLRRIDS 77
Query: 56 PNVLRFYSWY----ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
N+L+ Y + + L L+LEYC G L +L ++ L + D+A D + L
Sbjct: 78 NNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYN 137
Query: 112 LHSK-GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAP 170
L+ Y +L + L+ EN + K+ GL + LS P Y +
Sbjct: 138 LYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--------PFKNVNFMVYFSY 189
Query: 171 EL----FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD-PSPPLPGN 225
++ F E ++ D++ LG VL+E + G+ PF ++ I++ S LP +
Sbjct: 190 KMLNDIFSE---YTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLD 246
Query: 226 PSRPFANLINSLLVKDPAQR 245
++ + D +R
Sbjct: 247 CPLEIKCIVEACTSHDSIKR 266
|
Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 30/227 (13%)
Query: 41 SKVLQEVRMLHSLD-HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDN-------- 91
+ ++ E+ ++ + H N++ L++++EY G+L LR
Sbjct: 62 ADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTF 121
Query: 92 ---QLPED--SIRDL---AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143
++PE+ S +DL A + R ++YL S+ I+ DL N+L+ E+ K+ DFGLA
Sbjct: 122 DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 144 RKLSDA---SKAPSSMLPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-G 198
R + D K + LP +MAPE LF+ V+++ SD+W G +++E + G
Sbjct: 182 RGVHDIDYYKKTSNGRLPVK------WMAPEALFDR--VYTHQSDVWSFGILMWEIFTLG 233
Query: 199 RPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQR 245
P+ G +L K + P N + L+ P QR
Sbjct: 234 GSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQR 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-12
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 3 QYHIYEAIGRGKYSTVY------KGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHP 56
QY+I ++ G V+ ++KK I +K+V + +E+ +L ++ H
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVI----VKAVTGGKTPG--REIDILKTISHR 146
Query: 57 NVLRF---YSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLH 113
++ Y W T + + DL + + + LP + + + L+ AL YLH
Sbjct: 147 AIINLIHAYRWKSTVCMVMPKYKC----DLFTYVDRSGPLPLEQAITIQRRLLEALAYLH 202
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC----GTPCYMA 169
+GII+ D+K NI LDE L DFG A KL P +C GT +
Sbjct: 203 GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP-------QCYGWSGTLETNS 255
Query: 170 PELFEEGGVHSYA--SDLWGLGCVLYECYAGRPPFVGRE 206
PEL + Y +D+W G VL+E G++
Sbjct: 256 PELL---ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291
|
Length = 392 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 63/257 (24%), Positives = 110/257 (42%), Gaps = 20/257 (7%)
Query: 8 EAIGRGKYSTVYKG------RKKKTIEYFAIKSVD----KSQKSKVLQEVRMLHSLDHPN 57
+ IG G++ V++G RK+ + AIK++ + Q+ L E ++ H N
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAV---AIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSKG 116
++R ++ EY G L LR D + + + + + ++YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC-YMAPELFEE 175
++ DL NIL++ N K+ DFGL+R L D P + P + APE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLED---DPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 176 GGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
S ASD+W G V++E + G P+ +++K+I P P + L+
Sbjct: 185 RKFTS-ASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLM 243
Query: 235 NSLLVKDPAQRLHWSDL 251
+D A+R + D+
Sbjct: 244 LQCWQQDRARRPRFVDI 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 48/211 (22%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS--KVLQEVRMLHSLDHPNVLRFYSWYET 67
+G G++ V+ K + A+K++ S L E ++ +L H +++ ++ T
Sbjct: 14 LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVT 71
Query: 68 SAHLWLVLEYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPS 125
++++ E+ G L+ L+ D ++ P + D + + + ++ + I+ DL+ +
Sbjct: 72 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 131
Query: 126 NILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC-YMAPELFEEGGVHSYASD 184
NIL+ + K+ DFGLAR + D + + P + APE G + SD
Sbjct: 132 NILVSASLVCKIADFGLARVIED-----NEYTAREGAKFPIKWTAPEAINFGSF-TIKSD 185
Query: 185 LWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
+W G +L E GR P+ G ++++++
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 23/224 (10%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS--KVLQEVRMLHSLDHPNVLRFYSWYET 67
+G+G + V+ G T AIK++ S LQE +++ L H +++ Y+ +
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVS 71
Query: 68 SAHLWLVLEYCVGGDLMSLLRQDN----QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
+++V EY G L+ L+ + +LP+ + D+A + + Y+ ++ DL+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ--LVDMAAQIASGMAYVERMNYVHRDLR 129
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE--LFEEGGVHSY 181
+NIL+ EN K+ DFGLAR + D Q + APE L+ G +
Sbjct: 130 AANILVGENLVCKVADFGLARLIEDNEYTAR----QGAKFPIKWTAPEAALY---GRFTI 182
Query: 182 ASDLWGLGCVLYE-CYAGRPPF---VGREFTQLVKSILSDPSPP 221
SD+W G +L E GR P+ V RE V+ P PP
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 226
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 31/231 (13%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYF--AIKSV----DKSQKSKVLQEVRMLHSL-DHPNVLR 60
+ IG G + V + KK AIK + ++ E+ +L L HPN++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPED----------------SIRDLAQD 104
E +L++ +EY G+L+ LR+ L D + A D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 105 LVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGT 164
+ +QYL K I+ DL N+L+ EN +K+ DFGL+R K LP
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR---- 183
Query: 165 PCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
+MA E V++ SD+W G +L+E + G P+ G +L + +
Sbjct: 184 --WMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 61/250 (24%), Positives = 112/250 (44%), Gaps = 26/250 (10%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS--KVLQEVRMLHSLDHPNVLRFYSWY 65
+ +G G++ V+ G + A+K++ S L+E +++ L H +++ Y+
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYA-V 69
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQDN----QLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
+ +++V EY G L+ L+ +LP + D+A + + Y+ I+ D
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPN--LVDMAAQVAAGMAYIERMNYIHRD 127
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC---YMAPE--LFEEG 176
L+ +NIL+ + K+ DFGLAR + D A+ G + APE L+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAALY--- 177
Query: 177 GVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235
G + SD+W G +L E GR P+ G ++++ + P P + L+
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELML 237
Query: 236 SLLVKDPAQR 245
KDP +R
Sbjct: 238 QCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 65/274 (23%), Positives = 114/274 (41%), Gaps = 38/274 (13%)
Query: 8 EAIGRGKYSTVYKGR----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNVL 59
E +G + +YKG + AIK++ + Q + QE ++ L HPN++
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLL-------------RQD----NQLPEDSIRDLA 102
+ ++ EY GDL L +D + L +A
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 103 QDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK---APSSMLPQ 159
+ ++YL S ++ DL NIL+ E K+ D GL+R++ A P S+LP
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDP 218
+M PE G S SD+W G VL+E ++ G P+ G ++++ +
Sbjct: 191 R------WMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ 243
Query: 219 SPPLPGN-PSRPFANLINSLLVKDPAQRLHWSDL 251
P + P R ++ L+ + P++R + D+
Sbjct: 244 LLPCSEDCPPRMYS-LMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 55/223 (24%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 8 EAIGRGKYSTVYKGR--KKKTIEYFAIKSVD-----KSQKSKVLQEVRMLHSLDHPNVLR 60
+ +G G++ +V +G+ + +I A+K++ +S+ L E + DHPNV+R
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 61 FY------SWYETSAHLWLVLEYCVGGDLMSLL---RQDNQ---LPEDSIRDLAQDLVRA 108
E ++L + GDL S L R + LP + D+
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 109 LQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
++YL SK I+ DL N +L+EN + DFGL++K+ + + + ++
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK---WI 181
Query: 169 APELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQL 210
A E + V++ SD+W G ++E G+ P+ G E +++
Sbjct: 182 AIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 51/193 (26%), Positives = 80/193 (41%), Gaps = 27/193 (13%)
Query: 30 FAIK----SVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMS 85
A+K + + L+EV++L L PN+ R L +++EY GDL
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 86 LLRQ----DNQLPEDSIRDLAQDLVR-ALQ------YLHSKGIIYCDLKPSNILLDENGR 134
L++ + L +S L+ A Q YL S ++ DL N L+ +N
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT 168
Query: 135 TKLCDFGLARKL--SDASKAP-SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCV 191
K+ DFG++R L SD + + LP +MA E G + SD+W G
Sbjct: 169 IKIADFGMSRNLYSSDYYRVQGRAPLPIR------WMAWESV-LLGKFTTKSDVWAFGVT 221
Query: 192 LYECY--AGRPPF 202
L+E P+
Sbjct: 222 LWEILTLCREQPY 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 40/228 (17%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKS------------------VDKSQKSKV 43
Q + E +G G++ V+ + E+ + V K+ ++
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 44 LQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ---------DNQLP 94
L+E++++ L +PN++R + L ++ EY GDL L Q N +P
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124
Query: 95 EDSIRDL---AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKL--SDA 149
SI +L A + ++YL S ++ DL N L+ + K+ DFG++R L D
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 150 SKAPSSMLPQAKCGTPC-YMAPELFEEGGVHSYASDLWGLGCVLYECY 196
+ Q + P +MA E G + ASD+W G L+E +
Sbjct: 185 YRI------QGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-11
Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 36 DKSQKSKVLQEVRMLHSLDHPNVLRFYSWY------ETSAHLWLVLEYCVGGDLMSLLRQ 89
+++ + +E+ +L ++H N++ + + E ++LV+E + +L ++
Sbjct: 60 NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIHM 118
Query: 90 DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA 149
+ L + + L ++ +++LHS GII+ DLKPSNI++ + K+ DFGLAR
Sbjct: 119 E--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----- 171
Query: 150 SKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ 209
A ++ + T Y APE+ G + D+W +GC++ E G F G +
Sbjct: 172 -TACTNFMMTPYVVTRYYRAPEVI-LGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID 229
Query: 210 LVKSILSDPSPPLPGNPSRPFAN 232
++ G PS F N
Sbjct: 230 QWNKVIE-----QLGTPSAEFMN 247
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 51/216 (23%), Positives = 88/216 (40%), Gaps = 7/216 (3%)
Query: 38 SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPED 96
Q+ L E L DH N++R + +V EY G L S LR+ + QL
Sbjct: 48 KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAG 107
Query: 97 SIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156
+ + L ++YL G ++ L +L++ + K+ F R D S+A +
Sbjct: 108 QLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTT 165
Query: 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSIL 215
+ + APE + S ASD+W G V++E + G P+ ++K++
Sbjct: 166 MSGKS--PVLWAAPEAIQYHHFSS-ASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE 222
Query: 216 SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDL 251
P P N L+ K+ +R +S +
Sbjct: 223 DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 30/184 (16%)
Query: 38 SQKSKVLQEVRMLHSLDHPNVLR-FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPED 96
Q + +LQE +L+ L H N+L + E +++ Y G+L L+Q +
Sbjct: 50 IQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEAN 109
Query: 97 SIRDLA-QDLV-------RALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARK--- 145
+ + L+ Q LV + YLH +G+I+ D+ N ++DE + K+ D L+R
Sbjct: 110 NPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169
Query: 146 -----LSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYE-CYAGR 199
L D P +MA E +S ASD+W G +L+E G+
Sbjct: 170 MDYHCLGDNENRPVK-----------WMALESLVNK-EYSSASDVWSFGVLLWELMTLGQ 217
Query: 200 PPFV 203
P+V
Sbjct: 218 TPYV 221
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-11
Identities = 53/185 (28%), Positives = 89/185 (48%), Gaps = 19/185 (10%)
Query: 45 QEVRMLHSLDHPNVLRFY------SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSI 98
+E+ ++ ++H N++ E ++LV+E + +L +++ D L + +
Sbjct: 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQMD--LDHERM 120
Query: 99 RDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158
L ++ +++LHS GII+ DLKPSNI++ + K+ DFGLAR + M P
Sbjct: 121 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTP 176
Query: 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-FTQLVKSI--L 215
T Y APE+ G + D+W +GC++ E G F G + Q K I L
Sbjct: 177 YVV--TRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233
Query: 216 SDPSP 220
PS
Sbjct: 234 GTPSD 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 44/117 (37%), Positives = 66/117 (56%), Gaps = 17/117 (14%)
Query: 105 LVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR---KLSDASKAPSSMLPQAK 161
+ R +++L S+ I+ DL NILL EN K+CDFGLAR K D + S+ LP
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK- 241
Query: 162 CGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVG----REFTQLVK 212
+MAPE +F++ V++ SD+W G +L+E ++ G P+ G EF Q +K
Sbjct: 242 -----WMAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 63/260 (24%), Positives = 102/260 (39%), Gaps = 32/260 (12%)
Query: 8 EAIGRGKYSTVYKG-RKKKTIEYFAIKSVDKSQKSKVLQE-----------VRMLHSLDH 55
E +G+G ++ +YKG + ++ + S KVL ++ L H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLL-RQDNQLPEDSIRDLAQDLVRALQYLHS 114
++++ Y ++ +V EY G L L R+ N + D+A+ L AL YL
Sbjct: 61 KHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED 119
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC-YMAPELF 173
K +++ ++ NIL+ G + KLSD P ++L + + ++APE
Sbjct: 120 KKLVHGNVCGKNILVARYGLNEGY--VPFIKLSDPG-IPITVLSREERVERIPWIAPECI 176
Query: 174 EEGGVH-SYASDLWGLGCVLYE-CYAGRPPFVGR-----EFTQLVKSILSDPSPPLPGNP 226
G + A+D W G L E C G P E + L P
Sbjct: 177 RNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCA----- 231
Query: 227 SRPFANLINSLLVKDPAQRL 246
ANLIN DP +R
Sbjct: 232 --ELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 25/234 (10%)
Query: 10 IGRGKYSTVYKG------RKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYS 63
IG G + V G K + + S ++ LQEV+ L+HPNVL+
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDN----QLPE-DSIRDLAQDLVRALQYLHSKGII 118
S LVLE+C GDL + LR + Q+ + D ++ +A ++ L +LH I
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI 122
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC-GTPC-YMAPELFEEG 176
+ DL N L + K+ D+GLA + P C P ++APEL E
Sbjct: 123 HSDLALRNCQLTADLSVKIGDYGLAL-----EQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 177 GVH------SYASDLWGLGCVLYECY-AGRPPFVGREFTQLVKSILSDPSPPLP 223
G + S++W LG ++E + A P+ Q++K ++ + LP
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 51/202 (25%), Positives = 93/202 (46%), Gaps = 28/202 (13%)
Query: 32 IKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQD- 90
+K + + +E +L +L H ++++FY L +V EY GDL LR
Sbjct: 43 LKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHG 102
Query: 91 ------------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLC 138
+L + + +AQ + + YL S+ ++ DL N L+ EN K+
Sbjct: 103 PDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162
Query: 139 DFGLARKL--SDASKAPS-SMLPQAKCGTPCYMAPE--LFEEGGVHSYASDLWGLGCVLY 193
DFG++R + +D + +MLP +M PE ++ + + SD+W LG VL+
Sbjct: 163 DFGMSRDVYSTDYYRVGGHTMLPIR------WMPPESIMYRK---FTTESDVWSLGVVLW 213
Query: 194 ECYA-GRPPFVGREFTQLVKSI 214
E + G+ P+ ++++ I
Sbjct: 214 EIFTYGKQPWYQLSNNEVIECI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-10
Identities = 53/196 (27%), Positives = 86/196 (43%), Gaps = 20/196 (10%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSA 69
I RGK YKG+ K F +K ++ S E+ + L HPN+++ +
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVN-SIPSSEIADMGKLQHPNIVKLIGLCRSEK 756
Query: 70 HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLH---SKGIIYCDLKPSN 126
+L+ EY G +L +LR L + R +A + +AL++LH S ++ +L P
Sbjct: 757 GAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEK 813
Query: 127 ILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCG-TPCYMAPELFEEGGVHSYASDL 185
I++D L L P + KC + Y+APE E + SD+
Sbjct: 814 IIIDGKDEPHLR-LSL----------PGLLCTDTKCFISSAYVAPETRETKDITE-KSDI 861
Query: 186 WGLGCVLYECYAGRPP 201
+G G +L E G+ P
Sbjct: 862 YGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 67/282 (23%), Positives = 120/282 (42%), Gaps = 40/282 (14%)
Query: 8 EAIGRGKYSTVYKGR-----KKKTIEYFAIKSV-DKSQ---KSKVLQEVRMLHSLDHPNV 58
E +G ++ VYKG + + AIK++ DK++ + + E M L HPN+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLL-----------RQDNQL------PEDSIRDL 101
+ L ++ YC DL L D++ P D + +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 102 AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP---SSMLP 158
Q + +++L S +++ DL N+L+ + K+ D GL R++ A +S+LP
Sbjct: 131 TQ-IAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD 217
+M+PE G S SD+W G VL+E ++ G P+ G +++ I +
Sbjct: 190 IR------WMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR 242
Query: 218 PSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRT 259
P P + L+ + P++R + D+ H+ RT
Sbjct: 243 QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI--HSRLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 51/221 (23%), Positives = 99/221 (44%), Gaps = 31/221 (14%)
Query: 10 IGRGKYSTVYKGRKKK---TIEYFAIKS--VDKSQKSKV---LQEVRMLHSLDHPNVLRF 61
+G G++ +V +G+ + + A+K+ +D S++ L E + DHPNV++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 62 Y------SWYETSAHLWLVLEYCVGGDLMSLL------RQDNQLPEDSIRDLAQDLVRAL 109
S + ++L + GDL S L +LP ++ D+ +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSMLPQAKCGTPC 166
+YL ++ I+ DL N +L E+ + DFGL++K+ + + +P
Sbjct: 127 EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK------ 180
Query: 167 YMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGRE 206
++A E + V++ SD+W G ++E G+ P+ G E
Sbjct: 181 WIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVE 220
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 42/115 (36%), Positives = 64/115 (55%), Gaps = 17/115 (14%)
Query: 107 RALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR---KLSDASKAPSSMLPQAKCG 163
R +++L S+ I+ DL NILL EN K+CDFGLAR K D + + LP
Sbjct: 184 RGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK--- 240
Query: 164 TPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVG----REFTQLVK 212
+MAPE +F++ V++ SD+W G +L+E ++ G P+ G EF + +K
Sbjct: 241 ---WMAPESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 52/229 (22%), Positives = 106/229 (46%), Gaps = 30/229 (13%)
Query: 10 IGRGKYSTVYKGRKKKTIE-----YFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLR 60
+G+G + VY+G K ++ AIK+V+++ ++ + L E ++ + +V+R
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLR------QDNQL----PEDSIRDLAQDLVRALQ 110
+++E GDL S LR ++N + + +A ++ +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 111 YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSMLPQAKCGTPCY 167
YL++ ++ DL N ++ E+ K+ DFG+ R + + K +LP +
Sbjct: 134 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR------W 187
Query: 168 MAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSIL 215
M+PE ++ GV + SD+W G VL+E P+ G Q+++ ++
Sbjct: 188 MSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-10
Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 9/175 (5%)
Query: 25 KTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLM 84
KT E+ IK+ Q+ E +L +++HP++++ + + L+L DL
Sbjct: 115 KTCEHVVIKA---GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR-YKTDLY 170
Query: 85 SLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR 144
L + I + + ++RA+QYLH II+ D+K NI ++ G L DFG A
Sbjct: 171 CYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC 230
Query: 145 KLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGR 199
D + GT APEL + A D+W G VL+E
Sbjct: 231 FPVDINANKY----YGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 60/272 (22%), Positives = 111/272 (40%), Gaps = 37/272 (13%)
Query: 10 IGRGKYSTV----YKGRKKKTIEYFAIKSVD----KSQKSKVLQEVRMLHSLDHPNVLRF 61
+G G + V Y T E A+KS+ + + + +E+ +L +L H N++++
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 62 YSWYETSA--HLWLVLEYCVGGDLMSLL-RQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ L++E+ G L L R N++ A + + + YL S+ +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYV 131
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCY-MAPELFEEGG 177
+ DL N+L++ + K+ DFGL + + + + + +P + APE
Sbjct: 132 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV---KDDLDSPVFWYAPECL---- 184
Query: 178 VHS---YASDLWGLGCVLYE----CYAGRPP------FVG-----REFTQLVKSILSDPS 219
+ S ASD+W G LYE C + P +G T+LV+ +
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244
Query: 220 PPLPGNPSRPFANLINSLLVKDPAQRLHWSDL 251
P P N L+ P++R + +L
Sbjct: 245 LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 62/287 (21%), Positives = 119/287 (41%), Gaps = 39/287 (13%)
Query: 10 IGRGKYSTVYKG--------RKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRF 61
+G G + V+ + K + A+K + + +E +L +L H ++++F
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLR----------------QDNQLPEDSIRDLAQDL 105
Y L +V EY GDL LR +L + +A +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 106 VRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKL--SDASKAPS-SMLPQAKC 162
+ YL S+ ++ DL N L+ N K+ DFG++R + +D + +MLP
Sbjct: 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR-- 190
Query: 163 GTPCYMAPE--LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPS 219
+M PE ++ + + SD+W G +L+E + G+ P+ T++++ I
Sbjct: 191 ----WMPPESIMYRK---FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 243
Query: 220 PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPL 266
P + +++ ++P QRL+ ++ K TP+ L
Sbjct: 244 LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKATPIYL 290
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 8e-10
Identities = 47/160 (29%), Positives = 80/160 (50%), Gaps = 9/160 (5%)
Query: 39 QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLL-RQDNQLPEDS 97
QK L E +L +++HP+V+R + A +VL + DL + L ++ LP D
Sbjct: 100 QKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH-YSSDLYTYLTKRSRPLPIDQ 158
Query: 98 IRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157
+ + ++ L+YLH++ II+ D+K NI +++ + + D G A+ AP+ +
Sbjct: 159 ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFL- 214
Query: 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA 197
GT APE+ +S A D+W G VL+E A
Sbjct: 215 --GLAGTVETNAPEVLARDKYNSKA-DIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 9e-10
Identities = 52/174 (29%), Positives = 90/174 (51%), Gaps = 20/174 (11%)
Query: 82 DLMSLLRQDNQLPEDSIRDL---AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLC 138
D+ S + ++++L D DL + + + + +L SK I+ DL NILL TK+C
Sbjct: 198 DVTSEILEEDELALD-TEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKIC 256
Query: 139 DFGLARKLSDASKAPSSMLPQAKCGTPC-YMAPE-LFEEGGVHSYASDLWGLGCVLYECY 196
DFGLAR + + S+ + + P +MAPE +F V+++ SD+W G +L+E +
Sbjct: 257 DFGLARDI----RNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIF 310
Query: 197 A-GRPPF----VGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQR 245
+ G P+ V +F +++K SP PS + +++ S DP +R
Sbjct: 311 SLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC--APSEMY-DIMKSCWDADPLKR 361
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 38/105 (36%), Positives = 59/105 (56%), Gaps = 13/105 (12%)
Query: 105 LVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR---KLSDASKAPSSMLPQAK 161
+ + +++L S+ I+ DL NILL EN K+CDFGLAR K D + + LP
Sbjct: 188 VAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK- 246
Query: 162 CGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVG 204
+MAPE +F+ V++ SD+W G +L+E ++ G P+ G
Sbjct: 247 -----WMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 58/250 (23%), Positives = 106/250 (42%), Gaps = 15/250 (6%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAI-------KSVDKSQKS---KVLQEVRMLHSLDHPN 57
E++G+G ++ ++KG +++ +Y + K +DKS ++ + M+ L H +
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDL-MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
++ Y +V EY G L L + N + ++A+ L AL +L KG
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
+ + ++ N+LL K + KLSD + + + + ++ PE E
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFI-KLSDPGISITVLPKEILLERIPWVPPECIENP 179
Query: 177 GVHSYASDLWGLGCVLYECYAG-RPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235
S A+D W G L+E ++G P + + K + LP ANLIN
Sbjct: 180 QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFYEDRHQLPAPKWTELANLIN 237
Query: 236 SLLVKDPAQR 245
+ +P R
Sbjct: 238 QCMDYEPDFR 247
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 62/271 (22%), Positives = 109/271 (40%), Gaps = 38/271 (14%)
Query: 10 IGRGKYSTVYKG--------RKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRF 61
+G G + V+ + K + A+K +S + +E +L L H +++RF
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQD---------------NQLPEDSIRDLAQDLV 106
Y L +V EY GDL LR QL + +A +
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 107 RALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKL--SDASKAPS-SMLPQAKCG 163
+ YL S ++ DL N L+ + K+ DFG++R + +D + +MLP
Sbjct: 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR--- 189
Query: 164 TPCYMAPE--LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSP 220
+M PE L+ + + SD+W G VL+E + G+ P+ T+ ++ I
Sbjct: 190 ---WMPPESILYRK---FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL 243
Query: 221 PLPGNPSRPFANLINSLLVKDPAQRLHWSDL 251
P ++ ++P QR+ D+
Sbjct: 244 ERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 55/227 (24%), Positives = 100/227 (44%), Gaps = 16/227 (7%)
Query: 8 EAIGRGKYSTVYKG---RKKKTIEY-FAIKSVDKSQKSKV----LQEVRMLHSLDHPNVL 59
+ +G G + TVYKG + +T++ AIK ++++ K + E ++ S+DHP+++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGII 118
R S + LV + G L+ + + + + + + + + + YL + ++
Sbjct: 73 RLLG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 131
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASK---APSSMLPQAKCGTPCYMAPELFEE 175
+ DL N+L+ K+ DFGLAR L K A +P C + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 191
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL 222
V SY +W L + Y G P RE L++ P PP+
Sbjct: 192 SDVWSYGVTIWELMTFGGKPYDGIPT---REIPDLLEKGERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 59/266 (22%), Positives = 112/266 (42%), Gaps = 31/266 (11%)
Query: 10 IGRGKYSTVYKGRKKK---TIEYFAIKSVD-----KSQKSKVLQEVRMLHSLDHPNVLRF 61
+G+G++ +V + + K + + A+K + S + L+E + DHPNV++
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 62 YS---WYETSAHL---WLVLEYCVGGDLMSLLRQDN------QLPEDSIRDLAQDLVRAL 109
L ++L + GDL + L LP ++ D+ +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSMLPQAKCGTPC 166
+YL SK I+ DL N +L+EN + DFGL++K+ + +S LP
Sbjct: 127 EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK------ 180
Query: 167 YMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGN 225
++A E + V++ SD+W G ++E G+ P+ G E +++ ++ P +
Sbjct: 181 WLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPD 239
Query: 226 PSRPFANLINSLLVKDPAQRLHWSDL 251
L+ +P R + L
Sbjct: 240 CLEDVYELMCQCWSPEPKCRPSFQHL 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 9e-09
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 12/154 (7%)
Query: 45 QEVRMLHSLDHPNVLRFYSWYETSAHLWLVL-EYCVGGDLMSLL-RQDNQLPEDSIRDLA 102
E R+L L HP VL LVL +Y DL + L + L + +A
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYLGARLRPLGLAQVTAVA 266
Query: 103 QDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLC--DFGLARKLSDASKAPSSMLPQA 160
+ L+ A+ Y+H +GII+ D+K N+L+ NG +C DFG A A + S+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLV--NGPEDICLGDFGAA---CFARGSWSTPFHYG 321
Query: 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYE 194
GT APE+ G ++ + D+W G V++E
Sbjct: 322 IAGTVDTNAPEVL-AGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 9e-09
Identities = 51/176 (28%), Positives = 78/176 (44%), Gaps = 8/176 (4%)
Query: 73 LVLEYCVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE 131
+V E+ G L LR++ ++P +AQ L AL YL K +++ ++ NILL
Sbjct: 93 MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILL-- 150
Query: 132 NGRTKLCDFGLAR-KLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGC 190
R L + KLSD + +++ + + ++APE G S A+D W G
Sbjct: 151 -ARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGT 209
Query: 191 VLYE-CYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQR 245
L E C+ G P R T K + LP + A LI+ L +P QR
Sbjct: 210 TLLEICFDGEVPLKER--TPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQR 263
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 65/259 (25%), Positives = 108/259 (41%), Gaps = 27/259 (10%)
Query: 8 EAIGRGKYSTVYKGR-------------KKKTIEYFAIKSVDKSQKSKVL---QEVRMLH 51
E +GRG + +Y G +K I+ +K +D S + L + M+
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVI-LKVLDPSHRDISLAFFETASMMR 59
Query: 52 SLDHPNVLRFYSWYETSAHLWLVLEYCVGGDL-MSLLRQDNQLPEDSIRDLAQDLVRALQ 110
+ H +++ Y +V E+ G L + + R+ + L +A+ L AL
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 111 YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC--GTPCYM 168
YL K +++ ++ NILL G C G KLSD P ++L + +C P ++
Sbjct: 120 YLEDKDLVHGNVCTKNILLAREGIDGEC--GPFIKLSDPG-IPITVLSRQECVERIP-WI 175
Query: 169 APELFEEGGVHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKSILSDPSPPLPGNPS 227
APE E+ S A+D W G L+E CY G P + + + P
Sbjct: 176 APECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPS--C 233
Query: 228 RPFANLINSLLVKDPAQRL 246
+ A+L+ + DP QR
Sbjct: 234 KELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 50/178 (28%), Positives = 75/178 (42%), Gaps = 25/178 (14%)
Query: 37 KSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLR-------- 88
K+ ++ L+EV++L L PN++R L ++ EY GDL L
Sbjct: 60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKE 119
Query: 89 --------QDNQLPEDSIRDL---AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKL 137
+ LP S L A + ++YL S ++ DL N L+ EN K+
Sbjct: 120 ENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKI 179
Query: 138 CDFGLARKLSDASKAPSSMLPQAKCGTPC-YMAPELFEEGGVHSYASDLWGLGCVLYE 194
DFG++R L A Q + P +MA E G + ASD+W G L+E
Sbjct: 180 ADFGMSRNLY----AGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWE 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 70/318 (22%), Positives = 123/318 (38%), Gaps = 81/318 (25%)
Query: 10 IGRG--KYSTVYKGRKKKTIEYFAIKSVD----KSQKSKVLQ-EVRMLHSLDHPNVLRFY 62
IGRG TV R K T EY ++ ++ ++ LQ E+ + +HPN++ +
Sbjct: 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYR 65
Query: 63 SWYETSAHLWLV---LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ + LW+V + Y DL+ D + E +I + Q +++AL Y+H G ++
Sbjct: 66 ATFIADNELWVVTSFMAYGSAKDLICTHFMDG-MSELAIAYILQGVLKALDYIHHMGYVH 124
Query: 120 CDLKPSNILLDENGRTKLCDFGL------------ARKLSDASKAPSSMLPQAKCGTPCY 167
+K S+IL+ +G K+ GL R + D K +LP +
Sbjct: 125 RSVKASHILISVDG--KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP--------W 174
Query: 168 MAPELFEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--- 222
++PE+ ++ + Y SD++ +G E G PF TQ++ L+ P L
Sbjct: 175 LSPEVLQQ-NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 233
Query: 223 -------------------------------PGNPSRP-----------FANLINSLLVK 240
P N F + + L +
Sbjct: 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQR 293
Query: 241 DPAQRLHWSDLCGHAFWR 258
+P R S L H+F++
Sbjct: 294 NPDARPSASTLLNHSFFK 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 59/229 (25%), Positives = 106/229 (46%), Gaps = 24/229 (10%)
Query: 10 IGRGKYSTVYKG----RKKKTIEYFAIKSVDKSQKSK----VLQEVRMLHSLDHPNVLRF 61
+G G + TVYKG +K AIK + ++ K +L E ++ S+D+P+V R
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
TS + L+ + G L+ +R+ + + + + + + + YL + +++
Sbjct: 75 LGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHR 133
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCG-TPC-YMAPELFEEGGV 178
DL N+L+ K+ DFGLA+ L K A+ G P +MA E +
Sbjct: 134 DLAARNVLVKTPQHVKITDFGLAKLLGADEKE-----YHAEGGKVPIKWMALESILH-RI 187
Query: 179 HSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD----PSPPL 222
+++ SD+W G ++E G P+ G ++ + SIL P PP+
Sbjct: 188 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 25/213 (11%)
Query: 10 IGRGKYSTVYKGRKKKTIE--YFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYS 63
IG G + V G +K + S ++ K L+E + SL H N+L+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQ----DNQLPE-DSIRDLAQDLVRALQYLHSKGII 118
LV+E+C GDL LR + P+ +++ +A ++ L +LH I
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI 122
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
+ DL N LL + K+ D+GL+ + K + P ++APEL +E V
Sbjct: 123 HSDLALRNCLLTADLTVKIGDYGLSH---NKYKEDYYVTPDQLWVPLRWIAPELVDE--V 177
Query: 179 H--------SYASDLWGLGCVLYECYA-GRPPF 202
H + S++W LG ++E + G P+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-08
Identities = 45/174 (25%), Positives = 82/174 (47%), Gaps = 23/174 (13%)
Query: 36 DKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPE 95
+K+ ++ L+E++++ L PN++R + TS L ++ EY GDL L + ++ E
Sbjct: 59 NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSR-HEPQE 117
Query: 96 DS------------IRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143
+ + +A + ++YL S ++ DL N L+ +N K+ DFG++
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 144 RKL--SDASKAPSSMLPQAKCGTPC-YMAPELFEEGGVHSYASDLWGLGCVLYE 194
R L D + Q + P +M+ E G + ASD+W G L+E
Sbjct: 178 RNLYSGDYYRI------QGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWE 224
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 59/265 (22%), Positives = 108/265 (40%), Gaps = 31/265 (11%)
Query: 10 IGRGKYSTVYKGRKKKTIE-----YFAIKSVDKSQKSKVLQEVR----MLHSLDHPNVLR 60
+GRG++ V+ + K E +K++ K++ + E R M L H NV+R
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 61 FYSW-YETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDS---------IRDLAQDLVRALQ 110
E H +++LEY GDL LR E L + +
Sbjct: 73 LLGLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 111 YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKL--SDASKAPSSMLPQAKCGTPCYM 168
+L + ++ DL N L+ K+ L++ + S+ K ++++P ++
Sbjct: 132 HLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR------WL 185
Query: 169 APELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILS-DPSPPLPGNP 226
APE +E S SD+W G +++E + G PF G +++ + + P+P
Sbjct: 186 APEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGC 244
Query: 227 SRPFANLINSLLVKDPAQRLHWSDL 251
L+ +P R +S+L
Sbjct: 245 PSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 34/162 (20%), Positives = 76/162 (46%), Gaps = 22/162 (13%)
Query: 3 QYHIYEAIGRGKYSTVY--KGRKKKTIEYFAIKSVDKSQKSKVLQEV------------- 47
++ I + IG G + VY + I A+ ++ + ++ E
Sbjct: 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIA 72
Query: 48 --RMLHSLDHPNVLRFYSW----YETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDL 101
+ +H++DH + ++Y + +++LE V + + ++ + I+++
Sbjct: 73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNI 131
Query: 102 AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143
+D++ L+Y+H GI + D+KP NI++D N R + D+G+A
Sbjct: 132 MKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-08
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 21/147 (14%)
Query: 79 VGGDLMSLLRQDNQLPEDSIRDLAQ---DLVRALQYLHSKGIIYCDLKPSNILLDENGRT 135
D ++ P D + DL + + + + +L SK I+ D+ N+LL +
Sbjct: 193 QSSDSKDEEDTEDSWPLD-LDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVA 251
Query: 136 KLCDFGLARKLSDASK---APSSMLPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCV 191
K+CDFGLAR + + S ++ LP +MAPE +F+ V++ SD+W G +
Sbjct: 252 KICDFGLARDIMNDSNYVVKGNARLPVK------WMAPESIFD--CVYTVQSDVWSYGIL 303
Query: 192 LYECYA-GRPPF----VGREFTQLVKS 213
L+E ++ G+ P+ V +F ++VK
Sbjct: 304 LWEIFSLGKSPYPGILVNSKFYKMVKR 330
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 28/107 (26%), Positives = 45/107 (42%), Gaps = 12/107 (11%)
Query: 43 VLQEVRMLHSLDH-----PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDS 97
+EV +L L P VL S +L++E+ G L + ++ ED
Sbjct: 38 REREVAILQLLARKGLPVPKVLASGESDGWS---YLLMEWIEGETLDEVSEEEK---EDI 91
Query: 98 IRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR 144
LA+ L+ L L + + DL P NIL+D+ + D+ A
Sbjct: 92 AEQLAE-LLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-07
Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 13/105 (12%)
Query: 105 LVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKL---SDASKAPSSMLPQAK 161
+ R +++L SK ++ DL N+LL + K+CDFGLAR + S+ S+ LP
Sbjct: 246 VARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK- 304
Query: 162 CGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVG 204
+MAPE +F+ +++ SD+W G +L+E ++ G P+ G
Sbjct: 305 -----WMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-07
Identities = 54/227 (23%), Positives = 106/227 (46%), Gaps = 44/227 (19%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV--------DKSQKSKVLQEVRMLHSLD 54
++ I +G G + V + +K EY A+K V D + + +++VR D
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPAD 189
Query: 55 HPNVLRFYSWYET-SAHLWLVL-EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVR---AL 109
+++ +++ + H+ +V+ +Y G L+ + + S R LAQ + + AL
Sbjct: 190 RFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPF---SHRHLAQIIFQTGVAL 244
Query: 110 QYLHSK-GIIYCDLKPSNILLD----------------ENGRTKLCDFGLARKLSDASKA 152
Y H++ +++ DLKP NIL++ + R ++CD G D +
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG---GCCDERHS 301
Query: 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGR 199
++++ T Y +PE+ G Y++D+W +GC++YE Y G+
Sbjct: 302 RTAIV-----STRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-07
Identities = 35/128 (27%), Positives = 62/128 (48%), Gaps = 13/128 (10%)
Query: 80 GGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCD 139
+L+ + L + + + +++L SK ++ DL N+L+ E K+CD
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICD 282
Query: 140 FGLARKL---SDASKAPSSMLPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYEC 195
FGLAR + S+ S+ LP +MAPE +F +++ SD+W G +L+E
Sbjct: 283 FGLARDIMRDSNYISKGSTFLPLK------WMAPESIFNN--LYTTLSDVWSFGILLWEI 334
Query: 196 YA-GRPPF 202
+ G P+
Sbjct: 335 FTLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-07
Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 10 IGRGKYSTVYKG---RKKKTIEY-FAIKSVDKSQKSKVLQEV--RMLH--SLDHPNVLRF 61
+G G + TV+KG + +I+ AIK++ + QE+ ML SLDH ++R
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
A L LV + G L+ +RQ D+ P+ + Q + + + YL +++
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ-IAKGMYYLEEHRMVH 132
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC-YMAPE--LFEEG 176
+L NILL + ++ DFG+A L K + K TP +MA E LF
Sbjct: 133 RNLAARNILLKSDSIVQIADFGVADLLYPDDK--KYFYSEHK--TPIKWMALESILF--- 185
Query: 177 GVHSYASDLWGLGCVLYECYA-GRPPFVG 204
G +++ SD+W G ++E + G P+ G
Sbjct: 186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-06
Identities = 41/116 (35%), Positives = 50/116 (43%), Gaps = 9/116 (7%)
Query: 163 GTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD--PSP 220
GTP Y+APEL H A D W LG L+E G PPF Q+ ++IL+ P P
Sbjct: 542 GTPDYLAPELLLGKP-HGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 221 PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAF-----WRT-KLTPMPLPPQP 270
S N I LL DP +R +L H W + MP PQP
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQP 656
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 9e-06
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 15/179 (8%)
Query: 34 SVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQL 93
+ ++++ LQ+ L HPN+L+ + LV EYC GDL S L Q+
Sbjct: 33 NASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWH 92
Query: 94 PEDS----IRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA 149
+S ++ +A ++ + ++H ++ DL N L + K+ D+G+
Sbjct: 93 RRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIG---PSR 149
Query: 150 SKAPSSMLPQAKCGTPCYMAPELFEE--GGV----HSYASDLWGLGCVLYECY--AGRP 200
K KC ++APEL E GG+ + S++W LG L+E + A +P
Sbjct: 150 YKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-05
Identities = 46/201 (22%), Positives = 84/201 (41%), Gaps = 27/201 (13%)
Query: 46 EVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDS-----IRD 100
E+ L L+H N+L+ + A+ +++ + DL S + + +D R
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQK-YDFDLYSFMYDEAFDWKDRPLLKQTRA 271
Query: 101 LAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160
+ + L+ A++Y+H K +I+ D+K NI L+ +G+ L DFG A
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK----EREAFDYG 327
Query: 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP 220
GT +PE+ G + +D+W G +L + + +F +
Sbjct: 328 WVGTVATNSPEILAGDG-YCEITDIWSCGLILLD-------MLSHDFCPIGDG------- 372
Query: 221 PLPGNPSRPFANLINSLLVKD 241
G P + +I+SL V D
Sbjct: 373 --GGKPGKQLLKIIDSLSVCD 391
|
Length = 501 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 57/236 (24%), Positives = 98/236 (41%), Gaps = 38/236 (16%)
Query: 10 IGRGKYSTVYKG---------RKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
+G G + TVYKG + I+ + K+ K ++L E ++ + P V R
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK-EILDEAYVMAGVGSPYVCR 73
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
TS + LV + G L+ +R++ +++ + + + + + YL +++
Sbjct: 74 LLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVH 132
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKL--------SDASKAPSSMLPQAKCGTPCYMAPE 171
DL N+L+ K+ DFGLAR L +D K P +MA E
Sbjct: 133 RDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK-----------WMALE 181
Query: 172 -LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVG---REFTQLVKSILSDPSPPL 222
+ H SD+W G ++E G P+ G RE L++ P PP+
Sbjct: 182 SILHRRFTHQ--SDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 40/186 (21%), Positives = 71/186 (38%), Gaps = 29/186 (15%)
Query: 81 GDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCD 139
L +L + L E+ I + + AL+ LH + K NILL +G KL
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA------KSGNILLTWDGLLKL-- 52
Query: 140 FGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGR 199
G + P+ P +MAPE+ + + +D++ LG LYE
Sbjct: 53 DGSV----------AFKTPEQSRPDPYFMAPEVIQGQSY-TEKADIYSLGITLYEALDYE 101
Query: 200 PPFVG-REFTQLVKSILSDPSPPLPGN--------PSRPFANLINSLLVKDPAQRLHWSD 250
P+ RE + +++ +L+ P + +R F + + + P +R +
Sbjct: 102 LPYNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANH 161
Query: 251 LCGHAF 256
H
Sbjct: 162 YLAHCR 167
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 5e-05
Identities = 36/138 (26%), Positives = 59/138 (42%), Gaps = 19/138 (13%)
Query: 18 VYKGRKKKTIEYFAIKSVDKS-QKSKVLQEVRMLHSL-----DHPNVLRFYSWYETSAHL 71
V K R K + +D+ ++ + +E R++ + P V
Sbjct: 23 VIKWRIPKR---YRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-NFI--- 75
Query: 72 WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE 131
+V+EY G L L+ +L++++ R + LHS GII+ DL SN++L
Sbjct: 76 -IVMEYIEGEPLKDLINS----NGMEELELSREIGRLVGKLHSAGIIHGDLTTSNMIL-S 129
Query: 132 NGRTKLCDFGLARKLSDA 149
G+ L DFGLA D
Sbjct: 130 GGKIYLIDFGLAEFSKDL 147
|
Length = 211 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 9e-05
Identities = 21/73 (28%), Positives = 39/73 (53%), Gaps = 8/73 (10%)
Query: 73 LVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN 132
+V+EY + G + + E+ +L +++ R + LH GI++ DL SNI++ +
Sbjct: 74 IVMEY-IEGKPL------KDVIEEGNDELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D 125
Query: 133 GRTKLCDFGLARK 145
+ L DFGL +
Sbjct: 126 DKLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-04
Identities = 23/68 (33%), Positives = 38/68 (55%), Gaps = 5/68 (7%)
Query: 80 GGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRT-KLC 138
DL L ++N++ I+ + + ++ AL LHS GI++ D+KP NI+ E + K+
Sbjct: 243 VQDLPKGLERENKI----IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKII 298
Query: 139 DFGLARKL 146
D G A L
Sbjct: 299 DLGAAADL 306
|
Length = 566 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 38/146 (26%), Positives = 59/146 (40%), Gaps = 25/146 (17%)
Query: 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-KSQKSKVLQEVRMLHSLDHP--NVLRFY 62
IY G V K R K + +D K ++ + +E R+L V Y
Sbjct: 12 IYLTDFLG-LPAVVKERIPKR---YRHPELDEKLRRERTRREARILAKAREAGVPVPIVY 67
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY----LHSKGII 118
+ + + EY + G+L+ D++ + DL+R + LH GI+
Sbjct: 68 DVDPDNGLIVM--EY-IEGELLK----------DALEEARPDLLREVGRLVGKLHKAGIV 114
Query: 119 YCDLKPSNILLDENGRTKLCDFGLAR 144
+ DL SNI+L GR DFGL
Sbjct: 115 HGDLTTSNIIL-SGGRIYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-04
Identities = 21/71 (29%), Positives = 42/71 (59%), Gaps = 5/71 (7%)
Query: 78 CVGGDLMSLLRQDNQLPEDS-----IRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN 132
C+ +M+ + + +P+D I+ + + ++ L+ LH GI++ D+KP N+L+ +
Sbjct: 286 CLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD 345
Query: 133 GRTKLCDFGLA 143
G+ K+ DFG A
Sbjct: 346 GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 0.001
Identities = 25/76 (32%), Positives = 40/76 (52%), Gaps = 10/76 (13%)
Query: 73 LVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN 132
+V+EY G DL +L + + +R + + + + LH GI++ DL SN ++ +
Sbjct: 413 IVMEYIGGKDLKDVLEGN----PELVRKVGEIVAK----LHKAGIVHGDLTTSNFIVR-D 463
Query: 133 GRTKLCDFGLARKLSD 148
R L DFGL K SD
Sbjct: 464 DRLYLIDFGLG-KYSD 478
|
Length = 535 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.002
Identities = 21/53 (39%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 97 SIRDLAQDLVRA-LQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSD 148
++LA+ LVRA L+ L G + D P NIL+ +GR L DFG+ +L
Sbjct: 265 DRKELAELLVRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317
|
Length = 517 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 25/97 (25%), Positives = 36/97 (37%), Gaps = 8/97 (8%)
Query: 50 LHSLDHPNVLRFYSWYETSA-HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRA 108
LHS+ P L L + LL + +L E + L A
Sbjct: 105 LHSVP-PEALPLARRLRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLAAL-----LA 158
Query: 109 LQYLHSKGIIYCDLKPSNILLDENGR-TKLCDFGLAR 144
L +++ DL P N+L+D GR T + DF A
Sbjct: 159 LLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAG 195
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1335 | |||
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.88 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.87 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.77 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.75 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.6 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.56 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.34 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.32 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.28 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.27 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.22 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.19 | |
| PLN03200 | 2102 | cellulose synthase-interactive protein; Provisiona | 98.18 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.16 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.1 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 98.0 | |
| PLN03200 | 2102 | cellulose synthase-interactive protein; Provisiona | 97.99 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.97 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.83 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.76 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.66 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.6 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.47 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.46 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.45 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.43 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.33 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.31 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.28 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.24 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.23 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.09 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.97 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.89 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.69 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.2 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.05 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.66 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.64 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.54 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.48 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.48 | |
| PLN02236 | 344 | choline kinase | 95.44 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.41 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.21 | |
| cd00020 | 120 | ARM Armadillo/beta-catenin-like repeats. An approx | 95.18 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.94 | |
| cd00020 | 120 | ARM Armadillo/beta-catenin-like repeats. An approx | 94.85 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.76 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.7 | |
| PF13646 | 88 | HEAT_2: HEAT repeats; PDB: 1OYZ_A 3FGA_A 2PF4_C 2I | 93.17 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.8 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.67 | |
| PTZ00384 | 383 | choline kinase; Provisional | 91.89 |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-102 Score=894.71 Aligned_cols=782 Identities=53% Similarity=0.823 Sum_probs=643.3
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHH-----HHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-----KVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e-----~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
|++|.+.+.||+|+||.||+|+.+.|++.||+|.++|..+. .+.+|++|++.++||||+.++++|++..++|+|+
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 79999999999999999999999999999999999876443 4899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|||.| +|+.++..++.++|++++.+..|++.||.|||+++|+|||+||.||+++.+|.+|+||||+|+........
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~v--- 156 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSV--- 156 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCcee---
Confidence 99977 99999999999999999999999999999999999999999999999999999999999999988764332
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
.....|||.|||||++. ++.|+..+|+||+|||+|||+.|++||......++.+.|..++. ..|...+..+.+|++
T Consensus 157 --ltsikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v-~~p~~~S~~f~nfl~ 232 (808)
T KOG0597|consen 157 --LTSIKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV-KPPSTASSSFVNFLQ 232 (808)
T ss_pred --eeeccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC-CCcccccHHHHHHHH
Confidence 34456999999999997 67789999999999999999999999999999999999998764 345688999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccccCCCCCCCCCCccccccc--------------cccc----ccccccCCCCceeCCC
Q 000715 236 SLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKG--------------AVRQ----DENSMLGSTPVRVTPS 297 (1335)
Q Consensus 236 kcLqkDPsKRPTAeEILkHPfFq~~l~~~p~pp~P~f~slk~--------------~v~~----de~s~l~s~pirvtps 297 (1335)
.+|.+||.+|.||.+++.||||+....-...+..+.+.+... ..++ ++.......+.+.++.
T Consensus 233 gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spftn~~Ppe~kek~~kq~srqa~~~~qg~~l~~~~~~~~p~ 312 (808)
T KOG0597|consen 233 GLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFTNNTPPEYKEKDRKQGSRQAENSIQGSKLHETPIKGTPG 312 (808)
T ss_pred HHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCccccCCChHHHHhhhcccCcccCCccccccccccccccCCc
Confidence 999999999999999999999987655433333332222111 1111 1122333445555666
Q ss_pred CCcccccccccccccccCCCCCCcchhhhhhHHHHhhccccccccccccCCCCCCCCCCCcchhcccccccccccCCCCC
Q 000715 298 GRKTQTKTSGRVFEEKQKDPSGTTRQVNLLRLSRIVKSNLQRENDKENYRRPLPNGSENDSEVKIENNDMELDFNENTED 377 (1335)
Q Consensus 298 grk~~tktsgr~feE~~k~~SGTtrqvnL~rlirivks~l~~~~~se~~~~~~P~~s~~dse~tie~~~~e~~~~~~~e~ 377 (1335)
+.+.+.+..++..++.........++.++.++..+-+...+..+..+...++.|+...+.-+.+..+.+++..++.+..-
T Consensus 313 ~~~~k~~l~g~a~E~~~~ls~~a~~~~~~~vl~~~~~~~~~lsg~~aspl~~~p~~ns~t~eV~s~~re~~~t~ddn~df 392 (808)
T KOG0597|consen 313 GSKAKAKLPGRATEEKHGLSPAANRQVNILVLSRIAKANLQLSGEKASPLRPLPNSNSNTAEVKSDNREMELTFDDNNDF 392 (808)
T ss_pred cCcccccCCCcCchhhhcCCCCCCCCcceeeecccchhhhhcccccccccccCCCcCCcceeccCchhhhccCcccccCC
Confidence 66667777888888888877778888888888888788888888888888999999888888888888887778877777
Q ss_pred CCCCCCCCCCCCCCCcccccCCCCCCCCCccCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCcccCCcCCCCCCCCCc
Q 000715 378 ETNDEPDGPDNPNCASEDKLSGQPQHHEKAEETG--RNGNHSGTPSAEGMPVSDESRKQDRESSPERVEVAATPPTVSPQ 455 (1335)
Q Consensus 378 ~~~~~P~~~~~P~~~~~~~~~~qp~~~~~~e~~~--~~~s~~stps~e~~~l~~s~~p~p~tS~p~~~p~a~~~P~~pp~ 455 (1335)
...+++....++.|.-..+.--.++-++...-.. .+-+....... +.-.+.+..-..++-. ..-..-||...++
T Consensus 393 p~~d~~~g~~~~p~v~d~~~~s~~~d~e~q~L~~~~~p~~~~L~~~~---~~l~~~~~c~~aqsek-hn~~~~pp~g~~s 468 (808)
T KOG0597|consen 393 PGPDESEGTENTPCVQDERVMSHNEDHERQRLVSSNVPDENSLANET---PTLGEARDCHEAQSEK-HNMSAAPPSGSPS 468 (808)
T ss_pred cCCCccccccCCCccchhhhcCCcchhHHHHhhhcCCCchhhhcCcC---ccccchhhHHHHHhhh-hccCcCCCcCCcc
Confidence 7777777777777754444333333322111000 00000000000 0001111111111111 1111223333333
Q ss_pred cccccccCCCCCCCCccccccccchhhhcccCCCceeeccCCCcccccccCccCCCCCCccchhhhccCCHHHHHHHHHH
Q 000715 456 LKTTRIREGSGPPLDSESSRSSNSLSQVLWHPSDLSVRPVMPSRKADKVSEVFPSLPFEALKASDFVKMSKEQLDALNAR 535 (1335)
Q Consensus 456 ~k~~~~~~~~~~~~~~~~~~ss~~~~~~~~~~sdl~v~pi~~~~k~~~~~~~~k~l~~~~~~~~~~~~~~~~~~~~f~~~ 535 (1335)
++..+++..||...-.++.| .=+.+.|..|++.++++|..++-++-.. ..+.++ +-.+|++-..|++.+..-+
T Consensus 469 -ga~hq~P~f~p~~~~~ss~a--dss~l~sf~~gls~~ll~g~rhsdes~s--~~~~~~--~~l~fl~~~~Qel~~~~~~ 541 (808)
T KOG0597|consen 469 -GAHHQRPTFGPAVNHDSSKA--DSSLLDSFWSGLSVRLLMGSRHSDESAS--HSLSFE--TPLDFLKKGKQELEPLNNR 541 (808)
T ss_pred -cccCCCCCCCCccccccccC--chhhhhcccCCCCCcccccccccchhcC--Cccccc--cHHHHHHHHHHHhcccccc
Confidence 44455555554444444444 3456777789999999999999876542 223333 3566777778888888888
Q ss_pred HHHhhcCCc-chhhhhhHHHHHHHhcCccchhhHhhcchhHHHHHHHhcccCCchHHHHHHHHHHHHhhccccccccccc
Q 000715 536 ILAVLNGNS-SIGEKQNVIRYLEMLSSNADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLAN 614 (1335)
Q Consensus 536 ~~~~~~~~~-~~~~k~n~~~yl~~v~~~~~~a~~~~~~~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~~~~ 614 (1335)
+..++++.+ .+-+|.|.+.|+++...++++||.+.+.+.|.|+++.+++++.+.+|+++++.||++..|+|-++.|
T Consensus 542 ~~~~~~~~S~~v~~~~n~~~~~~~lk~~Aq~~~~~~~l~~~~llv~~~l~~~~~~~~~~i~~l~y~~~l~~~~~~ld--- 618 (808)
T KOG0597|consen 542 IITVLSGSSSGVSEKQNLIRYLETLKTNAQAANILTNLPIMLLLVKVLLLSKTPAFRVQIASLIYLLILHSTSIELD--- 618 (808)
T ss_pred eeeeecccchhhhhhhHhHHHHHHHHhhcchhhccccccchhhhhhhhhhhcCchhHHHHHHHHHHHHHHhhhhhhh---
Confidence 999998885 8899999999999999999999999999999999999999999999999999999999999999999
Q ss_pred chhhhhhhhhhhhHHHHHHHHHHHhhhhheeeeeecCCccCCCCCCCCCCcCcccccccccchhHHHHHHHHHhcCcchh
Q 000715 615 SGILGSLTDGLRDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDM 694 (1335)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~ge~~~~~~~q~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~~~~~~ 694 (1335)
+.+++|-+.+++-+|+||+.|+.+||+|||+|+|+++. |-.||++|+|--+.++||+ |+|+.
T Consensus 619 --~~~~~~p~~t~~~~~~~r~~~~~~~E~l~~a~s~~e~~-~~~~p~~~~~~t~~~~~v~---------------~~~a~ 680 (808)
T KOG0597|consen 619 --ILDSLTPGLTDKHEKVRRFSMAALGELLFYASSQNEHK-DFKPPESPSKETRSASGVQ---------------GEDAL 680 (808)
T ss_pred --hhcccCCCcCCccchhhccCHHHHHhHHhhhhhhhhhh-hhcCCCCchHHHhHhhhhh---------------hhhhH
Confidence 89999999999999999999999999999999999987 6889999999999999986 57888
Q ss_pred hHHHHHHHHHhhhccCCceeeeeehhhhcccceeeeeccCccceeeccccceeEEEeecCCchhHHHHhhccHHHHHHhh
Q 000715 695 TQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESMRLTAGSCLVRLVRFNAPSMQSVMDKLSIKDIASSL 774 (1335)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 774 (1335)
+.-|+++||||+||+|.-|+-||.++|.+.|+||+|+++ ||-|+|+|+|||-|||+++.+.|-+|++.|+++++|
T Consensus 681 ~l~~~~~t~~~~~s~g~~~~~r~~~~~l~l~~C~l~~~~-----~~~~lg~~~v~l~rln~~~~~~v~~~l~~~~~~~~l 755 (808)
T KOG0597|consen 681 TLVYALRTIENICSQGAYWATRFSSQDLILNLCYLYKAT-----MRQTLGSCLVRLARLNPPCIQTVVEKLSLKEIASSL 755 (808)
T ss_pred HHHHHHhhcchhhccchHHHHHHHHHHHHHhhhheecch-----hhHHHhhhhhhhccccchhhHHHHHHHHHHHHHHHH
Confidence 899999999999999999999999999999999999988 999999999999999999999999999999999999
Q ss_pred hcCCccchhhhhhhhhHHhhhhhhhccccccccccccccccchhhHHhhhcccccc
Q 000715 775 IKGSPREQQISLNLLNLAMLGSQMCTNIGRNLLPLVEDKNLVPSLVSLTEQGSEVL 830 (1335)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (1335)
.++++++|| +.||+|++|.|+ |+.+|||+.+++.+||..|+|.+|.|||.+|+
T Consensus 756 ~~ls~~~~r-~qnl~ng~~~~~--~~~l~~H~~~~tl~~~aa~~L~~i~~qg~~v~ 808 (808)
T KOG0597|consen 756 VKLSAREQR-CQNLLNGAMIGS--FTSLGRHLVTLTLEKNAAPSLLSIIEQGTEVL 808 (808)
T ss_pred HHHHHHHHH-HHhhhhHHHHHH--HHHHhhhhhhHhHhhhhhhhHHHHHhhceeeC
Confidence 999999999 999999999999 99999999999999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=464.86 Aligned_cols=254 Identities=35% Similarity=0.610 Sum_probs=227.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh----------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~----------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~l 71 (1335)
+.|.+.+.||.|+||.|.+|+.+.||+.||||++++.. ...+.+|+++|++|+|||||+++++|+...+.
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 45899999999999999999999999999999997642 23467999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCC---CCeeeccccccccccC
Q 000715 72 WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN---GRTKLCDFGLARKLSD 148 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDed---G~VKLiDFGLAr~l~e 148 (1335)
||||||++||+|++.+..++.+.++..+.+++|++.|+.|||++||+||||||+|||++.+ -.+||+|||+|...++
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~ 331 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE 331 (475)
T ss_pred EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence 9999999999999999999999999999999999999999999999999999999999766 6799999999988764
Q ss_pred CCCCCCCCCCCCccCCCCCCCcchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHhcCC---CCCC
Q 000715 149 ASKAPSSMLPQAKCGTPCYMAPELFEEGG--VHSYASDLWGLGCVLYECYAGRPPFVGREFTQ-LVKSILSDP---SPPL 222 (1335)
Q Consensus 149 ~~~~~ss~l~~t~~GTp~YmAPEVL~~~~--~yS~kSDIWSLGVILYELLTGrpPF~g~d~~e-LikkIl~~~---~~pi 222 (1335)
.. ...+.||||.|.|||++...+ .+..++|+||+||++|.+++|.+||.+..... +.++|..+. .++.
T Consensus 332 ~s------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~ 405 (475)
T KOG0615|consen 332 GS------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQ 405 (475)
T ss_pred ce------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChh
Confidence 32 247799999999999997543 44558999999999999999999999876555 677776654 4556
Q ss_pred CCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 223 PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 223 p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
+..++++..+||++||..||++|||++|+|+||||+...
T Consensus 406 w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 406 WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 778899999999999999999999999999999998754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=470.70 Aligned_cols=258 Identities=38% Similarity=0.702 Sum_probs=238.3
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
+|+.++.||+|||+.||.+++..+|+.||+|++.+. .++++.+||+|.+.|+|||||+++++|++.+++|||.|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 599999999999999999999999999999999773 46789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+|..++|..++++.+.++|.+++.|++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|..+......
T Consensus 99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er---- 174 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER---- 174 (592)
T ss_pred ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999988754332
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
..+.||||.|+|||++. +..+++.+||||+||+||.|++|+|||+..+..+.+.+|.... ..+|...+.++++||.+
T Consensus 175 -k~TlCGTPNYIAPEVl~-k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-Y~~P~~ls~~A~dLI~~ 251 (592)
T KOG0575|consen 175 -KKTLCGTPNYIAPEVLN-KSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-YSMPSHLSAEAKDLIRK 251 (592)
T ss_pred -cceecCCCcccChhHhc-cCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-cccccccCHHHHHHHHH
Confidence 35689999999999997 5667999999999999999999999999999999999987553 45677999999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccccCCCCCCC
Q 000715 237 LLVKDPAQRLHWSDLCGHAFWRTKLTPMPLP 267 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILkHPfFq~~l~~~p~p 267 (1335)
||+.||.+|||+++++.|+||.+...+...|
T Consensus 252 lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 252 LLRPNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred HhcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 9999999999999999999997766655433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=435.77 Aligned_cols=255 Identities=38% Similarity=0.661 Sum_probs=235.5
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|+++++||+|+||+||.++.++|++.||+|++.|. ..+....|..+|.+++||.||+++..|++..++|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 6899999999999999999999999999999998765 3456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||+.||+|+..+++.+.|+|+.++.|+.+|+.||.|||++||+|||+||+|||+|.+|+++|+|||++......+..
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~--- 181 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA--- 181 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999865444332
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
..++|||+.|||||++.+. .|+.++|+||||+++|+|++|.+||.+.+....+++|........|...+.+++++++
T Consensus 182 --t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 182 --TRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred --cccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 3458999999999999754 6788999999999999999999999999999999999988767777889999999999
Q ss_pred HhcccCCCCCC----CHHHHhcCccccccCC
Q 000715 236 SLLVKDPAQRL----HWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 236 kcLqkDPsKRP----TAeEILkHPfFq~~l~ 262 (1335)
++|..||++|. ++.+|.+||||....+
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 99999999996 6899999999986543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=438.42 Aligned_cols=252 Identities=34% Similarity=0.644 Sum_probs=232.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--------hHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--------QKSKVLQEVRMLHSLD-HPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--------~~e~LlrEIqILkkL~-HPNIVrL~dvfeds~~ly 72 (1335)
++|++++.||+|+||+|+.|.+..+|..||+|++++. ..+.+.+|+.+++.+. ||||+++++++.....+|
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 5899999999999999999999999999999988774 2345678999999998 999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCC-CCeeeccccccccccCCCC
Q 000715 73 LVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN-GRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDed-G~VKLiDFGLAr~l~e~~~ 151 (1335)
+|||||.||+|++++.+.+++.|.+++.+|+|+++|++|||++||+||||||+||+++.+ +++||+|||++.....
T Consensus 97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~--- 173 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG--- 173 (370)
T ss_pred EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC---
Confidence 999999999999999999999999999999999999999999999999999999999999 9999999999987641
Q ss_pred CCCCCCCCCccCCCCCCCcchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCC-Chh
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGG-VHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP-SRP 229 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~~-~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~i-S~e 229 (1335)
......+.|||+.|+|||++.... +.+.++||||+|+++|.|++|+.||.+.+...++.+|..+ ...+|..+ +.+
T Consensus 174 --~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~-~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 174 --EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG-EFKIPSYLLSPE 250 (370)
T ss_pred --CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC-CccCCCCcCCHH
Confidence 112356789999999999998777 7789999999999999999999999999999999887665 45677788 999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 230 FANLINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 230 L~DLIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
+.+++.+||..||.+|+|+.+++.||||+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999987
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=430.19 Aligned_cols=250 Identities=33% Similarity=0.609 Sum_probs=232.1
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEc----CchhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSA-HLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiI----dKe~~e~LlrEIqILkkL~HPNIVrL~dvfeds~-~lyLVMEY 77 (1335)
+.+.++.||+|+.|+||+++|+.|++.||+|.+ +....+++.+|+++++..+|||||.+|+.|.+.+ .++++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 456788999999999999999999999999999 4455778999999999999999999999999999 49999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
++||+|.++++..++++|..+..++.++++||.|||+ ++||||||||+|||++..|.|||||||.+..+...
T Consensus 160 MDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS------- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS------- 232 (364)
T ss_pred cCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-------
Confidence 9999999999999999999999999999999999996 99999999999999999999999999999877543
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCCCCCCCCC-CChhH
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-----EFTQLVKSILSDPSPPLPGN-PSRPF 230 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~-----d~~eLikkIl~~~~~pip~~-iS~eL 230 (1335)
...+++||..|||||.+. +..|+.++||||||++++|+..|+.||... ++.+++..|..++.+..|.. +|+++
T Consensus 233 ~a~tfvGT~~YMsPERi~-g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef 311 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERIS-GESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF 311 (364)
T ss_pred hcccccccccccChhhhc-CCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 236789999999999996 557899999999999999999999999875 78899999999988889987 99999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 231 ANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 231 ~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
++||..||++||.+|+|+.|+++|||+++.
T Consensus 312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 999999999999999999999999999764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=433.83 Aligned_cols=259 Identities=37% Similarity=0.618 Sum_probs=234.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLV 74 (1335)
++|.+++.||+|+|++|++|+++.+++.||||+.+|.. .+-+.+|-.+|.+| .||.|+++|..|++...+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 68999999999999999999999999999999998763 23356788889999 999999999999999999999
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC--
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA-- 152 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~-- 152 (1335)
+||+++|+|.++|++.+.|++...+.|+.||+.||+|||++|||||||||+|||+|+||++||.|||.|..+......
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~ 232 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE 232 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999988653322
Q ss_pred ----C--CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 000715 153 ----P--SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP 226 (1335)
Q Consensus 153 ----~--ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~i 226 (1335)
. .......++||..|++||++. +...++.+|+|+||||+|.|+.|.+||.+.+..-++++|+.. ...+|.+.
T Consensus 233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~-~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-~y~fp~~f 310 (604)
T KOG0592|consen 233 NPVDPNQASSRRSSFVGTAEYVSPELLN-DSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-DYEFPEGF 310 (604)
T ss_pred CccCcccccCcccceeeeecccCHHHhc-CCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh-cccCCCCC
Confidence 1 111124589999999999996 567789999999999999999999999999999999999875 34678899
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 000715 227 SRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 227 S~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~ 262 (1335)
++.+.|||+++|..||.+|+|+.+|.+||||.+..+
T Consensus 311 p~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 311 PEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred CHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 999999999999999999999999999999987643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=417.81 Aligned_cols=255 Identities=33% Similarity=0.537 Sum_probs=222.4
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
|++|+.+.++|+|+||.||+|+++.||+.||||.+-.+. ++-..+|+++|++++|||+|.++++|.....+++|+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 899999999999999999999999999999999984332 345689999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|||+..-|.++-.....++++.++.|++|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+.+..++..
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~--- 157 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDN--- 157 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcch---
Confidence 99977666665555668999999999999999999999999999999999999999999999999999998754433
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD------------------ 217 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~------------------ 217 (1335)
.+.++.|.||+|||.+.++..|+..+||||+||++.||++|++.|.+...-++...|...
T Consensus 158 --YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F 235 (396)
T KOG0593|consen 158 --YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF 235 (396)
T ss_pred --hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence 345789999999999999899999999999999999999999999998777666544321
Q ss_pred --CCCCCC----------CCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 218 --PSPPLP----------GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 218 --~~~pip----------~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
...|.+ ...+..+.||+++||..||.+|++.++++.|+||.+.
T Consensus 236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 011111 2346778999999999999999999999999999543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=429.15 Aligned_cols=260 Identities=34% Similarity=0.581 Sum_probs=228.8
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
+++|++++.||+|+||.||+|+.+.||+.||+|++.|+ +.+.+..|-.+|...++|+||++|..|++..++|+|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 47899999999999999999999999999999999765 456678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCC-----
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA----- 149 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~----- 149 (1335)
|||++||++..++.+.+.|+++.++.|+.+++.||..||+.|+|||||||+|+|||..|++||+|||++.-+...
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999999999998654220
Q ss_pred ------------CCCCCCCC-------------------------CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHH
Q 000715 150 ------------SKAPSSML-------------------------PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVL 192 (1335)
Q Consensus 150 ------------~~~~ss~l-------------------------~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVIL 192 (1335)
...+.... ....+|||.|||||++.+.+ |+..+|+|||||||
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIM 378 (550)
T ss_pred hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHH
Confidence 00000000 01347999999999998655 79999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCChhHHHHHHHhcccCCCCCCC---HHHHhcCccccccCC
Q 000715 193 YECYAGRPPFVGREFTQLVKSILSDP---SPPLPGNPSRPFANLINSLLVKDPAQRLH---WSDLCGHAFWRTKLT 262 (1335)
Q Consensus 193 YELLTGrpPF~g~d~~eLikkIl~~~---~~pip~~iS~eL~DLIkkcLqkDPsKRPT---AeEILkHPfFq~~l~ 262 (1335)
||||.|.+||.+++..+.+.+|.... ..|....++++++|||.+||. ||.+|.. ++||.+||||+...+
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 99999999999999999999987543 334445678999999999999 9999975 999999999987654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=420.73 Aligned_cols=254 Identities=39% Similarity=0.724 Sum_probs=229.6
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
+.+|.+.+.||+|+||+||+|+++.++..||||.+.+. ..+.+..|+.+|+.++|||||++++++++++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 46899999999999999999999999999999999776 3556789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCC------CCeeeccccccccccCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN------GRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDed------G~VKLiDFGLAr~l~e~ 149 (1335)
|||.||+|.++|++.+.++|..++.++.||+.|+++||+++||||||||+|||++.+ -.+||+|||+|+.+.+.
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 999999999999999999999999999999999999999999999999999999764 35899999999988743
Q ss_pred CCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCC
Q 000715 150 SKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP--SPPLPGNPS 227 (1335)
Q Consensus 150 ~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~--~~pip~~iS 227 (1335)
. +..+.||+|.|||||++. ...|+.|+|+||+|+|+|+|++|++||...+..++...+..+. .+..+...+
T Consensus 169 ~------~a~tlcGSplYMAPEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s 241 (429)
T KOG0595|consen 169 S------MAETLCGSPLYMAPEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELS 241 (429)
T ss_pred h------HHHHhhCCccccCHHHHH-hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhcc
Confidence 3 235689999999999996 4567889999999999999999999999999999988776543 345566778
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 228 RPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 228 ~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
.++.+++...++.+|.+|.+..+-..|++....+
T Consensus 242 ~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 242 NPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred CchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8899999999999999999999999999876543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=437.42 Aligned_cols=253 Identities=30% Similarity=0.543 Sum_probs=237.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
+=|++++.||+|+.|.|.+|++..||+..|||++.+. ....+.+|+-||+.+.|||++++|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 4599999999999999999999999999999999765 3567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||++||.|++++..+++++|.+++++++||+.|+.|||..+|+|||+||+|+|+|..+++||+|||+|..-.++.
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk----- 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK----- 166 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999997654432
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
+..+.||+|.|.|||++.+..|.+.++||||.|||||.|++|+.||++++...++.++..+. ..+|..++.++.+||.
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~-f~MPs~Is~eaQdLLr 244 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV-FEMPSNISSEAQDLLR 244 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc-ccCCCcCCHHHHHHHH
Confidence 34678999999999999999999999999999999999999999999999999999998774 5678999999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccccC
Q 000715 236 SLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 236 kcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
+||..||.+|+|.+||++|||+....
T Consensus 245 ~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 245 RMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHhccCccccccHHHHhhCchhhcCC
Confidence 99999999999999999999987654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=405.17 Aligned_cols=251 Identities=35% Similarity=0.640 Sum_probs=232.8
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
+++|++++.||.|+||.|.+++++.+|..||+|++++++ .+...+|-++|+.+.||.++++++.+.+.+++|||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 468999999999999999999999999999999998764 45567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|||++||.|+.++++.++|++..++.|+.||+.|++|||+++|++||+||+|||+|.+|++||+|||+|......
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----- 197 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----- 197 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
..+.||||.|+|||++. .+.|+.++|+||||+++|||+.|.+||.+.+..+++++|..+. ..+|...+.++++||
T Consensus 198 ---T~TlCGTPeYLAPEii~-sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~-v~fP~~fs~~~kdLl 272 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQ-SKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK-VKFPSYFSSDAKDLL 272 (355)
T ss_pred ---EEEecCCccccChHHhh-cCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc-ccCCcccCHHHHHHH
Confidence 24589999999999997 4567899999999999999999999999999999999999864 467889999999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCccccccC
Q 000715 235 NSLLVKDPAQRL-----HWSDLCGHAFWRTKL 261 (1335)
Q Consensus 235 kkcLqkDPsKRP-----TAeEILkHPfFq~~l 261 (1335)
+++|+.|-.+|. ..++|..||||++..
T Consensus 273 ~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 273 KKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred HHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 999999999994 478999999998654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=417.70 Aligned_cols=268 Identities=31% Similarity=0.525 Sum_probs=230.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETS--AHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds--~~lyLV 74 (1335)
+.|+.+++||+|.||.||+|++..||+.||+|.+..+. .....+||.||++|+||||+++.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 46888999999999999999999999999999985443 44578999999999999999999988766 789999
Q ss_pred EeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
+||++ .||.-++... -.|++.+++.||+||+.||.|||++||+|||||.+|||||.+|.+||+|||+|+.+.......
T Consensus 197 FeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 197 FEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred Eeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence 99985 6888888764 489999999999999999999999999999999999999999999999999999886655432
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---------C--
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP---------L-- 222 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p---------i-- 222 (1335)
.+..+-|.||+|||.+.+...|+.++|+||.||||.||+.|++.|.+.+..+++++|++....| +
T Consensus 276 ----~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 276 ----YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred ----cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 2446789999999999999999999999999999999999999999999999988886532211 1
Q ss_pred -----------------CCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCCCCCCCCCcccc
Q 000715 223 -----------------PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDS 274 (1335)
Q Consensus 223 -----------------p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~~p~pp~P~f~s 274 (1335)
....+....+|+..||..||.+|.|+.++++|+||...+.+..+...|.+..
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~Lp~y~~ 420 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSSLPKYPP 420 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCcccCCCCCc
Confidence 1234678899999999999999999999999999977666555544444433
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=412.50 Aligned_cols=260 Identities=34% Similarity=0.579 Sum_probs=226.1
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----------------HHHHHHHHHHHHhCCCCCcceEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----------------KSKVLQEVRMLHSLDHPNVLRFYS 63 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----------------~e~LlrEIqILkkL~HPNIVrL~d 63 (1335)
+|+|++.+.||+|.||+|.+|++..+++.||||++++.. .+++.+||.+|+++.|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 589999999999999999999999999999999997642 246889999999999999999999
Q ss_pred EEEeC--CEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccc
Q 000715 64 WYETS--AHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFG 141 (1335)
Q Consensus 64 vfeds--~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFG 141 (1335)
+..+. +++|||+|||..|.+.+.=.....+++.+++.|+++++.||+|||.+||+||||||.|+|++++|++||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 98765 6899999999999887654434449999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCCCCCCCCCccCCCCCCCcchhcc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Q 000715 142 LARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE---GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP 218 (1335)
Q Consensus 142 LAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~---~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~ 218 (1335)
.+..+...............+|||.|+|||.... ..+.+.+.||||+||+||.|+.|+.||.++...+++.+|...+
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP 335 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence 9987754432222222233679999999999875 3456789999999999999999999999999999999998765
Q ss_pred C-CCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 219 S-PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 219 ~-~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
. .|..+.+.+.++|+|.+||.+||++|++..++..|||....
T Consensus 336 L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 336 LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 3 23334579999999999999999999999999999997654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=425.53 Aligned_cols=254 Identities=31% Similarity=0.532 Sum_probs=224.0
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh--HH--HHHHHHHHHHhCC-CCCcceEEEEEEeCC-EEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KS--KVLQEVRMLHSLD-HPNVLRFYSWYETSA-HLWLV 74 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~--~e--~LlrEIqILkkL~-HPNIVrL~dvfeds~-~lyLV 74 (1335)
|++|.++++||.|.||.||+|+.+.+|..||||.+.+.. .+ .-.||++.|++|+ ||||+++.+++.+.. .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 578999999999999999999999999999999886642 22 2368999999998 999999999998887 99999
Q ss_pred EeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
|||+ ..+|+++|+.. ..|++.+++.||+||++||+|+|++|++|||+||||||+..+..+||+|||+|+.......
T Consensus 89 fE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP-- 165 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP-- 165 (538)
T ss_pred HHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC--
Confidence 9997 68999999765 5799999999999999999999999999999999999999888999999999998754332
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC------------
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP------------ 221 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p------------ 221 (1335)
.+.++.|.||+|||++.+.++|+.++|+|++|||++|+.+-++.|.|.+..+++.+|..-...|
T Consensus 166 ----YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La 241 (538)
T KOG0661|consen 166 ----YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA 241 (538)
T ss_pred ----cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence 2568899999999999999999999999999999999999999999999888887775421111
Q ss_pred -----------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 222 -----------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 222 -----------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
+-...+.++.++|.+||.+||++|||+.++++||||+...
T Consensus 242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 1123678899999999999999999999999999998643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=398.64 Aligned_cols=250 Identities=36% Similarity=0.653 Sum_probs=225.9
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
+++|++.+.||+|+||.||+|+++.+++.||+|++.+. ....+.+|++++++++||||+++++++.+.+.+|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 47899999999999999999999999999999998654 234578999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 172 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT---- 172 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc----
Confidence 9999999999999998999999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
...+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+.+..+... ...++...+..+.++|
T Consensus 173 ----~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li 246 (329)
T PTZ00263 173 ----FTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG-RLKFPNWFDGRARDLV 246 (329)
T ss_pred ----ceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CcCCCCCCCHHHHHHH
Confidence 23579999999999864 45688999999999999999999999998888888877655 3456777899999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCcccccc
Q 000715 235 NSLLVKDPAQRLH-----WSDLCGHAFWRTK 260 (1335)
Q Consensus 235 kkcLqkDPsKRPT-----AeEILkHPfFq~~ 260 (1335)
.+||+.||.+|++ +++++.||||.+.
T Consensus 247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 9999999999997 7999999999763
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=389.98 Aligned_cols=249 Identities=35% Similarity=0.617 Sum_probs=224.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|.++.+|+.||+|.+... ....+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 5899999999999999999999999999999998643 2345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||+.|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~----- 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT----- 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-----
Confidence 999999999999998999999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
...+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.... ..++...+..+.++|+
T Consensus 156 ---~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~ 230 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPRHLDLYAKDLIK 230 (291)
T ss_pred ---ccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-cCCCccCCHHHHHHHH
Confidence 23569999999999864 456889999999999999999999999998888888776553 4566778999999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCcccccc
Q 000715 236 SLLVKDPAQRLH-----WSDLCGHAFWRTK 260 (1335)
Q Consensus 236 kcLqkDPsKRPT-----AeEILkHPfFq~~ 260 (1335)
+||+.||.+|++ ++++++||||...
T Consensus 231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 231 KLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 999999999995 9999999999753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=383.73 Aligned_cols=251 Identities=31% Similarity=0.512 Sum_probs=213.9
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
|++|++.+.||+|+||.||+|+++.+++.||+|.+... ....+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 57899999999999999999999999999999988543 23467799999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~-~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|+.+ +|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++........
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~--- 159 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--- 159 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc---
Confidence 9975 8998887654 5899999999999999999999999999999999999999999999999998765332211
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC--------------
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP-------------- 221 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p-------------- 221 (1335)
.....|++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+....+......+
T Consensus 160 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 160 --YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred --ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 1234689999999998766678899999999999999999999999887666554443211000
Q ss_pred ---------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 222 ---------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 222 ---------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.....+.++.+||.+||+.||.+|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 012457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=402.37 Aligned_cols=252 Identities=31% Similarity=0.574 Sum_probs=228.9
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
+|++.+.||+|.||+|.+|+....|+.||||.|.++. .-.+.+|++||..|+||||+.+|++|++.+.+.+|||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 6999999999999999999999999999999997653 3357899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
|..+|+|+|||.+.+.|+|.+++.+|+||.+|+.|||+++++|||+|.+|||+|.++++||+|||++..+....
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k------ 207 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK------ 207 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc------
Confidence 99999999999999999999999999999999999999999999999999999999999999999998876543
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
+.+++||+|.|.+||++.+..|-++.+|-||||+++|.|+.|.+||++.+...++.+|-.+.... ..-+..+.-||++
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrE--P~~PSdA~gLIRw 285 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYRE--PETPSDASGLIRW 285 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccC--CCCCchHHHHHHH
Confidence 24789999999999999988899999999999999999999999999999999999998765322 2334567789999
Q ss_pred hcccCCCCCCCHHHHhcCccccccCCC
Q 000715 237 LLVKDPAQRLHWSDLCGHAFWRTKLTP 263 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILkHPfFq~~l~~ 263 (1335)
||-.||++|.|++||..| ||-++-..
T Consensus 286 mLmVNP~RRATieDiAsH-WWvNwgy~ 311 (668)
T KOG0611|consen 286 MLMVNPERRATIEDIASH-WWVNWGYN 311 (668)
T ss_pred HHhcCcccchhHHHHhhh-heeecccc
Confidence 999999999999999998 55444433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=404.74 Aligned_cols=257 Identities=36% Similarity=0.652 Sum_probs=221.9
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh---HHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---KSKVLQEVRMLHSLDHPNVLRFYSWYETSA--HLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~---~e~LlrEIqILkkL~HPNIVrL~dvfeds~--~lyLVMEY 77 (1335)
+|...+.||+|+||.||++.+.++|..+|+|.+...+ .+.+.+|+++|++++|||||++++...... .++++|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 5788999999999999999999999999999997765 556899999999999999999999754444 69999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC-CCCeeeccccccccccCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE-NGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~-~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe-dG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
+.||+|.+++.+.+ .|+|..++.+.+||++||.|||++||+||||||+|||++. +|.+||+|||++......... .
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~--~ 175 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK--S 175 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc--c
Confidence 99999999999877 8999999999999999999999999999999999999999 799999999999876541111 1
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHh-cCCCCCCCCCCChhHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVG-REFTQLVKSIL-SDPSPPLPGNPSRPFANL 233 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g-~d~~eLikkIl-~~~~~pip~~iS~eL~DL 233 (1335)
.......||+.|||||++..+...++++|||||||++.||+||++||.. ....+.+..+. ....+.+|..+++++++|
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~F 255 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDF 255 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 1123467999999999997644445699999999999999999999987 45444444444 344567899999999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 234 INSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 234 IkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
|.+|+.+||.+|||++++|+|||.+...
T Consensus 256 l~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 256 LRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 9999999999999999999999987643
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=388.58 Aligned_cols=259 Identities=29% Similarity=0.508 Sum_probs=228.0
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
+.+|...+.||+|.||.||+|++..||+.||||.+...+ .....+|++.|+.++|+||+.++++|.+.+.+.+|+
T Consensus 1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 468999999999999999999999999999999986543 235789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
||+ ..+|..+|+.. ..++..+++.|+.|++.|++|||++.|+||||||+|+||+.+|.+||+|||+++.+.......
T Consensus 81 Efm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~- 158 (318)
T KOG0659|consen 81 EFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ- 158 (318)
T ss_pred Eec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccc-
Confidence 998 57999999875 479999999999999999999999999999999999999999999999999999987654432
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC------------
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL------------ 222 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pi------------ 222 (1335)
...+-|.||+|||.+.+.+.|+..+|+||.|||+.||+-|.+.|.+++.-+++..|+.....|-
T Consensus 159 ----~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 159 ----THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ----ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 2236899999999999999999999999999999999999999999988888877764322221
Q ss_pred ---------------CCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCCCC
Q 000715 223 ---------------PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMP 265 (1335)
Q Consensus 223 ---------------p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~~p 265 (1335)
....+.++.||+.+||.+||.+|+|+.|+++|+||++.+.+.+
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP 292 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence 1223677899999999999999999999999999998655443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=391.44 Aligned_cols=246 Identities=35% Similarity=0.608 Sum_probs=219.0
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
+.||+|+||.||+|+++.+|+.||+|++.+. ....+.+|++++++++||||+++++++...+.+|+||||+.|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999999999999998653 2345678999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCc
Q 000715 82 DLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161 (1335)
Q Consensus 82 SL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~ 161 (1335)
+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+||+++.+|.+||+|||++........ .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-----~~~~~ 155 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-----TMKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-----cccce
Confidence 9999999989999999999999999999999999999999999999999999999999999875322211 12346
Q ss_pred cCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccC
Q 000715 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKD 241 (1335)
Q Consensus 162 ~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkD 241 (1335)
+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+.+.......+... ...++...++++.++|.+||..|
T Consensus 156 ~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05571 156 CGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred ecCccccChhhhc-CCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccCC
Confidence 7999999999986 455788999999999999999999999998888777777654 34567788999999999999999
Q ss_pred CCCCC-----CHHHHhcCcccccc
Q 000715 242 PAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 242 PsKRP-----TAeEILkHPfFq~~ 260 (1335)
|++|| ++.++++||||...
T Consensus 234 P~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 234 PKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99999 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=380.88 Aligned_cols=253 Identities=29% Similarity=0.481 Sum_probs=209.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
++|++.+.||+|+||.||+|+++.+++.||+|++.... .....+|+++++.++||||+++++++.+....|+||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 68999999999999999999999999999999986432 34567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+. ++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.........
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---- 159 (303)
T cd07869 85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT---- 159 (303)
T ss_pred CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc----
Confidence 95 677777765 467999999999999999999999999999999999999999999999999998754322111
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc---CCC-CC----------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-FTQLVKSILS---DPS-PP---------- 221 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d-~~eLikkIl~---~~~-~p---------- 221 (1335)
....+|++.|+|||++.+...++.++||||+||++|+|++|..||.+.. ..+....+.. .+. ..
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 160 -YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred -CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 1335689999999998766677889999999999999999999998753 2233332211 000 00
Q ss_pred --------CC---------CCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 222 --------LP---------GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 222 --------ip---------~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
.+ ...+..+.+|+.+||++||.+|||+.++++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 00 0234678999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=377.37 Aligned_cols=251 Identities=31% Similarity=0.517 Sum_probs=212.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
++|++.+.||+|+||.||+|+++.+++.||+|.+... ....+.+|+++++.++||||+++++++...+.+|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 6899999999999999999999999999999988543 24567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
|++++.+..+......+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--- 157 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--- 157 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc---
Confidence 99988887766666789999999999999999999999999999999999999999999999999998764322111
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP------------------ 218 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~------------------ 218 (1335)
.....|++.|+|||++.+ ..++.++|+||+||++|+|++|++||.+.+..+....+....
T Consensus 158 -~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07848 158 -YTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH 235 (287)
T ss_pred -ccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence 123568999999999864 457889999999999999999999998876544332221100
Q ss_pred --CCC-----------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 219 --SPP-----------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 219 --~~p-----------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
..+ .....+.++.+||++||++||++|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 012357789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=418.88 Aligned_cols=254 Identities=34% Similarity=0.616 Sum_probs=229.4
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyL 73 (1335)
+++|.++++||+|+||+|+++..+.+++.||||...|. +.+....|-+|+... +||.++.++..|++.+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 57899999999999999999999999999999988664 466778898888877 59999999999999999999
Q ss_pred EEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
||||+.||+ ...+.+.+.|++..++.|+..++.||.|||++||||||||.+|||+|.+|++||+|||+++.....+.
T Consensus 447 vmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~-- 523 (694)
T KOG0694|consen 447 VMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD-- 523 (694)
T ss_pred EEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCC--
Confidence 999999999 44455668999999999999999999999999999999999999999999999999999986543222
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DL 233 (1335)
...++||||.|||||++. +..|+.++|+|||||+||||+.|+.||.+++.++++..|+.+ .+.+|..++.++.++
T Consensus 524 ---~TsTfCGTpey~aPEil~-e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-~~~yP~~ls~ea~~i 598 (694)
T KOG0694|consen 524 ---RTSTFCGTPEFLAPEVLT-EQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-EVRYPRFLSKEAIAI 598 (694)
T ss_pred ---ccccccCChhhcChhhhc-cCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CCCCCCcccHHHHHH
Confidence 246799999999999996 567899999999999999999999999999999999999876 456889999999999
Q ss_pred HHHhcccCCCCCCC-----HHHHhcCccccccCC
Q 000715 234 INSLLVKDPAQRLH-----WSDLCGHAFWRTKLT 262 (1335)
Q Consensus 234 IkkcLqkDPsKRPT-----AeEILkHPfFq~~l~ 262 (1335)
++++|.++|++|.. +++|..||||++..+
T Consensus 599 l~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 599 MRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred HHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 99999999999975 699999999987553
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=382.86 Aligned_cols=256 Identities=27% Similarity=0.499 Sum_probs=211.1
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS-----AHLW 72 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds-----~~ly 72 (1335)
+|++.+.||+|+||.||+|+++.+|+.||+|.+... ....+.+|++++++++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 699999999999999999999999999999988532 334678999999999999999999987543 3589
Q ss_pred EEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 73 LVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
+||||+ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++........
T Consensus 81 lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 999999 5799999998889999999999999999999999999999999999999999999999999999765332211
Q ss_pred CCCCCCCCccCCCCCCCcchhcc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----------------
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEE-GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL---------------- 215 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~-~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl---------------- 215 (1335)
. ......+||+.|+|||++.. ...++.++|||||||++|+|++|++||.+.+.......+.
T Consensus 160 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 160 A--IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred c--ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 1 11234579999999999864 2567889999999999999999999998766433222111
Q ss_pred -----------cCCCCC---CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 216 -----------SDPSPP---LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 216 -----------~~~~~p---ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
.....+ .....++.+.++|.+||..||++|||++++++||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence 000001 1124577899999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=391.56 Aligned_cols=257 Identities=28% Similarity=0.473 Sum_probs=219.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||+||+|+++.+++.||+|++.+.. ...+.+|+.++.+++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999996532 345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC--
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP-- 153 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~-- 153 (1335)
||++||+|.+++.+.+.+++.+++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999999999998999999999999999999999999999999999999999999999999999987653211000
Q ss_pred ----------------------------CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 000715 154 ----------------------------SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR 205 (1335)
Q Consensus 154 ----------------------------ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~ 205 (1335)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0000123579999999999864 45788999999999999999999999998
Q ss_pred CHHHHHHHHhcCC-CCCCC--CCCChhHHHHHHHhcccCCC---CCCCHHHHhcCcccccc
Q 000715 206 EFTQLVKSILSDP-SPPLP--GNPSRPFANLINSLLVKDPA---QRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 206 d~~eLikkIl~~~-~~pip--~~iS~eL~DLIkkcLqkDPs---KRPTAeEILkHPfFq~~ 260 (1335)
+..+.+.++.... ...+| ...++++.++|.+|+. +|. .||+++++++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 8888888776532 12222 3468999999999775 444 45899999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=391.85 Aligned_cols=257 Identities=31% Similarity=0.545 Sum_probs=220.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|++..+|+.||+|++.+. ....+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 5899999999999999999999999999999998653 2345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC-
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS- 154 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s- 154 (1335)
||+.||+|.+++..++.+++.+++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..+........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999876532211000
Q ss_pred --------------------------------CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 000715 155 --------------------------------SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPF 202 (1335)
Q Consensus 155 --------------------------------s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF 202 (1335)
.......+||+.|+|||++.. ..++.++|||||||++|+|++|.+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCCCCC
Confidence 001113479999999999864 45788999999999999999999999
Q ss_pred CCCCHHHHHHHHhcCC-CCCCC--CCCChhHHHHHHHhcccCCCCCCC---HHHHhcCcccccc
Q 000715 203 VGREFTQLVKSILSDP-SPPLP--GNPSRPFANLINSLLVKDPAQRLH---WSDLCGHAFWRTK 260 (1335)
Q Consensus 203 ~g~d~~eLikkIl~~~-~~pip--~~iS~eL~DLIkkcLqkDPsKRPT---AeEILkHPfFq~~ 260 (1335)
.+.+..+....+.... ....+ ...++++.++|.+||. +|.+|++ +.+++.||||+..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9988887777765422 11222 3468999999999996 9999998 9999999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=386.49 Aligned_cols=250 Identities=31% Similarity=0.528 Sum_probs=221.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|++..+++.||+|++.+. ....+.+|++++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999998654 2345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||++|++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~------- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT------- 153 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-------
Confidence 9999999999999888999999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCC----CCCCh
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP---SPPLP----GNPSR 228 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~---~~pip----~~iS~ 228 (1335)
.....+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+.+..+.... ..+.. ...+.
T Consensus 154 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~ 231 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD 231 (333)
T ss_pred -ccCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCH
Confidence 1234579999999999864 467889999999999999999999999988877766654321 11111 24589
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 229 PFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 229 eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
++.++|.+||..+|++||++.++++||||.+.
T Consensus 232 ~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 232 EAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=397.72 Aligned_cols=241 Identities=36% Similarity=0.644 Sum_probs=216.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcC-----chhHHHHHHHHHHHHhCCCCCcceEEE-EEEeCCE-EEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-----KSQKSKVLQEVRMLHSLDHPNVLRFYS-WYETSAH-LWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiId-----Ke~~e~LlrEIqILkkL~HPNIVrL~d-vfeds~~-lyLV 74 (1335)
.+|++.++||+|+||.||++.+..+|+.+|.|.+. ...+..+..|+.+|++|+|||||++++ .|.+++. +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 35899999999999999999999999999999874 345667889999999999999999998 3444444 8999
Q ss_pred EeecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--CC--CcccCCCCCCeEECCCCCeeeccccccccc
Q 000715 75 LEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHS--KG--IIYCDLKPSNILLDENGRTKLCDFGLARKL 146 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHs--kG--IVHRDIKPENILIDedG~VKLiDFGLAr~l 146 (1335)
||||.+|+|..+|+. +..++|..++.++.|++.||.++|. .. |+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999964 4579999999999999999999999 45 999999999999999999999999999988
Q ss_pred cCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC-CC
Q 000715 147 SDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLP-GN 225 (1335)
Q Consensus 147 ~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip-~~ 225 (1335)
..... .....+|||+||+||++.. ..|++++||||+||++|||..-++||.+++..++.++|..+..+++| ..
T Consensus 179 ~s~~t-----fA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~ 252 (375)
T KOG0591|consen 179 SSKTT-----FAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEH 252 (375)
T ss_pred cchhH-----HHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHH
Confidence 65432 2356789999999999974 56799999999999999999999999999999999999998888888 77
Q ss_pred CChhHHHHHHHhcccCCCCCCCH
Q 000715 226 PSRPFANLINSLLVKDPAQRLHW 248 (1335)
Q Consensus 226 iS~eL~DLIkkcLqkDPsKRPTA 248 (1335)
.|..+..+|..|+..||++||+.
T Consensus 253 YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 253 YSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hhhHHHHHHHHHccCCcccCCCc
Confidence 89999999999999999999985
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=381.22 Aligned_cols=253 Identities=32% Similarity=0.589 Sum_probs=217.4
Q ss_pred cEEEEEEEeccCcEEEEEEEEC---CCCeEEEEEEcCchh-------HHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKK---KTIEYFAIKSVDKSQ-------KSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk---~TGk~VAIKiIdKe~-------~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~l 71 (1335)
+|++.+.||+|+||.||++++. .+++.||+|++.+.. .+.+.+|+++++.+ +||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5999999999999999998874 578999999986532 33567899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCC
Q 000715 72 WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~ 151 (1335)
|+||||+.||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999876543222
Q ss_pred CCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHhcCCCCCCCCCCC
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR----EFTQLVKSILSDPSPPLPGNPS 227 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~----d~~eLikkIl~~~~~pip~~iS 227 (1335)
.. ....+||+.|+|||++.+...++.++|||||||++|+|++|+.||... ........+.. ..++++..++
T Consensus 161 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (332)
T cd05614 161 ER----TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-CDPPFPSFIG 235 (332)
T ss_pred Cc----cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc-CCCCCCCCCC
Confidence 11 123579999999999976556788999999999999999999999653 22333344433 3456677889
Q ss_pred hhHHHHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 000715 228 RPFANLINSLLVKDPAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 228 ~eL~DLIkkcLqkDPsKRP-----TAeEILkHPfFq~~ 260 (1335)
+.+.++|.+||..||++|| +++++++||||++.
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=383.05 Aligned_cols=244 Identities=33% Similarity=0.611 Sum_probs=217.3
Q ss_pred EeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 000715 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDL 83 (1335)
Q Consensus 10 LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL 83 (1335)
||+|+||.||+|++..+++.||+|.+.+. ....+.+|+.++++++||||+++++++...+..|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999998643 234567899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccC
Q 000715 84 MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCG 163 (1335)
Q Consensus 84 ~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~G 163 (1335)
.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++........ .....+|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~g 155 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-----KTNTFCG 155 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-----ccccccC
Confidence 99999888999999999999999999999999999999999999999999999999999875432211 1234679
Q ss_pred CCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCCC
Q 000715 164 TPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPA 243 (1335)
Q Consensus 164 Tp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPs 243 (1335)
|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+.+..+.... ..++...++++.++|.+||..||.
T Consensus 156 t~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~ 233 (312)
T cd05585 156 TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP-LRFPDGFDRDAKDLLIGLLSRDPT 233 (312)
T ss_pred CcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC-CCCCCcCCHHHHHHHHHHcCCCHH
Confidence 999999999864 557889999999999999999999999988888888777653 456778899999999999999999
Q ss_pred CCC---CHHHHhcCcccccc
Q 000715 244 QRL---HWSDLCGHAFWRTK 260 (1335)
Q Consensus 244 KRP---TAeEILkHPfFq~~ 260 (1335)
+|| ++.+++.||||.+.
T Consensus 234 ~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 234 RRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HcCCCCCHHHHHcCCCcCCC
Confidence 997 58999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=390.29 Aligned_cols=250 Identities=31% Similarity=0.568 Sum_probs=223.0
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCC-eEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTI-EYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TG-k~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
+++|++.+.||+|+||.||+|.++.++ ..||+|.+.+. ....+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 368999999999999999999977655 78999988543 24467789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
||||+.||+|.+++..++.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~---- 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR---- 184 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC----
Confidence 9999999999999999899999999999999999999999999999999999999999999999999998765321
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DL 233 (1335)
....+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+....++.+.... ..+|...++.+.++
T Consensus 185 ----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~l 258 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI-IYFPKFLDNNCKHL 258 (340)
T ss_pred ----cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHH
Confidence 123579999999999864 456889999999999999999999999988888788777653 34677889999999
Q ss_pred HHHhcccCCCCCC-----CHHHHhcCcccccc
Q 000715 234 INSLLVKDPAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 234 IkkcLqkDPsKRP-----TAeEILkHPfFq~~ 260 (1335)
|++||+.||.+|+ +++++++||||.+.
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 9999999999995 89999999999864
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=389.69 Aligned_cols=257 Identities=30% Similarity=0.493 Sum_probs=218.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|++..+++.||+|++.+. ....+.+|++++++++||||+++++.+.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 5799999999999999999999999999999998653 2345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC---
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA--- 152 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~--- 152 (1335)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..+......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999999889999999999999999999999999999999999999999999999999997543210000
Q ss_pred -----------------------------------CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh
Q 000715 153 -----------------------------------PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA 197 (1335)
Q Consensus 153 -----------------------------------~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT 197 (1335)
.........+||+.|+|||++. +..++.++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHc-CCCCCcceeeeeccceeeehhh
Confidence 0000012357999999999986 4556889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhcCC---CCCCCCCCChhHHHHHHHhcccCCCCCC---CHHHHhcCcccccc
Q 000715 198 GRPPFVGREFTQLVKSILSDP---SPPLPGNPSRPFANLINSLLVKDPAQRL---HWSDLCGHAFWRTK 260 (1335)
Q Consensus 198 GrpPF~g~d~~eLikkIl~~~---~~pip~~iS~eL~DLIkkcLqkDPsKRP---TAeEILkHPfFq~~ 260 (1335)
|+.||.+.+..+....+.... ..+....+++++.++|.+|+ .+|.+|+ ++.++++||||+..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence 999999988777666554321 12223467899999999976 5999999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=384.18 Aligned_cols=254 Identities=32% Similarity=0.534 Sum_probs=221.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|+++.+|+.||+|.+.+.. ...+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 58999999999999999999999999999999986542 345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
||++|++|.+++.+. +.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..+......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-- 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-- 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce--
Confidence 999999999999876 68999999999999999999999999999999999999999999999999999876443221
Q ss_pred CCCCCCccCCCCCCCcchhcc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---CCCCCCC
Q 000715 155 SMLPQAKCGTPCYMAPELFEE-----GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS---PPLPGNP 226 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~-----~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~---~pip~~i 226 (1335)
......||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+......+.++..... .+.....
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (330)
T cd05601 159 --NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV 236 (330)
T ss_pred --eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence 1223469999999999863 45567899999999999999999999998888777777754321 1223357
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 227 SRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 227 S~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
+.++.++|.+||. ||.+|||+++++.||||...
T Consensus 237 ~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 237 SSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 8999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=385.98 Aligned_cols=257 Identities=35% Similarity=0.608 Sum_probs=223.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|++..+|+.||+|++.+. ....+.+|++++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 5899999999999999999999999999999998653 3445788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC---
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA--- 152 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~--- 152 (1335)
||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999876543200
Q ss_pred ---------------------CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 000715 153 ---------------------PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLV 211 (1335)
Q Consensus 153 ---------------------~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLi 211 (1335)
..........||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 00011234579999999999964 46788999999999999999999999998877777
Q ss_pred HHHhcC---CCCCCCCCCChhHHHHHHHhcccCCCCCCC-HHHHhcCcccccc
Q 000715 212 KSILSD---PSPPLPGNPSRPFANLINSLLVKDPAQRLH-WSDLCGHAFWRTK 260 (1335)
Q Consensus 212 kkIl~~---~~~pip~~iS~eL~DLIkkcLqkDPsKRPT-AeEILkHPfFq~~ 260 (1335)
.++... ...+....+++++.++|.+||. ||.+|++ ++++++||||+..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 776651 1222233469999999999997 9999999 9999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=374.16 Aligned_cols=251 Identities=29% Similarity=0.500 Sum_probs=215.3
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
.|++.+.||+|+||.||+|.+..+|+.||+|.+.+.. ...+.+|++++++++|+||+++++++.+.+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 4899999999999999999999999999999986532 2346789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 77 YCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--- 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---
Confidence 99999999888643 4699999999999999999999999999999999999999999999999999876533211
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcCCCCCCCCCCChhHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ---LVKSILSDPSPPLPGNPSRPFA 231 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~e---LikkIl~~~~~pip~~iS~eL~ 231 (1335)
.....||+.|+|||++. +..++.++||||+||++|+|++|+.||.+..... ............++...+.++.
T Consensus 158 ---~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 233 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVIN-NEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAK 233 (285)
T ss_pred ---ecCCCCCCCccCHhhhc-CCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHH
Confidence 12356999999999996 4567889999999999999999999998765432 2222233334456677899999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCcccccc
Q 000715 232 NLINSLLVKDPAQRLH-----WSDLCGHAFWRTK 260 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPT-----AeEILkHPfFq~~ 260 (1335)
+|+++||+.||.+||+ ++++++||||...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 234 SICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999999999997 8999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=392.75 Aligned_cols=260 Identities=30% Similarity=0.539 Sum_probs=225.8
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEe-----CCEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK-----SQKSKVLQEVRMLHSLDHPNVLRFYSWYET-----SAHLW 72 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK-----e~~e~LlrEIqILkkL~HPNIVrL~dvfed-----s~~ly 72 (1335)
+|...+.||+|+||.|+.|.++.+|+.||||.+.. ...++..+|+++++.++|+||+.+++++.. -+.+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 46667999999999999999999999999999863 346678899999999999999999999865 36799
Q ss_pred EEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 73 LVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
+|+|++ +.+|...|+.++.++++.++.+++||++||+|+|+.||+|||+||.|++++.+..+||||||+|+.....
T Consensus 103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~--- 178 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF--- 178 (359)
T ss_pred EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc---
Confidence 999998 7899999999988999999999999999999999999999999999999999999999999999988654
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----------
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP----------- 221 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p----------- 221 (1335)
......+.++-|.||+|||++.....|+.++||||+|||+.||++|++.|.|.+...+++.|+.-...|
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 112224568899999999999988899999999999999999999999999988776665554311111
Q ss_pred -------------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCCCCC
Q 000715 222 -------------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPL 266 (1335)
Q Consensus 222 -------------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~~p~ 266 (1335)
.....++.+.||+++||..||.+|+|++|+|.|||+...-.+...
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dE 322 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDE 322 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccC
Confidence 123668899999999999999999999999999999876554433
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=389.27 Aligned_cols=257 Identities=31% Similarity=0.540 Sum_probs=218.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|.++.+++.||+|.+.+. ....+.+|++++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 5899999999999999999999999999999988543 2345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC--
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP-- 153 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~-- 153 (1335)
||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.+.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999986432210000
Q ss_pred ---------C-------------------------------CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHH
Q 000715 154 ---------S-------------------------------SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLY 193 (1335)
Q Consensus 154 ---------s-------------------------------s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILY 193 (1335)
. .......+||+.|+|||++.. ..++.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchhhh
Confidence 0 000113579999999999864 55789999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCChhHHHHHHHhcccCCCCC---CCHHHHhcCcccccc
Q 000715 194 ECYAGRPPFVGREFTQLVKSILSDP-SPPLP--GNPSRPFANLINSLLVKDPAQR---LHWSDLCGHAFWRTK 260 (1335)
Q Consensus 194 ELLTGrpPF~g~d~~eLikkIl~~~-~~pip--~~iS~eL~DLIkkcLqkDPsKR---PTAeEILkHPfFq~~ 260 (1335)
+|++|.+||.+.+..+.+..+.... ...++ ..++.++.++|.+||. +|.+| +++.+++.||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999999999988877777775422 12223 3578999999999997 77765 599999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=390.83 Aligned_cols=257 Identities=30% Similarity=0.522 Sum_probs=218.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++++.||+|+||.||+|++..+++.||+|.+.+.. ...+.+|++++++++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999999999986542 346788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC---
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA--- 152 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~--- 152 (1335)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999997643210000
Q ss_pred ---------------------------------------CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHH
Q 000715 153 ---------------------------------------PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLY 193 (1335)
Q Consensus 153 ---------------------------------------~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILY 193 (1335)
.........+||+.|+|||++.+ ..++.++||||+||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHHHH
Confidence 00001123579999999999864 45788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCChhHHHHHHHhcccCCCCCCC---HHHHhcCcccccc
Q 000715 194 ECYAGRPPFVGREFTQLVKSILSDP---SPPLPGNPSRPFANLINSLLVKDPAQRLH---WSDLCGHAFWRTK 260 (1335)
Q Consensus 194 ELLTGrpPF~g~d~~eLikkIl~~~---~~pip~~iS~eL~DLIkkcLqkDPsKRPT---AeEILkHPfFq~~ 260 (1335)
+|++|++||.+.+..+...++.... ..+.....++++.++|.+|+ .+|.+|++ ++++++||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 9999999999988777666665321 22233467899999999976 59999997 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=382.43 Aligned_cols=246 Identities=34% Similarity=0.607 Sum_probs=217.7
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
+.||+|+||.||+++++.+|+.||+|.+.+. ....+.+|+++++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999999999999999998653 2345678999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCc
Q 000715 82 DLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161 (1335)
Q Consensus 82 SL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~ 161 (1335)
+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~ 155 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-----MKTF 155 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc-----cccc
Confidence 99999998889999999999999999999999999999999999999999999999999998753222111 1345
Q ss_pred cCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccC
Q 000715 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKD 241 (1335)
Q Consensus 162 ~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkD 241 (1335)
+||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+.......+.... ..++...++++.++|.+||..|
T Consensus 156 ~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~d 233 (323)
T cd05595 156 CGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKD 233 (323)
T ss_pred cCCcCcCCccccc-CCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccCC
Confidence 7999999999986 4567889999999999999999999999988887777766443 3466788999999999999999
Q ss_pred CCCCC-----CHHHHhcCcccccc
Q 000715 242 PAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 242 PsKRP-----TAeEILkHPfFq~~ 260 (1335)
|++|+ ++.++++|+||.+.
T Consensus 234 P~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 234 PKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred HHHhCCCCCCCHHHHHcCCCcCCC
Confidence 99998 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=388.95 Aligned_cols=267 Identities=30% Similarity=0.475 Sum_probs=230.0
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHH-----HHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-----KVLQEVRMLHSLDHPNVLRFYSWYETS--AHLWL 73 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e-----~LlrEIqILkkL~HPNIVrL~dvfeds--~~lyL 73 (1335)
+++|+.+..|++|+||.||+|+++.|++.||+|.+..+..+ ...+||.+|.+++|||||.+-++.... +.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 46789999999999999999999999999999999765422 357999999999999999999987554 67999
Q ss_pred EEeecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~-~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
|||||+ .+|..++..-+ +|...+++.++.|++.|++|||++.|+|||+||+|+|+++.|.+||+|||+|+.++.+...
T Consensus 155 VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred eHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence 999995 68999998754 8999999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----------
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP----------- 221 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p----------- 221 (1335)
. +..+-|.||+|||.+.+...|+.++|+||+|||+.||+.+++.|.+....+++++|+.....|
T Consensus 234 ~-----T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 234 Y-----TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred C-----cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 2 335689999999999999999999999999999999999999999999888888875422111
Q ss_pred -------------------CCCC-CChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCCCCCCCCCccc
Q 000715 222 -------------------LPGN-PSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFD 273 (1335)
Q Consensus 222 -------------------ip~~-iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~~p~pp~P~f~ 273 (1335)
++.. .++...+|++.+|.+||.+|.|++|.|+|+||.+.+.+.++..-|.+.
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~P 380 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTWP 380 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCCc
Confidence 0111 357889999999999999999999999999999977665544444443
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=390.32 Aligned_cols=258 Identities=29% Similarity=0.464 Sum_probs=216.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
..|++++.||+|+||+||+|++..+++.||+|++.+. ....+.+|++++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 4699999999999999999999999999999998653 2345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC---
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA--- 152 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~--- 152 (1335)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+|++||+|||++..+......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999999889999999999999999999999999999999999999999999999999997643211000
Q ss_pred ---------------------------------------CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHH
Q 000715 153 ---------------------------------------PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLY 193 (1335)
Q Consensus 153 ---------------------------------------~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILY 193 (1335)
.........+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhhHHH
Confidence 00001124579999999999864 45788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCChhHHHHHHHhccc--CCCCCCCHHHHhcCcccccc
Q 000715 194 ECYAGRPPFVGREFTQLVKSILSD---PSPPLPGNPSRPFANLINSLLVK--DPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 194 ELLTGrpPF~g~d~~eLikkIl~~---~~~pip~~iS~eL~DLIkkcLqk--DPsKRPTAeEILkHPfFq~~ 260 (1335)
+|++|..||...+..+....+... ...+....+++++.++|.+|+.. +|..|+++.+++.||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 999999999988776666555432 12222335789999999996654 45559999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=400.76 Aligned_cols=251 Identities=35% Similarity=0.604 Sum_probs=230.6
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK----e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
.|...+.||+|+||.||+|.+..+++.||+|+++- ...+++++|+.++.+++++||.++|+.|..+..+|++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 58888999999999999999999999999999964 35678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
.||++.+.++.+..++|.++..++++++.|+.|||.++.+|||||+.||++..+|.+||+|||.+..+...... .
T Consensus 94 ~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r-----r 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR-----R 168 (467)
T ss_pred cCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc-----c
Confidence 99999999999888899999999999999999999999999999999999999999999999999887654332 3
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhc
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLL 238 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcL 238 (1335)
.+++|||+|||||++. ...|+.++||||||++.|||.+|.+||.+......+..|-+...+.+...+++.+++||..||
T Consensus 169 ~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL 247 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACL 247 (467)
T ss_pred ccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHh
Confidence 6789999999999997 556788999999999999999999999998886666666666677777899999999999999
Q ss_pred ccCCCCCCCHHHHhcCccccc
Q 000715 239 VKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 239 qkDPsKRPTAeEILkHPfFq~ 259 (1335)
.+||+.||+|.++++|+|.+.
T Consensus 248 ~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 248 DKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred hcCcccCcCHHHHhhhHHHHh
Confidence 999999999999999999876
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=379.66 Aligned_cols=251 Identities=34% Similarity=0.591 Sum_probs=220.9
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHP-NVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HP-NIVrL~dvfeds~~lyLVM 75 (1335)
+|++.+.||+|+||.||+|+++.+++.||+|++.+. ....+..|.+++..++|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 599999999999999999999999999999998653 344567899999999765 5888999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---- 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---- 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC----
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864322111
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
.....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+.+..+... ...++...+.++.+++.
T Consensus 157 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~ 233 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH-NVSYPKSLSKEAVSICK 233 (324)
T ss_pred -ceeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHH
Confidence 1234579999999999864 45688999999999999999999999999888888887654 34567788999999999
Q ss_pred HhcccCCCCCCCH-----HHHhcCcccccc
Q 000715 236 SLLVKDPAQRLHW-----SDLCGHAFWRTK 260 (1335)
Q Consensus 236 kcLqkDPsKRPTA-----eEILkHPfFq~~ 260 (1335)
+||.+||.+|++. +++++||||+..
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 234 GLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999976 899999999763
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=383.03 Aligned_cols=246 Identities=35% Similarity=0.618 Sum_probs=217.9
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
+.||+|+||.||+|+++.+|+.||+|++.+. ....+.+|+++++.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999999999999998653 3346778999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCc
Q 000715 82 DLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161 (1335)
Q Consensus 82 SL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~ 161 (1335)
+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........ .....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-----~~~~~ 155 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-----TMKTF 155 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-----ccccc
Confidence 9999998888999999999999999999999999999999999999999999999999999875322111 12345
Q ss_pred cCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccC
Q 000715 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKD 241 (1335)
Q Consensus 162 ~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkD 241 (1335)
+||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+..+....+... ...++...+.++.++|.+||.+|
T Consensus 156 ~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~li~~~L~~d 233 (328)
T cd05593 156 CGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-DIKFPRTLSADAKSLLSGLLIKD 233 (328)
T ss_pred cCCcCccChhhhc-CCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-CccCCCCCCHHHHHHHHHHcCCC
Confidence 7999999999986 445788999999999999999999999988887777776543 34567788999999999999999
Q ss_pred CCCCC-----CHHHHhcCcccccc
Q 000715 242 PAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 242 PsKRP-----TAeEILkHPfFq~~ 260 (1335)
|++|+ ++.++++||||...
T Consensus 234 P~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99997 89999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=396.59 Aligned_cols=251 Identities=31% Similarity=0.564 Sum_probs=226.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLD-HPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~-HPNIVrL~dvfeds~~lyLV 74 (1335)
++|++.+.||+|.||.||+|+++.||+.||+|.+.+.. ...+.+|+++|+++. ||||+.++++|++...+|+|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 36999999999999999999999999999999997653 357899999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC----CCCeeeccccccccccCCC
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE----NGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe----dG~VKLiDFGLAr~l~e~~ 150 (1335)
||+|.||+|++.|... .++|.++..+++|++.+++|||+.||+|||+||+|+|+.. ++.+|++|||++.......
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~ 193 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGE 193 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCc
Confidence 9999999999999887 5999999999999999999999999999999999999953 3589999999998876521
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCCCCCCCC
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD---PSPPLPGNPS 227 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~---~~~pip~~iS 227 (1335)
.....||||.|+|||++.. ..|+..+||||+|+++|.|++|.+||.+.+......++..+ +..+.+..++
T Consensus 194 ------~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 194 ------RLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred ------eEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 1345789999999999963 56799999999999999999999999999988888888765 3445667889
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 228 RPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 228 ~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
..++++|.+||..||.+|+|+.++|+|||++..
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999999999999999999999999998764
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=376.17 Aligned_cols=249 Identities=34% Similarity=0.600 Sum_probs=217.0
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEE
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRML---HSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqIL---kkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
|++.+.||+|+||.||+|.+..+|+.||+|.+.+. ..+.+.+|.+++ ..++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999998653 234566676655 466899999999999999999999
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|||++|++|...+.. +.+++.+++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--- 156 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--- 156 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC---
Confidence 999999999988854 5799999999999999999999999999999999999999999999999999865332211
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
.....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.... ...+...+..+.++|
T Consensus 157 --~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li 232 (324)
T cd05589 157 --RTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE-VRYPRFLSREAISIM 232 (324)
T ss_pred --cccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCCCCHHHHHHH
Confidence 1234679999999999864 567889999999999999999999999998888887776543 346678899999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCcccccc
Q 000715 235 NSLLVKDPAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 235 kkcLqkDPsKRP-----TAeEILkHPfFq~~ 260 (1335)
.+||..||.+|| ++.++++||||++.
T Consensus 233 ~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 233 RRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 999999999999 79999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=379.78 Aligned_cols=247 Identities=32% Similarity=0.605 Sum_probs=210.8
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|+++.+++.||+|++.+. ....+.+|..++.++ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999998653 234567899999888 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
|+|.+++.+.+++++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........ ....
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-----~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-----TTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-----cccc
Confidence 99999998888999999999999999999999999999999999999999999999999999864322111 1234
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHhcCCCCCCCCCCChhHHH
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR--------EFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~--------d~~eLikkIl~~~~~pip~~iS~eL~D 232 (1335)
.+||+.|+|||++.+ ..++.++|+||+||++|+|++|+.||... ...+...+.........|..++..+.+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 234 (329)
T cd05588 156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS 234 (329)
T ss_pred ccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 679999999999864 56788999999999999999999999632 122222222333344567788999999
Q ss_pred HHHHhcccCCCCCCC------HHHHhcCcccccc
Q 000715 233 LINSLLVKDPAQRLH------WSDLCGHAFWRTK 260 (1335)
Q Consensus 233 LIkkcLqkDPsKRPT------AeEILkHPfFq~~ 260 (1335)
+|.+||+.||.+|++ ++++++||||...
T Consensus 235 li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 235 VLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999999987 7999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=372.94 Aligned_cols=255 Identities=29% Similarity=0.485 Sum_probs=214.9
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
|++|.+.+.||+|+||.||+|+++.+++.||+|.+... ....+.+|++++++++||||+++++++...+..|+|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 57899999999999999999999999999999988543 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|+.+ +|.+++... ..+++.+++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.........
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 160 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--- 160 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc---
Confidence 9965 788877654 46899999999999999999999999999999999999999999999999998764332211
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---------------
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP--------------- 220 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~--------------- 220 (1335)
.....+++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+....+......
T Consensus 161 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 161 --YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred --cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 123468999999999876667889999999999999999999999887765554433221000
Q ss_pred --------------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 221 --------------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 221 --------------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
.....+++++.++|.+||+.||.+|||+.|+++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 01124578899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=379.80 Aligned_cols=246 Identities=32% Similarity=0.596 Sum_probs=217.1
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|+++.+++.||+|++.+. ....+.+|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999998653 234566788888776 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++......... ...
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~-----~~~ 155 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT-----TST 155 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc-----ccc
Confidence 999999999889999999999999999999999999999999999999999999999999998754222111 234
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+.+..+.+..+.... ...+...+.++.++|.+||+.
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~ 233 (320)
T cd05590 156 FCGTPDYIAPEILQ-EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLSQDAVDILKAFMTK 233 (320)
T ss_pred cccCccccCHHHHc-CCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccc
Confidence 57999999999986 4567889999999999999999999999999888888877643 345677899999999999999
Q ss_pred CCCCCCCH------HHHhcCcccccc
Q 000715 241 DPAQRLHW------SDLCGHAFWRTK 260 (1335)
Q Consensus 241 DPsKRPTA------eEILkHPfFq~~ 260 (1335)
||.+||++ +++++||||...
T Consensus 234 dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 234 NPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 99999998 999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=381.19 Aligned_cols=246 Identities=35% Similarity=0.617 Sum_probs=217.0
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
+.||+|+||.||+|++..+|+.||+|++.+. ....+.+|++++..++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999999999999999998653 2345678999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 82 DLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 82 SL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
+|.+++.....+++.+++.++.||+.||.|||+ +||+||||||+||+++.+|.+||+|||++......... ...
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-----~~~ 155 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-----MKT 155 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-----ccc
Confidence 999999888899999999999999999999997 79999999999999999999999999998754322111 134
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+... ...++...++++.++|.+||..
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~~~~~~~li~~~L~~ 233 (325)
T cd05594 156 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-EIRFPRTLSPEAKSLLSGLLKK 233 (325)
T ss_pred ccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCHHHHHHHHHHhhc
Confidence 579999999999864 56788999999999999999999999998887777776543 3456778899999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccccc
Q 000715 241 DPAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 241 DPsKRP-----TAeEILkHPfFq~~ 260 (1335)
||++|+ ++.++++||||...
T Consensus 234 dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred CHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 999997 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=378.00 Aligned_cols=246 Identities=33% Similarity=0.561 Sum_probs=217.2
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|+++.+++.||+|++.+. .......|.+++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999998653 234466788888866 899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........ ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-----~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-----TTTT 155 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-----cccc
Confidence 99999999888999999999999999999999999999999999999999999999999999875432221 1234
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+.+..+.+..+.... ...+...+.++.++|.+||.+
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~ll~~~L~~ 233 (321)
T cd05591 156 FCGTPDYIAPEILQ-ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-VLYPVWLSKEAVSILKAFMTK 233 (321)
T ss_pred cccCccccCHHHHc-CCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhcc
Confidence 57999999999986 4567889999999999999999999999999888888877653 345667899999999999999
Q ss_pred CCCCCC-------CHHHHhcCcccccc
Q 000715 241 DPAQRL-------HWSDLCGHAFWRTK 260 (1335)
Q Consensus 241 DPsKRP-------TAeEILkHPfFq~~ 260 (1335)
||++|+ ++.++++||||...
T Consensus 234 dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 234 NPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred CHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 999999 99999999999653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=387.39 Aligned_cols=254 Identities=28% Similarity=0.510 Sum_probs=221.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|+++.+++.||+|.+.+. ....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 5799999999999999999999999999999998653 2334678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~--- 198 (370)
T cd05596 123 EYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV--- 198 (370)
T ss_pred cCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc---
Confidence 99999999998865 46899999999999999999999999999999999999999999999999998765432211
Q ss_pred CCCCCccCCCCCCCcchhccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCC--CCChh
Q 000715 156 MLPQAKCGTPCYMAPELFEEG---GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP-SPPLPG--NPSRP 229 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~---~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~-~~pip~--~iS~e 229 (1335)
.....+||+.|+|||++... ..++.++|||||||++|+|++|++||.+.+....+.++.... ...++. ..+.+
T Consensus 199 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (370)
T cd05596 199 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQ 277 (370)
T ss_pred -cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHH
Confidence 12345799999999998642 357889999999999999999999999998888888876532 222333 57899
Q ss_pred HHHHHHHhcccCCCC--CCCHHHHhcCcccccc
Q 000715 230 FANLINSLLVKDPAQ--RLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 230 L~DLIkkcLqkDPsK--RPTAeEILkHPfFq~~ 260 (1335)
+.++|.+||..+|.+ |+|++++++||||++.
T Consensus 278 ~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 278 AKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 999999999999988 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=406.64 Aligned_cols=251 Identities=31% Similarity=0.585 Sum_probs=225.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
..|...++||+|+.|.||.|+...+++.||||.++.. .++-+.+|+.+|+..+|+|||.+++.|-..+.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4688889999999999999999999999999998654 3556899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
+||+|.|.+... .++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+...... .
T Consensus 353 ~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-----R 426 (550)
T KOG0578|consen 353 EGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-----R 426 (550)
T ss_pred CCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-----c
Confidence 999999988654 5999999999999999999999999999999999999999999999999999988765543 3
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCChhHHHHHHH
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP--PLPGNPSRPFANLINS 236 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~--pip~~iS~eL~DLIkk 236 (1335)
.+.+|||+|||||++. ...|++++||||||++.+||+-|++||..++.-..++.|.....+ ..+..+|+.++||+.+
T Consensus 427 ~TmVGTPYWMAPEVvt-rk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVT-RKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccccCCCCccchhhhh-hcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 4568999999999996 567899999999999999999999999988777777666554433 3567889999999999
Q ss_pred hcccCCCCCCCHHHHhcCccccc
Q 000715 237 LLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
||+.|+++|+++.++|+||||+.
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhhh
Confidence 99999999999999999999954
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=373.52 Aligned_cols=251 Identities=33% Similarity=0.555 Sum_probs=220.6
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVM 75 (1335)
+|++.+.||+|+||.||+|+++.+++.||+|++.+.. ......|..++..+ .|++|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5999999999999999999999999999999986542 23456677887777 6899999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||++||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~---- 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV---- 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC----
Confidence 9999999999999888999999999999999999999999999999999999999999999999999875432211
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
.....+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..++...+.... ..+|...+.++.+++.
T Consensus 157 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 233 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICK 233 (323)
T ss_pred -ccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCCcCCHHHHHHHH
Confidence 1234679999999999964 557889999999999999999999999998888888777543 4567788999999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCcccccc
Q 000715 236 SLLVKDPAQRLH-----WSDLCGHAFWRTK 260 (1335)
Q Consensus 236 kcLqkDPsKRPT-----AeEILkHPfFq~~ 260 (1335)
+||++||++|++ ..++++||||+..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 234 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 999999999997 4899999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=374.38 Aligned_cols=246 Identities=35% Similarity=0.647 Sum_probs=214.4
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHS-LDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkk-L~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|++..+++.||+|.+.+. .......|..++.. .+||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999998653 23345567777665 4899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
|+|.+++...+.+++.+++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++........ ....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-----~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-----KAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC-----cccc
Confidence 99999999888999999999999999999999999999999999999999999999999999875433221 1234
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+... .+.++..++.++.++|.+||..
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~ll~~~l~~ 233 (316)
T cd05592 156 FCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-RPHFPRWISKEAKDCLSKLFER 233 (316)
T ss_pred ccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCHHHHHHHHHHccC
Confidence 679999999999864 45788999999999999999999999999888887776553 4556778899999999999999
Q ss_pred CCCCCCCH-HHHhcCcccccc
Q 000715 241 DPAQRLHW-SDLCGHAFWRTK 260 (1335)
Q Consensus 241 DPsKRPTA-eEILkHPfFq~~ 260 (1335)
||++||++ .++++||||...
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 234 DPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CHHHcCCChHHHHcCcccCCC
Confidence 99999986 589999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=374.50 Aligned_cols=251 Identities=29% Similarity=0.537 Sum_probs=215.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
++|++.+.||+|+||.||++++..+|..||+|.+... ....+.+|++++++++||||+++++++...+.+++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 6899999999999999999999999999999998643 245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHsk-GIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
++|++|.+++.....+++..+..++.|++.||.|||++ +|+||||||+||+++.+|.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------ 158 (331)
T cd06649 85 MDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------ 158 (331)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc------
Confidence 99999999999888999999999999999999999986 69999999999999999999999999987653321
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----------------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSI---------------------- 214 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkI---------------------- 214 (1335)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..++...+
T Consensus 159 -~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -cccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 133569999999999864 45788999999999999999999999876554432221
Q ss_pred ------------------------hcCCCCCC-CCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 215 ------------------------LSDPSPPL-PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 215 ------------------------l~~~~~pi-p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
.....+.. ....++++.+||.+||.+||++|||+.++++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 11111111 12357889999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=376.76 Aligned_cols=247 Identities=34% Similarity=0.615 Sum_probs=217.2
Q ss_pred EEEEeccCcEEEEEEEEC---CCCeEEEEEEcCchh-------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 7 YEAIGRGKYSTVYKGRKK---KTIEYFAIKSVDKSQ-------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk---~TGk~VAIKiIdKe~-------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
++.||+|+||.||++++. .+++.||+|.+.+.. ...+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 578999999986532 2346789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
|+.|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 155 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT----- 155 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-----
Confidence 999999999999989999999999999999999999999999999999999999999999999999875432221
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.... ...+...++.+.++|.+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 233 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-LNLPPYLTPEARDLLKK 233 (323)
T ss_pred cccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHH
Confidence 1234579999999999864 456789999999999999999999999988888777776653 45677889999999999
Q ss_pred hcccCCCCCC-----CHHHHhcCcccccc
Q 000715 237 LLVKDPAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 237 cLqkDPsKRP-----TAeEILkHPfFq~~ 260 (1335)
||.+||++|| +++++++||||...
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 9999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=383.19 Aligned_cols=252 Identities=29% Similarity=0.502 Sum_probs=227.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK-----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK-----e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
++|++.+.||+|.|+.||++.+..||+.||+|+++- ...+++.+|++|-+.|+||||+++++.+......|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 468889999999999999999999999999998853 346778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC---CCCeeeccccccccccCCCCCC
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE---NGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe---dG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
+++|++|..-|.+..-++|..+-.+++||+++|.|+|.+||||||+||+|+++-. ..-+||+|||+|..+....
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~--- 167 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE--- 167 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc---
Confidence 9999999998887788999999999999999999999999999999999999953 3479999999999887322
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCChhH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP---SPPLPGNPSRPF 230 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~---~~pip~~iS~eL 230 (1335)
....+.|||.|||||++.+ ..|+..+|||+.|||+|.|+.|++||.+.+...++++|..+. ..+.+..+++++
T Consensus 168 ---~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A 243 (355)
T KOG0033|consen 168 ---AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA 243 (355)
T ss_pred ---ccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence 1244689999999999974 567889999999999999999999999999999999998654 445678899999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 231 ANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 231 ~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
++||++||..||.+|+|+.|+|+|||..+.
T Consensus 244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 244 KSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999765
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=376.32 Aligned_cols=246 Identities=33% Similarity=0.625 Sum_probs=214.9
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHS-LDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkk-L~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|+++.+|+.||+|.+.+. .......|..++.. .+||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999998653 23446678888775 4999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
|+|.+++..++.+++.++..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++....... ....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-----RAST 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-----ceec
Confidence 99999999888999999999999999999999999999999999999999999999999999864322111 1234
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+... .+..+...+.++.++|.+||..
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05620 156 FCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD-TPHYPRWITKESKDILEKLFER 233 (316)
T ss_pred cCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCCCCHHHHHHHHHHccC
Confidence 679999999999864 45788999999999999999999999998887777776543 3456677899999999999999
Q ss_pred CCCCCCCH-HHHhcCcccccc
Q 000715 241 DPAQRLHW-SDLCGHAFWRTK 260 (1335)
Q Consensus 241 DPsKRPTA-eEILkHPfFq~~ 260 (1335)
||++||++ +++++||||+..
T Consensus 234 dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 234 DPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred CHHHcCCChHHHHcCCCcCCC
Confidence 99999997 689999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=372.87 Aligned_cols=246 Identities=36% Similarity=0.617 Sum_probs=217.1
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||+||+|+++.+++.||+|.+.+. ....+.+|.+++..+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999998754 234567888898887 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
++|.+++.+.+.+++.++..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++........ ....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-----TTST 155 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-----cccc
Confidence 99999999888999999999999999999999999999999999999999999999999999865322211 1233
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+|++.|+|||++. +..++.++|+||+||++|+|++|+.||.+.+..+....+... ....+...+.++.++|.+||..
T Consensus 156 ~~g~~~y~aPE~~~-~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~l~~ 233 (318)
T cd05570 156 FCGTPDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-EVRYPRWLSKEAKSILKSFLTK 233 (318)
T ss_pred eecCccccCHHHhc-CCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcCCHHHHHHHHHHccC
Confidence 57999999999986 456788999999999999999999999998888777776654 3346677899999999999999
Q ss_pred CCCCCCCH-----HHHhcCcccccc
Q 000715 241 DPAQRLHW-----SDLCGHAFWRTK 260 (1335)
Q Consensus 241 DPsKRPTA-----eEILkHPfFq~~ 260 (1335)
||++||++ .+++.||||+..
T Consensus 234 dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 234 NPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999999 999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=388.26 Aligned_cols=260 Identities=32% Similarity=0.577 Sum_probs=227.5
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+.|++...||.|..++||+|+...++..||||+++-++ .+.+.+|++.++.++||||++++..|..+..+|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 57999999999999999999999999999999997543 46789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 78 CVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 78 ~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
+.+|++.++++.. ..++|..|..++++++.||.|||++|.||||||+.||||+.+|.|||+|||.+-.+...+.....
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~ 185 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVT 185 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeE
Confidence 9999999999874 46999999999999999999999999999999999999999999999999988777655432222
Q ss_pred CCCCCccCCCCCCCcch-hccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----C----CCC
Q 000715 156 MLPQAKCGTPCYMAPEL-FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP-----L----PGN 225 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEV-L~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p-----i----p~~ 225 (1335)
.. ++++|||+|||||+ ..+...|+.|+||||||++..||.+|..||......+.+...+.+..+. . ...
T Consensus 186 rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~ 264 (516)
T KOG0582|consen 186 RF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKK 264 (516)
T ss_pred ee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhh
Confidence 22 67899999999999 4555678999999999999999999999999988777665555543331 1 123
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 000715 226 PSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 226 iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~ 262 (1335)
.+..++.+|..||.+||++|||++++++|+||+....
T Consensus 265 ~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 265 FSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred hcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 4678999999999999999999999999999987543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=382.65 Aligned_cols=257 Identities=29% Similarity=0.516 Sum_probs=219.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|.++.+++.||+|++.+. ....+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5799999999999999999999999999999998643 2446778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC---
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA--- 152 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~--- 152 (1335)
||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999999889999999999999999999999999999999999999999999999999998755321100
Q ss_pred ---------------------------CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 000715 153 ---------------------------PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR 205 (1335)
Q Consensus 153 ---------------------------~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~ 205 (1335)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCCCCC
Confidence 00001123579999999999864 55788999999999999999999999999
Q ss_pred CHHHHHHHHhcCC-CCCCC--CCCChhHHHHHHHhcccCCCCCC---CHHHHhcCcccccc
Q 000715 206 EFTQLVKSILSDP-SPPLP--GNPSRPFANLINSLLVKDPAQRL---HWSDLCGHAFWRTK 260 (1335)
Q Consensus 206 d~~eLikkIl~~~-~~pip--~~iS~eL~DLIkkcLqkDPsKRP---TAeEILkHPfFq~~ 260 (1335)
+....+.++.... ...++ ...+.++.++|.+|+ .||.+|+ +++++++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 8888877776422 12222 246889999999987 4999998 48999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=374.60 Aligned_cols=255 Identities=29% Similarity=0.531 Sum_probs=218.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||++++..+++.||+|++.+. ....+.+|+.++..++|+||+++++++.+.+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 5899999999999999999999999999999998653 2344778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 76 EY~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
||+.||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++..+.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~- 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ- 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc-
Confidence 99999999999976 5689999999999999999999999999999999999999999999999999987654332211
Q ss_pred CCCCCCccCCCCCCCcchhcc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-C---CCCCCCC
Q 000715 155 SMLPQAKCGTPCYMAPELFEE----GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP-S---PPLPGNP 226 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~----~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~-~---~pip~~i 226 (1335)
....+||+.|+|||++.. ...++.++||||+||++|+|++|+.||.+....+.+..+.... . ++....+
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 236 (331)
T cd05597 160 ---SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236 (331)
T ss_pred ---ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCC
Confidence 123469999999999863 3457889999999999999999999999988877777765422 1 1222357
Q ss_pred ChhHHHHHHHhcccCCCC--CCCHHHHhcCcccccc
Q 000715 227 SRPFANLINSLLVKDPAQ--RLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 227 S~eL~DLIkkcLqkDPsK--RPTAeEILkHPfFq~~ 260 (1335)
+.++.++|++||..++++ |+++.++++||||...
T Consensus 237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 899999999999765444 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=373.64 Aligned_cols=246 Identities=35% Similarity=0.631 Sum_probs=214.2
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVR-MLHSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIq-ILkkL~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||+||+|+++.+|+.||+|++.+.. ...+.+|.. +++.++||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999986542 233445554 46779999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........ ....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-----~~~~ 155 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-----TTST 155 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-----cccc
Confidence 99999999888999999999999999999999999999999999999999999999999999875422211 1234
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.... ...+...+..+.++|.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 233 (323)
T cd05575 156 FCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LRLKPNISVSARHLLEGLLQK 233 (323)
T ss_pred ccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhhc
Confidence 579999999999864 557889999999999999999999999998888888877654 335567799999999999999
Q ss_pred CCCCCCCH----HHHhcCcccccc
Q 000715 241 DPAQRLHW----SDLCGHAFWRTK 260 (1335)
Q Consensus 241 DPsKRPTA----eEILkHPfFq~~ 260 (1335)
||.+||++ .++++||||...
T Consensus 234 ~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 234 DRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CHHhCCCCCCCHHHHHcCCCcCCC
Confidence 99999987 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=363.11 Aligned_cols=248 Identities=31% Similarity=0.509 Sum_probs=205.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC-CCeEEEEEEcCch-----hHHHHHHHHHHHHhC---CCCCcceEEEEEE-----e
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-TIEYFAIKSVDKS-----QKSKVLQEVRMLHSL---DHPNVLRFYSWYE-----T 67 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~-TGk~VAIKiIdKe-----~~e~LlrEIqILkkL---~HPNIVrL~dvfe-----d 67 (1335)
++|++.+.||+|+||.||+|++.. +++.||+|.+... ......+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 589999999999999999999864 5788999987532 233456777777665 6999999999875 3
Q ss_pred CCEEEEEEeecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccccc
Q 000715 68 SAHLWLVLEYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARK 145 (1335)
Q Consensus 68 s~~lyLVMEY~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~ 145 (1335)
...+++||||+. ++|.+++... ..+++.+++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 456899999995 6899988763 4589999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----
Q 000715 146 LSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP---- 221 (1335)
Q Consensus 146 l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p---- 221 (1335)
..... ......||+.|+|||++.. ..++.++||||+||++|+|++|++||.+....+.+..+......+
T Consensus 160 ~~~~~------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 160 YSFQM------ALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232 (290)
T ss_pred ccCCc------ccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 54321 1234569999999999864 457889999999999999999999999887776666554321100
Q ss_pred ----------------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 222 ----------------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 222 ----------------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.....++.+.+++.+||+.||++|||+.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 112457788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=379.58 Aligned_cols=246 Identities=31% Similarity=0.546 Sum_probs=213.2
Q ss_pred EeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSL---DHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 10 LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL---~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
||+|+||+||+|+++.+++.||+|++.+.. ......|..++... +||||+++++++.....+|+||||+.|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999986542 22345566777665 799999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........ ....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-----~~~~ 155 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-----TTNT 155 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-----CccC
Confidence 99999999989999999999999999999999999999999999999999999999999999875432211 1234
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+.+..+............++++.++|++||..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~ 235 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNR 235 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 67999999999997666678999999999999999999999999988888877765443222345789999999999999
Q ss_pred CCCCCC----CHHHHhcCcccccc
Q 000715 241 DPAQRL----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 241 DPsKRP----TAeEILkHPfFq~~ 260 (1335)
||.+|| ++.++++||||.+.
T Consensus 236 ~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 236 NPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CHHHCCCCCCCHHHHhcCccccCC
Confidence 999998 79999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=374.92 Aligned_cols=247 Identities=36% Similarity=0.640 Sum_probs=210.1
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|+++.+++.||+|++.+. ....+.+|+.++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999998653 234567888888776 899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
|+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++........ ....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-----~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-----TTST 155 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-----cccc
Confidence 99999998888999999999999999999999999999999999999999999999999999875322211 1234
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHhcCCCCCCCCCCChhHHH
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR--------EFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~--------d~~eLikkIl~~~~~pip~~iS~eL~D 232 (1335)
.+||+.|+|||++. +..++.++|||||||++|+|++|+.||... .......+........+|...+..+.+
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 234 (329)
T cd05618 156 FCGTPNYIAPEILR-GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS 234 (329)
T ss_pred ccCCccccCHHHHc-CCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 67999999999986 456788999999999999999999999531 112222222223344577888999999
Q ss_pred HHHHhcccCCCCCCC------HHHHhcCcccccc
Q 000715 233 LINSLLVKDPAQRLH------WSDLCGHAFWRTK 260 (1335)
Q Consensus 233 LIkkcLqkDPsKRPT------AeEILkHPfFq~~ 260 (1335)
+|.+||..||++||+ +.++++||||++.
T Consensus 235 ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 235 VLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=379.15 Aligned_cols=250 Identities=30% Similarity=0.552 Sum_probs=212.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+|+++++.++|+||+++++++...+.+|+||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4688999999999999999999999999999998543 245678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+++++|.+. ...++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+......
T Consensus 154 ~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~----- 224 (353)
T PLN00034 154 MDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP----- 224 (353)
T ss_pred CCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc-----
Confidence 999998653 34678889999999999999999999999999999999999999999999999876432211
Q ss_pred CCCccCCCCCCCcchhcc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCCCCCCCCCChhH
Q 000715 158 PQAKCGTPCYMAPELFEE----GGVHSYASDLWGLGCVLYECYAGRPPFVGRE---FTQLVKSILSDPSPPLPGNPSRPF 230 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~----~~~yS~kSDIWSLGVILYELLTGrpPF~g~d---~~eLikkIl~~~~~pip~~iS~eL 230 (1335)
.....||+.|+|||++.. +.+++.++|||||||++|+|++|+.||.... .......+........+...+.++
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 304 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF 304 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence 123579999999998742 3455679999999999999999999997533 333334444444455667889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 231 ANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 231 ~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
.+||.+||..||++|||+.|+++||||...
T Consensus 305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 305 RHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 999999999999999999999999999875
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=385.46 Aligned_cols=255 Identities=25% Similarity=0.355 Sum_probs=209.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|++++++++||||+++++++......++|||++ ++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~ 167 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KT 167 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CC
Confidence 579999999999999999999999999999997543 35678999999999999999999999999999999998 57
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCc
Q 000715 82 DLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161 (1335)
Q Consensus 82 SL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~ 161 (1335)
+|..++.....+++.+++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......... .....
T Consensus 168 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~----~~~~~ 243 (391)
T PHA03212 168 DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN----KYYGW 243 (391)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc----ccccc
Confidence 89999988889999999999999999999999999999999999999999999999999998754322111 11335
Q ss_pred cCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHhc------------------
Q 000715 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-------FTQLVKSILS------------------ 216 (1335)
Q Consensus 162 ~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d-------~~eLikkIl~------------------ 216 (1335)
+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.... ....+..+..
T Consensus 244 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 244 AGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred cCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 79999999999864 567899999999999999999998875421 1111111110
Q ss_pred --------CC-CCC--CC-----CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCCCC
Q 000715 217 --------DP-SPP--LP-----GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMP 265 (1335)
Q Consensus 217 --------~~-~~p--ip-----~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~~p 265 (1335)
.. ..+ .+ ...+.++.++|.+||+.||.+|||+.|+++||||++...+.+
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~ 387 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYP 387 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCC
Confidence 00 000 00 123567999999999999999999999999999988654433
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=384.28 Aligned_cols=254 Identities=28% Similarity=0.524 Sum_probs=218.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|+++.+++.||+|++.+. ....+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 5799999999999999999999999999999998653 2334678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~--- 198 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV--- 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce---
Confidence 999999999999654 6899999999999999999999999999999999999999999999999999876432211
Q ss_pred CCCCCccCCCCCCCcchhccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCChh
Q 000715 156 MLPQAKCGTPCYMAPELFEEG---GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP-SPPLP--GNPSRP 229 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~---~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~-~~pip--~~iS~e 229 (1335)
.....+||+.|+|||++... ..++.++|+||+||++|+|++|++||.+.+....+.++.... ...++ ..++..
T Consensus 199 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 199 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred -ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 12346799999999998643 347889999999999999999999999998888877776532 22233 356899
Q ss_pred HHHHHHHhcccCCCC--CCCHHHHhcCcccccc
Q 000715 230 FANLINSLLVKDPAQ--RLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 230 L~DLIkkcLqkDPsK--RPTAeEILkHPfFq~~ 260 (1335)
+.+++.+||..++.+ |+++.++++||||+..
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999865544 8999999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=356.16 Aligned_cols=249 Identities=38% Similarity=0.698 Sum_probs=211.9
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHH-----HHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-----KVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e-----~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
|++.+.||+|+||+||++++..+++.||+|.+...... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999765432 2345999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
.+++|.+++...+.+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~-----~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE-----NF 155 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS-----EB
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cc
Confidence 9999999999888999999999999999999999999999999999999999999999999999876421111 12
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCC-C--CCCCCCChhHHH
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE---FTQLVKSILSDPS-P--PLPGNPSRPFAN 232 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d---~~eLikkIl~~~~-~--pip~~iS~eL~D 232 (1335)
....+++.|+|||++.....++.++|+||+|+++|+|++|..||.... ......+...... . ......+..+.+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 345689999999998646678899999999999999999999999873 2333333222110 0 111122489999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+|.+||+.||++||++.++++||||
T Consensus 236 li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=391.60 Aligned_cols=253 Identities=29% Similarity=0.453 Sum_probs=209.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--------CEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETS--------AHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HPNIVrL~dvfeds--------~~lyL 73 (1335)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ....+|+.+++.++||||+++++++... ..+++
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 47999999999999999999999999999999886542 2345799999999999999999877432 24779
Q ss_pred EEeecCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC-CeeeccccccccccC
Q 000715 74 VLEYCVGGDLMSLLR----QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG-RTKLCDFGLARKLSD 148 (1335)
Q Consensus 74 VMEY~eGGSL~dlIk----q~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG-~VKLiDFGLAr~l~e 148 (1335)
||||+++ ++.+++. .+..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.+..
T Consensus 145 vmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 145 VMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223 (440)
T ss_pred EEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence 9999964 6766664 356799999999999999999999999999999999999998665 799999999986643
Q ss_pred CCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---------
Q 000715 149 ASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS--------- 219 (1335)
Q Consensus 149 ~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~--------- 219 (1335)
... ....+||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+.++.....
T Consensus 224 ~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~ 297 (440)
T PTZ00036 224 GQR------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297 (440)
T ss_pred CCC------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 12357899999999987666789999999999999999999999998876655544432100
Q ss_pred -------------------CCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 000715 220 -------------------PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 220 -------------------~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~ 262 (1335)
..+|...++++.+||.+||.+||.+|||+.|+++||||.....
T Consensus 298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 0123456788999999999999999999999999999986543
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=352.11 Aligned_cols=253 Identities=26% Similarity=0.466 Sum_probs=219.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
++|++.+.||+|+||.||.|.+..+++.|++|.+... ....+.+|++++++++||||+++++++......|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999987432 23467889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
||||++|++|.+++...+.+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999987654322111
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCChhHHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~-~~~~pip~~iS~eL~D 232 (1335)
. ......|+..|+|||++.+ ..++.++||||+|+++|+|++|+.||...+......++.. ......+...+..+.+
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (263)
T cd06625 162 T--GMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARN 238 (263)
T ss_pred c--cccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHH
Confidence 1 0123568899999999874 4478899999999999999999999988766655544433 3344567788999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+|.+||..+|++|||+.++++|+||
T Consensus 239 li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 239 FLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=371.37 Aligned_cols=251 Identities=33% Similarity=0.573 Sum_probs=220.0
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLD-HPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~-HPNIVrL~dvfeds~~lyLVM 75 (1335)
+|++.+.||+|+||.||+|+++.+|+.||+|++.+.. ...+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999986532 334677888888885 577888999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||++||+|.+++...+.+++.+++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++........
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~---- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc----
Confidence 9999999999999988999999999999999999999999999999999999999999999999999875432211
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
.....+||+.|+|||++.. ..++.++||||+||++|+|++|++||.+.+.......+.... ...+...+.++.+++.
T Consensus 157 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~ 233 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-VSYPKSLSKEAVSICK 233 (323)
T ss_pred -cccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHH
Confidence 1234579999999999864 557889999999999999999999999998888888776543 3466788999999999
Q ss_pred HhcccCCCCCCC-----HHHHhcCcccccc
Q 000715 236 SLLVKDPAQRLH-----WSDLCGHAFWRTK 260 (1335)
Q Consensus 236 kcLqkDPsKRPT-----AeEILkHPfFq~~ 260 (1335)
+||.+||.+|++ .+++++||||+..
T Consensus 234 ~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 234 GLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999999997 5899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=372.01 Aligned_cols=246 Identities=34% Similarity=0.610 Sum_probs=214.5
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHS-LDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkk-L~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|++..+++.||+|.+.+. .......|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999998654 23445677778776 4999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
|+|.+++.....+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... ...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~ 155 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-----TCT 155 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc-----eee
Confidence 999999998889999999999999999999999999999999999999999999999999998753222111 234
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+.... +..+...+.++.++|.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 233 (316)
T cd05619 156 FCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN-PCYPRWLTREAKDILVKLFVR 233 (316)
T ss_pred ecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHHHhcc
Confidence 579999999999864 457889999999999999999999999988887777765432 345667899999999999999
Q ss_pred CCCCCCCHH-HHhcCcccccc
Q 000715 241 DPAQRLHWS-DLCGHAFWRTK 260 (1335)
Q Consensus 241 DPsKRPTAe-EILkHPfFq~~ 260 (1335)
||++||++. ++++||||+..
T Consensus 234 ~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 234 EPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred CHhhcCCChHHHHcCcccCCC
Confidence 999999996 99999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=393.42 Aligned_cols=255 Identities=31% Similarity=0.576 Sum_probs=234.1
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
=|.+.+.||+|.|+.|.+|++.-||..||||++++.. ...+.+|++.|+.++|||||++|++......+|+|+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3888999999999999999999999999999998865 34689999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEE-CCCCCeeeccccccccccCCCCCCCC
Q 000715 78 CVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILL-DENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 78 ~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILI-DedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
-++|+|+|||.++ ..+.|+-+++||.||+.|+.|||+..+||||+||+||.+ .+-|-|||.|||++..+.++..
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---- 174 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---- 174 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch----
Confidence 9999999999775 579999999999999999999999999999999999876 5669999999999988866543
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
..+.||+..|.|||++.++.|..+++||||||||+|.|+||++||+..+..+.+..|+.- ....|..++.+++|||.
T Consensus 175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC-KYtvPshvS~eCrdLI~ 251 (864)
T KOG4717|consen 175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC-KYTVPSHVSKECRDLIQ 251 (864)
T ss_pred --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc-cccCchhhhHHHHHHHH
Confidence 367899999999999999999999999999999999999999999999999988888753 45678899999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccccCCCC
Q 000715 236 SLLVKDPAQRLHWSDLCGHAFWRTKLTPM 264 (1335)
Q Consensus 236 kcLqkDPsKRPTAeEILkHPfFq~~l~~~ 264 (1335)
.||..||++|.+.++|..|+|++....+.
T Consensus 252 sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 252 SMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred HHHhcCchhhccHHHHhccccccCCCCCc
Confidence 99999999999999999999998765543
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=371.07 Aligned_cols=246 Identities=33% Similarity=0.602 Sum_probs=213.1
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVR-MLHSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIq-ILkkL~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|+++.+|+.||+|++.+. ....+.+|.. +++.++||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4799999999999999999999999998653 2234455554 46779999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........ ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-----~~~~ 155 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-----TTTT 155 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-----Cccc
Confidence 99999999888999999999999999999999999999999999999999999999999999875322111 1234
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+..... ..+...+..+.++|.+||..
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~ll~~ 233 (325)
T cd05604 156 FCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL-VLRPGASLTAWSILEELLEK 233 (325)
T ss_pred ccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc-cCCCCCCHHHHHHHHHHhcc
Confidence 679999999999864 4568899999999999999999999999988888887776532 34456889999999999999
Q ss_pred CCCCCCCH----HHHhcCcccccc
Q 000715 241 DPAQRLHW----SDLCGHAFWRTK 260 (1335)
Q Consensus 241 DPsKRPTA----eEILkHPfFq~~ 260 (1335)
||.+||++ .++++||||...
T Consensus 234 ~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 234 DRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred CHHhcCCCCCCHHHHhcCCCcCCC
Confidence 99999976 699999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=373.40 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=206.4
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSA------ 69 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~------ 69 (1335)
+++|++.+.||+|+||.||+|.+..+|+.||+|.+.+. ....+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46899999999999999999999999999999998542 3456789999999999999999999986543
Q ss_pred EEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCC
Q 000715 70 HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 70 ~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~ 149 (1335)
.+|+||||+.+ ++.+.+. ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 57999999965 5666654 35899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------
Q 000715 150 SKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP----------- 218 (1335)
Q Consensus 150 ~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~----------- 218 (1335)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 177 ~~------~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 177 FM------MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cc------CCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 11 233568999999999864 557889999999999999999999998876544332221100
Q ss_pred ----------CC--------------------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 000715 219 ----------SP--------------------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 219 ----------~~--------------------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~ 262 (1335)
.+ ......+..+.+||.+||..||++|||+.|+++||||.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 00 011123577899999999999999999999999999976443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=369.74 Aligned_cols=248 Identities=34% Similarity=0.615 Sum_probs=211.8
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|++..+++.||+|++.+. ....+.+|..++.++ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999754 234577899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......... ...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-----~~~ 155 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT-----TST 155 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc-----eec
Confidence 999999988889999999999999999999999999999999999999999999999999998753221111 234
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR------EFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~------d~~eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
.+||+.|+|||++. +..++.++|||||||++|+|++|+.||... ...+...+........+|...+..+.++|
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 234 (327)
T cd05617 156 FCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL 234 (327)
T ss_pred ccCCcccCCHHHHC-CCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 67999999999986 456788999999999999999999999642 22233333333334457778899999999
Q ss_pred HHhcccCCCCCCC------HHHHhcCccccccC
Q 000715 235 NSLLVKDPAQRLH------WSDLCGHAFWRTKL 261 (1335)
Q Consensus 235 kkcLqkDPsKRPT------AeEILkHPfFq~~l 261 (1335)
.+||..||.+|++ ++++++||||+...
T Consensus 235 ~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 235 KGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 9999999999997 57999999998643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=378.23 Aligned_cols=254 Identities=27% Similarity=0.448 Sum_probs=216.1
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSA-----HLW 72 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~-----~ly 72 (1335)
+|++.+.||+|+||.||+|.+..+|+.||+|.+... ...++.+|+++++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 588999999999999999999999999999988542 3456789999999999999999999998776 899
Q ss_pred EEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 73 LVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
+||||+. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999985 689998888889999999999999999999999999999999999999999999999999999865432211
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD--------------- 217 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~--------------- 217 (1335)
......+++.|+|||++.+...++.++||||+||++|+|++|++||.+.+..+....+...
T Consensus 160 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 160 ----HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred ----cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 1233468999999999976666889999999999999999999999988766555443211
Q ss_pred --------C-CC-------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 218 --------P-SP-------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 218 --------~-~~-------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
. .+ ......++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 0 00 12234578899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=361.61 Aligned_cols=255 Identities=30% Similarity=0.496 Sum_probs=215.2
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
+++|++.+.||+|+||.||+|+++.+++.||+|.+... ....+.+|+.++++++||||+++++++...+..|+|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 57899999999999999999999999999999988533 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 77 Y~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|+. ++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 160 (301)
T cd07873 85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--- 160 (301)
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc---
Confidence 996 588888765 457899999999999999999999999999999999999999999999999998764332211
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------------
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS---------------- 219 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~---------------- 219 (1335)
.....+++.|+|||++.+...++.++|||||||++|+|++|++||.+.+..+....+.....
T Consensus 161 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 161 --YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred --ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 12245789999999987666678899999999999999999999998876655443321100
Q ss_pred -----C--------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 220 -----P--------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 220 -----~--------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
+ ......++.+.++|.+||+.||.+|||++++++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 01124678899999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=371.51 Aligned_cols=255 Identities=28% Similarity=0.488 Sum_probs=219.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+++++.+++.||+|++.+.. ...+.+|+.++..++|+||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999986532 234678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 76 EY~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
||+.||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-- 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-- 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc--
Confidence 99999999999987 468999999999999999999999999999999999999999999999999998765432211
Q ss_pred CCCCCCccCCCCCCCcchhcc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-C---CCCCCC
Q 000715 155 SMLPQAKCGTPCYMAPELFEE----GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS-P---PLPGNP 226 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~----~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~-~---pip~~i 226 (1335)
.....+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+.+.++..... . .....+
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (332)
T cd05623 159 --QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236 (332)
T ss_pred --eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccC
Confidence 1123579999999999862 34678899999999999999999999999988888887765321 1 223457
Q ss_pred ChhHHHHHHHhcccCCCC--CCCHHHHhcCcccccc
Q 000715 227 SRPFANLINSLLVKDPAQ--RLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 227 S~eL~DLIkkcLqkDPsK--RPTAeEILkHPfFq~~ 260 (1335)
++++.++|.+||..++++ |++++++++||||...
T Consensus 237 s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred CHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 899999999999765554 6899999999999763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=372.96 Aligned_cols=246 Identities=33% Similarity=0.605 Sum_probs=216.5
Q ss_pred EEEeccCcEEEEEEEE---CCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 8 EAIGRGKYSTVYKGRK---KKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 8 K~LGeGgFGtVYkArd---k~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
+.||+|+||.||++++ ..+|+.||+|++.+.. .....+|++++++++||||+++++++.+.+.+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999986 4678999999987542 3346789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQ 159 (1335)
Q Consensus 80 GGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~ 159 (1335)
|++|.+++.+...+++.+++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......... ..
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-----~~ 156 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-----AY 156 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-----ee
Confidence 9999999988889999999999999999999999999999999999999999999999999998765432111 12
Q ss_pred CccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcc
Q 000715 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLV 239 (1335)
Q Consensus 160 t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLq 239 (1335)
..+|++.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+....+.... ...+...++.+.++|.+||+
T Consensus 157 ~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~li~~~l~ 234 (318)
T cd05582 157 SFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRALFK 234 (318)
T ss_pred cccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhh
Confidence 3579999999999864 456889999999999999999999999988888887776543 34667789999999999999
Q ss_pred cCCCCCCC-----HHHHhcCcccccc
Q 000715 240 KDPAQRLH-----WSDLCGHAFWRTK 260 (1335)
Q Consensus 240 kDPsKRPT-----AeEILkHPfFq~~ 260 (1335)
.||++||+ ++++++||||+..
T Consensus 235 ~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 235 RNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred cCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999999 7889999999763
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=379.16 Aligned_cols=254 Identities=29% Similarity=0.518 Sum_probs=218.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|+++.+++.||+|++.+.. ...+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999986532 334678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~--- 198 (371)
T cd05622 123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV--- 198 (371)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc---
Confidence 999999999998654 6899999999999999999999999999999999999999999999999999876432211
Q ss_pred CCCCCccCCCCCCCcchhccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCChh
Q 000715 156 MLPQAKCGTPCYMAPELFEEG---GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP---SPPLPGNPSRP 229 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~---~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~---~~pip~~iS~e 229 (1335)
.....+||+.|+|||++... ..++.++|||||||++|+|++|.+||.+.+....+.++.... ..+.+...+..
T Consensus 199 -~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 199 -RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred -cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 12346799999999998643 347889999999999999999999999998888888876532 22233468999
Q ss_pred HHHHHHHhcccCCCC--CCCHHHHhcCcccccc
Q 000715 230 FANLINSLLVKDPAQ--RLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 230 L~DLIkkcLqkDPsK--RPTAeEILkHPfFq~~ 260 (1335)
+.++|.+||..++.+ |++++++++|+||++.
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999854443 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=372.44 Aligned_cols=250 Identities=26% Similarity=0.507 Sum_probs=210.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS------AH 70 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds------~~ 70 (1335)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+. ....+.+|++++++++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 5899999999999999999999999999999998653 234567899999999999999999987543 45
Q ss_pred EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
.|++||++ |++|.+++. .+.+++.+++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 95 ~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~- 171 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE- 171 (343)
T ss_pred EEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence 79999987 889988775 457999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----------
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP---------- 220 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~---------- 220 (1335)
....+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+......
T Consensus 172 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 172 -------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred -------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 123579999999999976567889999999999999999999999887665544443211000
Q ss_pred ------------C--------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 221 ------------P--------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 221 ------------p--------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
. .....++.+.+||.+||..||.+|||+.+++.||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0 0123466789999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=360.63 Aligned_cols=244 Identities=32% Similarity=0.529 Sum_probs=208.4
Q ss_pred EeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 000715 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDL 83 (1335)
Q Consensus 10 LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL 83 (1335)
||+|+||+||++.++.+++.||+|.+.+.. ...+..|++++++++||||+++++++.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999999999999999986542 23467899999999999999999999999999999999999999
Q ss_pred HHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCC
Q 000715 84 MSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQ 159 (1335)
Q Consensus 84 ~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~ 159 (1335)
.+++.. +..+++.+++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++......... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-----~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-----TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-----cc
Confidence 988743 457999999999999999999999999999999999999999999999999998766443221 23
Q ss_pred CccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF----TQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 160 t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~----~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
...||+.|+|||++.+ ..++.++|+||+||++|+|++|+.||..... ......+... ....+...+..+.+++.
T Consensus 156 ~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~ 233 (280)
T cd05608 156 GYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND-SVTYPDKFSPASKSFCE 233 (280)
T ss_pred ccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc-CCCCcccCCHHHHHHHH
Confidence 3579999999999974 4568899999999999999999999986542 2233333332 33456678999999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCcccccc
Q 000715 236 SLLVKDPAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 236 kcLqkDPsKRP-----TAeEILkHPfFq~~ 260 (1335)
+||+.||++|| +++++++||||+..
T Consensus 234 ~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 234 ALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 99999999999 88999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=369.51 Aligned_cols=245 Identities=35% Similarity=0.640 Sum_probs=213.2
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVR-MLHSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIq-ILkkL~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|++..+++.||+|++.+.. ...+.+|.. +++.++||||+++++++.+.+..|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999986542 233445554 57889999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
++|.+.+.....+++.+++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++........ ....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-----~~~~ 155 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-----TTST 155 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-----cccc
Confidence 99999998888999999999999999999999999999999999999999999999999999875322211 1234
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+..+.+..+.... ...+...+..+.++|.+||+.
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 233 (321)
T cd05603 156 FCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP-LQLPGGKTVAACDLLVGLLHK 233 (321)
T ss_pred ccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCHHHHHHHHHHccC
Confidence 679999999999864 457889999999999999999999999998888888777653 456677889999999999999
Q ss_pred CCCCCCCH----HHHhcCccccc
Q 000715 241 DPAQRLHW----SDLCGHAFWRT 259 (1335)
Q Consensus 241 DPsKRPTA----eEILkHPfFq~ 259 (1335)
||.+|+++ .++++|+||..
T Consensus 234 ~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 234 DQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CHhhcCCCCCCHHHHhCCCCcCC
Confidence 99999875 59999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.34 Aligned_cols=247 Identities=32% Similarity=0.514 Sum_probs=204.2
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----CC
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSL---DHPNVLRFYSWYET-----SA 69 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL---~HPNIVrL~dvfed-----s~ 69 (1335)
+|++.+.||+|+||.||+|+++.+++.||+|.+... ......+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 699999999999999999999999999999988643 123456777777665 79999999998764 34
Q ss_pred EEEEEEeecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccccccc
Q 000715 70 HLWLVLEYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLS 147 (1335)
Q Consensus 70 ~lyLVMEY~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~ 147 (1335)
.+++||||+. ++|.+++... ..+++.+++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 6899999996 5888888764 358999999999999999999999999999999999999999999999999987664
Q ss_pred CCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----C---
Q 000715 148 DASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS----P--- 220 (1335)
Q Consensus 148 e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~----~--- 220 (1335)
.... .....||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+....+...++..... .
T Consensus 160 ~~~~------~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07863 160 CQMA------LTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232 (288)
T ss_pred Cccc------CCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence 3221 123468999999999864 4578899999999999999999999988776655544432100 0
Q ss_pred -------------------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 221 -------------------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 221 -------------------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.....++..+.++|.+||++||++|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0112457788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=369.88 Aligned_cols=251 Identities=30% Similarity=0.568 Sum_probs=214.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
++|++.+.||+|+||.||+|++..++..+|+|.+... ....+.+|++++++++||||+++++++.+.+.+|+||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 6899999999999999999999999999999987543 245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHsk-GIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+.|++|.+++...+.+++..+..++.|++.|+.|||++ +++||||||+||+++.+|.+||+|||++..+....
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~------ 158 (333)
T cd06650 85 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------ 158 (333)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc------
Confidence 99999999999888999999999999999999999985 79999999999999999999999999987653321
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----------------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKS----------------------- 213 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikk----------------------- 213 (1335)
.....|++.|+|||++. +..++.++|+|||||++|+|++|+.||......+....
T Consensus 159 -~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 159 -ANSFVGTRSYMSPERLQ-GTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred -cccCCCCccccCHHHhc-CCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 12356999999999986 45578899999999999999999999976554333211
Q ss_pred ---------------------HhcCCCCCCC-CCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 214 ---------------------ILSDPSPPLP-GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 214 ---------------------Il~~~~~pip-~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
+.....+..+ ...+.++.+||.+||++||++|||+.|++.||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 1111111111 1356789999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=359.86 Aligned_cols=251 Identities=30% Similarity=0.527 Sum_probs=215.2
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
.|++.+.||+|+||.||++.+..+++.||+|.+.+.. ...+.+|+++++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 5999999999999999999999999999999986532 2346789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 77 YCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|++||+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--- 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---
Confidence 99999999888653 4699999999999999999999999999999999999999999999999999876533221
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hcCCCCCCCCCCChhHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSI---LSDPSPPLPGNPSRPFA 231 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkI---l~~~~~pip~~iS~eL~ 231 (1335)
....+|++.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+.......+ ........+...+..+.
T Consensus 158 ---~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR 233 (285)
T ss_pred ---cccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence 123579999999999864 55788999999999999999999999886554332222 22333445667899999
Q ss_pred HHHHHhcccCCCCCC-----CHHHHhcCcccccc
Q 000715 232 NLINSLLVKDPAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 232 DLIkkcLqkDPsKRP-----TAeEILkHPfFq~~ 260 (1335)
+++.+||..||.+|| +++++++||||...
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 999999999999999 89999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=369.86 Aligned_cols=245 Identities=34% Similarity=0.613 Sum_probs=212.3
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVR-MLHSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIq-ILkkL~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|+++.+++.||+|++.+.. ...+.+|.. +++.++||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999986532 223344443 56778999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-----~~~~ 155 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-----TTST 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-----Cccc
Confidence 99999999888999999999999999999999999999999999999999999999999999875432211 1234
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+||+.|+|||++. +..++.++||||+||++|+|++|.+||.+.+..+.+..+.... ...+...+..+.++|.+||++
T Consensus 156 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~l~~ 233 (325)
T cd05602 156 FCGTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQK 233 (325)
T ss_pred ccCCccccCHHHHc-CCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-cCCCCCCCHHHHHHHHHHccc
Confidence 67999999999986 4567889999999999999999999999998888887776553 334567899999999999999
Q ss_pred CCCCCCCHH----HHhcCccccc
Q 000715 241 DPAQRLHWS----DLCGHAFWRT 259 (1335)
Q Consensus 241 DPsKRPTAe----EILkHPfFq~ 259 (1335)
||.+|+++. ++++|+||..
T Consensus 234 ~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 234 DRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CHHHCCCCCCCHHHHhcCcccCC
Confidence 999999865 8999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=345.12 Aligned_cols=249 Identities=31% Similarity=0.600 Sum_probs=218.1
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEEe
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYET-SAHLWLVLE 76 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfed-s~~lyLVME 76 (1335)
+|++.+.||+|+||.||++.++.+++.|++|.+... ..+.+.+|++++++++|||++++++.+.. ...+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 599999999999999999999999999999998543 34467889999999999999999998764 456899999
Q ss_pred ecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 77 YCVGGDLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 77 Y~eGGSL~dlIkq--~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|+++++|.+++.. ...+++.+++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-- 158 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM-- 158 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCc--
Confidence 9999999999976 346899999999999999999999999999999999999999999999999998766432221
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
.....|++.|+|||++.. ..++.++|+||+|+++|+|++|+.||...+.......+.....+..+...++.+.+++
T Consensus 159 ---~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 234 (257)
T cd08223 159 ---ASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELI 234 (257)
T ss_pred ---cccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHH
Confidence 234568999999999864 4567899999999999999999999998887777666666655566677899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccc
Q 000715 235 NSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 235 kkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.+||+.||++|||+.+++.||||
T Consensus 235 ~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 235 ATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHhccCcccCCCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=371.70 Aligned_cols=251 Identities=22% Similarity=0.402 Sum_probs=208.7
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeC------C
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS------A 69 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds------~ 69 (1335)
+++|++.+.||+|+||.||+|++..+++.||+|.+.+. ....+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999999999999999998642 345678899999999999999999987543 4
Q ss_pred EEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCC
Q 000715 70 HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 70 ~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~ 149 (1335)
.+|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 6799999996 467777753 5889999999999999999999999999999999999999999999999999765332
Q ss_pred CCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC--------
Q 000715 150 SKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP-------- 221 (1335)
Q Consensus 150 ~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p-------- 221 (1335)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+.++......+
T Consensus 180 ~------~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 180 F------MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred C------cccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 1 1234579999999999864 557889999999999999999999999887666555543211110
Q ss_pred ---------------------------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 222 ---------------------------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 222 ---------------------------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
.....+..+.++|.+||+.||.+|||+.++++||||....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence 0111346789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=344.23 Aligned_cols=249 Identities=33% Similarity=0.575 Sum_probs=222.9
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK-----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK-----e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+|.+.+.||+|+||.||+|.++.+++.|++|.+.. .....+.+|++++++++||||+++++++...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 58999999999999999999999999999998753 3456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 78 CVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 78 ~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
++|++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--- 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--- 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch---
Confidence 9999999999774 57999999999999999999999999999999999999999999999999998866543221
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
.....|++.|+|||++.. ..++.++|+||||+++|+|++|+.||...+..+....+.....++.+...+.++.+++.
T Consensus 158 --~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd08529 158 --ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLID 234 (256)
T ss_pred --hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence 133568999999999864 45678999999999999999999999998888877877777666777788999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccc
Q 000715 236 SLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 236 kcLqkDPsKRPTAeEILkHPfF 257 (1335)
+||+.+|++||++.+++.|||+
T Consensus 235 ~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 235 QCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHccCCcccCcCHHHHhhCCCC
Confidence 9999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=369.58 Aligned_cols=254 Identities=29% Similarity=0.507 Sum_probs=217.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+++++.+++.||+|++.+. ....+.+|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 6899999999999999999999999999999998653 2234678899999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 76 EY~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
||+.||+|.+++.+ ...+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-- 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-- 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce--
Confidence 99999999999987 568999999999999999999999999999999999999999999999999998766432211
Q ss_pred CCCCCCccCCCCCCCcchhccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCC---CCC
Q 000715 155 SMLPQAKCGTPCYMAPELFEEG----GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP-SPPLP---GNP 226 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~----~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~-~~pip---~~i 226 (1335)
.....+||+.|+|||++... +.++.++||||+||++|+|++|+.||.+.+..+.+.++.... ..+.+ ..+
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 236 (331)
T cd05624 159 --QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236 (331)
T ss_pred --eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccC
Confidence 11235799999999998632 456789999999999999999999999988887777776432 22222 346
Q ss_pred ChhHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 000715 227 SRPFANLINSLLVKDPAQ--RLHWSDLCGHAFWRT 259 (1335)
Q Consensus 227 S~eL~DLIkkcLqkDPsK--RPTAeEILkHPfFq~ 259 (1335)
+.++.++|.+||..++++ |++++++++||||+.
T Consensus 237 ~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 237 SEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred CHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 899999999999876654 468999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=350.85 Aligned_cols=251 Identities=33% Similarity=0.548 Sum_probs=213.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
++|++.+.||+|+||.||+|+++.+|+.||+|.+... ..+.+.+|++++++++|||++++++++.....+++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 5899999999999999999999999999999987532 23456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
|+++++|..++.....+++.+++.++.|++.||.|||++|++||||||+||+++.+|.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---- 156 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---- 156 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc----
Confidence 9999999888877778999999999999999999999999999999999999999999999999999876443211
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---C----------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS---D---------------- 217 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~---~---------------- 217 (1335)
.....++..|+|||++.+...++.++|+||+|+++|+|++|++||.+.+..+....+.. .
T Consensus 157 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 157 -YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred -ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 12345889999999987656678899999999999999999999988765444332211 0
Q ss_pred -CCCC----------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 218 -PSPP----------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 218 -~~~p----------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
...+ .....+..+.+|+.+||..||++|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 012457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=357.20 Aligned_cols=257 Identities=28% Similarity=0.507 Sum_probs=218.5
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh--------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~--------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
+|++.+.||+|+||.||+|.+..+|+.|++|.+.... ...+.+|++++++++|+||+++++++.+.+..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 6999999999999999999999999999999986442 23467899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~-~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
|||+ +++|.+++.... .+++..+..++.||++||.|||++|++||||||+||+++.+|.+||+|||++.........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK- 158 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc-
Confidence 9999 999999998776 8999999999999999999999999999999999999999999999999999876543221
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC------------
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP------------ 221 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p------------ 221 (1335)
.....+++.|+|||.+.....++.++|+||+||++|+|++|.+||.+.+..+.+.++......+
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 159 ----MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred ----ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 1223578899999998665677889999999999999999999998877655554443211000
Q ss_pred ---------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCCCC
Q 000715 222 ---------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMP 265 (1335)
Q Consensus 222 ---------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~~p 265 (1335)
.....+..+.++|.+||.+||++|||+.+++.|+||++...+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 11334678999999999999999999999999999998766554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=348.36 Aligned_cols=254 Identities=29% Similarity=0.522 Sum_probs=220.8
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAH 70 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~ 70 (1335)
+|.+.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588999999999999999999999999999987532 12457789999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999988775322
Q ss_pred CCCC-CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChh
Q 000715 151 KAPS-SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRP 229 (1335)
Q Consensus 151 ~~~s-s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~e 229 (1335)
.... ........|++.|+|||.+.. ..++.++|+||+||++|+|++|+.||.+.+....+.++.....+..+...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1111 111223568999999999864 45678999999999999999999999887766666666555556677788999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 230 FANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 230 L~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+.++|.+||+.||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=362.93 Aligned_cols=248 Identities=28% Similarity=0.505 Sum_probs=196.7
Q ss_pred EEEEeccCcEEEEEEEEC--CCCeEEEEEEcCchh-HHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEeecCCC
Q 000715 7 YEAIGRGKYSTVYKGRKK--KTIEYFAIKSVDKSQ-KSKVLQEVRMLHSLDHPNVLRFYSWYET--SAHLWLVLEYCVGG 81 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk--~TGk~VAIKiIdKe~-~e~LlrEIqILkkL~HPNIVrL~dvfed--s~~lyLVMEY~eGG 81 (1335)
.+.||+|+||.||+|+++ .+++.||+|.+.... ...+.+|++++++++||||+++++++.. ...+|+||||+ ++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CC
Confidence 568999999999999976 467899999986543 3457899999999999999999998854 46789999997 56
Q ss_pred CHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEE----CCCCCeeeccccccccccC
Q 000715 82 DLMSLLRQD---------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILL----DENGRTKLCDFGLARKLSD 148 (1335)
Q Consensus 82 SL~dlIkq~---------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILI----DedG~VKLiDFGLAr~l~e 148 (1335)
+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++.+..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence 888887532 258999999999999999999999999999999999999 4567999999999987644
Q ss_pred CCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHhcCCC
Q 000715 149 ASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF---------TQLVKSILSDPS 219 (1335)
Q Consensus 149 ~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~---------~eLikkIl~~~~ 219 (1335)
...... .....+||+.|+|||++.+...++.++||||+||++|+|++|++||..... ......+.....
T Consensus 165 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07868 165 PLKPLA--DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242 (317)
T ss_pred CCcccc--ccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcC
Confidence 322111 123467899999999997666788999999999999999999999975431 111111111000
Q ss_pred C-------------------------------------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 220 P-------------------------------------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 220 ~-------------------------------------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
. ......+..+.++|.+||+.||.+|||++|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 243 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0011234578899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=372.98 Aligned_cols=253 Identities=32% Similarity=0.552 Sum_probs=228.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-------h----HHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-------Q----KSKVLQEVRMLHSL-DHPNVLRFYSWYETSA 69 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-------~----~e~LlrEIqILkkL-~HPNIVrL~dvfeds~ 69 (1335)
++|.-.+.||+|..+.|.+|.++.+|+.+|+|+++.. + .+.-.+|+.||+++ .||+|+++.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 5788889999999999999999999999999998431 1 23456899999998 8999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCC
Q 000715 70 HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 70 ~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~ 149 (1335)
.+++|+|.++.|.|+|++...-.++|++.+.+|+|+++|+.|||.++|+|||+||+|||++++.++||+|||+++.+..+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCCCCCCCccCCCCCCCcchhc-----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---CCCC
Q 000715 150 SKAPSSMLPQAKCGTPCYMAPELFE-----EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD---PSPP 221 (1335)
Q Consensus 150 ~~~~ss~l~~t~~GTp~YmAPEVL~-----~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~---~~~p 221 (1335)
... ...||||+|+|||.+. +.+.|+..+|+|++|+|||.|+.|.+||......-++..|+.+ +..+
T Consensus 177 ekL------relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 177 EKL------RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred hhH------HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 542 4579999999999985 3566788999999999999999999999998887777777764 3556
Q ss_pred CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 222 ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
.+.+++...+|||.+||+.||.+|+|+.++|.||||...
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 678899999999999999999999999999999999653
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=379.98 Aligned_cols=261 Identities=35% Similarity=0.574 Sum_probs=226.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++++.||.|.-|+||+|+.++++..+|+|+++++. ..+++.|-+||..++||.+..+|..|+.++..|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 46778899999999999999999999999999998864 345677999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCC----
Q 000715 76 EYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA---- 149 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~---- 149 (1335)
|||+||+|..+.+++ +.|++..++.|+.+++.||+|||-.|||+|||||+||||.++|++-|+||.++......
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 999999999998764 57999999999999999999999999999999999999999999999999987543110
Q ss_pred ----------------------------C-C------------------CCCCCCCCCccCCCCCCCcchhccCCCCCch
Q 000715 150 ----------------------------S-K------------------APSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182 (1335)
Q Consensus 150 ----------------------------~-~------------------~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~k 182 (1335)
. . .+.......++||-.|+|||++.+ ...+.+
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~GHgsA 315 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EGHGSA 315 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CCCCch
Confidence 0 0 011122345789999999999975 456889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCCCChhHHHHHHHhcccCCCCCCC----HHHHhcCccc
Q 000715 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP-SPPLPGNPSRPFANLINSLLVKDPAQRLH----WSDLCGHAFW 257 (1335)
Q Consensus 183 SDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~-~~pip~~iS~eL~DLIkkcLqkDPsKRPT----AeEILkHPfF 257 (1335)
+|+|+||+.+|||++|..||.+.+..+.+.+|+..+ ..+-...++..++|||+++|.+||++|.. ++||.+||||
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFF 395 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccc
Confidence 999999999999999999999999999998887643 33333467899999999999999999998 9999999999
Q ss_pred cccCCC
Q 000715 258 RTKLTP 263 (1335)
Q Consensus 258 q~~l~~ 263 (1335)
+...++
T Consensus 396 ~gVnWa 401 (459)
T KOG0610|consen 396 EGVNWA 401 (459)
T ss_pred cCCChh
Confidence 987665
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=386.09 Aligned_cols=253 Identities=30% Similarity=0.482 Sum_probs=223.4
Q ss_pred cEEEEEEEeccCcEEEEEEEECCC-CeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKT-IEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~T-Gk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
.|.+.+.||+|+||.||+|.+..+ ++.|++|.+... ....+.+|+.+++.++||||+++++++...+.+|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 499999999999999999999887 788999977432 2345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 79 VGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 79 eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
+||+|.+++.+ ..++++.++..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..+......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~-- 225 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL-- 225 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc--
Confidence 99999988754 457999999999999999999999999999999999999999999999999999876443211
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
......+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+....+..+...+.+..++.++.++|
T Consensus 226 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 303 (478)
T PTZ00267 226 -DVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALL 303 (478)
T ss_pred -ccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHH
Confidence 11244679999999999864 5678899999999999999999999999988888888877666667778899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccc
Q 000715 235 NSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 235 kkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
.+||..||++||++.+++.|+|++.
T Consensus 304 ~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 304 DPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHhccChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999999999864
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=380.23 Aligned_cols=244 Identities=32% Similarity=0.555 Sum_probs=216.3
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEEEee
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETSA-HLWLVLEY 77 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds~-~lyLVMEY 77 (1335)
..+.+.||+|+||+||+|.++.+.. ||+|++.... .+.+.+|+.+|.+++|||||++++++.... .+++||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 3455679999999999999988533 9999997643 558999999999999999999999999988 79999999
Q ss_pred cCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCCCCCeEECCCC-CeeeccccccccccCCCCCC
Q 000715 78 CVGGDLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYLHSKG-IIYCDLKPSNILLDENG-RTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 78 ~eGGSL~dlIkq--~~~LSEeqIr~I~rQILsGLkYLHskG-IVHRDIKPENILIDedG-~VKLiDFGLAr~l~e~~~~~ 153 (1335)
+++|+|.+++.. ...++...+..|+.||+.|+.|||+++ ||||||||+|||++.++ ++||+|||+++........
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~- 200 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS- 200 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccccc-
Confidence 999999999988 679999999999999999999999999 99999999999999998 9999999999877653211
Q ss_pred CCCCCCCccCCCCCCCcchhcc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCCCCCChhHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEE-GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL-SDPSPPLPGNPSRPFA 231 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~-~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl-~~~~~pip~~iS~eL~ 231 (1335)
.....||+.|||||++.+ ...|+.++||||||+++|||++|+.||.+....+....+. ...++.+|..+++.+.
T Consensus 201 ----~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~ 276 (362)
T KOG0192|consen 201 ----MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLS 276 (362)
T ss_pred ----ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 122569999999999975 3578999999999999999999999999998877666664 6677888888999999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 000715 232 NLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPTAeEILk 253 (1335)
.++++||..||.+||+..+++.
T Consensus 277 ~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 277 SLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999864
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=350.55 Aligned_cols=249 Identities=28% Similarity=0.466 Sum_probs=209.2
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+|++.+.||+|+||.||+|++..+++.||+|.+... ....+.+|+.++++++||||+++++++.+...+|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 599999999999999999999999999999987532 235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 78 CVGGDLMSLLRQD---NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 78 ~eGGSL~dlIkq~---~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
+. ++|.+++... ..+++.+++.++.|++.||.|||++|++||||||+||+++.+|.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-- 157 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV-- 157 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc--
Confidence 96 6888887642 56999999999999999999999999999999999999999999999999998765332111
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----------------
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP---------------- 218 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~---------------- 218 (1335)
.....+++.|+|||++.+...++.++|+|||||++|+|++|++||.+....+....+....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 158 ---YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred ---ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 1234578999999998766667889999999999999999999998765443322221100
Q ss_pred ------------CCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 219 ------------SPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 219 ------------~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.......+++++.++|.+||..||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 001123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=354.46 Aligned_cols=249 Identities=37% Similarity=0.647 Sum_probs=223.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||++.+..+++.||+|.+.+. ....+.+|++++++++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 5899999999999999999999999999999998643 3456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||+.+++|.+++...+.+++..+..++.|++.||.|||++|++||||+|.||+++.+|.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999999999999899999999999999999999999999999999999999999999999999998766432
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
....+|++.|+|||.+.. ..++.++|+||||+++|+|++|+.||...+.......+... ..+++...+..+.++|.
T Consensus 155 --~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~ 230 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-KVRFPSFFSPDAKDLIR 230 (290)
T ss_pred --CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CccCCccCCHHHHHHHH
Confidence 123468999999999864 45678999999999999999999999888876666666543 34567778999999999
Q ss_pred HhcccCCCCCC-----CHHHHhcCcccccc
Q 000715 236 SLLVKDPAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 236 kcLqkDPsKRP-----TAeEILkHPfFq~~ 260 (1335)
+||..||.+|+ +++++++||||+..
T Consensus 231 ~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 231 NLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 99999999999 89999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=368.26 Aligned_cols=251 Identities=23% Similarity=0.405 Sum_probs=206.8
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeC------C
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS------A 69 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds------~ 69 (1335)
+++|++.+.||+|+||.||+|++..+++.||+|.+.+. ....+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 46899999999999999999999999999999998642 345677899999999999999999988644 3
Q ss_pred EEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCC
Q 000715 70 HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 70 ~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~ 149 (1335)
..|+||||+++ ++.+.+.. .+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++.....
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 57999999965 66666643 5899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------
Q 000715 150 SKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS---------- 219 (1335)
Q Consensus 150 ~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~---------- 219 (1335)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 173 ~~------~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 173 FM------MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cc------cCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 11 234579999999999864 4578899999999999999999999988775544433221100
Q ss_pred -------------------------------CCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 220 -------------------------------PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 220 -------------------------------~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
...+...+..+.++|.+||..||++|||+.|+++||||....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 001122356789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=344.60 Aligned_cols=255 Identities=31% Similarity=0.596 Sum_probs=221.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
++|++.+.||.|+||.||+|.+..++..+++|.+... ....+.+|+.+++.++|+||+++++.+......|+||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 5899999999999999999999999999999998543 346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 78 CVGGDLMSLLRQD---NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 78 ~eGGSL~dlIkq~---~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
++|++|.+++... ..+++..++.++.|++.|+.|||++|++||||||+||++++++.+||+|||++..+........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR 160 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence 9999999999764 4689999999999999999999999999999999999999999999999999987765433211
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC-----CCCChh
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLP-----GNPSRP 229 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip-----~~iS~e 229 (1335)
.......|+..|+|||++.....++.++|+||||+++|+|++|+.||...+....+.+.........+ ...+..
T Consensus 161 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06610 161 -KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239 (267)
T ss_pred -cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHH
Confidence 11234578999999999876556788999999999999999999999887766666665544322222 256788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 230 FANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 230 L~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+.+++.+||..||++|||+.+++.||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 240 FRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=375.51 Aligned_cols=255 Identities=32% Similarity=0.533 Sum_probs=220.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCC-cceEEEEEEeCC------
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPN-VLRFYSWYETSA------ 69 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPN-IVrL~dvfeds~------ 69 (1335)
..|..++.||+|+||+||+|+.+.+|+.||+|.+.-+. .....+|+.+++.++|+| |+.+++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45777888999999999999999999999999985432 345689999999999999 999999998877
Q ss_pred EEEEEEeecCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccccc
Q 000715 70 HLWLVLEYCVGGDLMSLLRQDN----QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARK 145 (1335)
Q Consensus 70 ~lyLVMEY~eGGSL~dlIkq~~----~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~ 145 (1335)
.+++|+||. ..+|.+++.... .++...++.+++||+.||.|||++||+||||||+||+|+++|.+||+|||+|+.
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 899999997 679999998765 588899999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC----
Q 000715 146 LSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP---- 221 (1335)
Q Consensus 146 l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p---- 221 (1335)
+.-+... ....++|.||+|||++.+...|+..+||||+|||++||+++++.|.+....++...|......|
T Consensus 170 ~~ip~~~-----yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 170 FSIPMRT-----YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hcCCccc-----ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 7544332 2446799999999999988889999999999999999999999999998888887775422111
Q ss_pred -------------CC------------CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 000715 222 -------------LP------------GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 222 -------------ip------------~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~ 262 (1335)
++ ...++...+++.+||+.+|.+|.|+..++.||||.....
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 11 111357889999999999999999999999999987644
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=383.62 Aligned_cols=251 Identities=21% Similarity=0.405 Sum_probs=202.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCC------CCcceEEEEEEeC-CEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDH------PNVLRFYSWYETS-AHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~H------PNIVrL~dvfeds-~~ly 72 (1335)
++|++.+.||+|+||+||+|.+..+++.||||++... .......|+++++.+.| ++++++++++... .++|
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 5799999999999999999999999999999998642 23345667777777654 4588899988765 5789
Q ss_pred EEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCC----------------Ce
Q 000715 73 LVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENG----------------RT 135 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG----------------~V 135 (1335)
+|||++ |++|.+++.+.+.+++.+++.++.||+.||.|||+ .||+||||||+|||++.++ .+
T Consensus 209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~v 287 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287 (467)
T ss_pred EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceE
Confidence 999987 88999999888899999999999999999999998 5999999999999998765 49
Q ss_pred eeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q 000715 136 KLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL 215 (1335)
Q Consensus 136 KLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl 215 (1335)
||+|||.+...... ....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+....+.
T Consensus 288 kl~DfG~~~~~~~~--------~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~ 358 (467)
T PTZ00284 288 RICDLGGCCDERHS--------RTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLME 358 (467)
T ss_pred EECCCCccccCccc--------cccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999987543211 234679999999999964 567889999999999999999999998877655443322
Q ss_pred cCCCC--------------------------CC---------------CCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 216 SDPSP--------------------------PL---------------PGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 216 ~~~~~--------------------------pi---------------p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
..... .. ....++.+.|||.+||++||.+|||++|+++|
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 11000 00 00113557799999999999999999999999
Q ss_pred ccccccCC
Q 000715 255 AFWRTKLT 262 (1335)
Q Consensus 255 PfFq~~l~ 262 (1335)
|||.....
T Consensus 439 p~~~~~~~ 446 (467)
T PTZ00284 439 PYVLKYYP 446 (467)
T ss_pred ccccccCC
Confidence 99987543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=349.01 Aligned_cols=251 Identities=31% Similarity=0.569 Sum_probs=214.7
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+|++.+.||+|+||.||+|.+..+|+.|++|.+.... ...+.+|+.++++++||||+++++++......|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 6999999999999999999999999999999986432 45688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+ |++|.+++.. ...+++.+++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~---- 155 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR---- 155 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC----
Confidence 9 9999999865 457999999999999999999999999999999999999999999999999998876543221
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP--------------- 221 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p--------------- 221 (1335)
......|+.+|+|||++.....++.++||||+|+++|+|++|.+||.+......+..+......+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence 11234689999999998766667899999999999999999999998876655554433211000
Q ss_pred --------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 000715 222 --------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWR 258 (1335)
Q Consensus 222 --------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq 258 (1335)
.....+.++.++|.+||..||.+|||+++++.||||.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 1124568899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=349.92 Aligned_cols=252 Identities=32% Similarity=0.609 Sum_probs=222.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
++|++.+.||.|+||.||+|.+..+++.|++|.+... ....+.+|+++++.++||||+++++.+.+....|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 5899999999999999999999999999999998643 345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+.+++|.+++... ++++..++.++.|++.|+.|||++|++||||+|+||+++++|.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~----- 154 (274)
T cd06609 81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK----- 154 (274)
T ss_pred eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc-----
Confidence 9999999999765 8999999999999999999999999999999999999999999999999999877543211
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCC-CChhHHHHHHH
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN-PSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~-iS~eL~DLIkk 236 (1335)
.....|++.|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+.....+..+.. .+.++.+++.+
T Consensus 155 ~~~~~~~~~y~~PE~~~~~-~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 233 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL 233 (274)
T ss_pred cccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHH
Confidence 1235688999999998754 478999999999999999999999988776666666555544444444 78899999999
Q ss_pred hcccCCCCCCCHHHHhcCcccccc
Q 000715 237 LLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
||..||++|||++++++||||++.
T Consensus 234 ~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 234 CLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred HhhCChhhCcCHHHHhhChhhcCC
Confidence 999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=353.97 Aligned_cols=244 Identities=31% Similarity=0.518 Sum_probs=205.8
Q ss_pred EeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 000715 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDL 83 (1335)
Q Consensus 10 LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL 83 (1335)
||+|+||.||++.++.+|+.||+|.+.+.. ......|++++++++||||+++++++.+...+|+||||+.|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999999999999999986532 23456799999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCc
Q 000715 84 MSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161 (1335)
Q Consensus 84 ~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~ 161 (1335)
.+++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~------~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT------ITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce------eecc
Confidence 98886543 589999999999999999999999999999999999999999999999999876643221 1234
Q ss_pred cCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCCCCCCCCChhHHHHHHHh
Q 000715 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF----TQLVKSILSDPSPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 162 ~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~----~eLikkIl~~~~~pip~~iS~eL~DLIkkc 237 (1335)
.|++.|+|||++... .++.++|+||+||++|+|++|+.||.+... .+.................+.++.+++.+|
T Consensus 155 ~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (277)
T cd05607 155 AGTNGYMAPEILKEE-PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLF 233 (277)
T ss_pred CCCCCccCHHHHccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHH
Confidence 689999999998654 478899999999999999999999976432 233333333322222346789999999999
Q ss_pred cccCCCCCCCH----HHHhcCcccccc
Q 000715 238 LVKDPAQRLHW----SDLCGHAFWRTK 260 (1335)
Q Consensus 238 LqkDPsKRPTA----eEILkHPfFq~~ 260 (1335)
|++||++||++ ++++.||||+..
T Consensus 234 L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 234 LAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred hccCHhhCCCCccchhhhhcChhhcCC
Confidence 99999999999 778899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=363.59 Aligned_cols=248 Identities=24% Similarity=0.461 Sum_probs=205.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEE-----CCCCeEEEEEEcCch----hHHHHHHHHHHHHhC-CCCCcceEEEEEEeC-CE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRK-----KKTIEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETS-AH 70 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArd-----k~TGk~VAIKiIdKe----~~e~LlrEIqILkkL-~HPNIVrL~dvfeds-~~ 70 (1335)
++|++.+.||+|+||.||+|.+ ..+++.||+|.+... ....+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 5899999999999999999985 345678999998642 245688999999999 899999999988764 46
Q ss_pred EEEEEeecCCCCHHHHHHhC------------------------------------------------------------
Q 000715 71 LWLVLEYCVGGDLMSLLRQD------------------------------------------------------------ 90 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~------------------------------------------------------------ 90 (1335)
+|+||||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 89999999999999998753
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCC
Q 000715 91 --NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168 (1335)
Q Consensus 91 --~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~Ym 168 (1335)
.++++.++..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++........ .......+++.|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch---hcccCCCCCcccc
Confidence 24788899999999999999999999999999999999999999999999999865432211 1112334678899
Q ss_pred CcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCC
Q 000715 169 APELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQ-LVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRL 246 (1335)
Q Consensus 169 APEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~e-LikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRP 246 (1335)
|||++. +..++.++|||||||++|+|++ |..||.+....+ ....+..+.....+...++++.+++.+||+.||.+||
T Consensus 244 aPE~~~-~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIF-DKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhh-cCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 999986 4557889999999999999997 999998865433 3344444444555678899999999999999999999
Q ss_pred CHHHHhc
Q 000715 247 HWSDLCG 253 (1335)
Q Consensus 247 TAeEILk 253 (1335)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=353.05 Aligned_cols=249 Identities=30% Similarity=0.540 Sum_probs=207.4
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+|++.+.||+|+||.||+|++..+|+.|++|.+... ....+.+|+.++++++||||+++++++.+.+.+|+|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 699999999999999999999999999999988543 234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+. ++|.+++.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..+......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~---- 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---- 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC----
Confidence 96 577777754 567999999999999999999999999999999999999999999999999998765432211
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHhcCC-----------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPF-VGREFTQLVKSILSDP----------------- 218 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF-~g~d~~eLikkIl~~~----------------- 218 (1335)
.....+++.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+....
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence 123457899999999876666788999999999999999988775 4444444433332100
Q ss_pred --CC---------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 219 --SP---------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 219 --~~---------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.+ ......++++.++|.+||..||.+|||+++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00 0112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=354.97 Aligned_cols=259 Identities=32% Similarity=0.496 Sum_probs=216.4
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETS--AHLWL 73 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds--~~lyL 73 (1335)
+++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .....+|+.++++++|+||+++++++... +.+|+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 478999999999999999999999999999999885332 22456899999999999999999998765 56899
Q ss_pred EEeecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
||||+. ++|.+++.. ...+++.+++.++.|++.||.|||++|++||||||+||+++.+|.+||+|||++.........
T Consensus 86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 999996 588888876 467999999999999999999999999999999999999999999999999999876543211
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC------------
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP------------ 220 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~------------ 220 (1335)
.....+++.|+|||++.+...++.++|+||+||++|+|++|++||.+.+..+.+..+......
T Consensus 165 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07845 165 -----MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL 239 (309)
T ss_pred -----CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence 122346888999999876666788999999999999999999999988877766555431100
Q ss_pred ------CC-----------CCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCCCC
Q 000715 221 ------PL-----------PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMP 265 (1335)
Q Consensus 221 ------pi-----------p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~~p 265 (1335)
.. ....++.+.++|.+||+.||++|||+.+++.||||+....+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~ 301 (309)
T cd07845 240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301 (309)
T ss_pred cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence 00 0124788999999999999999999999999999987765533
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=354.11 Aligned_cols=251 Identities=30% Similarity=0.517 Sum_probs=213.5
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ...+.+|+.++++++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 4889999999999999999999999999999886432 2346789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 77 YCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|+.|++|.+++... ..+++.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--- 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---
Confidence 99999999988653 3699999999999999999999999999999999999999999999999999875432221
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCCCCCCCChhHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF---TQLVKSILSDPSPPLPGNPSRPFA 231 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~---~eLikkIl~~~~~pip~~iS~eL~ 231 (1335)
.....|++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||..... ...............+...++++.
T Consensus 158 ---~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDAR 233 (285)
T ss_pred ---ccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHH
Confidence 123469999999999864 4578899999999999999999999987532 122233333223345667889999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCcccccc
Q 000715 232 NLINSLLVKDPAQRLH-----WSDLCGHAFWRTK 260 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPT-----AeEILkHPfFq~~ 260 (1335)
+++.+||+.||++||| ++++++||||+..
T Consensus 234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 9999999999999999 9999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=387.54 Aligned_cols=254 Identities=29% Similarity=0.462 Sum_probs=223.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-------
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSA------- 69 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~------- 69 (1335)
++|++.+.||+|+||+||+|++..+|+.||+|.+... ....+.+|+.++..++|+||+++++.+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 5899999999999999999999999999999998542 3456788999999999999999988764332
Q ss_pred -EEEEEEeecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccc
Q 000715 70 -HLWLVLEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 70 -~lyLVMEY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr 144 (1335)
.+++||||+.+|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 47899999999999999865 3479999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 000715 145 KLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPG 224 (1335)
Q Consensus 145 ~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~ 224 (1335)
.+...... ......+||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+.+..+.+..+......+.+.
T Consensus 192 ~~~~~~~~---~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 267 (496)
T PTZ00283 192 MYAATVSD---DVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPP 267 (496)
T ss_pred eccccccc---cccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 76432211 11234679999999999964 557899999999999999999999999999888888888777777888
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 225 NPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 225 ~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
.+++++.+++.+||+.||.+||++.++++|||++.
T Consensus 268 ~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 89999999999999999999999999999999865
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=351.41 Aligned_cols=254 Identities=32% Similarity=0.555 Sum_probs=220.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
++|++.+.||.|+||.||++.+..+++.||+|.+... ....+.+|++++++++||||+++++++......|+||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 5799999999999999999999999999999998543 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 79 eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
++++|.+++... ..+++.+++.++.|++.|+.|||++||+||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~----- 159 (280)
T cd06611 85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK----- 159 (280)
T ss_pred CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccc-----
Confidence 999999998764 57999999999999999999999999999999999999999999999999988765332211
Q ss_pred CCCccCCCCCCCcchhcc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCChhHH
Q 000715 158 PQAKCGTPCYMAPELFEE----GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP--PLPGNPSRPFA 231 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~----~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~--pip~~iS~eL~ 231 (1335)
.....|++.|+|||++.. ...++.++|+||+|+++|+|++|++||.+.+......++.....+ ..+..++.++.
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHH
Confidence 123468999999999752 344677999999999999999999999988777766666554332 23456789999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 232 NLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
++|.+||..||.+||++.++++||||.+.
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 240 DFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=388.00 Aligned_cols=253 Identities=31% Similarity=0.585 Sum_probs=233.2
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAH-LWLV 74 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~-lyLV 74 (1335)
|++|+.++++|+|+||.++.++++..++.|++|.+.-. .+....+|+.+++++.|||||.+++.|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 68999999999999999999999999999999998533 34467899999999999999999999988887 9999
Q ss_pred EeecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 75 LEYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
|+||+||++.+.|.+. ..|+|+.+..|+.|++.|+.|||+++|+|||||+.|||++.++.|||+|||+|+.+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 9999999999999764 47999999999999999999999999999999999999999999999999999988765421
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHH
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~D 232 (1335)
..+.+|||.||.||++. +..|+.++|||||||++|||++-+++|.+.+...++.+|......|.|...+.+++.
T Consensus 163 -----a~tvvGTp~YmcPEil~-d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~ 236 (426)
T KOG0589|consen 163 -----ASTVVGTPYYMCPEILS-DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRS 236 (426)
T ss_pred -----hheecCCCcccCHHHhC-CCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHH
Confidence 34578999999999996 567899999999999999999999999999999999999998889999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
+|+.||.++|..||++.+++.+|..+.
T Consensus 237 lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 237 LVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 999999999999999999999987654
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=351.13 Aligned_cols=255 Identities=29% Similarity=0.515 Sum_probs=217.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh---HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~---~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
++|++.+.||+|+||.||+|++..+++.|++|.+.... ...+.+|+.+++.++||||+++++.+..++.+|+||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46999999999999999999999999999999986543 456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 79 eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+|++|..++.+ ...+++..+..++.|++.|+.|||++|++||||||+||+++.+|.+||+|||++.........
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~----- 166 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR----- 166 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc-----
Confidence 99999988765 457999999999999999999999999999999999999999999999999988654322111
Q ss_pred CCCccCCCCCCCcchhcc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCChhHH
Q 000715 158 PQAKCGTPCYMAPELFEE----GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP--PLPGNPSRPFA 231 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~----~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~--pip~~iS~eL~ 231 (1335)
.....+++.|+|||++.. ...++.++|+|||||++|+|++|.+||...+......++.....+ ..+..++.++.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence 123468899999999852 344677999999999999999999999887766655555443222 23456788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 232 NLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
++|.+||..||++||++.++++||||....
T Consensus 247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 247 DFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 999999999999999999999999997643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=353.39 Aligned_cols=261 Identities=36% Similarity=0.587 Sum_probs=222.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|.+..+++.||+|.+.+. ....+.+|+++++.++||||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 5899999999999999999999999999999998653 2345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 76 EYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
||+.|++|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.+|.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998764 579999999999999999999999999999999999999999999999999987653321110
Q ss_pred ------------------------CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 000715 154 ------------------------SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ 209 (1335)
Q Consensus 154 ------------------------ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~e 209 (1335)
.........|+..|+|||++.+ ..++.++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 0011123568999999999864 456889999999999999999999999888777
Q ss_pred HHHHHhcCC-CCCCCCCCChhHHHHHHHhcccCCCCCCC----HHHHhcCccccccCCC
Q 000715 210 LVKSILSDP-SPPLPGNPSRPFANLINSLLVKDPAQRLH----WSDLCGHAFWRTKLTP 263 (1335)
Q Consensus 210 LikkIl~~~-~~pip~~iS~eL~DLIkkcLqkDPsKRPT----AeEILkHPfFq~~l~~ 263 (1335)
.+..+.... ..+.....+..+.++|.+||..||++||| +++++.||||++...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~ 298 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWA 298 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChh
Confidence 776665432 22222336899999999999999999999 9999999999876543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=347.56 Aligned_cols=250 Identities=30% Similarity=0.533 Sum_probs=211.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
++|++.+.||+|+||.||+|++..+++.||+|.+... ....+.+|+.+++.++||||+++++.+...+.+|+||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4688889999999999999999999999999988543 2345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
++++|.+++...+.+++.+++.++.|++.|+.|||++|++||||||+||+++.++.+||+|||++......... .
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~-----~ 163 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK-----R 163 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc-----c
Confidence 99999999998889999999999999999999999999999999999999999999999999998765432211 1
Q ss_pred CCccCCCCCCCcchhc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCC---CCCCChhHHH
Q 000715 159 QAKCGTPCYMAPELFE--EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPSPPL---PGNPSRPFAN 232 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~--~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~-~~~~pi---p~~iS~eL~D 232 (1335)
....|++.|+|||++. ....++.++|+||+||++|+|++|..||.............. ...++. ...++..+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHH 243 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHH
Confidence 3356999999999974 234567899999999999999999999976554433332221 111111 1246788999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcc
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAF 256 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPf 256 (1335)
+|.+||..||++|||++++++|||
T Consensus 244 li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 244 FVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHccCCchhCcCHHHHhcCCC
Confidence 999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.88 Aligned_cols=250 Identities=31% Similarity=0.524 Sum_probs=211.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+|+.++++++||||+++++++.....+|+||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4799999999999999999999999999999998543 3446788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
++++|.+++...+.+++.++..++.|++.|+.|||++||+||||||+||+++.+|.+||+|||++......... .
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~-----~ 163 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK-----R 163 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc-----c
Confidence 99999999988889999999999999999999999999999999999999999999999999998866432211 1
Q ss_pred CCccCCCCCCCcchhcc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCC---CCCCCChhHHH
Q 000715 159 QAKCGTPCYMAPELFEE--GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD-PSPP---LPGNPSRPFAN 232 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~--~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~-~~~p---ip~~iS~eL~D 232 (1335)
....|++.|+|||.+.. ...++.++|+||+||++|+|++|+.||......+....+... ..++ ....++..+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence 23468999999998742 344677999999999999999999999765544333222111 1111 12346789999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcc
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAF 256 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPf 256 (1335)
+|.+||..||++|||++++++|+|
T Consensus 244 li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 244 FVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=348.49 Aligned_cols=253 Identities=29% Similarity=0.511 Sum_probs=217.7
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
.|++.+.||+|+||.||+|.+..++..+++|.+... ....+.+|+++++.++||||+++++++...+..|+||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 378889999999999999999999999999998653 34567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 80 GGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
+++|..++.+ ..++++..+..++.|++.||.|||+.|++||||||+||+++.+|.+||+|||++......... .
T Consensus 86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~-----~ 160 (282)
T cd06643 86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-----R 160 (282)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccc-----c
Confidence 9999998765 567999999999999999999999999999999999999999999999999998765332211 1
Q ss_pred CCccCCCCCCCcchhc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCChhHHH
Q 000715 159 QAKCGTPCYMAPELFE----EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS--PPLPGNPSRPFAN 232 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~----~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~--~pip~~iS~eL~D 232 (1335)
....|++.|+|||++. .+..++.++|+||+||++|+|++|++||...+..+....+..... ...+..++.++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 2356899999999974 234567899999999999999999999988776666655544322 2345567899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
+|.+||..||++||++.++++||||...
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 9999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.52 Aligned_cols=251 Identities=33% Similarity=0.568 Sum_probs=212.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhC-CCCCcceEEEEEEeC------CEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSL-DHPNVLRFYSWYETS------AHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL-~HPNIVrL~dvfeds------~~ly 72 (1335)
++|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+|+.+++++ +||||+++++++... ..+|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 4688999999999999999999999999999998543 345688999999998 799999999998653 4689
Q ss_pred EEEeecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 73 LVLEYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
+||||+.+++|.+++... ..+++..+..++.|++.|+.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~ 165 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165 (272)
T ss_pred EEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence 999999999999999863 468999999999999999999999999999999999999999999999999987653322
Q ss_pred CCCCCCCCCCccCCCCCCCcchhcc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCCCC
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEE----GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP-SPPLPGN 225 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~----~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~-~~pip~~ 225 (1335)
.. .....|++.|+|||++.. +..++.++|+||+||++|+|++|..||...........+.... ....+..
T Consensus 166 ~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06637 166 GR-----RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240 (272)
T ss_pred cc-----CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCC
Confidence 11 234569999999999853 2356789999999999999999999998766555444443322 2223456
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 226 PSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 226 iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
++..+.+++.+||..||.+|||+.++++||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 78899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=371.73 Aligned_cols=255 Identities=34% Similarity=0.602 Sum_probs=231.8
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
|++|.++|+||+|.||+|.+|+.+.+|+.||||++.++ ....-..|-++|+..+||.+..+...|+..+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 68899999999999999999999999999999988654 455567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|||..||.|+..+.+...|+|+..+.|...|+.||.|||+++||+||+|.+|+|+|+||++||.|||++..--..+.
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~--- 323 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGD--- 323 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999975433222
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
...++||||.|+|||++. +..|+.++|+|.+||+||||+||+.||...+...++.-|+.. ...+|..++++++.|+
T Consensus 324 --t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-d~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 324 --TTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-DLKFPRTLSPEAKTLL 399 (516)
T ss_pred --eeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-hccCCccCCHHHHHHH
Confidence 246799999999999996 567899999999999999999999999999999998888754 3467889999999999
Q ss_pred HHhcccCCCCCC-----CHHHHhcCccccccCC
Q 000715 235 NSLLVKDPAQRL-----HWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 235 kkcLqkDPsKRP-----TAeEILkHPfFq~~l~ 262 (1335)
..+|.+||.+|. .+.+|..|+||....+
T Consensus 400 sGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 400 SGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred HHHhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 999999999996 4899999999986543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=338.89 Aligned_cols=250 Identities=33% Similarity=0.544 Sum_probs=215.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
++|++.+.||.|+||.||+|.+..+++.+++|.+... ....+.+|++++++++||||+++++.+.+...+|++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 6899999999999999999999999999999998644 3567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 79 eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
.+++|.+++... ..+++.++..++.|++.|+.|||++|++||||||+||+++++|.+||+|||++.........
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~----- 157 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK----- 157 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc-----
Confidence 999999999876 78999999999999999999999999999999999999999999999999998765432211
Q ss_pred CCCccCCCCCCCcchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CC---CCCCCCChhHH
Q 000715 158 PQAKCGTPCYMAPELFEEG--GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP-SP---PLPGNPSRPFA 231 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~--~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~-~~---pip~~iS~eL~ 231 (1335)
.....++..|+|||.+... ..++.++|+||+|+++|+|++|++||.+.+.......+.... .+ ..+...+.++.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH 237 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence 1234689999999998643 256789999999999999999999998876555544443221 11 12234567899
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcc
Q 000715 232 NLINSLLVKDPAQRLHWSDLCGHAF 256 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPTAeEILkHPf 256 (1335)
+++++||..||.+|||+.+++.|+|
T Consensus 238 ~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 238 DFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHcCCChhhCCCHHHHhcCCC
Confidence 9999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=358.72 Aligned_cols=250 Identities=34% Similarity=0.602 Sum_probs=228.7
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhH------HHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK------SKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~------e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
+++|++++.||+|.||.||.|+.++++-.||+|++-+++. .++.+|++|...|+||||+++|++|.++..+|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 5789999999999999999999999999999999987753 3578999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 75 LEYCVGGDLMSLLR--QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 75 MEY~eGGSL~dlIk--q~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
+||..+|+++..+. ...++++.....|++|++.|+.|+|.++|+||||||+|+|++.+|.+|++|||-+.....+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~--- 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN--- 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCCC---
Confidence 99999999999998 5678999999999999999999999999999999999999999999999999988654321
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHH
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~D 232 (1335)
...+.|||..|.+||+.. +..++..+|+|++|++.||++.|.+||......+.+++|.+. ...+|..++.++.|
T Consensus 178 ----kR~tlcgt~dyl~pEmv~-~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~-~~~~p~~is~~a~d 251 (281)
T KOG0580|consen 178 ----KRKTLCGTLDYLPPEMVE-GRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV-DLKFPSTISGGAAD 251 (281)
T ss_pred ----CceeeecccccCCHhhcC-CCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-cccCCcccChhHHH
Confidence 245689999999999996 455688999999999999999999999999999999988754 44567899999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
+|.+||.++|.+|.+..|++.|||...
T Consensus 252 lI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 252 LISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHhccCccccccHHHHhhhHHHHh
Confidence 999999999999999999999999753
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=338.22 Aligned_cols=249 Identities=32% Similarity=0.586 Sum_probs=218.4
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
+|+..+.||+|+||.||+|.+..+++.|++|.+... ....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 688999999999999999999999999999987432 345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|||++|++|.+++.+.+.+++..+..++.|++.|+.|||+.|++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--- 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc---
Confidence 99999999999999888899999999999999999999999999999999999999999999999999876543321
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCChhHHHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPSPPLPGNPSRPFANL 233 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~-~~~~pip~~iS~eL~DL 233 (1335)
.....|++.|+|||.+.....++.++|+||+|+++|+|++|+.||......+....+.. ...+..+...++.+.++
T Consensus 158 ---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 234 (258)
T cd06632 158 ---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234 (258)
T ss_pred ---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHH
Confidence 13356899999999986444478899999999999999999999987765555544443 33445667788999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 000715 234 INSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 234 IkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+.+||..+|++||++.+++.|||+
T Consensus 235 i~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 235 ILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=337.77 Aligned_cols=248 Identities=33% Similarity=0.561 Sum_probs=220.1
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 699999999999999999999999999999988543 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC-CeeeccccccccccCCCCCCC
Q 000715 78 CVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG-RTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 78 ~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG-~VKLiDFGLAr~l~e~~~~~s 154 (1335)
++|++|.+++... ..+++..+..++.|++.|+.|||++|++||||||+||+++.++ .+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--- 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--- 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---
Confidence 9999999999764 3589999999999999999999999999999999999998654 679999999987644321
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
.....|++.|+|||.+.. ..++.++|+||+|+++|+|++|+.||...+.......+......+.+...+.++.+++
T Consensus 158 ---~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 233 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLI 233 (256)
T ss_pred ---ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHH
Confidence 123468999999999864 4567899999999999999999999999888777777776666667778899999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccc
Q 000715 235 NSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 235 kkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.+||..||++|||+.+++.||||
T Consensus 234 ~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 234 LSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHccCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.97 Aligned_cols=254 Identities=28% Similarity=0.516 Sum_probs=215.8
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
+|+..+.||+|+||.||++.+..+++.||+|.+... ....+.+|++++++++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 589999999999999999999999999999998542 23567899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC-CeeeccccccccccCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG-RTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG-~VKLiDFGLAr~l~e~~~~ 152 (1335)
||||+.|++|.+++.+.+++++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||.+.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999999888999999999999999999999999999999999999998776 5999999998876543221
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh-cCCCCCCCCCCCh
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ---LVKSIL-SDPSPPLPGNPSR 228 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~e---LikkIl-~~~~~pip~~iS~ 228 (1335)
.. .......|+..|+|||++.. ..++.++|+||+|+++|+|++|..||....... ....+. ....+..+...++
T Consensus 161 ~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 161 AG-EFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred CC-ccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 11 11234568999999999864 456889999999999999999999997654322 222222 1223445667889
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 000715 229 PFANLINSLLVKDPAQRLHWSDLCGHAFWR 258 (1335)
Q Consensus 229 eL~DLIkkcLqkDPsKRPTAeEILkHPfFq 258 (1335)
++.+++.+||..+|++|||+.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.81 Aligned_cols=249 Identities=31% Similarity=0.586 Sum_probs=221.9
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+|++.+.||+|+||.||++.+..+|+.|++|.+... ....+.+|+.++++++||||+++++++...+..|+||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 699999999999999999999999999999987532 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 78 CVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 78 ~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
+.+++|.+++... ..+++.++..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--- 157 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--- 157 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh---
Confidence 9999999998764 36899999999999999999999999999999999999999999999999998766432211
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
.....|++.|+|||++.. ..++.++|+|||||++|+|++|..||...+..+....+..+..++.+...+.++.++|.
T Consensus 158 --~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08218 158 --ARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234 (256)
T ss_pred --hhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence 123458899999999864 45678999999999999999999999988888888887777666677788999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccc
Q 000715 236 SLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 236 kcLqkDPsKRPTAeEILkHPfF 257 (1335)
+||+.+|++||++.++++||||
T Consensus 235 ~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 235 QLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHhhCChhhCcCHHHHhhCcCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=353.12 Aligned_cols=251 Identities=29% Similarity=0.542 Sum_probs=213.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
++|++.+.||+|+||.||++.+..+++.||+|.+... ...++.+|++++++++||||+++++.+...+.+|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 5799999999999999999999999999999998543 234578999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
++|++|.+++.+.+.+++..+..++.|++.||.|||+ .|++||||||+||+++.+|.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~------ 154 (308)
T cd06615 81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------ 154 (308)
T ss_pred cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc------
Confidence 9999999999988899999999999999999999998 599999999999999999999999999986553321
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--------------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-------------------- 216 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~-------------------- 216 (1335)
....+|++.|+|||++. +..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 155 -~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 155 -ANSFVGTRSYMSPERLQ-GTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred -cccCCCCcCccChhHhc-CCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 23457899999999985 45578899999999999999999999976554333222211
Q ss_pred ----------------CCCCCCC-CCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 217 ----------------DPSPPLP-GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 217 ----------------~~~~pip-~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
...+..+ ...+.++.+++.+||..||++|||+.++++||||.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 1111111 1357789999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=341.64 Aligned_cols=253 Identities=29% Similarity=0.505 Sum_probs=214.8
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+... ....+.+|++++++++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999986 46788999987432 23457889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC-
Q 000715 74 VLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA- 152 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~- 152 (1335)
||||++|++|.+++.+.+++++..+..++.|++.|+.|||+.|++|+||||+||+++.++.+||+|||++.........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999998765322111
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCChhH
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS--DPSPPLPGNPSRPF 230 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~--~~~~pip~~iS~eL 230 (1335)
..........|++.|+|||++.. ..++.++|+||||+++|+|++|..||...+.......+.. ...+..+...+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 11111233568999999999864 4567899999999999999999999987665544433332 23345667789999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 231 ANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 231 ~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.++|.+||..+|++||++.+++.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=337.18 Aligned_cols=249 Identities=28% Similarity=0.510 Sum_probs=221.8
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+|++.+.||.|+||.||.+++..+++.+++|.+... ...++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 699999999999999999999999999999987532 345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 78 CVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 78 ~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
+++++|.+++... ..+++.++..++.|++.|+.|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~--- 157 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--- 157 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccc---
Confidence 9999999999775 56899999999999999999999999999999999999999999999999998876443321
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
.....|++.|+|||++.+ ..++.++|+||+|+++|+|++|..||......+....+..+...+.+...+.++.+++.
T Consensus 158 --~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd08221 158 --AETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVH 234 (256)
T ss_pred --ccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence 233568999999999864 34678999999999999999999999998888888887766555666778899999999
Q ss_pred HhcccCCCCCCCHHHHhcCccc
Q 000715 236 SLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 236 kcLqkDPsKRPTAeEILkHPfF 257 (1335)
+||..+|.+||++.++++|+|+
T Consensus 235 ~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 235 SLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHcccCcccCCCHHHHhhCcCC
Confidence 9999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=349.37 Aligned_cols=251 Identities=31% Similarity=0.478 Sum_probs=214.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
++|++.+.||+|+||.||+|.++.+++.||+|.+.+. ..+.+.+|+++++.++||||+++++++......|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 5899999999999999999999999999999987543 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
|+++++|.++......+++.+++.++.|++.|+.|||+.|++||||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~---- 156 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV---- 156 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc----
Confidence 9999999988877778999999999999999999999999999999999999999999999999998765443211
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-------------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD------------------- 217 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~------------------- 217 (1335)
.....++..|+|||++.....++.++||||||+++|+|++|++||.+....+....+...
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 157 -YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred -cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 123468899999999876566788999999999999999999999876654433332210
Q ss_pred -CCC----------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 218 -PSP----------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 218 -~~~----------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
... .....++..+.+++.+||..||++||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000 0123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=344.73 Aligned_cols=248 Identities=34% Similarity=0.611 Sum_probs=218.3
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
+|++.+.||.|+||.||+|.+..+++.||+|.+.+. ..+.+.+|++++++++||||+++++.+......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 699999999999999999999999999999998653 34578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
|+.|++|.+++.....+++.++..++.|+++||.|||++|++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----- 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----- 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-----
Confidence 999999999998888999999999999999999999999999999999999999999999999999876644321
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF--TQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~--~eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
.....|+..|+|||++.. ..++.++|+||+|+++|+|++|..||...+. .+.+...........+...+..+.++|
T Consensus 156 -~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (258)
T cd05578 156 -TTSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI 233 (258)
T ss_pred -ccccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHH
Confidence 123458899999999864 4478899999999999999999999988763 333333333244566777889999999
Q ss_pred HHhcccCCCCCCCH--HHHhcCccc
Q 000715 235 NSLLVKDPAQRLHW--SDLCGHAFW 257 (1335)
Q Consensus 235 kkcLqkDPsKRPTA--eEILkHPfF 257 (1335)
.+||..||.+||+. .|+++||||
T Consensus 234 ~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 234 NKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHccCChhHcCCccHHHHhcCCCC
Confidence 99999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=337.63 Aligned_cols=253 Identities=33% Similarity=0.625 Sum_probs=225.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
++|++.+.||+|++|.||+|.+..+++.|++|.+... ....+.+|++++.+++||||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 5799999999999999999999999999999998654 356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+++++|.+++.....+++..+..++.|++.|+.|||+ +|++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~---- 156 (264)
T cd06623 81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ---- 156 (264)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc----
Confidence 9999999999988899999999999999999999999 99999999999999999999999999998876443221
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCCCCCCCC-CChhHHH
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR---EFTQLVKSILSDPSPPLPGN-PSRPFAN 232 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~---d~~eLikkIl~~~~~pip~~-iS~eL~D 232 (1335)
.....++..|+|||.+.. ..++.++|+||||+++|+|++|..||... ...+....+.....+..+.. .+..+.+
T Consensus 157 -~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD 234 (264)
T ss_pred -ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 123458899999999864 46788999999999999999999999877 55666666666655666666 8899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
+|.+||..+|++||++.++++|||++..
T Consensus 235 li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 235 FISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 9999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=373.33 Aligned_cols=253 Identities=31% Similarity=0.533 Sum_probs=217.0
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSA-----HLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HPNIVrL~dvfeds~-----~lyLVMEY 77 (1335)
.|+-.+++|.|+||.||+|....+++.||||.+-.+.+ --.+|+++|++++|||||++..+|.... ...+||||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 47889999999999999999999999999999854432 2247999999999999999998885542 34689999
Q ss_pred cCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCC-CCeeeccccccccccCCCCC
Q 000715 78 CVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN-GRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 78 ~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDed-G~VKLiDFGLAr~l~e~~~~ 152 (1335)
+ ..+|.++++. +.+++..+++-|.+||++|+.|||+.||+||||||.|+|+|.+ |.+||||||.|..+..+...
T Consensus 104 m-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 104 M-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred c-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 8 5799998875 6789999999999999999999999999999999999999966 99999999999988665432
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----------
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP----------- 221 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p----------- 221 (1335)
..+..|.+|+|||.+.+...|+.+.||||.||++.||+.|++.|.|++..+++..|.+-...|
T Consensus 183 ------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~ 256 (364)
T KOG0658|consen 183 ------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN 256 (364)
T ss_pred ------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence 457789999999999999999999999999999999999999999998777766554311111
Q ss_pred -----------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCC
Q 000715 222 -----------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTP 263 (1335)
Q Consensus 222 -----------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~ 263 (1335)
+....++++.+|+.++|.++|.+|.++.+++.||||.+...+
T Consensus 257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 224568899999999999999999999999999999875443
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.88 Aligned_cols=253 Identities=28% Similarity=0.550 Sum_probs=217.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
++|++.+.||+|+||.||+|.+..+|+.||+|.+... ....+.+|++++++++||||+++++.+...+.+|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 5799999999999999999999999999999987532 245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 78 CVGGDLMSLLRQD---NQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 78 ~eGGSL~dlIkq~---~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
++|++|..++... ..+++..+..++.|++.|+.|||+ .|++||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc---
Confidence 9999999988763 479999999999999999999997 599999999999999999999999999987653221
Q ss_pred CCCCCCCccCCCCCCCcchhccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhcCCCCCCCCC
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEG-----GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLV---KSILSDPSPPLPGN 225 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~-----~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLi---kkIl~~~~~pip~~ 225 (1335)
.....|++.|+|||++... ..++.++|+||+||++|+|++|+.||......... ..+.....+..+..
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG 233 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence 1234688899999998532 23577999999999999999999999776544433 33444445566777
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 226 PSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 226 iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
.+.++.++|.+||..+|++||++.+++.||||....
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 899999999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=386.22 Aligned_cols=255 Identities=31% Similarity=0.537 Sum_probs=226.0
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc---hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK---SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK---e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
.|+++..||.|+||+||+|.++.++-..|.|+|.. +..+++.-||.||..++||+|+++++.|...+.+||..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 36778899999999999999999999899999854 356778899999999999999999999999999999999999
Q ss_pred CCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 80 GGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
||-....+-. +..|++++|+.+++|++.||.|||+++|||||+|..|||++-+|.++|+|||.+-.....- ...
T Consensus 113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-----qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-----QKR 187 (1187)
T ss_pred CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHH-----hhh
Confidence 9999888765 5689999999999999999999999999999999999999999999999999875432211 124
Q ss_pred CCccCCCCCCCcchhc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCChhHHH
Q 000715 159 QAKCGTPCYMAPELFE----EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP--LPGNPSRPFAN 232 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~----~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p--ip~~iS~eL~D 232 (1335)
+.++|||+|||||+.. .+..|++++||||||+++.||.-+.+|...-+....+-+|.+...+. .|..++..+.|
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D 267 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD 267 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence 6789999999999975 46788999999999999999999999999999888888887654433 46788999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccccccCC
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPfFq~~l~ 262 (1335)
|+++||.+||..||++.++++||||++.+.
T Consensus 268 fLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 268 FLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred HHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 999999999999999999999999987543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=346.20 Aligned_cols=250 Identities=25% Similarity=0.425 Sum_probs=217.2
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCC-----eEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTI-----EYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TG-----k~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~l 71 (1335)
+++|++.+.||+|+||.||+|.+...+ +.|++|.+... ....+.+|++++.+++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 357999999999999999999987655 78999988543 234678999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCe
Q 000715 72 WLVLEYCVGGDLMSLLRQD----------------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRT 135 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~----------------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~V 135 (1335)
|++|||+++++|.+++... ..+++.++..++.|++.||.|||++|++||||||+||++++++.+
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence 9999999999999999764 458889999999999999999999999999999999999999999
Q ss_pred eeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 000715 136 KLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214 (1335)
Q Consensus 136 KLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkI 214 (1335)
||+|||++......... .......+++.|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+....+
T Consensus 164 ~L~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 164 KISDFGLSRDIYSADYY---RVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred EECCCcceeeccccccc---cccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999998765332211 11233457889999999864 457889999999999999998 99999998888888887
Q ss_pred hcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 215 LSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 215 l~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
......+.+...++++.+++.+||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7776667778899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=348.03 Aligned_cols=251 Identities=31% Similarity=0.530 Sum_probs=214.9
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
.|+..+.||+|+||+||+|.+..+++.||+|.+.+.. ...+.+|+++++.++|+||+.+++.+...+..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 4889999999999999999999999999999986432 2346789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 77 YCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--- 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--- 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---
Confidence 99999999888653 4699999999999999999999999999999999999999999999999999875532211
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hcCCCCCCCCCCChhHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSI---LSDPSPPLPGNPSRPFA 231 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkI---l~~~~~pip~~iS~eL~ 231 (1335)
.....|++.|+|||++.+ ..++.++|+||+|+++|+|++|..||.+.........+ ........+...+.++.
T Consensus 158 ---~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd05632 158 ---IRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAK 233 (285)
T ss_pred ---ccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHH
Confidence 123469999999999864 55788999999999999999999999887654333332 22223345567889999
Q ss_pred HHHHHhcccCCCCCCC-----HHHHhcCcccccc
Q 000715 232 NLINSLLVKDPAQRLH-----WSDLCGHAFWRTK 260 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPT-----AeEILkHPfFq~~ 260 (1335)
+++.+||+.||++||+ +.+++.|+||+..
T Consensus 234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 234 SICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=339.01 Aligned_cols=251 Identities=34% Similarity=0.601 Sum_probs=213.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC------EEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSA------HLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~------~ly 72 (1335)
++|++.+.||+|+||.||+|.++.+++.|++|.+... ....+.+|+.+++++ +||||+++++++.... .+|
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 6899999999999999999999999999999998654 345688999999999 7999999999986644 589
Q ss_pred EEEeecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccC
Q 000715 73 LVLEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSD 148 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e 148 (1335)
+||||+++++|.+++.. +..+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.....
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 165 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceeccc
Confidence 99999999999998865 45899999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCCCCCCCCCccCCCCCCCcchhcc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--
Q 000715 149 ASKAPSSMLPQAKCGTPCYMAPELFEE----GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL-- 222 (1335)
Q Consensus 149 ~~~~~ss~l~~t~~GTp~YmAPEVL~~----~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pi-- 222 (1335)
.... .....|++.|+|||++.. ...++.++||||||+++|+|++|++||..........++.....+..
T Consensus 166 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd06608 166 TLGR-----RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS 240 (275)
T ss_pred chhh-----hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence 2211 233568999999999753 23467789999999999999999999987766665555554433222
Q ss_pred CCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 223 PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 223 p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+...+..+.++|.+||..||++|||+.++++|||+
T Consensus 241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 23367899999999999999999999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=350.94 Aligned_cols=248 Identities=28% Similarity=0.508 Sum_probs=195.5
Q ss_pred EEEEeccCcEEEEEEEECC--CCeEEEEEEcCchh-HHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEEeecCCC
Q 000715 7 YEAIGRGKYSTVYKGRKKK--TIEYFAIKSVDKSQ-KSKVLQEVRMLHSLDHPNVLRFYSWYE--TSAHLWLVLEYCVGG 81 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~--TGk~VAIKiIdKe~-~e~LlrEIqILkkL~HPNIVrL~dvfe--ds~~lyLVMEY~eGG 81 (1335)
...||+|+||.||+|+++. +++.||+|.+.... ...+.+|++++++++||||+++++++. ....+|+||||+. +
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence 4689999999999999764 66889999987543 345788999999999999999999884 4567899999985 5
Q ss_pred CHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEE----CCCCCeeeccccccccccC
Q 000715 82 DLMSLLRQD---------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILL----DENGRTKLCDFGLARKLSD 148 (1335)
Q Consensus 82 SL~dlIkq~---------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILI----DedG~VKLiDFGLAr~l~e 148 (1335)
+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.+|.+||+|||+++....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence 788777531 258999999999999999999999999999999999999 4667999999999987654
Q ss_pred CCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHhcCCC
Q 000715 149 ASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT---------QLVKSILSDPS 219 (1335)
Q Consensus 149 ~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~---------eLikkIl~~~~ 219 (1335)
...... ......||+.|+|||++.+...++.++||||+||++|+|++|++||...... .....+.....
T Consensus 165 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (317)
T cd07867 165 PLKPLA--DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242 (317)
T ss_pred Cccccc--ccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcC
Confidence 322111 1234568999999999976667889999999999999999999999754311 11111110000
Q ss_pred -------------------------------------CCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 220 -------------------------------------PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 220 -------------------------------------~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.......+..+.++|.+||..||.+|||+.|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00011235668899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=341.99 Aligned_cols=253 Identities=26% Similarity=0.459 Sum_probs=214.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--------hHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--------QKSKVLQEVRMLHSLDHPNVLRFYSWYET--SAHL 71 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--------~~e~LlrEIqILkkL~HPNIVrL~dvfed--s~~l 71 (1335)
.+|+..+.||+|+||.||+|.+..+++.|++|.+... ....+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4799999999999999999999999999999987432 23467889999999999999999998865 3678
Q ss_pred EEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCC
Q 000715 72 WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~ 151 (1335)
+++|||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876543211
Q ss_pred CCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCChhH
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD-PSPPLPGNPSRPF 230 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~-~~~pip~~iS~eL 230 (1335)
... ......|+..|+|||.+.+ ..++.++|+||+||++|+|++|+.||..........++... ..+..+...++.+
T Consensus 162 ~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd06651 162 SGT--GIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHA 238 (266)
T ss_pred cCC--ccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHH
Confidence 111 1123458899999999864 55788999999999999999999999887665555544332 2344566778899
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccc
Q 000715 231 ANLINSLLVKDPAQRLHWSDLCGHAFWR 258 (1335)
Q Consensus 231 ~DLIkkcLqkDPsKRPTAeEILkHPfFq 258 (1335)
.+++ +||..+|++||+++++++||||+
T Consensus 239 ~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 239 RDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 9999 57778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=343.74 Aligned_cols=254 Identities=31% Similarity=0.605 Sum_probs=219.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLD---HPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~---HPNIVrL~dvfeds~~lyLV 74 (1335)
+.|++.+.||+|+||.||+|.+..+++.|++|.+... ....+.+|+.+++++. |||++++++++......|+|
T Consensus 1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 4689999999999999999999999999999987542 3456788999999986 99999999999999999999
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|||++|++|.+++.. +.+++..+..++.|++.|+.|||+.|++||||+|+||+++.+|.++|+|||++..+......
T Consensus 81 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-- 157 (277)
T cd06917 81 MEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-- 157 (277)
T ss_pred EecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--
Confidence 999999999999866 47999999999999999999999999999999999999999999999999998876543321
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCC-CCChhHHHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPG-NPSRPFANL 233 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~-~iS~eL~DL 233 (1335)
.....|++.|+|||.+..+..++.++|+||||+++|+|++|..||.+.........+.....+.++. ..+.++.++
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (277)
T cd06917 158 ---RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF 234 (277)
T ss_pred ---cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHH
Confidence 1234689999999998766667889999999999999999999998877665554443333333333 378899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 234 INSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 234 IkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
+.+||..||++||++.+++.|+||++..
T Consensus 235 i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 235 VAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred HHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 9999999999999999999999997653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=367.52 Aligned_cols=252 Identities=25% Similarity=0.404 Sum_probs=207.6
Q ss_pred cEEEEEEEeccCcEEEEEEEEC--CCCeEEEEEEcCchhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKK--KTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk--~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+|++.+.||+|+||.||+|... .+++.|++|.+.... ...+|++++++++||||+++++++.....+|+|||++ +
T Consensus 93 ~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~ 169 (392)
T PHA03207 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-K 169 (392)
T ss_pred ceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-C
Confidence 6999999999999999999764 456889999987642 3568999999999999999999999999999999998 4
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.......... ...
T Consensus 170 ~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~---~~~ 246 (392)
T PHA03207 170 CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ---CYG 246 (392)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc---ccc
Confidence 78999998788999999999999999999999999999999999999999999999999999976654322111 123
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhc---------------------
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF---TQLVKSILS--------------------- 216 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~---~eLikkIl~--------------------- 216 (1335)
..||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+... ...+..+..
T Consensus 247 ~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 325 (392)
T PHA03207 247 WSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF 325 (392)
T ss_pred cccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHH
Confidence 579999999999864 4578899999999999999999999976532 111111110
Q ss_pred -----CCCCC--CC-----CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 217 -----DPSPP--LP-----GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 217 -----~~~~p--ip-----~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
...++ .+ ...+.++.++|.+||..||++|||+.+++.||||...+
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 326 KQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 00000 11 23467789999999999999999999999999997653
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=339.61 Aligned_cols=254 Identities=25% Similarity=0.459 Sum_probs=215.2
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc--------hhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK--------SQKSKVLQEVRMLHSLDHPNVLRFYSWYETS--AH 70 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK--------e~~e~LlrEIqILkkL~HPNIVrL~dvfeds--~~ 70 (1335)
.++|++.+.||+|+||.||.|++..+|+.|++|.+.. .....+.+|++++++++||||+++++++.+. ..
T Consensus 1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence 3689999999999999999999999999999998742 1234678899999999999999999988764 56
Q ss_pred EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
+++||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 88999999999999999888889999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCChh
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD-PSPPLPGNPSRP 229 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~-~~~pip~~iS~e 229 (1335)
..... .....|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||........+..+... ..+..+...+..
T Consensus 161 ~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 161 LSGTG--MKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH 237 (265)
T ss_pred ccccc--cccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHH
Confidence 11111 123468999999999864 45688999999999999999999999877655555544433 234456677889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 000715 230 FANLINSLLVKDPAQRLHWSDLCGHAFWR 258 (1335)
Q Consensus 230 L~DLIkkcLqkDPsKRPTAeEILkHPfFq 258 (1335)
+.++|.+||. +|++||+++++++|||+.
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999999995 999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=335.33 Aligned_cols=249 Identities=35% Similarity=0.604 Sum_probs=219.1
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK-----SQKSKVLQEVRMLHSLDHPNVLRFYSWYET--SAHLWLVL 75 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK-----e~~e~LlrEIqILkkL~HPNIVrL~dvfed--s~~lyLVM 75 (1335)
+|++.+.||.|+||.||+|.+..+++.|++|.+.. ...+.+.+|++++++++||||+++++++.. ....|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 69999999999999999999999999999998753 234567889999999999999999997754 45689999
Q ss_pred eecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCCcccCCCCCCeEECCCCCeeeccccccccc
Q 000715 76 EYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLH-----SKGIIYCDLKPSNILLDENGRTKLCDFGLARKL 146 (1335)
Q Consensus 76 EY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLH-----skGIVHRDIKPENILIDedG~VKLiDFGLAr~l 146 (1335)
||+++++|.+++.. ...+++.+++.++.||+.||.||| +.+++||||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999876 467999999999999999999999 999999999999999999999999999998876
Q ss_pred cCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 000715 147 SDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP 226 (1335)
Q Consensus 147 ~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~i 226 (1335)
...... .....|++.|+|||++.. ..++.++|+||||+++|+|++|+.||...+.......+........+...
T Consensus 161 ~~~~~~-----~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd08217 161 GHDSSF-----AKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRY 234 (265)
T ss_pred cCCccc-----ccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCcccc
Confidence 543221 123468999999999864 44788999999999999999999999998877777777766666677788
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 227 SRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 227 S~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+..+.+++.+||..+|++|||+.++++|||+
T Consensus 235 ~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 235 SSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 9999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=344.55 Aligned_cols=252 Identities=34% Similarity=0.565 Sum_probs=213.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhC-CCCCcceEEEEEEeC-----CEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSL-DHPNVLRFYSWYETS-----AHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL-~HPNIVrL~dvfeds-----~~lyL 73 (1335)
++|++.+.||+|+||.||+|.++.+++.||+|.+... ....+.+|+.+++++ +|||++++++++... ...|+
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 5799999999999999999999999999999998653 345677899999998 899999999988654 46899
Q ss_pred EEeecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCC
Q 000715 74 VLEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~ 149 (1335)
||||++|++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 181 (291)
T cd06639 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181 (291)
T ss_pred EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccc
Confidence 9999999999998863 457999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCCCCccCCCCCCCcchhccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC--CC
Q 000715 150 SKAPSSMLPQAKCGTPCYMAPELFEEGG----VHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP--LP 223 (1335)
Q Consensus 150 ~~~~ss~l~~t~~GTp~YmAPEVL~~~~----~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p--ip 223 (1335)
... .....|+..|+|||++.... .++.++||||+||++|+|++|++||...+.......+.....+. .+
T Consensus 182 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 256 (291)
T cd06639 182 RLR-----RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP 256 (291)
T ss_pred ccc-----ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcc
Confidence 211 12346899999999985432 35789999999999999999999998877655555554443222 23
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 000715 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWR 258 (1335)
Q Consensus 224 ~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq 258 (1335)
...+..+.++|.+||+.||++||++.++++||||+
T Consensus 257 ~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 257 EKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 45678899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=336.89 Aligned_cols=250 Identities=32% Similarity=0.598 Sum_probs=217.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
++|++.+.||+|+||.||+|.+..+++.|++|.+.... ...+.+|++++++++||||+++++++......|+++||+.+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 82 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence 57999999999999999999999999999999986553 66788999999999999999999999999999999999999
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQ 159 (1335)
Q Consensus 81 GSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~ 159 (1335)
++|.+++.. ...+++..++.++.|++.|+.|||+.|++||||+|+||+++.++.+||+|||++......... ..
T Consensus 83 ~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~-----~~ 157 (256)
T cd06612 83 GSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK-----RN 157 (256)
T ss_pred CcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccc-----cc
Confidence 999999976 457899999999999999999999999999999999999999999999999998876543211 12
Q ss_pred CccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCChhHHHHHHHh
Q 000715 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS--PPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 160 t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~--~pip~~iS~eL~DLIkkc 237 (1335)
...|+..|+|||++.+ ..++.++||||+|+++|+|++|+.||...........+..... ...+..++..+.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd06612 158 TVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKC 236 (256)
T ss_pred cccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHH
Confidence 3458899999999864 4568899999999999999999999988766554444333222 123445678999999999
Q ss_pred cccCCCCCCCHHHHhcCccc
Q 000715 238 LVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 238 LqkDPsKRPTAeEILkHPfF 257 (1335)
|..||++|||+.+++.||||
T Consensus 237 l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 237 LVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HhcChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=356.80 Aligned_cols=255 Identities=23% Similarity=0.399 Sum_probs=207.0
Q ss_pred EEEEEecc--CcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 6 IYEAIGRG--KYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 6 LlK~LGeG--gFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
++++||+| +||+||++.++.+|+.||+|.++.. ....+.+|+++++.++||||+++++++..++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7889999999999999999998653 2345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC--C
Q 000715 79 VGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP--S 154 (1335)
Q Consensus 79 eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~--s 154 (1335)
++++|.+++..+ ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||.+.......... .
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999999999753 469999999999999999999999999999999999999999999999998765442211110 0
Q ss_pred CCCCCCccCCCCCCCcchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-------------
Q 000715 155 SMLPQAKCGTPCYMAPELFEEG-GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP------------- 220 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~-~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~------------- 220 (1335)
........++..|+|||++... ..++.++||||+||++|+|++|+.||.................+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence 1112234578889999998643 45788999999999999999999999876544433222211100
Q ss_pred --------------------------------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 221 --------------------------------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 221 --------------------------------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
+.....++.+.+||.+||+.||++|||++++++||||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 0112346789999999999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=337.44 Aligned_cols=246 Identities=30% Similarity=0.582 Sum_probs=217.9
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
+|++.+.||+|+||.||++.+..+++.|++|.+... ..+.+.+|+.++++++||||+++++.+.+.+.+|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 699999999999999999999999999999987432 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 79 VGGDLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 79 eGGSL~dlIkq--~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~---- 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY---- 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc----
Confidence 99999998865 346899999999999999999999999999999999999999999999999998766432221
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
.....|++.|+|||++.+ ..++.++|+||+|+++|+|++|..||...+.......+..+...+.+...+..+.++|.+
T Consensus 157 -~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 157 -ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred -cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 123568999999999864 457889999999999999999999999988888777777666666777889999999999
Q ss_pred hcccCCCCCCCHHHHhcC
Q 000715 237 LLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILkH 254 (1335)
||..||++|||+.+++.-
T Consensus 235 ~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 MFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHhCCcccCCCHHHHhhc
Confidence 999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=344.53 Aligned_cols=251 Identities=30% Similarity=0.507 Sum_probs=207.3
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
+++|++.+.||+|+||.||+|.++.+++.||+|.+.... ...+.+|++++++++||||+++++++.+....|+|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 578999999999999999999999999999999985432 2346789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|+. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++........
T Consensus 84 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--- 159 (291)
T cd07844 84 YLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT--- 159 (291)
T ss_pred cCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc---
Confidence 997 4899988764 47899999999999999999999999999999999999999999999999998754322111
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCCC--------------
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-FTQLVKSILSDPSP-------------- 220 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d-~~eLikkIl~~~~~-------------- 220 (1335)
.....++..|+|||++.+...++.++||||+|+++|+|++|+.||.+.. ..+....+......
T Consensus 160 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 160 --YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred --ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1123478899999998755667889999999999999999999997665 33333222110000
Q ss_pred ----------C-----CCCCCC--hhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 221 ----------P-----LPGNPS--RPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 221 ----------p-----ip~~iS--~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+ .....+ ..+.+++.+||+.||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 001233 778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=343.64 Aligned_cols=251 Identities=33% Similarity=0.544 Sum_probs=210.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh--HHHHHHHHHHHHhC-CCCCcceEEEEEE-----eCCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSL-DHPNVLRFYSWYE-----TSAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~--~e~LlrEIqILkkL-~HPNIVrL~dvfe-----ds~~lyL 73 (1335)
++|++.+.||+|+||.||+|.+..+++.||+|...... ...+.+|+.+++.+ +||||+++++++. ....+|+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 97 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWL 97 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEE
Confidence 68999999999999999999999999999999886532 35678899999999 7999999999873 4567999
Q ss_pred EEeecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCC
Q 000715 74 VLEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~ 149 (1335)
||||++|++|.+++.. ...+++..++.++.|++.|+.|||+++++||||||+||+++.++.+||+|||++......
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 177 (286)
T cd06638 98 VLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 177 (286)
T ss_pred EEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccC
Confidence 9999999999998753 357899999999999999999999999999999999999999999999999998766432
Q ss_pred CCCCCCCCCCCccCCCCCCCcchhcc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCC
Q 000715 150 SKAPSSMLPQAKCGTPCYMAPELFEE----GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS--PPLP 223 (1335)
Q Consensus 150 ~~~~ss~l~~t~~GTp~YmAPEVL~~----~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~--~pip 223 (1335)
... .....|++.|+|||++.. ...++.++||||+||++|+|++|+.||..........++..... ...+
T Consensus 178 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (286)
T cd06638 178 RLR-----RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP 252 (286)
T ss_pred CCc-----cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCC
Confidence 211 123468999999999853 24467899999999999999999999988765554444333221 1234
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 224 ~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
...+..+.++|.+||+.||++|||+.++++|+||
T Consensus 253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 4567889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=344.77 Aligned_cols=249 Identities=29% Similarity=0.487 Sum_probs=209.9
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+|+..+.||.|+||.||+|+++.+|+.|++|.+... ....+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 599999999999999999999999999999988543 234678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 78 CVGGDLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 78 ~eGGSL~dlIkq--~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
+. ++|.+++.. ...+++..++.++.|++.|+.|||++|++||||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--- 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--- 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc---
Confidence 95 689888865 457899999999999999999999999999999999999999999999999998765432211
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---------------
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP--------------- 220 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~--------------- 220 (1335)
.....+++.|+|||++.+...++.++|+||||+++|+|++|+.||.+.+..+...++......
T Consensus 157 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 157 --YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred --cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 122457899999999876666788999999999999999999999887655443332211000
Q ss_pred -------------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 221 -------------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 221 -------------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
......++++.++|.+||+.||++|||++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=348.18 Aligned_cols=252 Identities=28% Similarity=0.530 Sum_probs=216.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
.+|++.+.||+|+||.||+|.+..+++.|++|.+... ....+.+|+.+++.++||||+++++.+......|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5899999999999999999999999999999988643 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
+|++|.+++.+ ..+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... .
T Consensus 100 ~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-----~ 173 (296)
T cd06654 100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-----R 173 (296)
T ss_pred CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc-----c
Confidence 99999999865 46899999999999999999999999999999999999999999999999998765432211 1
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCChhHHHHHHH
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP--PLPGNPSRPFANLINS 236 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~--pip~~iS~eL~DLIkk 236 (1335)
....|++.|+|||.+.. ..++.++|+|||||++|+|++|+.||...+.......+.....+ +.+...+..+.+++.+
T Consensus 174 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred CcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence 23468999999999864 45678999999999999999999999887765444433332222 2345678899999999
Q ss_pred hcccCCCCCCCHHHHhcCcccccc
Q 000715 237 LLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
||..||++|||+.++++||||...
T Consensus 253 ~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 253 CLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=342.42 Aligned_cols=252 Identities=34% Similarity=0.549 Sum_probs=214.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
++|++.+.||+|+||.||+|.++.+++.|++|.+... ....+.+|++++++++|+||+++++++...+..|+|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 5899999999999999999999999999999987542 34578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
|++++.+..+..+...+++.++..++.|++.|+.|||++|++||||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~---- 156 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS---- 156 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc----
Confidence 9998888877777778999999999999999999999999999999999999999999999999998876543321
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP------------------ 218 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~------------------ 218 (1335)
......++.+|+|||++.....++.++|+||+|+++|+|++|++||.+....+....+....
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence 11235689999999999765477889999999999999999999998775544332221100
Q ss_pred --C-----------CCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 219 --S-----------PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 219 --~-----------~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
. ...+...+.++.++|++||..||++|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 01223347889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=341.80 Aligned_cols=247 Identities=22% Similarity=0.352 Sum_probs=212.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEEC---CCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKK---KTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk---~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
++|++.+.||+|+||.||+|.++ ..+..||+|.+... ....+.+|+.++++++||||+++++++...+..|+|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 47999999999999999999875 45678999998643 234678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
|||+++|+|.+++... ..+++.+++.++.|++.||.|||++|++||||||+||+++.++.+|++|||.+.........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~- 163 (266)
T cd05064 85 TEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY- 163 (266)
T ss_pred EEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh-
Confidence 9999999999999774 57999999999999999999999999999999999999999999999999987653221110
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~D 232 (1335)
......++..|+|||++.. ..++.++||||+||++|++++ |..||.+....+....+......+.+..++..+.+
T Consensus 164 ---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 164 ---TTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred ---cccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 1112345678999999864 567889999999999999775 99999998888888877776666777888999999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 000715 233 LINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILk 253 (1335)
++.+||+.+|++||+++++++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=347.01 Aligned_cols=258 Identities=33% Similarity=0.544 Sum_probs=219.5
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||++.+..+++.|++|.+.+.. ...+.+|+++++.++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 57999999999999999999999999999999986542 345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC---
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA--- 152 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~--- 152 (1335)
||++|++|.+++...+.+++..+..++.|++.|+.|||++|++||||||+||+++.+|.+||+|||+++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999988642111000
Q ss_pred -------CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCC
Q 000715 153 -------PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS--PPLP 223 (1335)
Q Consensus 153 -------~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~--~pip 223 (1335)
..........|+..|+|||.+.. ..++.++|+|||||++|+|++|..||.+....+....+..... +...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 00001122468889999999864 4578899999999999999999999998888777776654321 2222
Q ss_pred CCCChhHHHHHHHhcccCCCCCCC---HHHHhcCcccccc
Q 000715 224 GNPSRPFANLINSLLVKDPAQRLH---WSDLCGHAFWRTK 260 (1335)
Q Consensus 224 ~~iS~eL~DLIkkcLqkDPsKRPT---AeEILkHPfFq~~ 260 (1335)
...+.++.++|.+||+.||++||+ +.++++||||...
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 357889999999999999999998 7999999999654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=344.17 Aligned_cols=247 Identities=30% Similarity=0.510 Sum_probs=209.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
++|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 5799999999999999999999999999999998543 234678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+++++|..+ ..+++..+..++.|++.|+.|||++||+|+||||+||+++.+|.+||+|||++.......
T Consensus 81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~------- 149 (279)
T cd06619 81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI------- 149 (279)
T ss_pred CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-------
Confidence 999999654 357899999999999999999999999999999999999999999999999987654321
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCCCCC-CCCCChh
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF-------TQLVKSILSDPSPPL-PGNPSRP 229 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~-------~eLikkIl~~~~~pi-p~~iS~e 229 (1335)
....+|++.|+|||++.+ ..++.++|+||+|+++|+|++|+.||..... ......+........ ....+++
T Consensus 150 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (279)
T cd06619 150 AKTYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK 228 (279)
T ss_pred ccCCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence 133579999999999864 4578899999999999999999999965321 122233322222222 2346789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 230 FANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 230 L~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
+.+++.+||+.||.+||+++++++||||+..
T Consensus 229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 229 FVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 9999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=341.65 Aligned_cols=249 Identities=28% Similarity=0.508 Sum_probs=211.3
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
+|++.+.||.|++|.||+|++..+|+.||+|.+... ....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 699999999999999999999999999999988643 2456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 79 VGGDLMSLLRQD---NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 79 eGGSL~dlIkq~---~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
.+ +|.+++... ..+++.++..++.|++.||.|||++|++||||||+||++++++.+||+|||++.........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~--- 156 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--- 156 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc---
Confidence 75 888888654 36899999999999999999999999999999999999999999999999998765432211
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---------------
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP--------------- 220 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~--------------- 220 (1335)
.....+++.|++||++.....++.++|+||+|+++|+|++|++||.+.+..+...++......
T Consensus 157 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 157 --FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred --cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 123457899999999876666788999999999999999999999988766555544321100
Q ss_pred --C-----------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 221 --P-----------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 221 --p-----------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
. .....+..+.++|.+||+.||.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 112347789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=330.34 Aligned_cols=249 Identities=39% Similarity=0.729 Sum_probs=223.9
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+|++.+.||+|+||.||++.+..+++.|++|.+... ....+.+|++++++++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 699999999999999999999999999999998643 455688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 78 CVGGDLMSLLRQD----NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 78 ~eGGSL~dlIkq~----~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
+++++|.+++... ..+++.++..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~-- 158 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-- 158 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcc--
Confidence 9999999999763 7899999999999999999999999999999999999999999999999999877644321
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DL 233 (1335)
......|++.|+|||.+.. ..++.++|+||+|+++|+|++|..||...+..+...........+.+...+..+.++
T Consensus 159 ---~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (258)
T cd08215 159 ---LAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNL 234 (258)
T ss_pred ---eecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 1233578999999999864 446889999999999999999999999888888887777766667777889999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 000715 234 INSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 234 IkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+.+||..+|++|||+.++++||||
T Consensus 235 i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 235 VSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHcCCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=334.72 Aligned_cols=249 Identities=33% Similarity=0.622 Sum_probs=219.1
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+|++.+.||+|+||.||++.++.+|..||+|.+... ..+.+.+|++++++++|+||+++++.+......|+|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 699999999999999999999999999999998643 345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCC-eeeccccccccccCCCCCCC
Q 000715 78 CVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGR-TKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~-VKLiDFGLAr~l~e~~~~~s 154 (1335)
+.+++|.+++.... .+++..+..++.|++.|+.|||++|++|+||||+||++++++. +||+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~-- 158 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL-- 158 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc--
Confidence 99999999997643 5899999999999999999999999999999999999998864 699999998766432211
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
.....|++.|+|||++.. ..++.++|+||+|+++|+|++|..||...+..+....+......+.+...+.++.++|
T Consensus 159 ---~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 234 (257)
T cd08225 159 ---AYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLI 234 (257)
T ss_pred ---ccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHH
Confidence 122458999999999864 4567899999999999999999999998887777777766655566667789999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccc
Q 000715 235 NSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 235 kkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.+||..+|++|||+.++++||||
T Consensus 235 ~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 235 SQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHhccChhhCcCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.18 Aligned_cols=253 Identities=27% Similarity=0.503 Sum_probs=218.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
.+|++.+.||.|+||.||+|.+..+++.|++|.+... ....+.+|+.+++.++||||+++++++.....+|+|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3699999999999999999999999999999988543 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
.|++|.+++... .+++.++..++.|++.|+.|||++|++||||||+||+++.+|.+||+|||++......... .
T Consensus 99 ~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-----~ 172 (296)
T cd06655 99 AGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-----R 172 (296)
T ss_pred CCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-----C
Confidence 999999988654 6899999999999999999999999999999999999999999999999998765433211 1
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCChhHHHHHHH
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP--SPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~--~~pip~~iS~eL~DLIkk 236 (1335)
....|++.|+|||.+.. ..++.++|+|||||++|+|++|+.||...+.......+.... ....+..+++.+.++|.+
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 23468999999999864 456889999999999999999999998887665554443322 223455678899999999
Q ss_pred hcccCCCCCCCHHHHhcCccccccC
Q 000715 237 LLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
||..||++|||+.+++.||||+...
T Consensus 252 ~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 252 CLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=348.35 Aligned_cols=253 Identities=28% Similarity=0.509 Sum_probs=216.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++.++||||+++++++......|+||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5799999999999999999999999999999988543 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
+|++|.+++.+ ..+++.++..++.|++.||.|||+.|++||||||+||+++.+|.+||+|||++......... .
T Consensus 99 ~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-----~ 172 (297)
T cd06656 99 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-----R 172 (297)
T ss_pred CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-----c
Confidence 99999999865 46899999999999999999999999999999999999999999999999998765432211 1
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--CCCCCCCCChhHHHHHHH
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP--SPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~--~~pip~~iS~eL~DLIkk 236 (1335)
....|++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+.......+.... ....+...+..+.+++.+
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (297)
T cd06656 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNR 251 (297)
T ss_pred CcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHH
Confidence 23468999999999864 556889999999999999999999998776544333332222 122345678889999999
Q ss_pred hcccCCCCCCCHHHHhcCccccccC
Q 000715 237 LLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
||..||++||++.++++||||+...
T Consensus 252 ~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 252 CLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HccCChhhCcCHHHHhcCchhcccc
Confidence 9999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=330.08 Aligned_cols=249 Identities=35% Similarity=0.634 Sum_probs=222.4
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+|++.+.||+|++|.||++.+..+++.|++|.+... ....+.+|++++.+++|||++++++++.+.+..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 699999999999999999999999999999998544 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+++++|.+++...+.+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~----- 155 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD----- 155 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-----
Confidence 999999999998889999999999999999999999999999999999999999999999999999876543321
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHh
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkc 237 (1335)
.....|+..|+|||..... .++.++|+||+|+++|+|++|..||...+......+.........+...+..+.+++.+|
T Consensus 156 ~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 234 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMS-GASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC 234 (254)
T ss_pred ccccccchhhcCHhhhcCC-CCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence 1234689999999998644 478899999999999999999999988776666655555555667778899999999999
Q ss_pred cccCCCCCCCHHHHhcCccc
Q 000715 238 LVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 238 LqkDPsKRPTAeEILkHPfF 257 (1335)
|..+|++|||+.+++.||||
T Consensus 235 l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 235 FQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HhCChhhCcCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.82 Aligned_cols=251 Identities=29% Similarity=0.475 Sum_probs=208.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE-----
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSL-DHPNVLRFYSWYETSAH----- 70 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~----- 70 (1335)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+|+.+++++ +||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 58999999999999999999999999999999875432 34678899999999 46999999999877665
Q ss_pred EEEEEeecCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC-CCCeeeccccccc
Q 000715 71 LWLVLEYCVGGDLMSLLRQD-----NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE-NGRTKLCDFGLAR 144 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~-----~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe-dG~VKLiDFGLAr 144 (1335)
.|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999975 788887642 35899999999999999999999999999999999999998 8899999999987
Q ss_pred cccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---
Q 000715 145 KLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP--- 221 (1335)
Q Consensus 145 ~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p--- 221 (1335)
.+...... .....+++.|+|||++.+...++.++|+||+|+++|+|++|.+||.+.+..+....+......+
T Consensus 160 ~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 160 AFSIPVKS-----YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred ecCCCccc-----cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 65332211 1223578999999998765667889999999999999999999998876655444332210000
Q ss_pred ------------------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 000715 222 ------------------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWR 258 (1335)
Q Consensus 222 ------------------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq 258 (1335)
.....+.++.++|.+||..||.+||++.+++.||||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0124678899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.71 Aligned_cols=255 Identities=31% Similarity=0.513 Sum_probs=206.6
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSA------ 69 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~------ 69 (1335)
+++|++.+.||+|+||.||+|.+..+++.||+|.+... ......+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 47899999999999999999999999999999987532 1234568999999999999999999876543
Q ss_pred --EEEEEEeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccc
Q 000715 70 --HLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKL 146 (1335)
Q Consensus 70 --~lyLVMEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l 146 (1335)
..|+||||+. ++|.+++... ..+++.+++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 4699999985 5788777654 47999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCCC--
Q 000715 147 SDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS---DPSPP-- 221 (1335)
Q Consensus 147 ~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~---~~~~p-- 221 (1335)
......... ......++..|+|||++.+...++.++|+||+|+++|+|++|++||.+.+.......+.. ...+.
T Consensus 170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 170 SLSKNSKPN-RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred cCCcccCCC-CccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 543322111 112346789999999987555578899999999999999999999988765443322211 00000
Q ss_pred -------------C-------------CCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 222 -------------L-------------PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 222 -------------i-------------p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
. +...+..+.++|.+||..||.+|||++++++||||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 0 11235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=340.46 Aligned_cols=251 Identities=31% Similarity=0.587 Sum_probs=218.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
++|++.+.||+|+||.||+|.++.+++.|++|.+... ...++.+|++++++++||||+++++.+...+.+|+++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 5789999999999999999999999999999987543 345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 78 CVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 78 ~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
+.+++|.+++... ..+++..+..++.|++.|+.|||+ .|++||||||+||+++.+|.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~---- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA---- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----
Confidence 9999999999876 789999999999999999999999 9999999999999999999999999999876543211
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCCCCCCCCC-CChh
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-----EFTQLVKSILSDPSPPLPGN-PSRP 229 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~-----d~~eLikkIl~~~~~pip~~-iS~e 229 (1335)
....|+..|+|||.+.+ ..++.++|+||+|+++|+|++|..||... ...+....+.....+..+.. .+.+
T Consensus 157 ---~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPD 232 (265)
T ss_pred ---hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 11568899999999864 46788999999999999999999999764 33444555555444444444 7899
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 230 FANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 230 L~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
+.++|.+||..||++|||+.+++.||||+..
T Consensus 233 ~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 9999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.69 Aligned_cols=246 Identities=31% Similarity=0.498 Sum_probs=205.5
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh----HHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEEEe
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLD-HPNVLRFYSWYETS--AHLWLVLE 76 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~----~e~LlrEIqILkkL~-HPNIVrL~dvfeds--~~lyLVME 76 (1335)
|++.+.||+|+||.||+|.+..+++.||+|.+.+.. .....+|+.++.++. |||++++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 789999999999999999999999999999886431 223457888898884 99999999999887 88999999
Q ss_pred ecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 77 Y~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|+. +++.+.+.. ...+++.+++.++.|++.||.|||++|++||||||+||+++. |.+||+|||++.........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~--- 155 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--- 155 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc---
Confidence 996 577777765 457999999999999999999999999999999999999999 99999999998766432211
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---C-------------
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP---S------------- 219 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~---~------------- 219 (1335)
....+++.|+|||++..+..++.++|+||+||++|+|++|.+||.+.+..+.+..+.... .
T Consensus 156 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 156 ---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred ---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 234588999999987666677889999999999999999999998877655444332100 0
Q ss_pred -CC-----------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 220 -PP-----------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 220 -~p-----------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.. .....+..+.++|.+||.+||++|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00 112457899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.88 Aligned_cols=251 Identities=33% Similarity=0.569 Sum_probs=211.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhC-CCCCcceEEEEEEe------CCEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSL-DHPNVLRFYSWYET------SAHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL-~HPNIVrL~dvfed------s~~ly 72 (1335)
+.|++.+.||.|+||.||+|.+..+++.||+|.+... ....+..|+.+++++ +||||+++++++.. ...+|
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 4799999999999999999999999999999998654 345678899999998 79999999998853 46789
Q ss_pred EEEeecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 73 LVLEYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
++|||+.+|+|.+++... ..+++..+..++.|++.|+.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 96 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~ 175 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175 (282)
T ss_pred EEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc
Confidence 999999999999999763 468999999999999999999999999999999999999999999999999987653321
Q ss_pred CCCCCCCCCCccCCCCCCCcchhcc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCCCC
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEE----GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP-PLPGN 225 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~----~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~-pip~~ 225 (1335)
.. .....|++.|+|||++.. ...++.++|+|||||++|+|++|..||...........+...... .....
T Consensus 176 ~~-----~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (282)
T cd06636 176 GR-----RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKK 250 (282)
T ss_pred cC-----CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccc
Confidence 11 233568999999999752 345677999999999999999999999876655544444333222 23346
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 226 PSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 226 iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
++..+.++|.+||+.||.+|||+.++++||||
T Consensus 251 ~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 251 WSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 78999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=352.78 Aligned_cols=258 Identities=28% Similarity=0.501 Sum_probs=211.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS-----AHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds-----~~ly 72 (1335)
++|++.+.||+|+||.||+|.+..+|+.||+|.+... ....+.+|+.++++++||||+++++++... ...|
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 5899999999999999999999999999999988532 234577899999999999999999886544 3589
Q ss_pred EEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 73 LVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
+||||+. +++.+++. ...+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.........
T Consensus 85 lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 162 (336)
T cd07849 85 IVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162 (336)
T ss_pred EEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc
Confidence 9999985 58888774 457999999999999999999999999999999999999999999999999998876443221
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--------------
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP-------------- 218 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~-------------- 218 (1335)
.. .....+|++.|+|||++.....++.++||||+||++|+|++|++||.+.+.......+....
T Consensus 163 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 163 TG--FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cC--CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 11 12345789999999998665667889999999999999999999998766443332221100
Q ss_pred -----------CCC-----CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCC
Q 000715 219 -----------SPP-----LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTP 263 (1335)
Q Consensus 219 -----------~~p-----ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~ 263 (1335)
... .....+.++.++|.+||+.||++|||+.++++||||+....+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 000 012457889999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=404.89 Aligned_cols=256 Identities=31% Similarity=0.533 Sum_probs=229.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++++.||+|+||.|..++++.|++.||+|+++|- ...-|..|-.+|..-+.+.|++++..|++..++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 4799999999999999999999999999999999873 2345677888999889999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||++||+|..++.+.++++|+.++.|+..|+.||..||+.|+|||||||+|||+|..|++||+|||.+..+...+...
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~-- 232 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR-- 232 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEE--
Confidence 999999999999998899999999999999999999999999999999999999999999999999998887655432
Q ss_pred CCCCCccCCCCCCCcchhc---cC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCCh
Q 000715 156 MLPQAKCGTPCYMAPELFE---EG-GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP-SPPLP--GNPSR 228 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~---~~-~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~-~~pip--~~iS~ 228 (1335)
....+|||.|++||++. .+ +.|+..+|+||+||++|||++|..||..+...+.|.+|+.-. ...+| ..+|+
T Consensus 233 --s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 233 --SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred --eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCH
Confidence 34568999999999986 23 688999999999999999999999999999999999998642 22333 56899
Q ss_pred hHHHHHHHhcccCCCCCCC---HHHHhcCccccccCC
Q 000715 229 PFANLINSLLVKDPAQRLH---WSDLCGHAFWRTKLT 262 (1335)
Q Consensus 229 eL~DLIkkcLqkDPsKRPT---AeEILkHPfFq~~l~ 262 (1335)
++++||.+++. +|+.|.. ++|+..||||.+..+
T Consensus 311 eakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 311 EAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 99999999875 7899988 999999999988665
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=341.96 Aligned_cols=250 Identities=29% Similarity=0.452 Sum_probs=204.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
++|.+.+.||+|+||.||+|.+..+|+.|++|.+.... ...+.+|+++++.++|+||+++++++......|+||||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 57999999999999999999999999999999985432 23567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+. +++.+++.. ...+++.+++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++........
T Consensus 85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~---- 159 (291)
T cd07870 85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT---- 159 (291)
T ss_pred cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC----
Confidence 95 666666654 457889999999999999999999999999999999999999999999999998754332211
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCC----------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF-TQLVKSILSDPS---------------- 219 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~-~eLikkIl~~~~---------------- 219 (1335)
.....+++.|+|||++.+...++.++|+||||+++|+|++|..||.+... .+.+.++.....
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 160 -YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred -CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 12345789999999987555678899999999999999999999976543 222222211000
Q ss_pred -CC------------CC--CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 220 -PP------------LP--GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 220 -~p------------ip--~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.. .+ ...+..+.+++.+||..||.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 00 00 1125688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.97 Aligned_cols=244 Identities=35% Similarity=0.655 Sum_probs=214.8
Q ss_pred EeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 000715 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDL 83 (1335)
Q Consensus 10 LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL 83 (1335)
||.|+||.||+|++..+++.|++|.+.+. ....+.+|++++++++||||+++++.+.+...+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999998643 335688999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccC
Q 000715 84 MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCG 163 (1335)
Q Consensus 84 ~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~G 163 (1335)
.+++.+...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++........ .....|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~------~~~~~~ 154 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK------TWTFCG 154 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc------cccccC
Confidence 99999888899999999999999999999999999999999999999999999999999887654321 123468
Q ss_pred CCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhc-CCCCCCCCCCChhHHHHHHHhccc
Q 000715 164 TPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE--FTQLVKSILS-DPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 164 Tp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d--~~eLikkIl~-~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
++.|++||.+.. ..++.++|+||+|+++|+|++|..||.... ..+...++.. ......+...+..+.++|.+||..
T Consensus 155 ~~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 233 (262)
T cd05572 155 TPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233 (262)
T ss_pred CcCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence 999999999864 456889999999999999999999998776 6666666653 334455666789999999999999
Q ss_pred CCCCCCC-----HHHHhcCcccccc
Q 000715 241 DPAQRLH-----WSDLCGHAFWRTK 260 (1335)
Q Consensus 241 DPsKRPT-----AeEILkHPfFq~~ 260 (1335)
||++||+ +.|+++||||++.
T Consensus 234 ~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 234 NPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred ChhhCcCCcccCHHHHhcChhhhCC
Confidence 9999999 9999999999863
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=326.39 Aligned_cols=251 Identities=36% Similarity=0.602 Sum_probs=218.8
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETS--AHLWLVL 75 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds--~~lyLVM 75 (1335)
+|++.+.||+|++|.||+|.+..+++.|++|.+.... .+.+.+|+.++++++||||+++++.+... ..+++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5899999999999999999999999999999986543 56788999999999999999999999988 8999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||+.+++|.+++.+...+++.++..++.|++.|+.|||+.|++||||+|+||+++.++.+||+|||.+.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--- 157 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG--- 157 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc---
Confidence 99999999999998889999999999999999999999999999999999999999999999999998877554321
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc-CCCCCCCCCCChhHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-FTQLVKSILS-DPSPPLPGNPSRPFANL 233 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d-~~eLikkIl~-~~~~pip~~iS~eL~DL 233 (1335)
.......++..|+|||.+.. ..++.++|+||||+++|+|++|..||...+ .......+.. ......+...+..+.++
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF 236 (260)
T ss_pred ccccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence 00123568899999999864 347889999999999999999999998876 3333333332 33455677789999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 000715 234 INSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 234 IkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
|.+||..||++||++.+++.||||
T Consensus 237 i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 237 LRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHhCcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=331.87 Aligned_cols=254 Identities=34% Similarity=0.601 Sum_probs=216.3
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+|.+.+.||+|+||.||+|.+..+++.|++|.+... ....+.+|+.++++++|+||+++++.+...+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 699999999999999999999999999999997543 345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+++++|.+++..+..+++..++.++.|++.|+.|||++|++||||+|+||++++++.+||+|||++.............
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~- 159 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE- 159 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc-
Confidence 9999999999988889999999999999999999999999999999999999999999999999988765433221110
Q ss_pred CCCccCCCCCCCcchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCCCCCCCC--CChhHHH
Q 000715 158 PQAKCGTPCYMAPELFEEGG--VHSYASDLWGLGCVLYECYAGRPPFVGRE-FTQLVKSILSDPSPPLPGN--PSRPFAN 232 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~--~yS~kSDIWSLGVILYELLTGrpPF~g~d-~~eLikkIl~~~~~pip~~--iS~eL~D 232 (1335)
.....+++.|+|||++.... .++.++||||+|+++|+|++|+.||...+ .......+.....+..+.. .+..+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 12356889999999986433 36789999999999999999999997653 3333333333334444444 4899999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCccc
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+|.+||+.||++|||+.+++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=342.10 Aligned_cols=253 Identities=33% Similarity=0.585 Sum_probs=220.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+.|+..+.||.|+||.||+|.+..++..||+|.+... ....+.+|+.++++++||||+++++.+.+.+..|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3588899999999999999999999999999988643 345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
++|++|.+++.. +++++.++..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~----- 157 (277)
T cd06640 84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK----- 157 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc-----
Confidence 999999999865 57899999999999999999999999999999999999999999999999998766432211
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHh
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkc 237 (1335)
.....++..|+|||++. +..++.++|+|||||++|+|++|..||...........+.....+..+...+..+.+++.+|
T Consensus 158 ~~~~~~~~~y~apE~~~-~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQ-QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC 236 (277)
T ss_pred cccccCcccccCHhHhc-cCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHH
Confidence 12346888999999986 34568899999999999999999999988877666665544444555667789999999999
Q ss_pred cccCCCCCCCHHHHhcCccccccC
Q 000715 238 LVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 238 LqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
|..+|++||++.+++.|+||.+..
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 237 LNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred cccCcccCcCHHHHHhChHhhhcc
Confidence 999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=338.39 Aligned_cols=254 Identities=37% Similarity=0.620 Sum_probs=221.5
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLD-HPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~-HPNIVrL~dvfeds~~lyLV 74 (1335)
++|++.+.||+|+||.||+|.+..+|+.|++|++.+. ....+.+|..++++++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 5899999999999999999999999999999998653 2345788999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|||+.+++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||||+||+++.+|.++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999988999999999999999999999999999999999999999999999999999887654322100
Q ss_pred ---------------CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC
Q 000715 155 ---------------SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS 219 (1335)
Q Consensus 155 ---------------s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~ 219 (1335)
........|+..|+|||++.. ..++.++|+||||+++|++++|+.||...+....+..+... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~ 238 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKL-E 238 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhc-C
Confidence 011234568899999999864 45788999999999999999999999988766666665532 3
Q ss_pred CCCCCCCChhHHHHHHHhcccCCCCCCCH----HHHhcCccc
Q 000715 220 PPLPGNPSRPFANLINSLLVKDPAQRLHW----SDLCGHAFW 257 (1335)
Q Consensus 220 ~pip~~iS~eL~DLIkkcLqkDPsKRPTA----eEILkHPfF 257 (1335)
...+...++.+.++|.+||..||++||++ +++++||||
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 34566779999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=342.03 Aligned_cols=254 Identities=28% Similarity=0.463 Sum_probs=211.9
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
|++|++.+.||+|++|.||+|.++.+|+.|++|.+... ....+.+|++++++++||||+++++++.+....|+||
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 68999999999999999999999999999999988543 2346788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC-CCCeeeccccccccccCCCCC
Q 000715 76 EYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE-NGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe-dG~VKLiDFGLAr~l~e~~~~ 152 (1335)
||+. ++|.+.+.... .+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++.........
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 9995 57888776544 3588999999999999999999999999999999999985 567999999998765332111
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----------
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP----------- 221 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p----------- 221 (1335)
.....|++.|+|||++.+...++.++||||+|+++|+|++|++||...+..+.+.++......+
T Consensus 160 -----~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 160 -----FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred -----cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence 1224578999999998765667889999999999999999999998876655554432210000
Q ss_pred -----------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 222 -----------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 222 -----------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
.....++.+.+++.+||+.||++||++.+++.||||.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 113457889999999999999999999999999999864
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=345.02 Aligned_cols=251 Identities=31% Similarity=0.502 Sum_probs=211.5
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETS--AHLWL 73 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds--~~lyL 73 (1335)
+++|++.+.||+|+||.||+|.++.+++.|++|.+.... ...+.+|+.++++++||||+++++++... ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 468999999999999999999999999999999885432 23467899999999999999999998877 89999
Q ss_pred EEeecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~-~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
||||+. ++|.+++.... .+++.+++.++.|++.||.|||++|++||||||+||+++.+|.+||+|||++.........
T Consensus 84 v~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 84 VMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred EehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 999996 59999887644 5999999999999999999999999999999999999999999999999998876543211
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-------------
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS------------- 219 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~------------- 219 (1335)
.....+++.|+|||.+.+...++.++|+||+|+++|+|++|.+||......+...++.....
T Consensus 163 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 163 -----YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred -----cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 12345789999999987655678899999999999999999999988776655544322110
Q ss_pred -----------------CCCCCC-CChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 220 -----------------PPLPGN-PSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 220 -----------------~pip~~-iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
..++.. .++.+.++|.+||+.||++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 112222 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.49 Aligned_cols=252 Identities=27% Similarity=0.527 Sum_probs=216.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
++|++.+.||+|+||+||++.+..+|+.||+|++... ....+.+|+++++.++||||+++++.+...+.+|+||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 5799999999999999999999999999999987543 245678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+++++|.+++...+.+++..++.++.|++.|+.|||+ +|++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~------ 158 (284)
T cd06620 85 MDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI------ 158 (284)
T ss_pred CCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc------
Confidence 9999999999888899999999999999999999997 699999999999999999999999999886543221
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----------HHHHHHHhcCCCCCCCC-
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF-----------TQLVKSILSDPSPPLPG- 224 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~-----------~eLikkIl~~~~~pip~- 224 (1335)
.....|+..|+|||++.. ..++.++|+||+||++|+|++|..||..... .+....+.....+.++.
T Consensus 159 -~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred -cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 123568999999999864 4678899999999999999999999986543 23344444433333333
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 225 NPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 225 ~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
..+..+.+++.+||..||++|||+.++++|+||....
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 3678899999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=336.45 Aligned_cols=252 Identities=31% Similarity=0.518 Sum_probs=213.5
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-------------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-------------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSA 69 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-------------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~ 69 (1335)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+... ..+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 699999999999999999999999999999987421 1235678999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCC
Q 000715 70 HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 70 ~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~ 149 (1335)
..++||||+.|++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999998765332
Q ss_pred CCCCCCCCCCCccCCCCCCCcchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCC----C
Q 000715 150 SKAPSSMLPQAKCGTPCYMAPELFEEGG-VHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD-PSPPL----P 223 (1335)
Q Consensus 150 ~~~~ss~l~~t~~GTp~YmAPEVL~~~~-~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~-~~~pi----p 223 (1335)
.... ......|+..|+|||++.... .++.++|+||+|+++|++++|..||......+....+... ..... .
T Consensus 162 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd06629 162 YDND---QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS 238 (272)
T ss_pred cccc---ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence 1111 112346889999999986543 4688999999999999999999999876655544443222 12222 2
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 224 ~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
..++.++.++|.+||..||++|||++++++||||
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 3568899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=359.45 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=199.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
.+|++.+.||+|+||.||+|++..+++.||+|+..+.. ...|+.++++++||||+++++++......++||||+. +
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 141 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-S 141 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-C
Confidence 36999999999999999999999999999999865443 3579999999999999999999999999999999985 5
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 82 DLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 82 SL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
+|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 142 ~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~------~~~ 215 (357)
T PHA03209 142 DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA------FLG 215 (357)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc------ccc
Confidence 77777755 56799999999999999999999999999999999999999999999999999874322111 123
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCH---------HHHHHHHhcC---CCCCCC----
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGR-PPFVGREF---------TQLVKSILSD---PSPPLP---- 223 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGr-pPF~g~d~---------~eLikkIl~~---~~~pip---- 223 (1335)
..||+.|+|||++.+ ..++.++|||||||++|+|+++. ++|..... ...+..+... ....++
T Consensus 216 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 294 (357)
T PHA03209 216 LAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPG 294 (357)
T ss_pred ccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCc
Confidence 569999999999864 45788999999999999999854 44443211 0111111110 000001
Q ss_pred --------------------------CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 224 --------------------------GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 224 --------------------------~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
...+..+.++|.+||+.||.+|||+.|+++||||++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 295 SRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred cHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 134667888999999999999999999999999975
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=343.51 Aligned_cols=252 Identities=29% Similarity=0.494 Sum_probs=206.2
Q ss_pred cEEEEEEEeccCcEEEEEEEECC--CCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKK--TIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETS--AHLW 72 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~--TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds--~~ly 72 (1335)
+|++.+.||+|+||.||+|.+.. +++.||+|.+... ....+.+|+.++++++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999998 8999999998662 245678899999999999999999999988 8899
Q ss_pred EEEeecCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC----CCCeeecccccc
Q 000715 73 LVLEYCVGGDLMSLLRQD-----NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE----NGRTKLCDFGLA 143 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~-----~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe----dG~VKLiDFGLA 143 (1335)
+||||++ +++.+.+... ..+++..++.++.|++.||.|||++||+||||||+||+++. +|.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999986 4677766432 36899999999999999999999999999999999999999 899999999999
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHH
Q 000715 144 RKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ---------LVKSI 214 (1335)
Q Consensus 144 r~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~e---------LikkI 214 (1335)
......... .......++++.|+|||++.+...++.++|+||||+++|+|++|++||.+..... .+..+
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 160 RLFNAPLKP--LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccCCCccc--ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 876443221 1112345789999999998766667889999999999999999999997654321 11111
Q ss_pred hc-------------------------CCCCCCC-----------CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 215 LS-------------------------DPSPPLP-----------GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 215 l~-------------------------~~~~pip-----------~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.. ......+ ...+.++.+++.+||+.||++|||+.+++.||||
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 00 0000111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=328.19 Aligned_cols=243 Identities=29% Similarity=0.521 Sum_probs=215.7
Q ss_pred EEEeccCcEEEEEEEECCC---CeEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKT---IEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~T---Gk~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|.+... +..|++|.+.... ...+.+|++++..++|+||+++++++.+...+++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4799999999999999876 8899999986542 46788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCC
Q 000715 81 GDLMSLLRQD---------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 81 GSL~dlIkq~---------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~ 151 (1335)
++|.+++... ..+++.+++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc
Confidence 9999999885 7899999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhH
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPF 230 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL 230 (1335)
. .......+++.|+|||.+... .++.++||||+|+++|+|++ |..||.+....+....+........+...+.++
T Consensus 161 ~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd00192 161 Y---RKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDEL 236 (262)
T ss_pred c---ccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHH
Confidence 1 112335578899999998644 67889999999999999999 699999998888888887766667778889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 000715 231 ANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 231 ~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
.+++.+||..||++|||+.+++++
T Consensus 237 ~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 237 YELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=349.68 Aligned_cols=261 Identities=25% Similarity=0.425 Sum_probs=215.7
Q ss_pred CcEEE-EEEEeccCcEEEEEEEECCCCeEEEEEEcCchhH-----------------HHHHHHHHHHHhCCCCCcceEEE
Q 000715 2 NQYHI-YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK-----------------SKVLQEVRMLHSLDHPNVLRFYS 63 (1335)
Q Consensus 2 nrYeL-lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~-----------------e~LlrEIqILkkL~HPNIVrL~d 63 (1335)
++|.. .+.||.|+||.||+|.++.+++.||+|.+..... ..+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 46765 5779999999999999999999999998854321 13678999999999999999999
Q ss_pred EEEeCCEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccc
Q 000715 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143 (1335)
Q Consensus 64 vfeds~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLA 143 (1335)
++......|+||||+. ++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999996 699999988888999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC---------CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 000715 144 RKLSDASKA---------PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSI 214 (1335)
Q Consensus 144 r~l~e~~~~---------~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkI 214 (1335)
......... ..........+++.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..+....+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i 246 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 766521110 00011123457889999999876566788999999999999999999999988776655544
Q ss_pred hcCCC---CC------------------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCC
Q 000715 215 LSDPS---PP------------------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTP 263 (1335)
Q Consensus 215 l~~~~---~p------------------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~ 263 (1335)
..... .. .....+..+.++|.+||+.||++|||+++++.||||+.....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 32110 00 012347789999999999999999999999999999876544
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.80 Aligned_cols=248 Identities=22% Similarity=0.403 Sum_probs=214.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC-----CCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-----TIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~-----TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~ly 72 (1335)
++|.+.+.||+|+||.||+|++.. +++.||+|.+... ....+.+|++++++++||||+++++++......|
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468999999999999999998754 4678999998653 2457889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeec
Q 000715 73 LVLEYCVGGDLMSLLRQDN--------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLC 138 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~--------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLi 138 (1335)
+||||++|++|.+++...+ .+++.++..++.|++.|+.|||++|++||||||+||+++.++.+||+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEEC
Confidence 9999999999999997642 47899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC
Q 000715 139 DFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD 217 (1335)
Q Consensus 139 DFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~ 217 (1335)
|||++......... .......+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+..+
T Consensus 165 d~g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 165 DFGMSRDVYTTDYY---RVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred CcccceecccCcce---ecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99998765332211 11123346788999999864 557889999999999999998 99999988888888877766
Q ss_pred CCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 218 PSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 218 ~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
.....+...+..+.+++.+||..||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 666667788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.88 Aligned_cols=236 Identities=22% Similarity=0.349 Sum_probs=206.1
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEee
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYET----SAHLWLVLEY 77 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfed----s~~lyLVMEY 77 (1335)
..||+|++|.||+|.. +|+.||+|.+.+.. .+.+.+|+.++++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999988 57899999986532 3556799999999999999999999876 4578999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHsk-GIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
++||+|.+++.+.+.+++.....++.|++.|+.|||+. +++||||||+||+++++|.+||+|||++.......
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------ 177 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------ 177 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc------
Confidence 99999999999888999999999999999999999984 99999999999999999999999999987654321
Q ss_pred CCCCccCCCCCCCcchhcc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCChhHHHHH
Q 000715 157 LPQAKCGTPCYMAPELFEE-GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~-~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~-~~~~pip~~iS~eL~DLI 234 (1335)
....|++.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+++..+.. ....+.+...++.+.+++
T Consensus 178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li 255 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIV 255 (283)
T ss_pred --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHH
Confidence 22458899999999864 25678999999999999999999999999888887777653 334556667899999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 000715 235 NSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 235 kkcLqkDPsKRPTAeEILk 253 (1335)
.+||+.||++|||+.++++
T Consensus 256 ~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 256 EACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHhcCCcccCcCHHHHHH
Confidence 9999999999999999975
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=334.32 Aligned_cols=247 Identities=23% Similarity=0.403 Sum_probs=216.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh--HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~--~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
.+|.+.+.||+|+||.||+|.++.+++.|++|.+.+.. ...+.+|++++++++||||+++++++.....+++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 46999999999999999999999999999999986543 4568899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 80 GGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 80 GGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||++..........
T Consensus 86 ~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~---- 161 (263)
T cd05052 86 YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA---- 161 (263)
T ss_pred CCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec----
Confidence 99999999764 368999999999999999999999999999999999999999999999999988764432111
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
.....+++.|+|||.+. +..++.++|||||||++|+|++ |..||.+.+..+....+........+...+.++.+++.+
T Consensus 162 ~~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (263)
T cd05052 162 HAGAKFPIKWTAPESLA-YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA 240 (263)
T ss_pred cCCCCCccccCCHHHhc-cCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 11123467899999886 4456889999999999999998 999999988888877777666666778889999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 000715 237 LLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILk 253 (1335)
||..||++|||+.++++
T Consensus 241 cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 241 CWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999999965
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=342.20 Aligned_cols=245 Identities=32% Similarity=0.560 Sum_probs=204.1
Q ss_pred EEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 9 AIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRML---HSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 9 ~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqIL---kkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
.||+|+||.||++.+..+++.||+|.+.+.. .....+|..++ ...+||||+.+++++...+..|+||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999885431 12233444333 34479999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQ 159 (1335)
Q Consensus 80 GGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~ 159 (1335)
|++|.+++..++.+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||++....... ..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-------~~ 153 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PH 153 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-------cc
Confidence 99999999988899999999999999999999999999999999999999999999999999987553321 12
Q ss_pred CccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCCCCCCCCCCChhHHHHHHHh
Q 000715 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF--TQLVKSILSDPSPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 160 t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~--~eLikkIl~~~~~pip~~iS~eL~DLIkkc 237 (1335)
...|++.|+|||.+..+..++.++|+||+||++|+|++|..||..... ...............+...+.++.++|.+|
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGL 233 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHH
Confidence 346999999999986556678899999999999999999999975432 122222222233445677899999999999
Q ss_pred cccCCCCCC-----CHHHHhcCcccccc
Q 000715 238 LVKDPAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 238 LqkDPsKRP-----TAeEILkHPfFq~~ 260 (1335)
|..||.+|+ |+.++++||||+..
T Consensus 234 l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 234 LQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred hcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 999999999 69999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.40 Aligned_cols=261 Identities=28% Similarity=0.485 Sum_probs=215.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYET----SAHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfed----s~~ly 72 (1335)
++|++.+.||+|+||.||+|.++.+|+.||+|.+... ....+.+|+.++++++||||+++++++.. ...+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 4799999999999999999999999999999988643 24567789999999999999999988753 45789
Q ss_pred EEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 73 LVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
+||||+. ++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.........
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 9999995 689999988888999999999999999999999999999999999999999999999999998766443222
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD--------------- 217 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~--------------- 217 (1335)
... ......|+.+|+|||++.....++.++||||+||++|+|++|++||.+.+....+..+...
T Consensus 164 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 164 HKY-FMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCc-ccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 111 1234578999999999876566789999999999999999999999887654433222110
Q ss_pred --------C--CCC-----CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCCC
Q 000715 218 --------P--SPP-----LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPM 264 (1335)
Q Consensus 218 --------~--~~p-----ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~~ 264 (1335)
. ... .....+.++.++|.+||+.||++|||+.+++.||||.....+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 0 001 1134688899999999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=332.04 Aligned_cols=246 Identities=24% Similarity=0.439 Sum_probs=213.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
++|++.+.||+|+||.||+++++. +..+|+|.+.+. ...++.+|+.++++++||||+++++++......|+||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 579999999999999999998865 457999987654 24578899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 80 GGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
||+|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.++......... .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~----~ 158 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS----S 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec----c
Confidence 99999999753 568999999999999999999999999999999999999999999999999987653322111 1
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHh
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkc 237 (1335)
....++..|+|||++.. ..++.++|+||+|+++|+|++ |+.||...+..+....+........+...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05114 159 SGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSC 237 (256)
T ss_pred CCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Confidence 12235668999999863 457889999999999999999 9999999888888888877666666777889999999999
Q ss_pred cccCCCCCCCHHHHhc
Q 000715 238 LVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 238 LqkDPsKRPTAeEILk 253 (1335)
|..||++||++.++++
T Consensus 238 ~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 238 WHEKPEGRPTFAELLR 253 (256)
T ss_pred ccCCcccCcCHHHHHH
Confidence 9999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=338.56 Aligned_cols=248 Identities=31% Similarity=0.511 Sum_probs=209.5
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
|++.+.||.|++|.||+|.++.+|+.|++|.+... ....+.+|++++++++|||++++++++.+.+..|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 78899999999999999999999999999988543 2346788999999999999999999999999999999998
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 79 eGGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+++|.+++.... .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~---- 155 (283)
T cd07835 81 -DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT---- 155 (283)
T ss_pred -CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc----
Confidence 468999987765 7999999999999999999999999999999999999999999999999998765332211
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS----------------- 219 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~----------------- 219 (1335)
.....+++.|+|||++.....++.++|+||+|+++|+|++|++||.+.+......++.....
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 12235788999999987655678899999999999999999999987765444333221100
Q ss_pred -----------CCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 220 -----------PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 220 -----------~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.......+..+.++|.+||+.||.+|||+++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01124567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=336.17 Aligned_cols=253 Identities=32% Similarity=0.580 Sum_probs=208.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRM-LHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqI-LkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
++|++.+.||+|+||.||++.++.+|+.||+|.+... ...++..|+.+ ++.++||||+++++++...+..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 5899999999999999999999999999999988643 23345566665 566799999999999999999999999
Q ss_pred ecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeEECCCCCeeeccccccccccCCCC
Q 000715 77 YCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 77 Y~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHsk-GIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~ 151 (1335)
|++ ++|.+++.. ...+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA 159 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 985 678777654 34789999999999999999999998 999999999999999999999999999876543211
Q ss_pred CCCCCCCCCccCCCCCCCcchhccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCCCC-CCC
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEG---GVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVKSILSDPSPPLP-GNP 226 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~---~~yS~kSDIWSLGVILYELLTGrpPF~g~-d~~eLikkIl~~~~~pip-~~i 226 (1335)
.....|+..|+|||++... ..++.++|+||+||++|+|++|+.||... ...+.+..+.....+..+ ..+
T Consensus 160 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 160 ------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred ------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 1224588999999988532 34678999999999999999999999753 223334444443333333 357
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 227 SRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 227 S~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
+.++.++|.+||..+|++||++.+++.||||....
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 89999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=336.09 Aligned_cols=249 Identities=21% Similarity=0.385 Sum_probs=211.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC-----CCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-----TIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~-----TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~ly 72 (1335)
++|++.+.||+|+||.||+|.++. ++..||+|.+... ....+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 579999999999999999998753 4577999988542 2345789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccc
Q 000715 73 LVLEYCVGGDLMSLLRQDN----------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGL 142 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~----------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGL 142 (1335)
+||||+++++|.+++.+.. .++...+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCC
Confidence 9999999999999997532 357788999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCC
Q 000715 143 ARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPP 221 (1335)
Q Consensus 143 Ar~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~p 221 (1335)
+........... .....+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+.........+.......
T Consensus 166 ~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05062 166 TRDIYETDYYRK---GGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLD 241 (277)
T ss_pred ccccCCcceeec---CCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 876533221110 112346788999999864 557889999999999999998 799999888877777766665556
Q ss_pred CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 222 ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
.+...+..+.+++.+||+.||++|||+.+++++
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 242 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 677889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=344.08 Aligned_cols=251 Identities=33% Similarity=0.607 Sum_probs=216.6
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
.|+..+.||+|+||.||+|.+..+++.||+|.+... ....+.+|++++++++||||+++++++...+..|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 466778899999999999999999999999998633 3456789999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
++++|.+++.. +.+++..++.++.|++.|+.|||++|++|+||+|+||++++++.++|+|||++......... .
T Consensus 85 ~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-----~ 158 (277)
T cd06642 85 GGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK-----R 158 (277)
T ss_pred CCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh-----h
Confidence 99999998864 57899999999999999999999999999999999999999999999999998765432211 1
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhc
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLL 238 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcL 238 (1335)
....|+..|+|||++.. ..++.++|+|||||++|+|++|+.||...........+.....+..+...+.++.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence 23458899999999864 45688999999999999999999999877665555555444444455667889999999999
Q ss_pred ccCCCCCCCHHHHhcCcccccc
Q 000715 239 VKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 239 qkDPsKRPTAeEILkHPfFq~~ 260 (1335)
..+|++||++.++++||||...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHHH
Confidence 9999999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=378.82 Aligned_cols=255 Identities=35% Similarity=0.576 Sum_probs=234.0
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++.|.+.+.||+|.|++|.+|++..||..||||++++.+ ...+.+|+++|+.++|||||+++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 357999999999999999999999999999999998864 345789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||+.+|++++++.++++..+..++.++.|++++++|||+++|+|||||++||+++.+.++||+|||++..+....
T Consensus 135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~----- 209 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL----- 209 (596)
T ss_pred EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999886432
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
+..++||++.|.|||++.+..+.++.+|+||+|+++|.|++|..||++.+..++-...+.+. ..+|-..+.++.++|+
T Consensus 210 -~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk-~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 210 -MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGK-YRIPFYMSCDCEDLLR 287 (596)
T ss_pred -cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeee-ecccceeechhHHHHH
Confidence 24678999999999999988899999999999999999999999999998887776665542 3466778999999999
Q ss_pred HhcccCCCCCCCHHHHhcCccccccCC
Q 000715 236 SLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 236 kcLqkDPsKRPTAeEILkHPfFq~~l~ 262 (1335)
++|..+|.+|++.+++.+|.|......
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchhhh
Confidence 999999999999999999999865543
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=337.30 Aligned_cols=250 Identities=23% Similarity=0.407 Sum_probs=213.9
Q ss_pred CCcEEEEEEEeccCcEEEEEEEE----CCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRK----KKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArd----k~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~ly 72 (1335)
+++|++.+.||+|+||+||+|.+ ..+++.|++|.+... ....+.+|+.++++++||||+++++++......|
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 46799999999999999999985 345678999998642 2356788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCe
Q 000715 73 LVLEYCVGGDLMSLLRQD-----------------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRT 135 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~-----------------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~V 135 (1335)
+||||+.+++|.+++... ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence 999999999999998532 247889999999999999999999999999999999999999999
Q ss_pred eeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 000715 136 KLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214 (1335)
Q Consensus 136 KLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkI 214 (1335)
||+|||+++........ .......++..|+|||++.. ..++.++|+||||+++|+|++ |.+||.+.........+
T Consensus 164 kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 164 KISDLGLSREIYSADYY---RVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred EeccccccccccCCcce---ecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999866432211 11123446778999999864 457889999999999999998 99999888777777777
Q ss_pred hcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 215 LSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 215 l~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
......+.+...++.+.+++.+||+.||.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6666666778889999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=338.84 Aligned_cols=252 Identities=30% Similarity=0.555 Sum_probs=216.7
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
+|...+.||+|++|.||++.+..+++.|++|.+... ..+.+.+|+.++++++||||+++++++...+..|+|+||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 466678999999999999999999999999987532 34457899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQ 159 (1335)
Q Consensus 80 GGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~ 159 (1335)
|++|.+++.. +++++.++..++.|++.|+.|||++|++||||+|+||+++.++.++|+|||++......... ..
T Consensus 100 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~-----~~ 173 (285)
T cd06648 100 GGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR-----RK 173 (285)
T ss_pred CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-----cc
Confidence 9999999987 67999999999999999999999999999999999999999999999999988755432211 12
Q ss_pred CccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCChhHHHHHHHh
Q 000715 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGNPSRPFANLINSL 237 (1335)
Q Consensus 160 t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pi--p~~iS~eL~DLIkkc 237 (1335)
...|++.|+|||.+.. ..++.++|+||+|+++|+|++|+.||...+.......+.....+.. +...+..+.+++.+|
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 3468999999999864 4578899999999999999999999988877666666654432222 233678999999999
Q ss_pred cccCCCCCCCHHHHhcCccccccC
Q 000715 238 LVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 238 LqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
|..+|++|||+.++++||||++..
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred cccChhhCcCHHHHccCcccccCC
Confidence 999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=339.69 Aligned_cols=245 Identities=32% Similarity=0.544 Sum_probs=206.6
Q ss_pred EEeccCcEEEEEEEECCCCeEEEEEEcCchhH------HHHHHHH---HHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 9 AIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK------SKVLQEV---RMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 9 ~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~------e~LlrEI---qILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
.||+|+||.||+|.+..+++.||+|.+.+... .....|. +.++...||+|+++++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999865321 1223333 34455689999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQ 159 (1335)
Q Consensus 80 GGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~ 159 (1335)
|++|.+++...+.+++.+++.++.|++.|+.|||++|++||||||+||+++.++.+||+|||++..+.... ..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-------~~ 153 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PH 153 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-------Cc
Confidence 99999999888899999999999999999999999999999999999999999999999999987553221 12
Q ss_pred CccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR---EFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 160 t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~---d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
..+|+..|+|||++..+..++.++||||+|+++|+|++|+.||.+. ........+ .......+...+.++.+++.+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~ 232 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSPELRSLLEG 232 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-hccCCCCCCcCCHHHHHHHHH
Confidence 3569999999999975556788999999999999999999999876 333333333 223445666789999999999
Q ss_pred hcccCCCCCC-----CHHHHhcCccccccC
Q 000715 237 LLVKDPAQRL-----HWSDLCGHAFWRTKL 261 (1335)
Q Consensus 237 cLqkDPsKRP-----TAeEILkHPfFq~~l 261 (1335)
||..||.+|| ++.++++||||++..
T Consensus 233 ~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 233 LLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 9999999999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=350.56 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=208.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS------AH 70 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds------~~ 70 (1335)
++|++.+.||+|+||.||+|++..+|+.||+|.+.+. ....+.+|+.++++++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 5799999999999999999999999999999998642 344677899999999999999999988644 35
Q ss_pred EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
.|+||||+. ++|.+.+... +++.++..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus 96 ~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred EEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 799999995 5888887654 9999999999999999999999999999999999999999999999999997654322
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---------
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP--------- 221 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p--------- 221 (1335)
. .....|++.|+|||++.+ ..++.++||||+||++|+|++|+.||...+....+..+......+
T Consensus 173 ~------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 173 M------MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C------CCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 1 233568999999999864 557889999999999999999999998876554444332211000
Q ss_pred --------------------------C-------CCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 000715 222 --------------------------L-------PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 222 --------------------------i-------p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~ 262 (1335)
. +...+..+.++|.+||+.||++|||+.+++.||||+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 0 1123556899999999999999999999999999976544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=337.40 Aligned_cols=255 Identities=22% Similarity=0.399 Sum_probs=215.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC-----CCeEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-----TIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~-----TGk~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~ly 72 (1335)
++|++.+.||+|+||.||+|+++. .+..||+|.+.... ...+.+|+.+++.++||||+++++++......|
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 579999999999999999997653 35689999886432 335678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccc
Q 000715 73 LVLEYCVGGDLMSLLRQD----------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGL 142 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~----------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGL 142 (1335)
+||||+.+|+|.+++... ..++...+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~ 165 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM 165 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCc
Confidence 999999999999999753 2356778999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCC
Q 000715 143 ARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPP 221 (1335)
Q Consensus 143 Ar~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~p 221 (1335)
++.......... .....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+....+....+.......
T Consensus 166 ~~~~~~~~~~~~---~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 166 TRDIYETDYYRK---GGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred cccccccccccc---cCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 876543221111 122345778999999864 457889999999999999998 899999888888777776665556
Q ss_pred CCCCCChhHHHHHHHhcccCCCCCCCHHHHhc------Ccccccc
Q 000715 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDLCG------HAFWRTK 260 (1335)
Q Consensus 222 ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk------HPfFq~~ 260 (1335)
.+...++.+.+++.+||+.||++|||+.++++ ||||+..
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 66777899999999999999999999999986 8888753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=336.73 Aligned_cols=250 Identities=32% Similarity=0.589 Sum_probs=218.9
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+|++++++++||||+++++++......|+||||+.
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 78899999999999999999999999999987643 23567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQ 159 (1335)
Q Consensus 80 GGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~ 159 (1335)
+++|.+++.. +.+++..+..++.|++.|+.|||++|++|+||||+||+++.+|.++|+|||++......... ..
T Consensus 86 ~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~-----~~ 159 (277)
T cd06641 86 GGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-----RN 159 (277)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh-----hc
Confidence 9999998864 57899999999999999999999999999999999999999999999999998765432211 12
Q ss_pred CccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcc
Q 000715 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLV 239 (1335)
Q Consensus 160 t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLq 239 (1335)
...|+..|+|||.+.. ...+.++|+||+||++|+|++|..||...........+.....+..+...+.++.+++.+||.
T Consensus 160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 238 (277)
T cd06641 160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238 (277)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 3468899999999863 456789999999999999999999998877766666665554555667788999999999999
Q ss_pred cCCCCCCCHHHHhcCcccccc
Q 000715 240 KDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 240 kDPsKRPTAeEILkHPfFq~~ 260 (1335)
.+|++||++.+++.||||.+.
T Consensus 239 ~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 239 KEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred CChhhCcCHHHHHhCHHHhhh
Confidence 999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.77 Aligned_cols=247 Identities=36% Similarity=0.675 Sum_probs=214.6
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
+|++.+.||+|++|.||++.+..+++.|++|.+... ....+.+|++++++++|||++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 589999999999999999999999999999998654 34678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 80 GGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
|++|.+++... ..+++..+..++.|++.|+.|||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~------~ 154 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA------R 154 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc------c
Confidence 99999999876 6899999999999999999999999999999999999999999999999999877654321 1
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCC--CChhHHHHHHH
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN--PSRPFANLINS 236 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~--iS~eL~DLIkk 236 (1335)
....|+..|+|||.+.. ..++.++|+||||+++|+|++|+.||...+.......+.....+..+.. ++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 23568899999999864 4478899999999999999999999988755544444433322233322 38899999999
Q ss_pred hcccCCCCCCCHHHHhcCcc
Q 000715 237 LLVKDPAQRLHWSDLCGHAF 256 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILkHPf 256 (1335)
||..||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=339.27 Aligned_cols=245 Identities=27% Similarity=0.461 Sum_probs=204.6
Q ss_pred CcEEEEEEE--eccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAI--GRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~L--GeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
++|++.+.+ |+|+||.||++.++.+++.||+|.+........ |+.....+ +||||+++++++...+.+|+||||+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 467777776 999999999999999999999999876543322 22222222 7999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC-CeeeccccccccccCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG-RTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG-~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+|++|.+++..+..+++++++.++.|++.|+.|||+.|++||||||+||+++.++ .++|+|||++......
T Consensus 92 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-------- 163 (267)
T PHA03390 92 KDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-------- 163 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--------
Confidence 9999999998888999999999999999999999999999999999999999988 9999999998765321
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCCCCCCCCCChhHHHH
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQL----VKSILSDPSPPLPGNPSRPFANL 233 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eL----ikkIl~~~~~pip~~iS~eL~DL 233 (1335)
....|+..|+|||++.. ..++.++|+||+|+++|+|++|+.||........ ..... ....+.+...++.+.++
T Consensus 164 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l 240 (267)
T PHA03390 164 -SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDF 240 (267)
T ss_pred -ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHH
Confidence 22458999999999964 4568899999999999999999999986543221 22222 22334556789999999
Q ss_pred HHHhcccCCCCCCC-HHHHhcCccccc
Q 000715 234 INSLLVKDPAQRLH-WSDLCGHAFWRT 259 (1335)
Q Consensus 234 IkkcLqkDPsKRPT-AeEILkHPfFq~ 259 (1335)
|.+||+.||.+||+ ++++++||||.+
T Consensus 241 i~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 241 VQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred HHHHhccChhhCCchHHHHhcCCcccC
Confidence 99999999999996 699999999964
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=333.72 Aligned_cols=249 Identities=32% Similarity=0.550 Sum_probs=211.1
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEEe
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS--AHLWLVLE 76 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds--~~lyLVME 76 (1335)
|++.+.||.|+||.||+|.+..+++.||+|.+... ....+.+|++++++++|||++++++++... +..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 78999999999999999999999999999998654 244678899999999999999999999888 89999999
Q ss_pred ecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|++ ++|.+++... ..+++.+++.++.|++.|+.|||++|++|+||||+||+++++|.+||+|||++..........
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~-- 157 (287)
T cd07840 81 YMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD-- 157 (287)
T ss_pred ccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc--
Confidence 996 5888888765 689999999999999999999999999999999999999999999999999998765433211
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC--------------
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP-------------- 221 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p-------------- 221 (1335)
.....++..|+|||.+.+...++.++||||||+++|+|++|+.||...+.......+......+
T Consensus 158 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07840 158 --YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235 (287)
T ss_pred --ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence 1223578899999987655567889999999999999999999998887665555443211000
Q ss_pred ----------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 222 ----------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 222 ----------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+....+..+.+++.+||..||++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 011137889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.13 Aligned_cols=254 Identities=29% Similarity=0.539 Sum_probs=215.4
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
.|.....||+|+||.||++.+..+++.||+|.+... ..+.+.+|+.+++.++||||+++++.+...+..|+||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 355567899999999999999999999999988543 34467899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQ 159 (1335)
Q Consensus 80 GGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~ 159 (1335)
+++|.+++.. +.+++.++..++.||+.|+.|||++||+||||||+||+++.++.+||+|||++......... ..
T Consensus 103 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-----~~ 176 (292)
T cd06658 103 GGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-----RK 176 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-----Cc
Confidence 9999998854 57999999999999999999999999999999999999999999999999998765332211 13
Q ss_pred CccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCChhHHHHHHHh
Q 000715 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP--PLPGNPSRPFANLINSL 237 (1335)
Q Consensus 160 t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~--pip~~iS~eL~DLIkkc 237 (1335)
...|++.|+|||++. +..++.++|+||+|+++|+|++|+.||.+.+.......+...... +.....+..+.+++.+|
T Consensus 177 ~~~~~~~y~aPE~~~-~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 255 (292)
T cd06658 177 SLVGTPYWMAPEVIS-RLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255 (292)
T ss_pred eeecCccccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHH
Confidence 356899999999985 345688999999999999999999999887766655554332222 22335688899999999
Q ss_pred cccCCCCCCCHHHHhcCccccccCCC
Q 000715 238 LVKDPAQRLHWSDLCGHAFWRTKLTP 263 (1335)
Q Consensus 238 LqkDPsKRPTAeEILkHPfFq~~l~~ 263 (1335)
|..||.+|||++++++||||.....+
T Consensus 256 l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 256 LVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred ccCChhHCcCHHHHhhChhhhccCCc
Confidence 99999999999999999999875443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=341.18 Aligned_cols=247 Identities=23% Similarity=0.335 Sum_probs=202.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC----------------CCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK----------------TIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRF 61 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~----------------TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL 61 (1335)
++|++.+.||+|+||.||+|.+.. ++..||+|.+... ....+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 479999999999999999998643 4457999998543 24568899999999999999999
Q ss_pred EEEEEeCCEEEEEEeecCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 000715 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDN-------------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122 (1335)
Q Consensus 62 ~dvfeds~~lyLVMEY~eGGSL~dlIkq~~-------------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDI 122 (1335)
++++.+.+..++||||+.+++|.+++.... .+++.++..++.||+.||.|||++||+||||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dl 164 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCc
Confidence 999999999999999999999999986532 3677889999999999999999999999999
Q ss_pred CCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh--CCC
Q 000715 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA--GRP 200 (1335)
Q Consensus 123 KPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT--Grp 200 (1335)
||+||+++.++.+||+|||+++........ .......++..|+|||++.. +.++.++||||||+++|+|++ +..
T Consensus 165 kp~Nill~~~~~~kl~DfG~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred chhheEEcCCccEEECCCccceecccCcee---EecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999998765432211 11123456788999999864 457889999999999999986 678
Q ss_pred CCCCCCHHHHHHHHhc-------CCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 000715 201 PFVGREFTQLVKSILS-------DPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLC 252 (1335)
Q Consensus 201 PF~g~d~~eLikkIl~-------~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEIL 252 (1335)
||.+....+....+.. ......+..++..+.+++.+||..||++|||+.++.
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 8887666555443321 111223456788999999999999999999999993
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.97 Aligned_cols=256 Identities=30% Similarity=0.500 Sum_probs=207.3
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeC-------
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETS------- 68 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds------- 68 (1335)
+++|++.+.||+|+||.||+|.++.+++.|++|.+.... .....+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999999999999999874321 23567899999999999999999877443
Q ss_pred -CEEEEEEeecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccc
Q 000715 69 -AHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKL 146 (1335)
Q Consensus 69 -~~lyLVMEY~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l 146 (1335)
..+|+||||+.+ ++...+.. ...+++.+++.++.|+++||.|||++||+||||||+||+++++|.+||+|||++...
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 357999999854 67666654 458999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCCCC------CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Q 000715 147 SDASKAPSS------MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP 220 (1335)
Q Consensus 147 ~e~~~~~ss------~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~ 220 (1335)
......... .......|++.|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 245 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGT 245 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 443221110 01123457899999999876666788999999999999999999999887766555444321100
Q ss_pred C----------------------C-------CCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 221 P----------------------L-------PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 221 p----------------------i-------p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+ . ....++.+.++|.+||..||.+|||+.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 246 PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 0 01234678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=336.97 Aligned_cols=244 Identities=32% Similarity=0.551 Sum_probs=208.1
Q ss_pred EeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 000715 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDL 83 (1335)
Q Consensus 10 LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL 83 (1335)
||+|+||+||+|.+..+|+.|++|.+.+.. ...+.+|++++++++||||+++++++...+.+|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999999999999999986432 33456899999999999999999999999999999999999999
Q ss_pred HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCc
Q 000715 84 MSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161 (1335)
Q Consensus 84 ~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~ 161 (1335)
.+++.... .+++.++..++.|++.|+.|||++|++||||+|+||+++.++.+||+|||.+........ ....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~------~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK------IKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc------cccc
Confidence 99997765 799999999999999999999999999999999999999999999999999876543211 1234
Q ss_pred cCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCCCCCCCCChhHHHHHHHh
Q 000715 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF----TQLVKSILSDPSPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 162 ~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~----~eLikkIl~~~~~pip~~iS~eL~DLIkkc 237 (1335)
.++..|+|||++.++ .++.++|+||+|+++|+|++|+.||..... ..+...+. ......+...++.+.++|.+|
T Consensus 155 ~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 155 AGTPGYMAPEVLQGE-VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-EMAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cCCCCcCCHHHhcCC-CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-cccccCCccCCHHHHHHHHHH
Confidence 578899999998644 478899999999999999999999977643 22222222 223445667899999999999
Q ss_pred cccCCCCCC-----CHHHHhcCccccccC
Q 000715 238 LVKDPAQRL-----HWSDLCGHAFWRTKL 261 (1335)
Q Consensus 238 LqkDPsKRP-----TAeEILkHPfFq~~l 261 (1335)
|+.||.+|| ++.+++.||||.+..
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 999999999 899999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.38 Aligned_cols=249 Identities=25% Similarity=0.419 Sum_probs=214.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCC---CeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKT---IEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~T---Gk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
++|++.+.||+|+||+||+|.++.+ ...||+|.+... ....+.+|+.++++++||||+++++++...+..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5799999999999999999998754 457999988543 245678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
|||+++++|.+++... +.+++.++..++.|++.|+.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd05033 84 TEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY 163 (266)
T ss_pred EEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce
Confidence 9999999999999764 579999999999999999999999999999999999999999999999999998775221111
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~D 232 (1335)
. .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||......+....+......+.+...+..+.+
T Consensus 164 ~---~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 164 T---TKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred e---ccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 112345678999999864 457889999999999999998 99999888888887777766566667788999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 000715 233 LINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkH 254 (1335)
++.+||+.+|++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=329.29 Aligned_cols=242 Identities=29% Similarity=0.481 Sum_probs=206.2
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDL 83 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL 83 (1335)
+.||+|+||.||+|+++.+++.||+|.+.+. ....+.+|++++++++||||+++++++......|+||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999999999999999987543 345688999999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCcc
Q 000715 84 MSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC 162 (1335)
Q Consensus 84 ~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~ 162 (1335)
.+++... ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS---TGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc---cCCCCC
Confidence 9999764 468999999999999999999999999999999999999999999999999987654321110 001122
Q ss_pred CCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccC
Q 000715 163 GTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKD 241 (1335)
Q Consensus 163 GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkD 241 (1335)
++..|+|||.+.. +.++.++|+||||+++|+|++ |..||...........+......+.+...+..+.+++.+||..|
T Consensus 158 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (252)
T cd05084 158 IPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYD 236 (252)
T ss_pred CceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCC
Confidence 3457999999864 457889999999999999997 99999887776666666555555667778999999999999999
Q ss_pred CCCCCCHHHHhc
Q 000715 242 PAQRLHWSDLCG 253 (1335)
Q Consensus 242 PsKRPTAeEILk 253 (1335)
|++|||+.++++
T Consensus 237 p~~Rps~~~~~~ 248 (252)
T cd05084 237 PGQRPSFSTVHQ 248 (252)
T ss_pred hhhCcCHHHHHH
Confidence 999999999964
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.87 Aligned_cols=247 Identities=28% Similarity=0.493 Sum_probs=207.8
Q ss_pred EEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCC
Q 000715 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGD 82 (1335)
Q Consensus 6 LlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGS 82 (1335)
....||+|+||.||+|.+..++..|++|.+... ....+.+|+.++++++|+||+++++++...+..++||||+++++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence 456899999999999999999999999988654 34568899999999999999999999999999999999999999
Q ss_pred HHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC-CCCeeeccccccccccCCCCCCCCCCC
Q 000715 83 LMSLLRQD-NQL--PEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE-NGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 83 L~dlIkq~-~~L--SEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe-dG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
|.+++... ..+ ++..+..++.|++.|+.|||++||+||||||+||+++. ++.+||+|||++......... .
T Consensus 92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-----~ 166 (268)
T cd06624 92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-----T 166 (268)
T ss_pred HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc-----c
Confidence 99999764 456 88999999999999999999999999999999999976 679999999998765432211 1
Q ss_pred CCccCCCCCCCcchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 159 QAKCGTPCYMAPELFEEG-GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ--LVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~-~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~e--LikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
....|++.|+|||++... ..++.++|+||+|+++|+|++|++||....... ..........+.++...++++.+++.
T Consensus 167 ~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (268)
T cd06624 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246 (268)
T ss_pred ccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHH
Confidence 224589999999998543 346789999999999999999999997653322 22222223344567778899999999
Q ss_pred HhcccCCCCCCCHHHHhcCccc
Q 000715 236 SLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 236 kcLqkDPsKRPTAeEILkHPfF 257 (1335)
+||..+|++|||+.+++.||||
T Consensus 247 ~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 247 RCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHcCCCchhCCCHHHHHhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=330.51 Aligned_cols=248 Identities=31% Similarity=0.559 Sum_probs=209.3
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc------hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK------SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK------e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
+++|++.+.||+|+||.||+|+++.+++.||+|.+.. .....+.+|+++++.++||||+++++++...+..|+|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 4789999999999999999999999999999997643 2244678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 75 LEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
|||+++++|.+++.. ...+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999988853 3458999999999999999999999999999999999999999999999999987664322
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCCCCC-CCCCC
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE--FTQLVKSILSDPSPPL-PGNPS 227 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d--~~eLikkIl~~~~~pi-p~~iS 227 (1335)
.. .....|++.|+|||.+.. ..++.++|+||+|+++|+|++|+.||.... .......+.....++. +...+
T Consensus 161 ~~-----~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 161 TA-----AHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred HH-----HhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 11 123468899999999864 446789999999999999999999997653 3344444443333333 34567
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 228 RPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 228 ~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
..+.+++.+||..+|++||++.++++.
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=375.89 Aligned_cols=249 Identities=32% Similarity=0.516 Sum_probs=213.9
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCC-C-----CCcceEEEEEEeCCEEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLD-H-----PNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~-H-----PNIVrL~dvfeds~~lyLV 74 (1335)
+|++++.||+|+||.|.+|.+.+|++.||||++... ...+...|+++|..|+ | -|+|+++++|...+++|+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 799999999999999999999999999999999654 4566788999999996 4 4799999999999999999
Q ss_pred EeecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCC--CCeeeccccccccccCCC
Q 000715 75 LEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN--GRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDed--G~VKLiDFGLAr~l~e~~ 150 (1335)
+|.. +.+|.++++++. .|+...++.++.||+.||.+||+.||||+||||||||+.+. ..||++|||.++.....-
T Consensus 267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v 345 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV 345 (586)
T ss_pred ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc
Confidence 9987 789999999875 69999999999999999999999999999999999999754 379999999998765432
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---------
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP--------- 221 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p--------- 221 (1335)
-+++-+..|+|||++.+ ..|+.+.||||||||++||++|.+.|.+.+..+++..|+.....|
T Consensus 346 --------ytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 346 --------YTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred --------eeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 25678999999999984 567889999999999999999999999999888877664311000
Q ss_pred ------------------------------------------CC-----------CCCChhHHHHHHHhcccCCCCCCCH
Q 000715 222 ------------------------------------------LP-----------GNPSRPFANLINSLLVKDPAQRLHW 248 (1335)
Q Consensus 222 ------------------------------------------ip-----------~~iS~eL~DLIkkcLqkDPsKRPTA 248 (1335)
.| ......+.|||++||.+||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 01 0112457899999999999999999
Q ss_pred HHHhcCccccccC
Q 000715 249 SDLCGHAFWRTKL 261 (1335)
Q Consensus 249 eEILkHPfFq~~l 261 (1335)
.++++||||....
T Consensus 497 ~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 497 AQALNHPFLTGTS 509 (586)
T ss_pred HHHhcCccccccc
Confidence 9999999998643
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=328.90 Aligned_cols=249 Identities=39% Similarity=0.641 Sum_probs=214.0
Q ss_pred EeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 000715 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDL 83 (1335)
Q Consensus 10 LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL 83 (1335)
||.|+||.||++++..+|+.|++|.+... ....+.+|++++++++||||+++++.+...+..|+||||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999998654 234678899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC---CCCCCCC
Q 000715 84 MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP---SSMLPQA 160 (1335)
Q Consensus 84 ~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~---ss~l~~t 160 (1335)
.+++.+.+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.......... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 9999987899999999999999999999999999999999999999999999999999987654322100 0001123
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCC--ChhHHHHHHHhc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP--SRPFANLINSLL 238 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~i--S~eL~DLIkkcL 238 (1335)
..+++.|+|||..... .++.++|+||||+++|+|++|..||......+....+.... ...+... +..+.+++.+||
T Consensus 161 ~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l 238 (265)
T cd05579 161 IVGTPDYIAPEVILGQ-GHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK-IEWPEDVEVSDEAIDLISKLL 238 (265)
T ss_pred cccCccccCHHHhcCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-cCCCccccCCHHHHHHHHHHh
Confidence 4688999999998644 47889999999999999999999999888888777766533 2333444 899999999999
Q ss_pred ccCCCCCCCH---HHHhcCcccccc
Q 000715 239 VKDPAQRLHW---SDLCGHAFWRTK 260 (1335)
Q Consensus 239 qkDPsKRPTA---eEILkHPfFq~~ 260 (1335)
+.+|++|||+ .++++||||++.
T Consensus 239 ~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 239 VPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred cCCHhhcCCCccHHHHhcCccccCC
Confidence 9999999999 999999999754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.92 Aligned_cols=251 Identities=25% Similarity=0.475 Sum_probs=215.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc--------hhHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK--------SQKSKVLQEVRMLHSLDHPNVLRFYSWYETS--AHL 71 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK--------e~~e~LlrEIqILkkL~HPNIVrL~dvfeds--~~l 71 (1335)
++|++.+.||+|+||.||+|++..+++.|++|.+.. .....+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 579999999999999999999999999999998642 2234678899999999999999999988664 568
Q ss_pred EEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCC
Q 000715 72 WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~ 151 (1335)
++||||+++++|.+++...+.+++..++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999987643221
Q ss_pred CCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCChhH
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD-PSPPLPGNPSRPF 230 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~-~~~pip~~iS~eL 230 (1335)
.... .....|+..|+|||++.. ..++.++|+|||||++|+|++|++||.+........++... ..+.+|...++.+
T Consensus 162 ~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 238 (264)
T cd06653 162 SGTG--IKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDAC 238 (264)
T ss_pred cCcc--ccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHH
Confidence 1111 123568999999999864 44678999999999999999999999887666655555533 3455678889999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcc
Q 000715 231 ANLINSLLVKDPAQRLHWSDLCGHAF 256 (1335)
Q Consensus 231 ~DLIkkcLqkDPsKRPTAeEILkHPf 256 (1335)
.++|.+||. +|.+||++.+++.|||
T Consensus 239 ~~~i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 239 RDFLKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred HHHHHHHhc-CcccCccHHHHhcCCC
Confidence 999999999 5799999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=332.82 Aligned_cols=245 Identities=25% Similarity=0.439 Sum_probs=215.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh---HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~---~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
++|++.+.||.|+||.||+|.+.. ++.+++|.+.... ...+.+|+++++.++||||+++++++.+....++||||+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 468999999999999999999988 8889999986543 456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 79 VGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 79 eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
++++|.+++... ..+++.++..++.|++.|+.|||++|++||||||+||+++.++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~---- 160 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL---- 160 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc----
Confidence 999999999763 46899999999999999999999999999999999999999999999999999766432211
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
.....+++.|+|||++.. ..++.++|+||||+++|+|++ |+.||.+....+.+..+......+.+...++.+.+++.
T Consensus 161 -~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 238 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML 238 (261)
T ss_pred -ccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHH
Confidence 112346778999999864 467889999999999999998 89999988888888877776666777888999999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 000715 236 SLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 236 kcLqkDPsKRPTAeEILk 253 (1335)
+||+.||++|||+.++++
T Consensus 239 ~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 239 ECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHcCCCchhCcCHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=335.21 Aligned_cols=249 Identities=24% Similarity=0.445 Sum_probs=212.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC-----CCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-----TIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~-----TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~ly 72 (1335)
++|.+.+.||+|+||.||+|.+.. ++..|++|.+... ....+.+|+.+++.++|+||+++++++.+....|
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 479999999999999999999987 7889999988532 2346788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC---Ceeeccccc
Q 000715 73 LVLEYCVGGDLMSLLRQDN-------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG---RTKLCDFGL 142 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~-------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG---~VKLiDFGL 142 (1335)
+||||+.|++|.+++.... .+++.++..++.||+.|+.|||++|++||||||+||+++.++ .+||+|||+
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~ 165 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCcc
Confidence 9999999999999997653 589999999999999999999999999999999999998665 589999999
Q ss_pred cccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCC
Q 000715 143 ARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPP 221 (1335)
Q Consensus 143 Ar~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~p 221 (1335)
++.......... .....+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+.......
T Consensus 166 ~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 166 ARDIYRASYYRK---GGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred ccccCCccceec---CCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 986632211100 112234567999999864 457899999999999999997 999999988887777776665556
Q ss_pred CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 222 ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
.+...+..+.+++.+||+.||++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 677889999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=330.49 Aligned_cols=243 Identities=36% Similarity=0.612 Sum_probs=207.5
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRML-HSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqIL-kkL~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|.+..+|+.||+|.+.+.. ...+..|..++ ...+|||++++++++...+.+|+||||+.|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 67999999999999999999999999986542 12234454443 455999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++..... ...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------~~~ 152 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------NKK 152 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---------ccc
Confidence 99999999888999999999999999999999999999999999999999999999999998875432 123
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---CCCCCCCCChhHHHHHHHh
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP---SPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~---~~pip~~iS~eL~DLIkkc 237 (1335)
..|++.|+|||.+.+. .++.++|+||+|+++|+|++|..||...+..+.+..+.... .......++.++.+++.+|
T Consensus 153 ~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 231 (260)
T cd05611 153 FVGTPDYLAPETILGV-GDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL 231 (260)
T ss_pred CCCCcCccChhhhcCC-CCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence 4688999999998754 47889999999999999999999999888777766654332 2223346789999999999
Q ss_pred cccCCCCCCC---HHHHhcCcccccc
Q 000715 238 LVKDPAQRLH---WSDLCGHAFWRTK 260 (1335)
Q Consensus 238 LqkDPsKRPT---AeEILkHPfFq~~ 260 (1335)
|..||++||+ ++|++.||||++.
T Consensus 232 l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 232 LCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred ccCCHHHccCCCcHHHHHcChHhhcC
Confidence 9999999995 5899999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=376.16 Aligned_cols=246 Identities=34% Similarity=0.546 Sum_probs=216.9
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc------hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK------SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK------e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
|.-++.||+|+||.||.|++..+.+.||||.++- +...++.+|++.|+++.|||++.+-++|-.....|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4445689999999999999999999999999853 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
|- |+-.|++.- ..++-+.+|..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||.|....+.
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA------- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA------- 179 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch-------
Confidence 95 677777754 468999999999999999999999999999999999999999999999999998766442
Q ss_pred CCCCccCCCCCCCcchhc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCCChhHHHH
Q 000715 157 LPQAKCGTPCYMAPELFE--EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL-PGNPSRPFANL 233 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~--~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pi-p~~iS~eL~DL 233 (1335)
+.++|||+|||||++. ..+.|+-++||||||+++.||.-.+||+...+....+.-|..+..+.+ ...++..+.+|
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence 4589999999999986 456778899999999999999999999988887766666655544444 45679999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccccc
Q 000715 234 INSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 234 IkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
+..||++-|.+|||.++++.|+|...
T Consensus 258 vd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 258 VDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred HHHHHhhCcccCCcHHHHhhcchhcc
Confidence 99999999999999999999999754
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.35 Aligned_cols=246 Identities=21% Similarity=0.427 Sum_probs=212.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
++|++.+.||+|+||.||+|.+.. +..||+|.+... ..+.+.+|+.++++++||||+++++.+...+..|+||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 579999999999999999999764 466999987643 35678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 80 GGDLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 80 GGSL~dlIkq--~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+++|.+++.. ...++...+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~---- 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA---- 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceec----
Confidence 9999999975 3568999999999999999999999999999999999999999999999999998764322111
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
.....++..|+|||++.. ..++.++|||||||++|+|++ |..||.+....+....+......+.+...+.++.+++.+
T Consensus 161 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05072 161 REGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKT 239 (261)
T ss_pred cCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 122346778999999864 457889999999999999998 999999888877777777665556666788999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 000715 237 LLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILk 253 (1335)
||..+|++||+++++.+
T Consensus 240 ~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 240 CWKEKAEERPTFDYLQS 256 (261)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.29 Aligned_cols=248 Identities=23% Similarity=0.409 Sum_probs=213.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEE-----CCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRK-----KKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArd-----k~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
++|.+.+.||+|+||+||++.+ ..++..||+|.+... ....+.+|+.++++++||||+++++++...+.+|+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 3699999999999999999986 335667999998653 34568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccc
Q 000715 74 VLEYCVGGDLMSLLRQDN-------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDF 140 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~-------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDF 140 (1335)
||||+++++|.+++...+ .+++.++..++.|++.||.|||++|++||||||+||++++++.+||+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~df 164 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDF 164 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccC
Confidence 999999999999997543 4899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCC
Q 000715 141 GLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPS 219 (1335)
Q Consensus 141 GLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~ 219 (1335)
|++......... .......+++.|+|||++. ...++.++|+|||||++|+|++ |.+||......+....+..+..
T Consensus 165 g~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 165 GMSRDVYSTDYY---RVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred CccccccCCcee---ecCCCCCccccccCHHHhc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 998765332211 1112334678899999986 4567889999999999999998 9999998888888888877665
Q ss_pred CCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 220 PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 220 ~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
...+...+.++.+++.+||+.||.+|||+.++..
T Consensus 241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 6667778999999999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=348.66 Aligned_cols=253 Identities=30% Similarity=0.545 Sum_probs=211.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS-----AHL 71 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds-----~~l 71 (1335)
++|.+.+.||+|+||.||+|++..+++.||+|.+... ....+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5899999999999999999999999999999987542 344677899999999999999999987654 358
Q ss_pred EEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCC
Q 000715 72 WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~ 151 (1335)
|+||||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 99999984 78999998888999999999999999999999999999999999999999999999999999876643221
Q ss_pred CCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS--------------- 216 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~--------------- 216 (1335)
......|+..|+|||++.....++.++|+|||||++|+|++|++||.+.+.......+..
T Consensus 164 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 164 -----FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred -----cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 123356899999999987555688899999999999999999999987654333222210
Q ss_pred ------------CCCC---CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 217 ------------DPSP---PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 217 ------------~~~~---pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
.... ......++++.++|.+||+.||++|||+.++++||||...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000 1123578889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.41 Aligned_cols=247 Identities=34% Similarity=0.587 Sum_probs=210.8
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc------hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK------SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK------e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
+++|++.+.||+|+||.||+|.+..+|+.||+|.+.. .....+.+|++++++++|+|++++++++...+..++|
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 4789999999999999999999999999999998743 2355788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 75 LEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
|||+++++|.+++.. +..+++.++..++.|++.|+.|||++|++||||||+||+++.+|.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999999864 3468999999999999999999999999999999999999999999999999987654322
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCCCCCCC-CCC
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE--FTQLVKSILSDPSPPLPG-NPS 227 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d--~~eLikkIl~~~~~pip~-~iS 227 (1335)
.. .....|++.|+|||.+. +..++.++|+||+|+++|+|++|+.||.... ..+....+.....++.+. ..+
T Consensus 161 ~~-----~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 161 TA-----AHSLVGTPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred cc-----cceecCCccccCHHHhc-cCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 11 12346889999999986 4456889999999999999999999996653 334444544444444444 678
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 228 RPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 228 ~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
.++.++|.+||..+|++|||+.++++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 89999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.72 Aligned_cols=248 Identities=23% Similarity=0.421 Sum_probs=213.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCC-----eEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTI-----EYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TG-----k~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~ly 72 (1335)
++|++.+.||+|+||.||+|.++..+ ..||+|.+... ....+.+|+++++.++||||+++++++......|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 68999999999999999999987544 88999998643 2345788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccc
Q 000715 73 LVLEYCVGGDLMSLLRQD----------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGL 142 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~----------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGL 142 (1335)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.+|.+||+|||+
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~ 165 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGM 165 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCccc
Confidence 999999999999998653 2367889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCC
Q 000715 143 ARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPP 221 (1335)
Q Consensus 143 Ar~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~p 221 (1335)
++......... ......++..|+|||.+.. ..++.++|||||||++|++++ |..||.+.+..+..+.+.......
T Consensus 166 ~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 166 TRDIYETDYYR---KGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred chhhccCcccc---cCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 87654332111 1123457889999999864 457889999999999999998 999999888888777777665566
Q ss_pred CCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 222 ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
.+..++.++.+++.+||+.+|++|||+.+++.
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 77788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.43 Aligned_cols=247 Identities=22% Similarity=0.414 Sum_probs=212.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh--HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~--~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
++|++.+.||+|+||.||+|.+... ..+|+|.+.... ...+.+|+.++++++||||+++++++......|+||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~-~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCC-CcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 5799999999999999999987654 459999886543 4568899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 80 GGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
+++|.+++... ..+++.++..++.|++.||.|||++|++|+||||+||+++.++.+||+|||.++......... .
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~----~ 158 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS----S 158 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee----c
Confidence 99999999764 478999999999999999999999999999999999999999999999999987654322110 1
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHh
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkc 237 (1335)
....++..|+|||++.. ..++.++|+||||+++|+|++ |..||......+....+........+...+..+.+++.+|
T Consensus 159 ~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05113 159 VGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSC 237 (256)
T ss_pred CCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence 11235678999999864 457889999999999999998 9999988887777777776666666677789999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 000715 238 LVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 238 LqkDPsKRPTAeEILkH 254 (1335)
|+.||.+|||+.+++.+
T Consensus 238 l~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 238 WHEKAEERPTFQQLLSS 254 (256)
T ss_pred cCCCcccCCCHHHHHHh
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.29 Aligned_cols=246 Identities=23% Similarity=0.399 Sum_probs=212.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
++|++.+.||+|+||.||+|.+.. ++.||+|.+... ..+.+.+|++++++++||||+++++++...+..|+||||+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 479999999999999999999765 467999998654 34568899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 80 GGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 80 GGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+++|.+++.... .+++.++..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~---- 160 (261)
T cd05068 85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA---- 160 (261)
T ss_pred CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc----
Confidence 999999997654 79999999999999999999999999999999999999999999999999998765322110
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
.....++..|+|||++. +..++.++|+||||+++|+|++ |+.||.+.........+......+.+...+..+.+++.+
T Consensus 161 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 239 (261)
T cd05068 161 REGAKFPIKWTAPEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD 239 (261)
T ss_pred cCCCcCceeccCccccc-cCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 01112345799999886 4557889999999999999999 999999888877777776665556667789999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 000715 237 LLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILk 253 (1335)
||+.+|++||++.++++
T Consensus 240 ~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 240 CWKEDPDDRPTFETLQW 256 (261)
T ss_pred HhhcCcccCCCHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=340.33 Aligned_cols=253 Identities=29% Similarity=0.532 Sum_probs=216.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
++|++.+.||+|+||.||++.+..+++.|++|.+... ..+.+.+|+.++++++||||+++++.+...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5799999999999999999999999999999998543 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
++++|.+++.+. .+++.++..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++......... .
T Consensus 99 ~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-----~ 172 (293)
T cd06647 99 AGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-----R 172 (293)
T ss_pred CCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc-----c
Confidence 999999998654 6889999999999999999999999999999999999999999999999988765433221 1
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCChhHHHHHHH
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP--PLPGNPSRPFANLINS 236 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~--pip~~iS~eL~DLIkk 236 (1335)
....|++.|+|||.+.. ..++.++|+||||+++|++++|+.||...+..+....+.....+ ..+...+..+.++|.+
T Consensus 173 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred ccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 23468999999999864 45688999999999999999999999887655544433322222 2234567889999999
Q ss_pred hcccCCCCCCCHHHHhcCccccccC
Q 000715 237 LLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
||..+|++||++.+++.|+||+...
T Consensus 252 ~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 252 CLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HccCChhhCcCHHHHhcCHHHhcCc
Confidence 9999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.27 Aligned_cols=247 Identities=25% Similarity=0.457 Sum_probs=213.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
.+|++.+.||+|+||.||+|.++. +..+|+|.+.+. ....+.+|++++++++||||+++++++...+..|+||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 468999999999999999998864 567999998654 34567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 80 GGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
|++|.+++... ..+++..+..++.|++.|+.|||++|++||||||+||+++.+|.+||+|||+++......... .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~----~ 158 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS----S 158 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc----c
Confidence 99999999764 478999999999999999999999999999999999999999999999999987654322110 1
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHh
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkc 237 (1335)
....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||...+..+....+........+...+.++.+++.+|
T Consensus 159 ~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 237 (256)
T cd05059 159 QGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSC 237 (256)
T ss_pred CCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHH
Confidence 11224567999999864 457889999999999999998 8999998888887777776666667778899999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 000715 238 LVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 238 LqkDPsKRPTAeEILkH 254 (1335)
|..+|++|||+.++++.
T Consensus 238 l~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 238 WHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred hcCChhhCcCHHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=339.75 Aligned_cols=249 Identities=34% Similarity=0.543 Sum_probs=212.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|++..+++.||+|.+... ....+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4689999999999999999999999999999987532 2346789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 76 EY~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
||+. |++.+++.. .+.+++.++..++.|++.||.|||++|++||||+|+||+++.+|.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----- 168 (307)
T cd06607 95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----- 168 (307)
T ss_pred HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-----
Confidence 9996 566666654 567999999999999999999999999999999999999999999999999988654321
Q ss_pred CCCCCCccCCCCCCCcchhc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC-CCCCChhHH
Q 000715 155 SMLPQAKCGTPCYMAPELFE--EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL-PGNPSRPFA 231 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~--~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pi-p~~iS~eL~ 231 (1335)
....|++.|+|||++. ....++.++||||||+++|+|++|++||.+.+.......+.....+.. +..++..+.
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 2346888999999874 245678899999999999999999999988876665555543332222 345688999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 232 NLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
++|.+||..||++||++.+++.||||...
T Consensus 245 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 245 NFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 99999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=343.71 Aligned_cols=258 Identities=29% Similarity=0.538 Sum_probs=219.0
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSA-----HLW 72 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~-----~ly 72 (1335)
+|++.+.||.|+||.||+|++..+++.|++|.+... ..+.+.+|+.+++.++||||+++++++.... .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 699999999999999999999999999999988653 3456889999999999999999999987775 789
Q ss_pred EEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 73 LVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
+||||+. ++|.+++.+...+++..++.++.|++.||.|||++||+||||||+||+++.+|.++|+|||++.........
T Consensus 81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 9999986 589999988889999999999999999999999999999999999999999999999999999876543311
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----------
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP----------- 221 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p----------- 221 (1335)
.. ......+++.|+|||++.+...++.++|+||+|+++|+|++|.+||.+.+..+.+..+......+
T Consensus 160 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 160 KG--FLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cc--cccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 01 11334689999999999765478889999999999999999999999888766665554321111
Q ss_pred -------------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCC
Q 000715 222 -------------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTP 263 (1335)
Q Consensus 222 -------------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~ 263 (1335)
.....+.++.++|.+||++||++|||+++++.||||+....+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 112357889999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.59 Aligned_cols=255 Identities=25% Similarity=0.437 Sum_probs=208.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeC----------
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETS---------- 68 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds---------- 68 (1335)
.+|++.+.||.|+||.||+|++..+|+.||+|.+... ..+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5899999999999999999999999999999988543 345678899999999999999999776544
Q ss_pred ----CEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC-CCCeeecccccc
Q 000715 69 ----AHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE-NGRTKLCDFGLA 143 (1335)
Q Consensus 69 ----~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe-dG~VKLiDFGLA 143 (1335)
...|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccc
Confidence 35899999996 589888754 47999999999999999999999999999999999999974 567899999998
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----
Q 000715 144 RKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS---- 219 (1335)
Q Consensus 144 r~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~---- 219 (1335)
.......... .......|+..|+|||++.....++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 163 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 163 RIVDPHYSHK--GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred eecCCccccc--cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 7653321111 1112245889999999886656678899999999999999999999987765544443322110
Q ss_pred --------------------C-----CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 220 --------------------P-----PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 220 --------------------~-----pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
. ......+.++.++|.+||+.||.+|||+.+++.||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0123467889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=341.28 Aligned_cols=247 Identities=28% Similarity=0.424 Sum_probs=209.1
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeE--EEEEEcCc----hhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEY--FAIKSVDK----SQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~--VAIKiIdK----e~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyL 73 (1335)
+++|++.+.||+|+||.||+|.++.++.. +++|.... .....+.+|+.++.++ +||||+++++++...+.+|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46899999999999999999999887754 57776643 2345678899999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeee
Q 000715 74 VLEYCVGGDLMSLLRQDN----------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKL 137 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~----------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKL 137 (1335)
||||+++++|.+++...+ .+++.+++.++.|++.|+.|||++|++||||||+||+++.++.+||
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence 999999999999997543 5789999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc
Q 000715 138 CDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILS 216 (1335)
Q Consensus 138 iDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~ 216 (1335)
+|||++........ .....++..|+|||++. ...++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 166 ~dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 166 ADFGLSRGQEVYVK------KTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred CccccCcccchhhh------cccCCCcccccCHHHHh-ccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 99999864321110 11123466799999885 4457889999999999999998 9999998887777776655
Q ss_pred CCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 217 DPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 217 ~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
......+...+.++.+++.+||+.+|++||++++++.+
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 54445566778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=324.04 Aligned_cols=247 Identities=33% Similarity=0.614 Sum_probs=220.4
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+|++.+.||+|+||.||++.++.+++.|++|.+... ....+.+|++++++++||||+++++++......|+||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 699999999999999999999999999999988643 344677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 78 CVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 78 ~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
+++++|.+++.+ ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~--- 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM--- 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC---
Confidence 999999999876 4578999999999999999999999999999999999999999999999999987765431
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DL 233 (1335)
.....|++.|+|||.+. +..++.++|+||+|+++|+|++|+.||...+..+....+.....++.+...+.++.++
T Consensus 158 ----~~~~~~~~~~~~Pe~~~-~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWK-GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNF 232 (256)
T ss_pred ----cccccCCccccCHHHHC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHH
Confidence 12345889999999986 4556789999999999999999999999988877777777666666777889999999
Q ss_pred HHHhcccCCCCCCCHHHHhcCccc
Q 000715 234 INSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 234 IkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+.+||..+|++|||+.++++||+.
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 233 IRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHcCCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999973
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=367.01 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=202.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
..|.+.+.||+|+||.||+|++..+++.||+|.... ....+|++++++++||||+++++++...+..++|||++ ++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~ 244 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RS 244 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CC
Confidence 369999999999999999999999999999996433 34568999999999999999999999999999999998 46
Q ss_pred CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 82 DLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 82 SL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
+|.+++... ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......... ....
T Consensus 245 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~---~~~~ 321 (461)
T PHA03211 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP---FHYG 321 (461)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc---cccc
Confidence 888887654 579999999999999999999999999999999999999999999999999998654322111 1123
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCC--CCCCC-------
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE--------FTQLVKSILSDP--SPPLP------- 223 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d--------~~eLikkIl~~~--~~pip------- 223 (1335)
.+||+.|+|||++.+ ..++.++|||||||++|||++|..|+.... ..++.+.+.... ...++
T Consensus 322 ~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 322 IAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred cCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 579999999999964 457889999999999999999876543221 122222211100 00000
Q ss_pred ------------------------CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 224 ------------------------GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 224 ------------------------~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
...+..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 123567899999999999999999999999999975
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=336.44 Aligned_cols=249 Identities=23% Similarity=0.402 Sum_probs=214.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCC-----CeEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKT-----IEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~T-----Gk~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~ly 72 (1335)
.+|++.+.||+|+||.||+|.+..+ ++.||+|.+.... ...+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 4688899999999999999987653 5789999986432 355788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCee
Q 000715 73 LVLEYCVGGDLMSLLRQD----------------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTK 136 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~----------------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VK 136 (1335)
+++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++++++.+|
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k 164 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK 164 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence 999999999999998532 3478899999999999999999999999999999999999999999
Q ss_pred eccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 000715 137 LCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSIL 215 (1335)
Q Consensus 137 LiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl 215 (1335)
|+|||+++......... ......+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 165 l~Dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 165 ISDLGLFREVYAADYYK---LMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ecccccccccccchhee---eccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999988654322111 1123346789999999864 457889999999999999998 899999988888888888
Q ss_pred cCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 216 SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 216 ~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
.....+.+...+..+.+++.+||+.+|.+||++++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 777777788899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=336.80 Aligned_cols=252 Identities=31% Similarity=0.512 Sum_probs=208.4
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSA------ 69 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~------ 69 (1335)
+++|++.+.||+|+||.||+|.++.+|+.||+|.+... ....+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 36899999999999999999999999999999998543 2345678999999999999999999887654
Q ss_pred ----EEEEEEeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccc
Q 000715 70 ----HLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 70 ----~lyLVMEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr 144 (1335)
.+|+||||+++ ++.+.+... ..+++.+++.++.|++.||.|||++||+||||||+||++++++.+||+|||++.
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 79999999976 676766653 579999999999999999999999999999999999999999999999999988
Q ss_pred cccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---CCCC-
Q 000715 145 KLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS---DPSP- 220 (1335)
Q Consensus 145 ~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~---~~~~- 220 (1335)
.......... ....+++.|+|||++.....++.++||||+||++|+|++|++||...+..+....+.. ...+
T Consensus 165 ~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 165 LYNSEESRPY----TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccCCccccc----ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 7644332111 1234678899999986555678899999999999999999999987765544433322 1100
Q ss_pred -------------------------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 221 -------------------------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 221 -------------------------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
......+..+.+++.+||+.||++|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0122457899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.86 Aligned_cols=249 Identities=24% Similarity=0.433 Sum_probs=213.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCC-----CeEEEEEEcCch----hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKT-----IEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~T-----Gk~VAIKiIdKe----~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~l 71 (1335)
++|++.+.||+|+||.||++.+... ...+|+|.+... ....+.+|+++++++ +||||+++++++...+.+
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL 91 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence 5799999999999999999998754 378999988643 234578899999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCe
Q 000715 72 WLVLEYCVGGDLMSLLRQ----------------DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRT 135 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq----------------~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~V 135 (1335)
|+||||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeE
Confidence 999999999999999964 2468999999999999999999999999999999999999999999
Q ss_pred eeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 000715 136 KLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214 (1335)
Q Consensus 136 KLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkI 214 (1335)
||+|||+++.+........ .....++..|+|||++. +..++.++|||||||++|+|++ |..||.+....+....+
T Consensus 172 kL~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 172 KIADFGLARDIHHIDYYRK---TTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred EeCccccccccccccceec---cCCCCCCccccCHHHhc-cCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999987654321111 11123567899999985 4567889999999999999997 99999998888888777
Q ss_pred hcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 215 LSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 215 l~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
........+...+..+.+++.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 248 KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 7666666677788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=332.11 Aligned_cols=251 Identities=33% Similarity=0.558 Sum_probs=209.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYET--SAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfed--s~~lyLVM 75 (1335)
++|+..+.||.|++|.||+|.+..+++.||+|.+... ...++.+|++++++++||||+++++++.. .+.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 5799999999999999999999999999999998643 34568899999999999999999998854 34789999
Q ss_pred eecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCC
Q 000715 76 EYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 76 EY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~ 151 (1335)
||++|++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999999987653 45689999999999999999999999999999999999999999999999999865533211
Q ss_pred CCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHhcCCCCCCC---
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-----EFTQLVKSILSDPSPPLP--- 223 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~-----d~~eLikkIl~~~~~pip--- 223 (1335)
....++..|+|||.+. +..++.++|+||+|+++|+|++|..||... ...+....+.....+..+
T Consensus 161 -------~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd06621 161 -------GTFTGTSFYMAPERIQ-GKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEP 232 (287)
T ss_pred -------ccccCCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCC
Confidence 2345788999999986 455788999999999999999999999866 223444444332222222
Q ss_pred ---CCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 224 ---GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 224 ---~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
...++.+.++|.+||..||++|||+.|++.||||++.
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 2345789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.55 Aligned_cols=247 Identities=22% Similarity=0.377 Sum_probs=209.9
Q ss_pred EEEEEEEeccCcEEEEEEEECC---CCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-----
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKK---TIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAH----- 70 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~---TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~----- 70 (1335)
|++.+.||+|+||.||+|.... ++..||+|.+... ....+.+|+++++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6789999999999999998765 3478999987532 23567899999999999999999998765543
Q ss_pred -EEEEEeecCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccc
Q 000715 71 -LWLVLEYCVGGDLMSLLRQD------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143 (1335)
Q Consensus 71 -lyLVMEY~eGGSL~dlIkq~------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLA 143 (1335)
.++||||+++++|..++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999999988542 36899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCC
Q 000715 144 RKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPL 222 (1335)
Q Consensus 144 r~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pi 222 (1335)
+......... ......++..|+|||++. ...++.++|||||||++|||++ |.+||.+....+....+..+.....
T Consensus 161 ~~~~~~~~~~---~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05035 161 KKIYSGDYYR---QGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236 (273)
T ss_pred eecccccccc---ccccccCCccccCHhhcc-cCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 8664332211 112233567899999985 4567889999999999999999 9999999888888888777766777
Q ss_pred CCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 223 PGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 223 p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
+...+..+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 88899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=329.40 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=213.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCe---EEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIE---YFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk---~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
+.|++.+.||+|+||.||+|.++.+++ .||+|.+... ....+..|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 579999999999999999999987765 5999998643 345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
|||+.+++|.+++... +.+++.+++.++.|++.|+.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 163 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 163 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcccc
Confidence 9999999999999764 578999999999999999999999999999999999999999999999999987664432221
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~D 232 (1335)
.........++..|+|||++.. ..++.++||||+||++|||++ |..||.+.+..+....+......+.+...+..+.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 242 (269)
T cd05065 164 TYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQ 242 (269)
T ss_pred ccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHH
Confidence 1110111112457999999864 456889999999999999886 99999988887777777665555666778899999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 000715 233 LINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILk 253 (1335)
++.+||..+|++||++.+++.
T Consensus 243 li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 243 LMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=336.06 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=210.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCe--EEEEEEcCc----hhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIE--YFAIKSVDK----SQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk--~VAIKiIdK----e~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLV 74 (1335)
++|++.+.||+|+||.||+|.++.++. .+++|.+.. .....+.+|++++.++ +||||+++++++...+.+|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 689999999999999999999987765 468887753 2345678899999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeec
Q 000715 75 LEYCVGGDLMSLLRQDN----------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLC 138 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~----------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLi 138 (1335)
|||+++++|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence 99999999999997542 48899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC
Q 000715 139 DFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD 217 (1335)
Q Consensus 139 DFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~ 217 (1335)
|||++........ .....++..|+|||++.. ..++.++|||||||++|+|++ |..||.+....+....+...
T Consensus 162 dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 162 DFGLSRGEEVYVK------KTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred CcCCCccccceec------cCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 9999864321110 111223557999999864 457889999999999999997 99999998888888877766
Q ss_pred CCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 218 PSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 218 ~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
.....+..++.++.+++.+||..||.+|||++++++.
T Consensus 235 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5566677889999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.76 Aligned_cols=253 Identities=32% Similarity=0.595 Sum_probs=219.5
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh--HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~--~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
+.|++.+.||+|+||.||+|.+..+++.|++|.+.... ...+.+|++++++++|+|++++++.+......|+|+||++
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 46888999999999999999999899999999987554 5678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 80 GGSL~dlIkq~~-~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
|++|.+++.... .+++.++..++.|++.||.|||+.|++|+||||+||+++.+|.++|+|||++......... .
T Consensus 99 ~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-----~ 173 (286)
T cd06614 99 GGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK-----R 173 (286)
T ss_pred CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh-----h
Confidence 999999998876 8999999999999999999999999999999999999999999999999988765432211 1
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCChhHHHHHHH
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGNPSRPFANLINS 236 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pi--p~~iS~eL~DLIkk 236 (1335)
....+++.|+|||++.. ..++.++|+||||+++|+|++|+.||...+.......+.....+.. +..++..+.++|.+
T Consensus 174 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (286)
T cd06614 174 NSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK 252 (286)
T ss_pred ccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence 23457889999999864 4568899999999999999999999988776655555544332222 23478899999999
Q ss_pred hcccCCCCCCCHHHHhcCcccccc
Q 000715 237 LLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
||+.+|.+|||+.+++.|+||...
T Consensus 253 ~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 253 CLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred HhccChhhCcCHHHHhhChHhhcc
Confidence 999999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=327.84 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=206.3
Q ss_pred EEeccCcEEEEEEEE--CCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 9 AIGRGKYSTVYKGRK--KKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 9 ~LGeGgFGtVYkArd--k~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
.||+|+||.||+|.+ +.+++.||+|++... ..+.+.+|+.+++.++||||+++++++.. ...++||||+.++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 689999999999965 567889999998543 24567889999999999999999998754 5678999999999
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCc
Q 000715 82 DLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161 (1335)
Q Consensus 82 SL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~ 161 (1335)
+|.+++.....+++..+..++.|++.|+.|||++|++||||||.||+++.++.+||+|||++............ ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~--~~~~ 158 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA--KTHG 158 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee--cCCC
Confidence 99999988888999999999999999999999999999999999999999999999999999876433221110 1223
Q ss_pred cCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 162 ~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+++.|+|||.+. ...++.++|+|||||++|+|++ |..||.+.+..+....+......+.+...++++.++|.+||+.
T Consensus 159 ~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~ 237 (257)
T cd05116 159 KWPVKWYAPECMN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY 237 (257)
T ss_pred CCCccccCHhHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence 4567899999985 4557889999999999999997 9999998888888887777666677788999999999999999
Q ss_pred CCCCCCCHHHHhc
Q 000715 241 DPAQRLHWSDLCG 253 (1335)
Q Consensus 241 DPsKRPTAeEILk 253 (1335)
||++||++++|..
T Consensus 238 ~p~~Rp~~~~i~~ 250 (257)
T cd05116 238 GVDERPGFAVVEL 250 (257)
T ss_pred CchhCcCHHHHHH
Confidence 9999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.24 Aligned_cols=248 Identities=22% Similarity=0.356 Sum_probs=210.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeE----EEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEY----FAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~----VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
++|++.+.||+|+||.||+|++..+++. ||+|.+... ....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 5799999999999999999998766654 899998533 345678899999999999999999988765 4679
Q ss_pred EEeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
|+||+.+|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 165 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE 165 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcc
Confidence 99999999999999875 46899999999999999999999999999999999999999999999999999876543221
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHH
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFA 231 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~ 231 (1335)
.. .....++..|+|||++. +..++.++||||||+++|+|++ |..||.+....+....+......+.+..++.++.
T Consensus 166 ~~---~~~~~~~~~y~apE~~~-~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 166 YH---AEGGKVPIKWMALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred ee---ccCCccceeecChHHhc-cCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 11 11233567899999986 4567889999999999999997 9999998877766655555555566677889999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 000715 232 NLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
+++.+||..||.+||++.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=328.49 Aligned_cols=247 Identities=23% Similarity=0.388 Sum_probs=207.0
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCe--EEEEEEcCc-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CE
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIE--YFAIKSVDK-----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETS------AH 70 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk--~VAIKiIdK-----e~~e~LlrEIqILkkL~HPNIVrL~dvfeds------~~ 70 (1335)
|.+.+.||+|+||.||+|.+..++. .||+|.+.. ...+.+.+|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999988775 699998743 3356678899999999999999999876332 35
Q ss_pred EEEEEeecCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccc
Q 000715 71 LWLVLEYCVGGDLMSLLRQ------DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq------~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr 144 (1335)
.++||||+.+|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 7899999999999988742 2358999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCC
Q 000715 145 KLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLP 223 (1335)
Q Consensus 145 ~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip 223 (1335)
.+....... ......+++.|+|||++. ...++.++||||||+++|+|++ |+.||.+....+....+..+...+.+
T Consensus 161 ~~~~~~~~~---~~~~~~~~~~~~~pe~~~-~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd05075 161 KIYNGDYYR---QGRIAKMPVKWIAIESLA-DRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236 (272)
T ss_pred ccCccccee---cCCcccCCcccCCHHHcc-CCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 764332111 112234677899999986 4567889999999999999999 89999988888877777766655666
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 224 ~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
...+..+.++|.+||..||++|||+.+++++
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=328.81 Aligned_cols=247 Identities=32% Similarity=0.583 Sum_probs=209.1
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
+++|++.+.||+|+||.||+|+++.+++.|++|.+... ....+.+|+++++.++||||+++++++...+..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 57899999999999999999999999999999977532 335678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 75 LEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
|||+.|++|.+++.. ...+++..++.++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999998864 4568999999999999999999999999999999999999999999999999987664322
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHhcCCCCCC-CCCCC
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF--TQLVKSILSDPSPPL-PGNPS 227 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~--~eLikkIl~~~~~pi-p~~iS 227 (1335)
.. .....|++.|+|||++.. ..++.++|+||+|+++|+|++|..||.+... ......+.....++. +...+
T Consensus 161 ~~-----~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08229 161 TA-----AHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234 (267)
T ss_pred cc-----cccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence 11 123568999999999864 4567899999999999999999999976543 344444433322222 34578
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 228 RPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 228 ~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
.++.+++.+||..||++|||+.++++
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 89999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=353.77 Aligned_cols=249 Identities=25% Similarity=0.450 Sum_probs=206.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEE-----CCCCeEEEEEEcCch----hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRK-----KKTIEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArd-----k~TGk~VAIKiIdKe----~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~l 71 (1335)
++|++.+.||+|+||.||+|++ ..++..||+|++... ..+.+.+|++++..+ +||||+++++++......
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4799999999999999999974 456778999998542 345678999999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhCC------------------------------------------------------------
Q 000715 72 WLVLEYCVGGDLMSLLRQDN------------------------------------------------------------ 91 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~~------------------------------------------------------------ 91 (1335)
|+||||++||+|.+++.+..
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999986432
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 92 ---------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 92 ---------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~--- 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV--- 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc---
Confidence 47888999999999999999999999999999999999999999999999998664332111
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQ-LVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~e-LikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
......++..|+|||++. +..++.++|||||||++|+|++ |..||.+..... ....+........+...+.++.+++
T Consensus 272 ~~~~~~~~~~y~aPE~~~-~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIF-NCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhc-CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 112234567899999986 4567889999999999999998 899998765443 3344444444445666788999999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q 000715 235 NSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 235 kkcLqkDPsKRPTAeEILkH 254 (1335)
.+||+.||++|||+.++++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=332.55 Aligned_cols=254 Identities=32% Similarity=0.597 Sum_probs=215.2
Q ss_pred cEEEEEEEeccCcEEEEEEEEC---CCCeEEEEEEcCch-------hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKK---KTIEYFAIKSVDKS-------QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk---~TGk~VAIKiIdKe-------~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~l 71 (1335)
+|++.+.||+|+||.||+|++. .+|+.||+|.+... ..+.+.+|+++++++ +|+||+++++.+..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999885 47899999998643 234577899999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCC
Q 000715 72 WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~ 151 (1335)
|+||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999876543221
Q ss_pred CCCCCCCCCccCCCCCCCcchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCCCCCCCC
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEG-GVHSYASDLWGLGCVLYECYAGRPPFVGRE----FTQLVKSILSDPSPPLPGNP 226 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~-~~yS~kSDIWSLGVILYELLTGrpPF~g~d----~~eLikkIl~~~~~pip~~i 226 (1335)
. ......|+..|+|||.+... ..++.++||||+|+++|+|++|..||.... .......+.. ..++.+...
T Consensus 161 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 235 (290)
T cd05613 161 E----RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILK-SEPPYPQEM 235 (290)
T ss_pred c----ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhc-cCCCCCccC
Confidence 1 11235689999999998643 346789999999999999999999997532 2333333333 234567778
Q ss_pred ChhHHHHHHHhcccCCCCCC-----CHHHHhcCccccccC
Q 000715 227 SRPFANLINSLLVKDPAQRL-----HWSDLCGHAFWRTKL 261 (1335)
Q Consensus 227 S~eL~DLIkkcLqkDPsKRP-----TAeEILkHPfFq~~l 261 (1335)
++.+.+++.+||..||++|| ++++++.||||+...
T Consensus 236 ~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 236 SALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 89999999999999999997 899999999997653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=345.02 Aligned_cols=252 Identities=28% Similarity=0.518 Sum_probs=211.5
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------E
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSA------H 70 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~------~ 70 (1335)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.+. ....+.+|++++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 5899999999999999999999999999999988542 2345778999999999999999999987654 4
Q ss_pred EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
+++||||+ |++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus 95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 172 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM 172 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc
Confidence 68999998 7899888864 579999999999999999999999999999999999999999999999999987553221
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----------
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP---------- 220 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~---------- 220 (1335)
....+++.|+|||++.....++.++|+||+|+++|+|++|++||.+.+......++......
T Consensus 173 --------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 173 --------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred --------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 23457899999999875456788999999999999999999999887655444433221100
Q ss_pred --------------------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCC
Q 000715 221 --------------------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTP 263 (1335)
Q Consensus 221 --------------------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~ 263 (1335)
......++.+.++|.+||..||++|||+.+++.||||+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 0123567889999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=346.06 Aligned_cols=252 Identities=29% Similarity=0.532 Sum_probs=213.5
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE------
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAH------ 70 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~------ 70 (1335)
++|++.+.||+|+||.||+|++..+++.||+|.+... ....+.+|+.++++++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 5799999999999999999999999999999998542 33557789999999999999999988766554
Q ss_pred EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
.|+|+||+ |++|.+++.. .++++.+++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 95 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 95 VYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 89999998 7799998875 57999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---------
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP--------- 221 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p--------- 221 (1335)
.....+++.|+|||.+.....++.++||||||+++|+|++|+.||.+.+..+.+..+......+
T Consensus 172 -------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 172 -------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred -------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 1234688999999998755567889999999999999999999998877666555543321110
Q ss_pred ---------------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCC
Q 000715 222 ---------------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTP 263 (1335)
Q Consensus 222 ---------------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~ 263 (1335)
.....+.++.++|.+||..||++|||+.+++.||||++...+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 112358899999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=386.34 Aligned_cols=254 Identities=30% Similarity=0.563 Sum_probs=212.6
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK-----SQKSKVLQEVRMLHSLDHPNVLRFYSWYET--SAHLWL 73 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK-----e~~e~LlrEIqILkkL~HPNIVrL~dvfed--s~~lyL 73 (1335)
+++|++++.||+|+||.||+|.+..+++.||+|.+.. .....+.+|+.++++++||||++++++|.+ ...+|+
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 4789999999999999999999999999999998853 234568899999999999999999998854 467999
Q ss_pred EEeecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-------CCcccCCCCCCeEECC-----------
Q 000715 74 VLEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSK-------GIIYCDLKPSNILLDE----------- 131 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHsk-------GIVHRDIKPENILIDe----------- 131 (1335)
||||+.+++|.++|.. .+.+++..++.|+.||+.||.|||+. +|+||||||+|||++.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999999999999875 35799999999999999999999995 4999999999999964
Q ss_pred ------CCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhcc-CCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 000715 132 ------NGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE-GGVHSYASDLWGLGCVLYECYAGRPPFVG 204 (1335)
Q Consensus 132 ------dG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~-~~~yS~kSDIWSLGVILYELLTGrpPF~g 204 (1335)
.+.+||+|||++..+..... ....+||+.|+|||++.. ...++.++||||||||+|+|++|..||..
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s~------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIESM------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccCCCCceEEccCCcccccccccc------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 23589999999976543221 133579999999999863 34578899999999999999999999986
Q ss_pred CCHH-HHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 205 REFT-QLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 205 ~d~~-eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
.+.. .++..+...+..+ ....+.++.+||..||..+|.+||++.+++.|+|+....
T Consensus 246 ~~~~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 246 ANNFSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCcHHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 6544 3444443333222 245689999999999999999999999999999997653
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.33 Aligned_cols=252 Identities=29% Similarity=0.534 Sum_probs=214.8
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
|.....||+|+||.||+|.+..+++.||+|.+... ....+.+|+.+++.++||||+++++.+...+..|+||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44456799999999999999999999999998542 345678999999999999999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
++|.+++.. ..+++.+++.++.|++.||.|||++|++||||||+||+++.+|.+||+|||++......... ...
T Consensus 103 ~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-----~~~ 176 (297)
T cd06659 103 GALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-----RKS 176 (297)
T ss_pred CCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-----ccc
Confidence 999987754 57899999999999999999999999999999999999999999999999998765432211 123
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCChhHHHHHHHhc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS--PPLPGNPSRPFANLINSLL 238 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~--~pip~~iS~eL~DLIkkcL 238 (1335)
.+|++.|+|||++.. ..++.++|+||+||++|+|++|+.||...+..+....+..... ...+...+..+.++|.+||
T Consensus 177 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l 255 (297)
T cd06659 177 LVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERML 255 (297)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHh
Confidence 568999999999864 4578899999999999999999999988776666655543322 1223456788999999999
Q ss_pred ccCCCCCCCHHHHhcCccccccCC
Q 000715 239 VKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 239 qkDPsKRPTAeEILkHPfFq~~l~ 262 (1335)
+.+|++||++.++++||||.+...
T Consensus 256 ~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 256 TREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred cCCcccCcCHHHHhhChhhccCCC
Confidence 999999999999999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=326.54 Aligned_cols=244 Identities=24% Similarity=0.425 Sum_probs=209.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
++|++.+.||+|+||.||+|.+.. +..||+|.+... ....+.+|+.++++++|||++++++++. ....|++|||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 579999999999999999998764 456999988643 3456889999999999999999999875 456799999999
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 80 GGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 80 GGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+++|.+++... ..+++.+++.++.|++.||.|||++|++||||||+||++++++.+||+|||++..+.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~---- 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA---- 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc----
Confidence 99999999763 468999999999999999999999999999999999999999999999999997664322111
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
.....++..|+|||++. ...++.++|+||||+++|+|++ |.+||.+.+..+....+......+.+...+..+.+++.+
T Consensus 160 ~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05070 160 RQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQ 238 (260)
T ss_pred ccCCCCCccccChHHHh-cCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 11223567899999985 4557889999999999999999 999999888888887777666666777889999999999
Q ss_pred hcccCCCCCCCHHHHh
Q 000715 237 LLVKDPAQRLHWSDLC 252 (1335)
Q Consensus 237 cLqkDPsKRPTAeEIL 252 (1335)
||.+||++|||+.++.
T Consensus 239 ~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 239 CWKKDPEERPTFEYLQ 254 (260)
T ss_pred HcccCcccCcCHHHHH
Confidence 9999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=325.50 Aligned_cols=249 Identities=23% Similarity=0.385 Sum_probs=212.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCe---EEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIE---YFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk---~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
++|+..+.||+|+||.||+|.++.+++ .+++|.+... ....+.+|++++++++||||+++++++...+..|+|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 479999999999999999999886654 7999998643 245678999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
|||+.+++|.+++... +.+++.++..++.|++.|+.|||+.|++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 164 (268)
T cd05063 85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT 164 (268)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccc
Confidence 9999999999999764 579999999999999999999999999999999999999999999999999987664332211
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~D 232 (1335)
.. ......++.|+|||++.. ..++.++|||||||++|+|++ |+.||...+..+....+......+.+...+.++.+
T Consensus 165 ~~--~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 241 (268)
T cd05063 165 YT--TSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQ 241 (268)
T ss_pred ee--ccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 10 111223567999999864 456889999999999999997 99999888887777777665555666678899999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 000715 233 LINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILk 253 (1335)
++.+||..||++||++.++++
T Consensus 242 li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 242 LMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHcCCCcccCcCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.36 Aligned_cols=259 Identities=31% Similarity=0.545 Sum_probs=213.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc-----hhHHHHHHHHHHHHhC-CCCCcceEEEEEEeC--CEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK-----SQKSKVLQEVRMLHSL-DHPNVLRFYSWYETS--AHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK-----e~~e~LlrEIqILkkL-~HPNIVrL~dvfeds--~~lyL 73 (1335)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.+ .....+.+|+.+++++ +||||+++++++... ...|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 579999999999999999999999999999998743 2344577899999999 999999999988654 46899
Q ss_pred EEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
||||+. ++|.+++..+ .+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..........
T Consensus 87 v~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~ 164 (337)
T cd07852 87 VFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164 (337)
T ss_pred Eecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence 999996 5999988776 88999999999999999999999999999999999999999999999999998765433211
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------------
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP--------------- 218 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~--------------- 218 (1335)
.........|++.|+|||++.....++.++|+||+|+++|+|++|++||.+....+...++....
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07852 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF 244 (337)
T ss_pred cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhh
Confidence 11122345789999999998766677889999999999999999999998766544433321110
Q ss_pred ------------CC---CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 000715 219 ------------SP---PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 219 ------------~~---pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~ 262 (1335)
.. ......+.++.++|.+||+.||++|||+.++++||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 00 111236889999999999999999999999999999987533
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=354.87 Aligned_cols=248 Identities=23% Similarity=0.433 Sum_probs=205.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCC-----CeEEEEEEcCch----hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKT-----IEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~T-----Gk~VAIKiIdKe----~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~l 71 (1335)
++|++.+.||+|+||.||+|++..+ ++.||+|.+... ....+.+|+++++.+ +||||+++++++...+.+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4699999999999999999987544 357999998643 244678999999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhC-------------------------------------------------------------
Q 000715 72 WLVLEYCVGGDLMSLLRQD------------------------------------------------------------- 90 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~------------------------------------------------------------- 90 (1335)
|+||||+.+|+|.+++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999998542
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCc
Q 000715 91 ---------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161 (1335)
Q Consensus 91 ---------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~ 161 (1335)
.++++.+++.++.||+.||.|||++||+||||||+||++++++.+||+|||+++........ ......
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~---~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY---VVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce---eeccCC
Confidence 24788899999999999999999999999999999999999999999999999765432211 111223
Q ss_pred cCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh-cCCCCCCCCCCChhHHHHHHHhcc
Q 000715 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSIL-SDPSPPLPGNPSRPFANLINSLLV 239 (1335)
Q Consensus 162 ~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl-~~~~~pip~~iS~eL~DLIkkcLq 239 (1335)
.+++.|+|||++. +..++.++|||||||++|+|++ |+.||........+.... .......+...++++.+++.+||+
T Consensus 275 ~~~~~y~aPE~~~-~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 275 RLPVKWMAPESIF-DCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred CCccceeCHHHhc-CCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence 4567899999986 4567889999999999999997 999998765544433333 333444566678999999999999
Q ss_pred cCCCCCCCHHHHhc
Q 000715 240 KDPAQRLHWSDLCG 253 (1335)
Q Consensus 240 kDPsKRPTAeEILk 253 (1335)
.||.+|||+.++++
T Consensus 354 ~dp~~RPs~~~l~~ 367 (374)
T cd05106 354 LEPTERPTFSQISQ 367 (374)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999965
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=327.24 Aligned_cols=245 Identities=25% Similarity=0.417 Sum_probs=209.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
++|++.+.||+|+||.||+|.+..++ .||+|.+.+. ..+.+.+|++++++++||||+++++.+.. ...|+||||+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCC
Confidence 57999999999999999999987765 4999998753 24568899999999999999999998754 55799999999
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 80 GGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 80 GGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+..+.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~---- 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA---- 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc----
Confidence 99999999763 458999999999999999999999999999999999999999999999999997664332211
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
.....++..|+|||+.. +..++.++|+||||+++|+|++ |..||.+....+....+......+.+...+..+.+++.+
T Consensus 160 ~~~~~~~~~y~~PE~~~-~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 238 (262)
T cd05071 160 RQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 238 (262)
T ss_pred ccCCcccceecCHhHhc-cCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence 12234677899999885 3457889999999999999999 899998888777777776655555667788999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 000715 237 LLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILk 253 (1335)
||+.||++||++.+++.
T Consensus 239 ~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 239 CWRKEPEERPTFEYLQA 255 (262)
T ss_pred HccCCcccCCCHHHHHH
Confidence 99999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=327.66 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=212.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCC---eEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTI---EYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TG---k~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
++|++.+.||+|+||.||+|+++.++ ..+|+|.+... ....+.+|+.++++++||||+++++++...+..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 57999999999999999999987544 37999988643 345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
|||++|++|.+++... +.+++.++..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA 163 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee
Confidence 9999999999999765 578999999999999999999999999999999999999999999999999998765432211
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~D 232 (1335)
.. .....++..|+|||.+.. ..++.++|+||||+++|++++ |..||.+....+....+......+.+...++.+.+
T Consensus 164 ~~--~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd05066 164 YT--TRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ 240 (267)
T ss_pred ee--cCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHH
Confidence 10 111224568999999864 457889999999999999886 99999988877777777766656666778899999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 000715 233 LINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILk 253 (1335)
++.+||+++|.+||++.++++
T Consensus 241 li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 241 LMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHcccCchhCCCHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=323.25 Aligned_cols=246 Identities=26% Similarity=0.442 Sum_probs=213.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
++|++.+.||+|+||.||+|.+..+ +.|++|.+... ...++.+|+.++++++||||+++++++......++||||++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~-~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCC-ceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 6899999999999999999998654 77999988653 35678899999999999999999999999899999999999
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 80 GGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 80 GGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+++|.+++... ..++..++..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~---- 160 (261)
T cd05034 85 KGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA---- 160 (261)
T ss_pred CCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhh----
Confidence 99999999764 378999999999999999999999999999999999999999999999999987664321110
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
.....++..|+|||.+. +..++.++|+||+|+++|+|++ |+.||.+.........+......+.+...+.++.+++.+
T Consensus 161 ~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 239 (261)
T cd05034 161 REGAKFPIKWTAPEAAN-YGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQ 239 (261)
T ss_pred hhccCCCccccCHHHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 11123467899999986 4557889999999999999998 999999888888888887766666677789999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 000715 237 LLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILk 253 (1335)
||..+|++||+++++.+
T Consensus 240 ~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 240 CWDKDPEERPTFEYLQS 256 (261)
T ss_pred HcccCcccCCCHHHHHH
Confidence 99999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=344.55 Aligned_cols=253 Identities=28% Similarity=0.478 Sum_probs=209.5
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS------AH 70 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds------~~ 70 (1335)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.+. ....+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 6899999999999999999999999999999998643 234577899999999999999999988643 34
Q ss_pred EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
.|++++++ |++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++......
T Consensus 97 ~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~- 173 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE- 173 (345)
T ss_pred EEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc-
Confidence 78888886 8899887764 46999999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----------
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS----------- 219 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~----------- 219 (1335)
.....|++.|+|||++.+...++.++||||+||++|+|++|++||...+.......+.....
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 174 -------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred -------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 12346899999999987555678899999999999999999999987665444333221000
Q ss_pred ----------------C---CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCCC
Q 000715 220 ----------------P---PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPM 264 (1335)
Q Consensus 220 ----------------~---pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~~ 264 (1335)
. ......++.+.++|.+||+.||.+||++.+++.||||++...+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 0 01123577899999999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=332.48 Aligned_cols=248 Identities=22% Similarity=0.394 Sum_probs=212.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEEC-----CCCeEEEEEEcCchh---HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKK-----KTIEYFAIKSVDKSQ---KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk-----~TGk~VAIKiIdKe~---~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+.... ...+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 47999999999999999999864 355679999986543 3568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeee
Q 000715 74 VLEYCVGGDLMSLLRQDN----------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKL 137 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~----------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKL 137 (1335)
||||+++++|.+++..++ .+++..++.++.||+.|+.|||++||+||||||+||+++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l 164 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKI 164 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEE
Confidence 999999999999997643 3899999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc
Q 000715 138 CDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILS 216 (1335)
Q Consensus 138 iDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~ 216 (1335)
+|||++......... .......|++.|+|||++.. ..++.++||||||+++|+|++ |..||......+....+..
T Consensus 165 ~dfg~a~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 240 (291)
T cd05094 165 GDFGMSRDVYSTDYY---RVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240 (291)
T ss_pred CCCCcccccCCCcee---ecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC
Confidence 999998765432211 11123457889999999864 557889999999999999998 9999988888777777766
Q ss_pred CCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 217 DPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 217 ~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
......+...+..+.+++.+||..||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 241 GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 6555566677899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.09 Aligned_cols=248 Identities=32% Similarity=0.559 Sum_probs=210.8
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
|++.+.||.|++|.||+|.+..+++.+++|.+.... ...+.+|++++++++||||+++++++......++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 778899999999999999999999999999885442 346788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 79 eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
.+ ++.+.+.. ...+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+.........
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~----- 154 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP----- 154 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccc-----
Confidence 65 88887766 468999999999999999999999999999999999999999999999999998776543311
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----------------
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP----------------- 220 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~----------------- 220 (1335)
.....++..|+|||.+.....++.++|+||+|+++|+|++|+.||.+.+..+.+..+......
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence 122458889999999876557889999999999999999999999887766555443221100
Q ss_pred ------------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 221 ------------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 221 ------------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
......+.++.++|.+||..||.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0112457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=325.20 Aligned_cols=242 Identities=24% Similarity=0.435 Sum_probs=209.0
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-HHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEEEEEEeec
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-KSKVLQEVRMLHSLDHPNVLRFYSWY-ETSAHLWLVLEYC 78 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-~e~LlrEIqILkkL~HPNIVrL~dvf-eds~~lyLVMEY~ 78 (1335)
+++|++.+.||+|+||.||++... |..|++|.+.... .+.+.+|+.++++++|+|++++++++ ...+..|+||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 368999999999999999999775 5779999886543 45688999999999999999999875 4556789999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 79 eGGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
++++|.+++.+.+ .+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~------ 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------ 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC------
Confidence 9999999997654 48999999999999999999999999999999999999999999999999987543321
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
....++..|+|||++. ...++.++|||||||++|+|++ |+.||...+..+....+........+...++.+.+++.
T Consensus 157 --~~~~~~~~y~aPE~~~-~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 233 (256)
T cd05082 157 --DTGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMK 233 (256)
T ss_pred --CCCccceeecCHHHHc-cCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 1233567899999985 4557889999999999999997 99999988888877777666555667788999999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 000715 236 SLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 236 kcLqkDPsKRPTAeEILk 253 (1335)
+||+.+|++|||+.++++
T Consensus 234 ~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 234 QCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=324.55 Aligned_cols=242 Identities=26% Similarity=0.446 Sum_probs=206.1
Q ss_pred EEEeccCcEEEEEEEECCCC---eEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTI---EYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TG---k~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|.+..++ ..||+|.+.... ...+.+|++++++++||||+++++++. ....++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999876554 789999986443 346788999999999999999999876 4567999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
++|.+++..++.+++..+..++.|++.|+.|||++|++||||||+||+++.++.+||+|||+++........... ...
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~--~~~ 157 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA--TTA 157 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc--ccC
Confidence 999999998888999999999999999999999999999999999999999999999999999876443221110 111
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLV 239 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLq 239 (1335)
..++..|+|||.+. ...++.++||||||+++|+|++ |.+||...+..+....+......+.+...+..+.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECIN-YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhc-CCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 22456799999985 4557889999999999999997 999998888777777776665666777889999999999999
Q ss_pred cCCCCCCCHHHHhc
Q 000715 240 KDPAQRLHWSDLCG 253 (1335)
Q Consensus 240 kDPsKRPTAeEILk 253 (1335)
.||++||++.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=335.24 Aligned_cols=249 Identities=24% Similarity=0.414 Sum_probs=211.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC-------CCeEEEEEEcCch----hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-------TIEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSA 69 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~-------TGk~VAIKiIdKe----~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~ 69 (1335)
++|.+.+.||+|+||.||+|++.. ++..||+|.+... ....+.+|+.+++++ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 579999999999999999998753 3357999998643 234677899999999 8999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC
Q 000715 70 HLWLVLEYCVGGDLMSLLRQDN----------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG 133 (1335)
Q Consensus 70 ~lyLVMEY~eGGSL~dlIkq~~----------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG 133 (1335)
..|+||||+.+++|.+++.... .++..++..++.|++.||.|||++|++||||||+||+++.++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 177 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 177 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC
Confidence 9999999999999999997642 488899999999999999999999999999999999999999
Q ss_pred CeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 000715 134 RTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVK 212 (1335)
Q Consensus 134 ~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLik 212 (1335)
.+||+|||++........... .....+++.|+|||++.+ ..++.++|+|||||++|+|++ |..||.+....+...
T Consensus 178 ~~kL~dfg~a~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 178 VMKIADFGLARDIHHIDYYKK---TTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cEEECCCcccccccccchhhc---cccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999876543211110 111234578999999864 557889999999999999998 899998888877777
Q ss_pred HHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 213 SILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 213 kIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
.+........+...+.++.+++.+||..+|++|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 254 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 776665556677889999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=339.07 Aligned_cols=257 Identities=26% Similarity=0.489 Sum_probs=210.5
Q ss_pred cEEEEEEEeccCcEEEEEEEECCC--CeEEEEEEcCch-----hHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CCE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKT--IEYFAIKSVDKS-----QKSKVLQEVRMLHSL-DHPNVLRFYSWYET----SAH 70 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~T--Gk~VAIKiIdKe-----~~e~LlrEIqILkkL-~HPNIVrL~dvfed----s~~ 70 (1335)
+|++.+.||+|+||.||++.+..+ ++.||+|.+... ....+.+|+.+++++ +||||+++++.... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 699999999999999999999988 999999988642 234577899999999 69999999986432 256
Q ss_pred EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
+|+++||+ +++|.+++..+..+++..++.++.||+.||.|||++|++||||||+||+++.+|.+||+|||++..+....
T Consensus 81 ~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 78999987 47899999888899999999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC------------
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP------------ 218 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~------------ 218 (1335)
..... ......|++.|+|||++.....++.++|+||+|+++|+|++|.+||.+.+.......+....
T Consensus 160 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAG-FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccc-cccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 22111 12345799999999998655567889999999999999999999998776544333222100
Q ss_pred ---------------CC---CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 219 ---------------SP---PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 219 ---------------~~---pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
.. ......+..+.+++.+||+.||++|||+.+++.||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 00 11223578899999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=333.35 Aligned_cols=252 Identities=30% Similarity=0.519 Sum_probs=206.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLD-HPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~-HPNIVrL~dvfeds~~lyLVME 76 (1335)
++|+..+.||+|+||.||++.+..+++.||+|.+... ....+.+|+.++.++. ||||+++++++...+..+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4677888999999999999999999999999988643 3446788999999995 9999999999999999999999
Q ss_pred ecCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 77 YCVGGDLMSLLR-----QDNQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 77 Y~eGGSL~dlIk-----q~~~LSEeqIr~I~rQILsGLkYLHsk-GIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
|+. +++.++.. ....+++..+..++.|++.|++|||+. |++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 975 45544332 246799999999999999999999975 99999999999999999999999999987654322
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCCCCC----C
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEG--GVHSYASDLWGLGCVLYECYAGRPPFVGREF-TQLVKSILSDPSPPL----P 223 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~--~~yS~kSDIWSLGVILYELLTGrpPF~g~d~-~eLikkIl~~~~~pi----p 223 (1335)
. .....|++.|+|||++... ..++.++||||+||++|+|++|++||..... .+...++.....+.. +
T Consensus 163 ~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 163 A------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred c------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence 1 1223588999999998754 3678899999999999999999999976542 223333332222222 2
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 224 ~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
...+.++.+||.+||..||++|||+++++.||||+..
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 3478899999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=321.92 Aligned_cols=241 Identities=39% Similarity=0.685 Sum_probs=214.4
Q ss_pred EeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 000715 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDL 83 (1335)
Q Consensus 10 LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL 83 (1335)
||.|+||.||++.+..+++.|++|.+.+. ....+..|++++++++||||+++++.+......|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999999999999998654 234678899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccC
Q 000715 84 MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCG 163 (1335)
Q Consensus 84 ~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~G 163 (1335)
.+++.....+++.++..++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||++......... .....|
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~ 155 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-----TNTFCG 155 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCc-----ccCCcC
Confidence 999998888999999999999999999999999999999999999999999999999998766443211 133568
Q ss_pred CCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCCC
Q 000715 164 TPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPA 243 (1335)
Q Consensus 164 Tp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPs 243 (1335)
+..|+|||.+.. ...+.++|+||||+++|+|++|..||...+.......+.. ...+.+...+..+.+++++||..||+
T Consensus 156 ~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~i~~~l~~~p~ 233 (250)
T cd05123 156 TPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLRFPEFLSPEARDLISGLLQKDPT 233 (250)
T ss_pred CccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence 899999999864 4467899999999999999999999988887776666665 34567777899999999999999999
Q ss_pred CCCCH---HHHhcCccc
Q 000715 244 QRLHW---SDLCGHAFW 257 (1335)
Q Consensus 244 KRPTA---eEILkHPfF 257 (1335)
+||++ +++++||||
T Consensus 234 ~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 234 KRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hCCCcccHHHHHhCCCC
Confidence 99999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=327.45 Aligned_cols=247 Identities=21% Similarity=0.329 Sum_probs=208.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCe----EEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIE----YFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk----~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
++|++.+.||+|+||.||+|++..+++ .||+|.+... ....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 579999999999999999999887776 4899987532 345678899999999999999999988754 4689
Q ss_pred EEeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
+|||+++|+|.+++..+ +.+++.++..++.|++.||.|||++||+||||||+||++++++.+||+|||+++........
T Consensus 86 ~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~ 165 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 165 (279)
T ss_pred EEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccce
Confidence 99999999999999774 57999999999999999999999999999999999999999999999999999876432211
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHH
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFA 231 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~ 231 (1335)
.. .....+++.|+|||.+.. ..++.++|||||||++|||++ |..||...........+......+.+...+..+.
T Consensus 166 ~~---~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05109 166 YH---ADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred ee---cCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence 10 112235678999999864 457889999999999999998 9999988777766666655555566677899999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 000715 232 NLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPTAeEILk 253 (1335)
+++.+||..||++||++.+++.
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=324.24 Aligned_cols=245 Identities=24% Similarity=0.452 Sum_probs=209.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
++|++.+.||+|+||.||+|..+. ++.||+|.+.+. ....+.+|+.++++++||||+++++++. .+..|++|||+.
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 479999999999999999998665 577999988654 3467889999999999999999999874 456899999999
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 80 GGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 80 GGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+++|.+++... ..+++.++..++.|++.||+|||++|++||||||+||+++.++.++|+|||++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~---- 159 (260)
T cd05067 84 NGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA---- 159 (260)
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc----
Confidence 99999998753 468999999999999999999999999999999999999999999999999987665322111
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
.....++..|+|||++. ...++.++||||||+++|+|++ |++||.+.+..+....+......+.+...+.++.+++.+
T Consensus 160 ~~~~~~~~~y~~pe~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05067 160 REGAKFPIKWTAPEAIN-YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRL 238 (260)
T ss_pred ccCCcccccccCHHHhc-cCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence 11234677899999986 4456889999999999999998 999999888777777776666666777888999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 000715 237 LLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILk 253 (1335)
||..+|++|||+++++.
T Consensus 239 ~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 239 CWKEKPEERPTFEYLRS 255 (260)
T ss_pred HccCChhhCCCHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=321.80 Aligned_cols=241 Identities=24% Similarity=0.420 Sum_probs=212.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh--HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~--~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
++|++.+.||.|+||.||+|... |+.||+|.+.... ..++.+|+.++++++|+||+++++++.+....|+||||+.
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 57999999999999999999875 6889999986553 4678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 80 GGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 80 GGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+++|.+++.... .+++..+..++.|++.|+.|||++|++||||||+||+++.+|.+||+|||.+........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~------ 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD------ 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc------
Confidence 999999998765 799999999999999999999999999999999999999999999999999876632211
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
...++..|+|||++. ...++.++|+||||+++|+|++ |..||......+....+........+...++.+.++|.+
T Consensus 158 --~~~~~~~~~ape~~~-~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05039 158 --SGKLPVKWTAPEALR-EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKD 234 (256)
T ss_pred --cCCCcccccCchhhc-CCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHH
Confidence 123456799999986 4457889999999999999997 999999888887777766655555667788999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 000715 237 LLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILk 253 (1335)
||..+|++|||+.++++
T Consensus 235 ~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 235 CWELDPAKRPTFKQLRE 251 (256)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=319.08 Aligned_cols=245 Identities=30% Similarity=0.520 Sum_probs=214.9
Q ss_pred EEEEEEEeccCcEEEEEEEECCCC----eEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTI----EYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TG----k~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
+++.+.||.|+||.||+|.+..++ ..||+|.+... ....+.+|+.+++.++|+||+++++++.+.+..|++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 357889999999999999998876 89999998644 3557889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~--LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
||+++++|.+++..... +++.++..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++..........
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccccc
Confidence 99999999999977554 9999999999999999999999999999999999999999999999999987765432211
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~D 232 (1335)
. ....+++.|+|||.+. ...++.++|+||+|+++|+|++ |.+||...+..+....+........+...+.++.+
T Consensus 161 ~----~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 161 K----KGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYK 235 (258)
T ss_pred c----ccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 1 1123778999999984 5667899999999999999998 89999988888888887776666677778999999
Q ss_pred HHHHhcccCCCCCCCHHHHhc
Q 000715 233 LINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILk 253 (1335)
++.+||..||++|||+.++++
T Consensus 236 ~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 236 LMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=326.04 Aligned_cols=248 Identities=31% Similarity=0.578 Sum_probs=213.7
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc--------hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK--------SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK--------e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
+|.+.+.||+|+||.||++.+..++..+++|.... .....+.+|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 69999999999999999999988877776666532 2233567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 75 LEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
|||+++++|.+++.. ...+++.+++.++.|++.|+.|||++|++|+||||+||+++. +.+||+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998864 457999999999999999999999999999999999999975 679999999987664332
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhH
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPF 230 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL 230 (1335)
.. .....|++.|+|||.+. +..++.++|+||+|+++|+|++|..||.+.........+.....+..+...+.++
T Consensus 160 ~~-----~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd08222 160 DL-----ATTFTGTPYYMSPEALK-HQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQL 233 (260)
T ss_pred cc-----ccCCCCCcCccCHHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHH
Confidence 21 22345889999999985 3456778999999999999999999998887777777776666666677888999
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 231 ANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 231 ~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.++|.+||..||++||++.++++||||
T Consensus 234 ~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 234 NSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.02 Aligned_cols=245 Identities=24% Similarity=0.411 Sum_probs=208.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
++|++.+.||+|+||.||+|.+..++ .+++|.+... ..+.+.+|++++++++|||++++++++. .+..|+||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 57999999999999999999987765 4899987643 2356789999999999999999999875 456789999999
Q ss_pred CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 80 GGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 80 GGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~---- 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA---- 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc----
Confidence 99999999764 358999999999999999999999999999999999999999999999999997654322111
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
.....++..|+|||... +..++.++|+||||+++|+|++ |+.||.+....+....+......+.+...+..+.+++.+
T Consensus 160 ~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 238 (260)
T cd05069 160 RQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKL 238 (260)
T ss_pred cCCCccchhhCCHHHhc-cCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHH
Confidence 11233667899999885 3457889999999999999999 999999888777777777665566677889999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 000715 237 LLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILk 253 (1335)
||.+||++||+++++++
T Consensus 239 ~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 239 CWKKDPDERPTFEYIQS 255 (260)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=329.17 Aligned_cols=248 Identities=22% Similarity=0.384 Sum_probs=211.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEEC-----CCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKK-----KTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk-----~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
.+|++.+.||+|+||.||++... .++..+++|.+... ....+.+|+++++.++||||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46889999999999999999753 35678999987643 34568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeec
Q 000715 74 VLEYCVGGDLMSLLRQDN---------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLC 138 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~---------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLi 138 (1335)
+|||+.+++|.+++.... .+++..+..++.|++.|+.|||++|++||||||+||++++++.+||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEEC
Confidence 999999999999997643 48899999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC
Q 000715 139 DFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD 217 (1335)
Q Consensus 139 DFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~ 217 (1335)
|||++......... .......+++.|+|||++.. ..++.++|||||||++|+|++ |.+||......+....+...
T Consensus 165 dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05092 165 DFGMSRDIYSTDYY---RVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQG 240 (280)
T ss_pred CCCceeEcCCCcee---ecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcC
Confidence 99998765332111 11122346788999999864 457889999999999999998 99999888777777777666
Q ss_pred CCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 218 PSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 218 ~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
.....+..+++.+.+++.+||+.||.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 241 RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 555566778899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.31 Aligned_cols=247 Identities=23% Similarity=0.435 Sum_probs=212.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh--HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~--~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
.+|++.+.||+|+||.||+|.+.. +..+|+|.+.... ...+.+|++++++++|||++++++++......|+||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 579999999999999999998864 5679999886542 4578899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 80 GGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
+++|.+++... +.++++.++.++.|++.|+.|||++|++||||||+||+++.++.+||+|||++.......... .
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~----~ 158 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS----S 158 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc----c
Confidence 99999998764 568999999999999999999999999999999999999999999999999987654322110 1
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHh
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkc 237 (1335)
....++..|+|||.+.. +.++.++|+||+|+++|+|++ |..||...........+........+...+..+.+++.+|
T Consensus 159 ~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 237 (256)
T cd05112 159 TGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHC 237 (256)
T ss_pred CCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHH
Confidence 12235678999999864 557889999999999999998 9999998888887777765544445666789999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 000715 238 LVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 238 LqkDPsKRPTAeEILkH 254 (1335)
|..+|++|||+.+++++
T Consensus 238 l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 238 WKERPEDRPSFSLLLHQ 254 (256)
T ss_pred cccChhhCCCHHHHHHh
Confidence 99999999999999764
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=331.77 Aligned_cols=249 Identities=23% Similarity=0.408 Sum_probs=212.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEEC-------CCCeEEEEEEcCch----hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKK-------KTIEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSA 69 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk-------~TGk~VAIKiIdKe----~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~ 69 (1335)
++|++.+.||+|+||.||+|++. ..+..||+|.+... ....+.+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 47999999999999999999753 24567999998643 345688999999999 8999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC
Q 000715 70 HLWLVLEYCVGGDLMSLLRQD----------------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG 133 (1335)
Q Consensus 70 ~lyLVMEY~eGGSL~dlIkq~----------------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG 133 (1335)
..|+||||+.+++|.+++... ..++..++..++.||+.||.|||++|++||||||+||+++.++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~ 174 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN 174 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence 999999999999999999764 2477888999999999999999999999999999999999999
Q ss_pred CeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 000715 134 RTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVK 212 (1335)
Q Consensus 134 ~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLik 212 (1335)
.+||+|||+++.......... .....+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+....+...
T Consensus 175 ~~kl~D~g~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 175 VMKIADFGLARDVNNIDYYKK---TTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cEEECCCccceeccccccccc---ccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 999999999987643322111 122346778999999864 457889999999999999998 899999988888888
Q ss_pred HHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 213 SILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 213 kIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
.+........+..++.++.+++.+||..+|++|||+.++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 251 LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 877666556677889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=328.27 Aligned_cols=247 Identities=31% Similarity=0.538 Sum_probs=208.5
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh----HHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeec
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLD-HPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~----~e~LlrEIqILkkL~-HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
|++.+.||+|+||+||+|....+++.|++|.+.+.. .....+|+..+++++ ||||+++++++...+..|+||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 789999999999999999999999999999875532 223467999999998 999999999999999999999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 79 eGGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+++|.+++.... .+++.++..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~----- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-----
Confidence 889999887764 789999999999999999999999999999999999999999999999999876543221
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP---------------- 220 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~---------------- 220 (1335)
.....|+..|+|||++.....++.++|+||||+++|+|++|++||......+.+.++......
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 123458899999999876666788999999999999999999999887655544433211000
Q ss_pred -------------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 221 -------------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 221 -------------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
......+..+.++|.+||+.||++|||+.|++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0011236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=329.67 Aligned_cols=248 Identities=22% Similarity=0.338 Sum_probs=207.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCC----------------eEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTI----------------EYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRF 61 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TG----------------k~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL 61 (1335)
++|++.+.||+|+||.||+|++..++ ..||+|.+... ..+.+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 58999999999999999999877644 56899998653 35567889999999999999999
Q ss_pred EEEEEeCCEEEEEEeecCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEEC
Q 000715 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDN-----------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLD 130 (1335)
Q Consensus 62 ~dvfeds~~lyLVMEY~eGGSL~dlIkq~~-----------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILID 130 (1335)
++++......++||||+.+++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~ 164 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec
Confidence 999999999999999999999999998765 789999999999999999999999999999999999999
Q ss_pred CCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHH
Q 000715 131 ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA--GRPPFVGREFT 208 (1335)
Q Consensus 131 edG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT--GrpPF~g~d~~ 208 (1335)
.++.++|+|||+++........ .......+++.|+|||++.. ..++.++|||||||++|+|++ |..||......
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 165 KNYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred CCCceEEccccceeecccCcce---eecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999998765432211 11223456788999999864 457889999999999999998 78899877666
Q ss_pred HHHHHHhcC-------CCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 209 QLVKSILSD-------PSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 209 eLikkIl~~-------~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
+.+...... ...+.+...+.++.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 665554322 112234456789999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=363.83 Aligned_cols=242 Identities=27% Similarity=0.479 Sum_probs=215.3
Q ss_pred EEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCC
Q 000715 5 HIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGD 82 (1335)
Q Consensus 5 eLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGS 82 (1335)
.+.+.||+|.||.||.|.++.+. .||+|.+... ..+.+.+|+++|++|+|+|||++++++.....+||||||+..|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCC-cccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 45678999999999999998863 4899988553 35678899999999999999999999999999999999999999
Q ss_pred HHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 83 LMSLLRQ--DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 83 L~dlIkq--~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
|.++++. ++.+...+...++.||++|++||+++++|||||-..||||++++.+||+|||+|+...+...... ..
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~----~~ 363 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS----EG 363 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeec----CC
Confidence 9999987 56799999999999999999999999999999999999999999999999999995544332211 11
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcc
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLV 239 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLq 239 (1335)
.--...|.|||.+.. +.++.++||||||++||||+| |+.||.+....+.++.+.++.+.+.|..+|+++.+++..||+
T Consensus 364 ~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~ 442 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWH 442 (468)
T ss_pred CCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhh
Confidence 123456999999975 457889999999999999999 999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCHHHHh
Q 000715 240 KDPAQRLHWSDLC 252 (1335)
Q Consensus 240 kDPsKRPTAeEIL 252 (1335)
.+|++|||++.+.
T Consensus 443 ~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 443 EDPEDRPTFETLR 455 (468)
T ss_pred CCcccCCCHHHHH
Confidence 9999999998664
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=348.12 Aligned_cols=257 Identities=31% Similarity=0.516 Sum_probs=220.2
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCCCC
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVGGD 82 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVMEY~eGGS 82 (1335)
.+.||+|+|+.|--|....+|+.||||+++|. .+.++.+|++++.+. .|+||+++++||+++.++|+|||.+.||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 35799999999999999999999999999886 467899999999998 79999999999999999999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC---CeeeccccccccccCCCCCC--CCCC
Q 000715 83 LMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG---RTKLCDFGLARKLSDASKAP--SSML 157 (1335)
Q Consensus 83 L~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG---~VKLiDFGLAr~l~e~~~~~--ss~l 157 (1335)
|...|.+...|+|.++..+.++|+.||.|||.+||.|||+||+|||-.+.. -+|||||.+........... ....
T Consensus 163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~ 242 (463)
T KOG0607|consen 163 LLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE 242 (463)
T ss_pred HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc
Confidence 999999999999999999999999999999999999999999999997654 57999998876554333211 1111
Q ss_pred CCCccCCCCCCCcchhc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---------------HHHHHHHHhcCC
Q 000715 158 PQAKCGTPCYMAPELFE----EGGVHSYASDLWGLGCVLYECYAGRPPFVGRE---------------FTQLVKSILSDP 218 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~----~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d---------------~~eLikkIl~~~ 218 (1335)
..+.+|+..|||||+.. ...+|+.++|.||||||+|.|++|++||.+.- ...++..|..+.
T Consensus 243 L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk 322 (463)
T KOG0607|consen 243 LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 322 (463)
T ss_pred ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC
Confidence 24568999999999863 35678999999999999999999999997641 235566776543
Q ss_pred ---CCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCC
Q 000715 219 ---SPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTP 263 (1335)
Q Consensus 219 ---~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~ 263 (1335)
...-+..+|.+.+|+|..+|..|+.+|.++.++++|||++.....
T Consensus 323 YeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 323 YEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred CcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 233456789999999999999999999999999999999875443
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.27 Aligned_cols=247 Identities=21% Similarity=0.308 Sum_probs=207.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCe----EEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIE----YFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk----~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
++|++.+.||+|+||.||+|.+..+++ .+++|.+... ...++..|+.++.+++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 579999999999999999999987766 4777877532 2345677888899999999999999875 455788
Q ss_pred EEeecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
++||+.+|+|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++........
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 9999999999999976 457999999999999999999999999999999999999999999999999999866432211
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHH
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFA 231 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~ 231 (1335)
. ......++..|+|||++.. ..++.++||||||+++|+|++ |..||.+.......+.+..+...+.+..++.++.
T Consensus 166 ~---~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 166 Y---FYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred c---ccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence 1 1123457788999999864 457889999999999999998 9999998877666666655555566667788999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 000715 232 NLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPTAeEILk 253 (1335)
+++.+||..||++|||+.++++
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=327.33 Aligned_cols=248 Identities=33% Similarity=0.543 Sum_probs=210.9
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
|++.+.||+|+||.||+|.+..+++.|++|.+... ....+.+|+.++++++|+|++++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 77889999999999999999999999999998653 2345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 79 eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
. ++|.+++.+. ..+++.++..++.|++.||.|||++||+||||+|+||++++++.+||+|||.+.........
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~----- 154 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT----- 154 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-----
Confidence 6 5899999886 68999999999999999999999999999999999999999999999999998766433211
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-----------------
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP----------------- 220 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~----------------- 220 (1335)
.....++..|+|||.+.....++.++|+||||+++|+|++|.+||.+.+..+.+.++......
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 122456788999999876557788999999999999999999999888766554443221000
Q ss_pred -----------CCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 221 -----------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 221 -----------pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
......+..+.++|.+||..||++||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0011346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=329.16 Aligned_cols=247 Identities=24% Similarity=0.416 Sum_probs=209.9
Q ss_pred cEEEEEEEeccCcEEEEEEEECC-----CCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKK-----TIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~-----TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
+|++.+.||+|+||.||+|++.. ....+++|.+... ....+.+|+++++.++||||+++++.+...+..|+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 58999999999999999998753 3367999987543 24568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEE
Q 000715 74 VLEYCVGGDLMSLLRQD------------------------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILL 129 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~------------------------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILI 129 (1335)
||||+.+++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 99999999999998642 247889999999999999999999999999999999999
Q ss_pred CCCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH
Q 000715 130 DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFT 208 (1335)
Q Consensus 130 DedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~ 208 (1335)
++++.+||+|||+++......... ......++..|+|||++. +..++.++||||||+++|+|++ |..||.+....
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYV---KRSKGRIPVKWMAIESLF-DHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred cCCCcEEeccccccccccCccchh---cccCCCCCccccCHHHHc-cCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999987653322110 012234677899999885 4557889999999999999998 99999988877
Q ss_pred HHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 209 QLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 209 eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
++...+......+.+...+.++.+++.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 237 RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 777766665555667788999999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=328.46 Aligned_cols=248 Identities=23% Similarity=0.410 Sum_probs=211.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC-----CCeEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-----TIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~-----TGk~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~ly 72 (1335)
++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ...+.+|+.++++++||||+++++++.+....|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 579999999999999999998753 67889999986432 456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEEC
Q 000715 73 LVLEYCVGGDLMSLLRQDN----------------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLD 130 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~----------------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILID 130 (1335)
+||||+.+++|.+++.... .+++.++..++.|++.||.|||++|++||||||+||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~ 164 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG 164 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec
Confidence 9999999999999997432 478889999999999999999999999999999999999
Q ss_pred CCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH
Q 000715 131 ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQ 209 (1335)
Q Consensus 131 edG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~e 209 (1335)
.++.+||+|||++.......... ......+++.|+|||++.. ..++.++|||||||++|+|++ |..||.+....+
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 165 ENMVVKIADFGLSRNIYSADYYK---ASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred CCCceEECccccceecccCcccc---ccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999987653322110 0112335677999999864 457889999999999999997 889998888888
Q ss_pred HHHHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 210 LVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 210 LikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
....+......+.+...+.++.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 77777666555567778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=364.69 Aligned_cols=247 Identities=30% Similarity=0.533 Sum_probs=217.6
Q ss_pred EEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHHH
Q 000715 9 AIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMS 85 (1335)
Q Consensus 9 ~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL~d 85 (1335)
+||+|.||+||.|++..|....|||-+... ...-+..|+.+.+.|+|.|||++++.+..++.+-|+||-++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 699999999999999999999999999654 34457899999999999999999999999999999999999999999
Q ss_pred HHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEEC-CCCCeeeccccccccccCCCCCCCCCCCCCc
Q 000715 86 LLRQD-NQL--PEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLD-ENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161 (1335)
Q Consensus 86 lIkq~-~~L--SEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILID-edG~VKLiDFGLAr~l~e~~~~~ss~l~~t~ 161 (1335)
+++.. +++ .|..+-.|.+||++||+|||++.|||||||-+||||+ -.|.+||+|||.+..+..-.. ...++
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-----~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-----CTETF 736 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc-----ccccc
Confidence 99864 677 8999999999999999999999999999999999996 579999999999887754332 23567
Q ss_pred cCCCCCCCcchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhcCCCCCCCCCCChhHHHHHHHhc
Q 000715 162 CGTPCYMAPELFEEG-GVHSYASDLWGLGCVLYECYAGRPPFVGREFT--QLVKSILSDPSPPLPGNPSRPFANLINSLL 238 (1335)
Q Consensus 162 ~GTp~YmAPEVL~~~-~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~--eLikkIl~~~~~pip~~iS~eL~DLIkkcL 238 (1335)
.||..|||||++..+ ..|+.++|||||||++.||.||++||...... .+++--+....+++|...+.++++||.+|+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF 816 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF 816 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence 899999999999643 46899999999999999999999999765433 333433556678899999999999999999
Q ss_pred ccCCCCCCCHHHHhcCcccccc
Q 000715 239 VKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 239 qkDPsKRPTAeEILkHPfFq~~ 260 (1335)
.+||.+||++.++|.+||++..
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCCcccCccHHHhccCcccccC
Confidence 9999999999999999998764
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=333.54 Aligned_cols=247 Identities=32% Similarity=0.538 Sum_probs=210.0
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
|...+.||+|+||.||+|++..+|+.|++|.+... ....+.+|+++++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999998532 234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+. +++.+++.. ..++++.++..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-------- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--------
Confidence 95 567776654 56799999999999999999999999999999999999999999999999998754321
Q ss_pred CCCCccCCCCCCCcchhcc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCChhHHHH
Q 000715 157 LPQAKCGTPCYMAPELFEE--GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP-LPGNPSRPFANL 233 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~--~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p-ip~~iS~eL~DL 233 (1335)
.....|+..|+|||++.. ...++.++|+||||+++|+|++|.+||...+.......+.....+. ....++..+.++
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 123568999999999842 3557889999999999999999999998877666555554433222 234567889999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 234 INSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 234 IkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
+.+||+.+|.+||++.+++.||||+..
T Consensus 253 i~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 253 VDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHccCChhhCcCHHHHhcCcccCCC
Confidence 999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=339.98 Aligned_cols=249 Identities=28% Similarity=0.504 Sum_probs=207.5
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS------AH 70 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds------~~ 70 (1335)
++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+. ....+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 6899999999999999999999999999999988642 234578899999999999999999988654 35
Q ss_pred EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
+|+||||+. .+|..++ +..++++.+..++.|++.|+.|||++|++||||||+||+++.+|.+||+|||++......
T Consensus 95 ~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred EEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 799999985 4777665 347899999999999999999999999999999999999999999999999998754221
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----------
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS----------- 219 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~----------- 219 (1335)
.....|++.|+|||++.+...++.++|+|||||++|+|++|+.||.+.+....+..+.....
T Consensus 171 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 171 -------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred -------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 12346889999999987555678899999999999999999999998776555444332110
Q ss_pred -----------CC--------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 220 -----------PP--------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 220 -----------~p--------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
+. .....+..+.++|.+||+.||.+||++.+++.||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00 0124567899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=339.76 Aligned_cols=254 Identities=27% Similarity=0.430 Sum_probs=204.6
Q ss_pred EEEecc--CcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRG--KYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeG--gFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
..||+| +||+||+|++..+|+.||+|++... ..+.+.+|+.+++.++||||+++++++...+..|+||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 9999999999999999999998542 245678899999999999999999999999999999999999
Q ss_pred CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC--CC
Q 000715 81 GDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS--SM 156 (1335)
Q Consensus 81 GSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s--s~ 156 (1335)
+++.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+|++|||.+........... ..
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 9999999874 3589999999999999999999999999999999999999999999999986544322111110 00
Q ss_pred CCCCccCCCCCCCcchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------------
Q 000715 157 LPQAKCGTPCYMAPELFEEG-GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS---------------- 219 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~-~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~---------------- 219 (1335)
.+....++..|+|||++.++ ..++.++||||+||++|+|++|.+||.+...............
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhh
Confidence 11123456779999998653 3468899999999999999999999987765444433322110
Q ss_pred ------------------------------CCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 220 ------------------------------PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 220 ------------------------------~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
.+.+...++.+.+|+.+||+.||++|||+.++++||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred ccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 011223467799999999999999999999999999997654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.21 Aligned_cols=246 Identities=31% Similarity=0.525 Sum_probs=204.7
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCE-----
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSL---DHPNVLRFYSWYETSAH----- 70 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL---~HPNIVrL~dvfeds~~----- 70 (1335)
|++.+.||+|+||.||+|.++.+++.||+|.+... ....+.+|+.+++++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78999999999999999999999999999998532 123456787777665 69999999999988776
Q ss_pred EEEEEeecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSD 148 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e 148 (1335)
++++|||+. ++|.+++.... .+++.+++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 999999996 58988887643 599999999999999999999999999999999999999999999999999877643
Q ss_pred CCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-------
Q 000715 149 ASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP------- 221 (1335)
Q Consensus 149 ~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p------- 221 (1335)
... .....+++.|+|||++.. ..++.++|+||+||++|+|++|.+||.+....+.+.++......+
T Consensus 160 ~~~------~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 160 EMA------LTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred Ccc------cccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 321 122357889999999864 457889999999999999999999999888776666554311000
Q ss_pred -------------------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 222 -------------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 222 -------------------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
.....+..+.++|.+||+.||++||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 001235778899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=330.07 Aligned_cols=245 Identities=33% Similarity=0.605 Sum_probs=206.8
Q ss_pred EEEEEEeccCcEEEEEEEEC----CCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 5 HIYEAIGRGKYSTVYKGRKK----KTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 5 eLlK~LGeGgFGtVYkArdk----~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
.+.+.||.|+||.||+|.+. ..+..|++|.+... ..+.+.+|++.+++++||||+++++++...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 57889999999999999998 45678999999432 35678999999999999999999999998888999999
Q ss_pred ecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 77 YCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|+++|+|.+++... ..+++.++..|+.|++.||.|||+++++||||+++||++++++.+||+|||++.........
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~-- 159 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY-- 159 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--
Confidence 99999999999886 78999999999999999999999999999999999999999999999999999876322111
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DL 233 (1335)
.......+...|+|||.+... .++.++||||||+++|||++ |+.||.+.+..+...++......+.+..++..+.++
T Consensus 160 -~~~~~~~~~~~~~aPE~~~~~-~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 237 (259)
T PF07714_consen 160 -KNDSSQQLPLRYLAPEVLKDG-EYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSL 237 (259)
T ss_dssp -EESTTSESGGGGS-HHHHHHS-EESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHH
T ss_pred -ccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHH
Confidence 111223467789999998644 47899999999999999999 789999998888888887777777788899999999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 000715 234 INSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 234 IkkcLqkDPsKRPTAeEILk 253 (1335)
|.+||..||++|||+.++++
T Consensus 238 i~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 238 IQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHT-SSGGGS--HHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHh
Confidence 99999999999999999864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=316.56 Aligned_cols=240 Identities=28% Similarity=0.465 Sum_probs=205.4
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDL 83 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL 83 (1335)
+.||+|+||.||+|... +++.||+|.+.... ...+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46899999999999865 57889999876432 34578899999999999999999999999999999999999999
Q ss_pred HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCcc
Q 000715 84 MSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC 162 (1335)
Q Consensus 84 ~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~ 162 (1335)
.+++... ..+++..+..++.|++.++.|+|++|++||||||+||+++.++.+||+|||++.......... .....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~----~~~~~ 155 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS----SGLKQ 155 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc----CCCCC
Confidence 9998754 468999999999999999999999999999999999999999999999999987543321110 11234
Q ss_pred CCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccC
Q 000715 163 GTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKD 241 (1335)
Q Consensus 163 GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkD 241 (1335)
+++.|+|||++. ...++.++||||||+++|++++ |..||.+.........+........+...+..+.+++.+||..+
T Consensus 156 ~~~~y~aPE~~~-~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 234 (250)
T cd05085 156 IPIKWTAPEALN-YGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYK 234 (250)
T ss_pred CcccccCHHHhc-cCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 567899999985 4557889999999999999998 99999988877777777666555667778999999999999999
Q ss_pred CCCCCCHHHHhc
Q 000715 242 PAQRLHWSDLCG 253 (1335)
Q Consensus 242 PsKRPTAeEILk 253 (1335)
|++||++.++.+
T Consensus 235 p~~Rp~~~~l~~ 246 (250)
T cd05085 235 PENRPKFSELQK 246 (250)
T ss_pred cccCCCHHHHHH
Confidence 999999999965
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=347.30 Aligned_cols=251 Identities=29% Similarity=0.484 Sum_probs=211.0
Q ss_pred CcEEEE-EEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHh-CCCCCcceEEEEEEeC----CEEEEEE
Q 000715 2 NQYHIY-EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHS-LDHPNVLRFYSWYETS----AHLWLVL 75 (1335)
Q Consensus 2 nrYeLl-K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkk-L~HPNIVrL~dvfeds----~~lyLVM 75 (1335)
++|.+. ++||-|-.|+|..|.++.||+.+|+|++....+ ..+|+++.-. -.|||||.++++|++. ..+.+||
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K--ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVm 138 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK--ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVM 138 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH--HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeee
Confidence 467763 579999999999999999999999999876644 3577776444 4899999999998664 5688999
Q ss_pred eecCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC---CCCeeeccccccccccCCC
Q 000715 76 EYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE---NGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~--LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe---dG~VKLiDFGLAr~l~e~~ 150 (1335)
|.++||+|+..|++++. |+|.++..+++||..|+.|||+.+|.||||||+|+|+.. |..+||+|||+|.......
T Consensus 139 E~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~ 218 (400)
T KOG0604|consen 139 ECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG 218 (400)
T ss_pred ecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCc
Confidence 99999999999998764 999999999999999999999999999999999999964 4579999999998655432
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHh---cCCCCCCC
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT----QLVKSIL---SDPSPPLP 223 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~----eLikkIl---~~~~~pip 223 (1335)
. ..+.|-||+|.|||++. ...|+..+|+||+||++|.|++|.+||.+.... ....+|. ..+..+.+
T Consensus 219 ~------L~TPc~TPyYvaPevlg-~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW 291 (400)
T KOG0604|consen 219 D------LMTPCFTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW 291 (400)
T ss_pred c------ccCCcccccccCHHHhC-chhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH
Confidence 2 35678999999999995 445888999999999999999999999876432 2333443 23444556
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 224 ~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
..+|+..+|+|+++|..+|.+|.|++++++|||.....
T Consensus 292 s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 292 SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 77899999999999999999999999999999987643
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=355.77 Aligned_cols=252 Identities=33% Similarity=0.602 Sum_probs=222.5
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc-hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCC
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK-SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGD 82 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK-e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGS 82 (1335)
|.++++||+|+||.||+|.++.+|+.+|||.+.- .+..++.+|+.++++++.|++|++|+.|-....+|+|||||..|+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 4567889999999999999999999999999865 467889999999999999999999999999999999999999999
Q ss_pred HHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCc
Q 000715 83 LMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161 (1335)
Q Consensus 83 L~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~ 161 (1335)
..|.++. +.+++|+++..+++..+.||+|||...-+|||||..|||++-+|+.||+|||.+..+.+.... .++.
T Consensus 115 iSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-----RNTV 189 (502)
T KOG0574|consen 115 ISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-----RNTV 189 (502)
T ss_pred HHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-----hCcc
Confidence 9999875 578999999999999999999999999999999999999999999999999999887654322 3567
Q ss_pred cCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCChhHHHHHHHhcc
Q 000715 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP--LPGNPSRPFANLINSLLV 239 (1335)
Q Consensus 162 ~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p--ip~~iS~eL~DLIkkcLq 239 (1335)
+|||.|||||++..-+ |..++||||||++..||.-|++||.+-.....+.-|-..+.+. -|..++.++.|||++||.
T Consensus 190 IGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLi 268 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLI 268 (502)
T ss_pred ccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhc
Confidence 8999999999997655 4669999999999999999999998876655544444443332 356779999999999999
Q ss_pred cCCCCCCCHHHHhcCccccccC
Q 000715 240 KDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 240 kDPsKRPTAeEILkHPfFq~~l 261 (1335)
+.|++|-|+.++++|||.++..
T Consensus 269 K~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 269 KKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred CCHHHHHHHHHHhhhhhhcCCC
Confidence 9999999999999999998753
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=331.58 Aligned_cols=248 Identities=23% Similarity=0.417 Sum_probs=210.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC-------CCeEEEEEEcCch----hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-------TIEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSA 69 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~-------TGk~VAIKiIdKe----~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~ 69 (1335)
++|.+.+.||+|+||.||+|++.. ....||+|.+... ....+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 479999999999999999998643 3457999987643 244678899999999 6999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC
Q 000715 70 HLWLVLEYCVGGDLMSLLRQD----------------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG 133 (1335)
Q Consensus 70 ~lyLVMEY~eGGSL~dlIkq~----------------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG 133 (1335)
.+|+||||+.+|+|.+++... ..++..++..++.|++.||.|||++|++||||||+||+++.++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN 171 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC
Confidence 999999999999999999763 3488999999999999999999999999999999999999999
Q ss_pred CeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q 000715 134 RTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVK 212 (1335)
Q Consensus 134 ~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLik 212 (1335)
.+||+|||+++.......... .....+++.|+|||++.. ..++.++||||||+++|+|++ |..||.+....+...
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKK---TSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cEEEccccccccccccccccc---cccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999976643221110 111234567999999864 567889999999999999999 899999988888887
Q ss_pred HHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 213 SILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 213 kIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
.+........+..++.++.+++.+||..||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 77766555566778899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.59 Aligned_cols=239 Identities=28% Similarity=0.433 Sum_probs=202.4
Q ss_pred EEEeccCcEEEEEEEECCCCe--EEEEEEcCc----hhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIE--YFAIKSVDK----SQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk--~VAIKiIdK----e~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|+++.++. .+++|.+.. .....+.+|++++.++ +||||+++++++...+.+|+||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999988875 468887753 2345678899999999 899999999999999999999999999
Q ss_pred CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccc
Q 000715 81 GDLMSLLRQDN----------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 81 GSL~dlIkq~~----------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr 144 (1335)
++|.+++.... .+++.+++.++.|++.|++|||++|++||||||+||++++++.+||+|||++.
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~ 160 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence 99999997543 47899999999999999999999999999999999999999999999999975
Q ss_pred cccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCC
Q 000715 145 KLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLP 223 (1335)
Q Consensus 145 ~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip 223 (1335)
....... ......++.|+|||++. ...++.++|+||||+++|+|++ |..||.+.+..+....+........+
T Consensus 161 ~~~~~~~------~~~~~~~~~y~apE~~~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 233 (270)
T cd05047 161 GQEVYVK------KTMGRLPVRWMAIESLN-YSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP 233 (270)
T ss_pred ccchhhh------ccCCCCccccCChHHHc-cCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC
Confidence 3221110 11123466799999985 4557889999999999999997 99999988877777777665555566
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 224 ~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
...+.++.+++.+||..||.+|||+.+++.
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 234 LNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 677899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=356.51 Aligned_cols=254 Identities=30% Similarity=0.534 Sum_probs=223.3
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHH------HHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS------KVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e------~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
++.|...+.||+||||.||-|+.+.||+.||+|..++...+ ...+|-+|+.+++.+.||.+-.+|++.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 36788999999999999999999999999999998776432 357899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 75 LEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
|..+.||+|.-.|-+.+ .|++..++.|+.+|+.||.+||+.+||+||+||+|||+|+.|+++|+|+|+|..+......
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~ 343 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI 343 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence 99999999999998765 8999999999999999999999999999999999999999999999999999988765432
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCCCCCCCCCh
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF----TQLVKSILSDPSPPLPGNPSR 228 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~----~eLikkIl~~~~~pip~~iS~ 228 (1335)
...+||.+|||||++.+.. |+...|+|||||++|+|+.|+.||..... +++-+.+. .....++...|+
T Consensus 344 ------~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~-~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 344 ------RGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL-EDPEEYSDKFSE 415 (591)
T ss_pred ------ccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh-cchhhcccccCH
Confidence 2247999999999997655 89999999999999999999999976532 23333333 334567789999
Q ss_pred hHHHHHHHhcccCCCCCCC-----HHHHhcCccccccCC
Q 000715 229 PFANLINSLLVKDPAQRLH-----WSDLCGHAFWRTKLT 262 (1335)
Q Consensus 229 eL~DLIkkcLqkDPsKRPT-----AeEILkHPfFq~~l~ 262 (1335)
+++++.+.+|.+||.+|.. ++++.+||||++...
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 9999999999999999974 789999999987654
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.82 Aligned_cols=247 Identities=27% Similarity=0.438 Sum_probs=210.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCC---CeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKT---IEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~T---Gk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
++|.+.+.||+|+||.||+|.+... ...|++|..... ..+.+.+|++++++++||||+++++++.+ ...|+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4689999999999999999987654 456999987543 34578899999999999999999998875 456899
Q ss_pred EeecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~-~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
|||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 164 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK 164 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccccee
Confidence 99999999999998754 68999999999999999999999999999999999999999999999999987664332111
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~D 232 (1335)
.....+++.|+|||.+. ...++.++||||||+++|+|++ |..||.+....+....+......+.+..++..+.+
T Consensus 165 ----~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05056 165 ----ASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239 (270)
T ss_pred ----cCCCCccccccChhhhc-cCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 11223557899999985 4457889999999999999986 99999988877777777666666677888999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 000715 233 LINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkH 254 (1335)
++.+||..+|++|||+.+++.+
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=321.92 Aligned_cols=241 Identities=23% Similarity=0.397 Sum_probs=203.7
Q ss_pred EEeccCcEEEEEEEEC--CCCeEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCC
Q 000715 9 AIGRGKYSTVYKGRKK--KTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGD 82 (1335)
Q Consensus 9 ~LGeGgFGtVYkArdk--~TGk~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGS 82 (1335)
.||+|+||.||+|.+. +++..||+|.+.... .+.+.+|+.++++++||||++++++++. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999775 456679999986442 3457899999999999999999998764 57899999999999
Q ss_pred HHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCc
Q 000715 83 LMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161 (1335)
Q Consensus 83 L~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~ 161 (1335)
|.+++.. ...+++.++..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++..+......... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~--~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA--RSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec--cCCC
Confidence 9999875 457999999999999999999999999999999999999999999999999998765433221111 1112
Q ss_pred cCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhccc
Q 000715 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240 (1335)
Q Consensus 162 ~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqk 240 (1335)
.+++.|+|||++.. ..++.++|||||||++|++++ |..||.+....+....+........+...++++.+++.+||..
T Consensus 159 ~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 34678999999864 457889999999999999996 9999999888887777777666677788899999999999999
Q ss_pred CCCCCCCHHHHhc
Q 000715 241 DPAQRLHWSDLCG 253 (1335)
Q Consensus 241 DPsKRPTAeEILk 253 (1335)
||++||++.++.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.55 Aligned_cols=248 Identities=29% Similarity=0.521 Sum_probs=211.0
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDL 83 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL 83 (1335)
...||+|+||.||++.++.+++.||+|.+... ....+.+|+.+++.++|+||+++++.+...+..|+||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 45799999999999999999999999987532 345678899999999999999999999999999999999999999
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccC
Q 000715 84 MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCG 163 (1335)
Q Consensus 84 ~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~G 163 (1335)
.+++.. +.+++..++.++.|++.|++|||++|++||||||+||+++.++.++|+|||++......... .....|
T Consensus 105 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~ 178 (292)
T cd06657 105 TDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-----RKSLVG 178 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-----cccccc
Confidence 997754 57899999999999999999999999999999999999999999999999988765432211 123568
Q ss_pred CCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCChhHHHHHHHhcccC
Q 000715 164 TPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS--PPLPGNPSRPFANLINSLLVKD 241 (1335)
Q Consensus 164 Tp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~--~pip~~iS~eL~DLIkkcLqkD 241 (1335)
++.|+|||.+. ...++.++|+||+|+++|+|++|..||.+.........+..... .......+..+.+++.+||..|
T Consensus 179 ~~~y~~pE~~~-~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 179 TPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred CccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence 99999999885 34568899999999999999999999988776655444432221 1223457889999999999999
Q ss_pred CCCCCCHHHHhcCccccccC
Q 000715 242 PAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 242 PsKRPTAeEILkHPfFq~~l 261 (1335)
|.+||++.+++.||||....
T Consensus 258 P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 258 PAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred cccCcCHHHHhcChHHhccC
Confidence 99999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.94 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=209.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC----CCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK----TIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYET-SAHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~----TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfed-s~~ly 72 (1335)
++|++.+.||+|+||.||+|.+.. +++.|++|.+... ....+.+|+.++++++||||+++++++.. ....+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 579999999999999999999876 3578999987532 34567899999999999999999998665 56789
Q ss_pred EEEeecCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccc
Q 000715 73 LVLEYCVGGDLMSLLRQD--------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~--------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr 144 (1335)
+++||+.+++|.+++... ..+++.++..++.|++.||.|||++|++||||||+||++++++.+||+|||+++
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~ 165 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcc
Confidence 999999999999998763 458999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCC
Q 000715 145 KLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLP 223 (1335)
Q Consensus 145 ~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip 223 (1335)
.+....... ......++..|+|||++.. ..++.++||||||+++|++++ |++||.+.+..+....+........+
T Consensus 166 ~~~~~~~~~---~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
T cd05043 166 DLFPMDYHC---LGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241 (280)
T ss_pred cccCCceEE---eCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence 664322110 0122346778999999864 457889999999999999998 99999988877777766665555555
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 224 ~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
...++++.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 667899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=341.74 Aligned_cols=249 Identities=24% Similarity=0.441 Sum_probs=204.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC-----CCeEEEEEEcCch----hHHHHHHHHHHHHhC-CCCCcceEEEEEEe-CCE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-----TIEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYET-SAH 70 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~-----TGk~VAIKiIdKe----~~e~LlrEIqILkkL-~HPNIVrL~dvfed-s~~ 70 (1335)
++|++.+.||+|+||.||+|.+.. +++.||+|.+... ....+.+|++++.++ +||||+++++++.. ...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 479999999999999999997543 4578999998542 234577899999999 89999999998765 457
Q ss_pred EEEEEeecCCCCHHHHHHhC------------------------------------------------------------
Q 000715 71 LWLVLEYCVGGDLMSLLRQD------------------------------------------------------------ 90 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~------------------------------------------------------------ 90 (1335)
++++|||+.+++|.+++...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 88999999999999998642
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCC
Q 000715 91 -NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169 (1335)
Q Consensus 91 -~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmA 169 (1335)
.++++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+...... .......++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~---~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch---hhccCCCCCccccC
Confidence 26789999999999999999999999999999999999999999999999999876432211 11123456788999
Q ss_pred cchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCC
Q 000715 170 PELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLV-KSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLH 247 (1335)
Q Consensus 170 PEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLi-kkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPT 247 (1335)
||++.. ..++.++|||||||++|+|++ |..||.+....+.. ..+........+...++++.+++.+||+.+|++||+
T Consensus 244 PE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 244 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred cHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999864 567889999999999999998 99999875543333 333333344456677899999999999999999999
Q ss_pred HHHHhcC
Q 000715 248 WSDLCGH 254 (1335)
Q Consensus 248 AeEILkH 254 (1335)
+.++++|
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=321.98 Aligned_cols=247 Identities=22% Similarity=0.353 Sum_probs=211.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCe----EEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIE----YFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk----~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
++|++.+.||+|+||.||+|.++.+|+ .||+|...+. ....+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 579999999999999999999877664 5899987654 24567899999999999999999999887 78899
Q ss_pred EEeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
||||+.+|+|.+++.++ ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.+||+|||+++........
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 165 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE 165 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccc
Confidence 99999999999999874 47999999999999999999999999999999999999999999999999999876532211
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHH
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFA 231 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~ 231 (1335)
. ......++..|+|||.+. ...++.++|+||||+++|++++ |..||.+....+....+......+.+...+..+.
T Consensus 166 ~---~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05057 166 Y---HAEGGKVPIKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred e---ecCCCcccccccCHHHhh-cCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 1 111122466899999985 4556889999999999999998 9999999888887777776666666777889999
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 000715 232 NLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPTAeEILk 253 (1335)
+++.+||..||.+||++.++++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.45 Aligned_cols=255 Identities=32% Similarity=0.563 Sum_probs=213.3
Q ss_pred cEEEEEEEeccCcEEEEEEEEC---CCCeEEEEEEcCchh-------HHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKK---KTIEYFAIKSVDKSQ-------KSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk---~TGk~VAIKiIdKe~-------~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~l 71 (1335)
+|++.+.||+|+||.||++++. .+++.||+|.+.+.. ...+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 467889999886432 24567899999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCC
Q 000715 72 WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~ 151 (1335)
|+||||+.+++|.+++.....+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||+++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876543321
Q ss_pred CCCCCCCCCccCCCCCCCcchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCCCCCCCC
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGG-VHSYASDLWGLGCVLYECYAGRPPFVGRE----FTQLVKSILSDPSPPLPGNP 226 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~~-~yS~kSDIWSLGVILYELLTGrpPF~g~d----~~eLikkIl~~~~~pip~~i 226 (1335)
. ......|++.|+|||.+.... ..+.++|+||+|+++|+|++|..||.... ..+....+... ..+.+...
T Consensus 161 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 235 (288)
T cd05583 161 E----RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-KPPFPKTM 235 (288)
T ss_pred c----ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-CCCCCccc
Confidence 1 112346899999999986432 36789999999999999999999996432 22333333333 34566778
Q ss_pred ChhHHHHHHHhcccCCCCCCC---HHHHhcCccccccCC
Q 000715 227 SRPFANLINSLLVKDPAQRLH---WSDLCGHAFWRTKLT 262 (1335)
Q Consensus 227 S~eL~DLIkkcLqkDPsKRPT---AeEILkHPfFq~~l~ 262 (1335)
+..+.+++.+||+.||++||| +.++++||||++...
T Consensus 236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred CHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 899999999999999999998 577899999987543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=317.79 Aligned_cols=246 Identities=21% Similarity=0.411 Sum_probs=209.6
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
.++|++.+.||+|+||.||++.+.. +..+++|.+... ....+.+|++++++++|+||+++++.+.. ...|++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3689999999999999999998664 456999988643 34578899999999999999999999887 7789999999
Q ss_pred CCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 79 VGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 79 eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
++++|.+++... ..++...+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---- 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT---- 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc----
Confidence 999999999763 46788999999999999999999999999999999999999999999999998765432211
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
......++..|+|||++. ...++.++|+|||||++|++++ |+.||.+.+..+....+......+.+...+.++.+++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~-~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 237 (260)
T cd05073 159 AREGAKFPIKWTAPEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMM 237 (260)
T ss_pred cccCCcccccccCHhHhc-cCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHH
Confidence 111233567899999986 4557889999999999999998 99999988877777777666555666778899999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 000715 236 SLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 236 kcLqkDPsKRPTAeEILk 253 (1335)
+||+.+|++||++.++.+
T Consensus 238 ~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 238 RCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHcccCcccCcCHHHHHH
Confidence 999999999999988853
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=324.69 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=200.5
Q ss_pred CcE-EEEEEEeccCcEEEEEEE----ECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CE
Q 000715 2 NQY-HIYEAIGRGKYSTVYKGR----KKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS--AH 70 (1335)
Q Consensus 2 nrY-eLlK~LGeGgFGtVYkAr----dk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds--~~ 70 (1335)
++| ++.+.||+|+||+||++. ...+++.||+|.+... ....+.+|++++++++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 566 999999999999998764 4457889999998643 345678899999999999999999987653 46
Q ss_pred EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
+|+||||+.+++|.+++... .+++.+++.++.|++.|+.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 89999999999999999764 69999999999999999999999999999999999999999999999999988764432
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHh
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT---------------QLVKSIL 215 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~---------------eLikkIl 215 (1335)
... .......++..|+|||++.. ..++.++||||||+++|+|++|..||...... .....+.
T Consensus 162 ~~~--~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 162 EYY--RVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred hhh--ccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 211 11122346677999999864 45788999999999999999999998653211 1111112
Q ss_pred cCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 216 SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 216 ~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
.....+.+...+..+.+++.+||+.||++|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22233456677899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=331.54 Aligned_cols=248 Identities=33% Similarity=0.538 Sum_probs=212.1
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
.|...+.||+|+||.||++++..++..||+|.+... ....+.+|++++++++|||++++++++.+....|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 477888999999999999999999999999998532 23467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 77 Y~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|+.| ++.+.+.. ..++++.++..++.|++.|+.|||++||+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------ 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA------ 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc------
Confidence 9965 67776654 567999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCCCccCCCCCCCcchhc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCChhHHH
Q 000715 156 MLPQAKCGTPCYMAPELFE--EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP-LPGNPSRPFAN 232 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~--~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p-ip~~iS~eL~D 232 (1335)
....|++.|+|||++. ..+.++.++|+||+||++|+|++|..||...+.......+.....+. .....++.+.+
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence 2346889999999974 23557889999999999999999999998887766666665443322 33467888999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
++.+||+.+|.+||++.++++|+|+...
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 9999999999999999999999998553
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=316.66 Aligned_cols=242 Identities=28% Similarity=0.436 Sum_probs=204.7
Q ss_pred EEEeccCcEEEEEEEECC-CC--eEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 8 EAIGRGKYSTVYKGRKKK-TI--EYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~-TG--k~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+.||+|+||.||+|.+.. ++ ..||+|.+.... .+.+.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999865 33 369999987643 4567899999999999999999999988 889999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 81 GSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..+........ ..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~--~~ 157 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV--ME 157 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee--cc
Confidence 99999998764 689999999999999999999999999999999999999999999999999987754322111 11
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc-CCCCCCCCCCChhHHHHHHH
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILS-DPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~-~~~~pip~~iS~eL~DLIkk 236 (1335)
....++..|+|||++. ...++.++|||||||++|+|++ |..||...+..+..+.+.. ......+...+..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLR-TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhc-ccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 2345788899999985 4457889999999999999998 9999988877777666653 23334556678999999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 000715 237 LLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILk 253 (1335)
||+.+|++||++.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=321.51 Aligned_cols=248 Identities=21% Similarity=0.398 Sum_probs=209.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC-----CCeEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-----TIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~-----TGk~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~ly 72 (1335)
++|++.+.||+|+||.||+|+++. +.+.|++|...... ...+.+|++++++++||||+++++++.+....|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 479999999999999999999764 45679999886532 356889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccc
Q 000715 73 LVLEYCVGGDLMSLLRQDN---------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~---------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLA 143 (1335)
+||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||++
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999999998765 6999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-CCC
Q 000715 144 RKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDP-SPP 221 (1335)
Q Consensus 144 r~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~-~~p 221 (1335)
......... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.+.........+.... ..+
T Consensus 165 ~~~~~~~~~----~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 165 KDVYNSEYY----KLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred cccCccccc----ccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 654322111 1123356788999999864 446789999999999999998 889998777666666654332 233
Q ss_pred CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 222 ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
.+...+..+.+++.+||+.||++|||+.+++++
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 455678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=318.18 Aligned_cols=240 Identities=25% Similarity=0.421 Sum_probs=206.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
++|++.+.||+|+||.||++.. +++.||+|.+... ....+.+|+.++++++|||++++++++... ..|+||||+.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 5799999999999999999864 6788999998654 345688999999999999999999998765 47999999999
Q ss_pred CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 81 GSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
++|.+++.... .+++..+..++.|++.|+.|||++|++||||||+||+++.+|.+||+|||++.......
T Consensus 83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-------- 154 (254)
T cd05083 83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-------- 154 (254)
T ss_pred CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC--------
Confidence 99999997653 58999999999999999999999999999999999999999999999999987543211
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHh
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkc 237 (1335)
.....+..|+|||.+. ...++.++|+||||+++|+|++ |++||...+..+....+........+...+..+.+++.+|
T Consensus 155 ~~~~~~~~y~~pe~~~-~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 233 (254)
T cd05083 155 DNSKLPVKWTAPEALK-HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSC 233 (254)
T ss_pred CCCCCCceecCHHHhc-cCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHH
Confidence 1123456799999985 4557889999999999999997 9999999888877777766655555677889999999999
Q ss_pred cccCCCCCCCHHHHhc
Q 000715 238 LVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 238 LqkDPsKRPTAeEILk 253 (1335)
|+.+|++||++.+++.
T Consensus 234 l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 234 WETEPKKRPSFHKLRE 249 (254)
T ss_pred cCCChhhCcCHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=315.93 Aligned_cols=241 Identities=30% Similarity=0.479 Sum_probs=206.7
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCH
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDL 83 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL 83 (1335)
+.||+|+||.||+|.+.. ++.|++|.+... ....+.+|++++++++||||+++++++.+....|+||||+.|++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999988 899999987653 345688999999999999999999999999999999999999999
Q ss_pred HHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCcc
Q 000715 84 MSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC 162 (1335)
Q Consensus 84 ~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~ 162 (1335)
.+++.. ...+++..+..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++........... .....
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~---~~~~~ 156 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS---DGLKQ 156 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec---cccCc
Confidence 999976 45789999999999999999999999999999999999999999999999999876542211110 11223
Q ss_pred CCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccC
Q 000715 163 GTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKD 241 (1335)
Q Consensus 163 GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkD 241 (1335)
++..|+|||.+.. +.++.++|+||||+++|+|++ |..||...........+......+.+...+..+.+++.+||..+
T Consensus 157 ~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 235 (251)
T cd05041 157 IPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYD 235 (251)
T ss_pred ceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccC
Confidence 4667999999864 567889999999999999998 89999888777766666655555567788899999999999999
Q ss_pred CCCCCCHHHHhc
Q 000715 242 PAQRLHWSDLCG 253 (1335)
Q Consensus 242 PsKRPTAeEILk 253 (1335)
|++|||+.++++
T Consensus 236 p~~Rp~~~ell~ 247 (251)
T cd05041 236 PENRPSFSEIYN 247 (251)
T ss_pred hhhCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=359.04 Aligned_cols=251 Identities=29% Similarity=0.532 Sum_probs=205.8
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEc-----CchhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiI-----dKe~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVME 76 (1335)
.|+++++||+||.+.||++..-+.+- ||+|.+ +......+.+|+..|.+| .|.+||++|+|-..++.+|||||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~~~i-yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSDKQI-YALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCCCcc-hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 59999999999999999998877655 555544 334566789999999999 68999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQDNQL-PEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~L-SEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
| ...+|..++++.... +.-.++.|..|++.+++++|++||||.||||.|+++ -.|.+||+|||.|..+..... .
T Consensus 441 ~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTT---s 515 (677)
T KOG0596|consen 441 C-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTT---S 515 (677)
T ss_pred c-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcccc---c
Confidence 6 578999999887643 346899999999999999999999999999999999 568999999999988765433 3
Q ss_pred CCCCCccCCCCCCCcchhccCC----------CCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcC-CCCCCC
Q 000715 156 MLPQAKCGTPCYMAPELFEEGG----------VHSYASDLWGLGCVLYECYAGRPPFVGRE-FTQLVKSILSD-PSPPLP 223 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~----------~yS~kSDIWSLGVILYELLTGrpPF~g~d-~~eLikkIl~~-~~~pip 223 (1335)
......+||+.||+||.+.... ..+.++||||||||+|+|+.|++||..-. ...-+..|... ...++|
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 4456789999999999985321 24678999999999999999999996643 33334444433 222455
Q ss_pred CCCChh-HHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 224 GNPSRP-FANLINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 224 ~~iS~e-L~DLIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
...+.. +.++++.||..||++|||+.++|+|||.+-
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 444433 999999999999999999999999999864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.52 Aligned_cols=253 Identities=31% Similarity=0.577 Sum_probs=208.2
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVM 75 (1335)
+++|++.+.||+|+||.||+|.+..+++.||+|.+.+. ....+.+|+.++.+. .||||+++++++.+....|+||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 36899999999999999999999999999999998643 234456677766666 5999999999999999999999
Q ss_pred eecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 76 EYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 76 EY~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
||+ ++++.+++.. .+.+++..+..++.|++.|+.|||+ .||+||||+|+||++++++.+||+|||++..+......
T Consensus 94 e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~- 171 (296)
T cd06618 94 ELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171 (296)
T ss_pred ecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc-
Confidence 997 5577777765 4579999999999999999999997 59999999999999999999999999998765432211
Q ss_pred CCCCCCCccCCCCCCCcchhccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCCCCCC--CCCC
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEG---GVHSYASDLWGLGCVLYECYAGRPPFVGREF-TQLVKSILSDPSPPLP--GNPS 227 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~---~~yS~kSDIWSLGVILYELLTGrpPF~g~d~-~eLikkIl~~~~~pip--~~iS 227 (1335)
....+++.|+|||.+... +.++.++|+||||+++|+|++|+.||..... .+.+..+.....+..+ ..++
T Consensus 172 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (296)
T cd06618 172 -----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS 246 (296)
T ss_pred -----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCC
Confidence 223578899999998643 3467899999999999999999999976432 3444444443322222 3468
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 228 RPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 228 ~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
.++.+++.+||..||++||++++++.||||+..
T Consensus 247 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 247 PDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=333.34 Aligned_cols=248 Identities=24% Similarity=0.400 Sum_probs=211.1
Q ss_pred cEEEEEEEeccCcEEEEEEEECCC-------CeEEEEEEcCch----hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKT-------IEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAH 70 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~T-------Gk~VAIKiIdKe----~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~ 70 (1335)
+|++.+.||+|+||.||+|++... +..||+|.+... ....+.+|+++++++ +||||+++++++...+.
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 92 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence 699999999999999999986432 236899987642 345688999999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDN----------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGR 134 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~----------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~ 134 (1335)
.|++|||+.+|+|.+++.+.. .++..++..++.|++.||.|||++|++||||||+||+++.++.
T Consensus 93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~ 172 (334)
T cd05100 93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV 172 (334)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc
Confidence 999999999999999997532 4778889999999999999999999999999999999999999
Q ss_pred eeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 000715 135 TKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKS 213 (1335)
Q Consensus 135 VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikk 213 (1335)
+||+|||+++.......... .....++..|+|||++.. ..++.++||||||+++|+|++ |..||.+.+..+....
T Consensus 173 ~kL~Dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 173 MKIADFGLARDVHNIDYYKK---TTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred EEECCcccceeccccccccc---ccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999876643221111 112234577999999864 557889999999999999998 8999999888888887
Q ss_pred HhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 214 ILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 214 Il~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
+........+...+.++.+++.+||..+|.+|||+.+++.+
T Consensus 249 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 77666666677788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=328.56 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=200.9
Q ss_pred EEecc--CcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 9 AIGRG--KYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 9 ~LGeG--gFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
.||+| ++|.||.+++..+++.||+|.+... ....+.+|+++++.++||||+++++++......|++|||++++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 34444 5566777777779999999997533 3457889999999999999999999999999999999999999
Q ss_pred CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC--CCCCC
Q 000715 82 DLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA--PSSML 157 (1335)
Q Consensus 82 SL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~--~ss~l 157 (1335)
+|.+++... ..+++..++.+++|++.||.|||++||+||||||+||+++.+|.+||+|||.+..+...... .....
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccc
Confidence 999999763 46899999999999999999999999999999999999999999999999988765432211 01111
Q ss_pred CCCccCCCCCCCcchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----------------
Q 000715 158 PQAKCGTPCYMAPELFEEG-GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS----------------- 219 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~-~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~----------------- 219 (1335)
.....++..|+|||++... ..++.++|+||+||++|+|++|..||..............+..
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcC
Confidence 2345678899999998643 3478899999999999999999999987654333221111100
Q ss_pred ----------------CCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 220 ----------------PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 220 ----------------~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
.......+.++.+++.+||..||++|||+.++++||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 001112246788999999999999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=327.92 Aligned_cols=248 Identities=22% Similarity=0.460 Sum_probs=207.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEE-----CCCCeEEEEEEcCch----hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRK-----KKTIEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArd-----k~TGk~VAIKiIdKe----~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~l 71 (1335)
++|++.+.||+|+||.||+|.+ ..++..||+|.+.+. ....+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4799999999999999999985 345668999988643 234678999999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCC
Q 000715 72 WLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~ 149 (1335)
|+||||+.+++|.+++.... .+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 194 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMND 194 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCC
Confidence 99999999999999997643 3899999999999999999999999999999999999999999999999998766433
Q ss_pred CCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh-cCCCCCCCCCCC
Q 000715 150 SKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSIL-SDPSPPLPGNPS 227 (1335)
Q Consensus 150 ~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl-~~~~~pip~~iS 227 (1335)
... .......+++.|+|||++.. ..++.++||||+||++|+|++ |..||.+....+...+.. .......+...+
T Consensus 195 ~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (302)
T cd05055 195 SNY---VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAP 270 (302)
T ss_pred Cce---eecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCC
Confidence 211 01122346788999999864 457889999999999999998 999998876554443333 333444556778
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 228 RPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 228 ~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
+.+.+++.+||..+|++|||+.++++
T Consensus 271 ~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 271 AEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=315.63 Aligned_cols=245 Identities=25% Similarity=0.405 Sum_probs=201.5
Q ss_pred EEEeccCcEEEEEEEECC---CCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEeecC
Q 000715 8 EAIGRGKYSTVYKGRKKK---TIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYE-TSAHLWLVLEYCV 79 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~---TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfe-ds~~lyLVMEY~e 79 (1335)
+.||+|+||.||+|.+.. .+..||+|.+... ....+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998753 3467999988532 3456788999999999999999999765 4566899999999
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 80 GGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
+++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++........... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~-~~ 159 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH-NH 159 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec-cc
Confidence 99999999764 45778889999999999999999999999999999999999999999999998765432211100 01
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHh
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkc 237 (1335)
....+++.|+|||.+.. ..++.++|||||||++|+|++ |.+||...+..+....+......+.+...++.+.+++.+|
T Consensus 160 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 238 (262)
T cd05058 160 TGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC 238 (262)
T ss_pred ccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHH
Confidence 12346778999999864 457889999999999999999 5778888777777777766655556677789999999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 000715 238 LVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 238 LqkDPsKRPTAeEILkH 254 (1335)
|..+|++||++.++++.
T Consensus 239 l~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 239 WHPKPEMRPTFSELVSR 255 (262)
T ss_pred cCCChhhCCCHHHHHHH
Confidence 99999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.23 Aligned_cols=236 Identities=23% Similarity=0.392 Sum_probs=196.7
Q ss_pred EEEeccCcEEEEEEEECCCCeE-------EEEEEcCchh---HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEY-------FAIKSVDKSQ---KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~-------VAIKiIdKe~---~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+.||+|+||.||+|.+..++.. |++|...... .+.+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 4699999999999998765443 8888876543 34678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCC--------eeeccccccccccC
Q 000715 78 CVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGR--------TKLCDFGLARKLSD 148 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~-~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~--------VKLiDFGLAr~l~e 148 (1335)
+.+|+|.+++..++ .+++..+..++.||+.|+.|||++||+||||||+||+++.++. ++++|||++.....
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~ 160 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP 160 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence 99999999997654 6899999999999999999999999999999999999987765 69999998765432
Q ss_pred CCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 000715 149 ASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAG-RPPFVGREFTQLVKSILSDPSPPLPGNPS 227 (1335)
Q Consensus 149 ~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTG-rpPF~g~d~~eLikkIl~~~~~pip~~iS 227 (1335)
. ....+++.|+|||++.....++.++||||||+++|+|++| .+||...+.......... ....+...+
T Consensus 161 ~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 229 (258)
T cd05078 161 K---------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED--RHQLPAPKW 229 (258)
T ss_pred c---------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc--cccCCCCCc
Confidence 1 2345888999999997656678899999999999999998 567766555443332222 334556677
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 228 RPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 228 ~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
.++.+++.+||+.||++|||++++++.
T Consensus 230 ~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 230 TELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=326.29 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=203.5
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCC--------------CeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKT--------------IEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYS 63 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~T--------------Gk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~d 63 (1335)
++|++.+.||+|+||.||+|++..+ ...||+|.+... ....+.+|++++++++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 4899999999999999999987653 235899998643 2456889999999999999999999
Q ss_pred EEEeCCEEEEEEeecCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC
Q 000715 64 WYETSAHLWLVLEYCVGGDLMSLLRQDN------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE 131 (1335)
Q Consensus 64 vfeds~~lyLVMEY~eGGSL~dlIkq~~------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe 131 (1335)
++...+..|+||||+.+++|.+++.... .+++.++..++.|++.||.|||++|++||||||+||+++.
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~ 164 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC
Confidence 9999999999999999999999986532 3688999999999999999999999999999999999999
Q ss_pred CCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHH
Q 000715 132 NGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA--GRPPFVGREFTQ 209 (1335)
Q Consensus 132 dG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT--GrpPF~g~d~~e 209 (1335)
++.+||+|||++......... .......+++.|+|||++.. +.++.++|+|||||++|+|++ |..||......+
T Consensus 165 ~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 165 HYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred CCcEEecccccccccccCcce---eccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999998765432211 11122345778999999864 457889999999999999988 778998876665
Q ss_pred HHHHHhc-------CCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 210 LVKSILS-------DPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 210 LikkIl~-------~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
....+.. ......+...++.+.+++.+||..||++|||++++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5544321 1112234557889999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=358.26 Aligned_cols=253 Identities=19% Similarity=0.290 Sum_probs=192.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCC-eEEEEE------------------EcC--chhHHHHHHHHHHHHhCCCCCcce
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTI-EYFAIK------------------SVD--KSQKSKVLQEVRMLHSLDHPNVLR 60 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TG-k~VAIK------------------iId--Ke~~e~LlrEIqILkkL~HPNIVr 60 (1335)
++|++++.||+|+||+||+|..+... ..++.| .+. ......+.+|++++++++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 57999999999999999998765432 222222 111 112345789999999999999999
Q ss_pred EEEEEEeCCEEEEEEeecCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCe
Q 000715 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQD-----NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRT 135 (1335)
Q Consensus 61 L~dvfeds~~lyLVMEY~eGGSL~dlIkq~-----~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~V 135 (1335)
+++++...+..|+|+|++ +++|.+++... ......+++.++.||+.||.|||++||+||||||+|||++.+|.+
T Consensus 228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~v 306 (501)
T PHA03210 228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKI 306 (501)
T ss_pred EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE
Confidence 999999999999999998 56777776442 234567888999999999999999999999999999999999999
Q ss_pred eeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCC--CHHHHHH
Q 000715 136 KLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPP-FVGR--EFTQLVK 212 (1335)
Q Consensus 136 KLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpP-F~g~--d~~eLik 212 (1335)
||+|||++..+...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..+ |.+. .....+.
T Consensus 307 kL~DFGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 307 VLGDFGTAMPFEKEREA----FDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred EEEeCCCceecCccccc----ccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999876543221 1123579999999999864 4578899999999999999998754 4322 1222222
Q ss_pred HHhcCC---CCCC----------------------------CCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 213 SILSDP---SPPL----------------------------PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 213 kIl~~~---~~pi----------------------------p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
++.... ...+ ....+..+.++|.+||++||.+|||+.|++.||||...
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 211100 0000 01245678889999999999999999999999999764
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.99 Aligned_cols=248 Identities=22% Similarity=0.356 Sum_probs=202.8
Q ss_pred EEEEEEEeccCcEEEEEEEE----CCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEE
Q 000715 4 YHIYEAIGRGKYSTVYKGRK----KKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS--AHLWL 73 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArd----k~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds--~~lyL 73 (1335)
|++.+.||+|+||.||+|.. ..+++.||+|.+... ....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 78999999999999999974 467889999998633 345688999999999999999999988775 56899
Q ss_pred EEeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
||||++|++|.+++.+. ..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.+......
T Consensus 86 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 165 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY 165 (284)
T ss_pred EEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCccc
Confidence 99999999999999765 46899999999999999999999999999999999999999999999999999876443221
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHhcC
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR---------------EFTQLVKSILSD 217 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~---------------d~~eLikkIl~~ 217 (1335)
. .......|+..|+|||++.+ ..++.++||||||+++|+|+++..|+... ........+...
T Consensus 166 ~--~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 166 Y--TVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred e--eecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 1 11233557788999999864 45788999999999999999987665321 111122222333
Q ss_pred CCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 218 PSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 218 ~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
...+.+...+..+.+|+.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 3445566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=329.91 Aligned_cols=248 Identities=33% Similarity=0.533 Sum_probs=210.3
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
.|...+.||+|+||.||+|+++.+++.+++|.+... ...++.+|+++++.++|+|++++++++......|+|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 477788999999999999999999999999987532 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 77 Y~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|+. |++.+.+.. ...+++.++..++.|++.|+.|||++|++||||||+||+++.+|.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------ 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------ 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc------
Confidence 996 577776654 557999999999999999999999999999999999999999999999999998755321
Q ss_pred CCCCCccCCCCCCCcchhcc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-CCCCCChhHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEE--GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP-LPGNPSRPFAN 232 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~--~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p-ip~~iS~eL~D 232 (1335)
....|++.|+|||++.. ...++.++|||||||++|+|++|..||...+..+....+.....+. .+...+..+.+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 23468899999999752 3456789999999999999999999998776555555444433322 24467889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
+|++||..+|++||++.+++.|||+...
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 9999999999999999999999998763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=330.96 Aligned_cols=252 Identities=29% Similarity=0.510 Sum_probs=208.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYET-SAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfed-s~~lyLVM 75 (1335)
++|++.+.||+|+||.||+|++..+++.||+|.+.+. ....+.+|+.++++++||||+++++++.. ....|+||
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 5799999999999999999999999999999987542 34567889999999999999999998865 56789999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
||+ +++|.+++.. ..+++..+..++.|+++||.|||++||+||||||.||+++.++.+||+|||.+......
T Consensus 90 e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~------ 161 (328)
T cd07856 90 ELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ------ 161 (328)
T ss_pred ehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC------
Confidence 998 6789887764 56899999999999999999999999999999999999999999999999998754221
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------------
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS------------------- 216 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~------------------- 216 (1335)
.....+++.|+|||++.....++.++|+||+|+++|+|++|++||.+.........+..
T Consensus 162 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 162 --MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred --cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 12346789999999986556788999999999999999999999987654322111100
Q ss_pred --------CCCCC---CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCCC
Q 000715 217 --------DPSPP---LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTP 263 (1335)
Q Consensus 217 --------~~~~p---ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~~ 263 (1335)
....+ .....+..+.++|.+||+.+|++|||+++++.||||.....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00000 113467889999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=314.56 Aligned_cols=234 Identities=23% Similarity=0.381 Sum_probs=195.0
Q ss_pred EEEeccCcEEEEEEEECCCC----------eEEEEEEcCchh--HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 8 EAIGRGKYSTVYKGRKKKTI----------EYFAIKSVDKSQ--KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TG----------k~VAIKiIdKe~--~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
+.||+|+||.||+|.+..++ ..+++|.+.... ...+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999999998877 358888775443 4678899999999999999999999888 7789999
Q ss_pred eecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC-------Ceeecccccccccc
Q 000715 76 EYCVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG-------RTKLCDFGLARKLS 147 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~-~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG-------~VKLiDFGLAr~l~ 147 (1335)
||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999998766 799999999999999999999999999999999999999887 79999999987654
Q ss_pred CCCCCCCCCCCCCccCCCCCCCcchhccC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 000715 148 DASKAPSSMLPQAKCGTPCYMAPELFEEG-GVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGN 225 (1335)
Q Consensus 148 e~~~~~ss~l~~t~~GTp~YmAPEVL~~~-~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~ 225 (1335)
.. ....++..|+|||++... ..++.++|+||||+++|+|++ |..||...+..+......... ..+..
T Consensus 160 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~ 228 (259)
T cd05037 160 SR---------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH--RLPMP 228 (259)
T ss_pred cc---------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC--CCCCC
Confidence 31 123467789999998654 467889999999999999999 688887765444333332222 22223
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 226 PSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 226 iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
....+.+++.+||..+|++|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3488999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=365.07 Aligned_cols=144 Identities=35% Similarity=0.630 Sum_probs=136.2
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
|++|++.+.||+|+||.||+|++..+++.||+|++.+.. ...+.+|+.+++.++||||+++++++....++|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 579999999999999999999999999999999986532 35678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccc
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr 144 (1335)
|||+.|++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=345.94 Aligned_cols=248 Identities=23% Similarity=0.441 Sum_probs=206.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCC-----CeEEEEEEcCch----hHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKT-----IEYFAIKSVDKS----QKSKVLQEVRMLHSLD-HPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~T-----Gk~VAIKiIdKe----~~e~LlrEIqILkkL~-HPNIVrL~dvfeds~~l 71 (1335)
++|++++.||+|+||.||+|.+... +..||+|.+... ....+.+|+++++++. ||||+++++++.....+
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 4688999999999999999987543 457999998643 2456889999999996 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhC-------------------------------------------------------------
Q 000715 72 WLVLEYCVGGDLMSLLRQD------------------------------------------------------------- 90 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~------------------------------------------------------------- 90 (1335)
|+|||||++|+|.+++.++
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 9999999999999988642
Q ss_pred -----------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCe
Q 000715 91 -----------------------------------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRT 135 (1335)
Q Consensus 91 -----------------------------------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~V 135 (1335)
..+++.++..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~ 276 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIV 276 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEE
Confidence 247888899999999999999999999999999999999999999
Q ss_pred eeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHH
Q 000715 136 KLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQ-LVKS 213 (1335)
Q Consensus 136 KLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~e-Likk 213 (1335)
||+|||+++........ .......+++.|+|||++. +..++.++|||||||++|+|++ |..||....... ....
T Consensus 277 kL~DfGla~~~~~~~~~---~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 277 KICDFGLARDIMHDSNY---VSKGSTFLPVKWMAPESIF-DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred EEEeCCcceeccccccc---cccCCcCCCcceEChhhhc-CCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 99999999866432221 1112345778899999986 4557889999999999999997 999998765433 3344
Q ss_pred HhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 214 ILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 214 Il~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
+......+.+...+.++.+++.+||..||++|||+.++.+
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 4444455566778899999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.69 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=200.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEE----CCCCeEEEEEEcCchh---HHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRK----KKTIEYFAIKSVDKSQ---KSKVLQEVRMLHSLDHPNVLRFYSWYET--SAHLW 72 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArd----k~TGk~VAIKiIdKe~---~e~LlrEIqILkkL~HPNIVrL~dvfed--s~~ly 72 (1335)
++|++.+.||+|+||.||+|.. ..+++.||+|.+.... ...+.+|++++++++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4699999999999999999974 5678899999986543 4467899999999999999999997643 35689
Q ss_pred EEEeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCC
Q 000715 73 LVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~ 151 (1335)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 999999999999999764 4689999999999999999999999999999999999999999999999999987643322
Q ss_pred CCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHh
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT----------------QLVKSIL 215 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~----------------eLikkIl 215 (1335)
... ......++..|+|||++. +..++.++||||||+++|+|++|..|+...... .....+.
T Consensus 164 ~~~--~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05081 164 YYK--VREPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK 240 (284)
T ss_pred cee--ecCCCCCceEeeCHHHhc-cCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence 100 011123455699999986 455788999999999999999987776443211 1111122
Q ss_pred cCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 216 SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 216 ~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
.....+.+...+.++.+++.+||..+|++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 22333455677899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=317.53 Aligned_cols=242 Identities=26% Similarity=0.398 Sum_probs=194.8
Q ss_pred EEEeccCcEEEEEEEECC--CCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 8 EAIGRGKYSTVYKGRKKK--TIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~--TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
+.||+|+||.||+|.... ....+++|.+... ....+.+|+.+++.++||||+++++.+.....+|+||||+.+|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999996543 4457899987533 2345778999999999999999999999999999999999999
Q ss_pred CHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 82 DLMSLLRQDN-----QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 82 SL~dlIkq~~-----~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+|.+++.... ..++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~--- 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI--- 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee---
Confidence 9999997643 24678889999999999999999999999999999999999999999999986543221110
Q ss_pred CCCCccCCCCCCCcchhcc------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-----CCCCCC
Q 000715 157 LPQAKCGTPCYMAPELFEE------GGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDP-----SPPLPG 224 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~------~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~-----~~pip~ 224 (1335)
......+++.|+|||++.. ...++.++|||||||++|+|++ |..||......+....+.... .+..+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL 237 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence 0122346778999999753 2356789999999999999999 889998877666655544332 222345
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 225 NPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 225 ~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
..+..+.+++..|+ .||++|||++++++
T Consensus 238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 238 KYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred cCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 67888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=322.95 Aligned_cols=248 Identities=21% Similarity=0.360 Sum_probs=203.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC----------------CCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK----------------TIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRF 61 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~----------------TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL 61 (1335)
++|++.+.||+|+||.||++.+.. ++..||+|.+... ....+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 479999999999999999986543 3457999998643 24568899999999999999999
Q ss_pred EEEEEeCCEEEEEEeecCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEEC
Q 000715 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDN-----------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLD 130 (1335)
Q Consensus 62 ~dvfeds~~lyLVMEY~eGGSL~dlIkq~~-----------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILID 130 (1335)
++++......|+||||+.+++|.+++.... .+++.++..++.|++.||.|||++|++||||||+||+++
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~ 164 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG 164 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc
Confidence 999999999999999999999999987643 367789999999999999999999999999999999999
Q ss_pred CCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHH
Q 000715 131 ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA--GRPPFVGREFT 208 (1335)
Q Consensus 131 edG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT--GrpPF~g~d~~ 208 (1335)
.++.++|+|||++..+....... ......+++.|+|||+... +.++.++|+|||||++|+|++ |..||......
T Consensus 165 ~~~~~~l~dfg~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 165 KNYTIKIADFGMSRNLYSGDYYR---IQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred CCCCEEeccCcccccccCCccee---ccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999987654322110 1122345678999998764 457889999999999999998 78999877655
Q ss_pred HHHHHHh-------cCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 209 QLVKSIL-------SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 209 eLikkIl-------~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
+.+.... .....+.+..++..+.+++.+||+.||++||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5443321 11122344567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=317.12 Aligned_cols=242 Identities=24% Similarity=0.466 Sum_probs=204.4
Q ss_pred EEEeccCcEEEEEEEECCCC------eEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 8 EAIGRGKYSTVYKGRKKKTI------EYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TG------k~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+.||+|+||.||+|+++... +.|++|.+.+. ....+.+|+++++.++||||+++++++......|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36899999999999987544 78999987543 355688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC-----Ceeecccccccc
Q 000715 78 CVGGDLMSLLRQD-------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG-----RTKLCDFGLARK 145 (1335)
Q Consensus 78 ~eGGSL~dlIkq~-------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG-----~VKLiDFGLAr~ 145 (1335)
+++++|.+++... ..+++.++..++.|++.|+.|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD 160 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence 9999999999642 3478899999999999999999999999999999999999877 899999999876
Q ss_pred ccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 000715 146 LSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPG 224 (1335)
Q Consensus 146 l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~ 224 (1335)
......... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+........+.
T Consensus 161 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05044 161 IYKSDYYRK---EGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPE 236 (269)
T ss_pred ccccccccc---CcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcc
Confidence 543221111 122346788999999864 557899999999999999998 999998887777776665555555667
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 225 NPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 225 ~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
..+..+.++|.+||..+|++||+++++++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 237 NCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred cchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 78899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=318.87 Aligned_cols=254 Identities=32% Similarity=0.558 Sum_probs=221.1
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
|.+|...++||+|.||+||+|+++++++.||+|.+.-+ -.....+|+-+++.++|.|||+++++...++.+-+|+
T Consensus 1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 57899999999999999999999999999999988433 2456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 76 EY~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
||| ..+|..+... ++.++.+.++.++.|++.|+.|+|++++.|||+||.|++|+.+|.+||+|||+++.++-+-...
T Consensus 81 e~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy- 158 (292)
T KOG0662|consen 81 EFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY- 158 (292)
T ss_pred HHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee-
Confidence 999 5688888876 6789999999999999999999999999999999999999999999999999999886543221
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCC----------CC
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPP----------LP 223 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~p----------ip 223 (1335)
...+-|.||++|.++.+.+.|+...|+||.|||+.|+.. |++.|.+.+..++.++|......+ .|
T Consensus 159 ----saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 159 ----SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred ----eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 224579999999999998999999999999999999987 899999999999988886422111 01
Q ss_pred ------------------CCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 224 ------------------GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 224 ------------------~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
...+..-+|+++++|..+|.+|++++++++||||.+.
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 1123457799999999999999999999999999763
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=370.52 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=207.1
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
|++|++.+.||+|+||.||+|++..+|+.||+|.+... ...++.+|++++++++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 68999999999999999999999999999999998642 245688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccc
Q 000715 75 LEYCVGGDLMSLLRQD-----------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~-----------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLA 143 (1335)
|||++|++|.+++... ..++...+..++.||+.||.|||++||+||||||+||+++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998641 23566788999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCC-------------CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Q 000715 144 RKLSDASKA-------------PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQL 210 (1335)
Q Consensus 144 r~l~e~~~~-------------~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eL 210 (1335)
......... .....+...+||+.|+|||++.+ ..++.++||||+||++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 876221100 00111234579999999999864 4568899999999999999999999987655443
Q ss_pred HHHH-hcCCC-CCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 211 VKSI-LSDPS-PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 211 ikkI-l~~~~-~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
.... ...+. ......+++.+.+++.+||..||++|++..+.+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3221 11111 11124678899999999999999999887666554
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=360.91 Aligned_cols=251 Identities=27% Similarity=0.463 Sum_probs=206.2
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEc---CchhHHHHHHHHHHHHhCC-CCCcceEEE-EEEe------CCEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV---DKSQKSKVLQEVRMLHSLD-HPNVLRFYS-WYET------SAHL 71 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiI---dKe~~e~LlrEIqILkkL~-HPNIVrL~d-vfed------s~~l 71 (1335)
++++.+.|.+|||+.||.|.+...|..||+|.+ ++...+.+.+|+++|++|+ |+|||.+++ .... ...+
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 578899999999999999999999899999976 4556677899999999995 999999999 3321 1357
Q ss_pred EEEEeecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCCeEECCCCCeeecccccccccc
Q 000715 72 WLVLEYCVGGDLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYLHSKG--IIYCDLKPSNILLDENGRTKLCDFGLARKLS 147 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq--~~~LSEeqIr~I~rQILsGLkYLHskG--IVHRDIKPENILIDedG~VKLiDFGLAr~l~ 147 (1335)
++.||||.||.|-|++.+ ..+|+|.++.+||+|+++||.+||..+ |||||||-|||||+.+|+.||||||.++...
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 899999999999999985 456999999999999999999999998 9999999999999999999999999987543
Q ss_pred CCCCCCCCC--C--CCCccCCCCCCCcchhc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC
Q 000715 148 DASKAPSSM--L--PQAKCGTPCYMAPELFE--EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP 221 (1335)
Q Consensus 148 e~~~~~ss~--l--~~t~~GTp~YmAPEVL~--~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p 221 (1335)
......... + .-....|+.|+|||++. .+...+.|+|||+|||+||-|++...||++.....+++.-. ..|
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y---~~P 274 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNY---SFP 274 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccc---cCC
Confidence 322110000 0 01235799999999974 35567889999999999999999999998875544433222 223
Q ss_pred CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 000715 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAF 256 (1335)
Q Consensus 222 ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPf 256 (1335)
.....+..+.+||+.||+.||++||++-+++.+-+
T Consensus 275 ~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 275 PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 33578899999999999999999999999987654
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=334.30 Aligned_cols=249 Identities=24% Similarity=0.455 Sum_probs=203.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEE-----CCCCeEEEEEEcCch----hHHHHHHHHHHHHhC-CCCCcceEEEEEEeC-CE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRK-----KKTIEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETS-AH 70 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArd-----k~TGk~VAIKiIdKe----~~e~LlrEIqILkkL-~HPNIVrL~dvfeds-~~ 70 (1335)
++|++.+.||+|+||.||+|.+ ..+++.||+|.+... ....+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4799999999999999999985 356789999998642 234678899999999 689999999977554 56
Q ss_pred EEEEEeecCCCCHHHHHHhC------------------------------------------------------------
Q 000715 71 LWLVLEYCVGGDLMSLLRQD------------------------------------------------------------ 90 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~------------------------------------------------------------ 90 (1335)
+++||||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 89999999999999998643
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccC
Q 000715 91 -------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCG 163 (1335)
Q Consensus 91 -------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~G 163 (1335)
..++..++..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......... .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---VRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch---hhcCCCCC
Confidence 23678888999999999999999999999999999999999999999999998765332211 11122345
Q ss_pred CCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHhcCCCCCCCCCCChhHHHHHHHhcccC
Q 000715 164 TPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFT-QLVKSILSDPSPPLPGNPSRPFANLINSLLVKD 241 (1335)
Q Consensus 164 Tp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~-eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkD 241 (1335)
++.|+|||++.. ..++.++||||||+++|+|++ |..||.+.... .....+......+.+...++++.+++..||+.|
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 678999999864 557889999999999999997 99999876433 333444444455556677889999999999999
Q ss_pred CCCCCCHHHHhcC
Q 000715 242 PAQRLHWSDLCGH 254 (1335)
Q Consensus 242 PsKRPTAeEILkH 254 (1335)
|++|||+.++++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=346.40 Aligned_cols=253 Identities=32% Similarity=0.562 Sum_probs=224.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLV 74 (1335)
.+|.++.+||+|+||+|-+|..+.|.+.||||++.++- .+--..|-++|... +-|.+++++..|++-+++|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 47889999999999999999999999999999987642 22234577777766 567899999999999999999
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
|||+.||+|.-.|++-+++.|..+..|+..|+-||-|||++||++||+|.+|||+|.+|++||.|||++..---..
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~---- 504 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG---- 504 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999986432211
Q ss_pred CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
....++||||.|+|||++.. ..|+.++|+||+||++|||+.|++||++++..+++..|.... ..+|+..|.++.++.
T Consensus 505 -~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-vsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 505 -VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-VSYPKSLSKEAVAIC 581 (683)
T ss_pred -cceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-CcCcccccHHHHHHH
Confidence 12467999999999999975 457899999999999999999999999999999999998653 467899999999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCccccccC
Q 000715 235 NSLLVKDPAQRLH-----WSDLCGHAFWRTKL 261 (1335)
Q Consensus 235 kkcLqkDPsKRPT-----AeEILkHPfFq~~l 261 (1335)
+..|.+.|.+|.. -.+|..||||+...
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 9999999999975 47899999998654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.03 Aligned_cols=229 Identities=28% Similarity=0.421 Sum_probs=194.5
Q ss_pred cCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHHHHHHhCCC
Q 000715 13 GKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ 92 (1335)
Q Consensus 13 GgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL~dlIkq~~~ 92 (1335)
|.||+||+++++.+++.||+|.+.+.. ...+|...+....||||+++++++.+....|+||||+.|++|.+++.+...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 81 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN 81 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcC
Confidence 899999999999999999999997653 234556666667899999999999999999999999999999999988888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcch
Q 000715 93 LPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172 (1335)
Q Consensus 93 LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEV 172 (1335)
+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+....... ....++..|+|||.
T Consensus 82 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--------~~~~~~~~y~aPE~ 153 (237)
T cd05576 82 IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--------DGEAVENMYCAPEV 153 (237)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc--------ccCCcCccccCCcc
Confidence 9999999999999999999999999999999999999999999999999876554321 12346778999998
Q ss_pred hccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCH----
Q 000715 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHW---- 248 (1335)
Q Consensus 173 L~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTA---- 248 (1335)
+. ...++.++|+||+|+++|+|++|+.||...... +........+...++.+.++|.+||+.||++||++
T Consensus 154 ~~-~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 227 (237)
T cd05576 154 GG-ISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAG 227 (237)
T ss_pred cC-CCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccc
Confidence 85 345688999999999999999999987643211 11111223556788999999999999999999985
Q ss_pred -HHHhcCccc
Q 000715 249 -SDLCGHAFW 257 (1335)
Q Consensus 249 -eEILkHPfF 257 (1335)
+++++||||
T Consensus 228 ~~~~~~h~~~ 237 (237)
T cd05576 228 VEDIKSHPFF 237 (237)
T ss_pred hHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.54 Aligned_cols=236 Identities=23% Similarity=0.348 Sum_probs=193.2
Q ss_pred EEEeccCcEEEEEEEECC------------CCeEEEEEEcCchh---HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 000715 8 EAIGRGKYSTVYKGRKKK------------TIEYFAIKSVDKSQ---KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~------------TGk~VAIKiIdKe~---~e~LlrEIqILkkL~HPNIVrL~dvfeds~~ly 72 (1335)
+.||+|+||.||+|+... ....+++|.++... ...+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998543 23458899876543 335678899999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCC-------eeeccccccc
Q 000715 73 LVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGR-------TKLCDFGLAR 144 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~-------VKLiDFGLAr 144 (1335)
+||||+++++|..++.. ...+++..+..++.||+.|+.|||++||+||||||+||+++.++. +|++|||++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~ 160 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI 160 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence 99999999999998875 457999999999999999999999999999999999999987664 8999999886
Q ss_pred cccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 000715 145 KLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECY-AGRPPFVGREFTQLVKSILSDPSPPLP 223 (1335)
Q Consensus 145 ~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELL-TGrpPF~g~d~~eLikkIl~~~~~pip 223 (1335)
..... ....|+..|+|||++.....++.++|||||||++|+|+ .|..||......+..... .. .....
T Consensus 161 ~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~-~~~~~ 229 (262)
T cd05077 161 TVLSR---------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EG-QCMLV 229 (262)
T ss_pred cccCc---------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hc-CccCC
Confidence 54321 22457888999999875677889999999999999997 589998876654443222 21 11222
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 224 ~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
...+.++.++|.+||+.||++||++.+|+.+
T Consensus 230 ~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 230 TPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 3345789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.59 Aligned_cols=248 Identities=21% Similarity=0.353 Sum_probs=208.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCe----EEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIE----YFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk----~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
++|+..+.||+|+||.||+|.+..+|. .||+|.+.... ...+.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 578999999999999999999987776 47888876432 33578899999999999999999988654 4678
Q ss_pred EEeecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~-~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~ 152 (1335)
++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 86 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 165 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 165 (303)
T ss_pred eehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcccc
Confidence 999999999999997754 6899999999999999999999999999999999999999999999999999876432221
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHH
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFA 231 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~ 231 (1335)
.. .....++..|+|||++. +..++.++||||||+++|+|++ |..||.+....+....+......+.+...+..+.
T Consensus 166 ~~---~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 166 YN---ADGGKMPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred cc---cCCCccccccCCHHHhc-cCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 11 12234677899999986 4557889999999999999997 9999988776666655555555556667889999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcC
Q 000715 232 NLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
+++.+||..+|++||++.++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=358.48 Aligned_cols=246 Identities=28% Similarity=0.474 Sum_probs=215.9
Q ss_pred EEEEEeccCcEEEEEEEECCCCeEEEEEEc-----Cc--hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--EEEEEe
Q 000715 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DK--SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAH--LWLVLE 76 (1335)
Q Consensus 6 LlK~LGeGgFGtVYkArdk~TGk~VAIKiI-----dK--e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~--lyLVME 76 (1335)
+...||+|+|-+||+|.+..+|..||.-.+ .+ ...+++..|+.+|+.|+||||+++|+++.+..+ +.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 356899999999999999999999985433 12 234789999999999999999999998877655 889999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCCeEECCC-CCeeeccccccccccCCCCCC
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG--IIYCDLKPSNILLDEN-GRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskG--IVHRDIKPENILIDed-G~VKLiDFGLAr~l~e~~~~~ 153 (1335)
.+.+|+|..|+++.++++...++.|++||+.||.|||++. |+|||||.+||||+.+ |.|||+|+|+|........
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a-- 201 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA-- 201 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc--
Confidence 9999999999999999999999999999999999999994 9999999999999865 9999999999998755432
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCC-CCCCCChhHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVG-REFTQLVKSILSDPSPP-LPGNPSRPFA 231 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g-~d~~eLikkIl~~~~~p-ip~~iS~eL~ 231 (1335)
...+|||.|||||++. ..|+..+||||||++|.||.|+.+||.. .+..++|+++..+..|. +...-.++++
T Consensus 202 -----ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr 274 (632)
T KOG0584|consen 202 -----KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVR 274 (632)
T ss_pred -----ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHH
Confidence 3367999999999996 6689999999999999999999999976 56778888888876544 3345578999
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 232 NLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
+||.+||.. .+.|+|+.|+|.||||....
T Consensus 275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 275 EFIEKCLAT-KSERLSAKELLKDPFFDEDG 303 (632)
T ss_pred HHHHHHhcC-chhccCHHHHhhChhhcccc
Confidence 999999999 99999999999999998753
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=314.01 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=193.9
Q ss_pred EEEeccCcEEEEEEEEC--CCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 8 EAIGRGKYSTVYKGRKK--KTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk--~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
+.||+|+||.||+|... .++..+++|.+... ....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46999999999999865 35677999988543 2346788999999999999999999999999999999999999
Q ss_pred CHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 82 DLMSLLRQDN-----QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 82 SL~dlIkq~~-----~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+|.+++.... ..++..++.++.|++.|+.|||++|++||||||+||+++.++.+||+|||++......... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~---~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY---V 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee---e
Confidence 9999997532 4567788899999999999999999999999999999999999999999998654322111 1
Q ss_pred CCCCccCCCCCCCcchhccC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-----CCCCCC
Q 000715 157 LPQAKCGTPCYMAPELFEEG------GVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDP-----SPPLPG 224 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~------~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~-----~~pip~ 224 (1335)
......|++.|+|||++... ..++.++|+||||+++|+|++ |..||......+......... .+....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL 237 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence 12234578899999998532 135779999999999999996 999998776665544332221 122233
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 225 NPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 225 ~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
..++.+.+++.+|+ .+|++|||++++..
T Consensus 238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 56788999999998 68999999999963
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.16 Aligned_cols=235 Identities=24% Similarity=0.348 Sum_probs=192.6
Q ss_pred EEeccCcEEEEEEEECC------------------------CCeEEEEEEcCchh---HHHHHHHHHHHHhCCCCCcceE
Q 000715 9 AIGRGKYSTVYKGRKKK------------------------TIEYFAIKSVDKSQ---KSKVLQEVRMLHSLDHPNVLRF 61 (1335)
Q Consensus 9 ~LGeGgFGtVYkArdk~------------------------TGk~VAIKiIdKe~---~e~LlrEIqILkkL~HPNIVrL 61 (1335)
.||+|+||.||+|.... ....|++|.+.... ...+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997532 12458899886543 3356788999999999999999
Q ss_pred EEEEEeCCEEEEEEeecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC-------
Q 000715 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG------- 133 (1335)
Q Consensus 62 ~dvfeds~~lyLVMEY~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG------- 133 (1335)
++++.+....|+||||+++++|..++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.+|
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~ 161 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP 161 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence 9999999999999999999999999875 56789999999999999999999999999999999999997654
Q ss_pred CeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHH
Q 000715 134 RTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECY-AGRPPFVGREFTQLVK 212 (1335)
Q Consensus 134 ~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELL-TGrpPF~g~d~~eLik 212 (1335)
.+|++|||++...... ....++..|+|||.+.....++.++|+||||+++|+|+ +|+.||.+....+...
T Consensus 162 ~~kl~d~g~~~~~~~~---------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 162 FIKLSDPGVSFTALSR---------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred eeeecCCccccccccc---------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3899999987543221 12347788999999876667889999999999999985 6999998776554433
Q ss_pred HHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 213 SILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 213 kIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
..... ...+...++.+.++|.+||+.+|++|||+.+++++
T Consensus 233 ~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 FYEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 22221 22344456789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.81 Aligned_cols=249 Identities=25% Similarity=0.413 Sum_probs=204.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEEC----CCCeEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKK----KTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYET--SAHL 71 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk----~TGk~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfed--s~~l 71 (1335)
++|++.+.||+|+||.||+|.+. .+++.||+|.+.... ...+.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46889999999999999999865 358899999986543 4578899999999999999999999877 5678
Q ss_pred EEEEeecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 72 WLVLEYCVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~~-~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
++||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 99999999999999997754 69999999999999999999999999999999999999999999999999998765322
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHh
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT---------------QLVKSIL 215 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~---------------eLikkIl 215 (1335)
.... ......++..|+|||.+.. ..++.++|+||||+++|+|++|..||...... .....+.
T Consensus 164 ~~~~--~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 164 DYYY--VKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred ccee--ccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 2111 1112345667999999864 45788999999999999999999998654221 1222223
Q ss_pred cCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 216 SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 216 ~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
.....+.+...+.++.+++.+||+.+|++|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 33334445667889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=312.55 Aligned_cols=247 Identities=23% Similarity=0.390 Sum_probs=204.5
Q ss_pred EEEEEEEeccCcEEEEEEEEC---CCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 000715 4 YHIYEAIGRGKYSTVYKGRKK---KTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSA------ 69 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk---~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~------ 69 (1335)
|++.+.||+|+||.||+|.+. .+++.||+|.+... ..+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999865 46789999987542 3456789999999999999999999886542
Q ss_pred EEEEEEeecCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccc
Q 000715 70 HLWLVLEYCVGGDLMSLLRQD------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143 (1335)
Q Consensus 70 ~lyLVMEY~eGGSL~dlIkq~------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLA 143 (1335)
..++++||+.+|+|.+++... ..++...+..++.|++.|+.|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 247889999999999887432 25789999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCC
Q 000715 144 RKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPL 222 (1335)
Q Consensus 144 r~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pi 222 (1335)
+.......... .....+++.|++||.+. ...++.++|||||||++|+|++ |++||.+.+..+....+........
T Consensus 161 ~~~~~~~~~~~---~~~~~~~~~~~~pe~~~-~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05074 161 KKIYSGDYYRQ---GCASKLPVKWLALESLA-DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ 236 (273)
T ss_pred ccccCCcceec---CCCccCchhhcCHhHHh-cCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence 86643221111 12234567899999986 4456789999999999999999 9999998887777777665544455
Q ss_pred CCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 223 PGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 223 p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
+...+..+.+++.+||+.+|++||++.+++.+
T Consensus 237 ~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56778999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=384.26 Aligned_cols=256 Identities=32% Similarity=0.558 Sum_probs=223.5
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
+++....||.|.||.||-|.+.++|...|+|-+.-+ ....+.+|..++..++|||+|++|++-.+...++|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 466778899999999999999999999999977432 234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
|+||+|.++.+.++-.+|...+.|-.|++.|+.|||++|||||||||+||+++.+|.+|++|||.|..+..........
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e- 1394 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE- 1394 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH-
Confidence 9999999999999889999999999999999999999999999999999999999999999999999886653221111
Q ss_pred CCCccCCCCCCCcchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 158 PQAKCGTPCYMAPELFEEG--GVHSYASDLWGLGCVLYECYAGRPPFVGREFT-QLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~--~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~-eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
.+...|||.|||||++.+. ...+-+.|||||||++.||.||+.||...+.. ++...+-.+..|++|...+.+..|||
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence 2346799999999999743 34456999999999999999999999875543 45566666778889999999999999
Q ss_pred HHhcccCCCCCCCHHHHhcCccccc
Q 000715 235 NSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 235 kkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
..||..||++|.++.|++.|.|=+.
T Consensus 1475 e~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHhcCchhhhHHHHHHHhhcccc
Confidence 9999999999999999999998543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=311.04 Aligned_cols=245 Identities=30% Similarity=0.576 Sum_probs=207.6
Q ss_pred cEEEEEEEeccCcEEEEEEEECC-CCeEEEEEEcCch-------------hHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKK-TIEYFAIKSVDKS-------------QKSKVLQEVRMLHS-LDHPNVLRFYSWYET 67 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~-TGk~VAIKiIdKe-------------~~e~LlrEIqILkk-L~HPNIVrL~dvfed 67 (1335)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+... ...++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999988 7889999987421 23456778888865 799999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCeeeccccc
Q 000715 68 SAHLWLVLEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTKLCDFGL 142 (1335)
Q Consensus 68 s~~lyLVMEY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~VKLiDFGL 142 (1335)
.+..|+||||++|++|.+++.. ...+++..++.++.|++.|+.|||+ .|++||||||+||+++.++.+||+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 4579999999999999999999996 7899999999999999999999999999
Q ss_pred cccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC
Q 000715 143 ARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL 222 (1335)
Q Consensus 143 Ar~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pi 222 (1335)
+........ .....|+..|+|||.+.. ..++.++|+||||+++|+|++|++||...+.......+......+.
T Consensus 161 ~~~~~~~~~------~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd08528 161 AKQKQPESK------LTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL 233 (269)
T ss_pred eeecccccc------cccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC
Confidence 876543321 133568999999999864 4578899999999999999999999988877766666655443333
Q ss_pred C-CCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 223 P-GNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 223 p-~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
+ ...++.+.++|.+||+.||++||++.++..+
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 3 3678999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=337.72 Aligned_cols=249 Identities=21% Similarity=0.395 Sum_probs=207.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEEC-----CCCeEEEEEEcCchh----HHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKK-----KTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLD-HPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk-----~TGk~VAIKiIdKe~----~e~LlrEIqILkkL~-HPNIVrL~dvfeds~~l 71 (1335)
++|.+.+.||+|+||.||+|++. .+++.||+|.+.... ...+.+|++++.++. ||||+++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46888999999999999999964 355789999996432 346788999999997 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhCC------------------------------------------------------------
Q 000715 72 WLVLEYCVGGDLMSLLRQDN------------------------------------------------------------ 91 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~~------------------------------------------------------------ 91 (1335)
|+||||+.+|+|.+++.+++
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999996532
Q ss_pred --------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC
Q 000715 92 --------------------------------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG 133 (1335)
Q Consensus 92 --------------------------------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG 133 (1335)
.++..++..++.|++.||.|||++|++||||||+||++++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~ 276 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK 276 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence 357778899999999999999999999999999999999999
Q ss_pred CeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHH-H
Q 000715 134 RTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQL-V 211 (1335)
Q Consensus 134 ~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eL-i 211 (1335)
.+||+|||+++.+....... ......+++.|+|||++.. ..++.++||||||+++|||++ |..||......+. .
T Consensus 277 ~~kL~DfGla~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 277 LVKICDFGLARDIMRDSNYI---SKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred EEEEEecCcceecccccccc---cCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 99999999997653322111 1123457889999999864 457889999999999999998 8999987654444 3
Q ss_pred HHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 212 KSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 212 kkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
..+..+...+.+...+.++.+++.+||..+|.+||++.++++.
T Consensus 353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4444454555677789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=348.92 Aligned_cols=246 Identities=32% Similarity=0.568 Sum_probs=214.1
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
.++||.|.||+||-|.++.+|+.||||+|+|. +...+.+|+.||+++.||.||.+.-.|++.+.+++|||.+ .|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 46899999999999999999999999999874 3467899999999999999999999999999999999998 55
Q ss_pred CHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCC---CCeeeccccccccccCCCCCCCCC
Q 000715 82 DLMSLLR--QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN---GRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 82 SL~dlIk--q~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDed---G~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
++.++|- +.+++++..-+.++.||+.||.|||.+||+|+|+||+|||+... -.+||||||+|+.+++..-
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF----- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF----- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-----
Confidence 6666663 46799999999999999999999999999999999999999654 3799999999999876542
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCCCCCCCChhHHHHHH
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~-d~~eLikkIl~~~~~pip~~iS~eL~DLIk 235 (1335)
....+|||.|+|||++.++ .|...-|+||.|||+|.-+.|..||..+ +..++++....-..+..+..+++++.|||+
T Consensus 723 -RrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn 800 (888)
T KOG4236|consen 723 -RRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLIN 800 (888)
T ss_pred -hhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHH
Confidence 3557899999999999754 4677899999999999999999999654 455555544434445566788999999999
Q ss_pred HhcccCCCCCCCHHHHhcCcccccc
Q 000715 236 SLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 236 kcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
.+|+..-.+|.|.+..+.|||+++.
T Consensus 801 ~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 801 NLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=348.55 Aligned_cols=257 Identities=31% Similarity=0.515 Sum_probs=216.4
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
|..++.||-|+||.|.+++..+|...||+|.+.|.+ ...+..|-.||..-+++.||++|..|++++.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 778999999999999999999999999999887653 45577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccccccc---C------
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLS---D------ 148 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~---e------ 148 (1335)
++||++..++.+.+-|.|+-++.|+.++.+|+++.|..|+|||||||+|||||.+|++||.|||+++-+. +
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999987541 0
Q ss_pred CCCCC------C----------------------CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCC
Q 000715 149 ASKAP------S----------------------SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRP 200 (1335)
Q Consensus 149 ~~~~~------s----------------------s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrp 200 (1335)
+.... + .......+||+.|+|||++... .|+..+|+||.|||||||+.|++
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHHHhhCCC
Confidence 00000 0 0011134699999999999754 46889999999999999999999
Q ss_pred CCCCCCHHHHHHHHhcC---CCCCCCCCCChhHHHHHHHhcccCCCCCCC---HHHHhcCccccccCC
Q 000715 201 PFVGREFTQLVKSILSD---PSPPLPGNPSRPFANLINSLLVKDPAQRLH---WSDLCGHAFWRTKLT 262 (1335)
Q Consensus 201 PF~g~d~~eLikkIl~~---~~~pip~~iS~eL~DLIkkcLqkDPsKRPT---AeEILkHPfFq~~l~ 262 (1335)
||.+....+.-.++.+. ...+....+++++.++|.+++ .+++.|.. ++++..||||+....
T Consensus 870 pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 870 PFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred CccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccch
Confidence 99888765554444321 123445678999999999965 57899975 788999999987654
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=332.73 Aligned_cols=259 Identities=30% Similarity=0.540 Sum_probs=211.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCC----eEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTI----EYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYET-SAHL 71 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TG----k~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfed-s~~l 71 (1335)
..|+..+.||+|.||.||+|..+++. +.||+|.+..+. -....+|+.+++.++|||++.+..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 47999999999999999999665543 368999986542 2356799999999999999999998876 8899
Q ss_pred EEEEeecCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCC----CCeeeccccc
Q 000715 72 WLVLEYCVGGDLMSLLRQD-----NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN----GRTKLCDFGL 142 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~-----~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDed----G~VKLiDFGL 142 (1335)
|+++||. ..+|.+.|+-+ ..++...++.+++||+.|+.|||++-|+|||+||.|||+..+ |.|||+|||+
T Consensus 104 ~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 104 WLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 9999997 56899988643 468999999999999999999999999999999999999887 8999999999
Q ss_pred cccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---------HHHHHH
Q 000715 143 ARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF---------TQLVKS 213 (1335)
Q Consensus 143 Ar~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~---------~eLikk 213 (1335)
++.+...-..-.. .+..+-|.||+|||.+.+...|+++.|+|+.|||+.||++-++.|.+... .++..+
T Consensus 183 aR~~~~plkpl~s--~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 183 ARLFNNPLKPLAS--LDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred HHHhhcccccccc--CCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9998764332211 23456799999999999999999999999999999999999999977531 234444
Q ss_pred HhcCCCCC----------CC--------------------------CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 214 ILSDPSPP----------LP--------------------------GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 214 Il~~~~~p----------ip--------------------------~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
|+.....| .| +.-++...+|+.+||.+||.+|+|++++++|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 43311111 01 1124558899999999999999999999999999
Q ss_pred cccCCC
Q 000715 258 RTKLTP 263 (1335)
Q Consensus 258 q~~l~~ 263 (1335)
.....+
T Consensus 341 ~~d~lp 346 (438)
T KOG0666|consen 341 TEDPLP 346 (438)
T ss_pred ccCCCC
Confidence 876443
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.85 Aligned_cols=242 Identities=21% Similarity=0.362 Sum_probs=193.6
Q ss_pred EEEeccCcEEEEEEEECCC--CeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 8 EAIGRGKYSTVYKGRKKKT--IEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~T--Gk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
+.||+|+||.||+|....+ ...+++|.+... ....+.+|+.+++.++||||+++++.+.+....|+||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 345677766432 3456889999999999999999999999999999999999999
Q ss_pred CHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 82 DLMSLLRQD----NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 82 SL~dlIkq~----~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~---~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI---ET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh---hc
Confidence 999999764 34677788999999999999999999999999999999999999999999987543221110 01
Q ss_pred CCCccCCCCCCCcchhccC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC-----CCCCCCC
Q 000715 158 PQAKCGTPCYMAPELFEEG------GVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDP-----SPPLPGN 225 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~------~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~-----~~pip~~ 225 (1335)
....+|+..|+|||++... ..++.++||||||+++|+|++ |..||......+.+..+.... .+..+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP 237 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence 1235688999999997421 234678999999999999996 678998777766666554332 2334455
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 226 PSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 226 iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
.++.+.+++..|| .+|++||+++++++
T Consensus 238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 238 YSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 7888999999999 68999999999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=328.02 Aligned_cols=256 Identities=33% Similarity=0.613 Sum_probs=223.4
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyL 73 (1335)
+++|.++.+||+|+|++|..++.++|.+.||+|++.++ +.+-++.|-.+..+- +||.+|-++.+|++...+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 47899999999999999999999999999999999765 334466777777665 89999999999999999999
Q ss_pred EEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 74 VLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
|.||+.||+|.-.+++..+++|+.++.|...|+.||.|||++||++||+|..||++|..|++||.|+|++..--.++..
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~- 407 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT- 407 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998754333322
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-------CCHHHHHHHHhcCCCCCCCCCC
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVG-------REFTQLVKSILSDPSPPLPGNP 226 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g-------~d~~eLikkIl~~~~~pip~~i 226 (1335)
..++||||.|+|||++. +..|++.+|+|+||++|+||+.|+.||+- .+.++.+-+++-.....+|...
T Consensus 408 ----tstfcgtpnyiapeilr-geeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl 482 (593)
T KOG0695|consen 408 ----TSTFCGTPNYIAPEILR-GEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL 482 (593)
T ss_pred ----cccccCCCcccchhhhc-ccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence 35689999999999996 56789999999999999999999999953 3445555555444455678888
Q ss_pred ChhHHHHHHHhcccCCCCCCC------HHHHhcCccccccCC
Q 000715 227 SRPFANLINSLLVKDPAQRLH------WSDLCGHAFWRTKLT 262 (1335)
Q Consensus 227 S~eL~DLIkkcLqkDPsKRPT------AeEILkHPfFq~~l~ 262 (1335)
+-.+..+++..|.+||.+|.. ..++..|+||+...+
T Consensus 483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 889999999999999999963 799999999986543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=348.62 Aligned_cols=253 Identities=32% Similarity=0.579 Sum_probs=230.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
.+.+++..||-||||.|-++..+.....+|+|++.|. +.+.+..|-+||...+.|.||++|..|.++.++||.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 4567788999999999999988876667999988654 4566888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|-|-||+++..++..+.|++...+.|..-+++|+.|||++|||+||+||+|.+++.+|.+||.|||+|..+..+..
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K---- 575 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK---- 575 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999876654
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCChhHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS-PPLPGNPSRPFANLI 234 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~-~pip~~iS~eL~DLI 234 (1335)
..++||||.|.|||++.+.+ .+.++|.||||+++|||++|.+||.+.+....++.|+++.. ..+|..++....++|
T Consensus 576 --TwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 576 --TWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred --eeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 35689999999999998654 57899999999999999999999999999999999988753 457889999999999
Q ss_pred HHhcccCCCCCCC-----HHHHhcCccccccC
Q 000715 235 NSLLVKDPAQRLH-----WSDLCGHAFWRTKL 261 (1335)
Q Consensus 235 kkcLqkDPsKRPT-----AeEILkHPfFq~~l 261 (1335)
++++..+|.+|.. +.||.+|.||....
T Consensus 653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 653 KKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred HHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 9999999999975 89999999997644
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=352.17 Aligned_cols=242 Identities=30% Similarity=0.480 Sum_probs=214.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
++|++...+|.|+||.|..|.+..+++.+++|++++. ..+..+|+.++... +||||+++++++.+..+.|+|||++.|
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 4799999999999999999999999999999999888 44556777666555 899999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEE-CCCCCeeeccccccccccCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILL-DENGRTKLCDFGLARKLSDASKAPSSMLPQ 159 (1335)
Q Consensus 81 GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILI-DedG~VKLiDFGLAr~l~e~~~~~ss~l~~ 159 (1335)
+.+.+.|.....+. .++..|+.||+.++.|||++|++|||+||+|||+ ++.|+++|+|||.++..... ..
T Consensus 401 ~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--------~~ 471 (612)
T KOG0603|consen 401 GELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--------CD 471 (612)
T ss_pred cHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--------hc
Confidence 99999998877666 8888999999999999999999999999999999 68899999999999876543 13
Q ss_pred CccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCChhHHHHHHHhc
Q 000715 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT-QLVKSILSDPSPPLPGNPSRPFANLINSLL 238 (1335)
Q Consensus 160 t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~-eLikkIl~~~~~pip~~iS~eL~DLIkkcL 238 (1335)
+.|-|..|.|||++. ...|++++||||||++||+|++|+.||...... ++..++..+ ++...+|.++++||.+||
T Consensus 472 tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~---~~s~~vS~~AKdLl~~LL 547 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP---KFSECVSDEAKDLLQQLL 547 (612)
T ss_pred ccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC---ccccccCHHHHHHHHHhc
Confidence 457899999999997 667899999999999999999999999887655 555555432 344789999999999999
Q ss_pred ccCCCCCCCHHHHhcCccc
Q 000715 239 VKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 239 qkDPsKRPTAeEILkHPfF 257 (1335)
+.||.+|+++.++..||||
T Consensus 548 ~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 548 QVDPALRLGADEIGAHPWF 566 (612)
T ss_pred cCChhhCcChhhhccCcch
Confidence 9999999999999999999
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.14 Aligned_cols=248 Identities=19% Similarity=0.300 Sum_probs=191.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCC---CeEEEEEEcCchhH--------------HHHHHHHHHHHhCCCCCcceEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKT---IEYFAIKSVDKSQK--------------SKVLQEVRMLHSLDHPNVLRFYSW 64 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~T---Gk~VAIKiIdKe~~--------------e~LlrEIqILkkL~HPNIVrL~dv 64 (1335)
++|++.+.||+|+||.||+|.+..+ +..+++|....... .....+...+..++|+|++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4799999999999999999999887 77788886532211 011233345566799999999987
Q ss_pred EEeCC----EEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccc
Q 000715 65 YETSA----HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDF 140 (1335)
Q Consensus 65 feds~----~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDF 140 (1335)
+.... ..++++|++ ..++.+.+......++..++.++.|++.|+.|||++||+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 65543 457888876 4577777777666889999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCC--CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHH-------
Q 000715 141 GLARKLSDASKAPS--SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-FTQL------- 210 (1335)
Q Consensus 141 GLAr~l~e~~~~~s--s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d-~~eL------- 210 (1335)
|+++.+........ ........||+.|+|||++. +..++.++|||||||++|+|++|.+||.+.. ....
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~-~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~ 249 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN-GACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCD 249 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHH
Confidence 99987643221111 11123356999999999986 4567899999999999999999999998763 2222
Q ss_pred -HHHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 211 -VKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 211 -ikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
+.++..+ .. .....++.+.++++.|+..+|++||+++++++
T Consensus 250 ~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 250 FIKRLHEG-KI-KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhhhh-hh-ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2222221 11 23456789999999999999999999999864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=344.79 Aligned_cols=235 Identities=28% Similarity=0.503 Sum_probs=209.0
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHHHH
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSL 86 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL~dl 86 (1335)
++-||.|+-|.||+|+.+. +.||||.+.... ..+|+-|++|+||||+.+.++|....-++||||||..|-|..+
T Consensus 129 LeWlGSGaQGAVF~Grl~n--etVAVKKV~elk----ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHN--ETVAVKKVRELK----ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhhccCcccceeeeeccC--ceehhHHHhhhh----hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 4559999999999998876 779999875442 3688999999999999999999999999999999999999999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccCCCC
Q 000715 87 LRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC 166 (1335)
Q Consensus 87 Ikq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~ 166 (1335)
++.+..++......|..+|+.|+.|||.++|||||||.-||||+.+..|||+|||.++...+... ...++||..
T Consensus 203 Lka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST------kMSFaGTVa 276 (904)
T KOG4721|consen 203 LKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST------KMSFAGTVA 276 (904)
T ss_pred HhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhh------hhhhhhhHh
Confidence 99999999999999999999999999999999999999999999999999999999887655422 235899999
Q ss_pred CCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCCCCCCCCCChhHHHHHHHhcccCCCCC
Q 000715 167 YMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPSPPLPGNPSRPFANLINSLLVKDPAQR 245 (1335)
Q Consensus 167 YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~-~~~~pip~~iS~eL~DLIkkcLqkDPsKR 245 (1335)
|||||++. +...+.|+|||||||+||||+||..||.+-+...++.-+-. ....+.|..+++.++=||+.||+..|..|
T Consensus 277 WMAPEvIr-nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNR 355 (904)
T KOG4721|consen 277 WMAPEVIR-NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNR 355 (904)
T ss_pred hhCHHHhh-cCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCC
Confidence 99999997 45678999999999999999999999988776666544432 22456788999999999999999999999
Q ss_pred CCHHHHhcC
Q 000715 246 LHWSDLCGH 254 (1335)
Q Consensus 246 PTAeEILkH 254 (1335)
|++.+|+.|
T Consensus 356 PSFrqil~H 364 (904)
T KOG4721|consen 356 PSFRQILLH 364 (904)
T ss_pred ccHHHHHHH
Confidence 999999998
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.31 Aligned_cols=259 Identities=29% Similarity=0.485 Sum_probs=214.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEe--------C
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYET--------S 68 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfed--------s 68 (1335)
+.|+...+||+|.||.||+|+.+++|+.||+|++-.+ ......+|++++..++|+|++.+++.+.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4677888999999999999999999999999876332 23457899999999999999999887643 2
Q ss_pred CEEEEEEeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccccccc
Q 000715 69 AHLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLS 147 (1335)
Q Consensus 69 ~~lyLVMEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~ 147 (1335)
..+|+||.+|+ .+|..++... .+++..+++.++.+++.||.|+|++.|+|||+||+|+||+.+|.+||+|||+++.+.
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccccee
Confidence 45899999995 5788888664 689999999999999999999999999999999999999999999999999998886
Q ss_pred CCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-------CCC-
Q 000715 148 DASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-------DPS- 219 (1335)
Q Consensus 148 e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~-------~~~- 219 (1335)
......... .+..+-|.||++||.+.+...|+++.|||..|||+.||++|.+.|.+....+.+..|-. +..
T Consensus 176 ~~~n~~kpr-ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 176 TSKNVVKPR-YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred cccccCCCC-cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 554432222 23345699999999999999999999999999999999999999999887766554421 000
Q ss_pred -------------CCCC-------------CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccCC
Q 000715 220 -------------PPLP-------------GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 220 -------------~pip-------------~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l~ 262 (1335)
+|.+ -.-++++.|+++++|..||.+|++++++++|.||...+.
T Consensus 255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 1111 112457889999999999999999999999999987543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=289.38 Aligned_cols=237 Identities=45% Similarity=0.767 Sum_probs=205.7
Q ss_pred CcEEEEEEEECCCCeEEEEEEcCchh----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHHHHHHh
Q 000715 14 KYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ 89 (1335)
Q Consensus 14 gFGtVYkArdk~TGk~VAIKiIdKe~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL~dlIkq 89 (1335)
+||.||+|.+..+|+.+++|.+.... .+.+.+|++.+++++|+||+++++++......+++|||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999999999999999986543 56788999999999999999999999999999999999999999999988
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCC
Q 000715 90 DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169 (1335)
Q Consensus 90 ~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmA 169 (1335)
...++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||.+........ .....++..|++
T Consensus 81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~ 154 (244)
T smart00220 81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGL------LTTFVGTPEYMA 154 (244)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccc------cccccCCcCCCC
Confidence 77799999999999999999999999999999999999999999999999999987654321 133568899999
Q ss_pred cchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCCCCCCCC--CChhHHHHHHHhcccCCCCCC
Q 000715 170 PELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVG-REFTQLVKSILSDPSPPLPGN--PSRPFANLINSLLVKDPAQRL 246 (1335)
Q Consensus 170 PEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g-~d~~eLikkIl~~~~~pip~~--iS~eL~DLIkkcLqkDPsKRP 246 (1335)
||.+. ...++.++|+||+|+++|+|++|..||.. .+................+.. .+.++.+++.+||..+|++||
T Consensus 155 pE~~~-~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 155 PEVLL-GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HHHHc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence 99986 44567799999999999999999999988 555555555444333322222 788999999999999999999
Q ss_pred CHHHHhcCccc
Q 000715 247 HWSDLCGHAFW 257 (1335)
Q Consensus 247 TAeEILkHPfF 257 (1335)
++.++++||||
T Consensus 234 ~~~~~~~~~~~ 244 (244)
T smart00220 234 TAEEALQHPFF 244 (244)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=340.95 Aligned_cols=245 Identities=30% Similarity=0.531 Sum_probs=213.4
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCe---E-EEEEEcC------chhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIE---Y-FAIKSVD------KSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk---~-VAIKiId------Ke~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~ly 72 (1335)
+-.+.+.||+|+||.||+|+.+..+. . ||+|... +.+..++.+|.++|++++|||||++|++......++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34567899999999999998765422 3 8999775 345678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCC
Q 000715 73 LVLEYCVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq~~-~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~ 151 (1335)
+|||+|.||+|.+++++.+ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++.......
T Consensus 238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~ 317 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVM 317 (474)
T ss_pred EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceee
Confidence 9999999999999999987 599999999999999999999999999999999999999999999999999876531111
Q ss_pred CCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH-hcCCCCCCCCCCChh
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI-LSDPSPPLPGNPSRP 229 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkI-l~~~~~pip~~iS~e 229 (1335)
. ....--...|+|||.+.. +.|++++|||||||++||+++ |..||.+....+...++ ..+.+.+.+...+..
T Consensus 318 ~-----~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~ 391 (474)
T KOG0194|consen 318 K-----KFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKE 391 (474)
T ss_pred c-----cccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHH
Confidence 1 001123567999999975 488999999999999999999 88999999999999999 567777888888999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 000715 230 FANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 230 L~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
+..++.+||..||++|||+.++.+
T Consensus 392 ~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 392 LAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHhccCChhhccCHHHHHH
Confidence 999999999999999999999854
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=360.74 Aligned_cols=253 Identities=33% Similarity=0.530 Sum_probs=201.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc----hhHHHHHHHHHHHHhCCCCCcceEEEEEEe----------
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK----SQKSKVLQEVRMLHSLDHPNVLRFYSWYET---------- 67 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK----e~~e~LlrEIqILkkL~HPNIVrL~dvfed---------- 67 (1335)
++|+.++.||+||||.||+++++-+|+.||||.|.- ....++.+|+..+.+|+|||||++|..+..
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 567888999999999999999999999999999843 345678999999999999999998732200
Q ss_pred --------------------------------------------------------------------------------
Q 000715 68 -------------------------------------------------------------------------------- 67 (1335)
Q Consensus 68 -------------------------------------------------------------------------------- 67 (1335)
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence
Q ss_pred ---------------------C--------CEEEEEEeecCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHCCC
Q 000715 68 ---------------------S--------AHLWLVLEYCVGGDLMSLLRQDNQL-PEDSIRDLAQDLVRALQYLHSKGI 117 (1335)
Q Consensus 68 ---------------------s--------~~lyLVMEY~eGGSL~dlIkq~~~L-SEeqIr~I~rQILsGLkYLHskGI 117 (1335)
. ..+||-||||+..++.++|.++... .....+.+|+||++||.|+|++||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 0 1368999999999999999887665 578899999999999999999999
Q ss_pred cccCCCCCCeEECCCCCeeecccccccccc------C-------CCCCCCCCCCCCccCCCCCCCcchhccCC--CCCch
Q 000715 118 IYCDLKPSNILLDENGRTKLCDFGLARKLS------D-------ASKAPSSMLPQAKCGTPCYMAPELFEEGG--VHSYA 182 (1335)
Q Consensus 118 VHRDIKPENILIDedG~VKLiDFGLAr~l~------e-------~~~~~ss~l~~t~~GTp~YmAPEVL~~~~--~yS~k 182 (1335)
|||||||.||++++++.|||+|||+|+... . ..........+..+||..|+|||++.+.. .|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999998732 0 00111111234578999999999997655 68999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCCCC----CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 183 SDLWGLGCVLYECYAGRPPFVGR-EFTQLVKSILSDPSPPLP----GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 183 SDIWSLGVILYELLTGrpPF~g~-d~~eLikkIl~~~~~pip----~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
+|+||||+|++||+. ||.-. .....+..+-+ ...|.+ ...-+.-..+|++||+.||.+||||.|+|++.||
T Consensus 799 iDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~-g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ll 874 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTSMERASILTNLRK-GSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELL 874 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCchHHHHHHHHhccc-CCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCC
Confidence 999999999999985 46432 33344444332 222322 2234556789999999999999999999999997
Q ss_pred c
Q 000715 258 R 258 (1335)
Q Consensus 258 q 258 (1335)
.
T Consensus 875 p 875 (1351)
T KOG1035|consen 875 P 875 (1351)
T ss_pred C
Confidence 4
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=343.11 Aligned_cols=245 Identities=27% Similarity=0.430 Sum_probs=209.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK-----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK-----e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
++..+.+.||+|.||+||+|+|.++ ||||+++. ++.+.+.+|+..+++=+|.||+-+.+++..... .||+.
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 4567789999999999999999987 99999854 356778999999999999999999999988887 99999
Q ss_pred ecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
+|+|.+|+.++... .+|...+.+.|++|+++|+.|||.++|||||||..||++.+++.|||+|||++..-........
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q- 546 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQ- 546 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccccc-
Confidence 99999999998653 4789999999999999999999999999999999999999999999999999976544322111
Q ss_pred CCCCCccCCCCCCCcchhc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC----CCCCCCChh
Q 000715 156 MLPQAKCGTPCYMAPELFE--EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP----PLPGNPSRP 229 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~--~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~----pip~~iS~e 229 (1335)
....-|...|||||++. ....|++.+||||||+++|||++|..||.....++++..+-.+... ..-.+++.+
T Consensus 547 --~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~ 624 (678)
T KOG0193|consen 547 --LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKA 624 (678)
T ss_pred --cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHH
Confidence 12345788899999986 3456889999999999999999999999977777777666555221 233566789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 000715 230 FANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 230 L~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
+++|+..||.+++++||.+.+|+.
T Consensus 625 mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 625 MKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHhcCcccCccHHHHHH
Confidence 999999999999999999999976
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=316.56 Aligned_cols=253 Identities=28% Similarity=0.406 Sum_probs=201.7
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcC---chhHHHHHHHHHHHHhCCCCCcceEEEEEE-----eCCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD---KSQKSKVLQEVRMLHSLDHPNVLRFYSWYE-----TSAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiId---Ke~~e~LlrEIqILkkL~HPNIVrL~dvfe-----ds~~lyL 73 (1335)
+||++.+.||+|||+.||+++...+++.||+|.+. .++.+...+|++..++++|||+++++++.. .....|+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 58999999999999999999999999999999883 355677899999999999999999987653 3345999
Q ss_pred EEeecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCCCCeEECCCCCeeecccccccccc
Q 000715 74 VLEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKG--IIYCDLKPSNILLDENGRTKLCDFGLARKLS 147 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHskG--IVHRDIKPENILIDedG~VKLiDFGLAr~l~ 147 (1335)
+++|+..|+|.+.|+. +..++|.++..|+.++++||++||+.. +.||||||.||++++++.++|.|||.++...
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~ 180 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAP 180 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccc
Confidence 9999999999999865 347999999999999999999999999 9999999999999999999999999987653
Q ss_pred CCCCCCCCC--C--CCCccCCCCCCCcchhcc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc-CC
Q 000715 148 DASKAPSSM--L--PQAKCGTPCYMAPELFEE--GGVHSYASDLWGLGCVLYECYAGRPPFVGREFT--QLVKSILS-DP 218 (1335)
Q Consensus 148 e~~~~~ss~--l--~~t~~GTp~YmAPEVL~~--~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~--eLikkIl~-~~ 218 (1335)
-.-...... . ......|..|+|||.+.- +...+.++|||||||++|+|++|..||+..-.. .+.-.+.. ..
T Consensus 181 i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~ 260 (302)
T KOG2345|consen 181 IQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQI 260 (302)
T ss_pred eEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecccc
Confidence 211110000 0 011246889999999853 345578999999999999999999999542110 00001111 11
Q ss_pred CCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 219 SPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 219 ~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
..|.....|+.+.++|++||+.||.+||++.+++.+
T Consensus 261 s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 261 SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 122234478999999999999999999999999865
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=349.44 Aligned_cols=247 Identities=27% Similarity=0.489 Sum_probs=215.8
Q ss_pred cEEEEEEEeccCcEEEEEEEECCC-C----eEEEEEEcCc----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKT-I----EYFAIKSVDK----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~T-G----k~VAIKiIdK----e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
+-++.+.||+|+||.||.|..... | ..||+|.+.+ ++..++.+|..+|++++||||+++++++.+....++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 456788999999999999987643 2 3499998854 457789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccc
Q 000715 74 VLEYCVGGDLMSLLRQD-------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKL 146 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~-------~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l 146 (1335)
++||++||+|..+|++. ..++..+...++.||++|.+||+++++|||||-..|+|++....+||+|||+|+.+
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhh
Confidence 99999999999999875 35899999999999999999999999999999999999999999999999999954
Q ss_pred cCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 000715 147 SDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGN 225 (1335)
Q Consensus 147 ~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~ 225 (1335)
........ ....--...|||||.+.. +.++.++|||||||++||+++ |..||.+.+..++......+.+.+.|..
T Consensus 853 y~~~yyr~---~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~ 928 (1025)
T KOG1095|consen 853 YDKDYYRK---HGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY 928 (1025)
T ss_pred hhchheec---cCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence 33221111 011112356999999974 778999999999999999999 9999999999999998888778889999
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 226 PSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 226 iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
++..+.+++..||+.+|++||++..|++
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999999999999999999987
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=343.60 Aligned_cols=245 Identities=24% Similarity=0.436 Sum_probs=214.3
Q ss_pred cEEEEEEEeccCcEEEEEEEECC-----CCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKK-----TIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~-----TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyL 73 (1335)
+-++.+.||+|+||+||+|+... ....||||...+. ...+|++|++++..++|||||++++++..++.+||
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 45677899999999999998644 3467999988543 45689999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhC----------C----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecc
Q 000715 74 VLEYCVGGDLMSLLRQD----------N----QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCD 139 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~----------~----~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiD 139 (1335)
|+||+..|||.+++... . +|+..+...++.||+.|+.||-++.+|||||-..|+||+++-.|||+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecc
Confidence 99999999999999642 1 288999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCC
Q 000715 140 FGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDP 218 (1335)
Q Consensus 140 FGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~ 218 (1335)
||+++..-...... ......-...|||||-+..+ .|+.++||||+||+|||+++ |+.||.+....+.++.+..+.
T Consensus 647 fGLsRdiYssDYYk---~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~ 722 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYK---VRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ 722 (774)
T ss_pred cccchhhhhhhhhc---ccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence 99998654322211 11112235679999999865 56889999999999999999 999999999999999999888
Q ss_pred CCCCCCCCChhHHHHHHHhcccCCCCCCCHHHH
Q 000715 219 SPPLPGNPSRPFANLINSLLVKDPAQRLHWSDL 251 (1335)
Q Consensus 219 ~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEI 251 (1335)
..+.|.+++.++++|+..||+.+|++||++.||
T Consensus 723 lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 723 LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 888999999999999999999999999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=334.93 Aligned_cols=255 Identities=19% Similarity=0.272 Sum_probs=180.6
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECCC----CeEEEEEEcCchhHHHHHHHHHHHHhCCCCCcceEEEE------EEeCCE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKT----IEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSW------YETSAH 70 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~T----Gk~VAIKiIdKe~~e~LlrEIqILkkL~HPNIVrL~dv------feds~~ 70 (1335)
.++|++.+.||+|+||.||+|++..+ +..||+|.+..........+.+ +....+.++..+... ......
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~-l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER-VRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH-HHhhchhhHHHHHHhhhcccccccCCc
Confidence 36899999999999999999999998 9999999886543222111111 122222223222211 245677
Q ss_pred EEEEEeecCCCCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEEC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQ--------------------LPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLD 130 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~--------------------LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILID 130 (1335)
+++||||+.+++|.+++..... ..+..++.++.||+.||.|||++||+||||||+|||++
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~ 289 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS 289 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEe
Confidence 9999999999999999875421 12345778999999999999999999999999999998
Q ss_pred C-CCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCC---------------------CCCchhhHHHH
Q 000715 131 E-NGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG---------------------VHSYASDLWGL 188 (1335)
Q Consensus 131 e-dG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~---------------------~yS~kSDIWSL 188 (1335)
. ++.+||+|||+++.+..... ..+...+|++.|+|||.+.... .++.++||||+
T Consensus 290 ~~~~~~KL~DFGlA~~l~~~~~----~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 290 EGSGSFKIIDLGAAADLRVGIN----YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred CCCCcEEEEeCCCccccccccc----cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 5 58999999999976543221 1234568999999999764221 13346799999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-----------C----------CCCCCCChhHHHHHHHhcccCCCCCCC
Q 000715 189 GCVLYECYAGRPPFVGREFTQLVKSILSDPS-----------P----------PLPGNPSRPFANLINSLLVKDPAQRLH 247 (1335)
Q Consensus 189 GVILYELLTGrpPF~g~d~~eLikkIl~~~~-----------~----------pip~~iS~eL~DLIkkcLqkDPsKRPT 247 (1335)
||++|||+++..|+... ...+..++.... . ...........+||.+||++||++|||
T Consensus 366 GviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 99999999977665432 111111111000 0 001112344669999999999999999
Q ss_pred HHHHhcCccccccCC
Q 000715 248 WSDLCGHAFWRTKLT 262 (1335)
Q Consensus 248 AeEILkHPfFq~~l~ 262 (1335)
+.++++||||+....
T Consensus 444 a~e~L~Hpff~~~~~ 458 (566)
T PLN03225 444 AKAALAHPYFDREGL 458 (566)
T ss_pred HHHHhCCcCcCCCCc
Confidence 999999999987543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=337.97 Aligned_cols=253 Identities=36% Similarity=0.616 Sum_probs=223.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----CCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSL-DHPNVLRFYSWYET-----SAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL-~HPNIVrL~dvfed-----s~~lyL 73 (1335)
+.|++.++||+|.+|.||+++++.+|+..|+|+.+.. ..++++.|+++++.+ .|||++.+|++|.- ++.+|+
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 3589999999999999999999999999999998643 456678899999887 89999999998853 468999
Q ss_pred EEeecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCC
Q 000715 74 VLEYCVGGDLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq--~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~ 151 (1335)
|||||.||+.-|+++. +.++.|+.+..|++.++.|+.+||.+.++|||||-.|||++.+|.|||+|||.+..+...-.
T Consensus 99 VMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g 178 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG 178 (953)
T ss_pred EeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccc
Confidence 9999999999999976 56899999999999999999999999999999999999999999999999999987754332
Q ss_pred CCCCCCCCCccCCCCCCCcchhccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--CCC
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEG----GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGN 225 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~----~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pi--p~~ 225 (1335)
...+.+|||+|||||++... ..|+..+|+||||++..||--|.+|+.+......+-.|...+++.+ |..
T Consensus 179 -----rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 179 -----RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred -----cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence 24668899999999999753 4456689999999999999999999999988877777776665543 577
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 226 PSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 226 iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
++..+.+||..||.+|-.+||+..++++|||...
T Consensus 254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 8999999999999999999999999999999863
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=309.55 Aligned_cols=252 Identities=29% Similarity=0.545 Sum_probs=211.5
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc----hhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK----SQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK----e~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVME 76 (1335)
|+.+.+..||.|+-|.|++++.+.+|...|||.+.+ ++.+++...+.++.+. ++|+||+.+++|..+..+++-||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 445667789999999999999999999999999854 4566778888876655 69999999999999999999999
Q ss_pred ecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCC
Q 000715 77 YCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 77 Y~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~s 154 (1335)
.+ +..+..++++ .++++|.-+-++..-++.||.||.+ +||+|||+||+|||+|+.|++||||||.+..+.+....
T Consensus 172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh-- 248 (391)
T KOG0983|consen 172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH-- 248 (391)
T ss_pred HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence 76 5566666654 5689999999999999999999986 59999999999999999999999999999877654332
Q ss_pred CCCCCCccCCCCCCCcchhc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCCCCCC--CCCChh
Q 000715 155 SMLPQAKCGTPCYMAPELFE--EGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-FTQLVKSILSDPSPPLP--GNPSRP 229 (1335)
Q Consensus 155 s~l~~t~~GTp~YmAPEVL~--~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d-~~eLikkIl~~~~~pip--~~iS~e 229 (1335)
....|-+.|||||.+. ....|+..+||||||++++||.||+.||.+.+ .-+.+.++++...+-++ ...|+.
T Consensus 249 ----trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~ 324 (391)
T KOG0983|consen 249 ----TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPD 324 (391)
T ss_pred ----ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHH
Confidence 2345899999999985 24567889999999999999999999999854 34566666665444444 347999
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 230 FANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 230 L~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
+.+|+..||.+|+.+||...++++|||....
T Consensus 325 F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 325 FQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 9999999999999999999999999998653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=316.89 Aligned_cols=244 Identities=32% Similarity=0.491 Sum_probs=195.9
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh---HHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---KSKVLQEVRMLHSLDHPNVLRFYSWYETSA-HLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~---~e~LlrEIqILkkL~HPNIVrL~dvfeds~-~lyLVMEY 77 (1335)
++|.-...||+|+||.||+|...++ ..||||..+... ..++.+|+.++.+++|||+|++++||.+.+ ..++|+||
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEy 153 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEY 153 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEc
Confidence 3566678999999999999998876 889999886543 456999999999999999999999999998 59999999
Q ss_pred cCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCCCCeEECCCCCeeeccccccccccC-CCC
Q 000715 78 CVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKG---IIYCDLKPSNILLDENGRTKLCDFGLARKLSD-ASK 151 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskG---IVHRDIKPENILIDedG~VKLiDFGLAr~l~e-~~~ 151 (1335)
+++|+|.+.+.... .+++.+..+|+.+++.||.|||+.. |+||||||+|||+|++.+.||+|||+|+.... ...
T Consensus 154 m~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~ 233 (361)
T KOG1187|consen 154 MPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTS 233 (361)
T ss_pred cCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccc
Confidence 99999999997754 8999999999999999999999864 99999999999999999999999999965543 211
Q ss_pred CCCCCCCCCc-cCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhcC------C
Q 000715 152 APSSMLPQAK-CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE------FTQLVKSILSD------P 218 (1335)
Q Consensus 152 ~~ss~l~~t~-~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d------~~eLikkIl~~------~ 218 (1335)
. .+. .||.+|+|||++.. +..+.++||||||+++.|+++|+.+.+... ..+.....+.. .
T Consensus 234 ~------~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 234 V------STTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred e------eeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 1 111 69999999999864 667899999999999999999998876432 12221111111 1
Q ss_pred CCCCC-CCCC--hh---HHHHHHHhcccCCCCCCCHHHHhc
Q 000715 219 SPPLP-GNPS--RP---FANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 219 ~~pip-~~iS--~e---L~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
.+.+. ...+ .. +..+..+|++.+|.+||++.++.+
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11222 2222 23 556777999999999999999743
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=334.32 Aligned_cols=238 Identities=38% Similarity=0.663 Sum_probs=194.0
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------EEEE
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSA------HLWL 73 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK----e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~------~lyL 73 (1335)
|...+.||+||||.||+++++.||+.||||.+.+ ...+...+|++++++++|||||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 5667899999999999999999999999999865 34677889999999999999999999866544 5689
Q ss_pred EEeecCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEE--CCCCC--eeeccccccccc
Q 000715 74 VLEYCVGGDLMSLLRQ---DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILL--DENGR--TKLCDFGLARKL 146 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq---~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILI--DedG~--VKLiDFGLAr~l 146 (1335)
|||||.||+|+.++++ ...|+|.++..++.++..|+.|||++||+||||||+||++ ..+|. -||+|||.|+.+
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 9999999999999975 4579999999999999999999999999999999999998 34453 599999999988
Q ss_pred cCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHH-hcCC---
Q 000715 147 SDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE----FTQLVKSI-LSDP--- 218 (1335)
Q Consensus 147 ~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d----~~eLikkI-l~~~--- 218 (1335)
.++.. ....+||+.|.+||++...++|+..+|.|||||++|+..||..||.... ..+....+ .+.+
T Consensus 175 ~d~s~------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 175 DDNSL------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred CCCCe------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 76552 2557899999999999866889999999999999999999999995432 22233222 2211
Q ss_pred ----------------CCCCCCCCChh----HHHHHHHhcccCCCCCCC
Q 000715 219 ----------------SPPLPGNPSRP----FANLINSLLVKDPAQRLH 247 (1335)
Q Consensus 219 ----------------~~pip~~iS~e----L~DLIkkcLqkDPsKRPT 247 (1335)
..|.|...+.. +...+..+|..+|.+|..
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 11233344444 345677888889988873
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=316.74 Aligned_cols=249 Identities=27% Similarity=0.514 Sum_probs=204.5
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh--HHHHHHHHHHHHhCCC--CC----cceEEEEEEeCCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSLDH--PN----VLRFYSWYETSAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~--~e~LlrEIqILkkL~H--PN----IVrL~dvfeds~~lyL 73 (1335)
++|.+++.+|+|.||.|..|.+..++..||+|++..-. .+...-|++++.++.+ |+ ++++.+||+..++.++
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi 168 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI 168 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence 58999999999999999999999999999999996543 3456679999999932 33 7889999999999999
Q ss_pred EEeecCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC--------------------
Q 000715 74 VLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE-------------------- 131 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe-------------------- 131 (1335)
|+|.+ |-++++++..++ +++.+.++.+.+|++++++|||+.+++|-|+||+||++.+
T Consensus 169 vfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~k 247 (415)
T KOG0671|consen 169 VFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLK 247 (415)
T ss_pred EEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCC
Confidence 99986 789999998865 7899999999999999999999999999999999999831
Q ss_pred CCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--
Q 000715 132 NGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ-- 209 (1335)
Q Consensus 132 dG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~e-- 209 (1335)
+-.+|++|||.|+...+.. .+.+.|..|+|||++.+ -.++..+||||+||||+|+.+|...|+..+..+
T Consensus 248 s~~I~vIDFGsAtf~~e~h--------s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 248 STAIKVIDFGSATFDHEHH--------STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred CcceEEEecCCcceeccCc--------ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 2358999999998654432 33578999999999974 457889999999999999999999998876444
Q ss_pred -HHHHHhcCCCC-----------------CCC-------------------------CCCChhHHHHHHHhcccCCCCCC
Q 000715 210 -LVKSILSDPSP-----------------PLP-------------------------GNPSRPFANLINSLLVKDPAQRL 246 (1335)
Q Consensus 210 -LikkIl~~~~~-----------------pip-------------------------~~iS~eL~DLIkkcLqkDPsKRP 246 (1335)
+.+.|+...+. .++ .....++.|||++||.+||.+|+
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 33444321100 000 00124588999999999999999
Q ss_pred CHHHHhcCcccccc
Q 000715 247 HWSDLCGHAFWRTK 260 (1335)
Q Consensus 247 TAeEILkHPfFq~~ 260 (1335)
|+.|++.||||...
T Consensus 399 Tl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 399 TLREALSHPFFARL 412 (415)
T ss_pred cHHHHhcCHHhhcC
Confidence 99999999999753
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=315.70 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=219.2
Q ss_pred cEEEEEEEeccCcEEEEEEEECC-CCe--EEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKK-TIE--YFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~-TGk--~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
+..+.++||+|.||.|++|.|+. +|+ .||||++... ...+|.+|+.+|.+|+|||++++|++..+ ..+.|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 44567899999999999999875 333 5999998543 35689999999999999999999999888 7788999
Q ss_pred eecCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC
Q 000715 76 EYCVGGDLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 76 EY~eGGSL~dlIkq--~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ 153 (1335)
|++++|+|.+.+.+ ...|--.....|+.||+.|+.||..+++||||+-..|+++-....|||+|||+.+.++......
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 99999999999987 3468889999999999999999999999999999999999988899999999999998765543
Q ss_pred CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHH
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 154 ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~D 232 (1335)
. + ....--...|+|||.+. ...++.++|+|++||++|||++ |+.||.+....+++++|-.+.+.+.|+.+++.+++
T Consensus 270 v-m-~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~ 346 (1039)
T KOG0199|consen 270 V-M-APQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQ 346 (1039)
T ss_pred E-e-cCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHH
Confidence 2 1 12222355699999996 4567889999999999999999 89999999999999999988888999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccc
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAFWR 258 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPfFq 258 (1335)
+++.||..+|.+|||+.+|...-+..
T Consensus 347 imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 347 IMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHhccCCccccccHHHHHHhHHHH
Confidence 99999999999999999997654443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-33 Score=314.34 Aligned_cols=258 Identities=31% Similarity=0.541 Sum_probs=214.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEc--Cchh--------HHHHHHHHHHHHhCCCCCcceEEEEEEe-CCE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQ--------KSKVLQEVRMLHSLDHPNVLRFYSWYET-SAH 70 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiI--dKe~--------~e~LlrEIqILkkL~HPNIVrL~dvfed-s~~ 70 (1335)
++|-++..||+|||+.||+|.+....++||+|+- ++.- .+...+|.+|.+.|+||.||++|++|.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 3688889999999999999999999999999985 2221 2345789999999999999999999864 467
Q ss_pred EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--CCcccCCCCCCeEECC---CCCeeecccccccc
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK--GIIYCDLKPSNILLDE---NGRTKLCDFGLARK 145 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHsk--GIVHRDIKPENILIDe---dG~VKLiDFGLAr~ 145 (1335)
+|-|+|||+|.+|.-+++++.-++|.+++.|+-||+.||.||.+. .|||-|+||.|||+.+ -|.+||.|||++.+
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 899999999999999999999999999999999999999999987 5999999999999943 47899999999998
Q ss_pred ccCCCCCCCC--CCCCCccCCCCCCCcchhccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHH--HHHhcC
Q 000715 146 LSDASKAPSS--MLPQAKCGTPCYMAPELFEEG---GVHSYASDLWGLGCVLYECYAGRPPFVGREFT-QLV--KSILSD 217 (1335)
Q Consensus 146 l~e~~~~~ss--~l~~t~~GTp~YmAPEVL~~~---~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~-eLi--kkIl~~ 217 (1335)
+......... .+.....||.||++||.+.-+ +..+.++||||+|||+|.++.|+.||...... +++ +-|++.
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA 702 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA 702 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc
Confidence 8765443221 223446799999999998643 34577999999999999999999999776433 232 223332
Q ss_pred --CCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 218 --PSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 218 --~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
...|....++.++++||++||.+.-++|....++..||||..
T Consensus 703 tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 703 TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 233444678999999999999999999999999999999854
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-33 Score=295.46 Aligned_cols=251 Identities=27% Similarity=0.495 Sum_probs=211.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLD-HPNVLRFYSWYETS--AHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~-HPNIVrL~dvfeds--~~lyLVMEY~ 78 (1335)
++|++.+++|+|.|+.||.|.+..+.+.++||+...-..+.+.+|++||..|. ||||++++++..+. ....+|+||+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v 117 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV 117 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence 67999999999999999999999999999999999998999999999999995 99999999998665 5678999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCC-CCeeeccccccccccCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN-GRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDed-G~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
.+.+...+. +.++..+++.+++|++.||.|||++||+|||+||.|++||.. -.++|+|||+|..+.+...-
T Consensus 118 ~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY----- 189 (338)
T KOG0668|consen 118 NNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY----- 189 (338)
T ss_pred ccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCcee-----
Confidence 887766554 568999999999999999999999999999999999999965 57999999999988765432
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHhc--------------------
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPF-VGREFTQLVKSILS-------------------- 216 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF-~g~d~~eLikkIl~-------------------- 216 (1335)
+..+.+.+|--||.+..-+.|+..-|+|||||++..|++.+-|| .+.+..+++-+|.+
T Consensus 190 -nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 190 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred -eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 33567889999999988888999999999999999999988776 44554444333311
Q ss_pred -------C-CCCCC--------CCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 217 -------D-PSPPL--------PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 217 -------~-~~~pi--------p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
. .+.++ ..-.++++.||+.++|..|-++|+|+.|++.||||....
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 0 00000 112368999999999999999999999999999997543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=315.93 Aligned_cols=240 Identities=28% Similarity=0.469 Sum_probs=208.9
Q ss_pred EEEEeccCcEEEEEEEECCC----CeEEEEEEcCc----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 7 YEAIGRGKYSTVYKGRKKKT----IEYFAIKSVDK----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~T----Gk~VAIKiIdK----e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
.+.||.|-||.||+|....- .-.||||.... ++.+.+.+|..+|++++||||+++++++.+. ..|+|||.+
T Consensus 394 ~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~ 472 (974)
T KOG4257|consen 394 KRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELA 472 (974)
T ss_pred HHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecc
Confidence 45799999999999976432 33588998754 4577899999999999999999999988754 479999999
Q ss_pred CCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 79 eGGSL~dlIkq~~-~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l 157 (1335)
+-|.|..+++.+. .++......|++||+.++.|||+.++|||||-..|||+.....|||+|||+++.+.+.......
T Consensus 473 ~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-- 550 (974)
T KOG4257|consen 473 PLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-- 550 (974)
T ss_pred cchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhhcc--
Confidence 9999999998764 7999999999999999999999999999999999999999999999999999988665432211
Q ss_pred CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHH
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkk 236 (1335)
...-..-|||||-+.. ..++.++|||.|||++||++. |..||.+-...+.+..+.++.+.|.|..+++.+..++.+
T Consensus 551 --~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmsk 627 (974)
T KOG4257|consen 551 --RGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSK 627 (974)
T ss_pred --ccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHH
Confidence 1123456999999864 456889999999999999887 999999999999999999999999999999999999999
Q ss_pred hcccCCCCCCCHHHHh
Q 000715 237 LLVKDPAQRLHWSDLC 252 (1335)
Q Consensus 237 cLqkDPsKRPTAeEIL 252 (1335)
||.+||.+||++.++.
T Consensus 628 cWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 628 CWAYEPSKRPRFTEIK 643 (974)
T ss_pred HhccCcccCCcHHHHH
Confidence 9999999999987764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=312.80 Aligned_cols=254 Identities=18% Similarity=0.310 Sum_probs=185.8
Q ss_pred CcEEEEEEEeccCcEEEEEEEEC----------------CCCeEEEEEEcCchh---HHH--------------HHHHHH
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKK----------------KTIEYFAIKSVDKSQ---KSK--------------VLQEVR 48 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk----------------~TGk~VAIKiIdKe~---~e~--------------LlrEIq 48 (1335)
++|++.++||+|+||+||+|.+. ..++.||+|.+.... .++ ...|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 68999999999999999999752 345679999875321 111 234667
Q ss_pred HHHhCCCCCc-----ceEEEEEEe--------CCEEEEEEeecCCCCHHHHHHhC------------------------C
Q 000715 49 MLHSLDHPNV-----LRFYSWYET--------SAHLWLVLEYCVGGDLMSLLRQD------------------------N 91 (1335)
Q Consensus 49 ILkkL~HPNI-----VrL~dvfed--------s~~lyLVMEY~eGGSL~dlIkq~------------------------~ 91 (1335)
++.+++|.++ +++++++.. .+..|+||||+.+++|.+++... .
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7777766654 566666543 35689999999999999988642 1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcc
Q 000715 92 QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171 (1335)
Q Consensus 92 ~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPE 171 (1335)
.++...++.++.|++.+|.|||++||+||||||+||+++.++.+||+|||++......... ......+++.|+|||
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~----~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF----NPLYGMLDPRYSPPE 380 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc----CccccCCCcceeChh
Confidence 2356788999999999999999999999999999999999999999999998755332111 111234589999999
Q ss_pred hhccCCC-------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCCHH-----------HHHHHHh-cC
Q 000715 172 LFEEGGV-------------------H--SYASDLWGLGCVLYECYAGRP-PFVGREFT-----------QLVKSIL-SD 217 (1335)
Q Consensus 172 VL~~~~~-------------------y--S~kSDIWSLGVILYELLTGrp-PF~g~d~~-----------eLikkIl-~~ 217 (1335)
++..... + ..+.|+||+||++|+|++|.. ||.+.... ..+..+. ..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 9753211 1 124799999999999999875 77542111 0111111 11
Q ss_pred CCCCCCCCCChhHHHHHHHhcccCC---CCCCCHHHHhcCccccc
Q 000715 218 PSPPLPGNPSRPFANLINSLLVKDP---AQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 218 ~~~pip~~iS~eL~DLIkkcLqkDP---sKRPTAeEILkHPfFq~ 259 (1335)
.........++..+||+.+||.++| .+|+|++|+|+||||..
T Consensus 461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 1223345678999999999999876 68999999999999964
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=321.37 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=220.6
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCe---EEEEEEcC----chhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIE---YFAIKSVD----KSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk---~VAIKiId----Ke~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
-.+.++||.|.||.||+|+.+..|+ .||||.+. ..++.++..|..||-+.+||||+++.++....+.+.||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 4678999999999999999987764 59999884 3456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|+++|+|..+++++ ++|+..++..+++.|+.|++||-++|+|||||-..|||++.+-.+|++|||+++.+.++......
T Consensus 711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~yt 790 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 790 (996)
T ss_pred hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcccc
Confidence 99999999999874 68999999999999999999999999999999999999999999999999999988665422211
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
.. + .--...|.|||.+.. +.++.++||||+|++|||.++ |..||.+....+.++.|..+.+.|.|-+++..+.+|+
T Consensus 791 t~-G-GKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLM 867 (996)
T KOG0196|consen 791 TL-G-GKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLM 867 (996)
T ss_pred cc-C-CccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHH
Confidence 10 0 111467999999975 456889999999999998776 9999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCHHHHhcC
Q 000715 235 NSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 235 kkcLqkDPsKRPTAeEILkH 254 (1335)
..||++|-.+||++.+|..+
T Consensus 868 ldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 868 LDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=303.52 Aligned_cols=249 Identities=24% Similarity=0.424 Sum_probs=219.8
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
..+..+||-|.||.||.|.|++-...||||.+..+ ..+++..|..+|+.++|||+|+++++|.....+|||+||+..|
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yG 348 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYG 348 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCc
Confidence 44567899999999999999998889999998654 5778999999999999999999999999999999999999999
Q ss_pred CHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCC
Q 000715 82 DLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQ 159 (1335)
Q Consensus 82 SL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~ 159 (1335)
+|.+|+++.. .++.-.+.+++.||.+|+.||..+++|||||-..|+|+.++..||++|||+++.+..+.......
T Consensus 349 NLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG--- 425 (1157)
T KOG4278|consen 349 NLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG--- 425 (1157)
T ss_pred cHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC---
Confidence 9999998754 57888889999999999999999999999999999999999999999999999887654321110
Q ss_pred CccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhc
Q 000715 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLL 238 (1335)
Q Consensus 160 t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcL 238 (1335)
.--..-|.|||-+..+ .++.++|||+|||+|||+.| |..||.+-+..+.+.-+.++.+..-|+.+++...+|+..||
T Consensus 426 -AKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW 503 (1157)
T KOG4278|consen 426 -AKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACW 503 (1157)
T ss_pred -ccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHh
Confidence 1124559999998754 46789999999999999988 99999999999999999899998999999999999999999
Q ss_pred ccCCCCCCCHHHHhcCccccc
Q 000715 239 VKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 239 qkDPsKRPTAeEILkHPfFq~ 259 (1335)
++.|.+||++.|+ |.-|.+
T Consensus 504 ~WsPsDRPsFaei--HqafEt 522 (1157)
T KOG4278|consen 504 NWSPSDRPSFAEI--HQAFET 522 (1157)
T ss_pred cCCcccCccHHHH--HHHHHH
Confidence 9999999999998 444433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=330.93 Aligned_cols=237 Identities=25% Similarity=0.392 Sum_probs=187.0
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCC
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGD 82 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGS 82 (1335)
.|...+.||+|+||.||+|++..+++.||+|.+..... ....|++++++++||||+++++++.+....|+||||+++|+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 35566789999999999999999999999999865432 22457899999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCC
Q 000715 83 LMSLLRQDNQLPEDSIRDLAQDLVRALQYLH---SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQ 159 (1335)
Q Consensus 83 L~dlIkq~~~LSEeqIr~I~rQILsGLkYLH---skGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~ 159 (1335)
|.++++ .+++.++..++.|++.|+.||| +.+|+||||||+||+++.++..++. ||....... ..
T Consensus 770 L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---------~~ 836 (968)
T PLN00113 770 LSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---------DT 836 (968)
T ss_pred HHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---------CC
Confidence 999995 3889999999999999999999 6699999999999999998887775 555433211 12
Q ss_pred CccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHhcCC------CCCC------
Q 000715 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-----FTQLVKSILSDP------SPPL------ 222 (1335)
Q Consensus 160 t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d-----~~eLikkIl~~~------~~pi------ 222 (1335)
...||+.|+|||++. +..++.++||||+||++|||++|+.||.... ..+......... .+..
T Consensus 837 ~~~~t~~y~aPE~~~-~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 837 KCFISSAYVAPETRE-TKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915 (968)
T ss_pred CccccccccCccccc-CCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCc
Confidence 235899999999986 4567889999999999999999999985431 111111111100 0011
Q ss_pred CCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 223 PGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 223 p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
+.....++.+++.+||+.||++|||+.++++.
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 11112357789999999999999999999765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=293.30 Aligned_cols=246 Identities=25% Similarity=0.460 Sum_probs=208.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeC------CE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS------AH 70 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~HPNIVrL~dvfeds------~~ 70 (1335)
.+|.-++.+|.|+- .|..|.+.-+++.||+|..... ..++..+|..++..++|+||++++.+|... ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 37888899999998 8999999999999999987443 355778999999999999999999998654 45
Q ss_pred EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
+|+||||+ ..+|...+. -.++.+.++.+++|+++|++|||+.||+||||||+||++..++.+||.|||+++.-...
T Consensus 96 ~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 89999997 678988887 46788999999999999999999999999999999999999999999999999864332
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC---------
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP--------- 221 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~p--------- 221 (1335)
+....++.|.+|.|||++.+.+ |...+||||+||++.||+.|...|.+.+.-+++.++......+
T Consensus 172 -----~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 172 -----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred -----cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 3345688999999999998666 8899999999999999999999999988776666553311111
Q ss_pred ---------------------CC-----------CCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 000715 222 ---------------------LP-----------GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWR 258 (1335)
Q Consensus 222 ---------------------ip-----------~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq 258 (1335)
+| ..-...+++++.+||..||++|.+++++|+|||++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 11 01134588999999999999999999999999997
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=310.80 Aligned_cols=254 Identities=31% Similarity=0.542 Sum_probs=220.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
++|+++..+|.|.||.||+|+++.+++..|+|+++-+ ...-+++|+-+++..+||||+.+++.|.....+|+.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 4799999999999999999999999999999998654 4566789999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
.||+|++.-.-.++++|.++.+.++..++|++|||++|-+|||||-.||++++.|.+|+.|||.+-.++..-. ..
T Consensus 95 gggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-----Kr 169 (829)
T KOG0576|consen 95 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-----KR 169 (829)
T ss_pred CCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh-----hh
Confidence 9999999887788999999999999999999999999999999999999999999999999999877654322 23
Q ss_pred CCccCCCCCCCcchhc--cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCC---CCCCCChhHHH
Q 000715 159 QAKCGTPCYMAPELFE--EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL-SDPSPP---LPGNPSRPFAN 232 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~--~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl-~~~~~p---ip~~iS~eL~D 232 (1335)
..++|||+|||||+-. ..+.|...+|||++|++..|+---++|..+........-+. .++.++ -+..+++.+.+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~ 249 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHN 249 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHH
Confidence 5678999999999853 45678899999999999999988888876666555444332 233332 23567889999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 233 LIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
|++.+|.++|++||+++.++.|||....
T Consensus 250 fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHhcCCCccCCChhhheeceeeccc
Confidence 9999999999999999999999997643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=249.51 Aligned_cols=209 Identities=44% Similarity=0.786 Sum_probs=187.5
Q ss_pred EeccCcEEEEEEEECCCCeEEEEEEcCchhH----HHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHHH
Q 000715 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK----SKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMS 85 (1335)
Q Consensus 10 LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~----e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL~d 85 (1335)
||+|++|.||++....+++.+++|.+..... ..+.+|++.++.++|++++++++++......+++|||+.|++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999999999999999977643 678999999999999999999999999999999999999999999
Q ss_pred HHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC-CCCeeeccccccccccCCCCCCCCCCCCCccC
Q 000715 86 LLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE-NGRTKLCDFGLARKLSDASKAPSSMLPQAKCG 163 (1335)
Q Consensus 86 lIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe-dG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~G 163 (1335)
++... ..++...+..++.+++.++.|||++|++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~ 155 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-----LLKTIVG 155 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-----hhhcccC
Confidence 99876 57999999999999999999999999999999999999998 89999999999886654321 0122457
Q ss_pred CCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCCC
Q 000715 164 TPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPA 243 (1335)
Q Consensus 164 Tp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPs 243 (1335)
...|++||.+.....++.+.|+|++|+++|+| ..+.+++.+|+..||+
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------~~~~~~l~~~l~~~p~ 203 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------PELKDLIRKMLQKDPE 203 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------HHHHHHHHHHhhCCcc
Confidence 88899999986543678899999999999998 7789999999999999
Q ss_pred CCCCHHHHhcCc
Q 000715 244 QRLHWSDLCGHA 255 (1335)
Q Consensus 244 KRPTAeEILkHP 255 (1335)
+||++.++++|+
T Consensus 204 ~R~~~~~l~~~~ 215 (215)
T cd00180 204 KRPSAKEILEHL 215 (215)
T ss_pred cCcCHHHHhhCC
Confidence 999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=304.01 Aligned_cols=250 Identities=22% Similarity=0.335 Sum_probs=210.8
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
+..+.++||+|-||.|.+|.-.. +..||+|..... .+.++.+|+++|.+++||||++++++|..++.+++|+||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred heehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 35678999999999999998766 688999998654 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 79 VGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 79 eGGSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+.|+|.+++..+. .........++.||++|++||.+.++|||||.+.|+|++.++++||+|||+++.+-..... .
T Consensus 618 EnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy---~ 694 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY---R 694 (807)
T ss_pred hcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce---e
Confidence 9999999998873 3456667789999999999999999999999999999999999999999999976443322 1
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhcCC-------CCCCCCCCC
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA--GRPPFVGREFTQLVKSILSDP-------SPPLPGNPS 227 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT--GrpPF~g~d~~eLikkIl~~~-------~~pip~~iS 227 (1335)
.....+-...|||||.+.. +.++.++|+|+||+++||+++ ...||.....++..+....-. ....|..++
T Consensus 695 vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp 773 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP 773 (807)
T ss_pred eecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence 2234556788999999875 456889999999999999765 889999988887776653221 234577889
Q ss_pred hhHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 228 RPFANLINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 228 ~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
..+.+++.+||..|-++||+++++ |-+|++
T Consensus 774 ~~lyelml~Cw~~es~~RPsFe~l--h~~lq~ 803 (807)
T KOG1094|consen 774 QGLYELMLRCWRRESEQRPSFEQL--HLFLQE 803 (807)
T ss_pred HHHHHHHHHHhchhhhcCCCHHHH--HHHHHH
Confidence 999999999999999999999999 555543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=304.53 Aligned_cols=249 Identities=30% Similarity=0.512 Sum_probs=207.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhH--HHHHHHHHHHHhCC------CCCcceEEEEEEeCCEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK--SKVLQEVRMLHSLD------HPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~--e~LlrEIqILkkL~------HPNIVrL~dvfeds~~lyL 73 (1335)
++|.+....|+|-||+|..|.+..-|+.||||+|..... +.-.+|+++|++|+ .-|+++++..|...+++|+
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 479999999999999999999999999999999976543 34578999999994 3589999999999999999
Q ss_pred EEeecCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCC-CCeeeccccccccccCC
Q 000715 74 VLEYCVGGDLMSLLRQDN---QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN-GRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~---~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDed-G~VKLiDFGLAr~l~e~ 149 (1335)
|+|.. ..+|.+++++.+ .|....++.|.+|++.||..|-..||+|.||||.|||+++. ..+||||||.|....+.
T Consensus 512 VFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en 590 (752)
T KOG0670|consen 512 VFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN 590 (752)
T ss_pred Eehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccc
Confidence 99976 789999998855 58899999999999999999999999999999999999876 46899999999877655
Q ss_pred CCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCCCC------
Q 000715 150 SKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS--DPSPP------ 221 (1335)
Q Consensus 150 ~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~--~~~~p------ 221 (1335)
... .+.-+..|.|||++.+ -.|+...|+||+||+||||.+|+..|.+....+++.-.+. +..+.
T Consensus 591 eit-------PYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 591 EIT-------PYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred ccc-------HHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 432 2345678999999984 5678899999999999999999999999876665543221 10000
Q ss_pred ---------------------------------CC-----------CCC-------ChhHHHHHHHhcccCCCCCCCHHH
Q 000715 222 ---------------------------------LP-----------GNP-------SRPFANLINSLLVKDPAQRLHWSD 250 (1335)
Q Consensus 222 ---------------------------------ip-----------~~i-------S~eL~DLIkkcLqkDPsKRPTAeE 250 (1335)
-| +.. -..+.+|+.+||..||.+|.|..+
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 00 001 135889999999999999999999
Q ss_pred HhcCccccc
Q 000715 251 LCGHAFWRT 259 (1335)
Q Consensus 251 ILkHPfFq~ 259 (1335)
+|.||||+.
T Consensus 743 AL~HpFi~~ 751 (752)
T KOG0670|consen 743 ALKHPFITE 751 (752)
T ss_pred HhcCCcccC
Confidence 999999975
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=289.08 Aligned_cols=248 Identities=31% Similarity=0.519 Sum_probs=202.7
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHS-LDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkk-L~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
+..||.|+||+|++-.++.+|+..|||.+... +..++..|.....+ -+.||||++|++.-..+..|+-||.+ .-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 45799999999999999999999999998543 23457778776554 48999999999999999999999987 45
Q ss_pred CHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 82 DLMSLLR-----QDNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 82 SL~dlIk-----q~~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
++..+-+ ++..++|.-+-.+..-.+.||.||.+ .+|+|||+||+|||++..|.+||||||.+..+.+...
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA---- 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA---- 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH----
Confidence 6655432 45689999999999999999999985 5899999999999999999999999999877654322
Q ss_pred CCCCCccCCCCCCCcchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhcCCCCCC--C---CCCCh
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGV-HSYASDLWGLGCVLYECYAGRPPFVGRE-FTQLVKSILSDPSPPL--P---GNPSR 228 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~-yS~kSDIWSLGVILYELLTGrpPF~g~d-~~eLikkIl~~~~~pi--p---~~iS~ 228 (1335)
.+...|-..|||||.+..... |+.++|+||||++|||+.||+.||.+.+ ..+++.++..+..+.+ + -..+.
T Consensus 224 --kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~ 301 (361)
T KOG1006|consen 224 --KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF 301 (361)
T ss_pred --hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence 223458888999999975443 7889999999999999999999997653 3344555555443332 2 23688
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 229 PFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 229 eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
++..+|..||.+|-+.||...+++++||++...
T Consensus 302 ~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 302 SMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred HHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 999999999999999999999999999987654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=292.54 Aligned_cols=250 Identities=26% Similarity=0.457 Sum_probs=209.2
Q ss_pred EEEEEeccCcEEEEEEEECCCCeEEEEEEcCc-----hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EEEEEE
Q 000715 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK-----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSA-----HLWLVL 75 (1335)
Q Consensus 6 LlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK-----e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~-----~lyLVM 75 (1335)
-.+.||-|+||.||.+++..+|+.||.|.+.. ...+++.+|++++...+|.|++..+++.+... .+|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 35679999999999999999999999998753 24567899999999999999999998876553 578889
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|.+ ..+|...|..-+.++.+.++-+++||++||+|||+.||.||||||.|++++.|..+||||||+++........
T Consensus 137 ELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~--- 212 (449)
T KOG0664|consen 137 ELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL--- 212 (449)
T ss_pred HHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh---
Confidence 986 6789999988899999999999999999999999999999999999999999999999999999976543221
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-----------------
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP----------------- 218 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~----------------- 218 (1335)
..+..+-|.+|+|||++.+...|+.++||||.|||+.|++..+..|...+..+..+-|....
T Consensus 213 -hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~ 291 (449)
T KOG0664|consen 213 -NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN 291 (449)
T ss_pred -hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence 12335678899999999998999999999999999999999999999887666555443211
Q ss_pred -------CCC---------CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 219 -------SPP---------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 219 -------~~p---------ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
..+ .+..-..+..+++.+++..||++|++.++++.|+|..+.
T Consensus 292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 111 112234567889999999999999999999999987543
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=301.23 Aligned_cols=245 Identities=26% Similarity=0.459 Sum_probs=209.7
Q ss_pred EEEEEEEeccCcEEEEEEEECC-------CCeEEEEEEcCc----hhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKK-------TIEYFAIKSVDK----SQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~-------TGk~VAIKiIdK----e~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~l 71 (1335)
..+.+.||+|+||.|++|.-.. ....||+|.... .+.+.+..|+++|+.+ .||||+.+.+++...+.+
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 3566799999999999997431 145799998743 4567889999999998 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCe
Q 000715 72 WLVLEYCVGGDLMSLLRQDN----------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRT 135 (1335)
Q Consensus 72 yLVMEY~eGGSL~dlIkq~~----------------~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~V 135 (1335)
++|+||+..|+|.+++++.+ .++..+...+.+||+.|++||++++++|||+-..|||++++..+
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~ 457 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVI 457 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEE
Confidence 99999999999999998765 48999999999999999999999999999999999999999999
Q ss_pred eeccccccccccCCCCCCCCCCCCCccC--CCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC-HHHHH
Q 000715 136 KLCDFGLARKLSDASKAPSSMLPQAKCG--TPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGRE-FTQLV 211 (1335)
Q Consensus 136 KLiDFGLAr~l~e~~~~~ss~l~~t~~G--Tp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d-~~eLi 211 (1335)
||+|||+++.......... ....| ...|||||.+.. ..|+.++||||+|+++||+++ |..||.+-. ..+++
T Consensus 458 kIaDFGlar~~~~~~~y~~----~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 458 KIADFGLARDHYNKDYYRT----KSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred EEccccceeccCCCCceEe----cCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 9999999986544322110 00112 334999999975 778999999999999999999 999998855 66777
Q ss_pred HHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 212 KSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 212 kkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
+.+..+.+...|..+++++.++++.||+.+|++||++.++.+
T Consensus 533 ~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 778888888899999999999999999999999999998854
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=250.57 Aligned_cols=213 Identities=42% Similarity=0.707 Sum_probs=184.5
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecC
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
|.+.+.||.|++|.||++.+..+++.+++|.+... ....+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 67889999999999999999999999999999765 45678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 80 GGSL~dlIkq~~~-LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~ 158 (1335)
+++|.+++..... +++..+..++.|++.++.|||++|++|+||+|.||+++.++.++|+|||.+......... ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~----~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA----LL 156 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc----cc
Confidence 9999999988766 899999999999999999999999999999999999999999999999998877544210 11
Q ss_pred CCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHH-HHHHHHhcCCCC
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVG-REFT-QLVKSILSDPSP 220 (1335)
Q Consensus 159 ~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g-~d~~-eLikkIl~~~~~ 220 (1335)
....++..|++||.+.....++.++|+|++|+++|+|++|+.||.+ .+.. .+.+.+..+...
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence 2356888999999984445567799999999999999999999988 4444 566666655433
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=300.96 Aligned_cols=195 Identities=27% Similarity=0.462 Sum_probs=178.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhH-----------HHHHHHHHHHHhCC---CCCcceEEEEEEe
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK-----------SKVLQEVRMLHSLD---HPNVLRFYSWYET 67 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~-----------e~LlrEIqILkkL~---HPNIVrL~dvfed 67 (1335)
.+|..++.+|.|+||.|+.|.++.+...|++|.|.|+.. ..+-.|++||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 469999999999999999999999999999999987642 23557999999996 9999999999999
Q ss_pred CCEEEEEEeec-CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccc
Q 000715 68 SAHLWLVLEYC-VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKL 146 (1335)
Q Consensus 68 s~~lyLVMEY~-eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l 146 (1335)
++++|++||-- +|-+|+++|..+..++|.+++.+++|+..|+++||+.||+|||||-+||.++.+|-+||+|||.+...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 99999999974 45699999999999999999999999999999999999999999999999999999999999998766
Q ss_pred cCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 000715 147 SDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFV 203 (1335)
Q Consensus 147 ~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~ 203 (1335)
+.++ -..++||..|.|||++.+..|.+...|||++|+++|.++....||.
T Consensus 721 ksgp-------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 721 KSGP-------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cCCC-------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 5433 2568899999999999988899999999999999999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=308.52 Aligned_cols=245 Identities=29% Similarity=0.477 Sum_probs=196.5
Q ss_pred EEEeccCcE-EEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCCCCHHH
Q 000715 8 EAIGRGKYS-TVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMS 85 (1335)
Q Consensus 8 K~LGeGgFG-tVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVMEY~eGGSL~d 85 (1335)
+.+|.|+-| .||+|...+ +.||||.+-.+..+...+|++.++.- +|||||++|..-.+.+..|+..|.| ..+|.+
T Consensus 515 eilG~Gs~Gt~Vf~G~ye~--R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~d 591 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYEG--REVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQD 591 (903)
T ss_pred HHcccCCCCcEEEEEeeCC--ceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHH
Confidence 468999988 678998755 79999999998888899999999988 7999999999999999999999999 689999
Q ss_pred HHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC---CC--CeeeccccccccccCCCCCCCCC
Q 000715 86 LLRQDN----QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE---NG--RTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 86 lIkq~~----~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe---dG--~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
+++... .......+..+.|++.||++||+.+||||||||.||||+. +| .++|+|||++..+..+......
T Consensus 592 lie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r- 670 (903)
T KOG1027|consen 592 LIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSR- 670 (903)
T ss_pred HHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhc-
Confidence 998741 1222456889999999999999999999999999999975 34 6799999999988665443222
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCC--CCCCCCChhHHHH
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSP--PLPGNPSRPFANL 233 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~--pip~~iS~eL~DL 233 (1335)
.....||-+|+|||++..... ..++||||+||++|..++ |..||.+.-..+. .|+.+... .+......++.||
T Consensus 671 -~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d~eA~dL 746 (903)
T KOG1027|consen 671 -LSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPDCEAKDL 746 (903)
T ss_pred -ccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCchHHHHHH
Confidence 234569999999999975443 569999999999998888 5899977543321 22222111 1111112289999
Q ss_pred HHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 234 INSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 234 IkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
|.+|+.+||..||++.+++.||||.+.
T Consensus 747 I~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 747 ISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred HHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 999999999999999999999999764
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=281.55 Aligned_cols=127 Identities=31% Similarity=0.645 Sum_probs=113.2
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh--HHHHHHHHHHHHhCC-----C---CCcceEEEEEEeC---
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSLD-----H---PNVLRFYSWYETS--- 68 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~--~e~LlrEIqILkkL~-----H---PNIVrL~dvfeds--- 68 (1335)
++|.+.++||.|.|++||+|.+..+.+.||+|++...+ .+....||++|+++. | .+||++++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 58999999999999999999999999999999996553 566789999999982 3 3699999999654
Q ss_pred -CEEEEEEeecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeEE
Q 000715 69 -AHLWLVLEYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLKPSNILL 129 (1335)
Q Consensus 69 -~~lyLVMEY~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHsk-GIVHRDIKPENILI 129 (1335)
.+++||+|+. |..|..+|+.. +.++...+++|++|++.||.|||++ ||||-||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 6899999987 88999998764 5799999999999999999999975 99999999999998
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=276.90 Aligned_cols=246 Identities=29% Similarity=0.497 Sum_probs=195.9
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHh--CCCCCcceEEEEEEeC----CEEEEEEe
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHS--LDHPNVLRFYSWYETS----AHLWLVLE 76 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkk--L~HPNIVrL~dvfeds----~~lyLVME 76 (1335)
+..+.+.||+|.||.||+|.+++ +.||||++...+.....+|.+|.+. |+|+||+.++.....+ .++|+|++
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrG--e~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd 289 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRG--EDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD 289 (513)
T ss_pred eeEEEEEecCccccceeeccccC--CceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence 56789999999999999999986 7799999988777777777776654 6999999999876444 46999999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CCcccCCCCCCeEECCCCCeeeccccccccccC
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK--------GIIYCDLKPSNILLDENGRTKLCDFGLARKLSD 148 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHsk--------GIVHRDIKPENILIDedG~VKLiDFGLAr~l~e 148 (1335)
|.+.|+|+|++.+ ..++.+...+++.-+++||.+||-. .|.|||||..||||.++|.+-|+|+|+|.....
T Consensus 290 YHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~ 368 (513)
T KOG2052|consen 290 YHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 368 (513)
T ss_pred cccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecc
Confidence 9999999999988 6899999999999999999999953 499999999999999999999999999988765
Q ss_pred CCCCCCCCCCCCccCCCCCCCcchhccCCC----CC-chhhHHHHHHHHHHHHhC----------CCCCCC-----CCHH
Q 000715 149 ASKAPSSMLPQAKCGTPCYMAPELFEEGGV----HS-YASDLWGLGCVLYECYAG----------RPPFVG-----REFT 208 (1335)
Q Consensus 149 ~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~----yS-~kSDIWSLGVILYELLTG----------rpPF~g-----~d~~ 208 (1335)
... .-...++..+||..|||||++...-. .+ ..+||||||.++||+... ++||.+ ...+
T Consensus 369 ~t~-~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 369 DTD-TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred cCC-cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 542 23334567899999999999853211 11 258999999999999763 478865 2344
Q ss_pred HHHHHHh-cCCCCCCCCCCC-----hhHHHHHHHhcccCCCCCCCHHHHh
Q 000715 209 QLVKSIL-SDPSPPLPGNPS-----RPFANLINSLLVKDPAQRLHWSDLC 252 (1335)
Q Consensus 209 eLikkIl-~~~~~pip~~iS-----~eL~DLIkkcLqkDPsKRPTAeEIL 252 (1335)
++.+-+. +..++.+|..+. ..+..+++.||..+|.-|.|+-.+.
T Consensus 448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 4444332 333455554442 2366789999999999999986664
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=280.68 Aligned_cols=242 Identities=25% Similarity=0.426 Sum_probs=193.5
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC----EEEEEEee
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHS--LDHPNVLRFYSWYETSA----HLWLVLEY 77 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkk--L~HPNIVrL~dvfeds~----~lyLVMEY 77 (1335)
.++.+.||+|.||.||+|.... +.||||++..++++.+..|-+|... ++|+||++++.+-+... .+++|+||
T Consensus 212 l~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLDN--RLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hhhHHHhhcCccceeehhhccC--ceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 4567889999999999998766 8999999999999999888888765 59999999999877665 89999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CCcccCCCCCCeEECCCCCeeeccccccccccC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK---------GIIYCDLKPSNILLDENGRTKLCDFGLARKLSD 148 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHsk---------GIVHRDIKPENILIDedG~VKLiDFGLAr~l~e 148 (1335)
.+.|+|.++++.+ .++.....+++.-+++||+|||+. .|+|||||..||||.+|++..|+|||+|..+..
T Consensus 290 h~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p 368 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP 368 (534)
T ss_pred ccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence 9999999999764 689999999999999999999963 599999999999999999999999999998875
Q ss_pred CCCCCCCCCCCCccCCCCCCCcchhccCCCCC-----chhhHHHHHHHHHHHHhCC------------CCCCC-----CC
Q 000715 149 ASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS-----YASDLWGLGCVLYECYAGR------------PPFVG-----RE 206 (1335)
Q Consensus 149 ~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS-----~kSDIWSLGVILYELLTGr------------pPF~g-----~d 206 (1335)
...... ....+||..|||||++.+.-... .+.||||+|.++|||++.. +||+. ..
T Consensus 369 ~~~~~d---~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 369 GKPQGD---THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred CCCCcc---hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 433221 12368999999999997533333 3689999999999999853 33431 12
Q ss_pred HHHHHHHHhc-CCCCCCCCCC-----ChhHHHHHHHhcccCCCCCCCHHHH
Q 000715 207 FTQLVKSILS-DPSPPLPGNP-----SRPFANLINSLLVKDPAQRLHWSDL 251 (1335)
Q Consensus 207 ~~eLikkIl~-~~~~pip~~i-----S~eL~DLIkkcLqkDPsKRPTAeEI 251 (1335)
.+++...+.. ..++.++..+ -..+.+.++.||..||+.|.|+.=+
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 3333333332 3344444332 3458899999999999999997433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=279.84 Aligned_cols=256 Identities=28% Similarity=0.476 Sum_probs=203.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC---CCeEEEEEEcCc-hhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEe
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK---TIEYFAIKSVDK-SQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~---TGk~VAIKiIdK-e~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVME 76 (1335)
+.|...++||+|.|++||+|.+.. ..+.||+|.+.. +...++..|+++|..+ .+.||+++.+++...+++.+|||
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 468899999999999999999887 788999998865 4567899999999998 78999999999999999999999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC-CCCeeeccccccccccCCC-----
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE-NGRTKLCDFGLARKLSDAS----- 150 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe-dG~VKLiDFGLAr~l~e~~----- 150 (1335)
|++..+..++... ++-.+++.|++.++.||.++|.+|||||||||.|++++. .+.-.|+|||+|.......
T Consensus 116 ~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s 192 (418)
T KOG1167|consen 116 YFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS 192 (418)
T ss_pred ccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence 9999988888754 678999999999999999999999999999999999984 5788999999998321100
Q ss_pred -------CCC-----------------CC----------CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHH
Q 000715 151 -------KAP-----------------SS----------MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECY 196 (1335)
Q Consensus 151 -------~~~-----------------ss----------~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELL 196 (1335)
..+ .. ...-...||++|+|||++..-+..+.++||||.|+|+..++
T Consensus 193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsll 272 (418)
T KOG1167|consen 193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLL 272 (418)
T ss_pred hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhh
Confidence 000 00 00012359999999999987777788999999999999999
Q ss_pred hCCCCCCCCCH-H----H---------HHHHH-hcCC------------------------------CC------CCCCC
Q 000715 197 AGRPPFVGREF-T----Q---------LVKSI-LSDP------------------------------SP------PLPGN 225 (1335)
Q Consensus 197 TGrpPF~g~d~-~----e---------LikkI-l~~~------------------------------~~------pip~~ 225 (1335)
+++.||..... . + +.+.. ..+. .. .....
T Consensus 273 s~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~ 352 (418)
T KOG1167|consen 273 SRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDV 352 (418)
T ss_pred ccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccccc
Confidence 99999854311 0 0 00000 0000 00 00112
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 226 PSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 226 iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
.+..+.+|+.+||..||.+|+|++++|+||||...
T Consensus 353 ~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 353 FPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 24578999999999999999999999999999853
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=280.98 Aligned_cols=244 Identities=24% Similarity=0.340 Sum_probs=210.4
Q ss_pred EEEEEEeccCcEEEEEEEECCCCe----EEEEEEcCch----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 5 HIYEAIGRGKYSTVYKGRKKKTIE----YFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 5 eLlK~LGeGgFGtVYkArdk~TGk----~VAIKiIdKe----~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
+..++||.|+||+||+|.+.-.|+ +||||++... ....+..|+-+|.+++|||++++++++..+. +-+|++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 456789999999999998865454 5788877432 3557899999999999999999999998777 788999
Q ss_pred ecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
|+++|+|.|+++.+ .++-......|..||++|++|||+++++||||-..|||+....++|+.|||+++.+.........
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~ 857 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSA 857 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccc
Confidence 99999999999875 57999999999999999999999999999999999999999999999999999988665443221
Q ss_pred CCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHH
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLI 234 (1335)
....-.+-|||=|.+. ...|+.++||||+||++||++| |..|+++....++.+.+..+.+.+.|+.++.++.-++
T Consensus 858 ---~~gK~pikwmale~i~-~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 858 ---PGGKVPIKWMALESIR-IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ---cccccCcHHHHHHHhh-ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 1111245588888886 4667999999999999999998 9999999999998888888888888999999999999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 000715 235 NSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 235 kkcLqkDPsKRPTAeEILk 253 (1335)
-+||..|+..||+++++..
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999988753
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=251.54 Aligned_cols=212 Identities=32% Similarity=0.567 Sum_probs=177.8
Q ss_pred EEEEEeccCcEEEEEEEECCCCeEEEEEEcCc----hhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK----SQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 6 LlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK----e~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
-+..||+|+||.|-+.++..+|...|+|.+.. +..+++.+|+.+..+. .+|.+|.+|+.+.+...+|+.||.+ .
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~ 128 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-D 128 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-h
Confidence 35679999999999999999999999998743 3445677888876654 8999999999999999999999987 5
Q ss_pred CCHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 81 GDLMSL----LRQDNQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 81 GSL~dl----Ikq~~~LSEeqIr~I~rQILsGLkYLHsk-GIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
.+|..+ +++++.++|..+-+++.-++.|+.|||++ .++|||+||+||||+.+|++|+||||.+..+.+.-..
T Consensus 129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk--- 205 (282)
T KOG0984|consen 129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK--- 205 (282)
T ss_pred hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH---
Confidence 677654 45678999999999999999999999987 8999999999999999999999999998776543221
Q ss_pred CCCCCccCCCCCCCcchhcc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhcCCCCCCCC
Q 000715 156 MLPQAKCGTPCYMAPELFEE---GGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVKSILSDPSPPLPG 224 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~---~~~yS~kSDIWSLGVILYELLTGrpPF~g~-d~~eLikkIl~~~~~pip~ 224 (1335)
....|-..|||||.+.. ...|+-++||||||++++||.+++.||+.. ..-++++++...+.+.+|.
T Consensus 206 ---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 206 ---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred ---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 22347788999999852 346788999999999999999999999764 5667888888877666553
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=296.87 Aligned_cols=205 Identities=21% Similarity=0.219 Sum_probs=148.4
Q ss_pred hCCC-CCcceEEEEE-------EeCCEEEEEEeecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 000715 52 SLDH-PNVLRFYSWY-------ETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122 (1335)
Q Consensus 52 kL~H-PNIVrL~dvf-------eds~~lyLVMEY~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDI 122 (1335)
.++| +||++++++| .....++.+|||+ +++|.+++.. ...+++.+++.+++||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3445 5788888877 2334678889976 7799999976 456999999999999999999999999999999
Q ss_pred CCCCeEECCC-------------------CCeeeccccccccccCCCC-----------CCCCCCCCCccCCCCCCCcch
Q 000715 123 KPSNILLDEN-------------------GRTKLCDFGLARKLSDASK-----------APSSMLPQAKCGTPCYMAPEL 172 (1335)
Q Consensus 123 KPENILIDed-------------------G~VKLiDFGLAr~l~e~~~-----------~~ss~l~~t~~GTp~YmAPEV 172 (1335)
||+|||++.. +.+|++|||+++....... .+........+||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999654 4556666666553211000 000000112468999999999
Q ss_pred hccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 000715 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLC 252 (1335)
Q Consensus 173 L~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEIL 252 (1335)
+.. ..++.++|||||||++|||++|.+||..... ....+.....++......+...+++.+||.+||.+||++.+++
T Consensus 187 ~~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNG-SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hcc-CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 864 4568999999999999999999998764321 1222211111111112345677999999999999999999999
Q ss_pred cCcccccc
Q 000715 253 GHAFWRTK 260 (1335)
Q Consensus 253 kHPfFq~~ 260 (1335)
+||||.+.
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-25 Score=225.77 Aligned_cols=253 Identities=40% Similarity=0.705 Sum_probs=207.4
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEe
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHP-NVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HP-NIVrL~dvfeds~~lyLVME 76 (1335)
|.+.+.||.|+||.||++.+. +.+++|.+... ....+.+|+.++..+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999998 67899988543 245688999999999988 79999999988888999999
Q ss_pred ecCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC-CeeeccccccccccCCCCC
Q 000715 77 YCVGGDLMSLLRQDN---QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG-RTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~---~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG-~VKLiDFGLAr~l~e~~~~ 152 (1335)
|+.++++.+++.... .+++.....++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998887765 799999999999999999999999999999999999999988 7999999999865443322
Q ss_pred CCC-CCCCCccCCCCCCCcchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhcCCCC--C--
Q 000715 153 PSS-MLPQAKCGTPCYMAPELFEEG--GVHSYASDLWGLGCVLYECYAGRPPFVGREF----TQLVKSILSDPSP--P-- 221 (1335)
Q Consensus 153 ~ss-~l~~t~~GTp~YmAPEVL~~~--~~yS~kSDIWSLGVILYELLTGrpPF~g~d~----~eLikkIl~~~~~--p-- 221 (1335)
... ......+|+..|+|||.+... ..+....|+||+|+++++++.|..||..... ......+...... .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 111 123557899999999999753 5778899999999999999999999887763 4444444433322 1
Q ss_pred CCCCC----ChhHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 222 LPGNP----SRPFANLINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 222 ip~~i----S~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
..... ...+.+++.+++..+|..|.+..+...++|...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 11111 157899999999999999999999988866543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-25 Score=223.81 Aligned_cols=159 Identities=24% Similarity=0.309 Sum_probs=128.4
Q ss_pred CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCC
Q 000715 81 GDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQ 159 (1335)
Q Consensus 81 GSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~ 159 (1335)
|+|.+++.. +..+++.+++.++.|++.||.|||+++ ||+||+++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 689999987 456999999999999999999999998 999999999999999 9998765432
Q ss_pred CccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCCCC------CCCCCCh--hH
Q 000715 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF-TQLVKSILSDPSPP------LPGNPSR--PF 230 (1335)
Q Consensus 160 t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~-~eLikkIl~~~~~p------ip~~iS~--eL 230 (1335)
...||+.|||||++.+ ..++.++||||+||++|+|++|+.||..... ...+..+....... .+...+. .+
T Consensus 63 ~~~g~~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 141 (176)
T smart00750 63 QSRVDPYFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSF 141 (176)
T ss_pred cCCCcccccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhH
Confidence 1258999999999964 5578899999999999999999999976543 23333332221111 1122333 69
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcCcccc
Q 000715 231 ANLINSLLVKDPAQRLHWSDLCGHAFWR 258 (1335)
Q Consensus 231 ~DLIkkcLqkDPsKRPTAeEILkHPfFq 258 (1335)
.++|.+||..||.+||++.++++|+|+.
T Consensus 142 ~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 142 ADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 9999999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-26 Score=246.92 Aligned_cols=247 Identities=24% Similarity=0.392 Sum_probs=194.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh--HHHHHHHHHHHHhC-CCCCcceEEEE-EEeCCEEEEEEee
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSL-DHPNVLRFYSW-YETSAHLWLVLEY 77 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~--~e~LlrEIqILkkL-~HPNIVrL~dv-feds~~lyLVMEY 77 (1335)
+.|.+.+.||+|.||++.+|+++.+...+++|.+.+.. ..++.+|...--.| .|.||+.-|++ |++.+.+++++||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 56899999999999999999999999999999998764 56788998866555 68899998874 7888999999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEEC--CCCCeeeccccccccccCCCCCCCC
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLD--ENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILID--edG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
++-|+|..-+.. ..+.|...+.++.|+++|+.|+|++++||||||.+||||- +..++||||||..+..+..-.
T Consensus 104 aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~---- 178 (378)
T KOG1345|consen 104 APRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK---- 178 (378)
T ss_pred CccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceeh----
Confidence 999999987754 4688999999999999999999999999999999999993 335899999999875543211
Q ss_pred CCCCCccCCCCCCCcchhcc----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCCCC---CCC
Q 000715 156 MLPQAKCGTPCYMAPELFEE----GGVHSYASDLWGLGCVLYECYAGRPPFVGRE----FTQLVKSILSDPSPP---LPG 224 (1335)
Q Consensus 156 ~l~~t~~GTp~YmAPEVL~~----~~~yS~kSDIWSLGVILYELLTGrpPF~g~d----~~eLikkIl~~~~~p---ip~ 224 (1335)
..-.+..|.+||+... .-...+.+|+|.||+++|.+++|++||.... ....+.+......+. ...
T Consensus 179 ----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~ 254 (378)
T KOG1345|consen 179 ----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFN 254 (378)
T ss_pred ----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhc
Confidence 1224567999998642 2234568899999999999999999997542 222233333332223 334
Q ss_pred CCChhHHHHHHHhcccCCCCCC---CHHHHhcCccc
Q 000715 225 NPSRPFANLINSLLVKDPAQRL---HWSDLCGHAFW 257 (1335)
Q Consensus 225 ~iS~eL~DLIkkcLqkDPsKRP---TAeEILkHPfF 257 (1335)
..++.+..+.++-|..+|++|- ++.+.....|-
T Consensus 255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 255 PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 5688999999999999999994 44555555554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=241.70 Aligned_cols=246 Identities=22% Similarity=0.312 Sum_probs=206.8
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCC-----eEEEEEEcCc----hhHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTI-----EYFAIKSVDK----SQKSKVLQEVRMLHSLDHPNVLRFYSWYE-TSAHLW 72 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TG-----k~VAIKiIdK----e~~e~LlrEIqILkkL~HPNIVrL~dvfe-ds~~ly 72 (1335)
|+++.-.+-+|.||.||.|.+++.. +.|.+|.+.. -+...+.+|--.+..+.|||+..+.++.. +....+
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~ 364 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF 364 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence 5666778899999999999776532 3345555432 24556788999999999999999999864 446678
Q ss_pred EEEeecCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccc
Q 000715 73 LVLEYCVGGDLMSLLRQ--------DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 73 LVMEY~eGGSL~dlIkq--------~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr 144 (1335)
+++.+..-|+|..++.. .+.++..++..++.|+..|+.|||++|++|.||-..|.+||+.-++||+|=.+++
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhcc
Confidence 88999888999999873 2347888899999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCC
Q 000715 145 KLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLP 223 (1335)
Q Consensus 145 ~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip 223 (1335)
.+.+.... ...+.......||+||.+. +..|+.++|+||||++||||++ |+.||.+-+..+....+.++.+...|
T Consensus 445 DLFP~DYh---cLGDnEnRPvkWMslEal~-n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP 520 (563)
T KOG1024|consen 445 DLFPGDYH---CLGDNENRPVKWMSLEALQ-NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQP 520 (563)
T ss_pred ccCccccc---ccCCCCCCcccccCHHHHh-hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCC
Confidence 87554321 1222334567799999997 4567889999999999999999 99999999999999999999988899
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 000715 224 GNPSRPFANLINSLLVKDPAQRLHWSDLC 252 (1335)
Q Consensus 224 ~~iS~eL~DLIkkcLqkDPsKRPTAeEIL 252 (1335)
-++++++..++..||..+|++||+.+|+.
T Consensus 521 ~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 99999999999999999999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-25 Score=269.86 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=204.3
Q ss_pred EEEEEeccCcEEEEEEEECCCCeEEEEEEcC----ch-h----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD----KS-Q----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 6 LlK~LGeGgFGtVYkArdk~TGk~VAIKiId----Ke-~----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
....+|.|++|.|+.+......+.++.|.+. .. . ...+..|+-+-..+.|||++.....+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999999988887766666665442 11 1 1125667778888999999887776666666666699
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCC
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~ 156 (1335)
||++ +|+.++...+.++..++..++.|++.|++|+|+.||.|||+||+|++++.+|.+||+|||.+..+..+..... .
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~-~ 479 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI-H 479 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh-h
Confidence 9999 9999999988999999999999999999999999999999999999999999999999999988765544321 2
Q ss_pred CCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHhc-------CCCCCCCCCCCh
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLV-KSILS-------DPSPPLPGNPSR 228 (1335)
Q Consensus 157 l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLi-kkIl~-------~~~~pip~~iS~ 228 (1335)
.....+|+..|+|||++....+.....||||.|++++.|.+|+.||......+.. ..... .....+...++.
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~ 559 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR 559 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence 2355789999999999988888888999999999999999999999775443221 11111 111123345678
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 229 PFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 229 eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
+.+.+|.+||+.||.+|.|+++|++.+||+...
T Consensus 560 ~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 560 ETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 899999999999999999999999999998754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-22 Score=225.78 Aligned_cols=250 Identities=23% Similarity=0.303 Sum_probs=196.0
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCC-eEEEEEEcCchh---HHHHHHHHHHHHhCCC----CCcceEEEEE-EeCCEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTI-EYFAIKSVDKSQ---KSKVLQEVRMLHSLDH----PNVLRFYSWY-ETSAHLWL 73 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TG-k~VAIKiIdKe~---~e~LlrEIqILkkL~H----PNIVrL~dvf-eds~~lyL 73 (1335)
+|.+.+.||+|+||.||.+.+..++ +.+|+|...... ...+..|..++..+.. +++..+++.. .....-|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999998875 679999876542 2267789999988863 6899999999 57788899
Q ss_pred EEeecCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCC-----CCeeeccccccccc
Q 000715 74 VLEYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN-----GRTKLCDFGLARKL 146 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDed-----G~VKLiDFGLAr~l 146 (1335)
||+.+ |.+|.++.... +.++..++..++.|++.+|++||+.|++||||||+|+++... ..+.|.|||+++.+
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~ 177 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF 177 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence 99986 99999988654 589999999999999999999999999999999999999865 35899999999943
Q ss_pred c--CCCCC--CCCCC-CCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCC
Q 000715 147 S--DASKA--PSSML-PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT---QLVKSILSDP 218 (1335)
Q Consensus 147 ~--e~~~~--~ss~l-~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~---eLikkIl~~~ 218 (1335)
. ..... ..... ...+.||..|.++.+.. +...+.+.|+||++.++.+++.|..||.+.... ..+.+.....
T Consensus 178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~-~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~ 256 (322)
T KOG1164|consen 178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHL-GIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL 256 (322)
T ss_pred cccCCCCcccccCCCCccCCCCccccccHHHhC-CCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence 2 22211 11111 23456999999999875 456688999999999999999999999775532 2222222222
Q ss_pred CCC-CCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 219 SPP-LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 219 ~~p-ip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
... .....+.++.++...+-..+...+|....+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 257 LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 211 334456788888888888999999998777544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=237.31 Aligned_cols=163 Identities=21% Similarity=0.188 Sum_probs=129.7
Q ss_pred CCcEEEEEEEeccCcEEEEEEEECC-CCeEEEEEEcCch--------hHHHHHHHHHHHHhCCCCCcce-EEEEEEeCCE
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKK-TIEYFAIKSVDKS--------QKSKVLQEVRMLHSLDHPNVLR-FYSWYETSAH 70 (1335)
Q Consensus 1 mnrYeLlK~LGeGgFGtVYkArdk~-TGk~VAIKiIdKe--------~~e~LlrEIqILkkL~HPNIVr-L~dvfeds~~ 70 (1335)
+++|.+.+.||+|+||+||+|+++. +++.||+|.+... ....+.+|++++++++|+|++. ++++ +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 4689999999999999999999886 7888899986422 2445889999999999999985 4432 45
Q ss_pred EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC-CCCCeEECCCCCeeeccccccccccCC
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL-KPSNILLDENGRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 71 lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDI-KPENILIDedG~VKLiDFGLAr~l~e~ 149 (1335)
.|+||||++|++|.. +.. .. ...++.|++.+|.|||++||+|||| ||+|||++.+|.+||+|||+++.+...
T Consensus 93 ~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 93 DGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred cEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 799999999999973 211 11 2578999999999999999999999 999999999999999999999987554
Q ss_pred CCCCCC---CCCCCccCCCCCCCcchhc
Q 000715 150 SKAPSS---MLPQAKCGTPCYMAPELFE 174 (1335)
Q Consensus 150 ~~~~ss---~l~~t~~GTp~YmAPEVL~ 174 (1335)
...... ..-....+++.|+|||.+.
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCC
Confidence 321110 0012456889999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.9e-23 Score=243.55 Aligned_cols=237 Identities=30% Similarity=0.518 Sum_probs=204.6
Q ss_pred EEeccCcEEEEEEEE---CCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeecC
Q 000715 9 AIGRGKYSTVYKGRK---KKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLD-HPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 9 ~LGeGgFGtVYkArd---k~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~-HPNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
.+|+|+||.|++++. .+.|+.||+|...+.. +.....|-.++...+ ||.+++++..++.++..+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999997653 4567889999875532 123456777888886 9999999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCC
Q 000715 80 GGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQ 159 (1335)
Q Consensus 80 GGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~ 159 (1335)
||+|+....+...+++...+.+...++-++.++|+.|++|||+|++||+++.+|++|+.|||+++..-...
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--------- 151 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--------- 151 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh---------
Confidence 99999999999999999999999999999999999999999999999999999999999999998764432
Q ss_pred CccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcc
Q 000715 160 AKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLV 239 (1335)
Q Consensus 160 t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLq 239 (1335)
..|||..|||||++. ....++|+||+|+++|+|++|..||.. +....|... ....|...+..+.+++..++.
T Consensus 152 ~~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~-~~~~p~~l~~~a~~~~~~l~~ 223 (612)
T KOG0603|consen 152 IACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA-ELEMPRELSAEARSLFRQLFK 223 (612)
T ss_pred hcccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh-ccCCchhhhHHHHHHHHHHHh
Confidence 238999999999986 346789999999999999999999988 556666543 356788899999999999999
Q ss_pred cCCCCCCC-----HHHHhcCccccccCC
Q 000715 240 KDPAQRLH-----WSDLCGHAFWRTKLT 262 (1335)
Q Consensus 240 kDPsKRPT-----AeEILkHPfFq~~l~ 262 (1335)
.+|.+|.- +.++++|+||+....
T Consensus 224 r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 224 RNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred hCHHHHhccCcchhHHHhccchheeeeH
Confidence 99999964 689999999986544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=209.53 Aligned_cols=247 Identities=23% Similarity=0.348 Sum_probs=202.8
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcC-chhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeecCC
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-KSQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiId-Ke~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLVMEY~eG 80 (1335)
+|+++++||+|+||..+.|++.-++++||||.-. +++..++..|.+..+.| ..++|..+|.+.....+-.+|+|+. |
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 6999999999999999999999999999999985 45667888999999988 6799999999999999999999986 9
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC-----CeeeccccccccccCCCCCCC
Q 000715 81 GDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG-----RTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 81 GSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG-----~VKLiDFGLAr~l~e~~~~~s 154 (1335)
.+|.|++.-. .+|+...+.-++.|++.-++|+|++.+|+|||||+|+||...| .+-++|||+|..+.++.....
T Consensus 108 PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqH 187 (449)
T KOG1165|consen 108 PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQH 187 (449)
T ss_pred cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccccc
Confidence 9999999875 5799999999999999999999999999999999999997543 578999999999876544222
Q ss_pred --CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCCC-C---CCCC
Q 000715 155 --SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR---EFTQLVKSILSDPSP-P---LPGN 225 (1335)
Q Consensus 155 --s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~---d~~eLikkIl~~~~~-p---ip~~ 225 (1335)
..-.....||..||+=-...+ ...+...|+=|||.+++..+-|..||.+- +..+-+++|-...+. + +-.+
T Consensus 188 IPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g 266 (449)
T KOG1165|consen 188 IPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEG 266 (449)
T ss_pred CccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhc
Confidence 112244579999999777654 34577899999999999999999999885 455666666443322 1 2356
Q ss_pred CChhHHHHHHHhcccCCCCCCCHHHH
Q 000715 226 PSRPFANLINSLLVKDPAQRLHWSDL 251 (1335)
Q Consensus 226 iS~eL~DLIkkcLqkDPsKRPTAeEI 251 (1335)
.+.++...++-.-..+-.+-|..+-+
T Consensus 267 ~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 267 FPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred CHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 67888888887777777777775433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.9e-21 Score=235.74 Aligned_cols=227 Identities=33% Similarity=0.526 Sum_probs=175.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
++|..+|.|..|+||.||..+|+.+.+.+|+| +++++. +.+- ++..-..|.+| |
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l--ilRn--ilt~a~npfvv---------------------g 136 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL--ILRN--ILTFAGNPFVV---------------------G 136 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch--hhhc--cccccCCccee---------------------c
Confidence 46889999999999999999999999999994 444432 1111 22222333333 5
Q ss_pred CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC----------C
Q 000715 82 DLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS----------K 151 (1335)
Q Consensus 82 SL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~----------~ 151 (1335)
+=...++.-++++.+. +.+++|+|+-||+|||+||+|++|+.=|++|+.|||++....-.. .
T Consensus 137 Dc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k 208 (1205)
T KOG0606|consen 137 DCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEK 208 (1205)
T ss_pred hhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHH
Confidence 5555666656666554 779999999999999999999999999999999999977542111 0
Q ss_pred CCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCChh
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGNPSRP 229 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~~~pi--p~~iS~e 229 (1335)
....+.....||||.|+|||++.. +.|+..+|+|++|+|+|+.+.|..||.++..++++.+.+....... ....+++
T Consensus 209 ~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~E 287 (1205)
T KOG0606|consen 209 DTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPE 287 (1205)
T ss_pred HHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHH
Confidence 111223344699999999999974 4579999999999999999999999999999999988876543222 3456889
Q ss_pred HHHHHHHhcccCCCCCC---CHHHHhcCccccccCCC
Q 000715 230 FANLINSLLVKDPAQRL---HWSDLCGHAFWRTKLTP 263 (1335)
Q Consensus 230 L~DLIkkcLqkDPsKRP---TAeEILkHPfFq~~l~~ 263 (1335)
+++++.++|+.+|..|. .+-++.+|+||+...+.
T Consensus 288 a~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 288 AQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred HHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 99999999999999994 57889999999876554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.1e-21 Score=199.47 Aligned_cols=136 Identities=22% Similarity=0.229 Sum_probs=111.4
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCchhH-----------------------------HHHHHHHHHHHhCCCCC
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK-----------------------------SKVLQEVRMLHSLDHPN 57 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~-----------------------------e~LlrEIqILkkL~HPN 57 (1335)
.+.||+|+||.||+|.+. +|+.||+|++..... ....+|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 899999999854310 12235999999998887
Q ss_pred cceEEEEEEeCCEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCCCeEECCCCCee
Q 000715 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL-HSKGIIYCDLKPSNILLDENGRTK 136 (1335)
Q Consensus 58 IVrL~dvfeds~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYL-HskGIVHRDIKPENILIDedG~VK 136 (1335)
+.....+.... .++||||++|+++...+...+.+++.++..++.|++.+|.|+ |+.||+||||||+||+++ ++.++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 75544333222 389999999988876655567899999999999999999999 799999999999999998 57899
Q ss_pred eccccccccc
Q 000715 137 LCDFGLARKL 146 (1335)
Q Consensus 137 LiDFGLAr~l 146 (1335)
|+|||++...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.8e-22 Score=241.62 Aligned_cols=245 Identities=26% Similarity=0.379 Sum_probs=186.6
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-------HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-------~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
+|...+.||.+.|=+|.+|++.+. . |++|++-+.. ..+-.+|++ ...++|||.+++..+.......|+|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG-~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG-L-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc-e-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 578899999999999999998874 3 8899885432 233345555 56679999999999988888899999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCC
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss 155 (1335)
+|. ..+|+|.+...+-+..-+.+.|+.|++.||..+|+.||+|||||.+||||+.-+.+.|+||..-+..--+.+.+..
T Consensus 101 qyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 997 6799999999888999999999999999999999999999999999999999999999999876543222222222
Q ss_pred C--CCCCccCCCCCCCcchhccC----------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcC---CC
Q 000715 156 M--LPQAKCGTPCYMAPELFEEG----------GVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PS 219 (1335)
Q Consensus 156 ~--l~~t~~GTp~YmAPEVL~~~----------~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~---~~ 219 (1335)
+ .-++...--.|+|||.+... ...+++.||||+||+++||++ |++||.-. +++..--.+ +.
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~aYr~~~~~~~e 256 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLAYRSGNADDPE 256 (1431)
T ss_pred ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHhHhccCccCHH
Confidence 1 11222334569999988532 224678999999999999999 79998421 111110000 00
Q ss_pred CCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 220 PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 220 ~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
.-+.+..+..++++|..|++.||++|.++++.|+.
T Consensus 257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 257 QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00112334578999999999999999999999875
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-20 Score=192.65 Aligned_cols=137 Identities=25% Similarity=0.259 Sum_probs=112.7
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----------------------------HHHHHHHHHHHHhCCCCC
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----------------------------KSKVLQEVRMLHSLDHPN 57 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----------------------------~e~LlrEIqILkkL~HPN 57 (1335)
.+.||+|+||.||+|++. +|+.||+|++.... .....+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999988 89999999985431 112357899999999998
Q ss_pred cceEEEEEEeCCEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCee
Q 000715 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTK 136 (1335)
Q Consensus 58 IVrL~dvfeds~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~VK 136 (1335)
+.....+.... .|+||||++|+++........++++.++..++.|++.++.++|+ +||+||||||+||+++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 86555443332 38999999988665443345678999999999999999999999 9999999999999998 89999
Q ss_pred ecccccccccc
Q 000715 137 LCDFGLARKLS 147 (1335)
Q Consensus 137 LiDFGLAr~l~ 147 (1335)
|+|||++....
T Consensus 158 liDFG~a~~~~ 168 (190)
T cd05145 158 IIDVSQAVELD 168 (190)
T ss_pred EEEcccceecC
Confidence 99999987553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=195.05 Aligned_cols=248 Identities=22% Similarity=0.273 Sum_probs=194.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-hHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeecC
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-QKSKVLQEVRMLHSLDH-PNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-~~e~LlrEIqILkkL~H-PNIVrL~dvfeds~~lyLVMEY~e 79 (1335)
++|++++.||.|+||.+|.|....+|..||||.-+.. .-.++..|.++.+.|++ ..|..+..+..+..+-.+||+..
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL- 93 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL- 93 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-
Confidence 6899999999999999999999999999999997654 34567789999988865 56777777888888889999986
Q ss_pred CCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCC---CCeeeccccccccccCCCCCCC-
Q 000715 80 GGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN---GRTKLCDFGLARKLSDASKAPS- 154 (1335)
Q Consensus 80 GGSL~dlIkq~-~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDed---G~VKLiDFGLAr~l~e~~~~~s- 154 (1335)
|.+|.+++.-. ..|+..++.-.+-|++.-++|+|.++++||||||+|+|+.-+ ..+.|+|||++..+.+......
T Consensus 94 GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HI 173 (341)
T KOG1163|consen 94 GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHI 173 (341)
T ss_pred CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccC
Confidence 99999998754 579999999999999999999999999999999999999643 4689999999998865432211
Q ss_pred -CCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCC----CCCCCCCC
Q 000715 155 -SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE---FTQLVKSILSDP----SPPLPGNP 226 (1335)
Q Consensus 155 -s~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d---~~eLikkIl~~~----~~pip~~i 226 (1335)
........||..|.+=-...+ ...+...|+-|+|.++..+.-|..||.+-. ..+-+++|.... ...+-...
T Consensus 174 pyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~ 252 (341)
T KOG1163|consen 174 PYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGF 252 (341)
T ss_pred ccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCC
Confidence 111233568999987555432 233567899999999999999999999864 334455554322 22234677
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHH
Q 000715 227 SRPFANLINSLLVKDPAQRLHWSDL 251 (1335)
Q Consensus 227 S~eL~DLIkkcLqkDPsKRPTAeEI 251 (1335)
|.++.-.+.-|-..--++-|...-+
T Consensus 253 P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 253 PAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred cHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 8889999998888777777775433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=197.74 Aligned_cols=166 Identities=13% Similarity=0.185 Sum_probs=129.3
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh------HHH------HHHHHHHHHhCCCCCcceEEEEEEeC-
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSK------VLQEVRMLHSLDHPNVLRFYSWYETS- 68 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~------~e~------LlrEIqILkkL~HPNIVrL~dvfeds- 68 (1335)
++|++.+.||.|+||.||++.. ++..+|+|.+.... ... +.+|++.+.++.||+|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 5899999999999999999765 35679999985431 112 57899999999999999999886643
Q ss_pred -------CEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccc
Q 000715 69 -------AHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFG 141 (1335)
Q Consensus 69 -------~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFG 141 (1335)
+..++||||++|.+|.++. .+++ ....+++.++..+|+.|++|||+||+||+++.+| ++|+|||
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence 3578999999999998873 2333 2466999999999999999999999999999998 9999999
Q ss_pred ccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHH
Q 000715 142 LARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECY 196 (1335)
Q Consensus 142 LAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELL 196 (1335)
........... +.+.-...++.++|+|+||+++....
T Consensus 180 ~~~~~~e~~a~------------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 180 GKRCTAQRKAK------------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CcccccchhhH------------------HHHHHHhHhcccccccceeEeehHHH
Confidence 87654321110 11212233557999999999987543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.6e-19 Score=199.46 Aligned_cols=228 Identities=26% Similarity=0.353 Sum_probs=147.7
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc------hhHHHHHHHHHHHHhCCC----------CCcceEEEEE--
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK------SQKSKVLQEVRMLHSLDH----------PNVLRFYSWY-- 65 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK------e~~e~LlrEIqILkkL~H----------PNIVrL~dvf-- 65 (1335)
+...+.||.|+++.||.+++..||+.+|+|++.. ...+++.+|.-....+.+ -.++..++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 5678899999999999999999999999998732 234455555543333322 1222223322
Q ss_pred -------EeC---C-----EEEEEEeecCCCCHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 000715 66 -------ETS---A-----HLWLVLEYCVGGDLMSLLRQ---DNQ----LPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123 (1335)
Q Consensus 66 -------eds---~-----~lyLVMEY~eGGSL~dlIkq---~~~----LSEeqIr~I~rQILsGLkYLHskGIVHRDIK 123 (1335)
... . +.+++|+-. .++|.+++.. ... +.......+..|++..+++||..|++|+|||
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 111 1 236677765 6788887642 222 2222234556899999999999999999999
Q ss_pred CCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccC-------CCCCchhhHHHHHHHHHHHH
Q 000715 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG-------GVHSYASDLWGLGCVLYECY 196 (1335)
Q Consensus 124 PENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~-------~~yS~kSDIWSLGVILYELL 196 (1335)
|+|++++.+|.++|+||+.....+..... ...+..|.+||..... -.++.+.|.|+||+++|.|+
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC--------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG--------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec--------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999987765442211 2245779999987532 24678999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCC
Q 000715 197 AGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQR 245 (1335)
Q Consensus 197 TGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKR 245 (1335)
||..||............+. ... +.++.+++||..+|++||.+|
T Consensus 245 C~~lPf~~~~~~~~~~~~f~----~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEWDFS----RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGGGGT----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccccch----hcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999987643321111121 223 778999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.6e-19 Score=188.93 Aligned_cols=190 Identities=19% Similarity=0.210 Sum_probs=141.9
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhH-------HHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK-------SKVLQEVRMLHSLD-HPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~-------e~LlrEIqILkkL~-HPNIVrL~dvfeds~~lyLVM 75 (1335)
+.+...|++|+||+||.+.. .+..++.+.+..... ..+.+|+++|+++. |+++.+++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34577899999999997766 456777666654321 24789999999995 5889999886 4469999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC-CCCCeEECCCCCeeeccccccccccCCCCC--
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL-KPSNILLDENGRTKLCDFGLARKLSDASKA-- 152 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDI-KPENILIDedG~VKLiDFGLAr~l~e~~~~-- 152 (1335)
||+.|.+|.+.... . ...++.|++.+|.++|++||+|||| ||+||+++.+|.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999999764422 1 2357899999999999999999999 799999999999999999999855432210
Q ss_pred --C-C---CCCCCCccCCCCCCCcchhccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 000715 153 --P-S---SMLPQAKCGTPCYMAPELFEEGGVHS-YASDLWGLGCVLYECYAGRPPFVGRE 206 (1335)
Q Consensus 153 --~-s---s~l~~t~~GTp~YmAPEVL~~~~~yS-~kSDIWSLGVILYELLTGrpPF~g~d 206 (1335)
. . ........+++.|++|+...--...+ ...++++.|+-+|.++|+..|+.+++
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 00001123688899998753222223 56799999999999999999876654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7e-19 Score=199.90 Aligned_cols=202 Identities=25% Similarity=0.395 Sum_probs=148.7
Q ss_pred CCCCcceEEEEEEe---------------------------CCEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 000715 54 DHPNVLRFYSWYET---------------------------SAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLV 106 (1335)
Q Consensus 54 ~HPNIVrL~dvfed---------------------------s~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQIL 106 (1335)
+|||||++..+|.+ ...+|+||..+ ..+|.+++..+ ..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 59999999877643 24689999987 57899988654 457777888999999
Q ss_pred HHHHHHHHCCCcccCCCCCCeEEC--CCC--CeeeccccccccccCCC-CCCCCCCCCCccCCCCCCCcchhccCC----
Q 000715 107 RALQYLHSKGIIYCDLKPSNILLD--ENG--RTKLCDFGLARKLSDAS-KAPSSMLPQAKCGTPCYMAPELFEEGG---- 177 (1335)
Q Consensus 107 sGLkYLHskGIVHRDIKPENILID--edG--~VKLiDFGLAr~l~e~~-~~~ss~l~~t~~GTp~YmAPEVL~~~~---- 177 (1335)
+|+.|||++||.|||+|.+|||+. +|+ .+.++|||++-.-...+ ..+.....-..-|....||||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999984 444 57899999875332211 011111112245888899999975221
Q ss_pred -CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCH---HHHh
Q 000715 178 -VHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKS-ILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHW---SDLC 252 (1335)
Q Consensus 178 -~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikk-Il~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTA---eEIL 252 (1335)
..-.++|.|+.|.+.||++....||.+....-+-.. ......+++|..+++.+++++..+|+.||++|++. ..++
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 112389999999999999999999988543322211 22334567889999999999999999999999984 4455
Q ss_pred cCccc
Q 000715 253 GHAFW 257 (1335)
Q Consensus 253 kHPfF 257 (1335)
+-..|
T Consensus 512 ~LsLw 516 (598)
T KOG4158|consen 512 NLSLW 516 (598)
T ss_pred HHHHh
Confidence 44333
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-18 Score=184.80 Aligned_cols=130 Identities=23% Similarity=0.366 Sum_probs=107.7
Q ss_pred EEEEEeccCcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---EEE-E
Q 000715 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSL-----DHPNVLRFYSWYETSA---HLW-L 73 (1335)
Q Consensus 6 LlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL-----~HPNIVrL~dvfeds~---~ly-L 73 (1335)
-.+.||+|+||.||. ++.++.. +||++... ..+.+.+|+++++.+ +||||++++++++++. .++ +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 357899999999995 7777665 69988654 456789999999999 6799999999999874 434 7
Q ss_pred EEee--cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCCcccCCCCCCeEECCC----CCeeecccc
Q 000715 74 VLEY--CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRAL-QYLHSKGIIYCDLKPSNILLDEN----GRTKLCDFG 141 (1335)
Q Consensus 74 VMEY--~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGL-kYLHskGIVHRDIKPENILIDed----G~VKLiDFG 141 (1335)
|||| +.+++|.+++++. .+++. ..++.|++.++ +|||+++|+||||||+||+++.. +.++|+||+
T Consensus 83 I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 8999 5579999999764 57666 46788888888 89999999999999999999742 379999955
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.3e-18 Score=185.41 Aligned_cols=138 Identities=24% Similarity=0.297 Sum_probs=113.6
Q ss_pred EEEEEEEeccCcEEEEEEE-ECCCCeEEEEEEcCchh---------------------------HHHHHHHHHHHHhCCC
Q 000715 4 YHIYEAIGRGKYSTVYKGR-KKKTIEYFAIKSVDKSQ---------------------------KSKVLQEVRMLHSLDH 55 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkAr-dk~TGk~VAIKiIdKe~---------------------------~e~LlrEIqILkkL~H 55 (1335)
|.+.+.||+|+||.||+|. +..+|+.||+|++.... ...+.+|++++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7788999999999999999 77889999999885321 1224689999999975
Q ss_pred CC--cceEEEEEEeCCEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-CcccCCCCCCeEECCC
Q 000715 56 PN--VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG-IIYCDLKPSNILLDEN 132 (1335)
Q Consensus 56 PN--IVrL~dvfeds~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskG-IVHRDIKPENILIDed 132 (1335)
.+ +.+++++ . ..|+||||+.|+++......+..+.+.++..++.|++.++.+||++| |+||||||+||+++ +
T Consensus 110 ~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~ 184 (237)
T smart00090 110 AGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D 184 (237)
T ss_pred cCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence 33 3444432 2 34899999999888776655566778888999999999999999999 99999999999999 8
Q ss_pred CCeeeccccccccc
Q 000715 133 GRTKLCDFGLARKL 146 (1335)
Q Consensus 133 G~VKLiDFGLAr~l 146 (1335)
+.++|+|||.+...
T Consensus 185 ~~i~LiDFg~a~~~ 198 (237)
T smart00090 185 GKVVIIDVSQSVEL 198 (237)
T ss_pred CCEEEEEChhhhcc
Confidence 89999999987643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.9e-18 Score=213.41 Aligned_cols=234 Identities=22% Similarity=0.296 Sum_probs=180.6
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEeec
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLD---HPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~---HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
++|.+.+.||+|+||+||+|.+.+ |+.||+|+-......++.-=.+++.+|+ -+.|..+...+...+.-++|+||.
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~ 776 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYS 776 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecc
Confidence 479999999999999999999988 9999999988776655544445555555 345667777777777789999999
Q ss_pred CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC-------CCCeeeccccccccccCCCC
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE-------NGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 79 eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe-------dG~VKLiDFGLAr~l~e~~~ 151 (1335)
+.|+|.+++...+.+++.-+..+..|++..|+.||..|||||||||+|+|+.. ..-++|+|||.+..+.-...
T Consensus 777 ~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~ 856 (974)
T KOG1166|consen 777 PYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPD 856 (974)
T ss_pred ccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCC
Confidence 99999999998889999999999999999999999999999999999999942 23689999999877654333
Q ss_pred CCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC----CCCCCCCC-
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP----SPPLPGNP- 226 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~----~~pip~~i- 226 (1335)
.. . -...++|-.+-.+|+.. ++.+++.+|.|.+..++|.|++|+.-- ...+. ...++..+
T Consensus 857 ~~-~--F~~~~~td~f~C~EM~~-grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~~~~~~~~Ry~~ 921 (974)
T KOG1166|consen 857 GT-K--FKAVWHTDLFDCIEMRE-GRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNGSSWMVKTNFPRYWK 921 (974)
T ss_pred Cc-E--EeeeeccccchhHHHhc-CCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCCcceeccccchhhhh
Confidence 21 1 13457899999999986 678999999999999999999997431 11111 11122222
Q ss_pred ChhHHHHHHHhcccCCCCCCCHHHH
Q 000715 227 SRPFANLINSLLVKDPAQRLHWSDL 251 (1335)
Q Consensus 227 S~eL~DLIkkcLqkDPsKRPTAeEI 251 (1335)
.+-|.+|+..+|..|-..=|.+.++
T Consensus 922 ~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 922 RDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred HHHHHHHHHHHhCcCcccchhHHHH
Confidence 2447788889998444444555554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-19 Score=216.51 Aligned_cols=255 Identities=26% Similarity=0.390 Sum_probs=211.1
Q ss_pred CcEEEEEEEeccCcEEEEEEEECC-CCeEEEEEEcCch-----hHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-TIEYFAIKSVDKS-----QKSKVLQEVRMLHSLD-HPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~-TGk~VAIKiIdKe-----~~e~LlrEIqILkkL~-HPNIVrL~dvfeds~~lyLV 74 (1335)
..|.+.+.||+|+|+.|-.+.... +...+|.|.+... .......|..+-+.+. |+|++.+++...+....+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 468999999999999999887744 4456777776543 2334556888888886 99999999999999999999
Q ss_pred EeecCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCCeEECCCC-CeeeccccccccccC-C
Q 000715 75 LEYCVGGDLMSLL-RQDN-QLPEDSIRDLAQDLVRALQYLH-SKGIIYCDLKPSNILLDENG-RTKLCDFGLARKLSD-A 149 (1335)
Q Consensus 75 MEY~eGGSL~dlI-kq~~-~LSEeqIr~I~rQILsGLkYLH-skGIVHRDIKPENILIDedG-~VKLiDFGLAr~l~e-~ 149 (1335)
++|..|+++++.+ ..+. ..+......++.|+..++.|+| ..++.||||||+|.+++..+ .+|+.|||+|..+.. .
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9999999999999 6555 7889999999999999999999 99999999999999999999 999999999998866 2
Q ss_pred CCCCCCCCCCCccC-CCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hc---CCCCCCCC
Q 000715 150 SKAPSSMLPQAKCG-TPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSI-LS---DPSPPLPG 224 (1335)
Q Consensus 150 ~~~~ss~l~~t~~G-Tp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkI-l~---~~~~pip~ 224 (1335)
+.. ......+| ++.|+|||...+..+.++..|+||.|+++..+++|..||...........- .. ......+.
T Consensus 180 g~~---~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (601)
T KOG0590|consen 180 GAE---RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN 256 (601)
T ss_pred Ccc---eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence 222 12344678 999999999987678889999999999999999999999776543322111 11 11234567
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 225 NPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 225 ~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
..+....+++.+++..+|..|.+.+++..++|+..
T Consensus 257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCChhhhhcccccccCCchhccccccccccccccc
Confidence 78889999999999999999999999999999876
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.6e-17 Score=169.08 Aligned_cols=131 Identities=27% Similarity=0.385 Sum_probs=112.7
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch-----------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
+.||+|++|.||+|++ .|..+++|..... ....+.+|+.++..+.|+++.....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 5567888875321 12356789999999999998887777777788899999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccccc
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARK 145 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~ 145 (1335)
|++|++|.+++..... +...++.+++.++.++|+.|++|||++|.||+++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999876432 8889999999999999999999999999999998 78999999998764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.2e-17 Score=181.00 Aligned_cols=234 Identities=20% Similarity=0.368 Sum_probs=188.8
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeec
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~ 78 (1335)
..+.-+|.+...|..|+|++.++. ++.|++.-.+ ..++..|.-.++-..||||..+++.+....++.++..|+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 345567888899999999998754 5556654322 346788888899999999999999999999999999999
Q ss_pred CCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCC-Cc-ccCCCCCCeEECCCCCeee--ccccccccccCCCCC
Q 000715 79 VGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHSKG-II-YCDLKPSNILLDENGRTKL--CDFGLARKLSDASKA 152 (1335)
Q Consensus 79 eGGSL~dlIkq~~~--LSEeqIr~I~rQILsGLkYLHskG-IV-HRDIKPENILIDedG~VKL--iDFGLAr~l~e~~~~ 152 (1335)
+.|+|+.++..+.. .+..++.+++.+++.|+.|||+.. ++ ---+....|+||++-+.+| +|--++.+
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq------- 342 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------- 342 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-------
Confidence 99999999987653 678899999999999999999874 33 3368888999999876555 34333321
Q ss_pred CCCCCCCCccCCCCCCCcchhccCCCC--CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCChh
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVH--SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSI-LSDPSPPLPGNPSRP 229 (1335)
Q Consensus 153 ~ss~l~~t~~GTp~YmAPEVL~~~~~y--S~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkI-l~~~~~pip~~iS~e 229 (1335)
.......|.||+||.+...+.. -.++|+|||.+++||+.|...||.+-...+.-.+| +.+.+..+|..++..
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~h 417 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRH 417 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHH
Confidence 1123467899999999755433 24899999999999999999999998776665444 677888899999999
Q ss_pred HHHHHHHhcccCCCCCCCHHHH
Q 000715 230 FANLINSLLVKDPAQRLHWSDL 251 (1335)
Q Consensus 230 L~DLIkkcLqkDPsKRPTAeEI 251 (1335)
...+++-|+..||.+||.++.+
T Consensus 418 m~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred HHHHHHHHhcCCCCcCCCccee
Confidence 9999999999999999988765
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=166.83 Aligned_cols=133 Identities=21% Similarity=0.231 Sum_probs=108.0
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-------------------------HHHHHHHHHHHHhCCCCC-
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-------------------------KSKVLQEVRMLHSLDHPN- 57 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-------------------------~e~LlrEIqILkkL~HPN- 57 (1335)
|.+.+.||+|+||.||+|.+. +|+.||+|++.... .....+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 788899999999999999875 78999999864321 113567899999997774
Q ss_pred -cceEEEEEEeCCEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCee
Q 000715 58 -VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTK 136 (1335)
Q Consensus 58 -IVrL~dvfeds~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VK 136 (1335)
+...++ ....++||||++|++|.+.... .....++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 444443 2445899999999999775431 45678999999999999999999999999999999999999
Q ss_pred ecccccccccc
Q 000715 137 LCDFGLARKLS 147 (1335)
Q Consensus 137 LiDFGLAr~l~ 147 (1335)
|+|||.+....
T Consensus 166 liDfg~~~~~~ 176 (198)
T cd05144 166 IIDWPQMVSTD 176 (198)
T ss_pred EEECCccccCC
Confidence 99999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-16 Score=163.91 Aligned_cols=127 Identities=25% Similarity=0.366 Sum_probs=105.4
Q ss_pred EEeccCcEEEEEEEECCCCeEEEEEEcCch-----------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEee
Q 000715 9 AIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 9 ~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-----------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY 77 (1335)
.||+|+||.||+|.+ +|..+++|..... ...++.+|++++..+.|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 4577899975321 124567899999999988766555555666777999999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccccc
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARK 145 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~ 145 (1335)
++|++|.+.+..... .++.|++.+|.++|+.|++|||+||+||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765322 8899999999999999999999999999999 88999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.5e-17 Score=189.88 Aligned_cols=182 Identities=27% Similarity=0.399 Sum_probs=137.3
Q ss_pred CEEEEEEeecCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccccc
Q 000715 69 AHLWLVLEYCVGGDLMSLLRQDN---QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARK 145 (1335)
Q Consensus 69 ~~lyLVMEY~eGGSL~dlIkq~~---~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~ 145 (1335)
.++||.|++|...+|.+++.... .-+......++.|+..|++| +|.+|||+||.||++..++.+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 35899999999999999997543 46778899999999999999 9999999999999999999999999999987
Q ss_pred ccCCCC-CCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhcCCCCCCC
Q 000715 146 LSDASK-APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLP 223 (1335)
Q Consensus 146 l~e~~~-~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLT-GrpPF~g~d~~eLikkIl~~~~~pip 223 (1335)
...... .+.........||.+||+||.+. +..|+.++||||||++++|++. =...|... .....+-.+..++..
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~-g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---~t~~d~r~g~ip~~~ 481 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIR-GQQYSEKVDIYALGLILAELLIQFSTQFERI---ATLTDIRDGIIPPEF 481 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHh-hhhhhhhcchhhHHHHHHHHHHHhccHHHHH---HhhhhhhcCCCChHH
Confidence 765441 11111123457999999999996 5678999999999999999997 22232211 112222222222222
Q ss_pred CCCChhHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 000715 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 224 ~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfF 257 (1335)
..-.+.-.+|+.+|+.+.|.+||++.+.-.|.|.
T Consensus 482 ~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 482 LQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 2223455689999999999999988777777764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.3e-16 Score=184.17 Aligned_cols=133 Identities=23% Similarity=0.301 Sum_probs=109.2
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcC---c------hhHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD---K------SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiId---K------e~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
|...+.||+|+||.||++.+......+..+... . .....+.+|+++++.++|++++..+.++.+....++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 456789999999999999876543322222211 1 1124578899999999999999888777777778999
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccccc
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARK 145 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~ 145 (1335)
|||++|++|.+++. ....++.|++.++.|||++|++||||||+||++ .++.++|+|||+++.
T Consensus 415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999885 457899999999999999999999999999999 678999999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.2e-15 Score=177.40 Aligned_cols=201 Identities=24% Similarity=0.377 Sum_probs=158.0
Q ss_pred HHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCC-cccCCCCCCe
Q 000715 50 LHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGI-IYCDLKPSNI 127 (1335)
Q Consensus 50 LkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL~dlIkq-~~~LSEeqIr~I~rQILsGLkYLHskGI-VHRDIKPENI 127 (1335)
|+.+.|.|+.++++.+.+....++|.+||..|+|.|.+.. ...++..-...++++|+.|+.|+|...| .|+.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3568999999999999999999999999999999999987 4578888899999999999999999876 9999999999
Q ss_pred EECCCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCC------CCchhhHHHHHHHHHHHHhCCCC
Q 000715 128 LLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV------HSYASDLWGLGCVLYECYAGRPP 201 (1335)
Q Consensus 128 LIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~------yS~kSDIWSLGVILYELLTGrpP 201 (1335)
++|....+||.|||+.......... .......-..-|.|||.+..... .+.+.|+||+|+++||+++...|
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~---~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEP---EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred eeeeeEEEEechhhhcccccccccc---cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999998766431000 00011123456999999864311 35679999999999999999999
Q ss_pred CCCC----CHHHHHHHHhc-CC---CCCCC--CCCChhHHHHHHHhcccCCCCCCCHHHHhc
Q 000715 202 FVGR----EFTQLVKSILS-DP---SPPLP--GNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 202 F~g~----d~~eLikkIl~-~~---~~pip--~~iS~eL~DLIkkcLqkDPsKRPTAeEILk 253 (1335)
|... +..+++..+.+ +. ++..+ ...++++..+++.||..+|.+||+++++..
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 9763 23455555544 22 12222 133457999999999999999999998853
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.8e-15 Score=152.68 Aligned_cols=133 Identities=24% Similarity=0.327 Sum_probs=97.8
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-----HHH----------------------HHHHHHHHHhCCCCC--
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSK----------------------VLQEVRMLHSLDHPN-- 57 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-----~e~----------------------LlrEIqILkkL~HPN-- 57 (1335)
.+.||+|+||.||+|.+. +|+.||+|++.... ... ...|.+.+.++.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999987 78999999875421 111 134566666664432
Q ss_pred cceEEEEEEeCCEEEEEEeecCCCCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCe
Q 000715 58 VLRFYSWYETSAHLWLVLEYCVGGDLMS-LLRQDNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRT 135 (1335)
Q Consensus 58 IVrL~dvfeds~~lyLVMEY~eGGSL~d-lIkq~~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~V 135 (1335)
+.++++. ...++||||++|+.+.. .+... .. ..+++.++.+++.++.++|. +||+||||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444443 23589999999854321 11111 11 16788999999999999999 9999999999999999 8999
Q ss_pred eecccccccccc
Q 000715 136 KLCDFGLARKLS 147 (1335)
Q Consensus 136 KLiDFGLAr~l~ 147 (1335)
+|+|||.+....
T Consensus 154 ~liDfg~a~~~~ 165 (187)
T cd05119 154 YIIDVPQAVEID 165 (187)
T ss_pred EEEECccccccc
Confidence 999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.6e-15 Score=140.26 Aligned_cols=130 Identities=25% Similarity=0.319 Sum_probs=113.2
Q ss_pred EEEEEeccCcEEEEEEEECCCCeEEEEEEcCchh-HHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEeecCCCC
Q 000715 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-KSKVLQEVRMLHSLDH--PNVLRFYSWYETSAHLWLVLEYCVGGD 82 (1335)
Q Consensus 6 LlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-~e~LlrEIqILkkL~H--PNIVrL~dvfeds~~lyLVMEY~eGGS 82 (1335)
+.+.||+|.++.||++...+ ..+++|...... ...+.+|+.+++.+.| .++.+++.++...+..|++|||+.|+.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 46789999999999999865 679999986654 3578899999999976 589999998888889999999999887
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCCCCeEECCCCCeeeccccccc
Q 000715 83 LMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK---GIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 83 L~dlIkq~~~LSEeqIr~I~rQILsGLkYLHsk---GIVHRDIKPENILIDedG~VKLiDFGLAr 144 (1335)
+..+ +......++.+++.++.++|.. +++|||++|+||++++++.++++|||.+.
T Consensus 80 ~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 80 LDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 7654 5667788999999999999985 79999999999999998999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.8e-14 Score=155.82 Aligned_cols=131 Identities=22% Similarity=0.336 Sum_probs=103.2
Q ss_pred EEEe-ccCcEEEEEEEECCCCeEEEEEEcCch----------------hHHHHHHHHHHHHhCCCCCc--ceEEEEEEeC
Q 000715 8 EAIG-RGKYSTVYKGRKKKTIEYFAIKSVDKS----------------QKSKVLQEVRMLHSLDHPNV--LRFYSWYETS 68 (1335)
Q Consensus 8 K~LG-eGgFGtVYkArdk~TGk~VAIKiIdKe----------------~~e~LlrEIqILkkL~HPNI--VrL~dvfeds 68 (1335)
..|| .||.|+||.++.. +..+++|.+.+. ...++.+|++++.++.|++| ..++++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 8889999988775 567888877431 22457789999999998875 6666654332
Q ss_pred -C---EEEEEEeecCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccccc
Q 000715 69 -A---HLWLVLEYCVG-GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143 (1335)
Q Consensus 69 -~---~lyLVMEY~eG-GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLA 143 (1335)
. ..++||||++| .+|.+++.. ..+++.. +.|++.++.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 23599999997 689988865 4566553 578999999999999999999999999999999999999987
Q ss_pred cc
Q 000715 144 RK 145 (1335)
Q Consensus 144 r~ 145 (1335)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 54
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1e-13 Score=165.25 Aligned_cols=251 Identities=28% Similarity=0.390 Sum_probs=197.5
Q ss_pred EEEEEEEec--cCcEEEEEEEE--CCCCeEEEEEEcCc-----hhHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 000715 4 YHIYEAIGR--GKYSTVYKGRK--KKTIEYFAIKSVDK-----SQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 4 YeLlK~LGe--GgFGtVYkArd--k~TGk~VAIKiIdK-----e~~e~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyL 73 (1335)
+.+.+.+|. |.+|.||.+.. ..++..+|+|.-.. .....-.+|+...+++ .|+|.++.+..++..+..|+
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 456778999 99999999998 88999999997432 2233445777777777 69999999999999999999
Q ss_pred EEeecCCCCHHHHHHhCC-CCCHHHHHHHHHHHHH----HHHHHHHCCCcccCCCCCCeEECCC-CCeeecccccccccc
Q 000715 74 VLEYCVGGDLMSLLRQDN-QLPEDSIRDLAQDLVR----ALQYLHSKGIIYCDLKPSNILLDEN-GRTKLCDFGLARKLS 147 (1335)
Q Consensus 74 VMEY~eGGSL~dlIkq~~-~LSEeqIr~I~rQILs----GLkYLHskGIVHRDIKPENILIDed-G~VKLiDFGLAr~l~ 147 (1335)
-+|+| |.+|..+...-. .+++..++..+.+... |+.++|..+++|-|+||.||+...+ ...+++|||+...+.
T Consensus 196 qtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~ 274 (524)
T KOG0601|consen 196 QTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKIS 274 (524)
T ss_pred eeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEcc
Confidence 99998 578888776654 4899999999999999 9999999999999999999999999 889999999999887
Q ss_pred CCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCCCCCCC
Q 000715 148 DASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR---EFTQLVKSILSDPSPPLPG 224 (1335)
Q Consensus 148 e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~---d~~eLikkIl~~~~~pip~ 224 (1335)
...............|...|++||... +.++...|+|++|.++.+-.+|..++... .+.++-+ .. ....+-.
T Consensus 275 ~~~~~~~~~~~~r~~~~~~Y~~ke~~~--~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-~~--ip~e~~~ 349 (524)
T KOG0601|consen 275 DGNFSSVFKVSKRPEGDCIYAAKELLN--GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-GY--IPLEFCE 349 (524)
T ss_pred CCccccceeeeecCCCCceEeChhhhc--cccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-cc--Cchhhhc
Confidence 765332222122225788899999985 66789999999999999988876655433 2221111 11 1112333
Q ss_pred CCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 225 NPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 225 ~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
..+..+...+..|+..+|-.|++++.+.+|++....
T Consensus 350 ~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 350 GGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred CcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 456677779999999999999999999999987643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.6e-14 Score=172.43 Aligned_cols=260 Identities=28% Similarity=0.407 Sum_probs=203.0
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVM 75 (1335)
+.+.+.+-+-.|++|.++.+.-..+|...++|...+. +.+.+.++-.++-...+|-++.....+.-....++++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 4567788889999999999999888877777654322 2222333333333334565665554455667889999
Q ss_pred eecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC-----
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS----- 150 (1335)
Q Consensus 76 EY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~----- 150 (1335)
+|..|++|...+..-+..+++-.+.++..+..+.+|||...+.|||++|.|+++..+|+.++.|||.........
T Consensus 884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 999999999999988889999999999999999999999999999999999999999999999998433321100
Q ss_pred ----------------CCC-----CCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Q 000715 151 ----------------KAP-----SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ 209 (1335)
Q Consensus 151 ----------------~~~-----ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~e 209 (1335)
... .........||+.|.+||...+ ...+..+|+|+.|+++++.++|.+||......+
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 000 0011234579999999999874 456779999999999999999999999999999
Q ss_pred HHHHHhcCCCCC--CCCCCChhHHHHHHHhcccCCCCCCCHH---HHhcCccccccCC
Q 000715 210 LVKSILSDPSPP--LPGNPSRPFANLINSLLVKDPAQRLHWS---DLCGHAFWRTKLT 262 (1335)
Q Consensus 210 LikkIl~~~~~p--ip~~iS~eL~DLIkkcLqkDPsKRPTAe---EILkHPfFq~~l~ 262 (1335)
.+..+.....+. -+...+....+++...+..+|.+|..+. +...|+||+...+
T Consensus 1043 ~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1043 IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 998887654322 3455688999999999999999999876 8999999987654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.8e-12 Score=151.58 Aligned_cols=136 Identities=23% Similarity=0.345 Sum_probs=95.7
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHH-------------------------------------------HH
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-------------------------------------------VL 44 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~-------------------------------------------Ll 44 (1335)
+.||.|++|.||+|+.+ +|+.||||+......+. +.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999876 57899999975432111 23
Q ss_pred HHHHHHHhC----C-CCCcceEEEEEEeCCEEEEEEeecCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHHCCC
Q 000715 45 QEVRMLHSL----D-HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVR-ALQYLHSKGI 117 (1335)
Q Consensus 45 rEIqILkkL----~-HPNIVrL~dvfeds~~lyLVMEY~eGGSL~dlIkq~-~~LSEeqIr~I~rQILs-GLkYLHskGI 117 (1335)
+|.+.+.++ + ++++.-..-+....+..++||||++|++|.++.... ... ....++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 444444444 2 333322222223345569999999999998876532 122 23445556655 4788999999
Q ss_pred cccCCCCCCeEECCCCCeeecccccccccc
Q 000715 118 IYCDLKPSNILLDENGRTKLCDFGLARKLS 147 (1335)
Q Consensus 118 VHRDIKPENILIDedG~VKLiDFGLAr~l~ 147 (1335)
+|+|+||.||+++.+|.++++|||++..+.
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999986553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=7e-12 Score=125.99 Aligned_cols=125 Identities=20% Similarity=0.263 Sum_probs=97.0
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCchh--HHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEeecCCCCH
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSLDHPNVL-RFYSWYETSAHLWLVLEYCVGGDL 83 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~--~e~LlrEIqILkkL~HPNIV-rL~dvfeds~~lyLVMEY~eGGSL 83 (1335)
.+.|+.|.++.||+++.. ++.|++|...... .....+|+.+++.+.+.+++ +++.+.. ...++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 467899999999999865 6789999986553 23467899999988665544 4444432 334799999999888
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----cccCCCCCCeEECCCCCeeeccccccc
Q 000715 84 MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI-----IYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 84 ~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGI-----VHRDIKPENILIDedG~VKLiDFGLAr 144 (1335)
.+. ......++.+++.++..||+.++ +|||++|.||+++ ++.++++|||.+.
T Consensus 79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 653 11124567899999999999985 9999999999998 6789999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.2e-11 Score=147.25 Aligned_cols=168 Identities=22% Similarity=0.397 Sum_probs=132.7
Q ss_pred EE-EEEECCCCeEEEEEEcCchh---HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHHHHHHhCCCC
Q 000715 18 VY-KGRKKKTIEYFAIKSVDKSQ---KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQL 93 (1335)
Q Consensus 18 VY-kArdk~TGk~VAIKiIdKe~---~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL~dlIkq~~~L 93 (1335)
+| .|..+.++.+|.+...+... .....+-++-++.++||||+++++.++.++.+|+|+|.+ ..|..++++.+
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-- 102 (690)
T ss_pred cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH--
Confidence 44 56777888888888775544 356778899999999999999999999999999999987 46777776643
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcch
Q 000715 94 PEDSIRDLAQDLVRALQYLH-SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172 (1335)
Q Consensus 94 SEeqIr~I~rQILsGLkYLH-skGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEV 172 (1335)
...+...++||+.||.||| +.+++|+++.-..|+|+..|++||++|.++......... .....-.-.|..|+.
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~-----~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP-----AKSLYLIESFDDPEE 176 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc-----cccchhhhcccChhh
Confidence 7888899999999999997 678999999999999999999999999988655433210 011122334667776
Q ss_pred hccCCCCCchhhHHHHHHHHHHHHhC
Q 000715 173 FEEGGVHSYASDLWGLGCVLYECYAG 198 (1335)
Q Consensus 173 L~~~~~yS~kSDIWSLGVILYELLTG 198 (1335)
+... ....|.|.|||++++++.|
T Consensus 177 ~~~s---~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPS---EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCcc---ccchhhhhHHHHHHHHhCc
Confidence 5321 2457999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=7.1e-12 Score=151.50 Aligned_cols=138 Identities=19% Similarity=0.290 Sum_probs=99.5
Q ss_pred cEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHH-----------------------------------------
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS----------------------------------------- 41 (1335)
Q Consensus 3 rYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e----------------------------------------- 41 (1335)
.|+. +.||.|++|.||+|+.+.+|+.||||++...-.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4565 7899999999999999999999999998643111
Q ss_pred --HHHHHHHHHHhC----CCCCcceEEEEEE-eCCEEEEEEeecCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHH
Q 000715 42 --KVLQEVRMLHSL----DHPNVLRFYSWYE-TSAHLWLVLEYCVGGDLMSL--LRQDN----QLPEDSIRDLAQDLVRA 108 (1335)
Q Consensus 42 --~LlrEIqILkkL----~HPNIVrL~dvfe-ds~~lyLVMEY~eGGSL~dl--Ikq~~----~LSEeqIr~I~rQILsG 108 (1335)
++.+|...+.++ .+.+.+.+-.+|. -.+.-++||||++|+.+.++ +...+ .+.+..+..++.|++
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 123344333333 2444444444443 25567899999999999875 33333 355666666777765
Q ss_pred HHHHHHCCCcccCCCCCCeEECCCC----CeeeccccccccccC
Q 000715 109 LQYLHSKGIIYCDLKPSNILLDENG----RTKLCDFGLARKLSD 148 (1335)
Q Consensus 109 LkYLHskGIVHRDIKPENILIDedG----~VKLiDFGLAr~l~e 148 (1335)
..|++|+|+||+||+++.+| .++++|||++..+..
T Consensus 278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 59999999999999999888 999999999876643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.20 E-value=9.3e-12 Score=148.80 Aligned_cols=245 Identities=25% Similarity=0.309 Sum_probs=187.5
Q ss_pred CcEEEEEEEeccCcEEEEEEEEC-CCCeEEEEEEcCchhH---H--HHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKK-KTIEYFAIKSVDKSQK---S--KVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk-~TGk~VAIKiIdKe~~---e--~LlrEIqILkkL-~HPNIVrL~dvfeds~~lyLV 74 (1335)
.+|..+..||.|.|+.|+.+... .++..|++|-..+... . .-..|+.+...+ .|.+++..+..+....+.|+=
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 46788999999999999998766 6788899997754321 1 224567666665 688888888777777777799
Q ss_pred EeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCC-CCeeeccccccccccCCCCCC
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN-GRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 75 MEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDed-G~VKLiDFGLAr~l~e~~~~~ 153 (1335)
-|||+++++...+.-...+.+...+....|++.++.++|+..++|+|+||+||++..+ +..++.|||....+.-.
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~---- 420 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS---- 420 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee----
Confidence 9999999999888666788999999999999999999999999999999999999886 78899999987642211
Q ss_pred CCCCCCCccCCCCCC-CcchhccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHhcCCCCCCCCCCChhHH
Q 000715 154 SSMLPQAKCGTPCYM-APELFEEGGVHSYASDLWGLGCVLYECYAGRPP-FVGREFTQLVKSILSDPSPPLPGNPSRPFA 231 (1335)
Q Consensus 154 ss~l~~t~~GTp~Ym-APEVL~~~~~yS~kSDIWSLGVILYELLTGrpP-F~g~d~~eLikkIl~~~~~pip~~iS~eL~ 231 (1335)
.....+.-+++ .+|++.....+..+.|++|||..+++..+|.+. +.+.. ...+..+..+..+ .....+.
T Consensus 421 ----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~~~~~p~~~-~~~~~~q 491 (524)
T KOG0601|consen 421 ----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIRSGDTPNLP-GLKLQLQ 491 (524)
T ss_pred ----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc----ceeeecccccCCC-chHHhhh
Confidence 12233444555 377776677788899999999999999988753 22222 2222333223333 3338888
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 232 NLINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 232 DLIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
.+.+.++..++..|+.+.++..|.-|..
T Consensus 492 ~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 492 VLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhcCCccccchhhhhhcccchhhh
Confidence 9999999999999999999988876643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.7e-10 Score=124.07 Aligned_cols=136 Identities=15% Similarity=0.209 Sum_probs=101.8
Q ss_pred EEEEeccCcEEEEEEEECC------CCeEEEEEEcCch------------------------h-HHH----HHHHHHHHH
Q 000715 7 YEAIGRGKYSTVYKGRKKK------TIEYFAIKSVDKS------------------------Q-KSK----VLQEVRMLH 51 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~------TGk~VAIKiIdKe------------------------~-~e~----LlrEIqILk 51 (1335)
...||.|.-+.||.|.... .+..+|+|+.... + ... ..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999998654 3578999976210 0 111 247999999
Q ss_pred hCCC--CCcceEEEEEEeCCEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCCCeE
Q 000715 52 SLDH--PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL-HSKGIIYCDLKPSNIL 128 (1335)
Q Consensus 52 kL~H--PNIVrL~dvfeds~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYL-HskGIVHRDIKPENIL 128 (1335)
++.. -++..++++ ..-++||||+.++.+....-++..+++++...++.|++.++.++ |+.|++|||+++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9843 456666654 45589999997754433222334567778888999999999999 8999999999999999
Q ss_pred ECCCCCeeecccccccccc
Q 000715 129 LDENGRTKLCDFGLARKLS 147 (1335)
Q Consensus 129 IDedG~VKLiDFGLAr~l~ 147 (1335)
++ +|.+.|+|||.+....
T Consensus 158 ~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 158 WH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EE-CCcEEEEECCCceeCC
Confidence 96 5789999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.2e-11 Score=137.60 Aligned_cols=204 Identities=19% Similarity=0.235 Sum_probs=142.7
Q ss_pred HHHHHhCCCCCcceEEEEEEeCC-----EEEEEEeecCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC--
Q 000715 47 VRMLHSLDHPNVLRFYSWYETSA-----HLWLVLEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSK-- 115 (1335)
Q Consensus 47 IqILkkL~HPNIVrL~dvfeds~-----~lyLVMEY~eGGSL~dlIkq----~~~LSEeqIr~I~rQILsGLkYLHsk-- 115 (1335)
..-+-++.|.||++++.++.+.+ ...++.||+..|++..++++ +..+.....++|+.||+.||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 34455668999999998876554 48899999999999999875 34688999999999999999999988
Q ss_pred CCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHH
Q 000715 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYEC 195 (1335)
Q Consensus 116 GIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYEL 195 (1335)
-|+|+++...-|++..+|-+|+.--...... .........-.....|-++|.+||.=. ....+-++|||++|+...+|
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h-~s~~~~~~~Ek~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTH-PSVNSTREAEKSVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccc-hhhhhhhHhhhhccccCCccccCCcCc-ccccccchhhhhhhHHHHHH
Confidence 5999999999999999998887522211100 000000000011234788999999632 22335589999999999999
Q ss_pred HhCCCC-CCCCCH---HHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 000715 196 YAGRPP-FVGREF---TQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 196 LTGrpP-F~g~d~---~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~ 259 (1335)
..+..- -.+... ++.+.....+ ....--++++.+|+...|..||++.+++.||...+
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~-------len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIG-------LENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheee-------ccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 887643 222221 1111111111 11223457889999999999999999999997644
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.8e-10 Score=115.91 Aligned_cols=136 Identities=22% Similarity=0.286 Sum_probs=107.6
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCchh----HHHHHHHHHHHHhCCCC--CcceEEEEEEeC---CEEEEEEee
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHP--NVLRFYSWYETS---AHLWLVLEY 77 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~----~e~LlrEIqILkkL~HP--NIVrL~dvfeds---~~lyLVMEY 77 (1335)
.+.||.|.++.||++...+ |+.|++|...... ...+.+|.++++.+.+. ++.+++.+.... +..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3678999999999998754 6789999986542 45788999999999663 456677766554 367899999
Q ss_pred cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS------------------------------------------- 114 (1335)
Q Consensus 78 ~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHs------------------------------------------- 114 (1335)
++|.++.+.+.. ..+++.+...++.+++.++.+||+
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999988876532 457778888888888888888884
Q ss_pred -------------CCCcccCCCCCCeEECC--CCCeeeccccccc
Q 000715 115 -------------KGIIYCDLKPSNILLDE--NGRTKLCDFGLAR 144 (1335)
Q Consensus 115 -------------kGIVHRDIKPENILIDe--dG~VKLiDFGLAr 144 (1335)
..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23689999999999998 6678999999764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1e-09 Score=133.42 Aligned_cols=159 Identities=20% Similarity=0.302 Sum_probs=119.3
Q ss_pred HHHHHHHHHHHHHC-CCcccCCCCCCeEECCCCCeeeccccccccccCCCCCC----CCCCCCCccCCCCCCCcchhccC
Q 000715 102 AQDLVRALQYLHSK-GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP----SSMLPQAKCGTPCYMAPELFEEG 176 (1335)
Q Consensus 102 ~rQILsGLkYLHsk-GIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~----ss~l~~t~~GTp~YmAPEVL~~~ 176 (1335)
+.+...|+.|+|.. ++||++|.|++|.++.+|.+||+.|+++.....+...+ ....+....-...|.|||++..
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~- 183 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG- 183 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-
Confidence 33445899999976 89999999999999999999999999987655422211 1111222335678999999864
Q ss_pred CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHh---cCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHh
Q 000715 177 GVHSYASDLWGLGCVLYECY-AGRPPFVGREFTQLVKSIL---SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLC 252 (1335)
Q Consensus 177 ~~yS~kSDIWSLGVILYELL-TGrpPF~g~d~~eLikkIl---~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEIL 252 (1335)
...++++|+||+|+.+|.+. .|+..+...+....+..-. .-...-....++.++++=+.+++..++..||++..++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 56688999999999999999 5776666654333332221 1122334567899999999999999999999999999
Q ss_pred cCccccccC
Q 000715 253 GHAFWRTKL 261 (1335)
Q Consensus 253 kHPfFq~~l 261 (1335)
..|||.+..
T Consensus 264 ~~~ff~D~~ 272 (700)
T KOG2137|consen 264 SIPFFSDPG 272 (700)
T ss_pred cccccCCch
Confidence 999998753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1e-08 Score=109.64 Aligned_cols=127 Identities=25% Similarity=0.317 Sum_probs=98.7
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEc-Cch----------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV-DKS----------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiI-dKe----------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVME 76 (1335)
..+++|+-+.+|.+.+.. ..+++|.- .|. ...+-.+|.+++.++.--.|.-.+-++.+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 467899999999997744 33666643 221 23456789999999866566555555566677789999
Q ss_pred ecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccc
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 77 Y~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr 144 (1335)
|++|..|.+.+... .-.+++.+-.-+.-||..||+|+|+.++||+++.++ +.++|||++.
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 99999999998775 245777777888899999999999999999997654 9999999975
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.84 E-value=4.7e-08 Score=116.26 Aligned_cols=209 Identities=22% Similarity=0.250 Sum_probs=157.5
Q ss_pred CcEEEEEEEECCCCeEEEEEEcCch---hHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCEEEEEEeecCCC-CHHH
Q 000715 14 KYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYE----TSAHLWLVLEYCVGG-DLMS 85 (1335)
Q Consensus 14 gFGtVYkArdk~TGk~VAIKiIdKe---~~e~LlrEIqILkkL~HPNIVrL~dvfe----ds~~lyLVMEY~eGG-SL~d 85 (1335)
-..+.|+|....+|..|++|.++.. .......-+++++++.|+|+|++.++|. .+..+++|++|+++. +|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3458899999999999999999332 2334456788999999999999999887 345789999998764 6766
Q ss_pred HHH---------------hCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCC
Q 000715 86 LLR---------------QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 86 lIk---------------q~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~ 150 (1335)
+-- ++...+|..+|.|+.|+..||.++|+.|+.-+-+.|.+|+++.+-+++|+..|....+....
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 542 23357899999999999999999999999999999999999998899998888765543322
Q ss_pred CCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCHHHH-HHHHhcCCCCCCCCCCCh
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPP-FVGREFTQL-VKSILSDPSPPLPGNPSR 228 (1335)
Q Consensus 151 ~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpP-F~g~d~~eL-ikkIl~~~~~pip~~iS~ 228 (1335)
. |-+.. -.+-|.-.||.++..|.+|..- +......+. ... +....+.
T Consensus 448 ~-------------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~--------I~~~yS~ 496 (655)
T KOG3741|consen 448 T-------------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR--------ITTTYST 496 (655)
T ss_pred C-------------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH--------hhhhhhH
Confidence 0 11111 1256888999999999998543 211222222 222 2346788
Q ss_pred hHHHHHHHhcccCCCCCCCHHHHhcC
Q 000715 229 PFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 229 eL~DLIkkcLqkDPsKRPTAeEILkH 254 (1335)
+++++|.-+...++++ -++.+++.|
T Consensus 497 D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 497 DLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 9999999999999886 578888876
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.4e-07 Score=105.79 Aligned_cols=130 Identities=15% Similarity=0.083 Sum_probs=95.2
Q ss_pred cCcEEEEEEEECCCCeEEEEEEcCchh----HH----------HHHHHHHHHHhCCCCC--cceEEEEEEe-----CCEE
Q 000715 13 GKYSTVYKGRKKKTIEYFAIKSVDKSQ----KS----------KVLQEVRMLHSLDHPN--VLRFYSWYET-----SAHL 71 (1335)
Q Consensus 13 GgFGtVYkArdk~TGk~VAIKiIdKe~----~e----------~LlrEIqILkkL~HPN--IVrL~dvfed-----s~~l 71 (1335)
.....|++... .|+.|.+|...... .+ ...+|.+.+.++..-+ ...+..+.+. ....
T Consensus 33 ~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s 110 (268)
T PRK15123 33 LEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTS 110 (268)
T ss_pred CCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcccee
Confidence 33344666544 45789999663322 11 3678999888874333 3334444433 2457
Q ss_pred EEEEeecCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECC-------CCCeeecccc
Q 000715 72 WLVLEYCVGG-DLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE-------NGRTKLCDFG 141 (1335)
Q Consensus 72 yLVMEY~eGG-SL~dlIkq--~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDe-------dG~VKLiDFG 141 (1335)
++|||++++. +|.+++.. ....++.....++.++...+.-||++||+|+|+++.|||++. ++.+.|+||+
T Consensus 111 ~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 111 FIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 8999999886 89998864 345677888899999999999999999999999999999975 4689999999
Q ss_pred ccc
Q 000715 142 LAR 144 (1335)
Q Consensus 142 LAr 144 (1335)
.+.
T Consensus 191 r~~ 193 (268)
T PRK15123 191 RAQ 193 (268)
T ss_pred ccc
Confidence 764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.6e-08 Score=103.63 Aligned_cols=138 Identities=25% Similarity=0.311 Sum_probs=104.6
Q ss_pred EEEEEeccCcEEEEEEEECCCCeEEEEEEc-Cch----------hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 000715 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-DKS----------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 6 LlK~LGeGgFGtVYkArdk~TGk~VAIKiI-dKe----------~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLV 74 (1335)
.+..+-+|+-+.|+++.+.. +.+.||.- .|. .+.+..+|++++.++.--.|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~~G--e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG--EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccCC--ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 46678899999999987754 66777743 221 245677899999988655665555566666666889
Q ss_pred EeecCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCC---Ceeecccccccc
Q 000715 75 LEYCVG-GDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG---RTKLCDFGLARK 145 (1335)
Q Consensus 75 MEY~eG-GSL~dlIkq~~--~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG---~VKLiDFGLAr~ 145 (1335)
|||++| .++.+++.... ....+-...++++|-+.+.-||.++|+|+|+..+||++..+| .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999977 47888876532 333334478999999999999999999999999999997665 348999998753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.60 E-value=4.5e-07 Score=97.20 Aligned_cols=105 Identities=34% Similarity=0.407 Sum_probs=85.1
Q ss_pred HHHHHHHHHHHhCCCC--CcceEEEEEEeC----CEEEEEEeecCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 000715 41 SKVLQEVRMLHSLDHP--NVLRFYSWYETS----AHLWLVLEYCVGG-DLMSLLRQDNQLPEDSIRDLAQDLVRALQYLH 113 (1335)
Q Consensus 41 e~LlrEIqILkkL~HP--NIVrL~dvfeds----~~lyLVMEY~eGG-SL~dlIkq~~~LSEeqIr~I~rQILsGLkYLH 113 (1335)
.+..+|.+.+..+..- ...+++.+.+.. ...++|+|+++|. +|.+++......+......++.++...+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 4577888888777432 344555555442 3468999999885 89999988666888889999999999999999
Q ss_pred HCCCcccCCCCCCeEECCCC---Ceeecccccccc
Q 000715 114 SKGIIYCDLKPSNILLDENG---RTKLCDFGLARK 145 (1335)
Q Consensus 114 skGIVHRDIKPENILIDedG---~VKLiDFGLAr~ 145 (1335)
++||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.5e-07 Score=97.96 Aligned_cols=122 Identities=28% Similarity=0.382 Sum_probs=82.2
Q ss_pred EEEEEEECCCCeEEEEEEcCch-----------------------------hHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 000715 17 TVYKGRKKKTIEYFAIKSVDKS-----------------------------QKSKVLQEVRMLHSLDHP--NVLRFYSWY 65 (1335)
Q Consensus 17 tVYkArdk~TGk~VAIKiIdKe-----------------------------~~e~LlrEIqILkkL~HP--NIVrL~dvf 65 (1335)
.||.|...+ |..+|+|+.... ......+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 489888755 568999986210 012357899999999765 455666442
Q ss_pred EeCCEEEEEEeecC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCCcccCCCCCCeEECCCCCeeeccccc
Q 000715 66 ETSAHLWLVLEYCV--GGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY-LHSKGIIYCDLKPSNILLDENGRTKLCDFGL 142 (1335)
Q Consensus 66 eds~~lyLVMEY~e--GGSL~dlIkq~~~LSEeqIr~I~rQILsGLkY-LHskGIVHRDIKPENILIDedG~VKLiDFGL 142 (1335)
.+ ++||||++ |..+..+.... ++.++...++.+++..+.. +|+.||+|+|+.+.||+++++ .+.++|||.
T Consensus 80 --~~--~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 --RN--VIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp --TT--EEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred --CC--EEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 22 79999998 65665544322 2255677888899986555 579999999999999999877 999999998
Q ss_pred cccc
Q 000715 143 ARKL 146 (1335)
Q Consensus 143 Ar~l 146 (1335)
+...
T Consensus 153 av~~ 156 (188)
T PF01163_consen 153 AVDS 156 (188)
T ss_dssp EEET
T ss_pred ceec
Confidence 7644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.4e-06 Score=98.11 Aligned_cols=130 Identities=26% Similarity=0.339 Sum_probs=102.5
Q ss_pred EEEEEEeccCcEEEEEEEECCCCeEEEEEEcC-------c-----------h-------hHHHHHHHHHHHHhCCCC--C
Q 000715 5 HIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-------K-----------S-------QKSKVLQEVRMLHSLDHP--N 57 (1335)
Q Consensus 5 eLlK~LGeGgFGtVYkArdk~TGk~VAIKiId-------K-----------e-------~~e~LlrEIqILkkL~HP--N 57 (1335)
.++..||-|.-|.||.|.+. .|..+|+|+=. + . .+...++|.++|.+|... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 46788999999999999988 46779999631 0 0 122357899999999655 6
Q ss_pred cceEEEEEEeCCEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeee
Q 000715 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKL 137 (1335)
Q Consensus 58 IVrL~dvfeds~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKL 137 (1335)
+.+.+++ +.-.+||||++|-.|... +++.+....++..|++-+.-+-..|++|+|+.+=||++++||.+.+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 7777663 455799999999777653 2346677778888888888777999999999999999999999999
Q ss_pred ccccccc
Q 000715 138 CDFGLAR 144 (1335)
Q Consensus 138 iDFGLAr 144 (1335)
+||--+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9997554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=7.4e-06 Score=96.22 Aligned_cols=234 Identities=16% Similarity=0.222 Sum_probs=148.6
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhC-CCCCcceEEEE------EEe-CCEEEEEEeec
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSL-DHPNVLRFYSW------YET-SAHLWLVLEYC 78 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL-~HPNIVrL~dv------fed-s~~lyLVMEY~ 78 (1335)
...||+|+-+.+|-.-...+ -+.|+..+--.....+.+..|... .||-+-.-+.| .-+ ...+.+.|..+
T Consensus 16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v 92 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV 92 (637)
T ss_pred CccccCCccceeeecchhhc---hhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence 45799999999996543322 345777654433333344444443 56654331222 112 23377889888
Q ss_pred CCCCHHHHH-------HhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCC
Q 000715 79 VGGDLMSLL-------RQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 79 eGGSL~dlI-------kq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~ 151 (1335)
.|..--..+ +.......+...+..+.++.+...||++|.+-+|+.++|+|+++++.+.|.|-..-..-.. +
T Consensus 93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n-g- 170 (637)
T COG4248 93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN-G- 170 (637)
T ss_pred CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccC-C-
Confidence 776332222 1223577889999999999999999999999999999999999999999998764332211 1
Q ss_pred CCCCCCCCCccCCCCCCCcchhcc----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCCC-------HHH--HHHHH---
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEE----GGVHSYASDLWGLGCVLYECYAG-RPPFVGRE-------FTQ--LVKSI--- 214 (1335)
Q Consensus 152 ~~ss~l~~t~~GTp~YmAPEVL~~----~~~yS~kSDIWSLGVILYELLTG-rpPF~g~d-------~~e--LikkI--- 214 (1335)
...-..+|.+.|.+||.-.- +-.-+...|.|.||+++++++.| +.||.+-. ..+ +..-.
T Consensus 171 ----~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y 246 (637)
T COG4248 171 ----TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY 246 (637)
T ss_pred ----ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence 11123469999999997531 22234578999999999999886 99997631 111 11100
Q ss_pred ---hcCCCCC-----CCCCCChhHHHHHHHhccc--CCCCCCCHH
Q 000715 215 ---LSDPSPP-----LPGNPSRPFANLINSLLVK--DPAQRLHWS 249 (1335)
Q Consensus 215 ---l~~~~~p-----ip~~iS~eL~DLIkkcLqk--DPsKRPTAe 249 (1335)
......+ .....++.+..++.+|+.. ++.-|||++
T Consensus 247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 0111111 1233467788888888864 355788764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.1e-05 Score=84.16 Aligned_cols=136 Identities=26% Similarity=0.356 Sum_probs=84.3
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCch-hHHHHHHHHHHHHhCCCC--CcceEEEEE---EeCCEEEEEEeecCC
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-QKSKVLQEVRMLHSLDHP--NVLRFYSWY---ETSAHLWLVLEYCVG 80 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-~~e~LlrEIqILkkL~HP--NIVrL~dvf---eds~~lyLVMEY~eG 80 (1335)
++.|+.|..+.||+..... + .|++|..... ....+.+|..+++.+... .+.+++... ......+++|++++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 5789999999999999877 4 7899998776 566788899988888433 345566533 333457999999999
Q ss_pred CCHHH----------------HHH---hC----CCCCHH------HHHH---H------------HHHHHH-HHHHHHH-
Q 000715 81 GDLMS----------------LLR---QD----NQLPED------SIRD---L------------AQDLVR-ALQYLHS- 114 (1335)
Q Consensus 81 GSL~d----------------lIk---q~----~~LSEe------qIr~---I------------~rQILs-GLkYLHs- 114 (1335)
..+.. .+. +. ..+... .... . ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 98887 111 11 011100 0000 0 111222 3333332
Q ss_pred ------CCCcccCCCCCCeEEC-CCCCeeeccccccc
Q 000715 115 ------KGIIYCDLKPSNILLD-ENGRTKLCDFGLAR 144 (1335)
Q Consensus 115 ------kGIVHRDIKPENILID-edG~VKLiDFGLAr 144 (1335)
..++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 4599999999999999 66777899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.27 E-value=9e-06 Score=89.14 Aligned_cols=131 Identities=16% Similarity=0.202 Sum_probs=99.0
Q ss_pred eccCcEEEEEEEECCCCeEEEEEEcCc---------hhHHHHHHHHHHHHhCCCCC--cceEEEEEE---e--CCEEEEE
Q 000715 11 GRGKYSTVYKGRKKKTIEYFAIKSVDK---------SQKSKVLQEVRMLHSLDHPN--VLRFYSWYE---T--SAHLWLV 74 (1335)
Q Consensus 11 GeGgFGtVYkArdk~TGk~VAIKiIdK---------e~~e~LlrEIqILkkL~HPN--IVrL~dvfe---d--s~~lyLV 74 (1335)
|+||.+.|+.....+. .|-+|.... --...+.+|+..+.++..-+ +.++. ++. . ....++|
T Consensus 27 ~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 6799999998765443 577887641 12456889999998884322 44444 222 1 2346899
Q ss_pred EeecCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCC--eeeccccccc
Q 000715 75 LEYCVG-GDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGR--TKLCDFGLAR 144 (1335)
Q Consensus 75 MEY~eG-GSL~dlIkq~--~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~--VKLiDFGLAr 144 (1335)
+|-+.| .+|.+++.+. .+.++.+...++.++...+.-||+.|+.|+|+-+.||+++.+|. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997754 5888887663 35688888999999999999999999999999999999987777 9999998654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.4e-06 Score=102.53 Aligned_cols=137 Identities=23% Similarity=0.331 Sum_probs=93.8
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCchhHH-------------------------------------------HHH
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-------------------------------------------KVL 44 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e-------------------------------------------~Ll 44 (1335)
+.|+.++-|.||+|+.++ |+.||||+....-.. ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 467889999999999887 899999987432110 134
Q ss_pred HHHHHHHhC-----CCCCcceEEEEEEeCCEEEEEEeecCCCCHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 000715 45 QEVRMLHSL-----DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLL--RQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117 (1335)
Q Consensus 45 rEIqILkkL-----~HPNIVrL~dvfeds~~lyLVMEY~eGGSL~dlI--kq~~~LSEeqIr~I~rQILsGLkYLHskGI 117 (1335)
+|..-+.++ +.|++.-..=+.+-.+.-.++|||++|-.+.+.. +. ..++...+...+.++ -+..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 455544444 3455444444445566668999999999998884 33 445533333222221 1233445899
Q ss_pred cccCCCCCCeEECCCCCeeeccccccccccC
Q 000715 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSD 148 (1335)
Q Consensus 118 VHRDIKPENILIDedG~VKLiDFGLAr~l~e 148 (1335)
+|.|.+|.||+++.+|.+.+.|||+...+.+
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 9999999999999999999999999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.7e-05 Score=87.65 Aligned_cols=132 Identities=21% Similarity=0.280 Sum_probs=86.4
Q ss_pred CcEEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHH------------HHHHHHHHHHhCCC---CCcceEEEEE-
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS------------KVLQEVRMLHSLDH---PNVLRFYSWY- 65 (1335)
Q Consensus 2 nrYeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e------------~LlrEIqILkkL~H---PNIVrL~dvf- 65 (1335)
++|...+.+-......|.+..- .|+.|++|........ ...+++..+.++.. .....++-+.
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 3577777777777666666543 3477889987543211 12334444444422 2233333222
Q ss_pred ----EeCCEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeecccc
Q 000715 66 ----ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFG 141 (1335)
Q Consensus 66 ----eds~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFG 141 (1335)
.-....+++|||++|..|.+... +++ .+...+.+++.-+|+.|++|+|.+|.|++++++ .++++||+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~ 179 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQ 179 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECc
Confidence 23345678999999998876532 222 244567788999999999999999999999865 49999998
Q ss_pred ccc
Q 000715 142 LAR 144 (1335)
Q Consensus 142 LAr 144 (1335)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.4e-05 Score=87.47 Aligned_cols=132 Identities=14% Similarity=0.199 Sum_probs=84.9
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCch-hHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEEEEEeecCCCC-H
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-QKSKVLQEVRMLHSLDHPN--VLRFYSWYETSAHLWLVLEYCVGGD-L 83 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-~~e~LlrEIqILkkL~HPN--IVrL~dvfeds~~lyLVMEY~eGGS-L 83 (1335)
..||.|..+.||+. .|..+++|..... ....+.+|.++++.+..-+ +.+++++....+..++|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 57899999999983 2445788987653 3556789999999885433 4677888788888899999999974 1
Q ss_pred H--------------HHHHh-----C----CCCCHHH-HHHHHHH----------HHHH-HHHHH----HCCCcccCCCC
Q 000715 84 M--------------SLLRQ-----D----NQLPEDS-IRDLAQD----------LVRA-LQYLH----SKGIIYCDLKP 124 (1335)
Q Consensus 84 ~--------------dlIkq-----~----~~LSEeq-Ir~I~rQ----------ILsG-LkYLH----skGIVHRDIKP 124 (1335)
. ..+.+ + ....... ...+..+ +... ..+|. ...++|+|++|
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~ 162 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI 162 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence 1 11111 0 0111111 0111100 1111 12222 12478999999
Q ss_pred CCeEECCCCCeeeccccccc
Q 000715 125 SNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 125 ENILIDedG~VKLiDFGLAr 144 (1335)
.||+++++| +.++||+.+.
T Consensus 163 ~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 163 GNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CcEEEcCCC-cEEEechhcC
Confidence 999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PLN03200 cellulose synthase-interactive protein; Provisional | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.9e-05 Score=106.98 Aligned_cols=617 Identities=17% Similarity=0.165 Sum_probs=345.2
Q ss_pred HHHHHHhcCccch-hhHhhcchhHHHHHHHhcccCCchHHHHHHHHHHHHhhcccccccccccchhhhhhhhhhhh-HHH
Q 000715 553 IRYLEMLSSNADA-ANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLRD-KQE 630 (1335)
Q Consensus 553 ~~yl~~v~~~~~~-a~~~~~~~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~~~~~~~~~~~~~~~~~-~~~ 630 (1335)
..-|..+|.+.+- +..++..-..+.++++|+. .+++.+..+++++..++.|..+.-+-.-..|++-.|.+.+++ ...
T Consensus 168 v~AL~nLs~~~en~~~~IIeaGaVp~LV~LLsS-~d~~lQ~eAa~aLa~Lass~ee~~~aVIeaGaVP~LV~LL~sg~~~ 246 (2102)
T PLN03200 168 TGALRNLCGSTDGFWSATLEAGGVDILVKLLSS-GNSDAQANAASLLARLMMAFESSISKVLDAGAVKQLLKLLGQGNEV 246 (2102)
T ss_pred HHHHHHHhcCccchHHHHHHcCCHHHHHHHHcC-CCHHHHHHHHHHHHHHHcCChHHHHHHHHCCCHHHHHHHHccCCCh
Confidence 3456666677763 4556677788999999985 889999999999999998877666656678899999999986 556
Q ss_pred HHHHHHHHhhhhheeeeeecCCccCCCCCCCCCCcCcccccccccchhHHHHHHHHHhcCcch--------hhHHHHHHH
Q 000715 631 KVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDD--------MTQLYALRT 702 (1335)
Q Consensus 631 ~~~~~~~~~~ge~~~~~~~q~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~~~~~--------~~~~~~~~~ 702 (1335)
+||.....+|+.+-. .+...+ + .-+=.+.+..+..+++...++ .++..|+.+
T Consensus 247 ~VRE~AA~AL~nLAs----~s~e~r----------~------~Iv~aGgIp~LI~lL~sp~~e~~~~~~~~~Lqe~AvwA 306 (2102)
T PLN03200 247 SVRAEAAGALEALSS----QSKEAK----------Q------AIADAGGIPALINATVAPSKEFMQGEFAQALQENAMGA 306 (2102)
T ss_pred HHHHHHHHHHHHHhc----CCHHHH----------H------HHHHCCCHHHHHHHHhCcchhhhccccchHHHHHHHHH
Confidence 999999999988753 221111 0 011122233444455433333 357789999
Q ss_pred HHhhhccCCceeeeee----h-------hhhcccceeeee-ccCccceee-ccccce---eEEEeecCCchh--HHHHhh
Q 000715 703 IENICSQGGHWVARFT----S-------QDVISNLCYIYR-ATGKQESMR-LTAGSC---LVRLVRFNAPSM--QSVMDK 764 (1335)
Q Consensus 703 ~~~~~~~~~~~~~~~~----~-------~~~~~~~~~~~~-~~~~~~~~~-~~~~~~---~~~~~~~~~~~~--~~~~~~ 764 (1335)
+-|||.-+.+-...+. + -|.++-++|+.+ ..+..|..+ .-+|.| ||+|.|=.-|.. +.|.+-
T Consensus 307 LsNIcgg~~~ll~~L~~ll~s~rd~~~~ada~gALayll~l~d~~~~~~~~i~~~~v~~~LV~Llr~k~p~~vqe~V~eA 386 (2102)
T PLN03200 307 LANICGGMSALILYLGELSESPRSPAPIADTLGALAYALMVFDSSAESTRAFDPTVIEQILVKLLKPRDTKLVQERIIEA 386 (2102)
T ss_pred HHHHhCCchhhHHHHHHhhcccchHHHHHHHHhhHHHHHHhcCCchhhhhhccccccHHHHHHHhCCCCCchhHHHHHHH
Confidence 9999953322111111 1 166788889844 344444444 223455 888888654443 334443
Q ss_pred c-----------------cHHHHHHhhhcCCccch-hhhhhhhhHHhhhhhhhccccccccccccccccchhhHHhhhcc
Q 000715 765 L-----------------SIKDIASSLIKGSPREQ-QISLNLLNLAMLGSQMCTNIGRNLLPLVEDKNLVPSLVSLTEQG 826 (1335)
Q Consensus 765 ~-----------------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (1335)
+ -+|-|+.-|..++...| |.+.+|.|++--+ .+....+-++.-+|.|+.++.-|
T Consensus 387 Lasl~gN~~l~~~L~~~daik~LV~LL~~~~~evQ~~Av~aL~~L~~~~--------~e~~~aIi~~ggIp~LV~LL~s~ 458 (2102)
T PLN03200 387 LASLYGNAYLSRKLNHAEAKKVLVGLITMATADVQEELIRALSSLCCGK--------GGLWEALGGREGVQLLISLLGLS 458 (2102)
T ss_pred HHHhcCChHHHHHHHhccchhhhhhhhccCCHHHHHHHHHHHHHHhCCC--------HHHHHHHHHcCcHHHHHHHHcCC
Confidence 3 12223333333444333 3445555543222 22233334566799999999999
Q ss_pred cccccchhhHHHHHHhccCc--eeeecccccccchhhhcccchhhhhHHH-HHHHHHHHHHHHhhhhhHHHHHHHHHHhh
Q 000715 827 SEVLRGKALVFVSLLCKNGR--RWLLHFFCNSRLLSSVDRLGKEKDSFLQ-QCLEAFVHVVASIIPGLLDIITGDIQQMM 903 (1335)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 903 (1335)
++..+-.|...+..|++.+. |+.. +++-.+|.+-++-+-.+.-+| ++.- .|-|++
T Consensus 459 s~~iQ~~A~~~L~nLa~~ndenr~aI---ieaGaIP~LV~LL~s~~~~iqeeAaw-------------------AL~NLa 516 (2102)
T PLN03200 459 SEQQQEYAVALLAILTDEVDESKWAI---TAAGGIPPLVQLLETGSQKAKEDSAT-------------------VLWNLC 516 (2102)
T ss_pred CHHHHHHHHHHHHHHHcCCHHHHHHH---HHCCCHHHHHHHHcCCCHHHHHHHHH-------------------HHHHHh
Confidence 99899888888888888553 3322 223344444332221121111 1111 222222
Q ss_pred CCcccccccccccccCCccccchhHHHHHHhccccccCccCCHHHHHHHHHHHHHHHhccCCchHHHHHHHHHHHhhhcc
Q 000715 904 GGRRHGQISAITSRAAPKTNVHLFPVVLHLLGSSSFKNRVVSPPVLQQLANLCKVVETQFQGRDDFQITLLRILESISEE 983 (1335)
Q Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 983 (1335)
+. ..+.+.+ . .....+|..++++.+..++-| ...+.-|++|++. | |..
T Consensus 517 ~~--~~qir~i-----V-~~aGAIppLV~LL~sgd~~~q---~~Aa~AL~nLi~~------~-d~~-------------- 564 (2102)
T PLN03200 517 CH--SEDIRAC-----V-ESAGAVPALLWLLKNGGPKGQ---EIAAKTLTKLVRT------A-DAA-------------- 564 (2102)
T ss_pred CC--cHHHHHH-----H-HHCCCHHHHHHHHhCCCHHHH---HHHHHHHHHHHhc------c-chh--------------
Confidence 21 1011110 0 012457788999998877555 3344444444332 1 111
Q ss_pred cccccCCCcceeecccccchhhcccCCCCcchhhhhhhhhhhHHhhcCCcchhHHHhhhhcccccCCCCCCCCccccCCC
Q 000715 984 SNVILGNPEIFFHEILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEPVEDEQRLQDLKSISNSHFLPLYPTLIEDED 1063 (1335)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1335)
.+|+|+.|+.+ ++..+..-+++.|.-...+.-.++ ...+. ..+..-+|....|+..++
T Consensus 565 --------------~I~~Lv~LLls-dd~~~~~~aL~vLgnIlsl~~~~d----~~~~g---~~~~ggL~~Lv~LL~sgs 622 (2102)
T PLN03200 565 --------------TISQLTALLLG-DLPESKVHVLDVLGHVLSVASLED----LVREG---SAANDALRTLIQLLSSSK 622 (2102)
T ss_pred --------------HHHHHHHHhcC-CChhHHHHHHHHHHHHHhhcchhH----HHHHh---hhccccHHHHHHHHcCCC
Confidence 22778888887 788888888886654433211111 01111 111245677777777665
Q ss_pred Ccc-hhHHHHHHHHHHhccchhhhhhhhhchhhHHHHHhhc-ccccchhhHHHHHHhhcCCcchHHHHHHHHHHHHHHHH
Q 000715 1064 PIP-MYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGD-LSSANVSNVKLCLALASAPEMESKLLSQLKVVRRIGNL 1141 (1335)
Q Consensus 1064 ~~p-~ya~k~l~~l~e~~~~~~~~v~~~~~~~~~f~~~~~~-l~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~v~~i~~l 1141 (1335)
+.= ..|...|..+...+.-...-|...|.++.+-+-|... ..=...-..+|.++.....+-+-..+-+.|+|+-+|+|
T Consensus 623 ~~ikk~Aa~iLsnL~a~~~d~~~avv~agaIpPLV~LLss~~~~v~keAA~AL~nL~~~~~~~q~~~~v~~GaV~pL~~L 702 (2102)
T PLN03200 623 EETQEKAASVLADIFSSRQDLCESLATDEIINPCIKLLTNNTEAVATQSARALAALSRSIKENRKVSYAAEDAIKPLIKL 702 (2102)
T ss_pred HHHHHHHHHHHHHHhcCChHHHHHHHHcCCHHHHHHHHhcCChHHHHHHHHHHHHHHhCCCHHHHHHHHHcCCHHHHHHH
Confidence 433 4555555555554444455566667777766655432 11122345566666666666666677899999999999
Q ss_pred HHHHHhhcccccccchHHHHHH---HHHhhccccccccccCCccccccccccccc----------------ccchHHHHH
Q 000715 1142 LELVYAKDMEDFLEPTLGLCRA---FLLRSVSSRKGFNYTKEPALLGDCSAEYGT----------------AIDQQQSIR 1202 (1335)
Q Consensus 1142 l~~~~~~~~e~~~~~~~~~~~~---~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~d~q~~~~ 1202 (1335)
|.-- +.. -.+.|-+ -|++--+...-+.-......|+.--. .|+ ..+..+.+.
T Consensus 703 L~~~-----d~~---v~e~Al~ALanLl~~~e~~~ei~~~~~I~~Lv~lLr-~G~~~~k~~Aa~AL~~L~~~~~~~~~~~ 773 (2102)
T PLN03200 703 AKSS-----SIE---VAEQAVCALANLLSDPEVAAEALAEDIILPLTRVLR-EGTLEGKRNAARALAQLLKHFPVDDVLK 773 (2102)
T ss_pred HhCC-----ChH---HHHHHHHHHHHHHcCchHHHHHHhcCcHHHHHHHHH-hCChHHHHHHHHHHHHHHhCCChhHHHH
Confidence 9421 111 1111111 11221111110010111222222111 222 222223355
Q ss_pred hhhhccCceEEEEeccCCCcchhhhh--hhHHHHHHhhcCCcc-----cchhhccchHHHHHHHHHHhhcchHHHHHHHH
Q 000715 1203 DIMDFSGNVGVFLKLSCSQEANVADV--ASECVVLLLKAAPRE-----GTTGFLTNLAKVTAILESWRRGTSHLILQRVL 1275 (1335)
Q Consensus 1203 d~~~~~~~~~~~~~l~~~~~~~i~~~--as~c~~l~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1275 (1335)
|-.-.-|.|--+..++...|.++.++ |=+-+.+|.++--+. .-.+|.-+-.-+.-+.+-+-++ ...++.+-+
T Consensus 774 ~~~~~~g~v~~l~~~L~~~~~~~~~~~~al~~l~~l~~~~~~~~~~~~~~~~~~e~p~~l~~l~~~l~~~-~p~~~~kai 852 (2102)
T PLN03200 774 DSVQCRGTVLALVDLLNSTDLDSSATSEALEALALLARTKGGANFSHPPWAVLAEVPSSLEPLVRCLAEG-HPLVQDKAI 852 (2102)
T ss_pred HHHHHhCcHHHHHHHHhcCCcchhhHHHHHHHHHHHHhhcccCCCCCCchhhHHhccCchHHHHHHHHcC-ChHHHHHHH
Confidence 55566777777888899999999998 899999999852222 3345555545555565666666 667888888
Q ss_pred HHHHhhHHH
Q 000715 1276 HALGYSCRQ 1284 (1335)
Q Consensus 1276 ~~~~~~~~~ 1284 (1335)
.-|.-=|+.
T Consensus 853 ~il~~~~~~ 861 (2102)
T PLN03200 853 EILSRLCRD 861 (2102)
T ss_pred HHHHHHhcc
Confidence 888877864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.5e-07 Score=112.33 Aligned_cols=242 Identities=22% Similarity=0.269 Sum_probs=170.5
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEeecCCC-
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPN-VLRFYSWYETSAHLWLVLEYCVGG- 81 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HPN-IVrL~dvfeds~~lyLVMEY~eGG- 81 (1335)
|.....+++|++++++|.+...+...+ .+++... ....-++++|.+++||| .+..++-++.+...+++|+++.++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 334455789999999999988876655 7777666 33456888999999999 777777778888999999999887
Q ss_pred CHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCC
Q 000715 82 DLMSLL-RQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 82 SL~dlI-kq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t 160 (1335)
+....+ ...-.+.+.+.....+.-+.+++|+|+.-=+||| ||+..+ +..|..||+....+.... .+.+
T Consensus 321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~------~~~t 389 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM------KPRT 389 (829)
T ss_pred cccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc------cccc
Confidence 222221 1222456667778888999999999999889999 777654 688999999887765433 2456
Q ss_pred ccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCChhHH-HHHHH
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP-SPPLP--GNPSRPFA-NLINS 236 (1335)
Q Consensus 161 ~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTGrpPF~g~d~~eLikkIl~~~-~~pip--~~iS~eL~-DLIkk 236 (1335)
..+++.++|||+...+ .+....|.|++|+--.+|--|-+|-...- .....+-.++ .+.+. ...++... ++...
T Consensus 390 ~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~ 466 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAP 466 (829)
T ss_pred CCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcccccCCccc
Confidence 7899999999988644 45668899999987777777777653311 0000000010 00000 01112222 47788
Q ss_pred hcccCCCCCCCHHHHhcCccccccCC
Q 000715 237 LLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 237 cLqkDPsKRPTAeEILkHPfFq~~l~ 262 (1335)
|+...|..|+....++.|.+|..-+.
T Consensus 467 ~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 467 CLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred ccCCCCCCCcchhhHHHHHHhccCcc
Confidence 99999999999999999999976543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.8e-05 Score=85.74 Aligned_cols=76 Identities=18% Similarity=0.223 Sum_probs=56.1
Q ss_pred EEeccCc-EEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeecCCCCHHHH
Q 000715 9 AIGRGKY-STVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLD-HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSL 86 (1335)
Q Consensus 9 ~LGeGgF-GtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~-HPNIVrL~dvfeds~~lyLVMEY~eGGSL~dl 86 (1335)
.|-.|.+ +.||+....+ ..+.+|+........+.+|+++++.+. +--+.+++++....+..++|||+++|.++...
T Consensus 5 ~~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 5 RVTEGQSGATVYRLDGKN--PGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred ecCCCCCcCeEEEEcCCC--CcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 4555665 6899987543 568899887654556778999988883 44466778777777778999999999887643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.7e-06 Score=100.12 Aligned_cols=132 Identities=9% Similarity=-0.011 Sum_probs=105.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCcccCC-----cCCCCCCCCCccccccccCCCCCCCCccccccccchhhhccc
Q 000715 412 RNGNHSGTPSAEGMPVSDESRKQDRESSPERVE-----VAATPPTVSPQLKTTRIREGSGPPLDSESSRSSNSLSQVLWH 486 (1335)
Q Consensus 412 ~~~s~~stps~e~~~l~~s~~p~p~tS~p~~~p-----~a~~~P~~pp~~k~~~~~~~~~~~~~~~~~~ss~~~~~~~~~ 486 (1335)
+++....++.+|+|+. .++++++.++.+..+- ....+-.++|. .++|.+ +..++..+| .+.++++|
T Consensus 315 ~~k~~l~g~a~E~~~~-ls~~a~~~~~~~vl~~~~~~~~~lsg~~aspl---~~~p~~---ns~t~eV~s--~~re~~~t 385 (808)
T KOG0597|consen 315 KAKAKLPGRATEEKHG-LSPAANRQVNILVLSRIAKANLQLSGEKASPL---RPLPNS---NSNTAEVKS--DNREMELT 385 (808)
T ss_pred cccccCCCcCchhhhc-CCCCCCCCcceeeecccchhhhhccccccccc---ccCCCc---CCcceeccC--chhhhccC
Confidence 3444556678888898 8888888888776442 12222334443 223333 456666777 89999999
Q ss_pred CCCceeeccCCCcccccccCcc---CCCCCCccchhhhccCCHHHHHHHHHHHHHhhcCCc----chhhhhhH
Q 000715 487 PSDLSVRPVMPSRKADKVSEVF---PSLPFEALKASDFVKMSKEQLDALNARILAVLNGNS----SIGEKQNV 552 (1335)
Q Consensus 487 ~sdl~v~pi~~~~k~~~~~~~~---k~l~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~----~~~~k~n~ 552 (1335)
++|..+.|++|+++.++++++. +.++.+.+...+.++.+.++|++|+++.|.++++.+ +-+||+|.
T Consensus 386 ~ddn~dfp~~d~~~g~~~~p~v~d~~~~s~~~d~e~q~L~~~~~p~~~~L~~~~~~l~~~~~c~~aqsekhn~ 458 (808)
T KOG0597|consen 386 FDDNNDFPGPDESEGTENTPCVQDERVMSHNEDHERQRLVSSNVPDENSLANETPTLGEARDCHEAQSEKHNM 458 (808)
T ss_pred cccccCCcCCCccccccCCCccchhhhcCCcchhHHHHhhhcCCCchhhhcCcCccccchhhHHHHHhhhhcc
Confidence 9999999999999999999998 999999999999999999999999999999999985 88999996
|
|
| >PLN03200 cellulose synthase-interactive protein; Provisional | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00042 Score=94.49 Aligned_cols=569 Identities=14% Similarity=0.162 Sum_probs=312.0
Q ss_pred HHHHHhhcCCcchhhhhhHHHHHHHhcCc-cchhhHhhcchhHHHHHHHhcccCCchHHHHHHHHHHHHhhccccccccc
Q 000715 534 ARILAVLNGNSSIGEKQNVIRYLEMLSSN-ADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDL 612 (1335)
Q Consensus 534 ~~~~~~~~~~~~~~~k~n~~~yl~~v~~~-~~~a~~~~~~~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~~ 612 (1335)
..+...|++ .....+.|-...|..+|.+ .+....++..-..+.|++.|+...++.+|..+||++|-+++|+.+..+-.
T Consensus 192 p~LV~LLsS-~d~~lQ~eAa~aLa~Lass~ee~~~aVIeaGaVP~LV~LL~sg~~~~VRE~AA~AL~nLAs~s~e~r~~I 270 (2102)
T PLN03200 192 DILVKLLSS-GNSDAQANAASLLARLMMAFESSISKVLDAGAVKQLLKLLGQGNEVSVRAEAAGALEALSSQSKEAKQAI 270 (2102)
T ss_pred HHHHHHHcC-CCHHHHHHHHHHHHHHHcCChHHHHHHHHCCCHHHHHHHHccCCChHHHHHHHHHHHHHhcCCHHHHHHH
Confidence 344444544 4456777888877767755 67888999999999999999987778999999999999999999988888
Q ss_pred ccchhhhhhhhhhhhH---------HHHHHHHHHHhhhhhe-------eeeeecCCccCCCCCCCCCCcCcccccccccc
Q 000715 613 ANSGILGSLTDGLRDK---------QEKVRRFSMAALGELL-------FYISTQNEHARDSNPPESPSKDNRTASGWQVP 676 (1335)
Q Consensus 613 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~ge~~-------~~~~~q~~~~~~~~~~~~~~~~~~~~~~~~~p 676 (1335)
-.-|++..|.+.+... +.-+++..+-+||.+- .|.+..-.+.+| ...-..-+|+++
T Consensus 271 v~aGgIp~LI~lL~sp~~e~~~~~~~~~Lqe~AvwALsNIcgg~~~ll~~L~~ll~s~rd--------~~~~ada~gALa 342 (2102)
T PLN03200 271 ADAGGIPALINATVAPSKEFMQGEFAQALQENAMGALANICGGMSALILYLGELSESPRS--------PAPIADTLGALA 342 (2102)
T ss_pred HHCCCHHHHHHHHhCcchhhhccccchHHHHHHHHHHHHHhCCchhhHHHHHHhhcccch--------HHHHHHHHhhHH
Confidence 8899999999998642 2345788888888644 222211111100 001123345544
Q ss_pred hhHHH---------H---------HHHHHhcCcchhhHHHHHHHHHhhhccCCceeeeeehhhhcccceeeeeccCccce
Q 000715 677 NSLIS---------L---------VSSVLRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQES 738 (1335)
Q Consensus 677 ~~~~~---------~---------~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 738 (1335)
..+.- + +..++|...+.+.+-++..++-.+..-.-- ...+...|++.-|=-.... +-+ -
T Consensus 343 yll~l~d~~~~~~~~i~~~~v~~~LV~Llr~k~p~~vqe~V~eALasl~gN~~l-~~~L~~~daik~LV~LL~~-~~~-e 419 (2102)
T PLN03200 343 YALMVFDSSAESTRAFDPTVIEQILVKLLKPRDTKLVQERIIEALASLYGNAYL-SRKLNHAEAKKVLVGLITM-ATA-D 419 (2102)
T ss_pred HHHHhcCCchhhhhhccccccHHHHHHHhCCCCCchhHHHHHHHHHHhcCChHH-HHHHHhccchhhhhhhhcc-CCH-H
Confidence 33210 0 112222222222232222222110000000 0000001100000000000 011 1
Q ss_pred eeccccceeEEEeecCCchhHHHHhhccHHHHHHhhhcCCccchhhhhhhh-hHHhhhhhhhccccccccccccccccch
Q 000715 739 MRLTAGSCLVRLVRFNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLNLL-NLAMLGSQMCTNIGRNLLPLVEDKNLVP 817 (1335)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (1335)
++.-|--||--|...+....+.|.++-.+.-|+.-|-.++...|...+-.+ |++- |+ -++-+.++ +-+.+|
T Consensus 420 vQ~~Av~aL~~L~~~~~e~~~aIi~~ggIp~LV~LL~s~s~~iQ~~A~~~L~nLa~-~n------denr~aIi-eaGaIP 491 (2102)
T PLN03200 420 VQEELIRALSSLCCGKGGLWEALGGREGVQLLISLLGLSSEQQQEYAVALLAILTD-EV------DESKWAIT-AAGGIP 491 (2102)
T ss_pred HHHHHHHHHHHHhCCCHHHHHHHHHcCcHHHHHHHHcCCCHHHHHHHHHHHHHHHc-CC------HHHHHHHH-HCCCHH
Confidence 222333344445555666677788888888888888888776666665555 3321 21 11112223 457899
Q ss_pred hhHHhhhcccccccchhhHHHHHHhccCceeeecccccccchhhhcccchhhhhHHH--HHHHHHHHHHHHhhhhhHHHH
Q 000715 818 SLVSLTEQGSEVLRGKALVFVSLLCKNGRRWLLHFFCNSRLLSSVDRLGKEKDSFLQ--QCLEAFVHVVASIIPGLLDII 895 (1335)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 895 (1335)
.|+.+++.|..-.+--|...+.-||.+. .+++..+. .|+..+++.+.+--+..-...
T Consensus 492 ~LV~LL~s~~~~iqeeAawAL~NLa~~~---------------------~qir~iV~~aGAIppLV~LL~sgd~~~q~~A 550 (2102)
T PLN03200 492 PLVQLLETGSQKAKEDSATVLWNLCCHS---------------------EDIRACVESAGAVPALLWLLKNGGPKGQEIA 550 (2102)
T ss_pred HHHHHHcCCCHHHHHHHHHHHHHHhCCc---------------------HHHHHHHHHCCCHHHHHHHHhCCCHHHHHHH
Confidence 9999999999999988888888888632 11222221 244455555444444444444
Q ss_pred HHHHHHhhCCcccccccccccccCCccccchhHHHHHHhccccccCccCCHHHHHHHHHHHHHHHhc-------------
Q 000715 896 TGDIQQMMGGRRHGQISAITSRAAPKTNVHLFPVVLHLLGSSSFKNRVVSPPVLQQLANLCKVVETQ------------- 962 (1335)
Q Consensus 896 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 962 (1335)
...|.+..-+-...++ |-.+.|+.+..-+.+ ..++.-+|++++..+.+
T Consensus 551 a~AL~nLi~~~d~~~I----------------~~Lv~LLlsdd~~~~---~~aL~vLgnIlsl~~~~d~~~~g~~~~ggL 611 (2102)
T PLN03200 551 AKTLTKLVRTADAATI----------------SQLTALLLGDLPESK---VHVLDVLGHVLSVASLEDLVREGSAANDAL 611 (2102)
T ss_pred HHHHHHHHhccchhHH----------------HHHHHHhcCCChhHH---HHHHHHHHHHHhhcchhHHHHHhhhccccH
Confidence 4445444322111111 223344555442211 12444555554433211
Q ss_pred -------cCCchHHHHHHHHHHHhhhcccccccCCCcceeecccccchhhcccCCCCcchhhhhhhhhhhHHhhcCCcch
Q 000715 963 -------FQGRDDFQITLLRILESISEESNVILGNPEIFFHEILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEPVE 1035 (1335)
Q Consensus 963 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1335)
-.|+++-++....+++.|.....=+ ....+...++|||+.|.+++. -+-|--+-.-|+-.+ +. ..
T Consensus 612 ~~Lv~LL~sgs~~ikk~Aa~iLsnL~a~~~d~--~~avv~agaIpPLV~LLss~~-~~v~keAA~AL~nL~----~~-~~ 683 (2102)
T PLN03200 612 RTLIQLLSSSKEETQEKAASVLADIFSSRQDL--CESLATDEIINPCIKLLTNNT-EAVATQSARALAALS----RS-IK 683 (2102)
T ss_pred HHHHHHHcCCCHHHHHHHHHHHHHHhcCChHH--HHHHHHcCCHHHHHHHHhcCC-hHHHHHHHHHHHHHH----hC-CC
Confidence 1236666777777777766432111 122567889999999999843 333332222222221 11 11
Q ss_pred hHHHhhhhcccccCCCCCCCCccccCCCCcc-hhHHHHHHHHHHhccchhhhhhhhhchhhHHHHHhhcccccchhhHHH
Q 000715 1036 DEQRLQDLKSISNSHFLPLYPTLIEDEDPIP-MYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGDLSSANVSNVKL 1114 (1335)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p-~ya~k~l~~l~e~~~~~~~~v~~~~~~~~~f~~~~~~l~~~~~~~~~l 1114 (1335)
.+++..-+ . ...+|-.-.++..+|..- .-|+.-|..+...+-.. ..+.+.+.++.+.++|.+.-....-+..+.
T Consensus 684 ~~q~~~~v---~-~GaV~pL~~LL~~~d~~v~e~Al~ALanLl~~~e~~-~ei~~~~~I~~Lv~lLr~G~~~~k~~Aa~A 758 (2102)
T PLN03200 684 ENRKVSYA---A-EDAIKPLIKLAKSSSIEVAEQAVCALANLLSDPEVA-AEALAEDIILPLTRVLREGTLEGKRNAARA 758 (2102)
T ss_pred HHHHHHHH---H-cCCHHHHHHHHhCCChHHHHHHHHHHHHHHcCchHH-HHHHhcCcHHHHHHHHHhCChHHHHHHHHH
Confidence 22222221 1 334444555666666554 67777778888777654 344556779999999999988888888988
Q ss_pred HHHhhcCCcchH---HHHHHHHHHHHHHHHHHHHHhhcccccccc-hHHHHHHHHHhhccccccccccCCcc
Q 000715 1115 CLALASAPEMES---KLLSQLKVVRRIGNLLELVYAKDMEDFLEP-TLGLCRAFLLRSVSSRKGFNYTKEPA 1182 (1335)
Q Consensus 1115 ~~~~~~~~~~~~---~~l~~~~~v~~i~~ll~~~~~~~~e~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~ 1182 (1335)
+..|......+- ....+.|.|..++-+|. +-|+|...-. .|. +=++|.| .++|..|+.+|-
T Consensus 759 L~~L~~~~~~~~~~~~~~~~~g~v~~l~~~L~---~~~~~~~~~~~al~-~l~~l~~---~~~~~~~~~~~~ 823 (2102)
T PLN03200 759 LAQLLKHFPVDDVLKDSVQCRGTVLALVDLLN---STDLDSSATSEALE-ALALLAR---TKGGANFSHPPW 823 (2102)
T ss_pred HHHHHhCCChhHHHHHHHHHhCcHHHHHHHHh---cCCcchhhHHHHHH-HHHHHHh---hcccCCCCCCch
Confidence 888888887655 55677777776666664 3344332210 111 2234444 344667776653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.97 E-value=8e-05 Score=95.96 Aligned_cols=203 Identities=25% Similarity=0.312 Sum_probs=145.0
Q ss_pred HHHHHHHHHhCCCCCcceEEEEEEeCCE----EEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 000715 43 VLQEVRMLHSLDHPNVLRFYSWYETSAH----LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118 (1335)
Q Consensus 43 LlrEIqILkkL~HPNIVrL~dvfeds~~----lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIV 118 (1335)
...|...+.++.|+|++.++.|...... ..+..++|.+.++...+..-+..+....+.+..++++|+.|+|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 3456777888999999999988654432 234568899999999999999999999999999999999999999666
Q ss_pred ccCCCCC---CeEECCCCCeeec--cccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCC-CCCchhhHHHHHHHH
Q 000715 119 YCDLKPS---NILLDENGRTKLC--DFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG-VHSYASDLWGLGCVL 192 (1335)
Q Consensus 119 HRDIKPE---NILIDedG~VKLi--DFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~-~yS~kSDIWSLGVIL 192 (1335)
|.-+... +--++.++.+..+ ||+....+....... ....+..|.+||...... ......|+|.+|...
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~------~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF------SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCcccch------hhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 6655555 4444556666666 898877665543322 233456688888775322 122346999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCccccccC
Q 000715 193 YECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 193 YELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~l 261 (1335)
..+..|..+-... ...... .+.....+..+.+.+|+.-++++|+++.+++.|+|.+...
T Consensus 383 ~~~~~~~~i~~~~---~~~~~~-------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 383 LQLSQGEDISEKS---AVPVSL-------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhhhhcCcccccc---cchhhh-------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 9998876552111 111111 1122222788999999999999999999999999976543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00013 Score=81.87 Aligned_cols=134 Identities=25% Similarity=0.297 Sum_probs=93.0
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCchh----------------------HH-----HHHHHHHHHHhCC--CCC
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----------------------KS-----KVLQEVRMLHSLD--HPN 57 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~----------------------~e-----~LlrEIqILkkL~--HPN 57 (1335)
...|+.|.-+.||+|.. .++..+|+|++.... .. -..+|++-|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 33667777789999886 456889999873210 11 1356888887773 444
Q ss_pred cceEEEEEEeCCEEEEEEeecCCCCH-HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCCeEECCCCCe
Q 000715 58 VLRFYSWYETSAHLWLVLEYCVGGDL-MSLLRQDNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRT 135 (1335)
Q Consensus 58 IVrL~dvfeds~~lyLVMEY~eGGSL-~dlIkq~~~LSEeqIr~I~rQILsGLkYLHs-kGIVHRDIKPENILIDedG~V 135 (1335)
+.+.+.+. +-.+||||+..... .-.++ .-++..++...+..++++.+.-|-. .|+||+|++.=|||+. +|.+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 55555543 23789999854311 11111 1233444788899999999998876 8999999999999998 8899
Q ss_pred eecccccccccc
Q 000715 136 KLCDFGLARKLS 147 (1335)
Q Consensus 136 KLiDFGLAr~l~ 147 (1335)
.++|||-+....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999876543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00022 Score=91.46 Aligned_cols=139 Identities=16% Similarity=0.334 Sum_probs=91.0
Q ss_pred EEEEeccCcEEEEEEEECCCC--eEEEEEEcCch----hHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CEEEEE
Q 000715 7 YEAIGRGKYSTVYKGRKKKTI--EYFAIKSVDKS----QKSKVLQEVRMLHSLD-HPNV--LRFYSWYETS---AHLWLV 74 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TG--k~VAIKiIdKe----~~e~LlrEIqILkkL~-HPNI--VrL~dvfeds---~~lyLV 74 (1335)
.+.++.|.++.+|+......+ ..+++|+.... ....+.+|+++++.+. |+++ .+++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 677899999999998765543 46778876432 2356889999999995 6664 7777777654 467899
Q ss_pred EeecCCCCHHH--------------------HHHhCCC----------------CCHHHHHHHHHH--------------
Q 000715 75 LEYCVGGDLMS--------------------LLRQDNQ----------------LPEDSIRDLAQD-------------- 104 (1335)
Q Consensus 75 MEY~eGGSL~d--------------------lIkq~~~----------------LSEeqIr~I~rQ-------------- 104 (1335)
|||++|..+.+ .+..-+. +...++..|..|
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998865321 1111000 112244433332
Q ss_pred -HHHHHHHHHH-----------CCCcccCCCCCCeEECCC-CC-eeecccccccc
Q 000715 105 -LVRALQYLHS-----------KGIIYCDLKPSNILLDEN-GR-TKLCDFGLARK 145 (1335)
Q Consensus 105 -ILsGLkYLHs-----------kGIVHRDIKPENILIDed-G~-VKLiDFGLAr~ 145 (1335)
+...+.+|.. ..++|+|+++.||+++.+ +. .-|.||+++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2223556633 249999999999999853 34 57999998754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00016 Score=88.56 Aligned_cols=137 Identities=20% Similarity=0.271 Sum_probs=88.8
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCchhH----------------------------------H------HHHHHH
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK----------------------------------S------KVLQEV 47 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~----------------------------------e------~LlrEI 47 (1335)
+.||.-+.|.||+|+.+. |+.||||+....-. + ++.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 568899999999999988 89999998743210 0 123444
Q ss_pred HHH----HhCCCCCc---ceEEEEE-EeCCEEEEEEeecCCCCHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 000715 48 RML----HSLDHPNV---LRFYSWY-ETSAHLWLVLEYCVGGDLMSL--LRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117 (1335)
Q Consensus 48 qIL----kkL~HPNI---VrL~dvf-eds~~lyLVMEY~eGGSL~dl--Ikq~~~LSEeqIr~I~rQILsGLkYLHskGI 117 (1335)
+-. +.+.|-+. |.+=.+| .-...-.++|||++|..+.|. |++ ..++...+..-+.+... .-|-..|+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~--~qIf~~Gf 322 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYL--EQIFKTGF 322 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHH--HHHHhcCC
Confidence 332 33345551 1122232 223445899999999987765 333 34555544443333322 23345789
Q ss_pred cccCCCCCCeEECC----CCCeeeccccccccccC
Q 000715 118 IYCDLKPSNILLDE----NGRTKLCDFGLARKLSD 148 (1335)
Q Consensus 118 VHRDIKPENILIDe----dG~VKLiDFGLAr~l~e 148 (1335)
+|+|-+|.||+++. ++.+.+-|||+...+.+
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999983 67899999999876543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00021 Score=77.64 Aligned_cols=72 Identities=17% Similarity=0.205 Sum_probs=47.2
Q ss_pred EEEeccCcE-EEEEEEECCCCeEEEEEEcCch-hHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CEEEEEEeecC
Q 000715 8 EAIGRGKYS-TVYKGRKKKTIEYFAIKSVDKS-QKSKVLQEVRMLHSLDHP---NVLRFYSWYETS---AHLWLVLEYCV 79 (1335)
Q Consensus 8 K~LGeGgFG-tVYkArdk~TGk~VAIKiIdKe-~~e~LlrEIqILkkL~HP---NIVrL~dvfeds---~~lyLVMEY~e 79 (1335)
+.|+.|+.. .||+.. ..+++|+.... ....+.+|.+++..+... .+.++++..... ...|++|++++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 567877777 589762 34778887654 345788999999887532 234444433322 24588999999
Q ss_pred CCCHH
Q 000715 80 GGDLM 84 (1335)
Q Consensus 80 GGSL~ 84 (1335)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0011 Score=71.38 Aligned_cols=134 Identities=18% Similarity=0.244 Sum_probs=81.5
Q ss_pred EEEEeccCcEEEEEEEECC-CCeEEEEEEcCchhH--HHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeecCCCC
Q 000715 7 YEAIGRGKYSTVYKGRKKK-TIEYFAIKSVDKSQK--SKVLQEVRMLHSLDHPNV-LRFYSWYETSAHLWLVLEYCVGGD 82 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~-TGk~VAIKiIdKe~~--e~LlrEIqILkkL~HPNI-VrL~dvfeds~~lyLVMEY~eGGS 82 (1335)
++.|+.|-...+|++.... .++.|++|+...... -...+|+.+++.+...++ .+++.... + .++|||++|.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 4678888888999987654 356788998765422 133578988888854444 44443322 2 47999999977
Q ss_pred HHHH--------------HHh----CCCC----------C-HHHHHHHHHHH-------------------------HHH
Q 000715 83 LMSL--------------LRQ----DNQL----------P-EDSIRDLAQDL-------------------------VRA 108 (1335)
Q Consensus 83 L~dl--------------Ikq----~~~L----------S-EeqIr~I~rQI-------------------------LsG 108 (1335)
+... +.+ .... . .+.+..|...+ +..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5321 111 0011 1 12233332211 111
Q ss_pred HH-HHH----HCCCcccCCCCCCeEECC-CCCeeeccccccc
Q 000715 109 LQ-YLH----SKGIIYCDLKPSNILLDE-NGRTKLCDFGLAR 144 (1335)
Q Consensus 109 Lk-YLH----skGIVHRDIKPENILIDe-dG~VKLiDFGLAr 144 (1335)
+. .+- ..+++|+|+++.||++++ ++.+.++||..+.
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 111 136999999999999997 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00051 Score=74.12 Aligned_cols=128 Identities=21% Similarity=0.263 Sum_probs=92.4
Q ss_pred EEEEEeccCcEEEEEEEECCCCeEEEEEEcCch-hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeecCCCCHH
Q 000715 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLM 84 (1335)
Q Consensus 6 LlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-~~e~LlrEIqILkkL~HPNIVrL~dvfeds~~lyLVMEY~eGGSL~ 84 (1335)
..+.||+|.+|.||++.+.. ..+|+|+-..+ .+..+..|.+++..+.--++.+=...|... ++.|||+.|..|.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i~me~i~G~~L~ 100 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRG--GEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED---FIRMEYIDGRPLG 100 (201)
T ss_pred hhhhhhcccccEEEEeeccC--ceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh---hhhhhhhcCcchh
Confidence 35679999999999999976 47888887544 466789999999999877765533333222 3459999998888
Q ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC-CCCeEECCCCCeeecccccccc
Q 000715 85 SLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK-PSNILLDENGRTKLCDFGLARK 145 (1335)
Q Consensus 85 dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIK-PENILIDedG~VKLiDFGLAr~ 145 (1335)
+..... + ++-...+++.-.-|-..||-|+.|. |...++..++.+.|+||..|+.
T Consensus 101 ~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 101 KLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 765432 1 2334455666556777899999986 4555555666999999998863
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0016 Score=70.97 Aligned_cols=124 Identities=29% Similarity=0.441 Sum_probs=91.1
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCchh-------------------HHHHHHHHHHHHhCC------CCCcceEE
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-------------------KSKVLQEVRMLHSLD------HPNVLRFY 62 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~-------------------~e~LlrEIqILkkL~------HPNIVrL~ 62 (1335)
..||+|+.=.||. |+.+ ....||+..... ..+..+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~--HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEE--CCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 4789999999995 3333 336788886655 556677877766665 78899999
Q ss_pred EEEEeCCEEEEEEeecCC------CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCC--C-
Q 000715 63 SWYETSAHLWLVLEYCVG------GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN--G- 133 (1335)
Q Consensus 63 dvfeds~~lyLVMEY~eG------GSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDed--G- 133 (1335)
++.+++....+|+|.+.+ .+|.+++++ +.+++ .+. ..+-+-..||-+++|+.+|++|.||++... |
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998643 357788854 34665 333 344455668899999999999999999533 2
Q ss_pred -Ceeecc
Q 000715 134 -RTKLCD 139 (1335)
Q Consensus 134 -~VKLiD 139 (1335)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 466665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.43 E-value=1.6e-05 Score=103.41 Aligned_cols=210 Identities=15% Similarity=-0.002 Sum_probs=144.0
Q ss_pred HHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEeecCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 000715 43 VLQEVRMLHSLDHPNVLRFYSWYET--SAHLWLVLEYCVGGDLMSLLRQD----NQLPEDSIRDLAQDLVRALQYLHSKG 116 (1335)
Q Consensus 43 LlrEIqILkkL~HPNIVrL~dvfed--s~~lyLVMEY~eGGSL~dlIkq~----~~LSEeqIr~I~rQILsGLkYLHskG 116 (1335)
...|...++...|+++...+.-... +...|.+++|+.+|.+++.|-++ ..+.+.-+.....+.+.+..-+|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3445556666789998887765543 34568999999999999998664 34556666666667688888888652
Q ss_pred -----CcccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHH
Q 000715 117 -----IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCV 191 (1335)
Q Consensus 117 -----IVHRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVI 191 (1335)
.+|+++|+-|.+|..+.++|++++|+.+...+... ..+...+++.|++|++... -.++.++|+|..|+-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-----f~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ 1429 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-----FFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLS 1429 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHh-----hhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHH
Confidence 68999999999999999999999999884322211 1245678999999998753 345667999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 000715 192 LYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWR 258 (1335)
Q Consensus 192 LYELLTGrpPF~g~d~~eLikkIl~~~~~pip~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq 258 (1335)
+|+.-.|..+|-......+-..+.+.....++...|.+.-.....+|-..-..||.-...+..+.|.
T Consensus 1430 ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1430 LYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 9999999888733322222222222222233333344444444445555557888888887777664
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00068 Score=74.50 Aligned_cols=129 Identities=19% Similarity=0.232 Sum_probs=78.2
Q ss_pred EEeccCcEEEEEEEECCCCeEEEEEEcCchhH---HHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEeecCCCCHH
Q 000715 9 AIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK---SKVLQEVRMLHSLDHPNVL-RFYSWYETSAHLWLVLEYCVGGDLM 84 (1335)
Q Consensus 9 ~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~---e~LlrEIqILkkL~HPNIV-rL~dvfeds~~lyLVMEY~eGGSL~ 84 (1335)
.+..|-.+.+|+.. .+++.|++|....... -...+|.++++.+...++. +++... . -++||||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccc
Confidence 35668888999887 4456788998654321 1357899999888544443 333332 2 26899999987653
Q ss_pred H--------------HHHh-------CCCCCH-HHHHHHHHHHH---------HHHHHHHH--------CCCcccCCCCC
Q 000715 85 S--------------LLRQ-------DNQLPE-DSIRDLAQDLV---------RALQYLHS--------KGIIYCDLKPS 125 (1335)
Q Consensus 85 d--------------lIkq-------~~~LSE-eqIr~I~rQIL---------sGLkYLHs--------kGIVHRDIKPE 125 (1335)
. .+.+ ..+++. ..+..+..++- ..+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 2 1111 011221 22333332221 11222222 25899999999
Q ss_pred CeEECCCCCeeeccccccc
Q 000715 126 NILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 126 NILIDedG~VKLiDFGLAr 144 (1335)
||++++++ +.++||+.+.
T Consensus 157 Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred cEEEeCCC-CEEEeccccC
Confidence 99999877 7899999764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0036 Score=74.76 Aligned_cols=74 Identities=15% Similarity=0.120 Sum_probs=53.8
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcC-------c---hhHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEE
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-------K---SQKSKVLQEVRMLHSL---DHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiId-------K---e~~e~LlrEIqILkkL---~HPNIVrL~dvfeds~~lyL 73 (1335)
.+.||.|.+..||++.....++.|++|... . ...++...|.+.|+.+ ...++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 468999999999999987655689999743 1 1345667788888776 23456667765 3355689
Q ss_pred EEeecCCCC
Q 000715 74 VLEYCVGGD 82 (1335)
Q Consensus 74 VMEY~eGGS 82 (1335)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0018 Score=72.13 Aligned_cols=136 Identities=22% Similarity=0.279 Sum_probs=84.9
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCCCCC--cceEEE------EEEeCCEEEEEEeec
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPN--VLRFYS------WYETSAHLWLVLEYC 78 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HPN--IVrL~d------vfeds~~lyLVMEY~ 78 (1335)
.+.|..|....+|+....+ ..+++|+........+..|++++..+.+.+ +.+++. +....+..++|++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~--~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS--GRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEeCC--CcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 5567778878999876433 458899987655667788888888874332 444443 223456678999999
Q ss_pred CCCCHHH----H-------HHh----CCCCCH--------HHHH------------HHHHHHHHHHHHHHH-------CC
Q 000715 79 VGGDLMS----L-------LRQ----DNQLPE--------DSIR------------DLAQDLVRALQYLHS-------KG 116 (1335)
Q Consensus 79 eGGSL~d----l-------Ikq----~~~LSE--------eqIr------------~I~rQILsGLkYLHs-------kG 116 (1335)
+|..+.. . +.+ ...+.. .... .....+..++.++.+ .+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 9877521 1 100 000000 0000 011112333444443 47
Q ss_pred CcccCCCCCCeEECCCCCeeeccccccc
Q 000715 117 IIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 117 IVHRDIKPENILIDedG~VKLiDFGLAr 144 (1335)
++|+|++|.||++++++.+.|+||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCceEEEeehhhhc
Confidence 9999999999999988777899999753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0028 Score=69.56 Aligned_cols=122 Identities=22% Similarity=0.325 Sum_probs=88.2
Q ss_pred CcEEEEEEEeccCc-EEEEEEEECCCCeEEEEEEcCc---------------h---------hHHHHHHHHHHHHhC---
Q 000715 2 NQYHIYEAIGRGKY-STVYKGRKKKTIEYFAIKSVDK---------------S---------QKSKVLQEVRMLHSL--- 53 (1335)
Q Consensus 2 nrYeLlK~LGeGgF-GtVYkArdk~TGk~VAIKiIdK---------------e---------~~e~LlrEIqILkkL--- 53 (1335)
.+++.++.||+|.- |.||+++-.+ +.||+|++.. . ...-+..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g--~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDG--RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECC--eEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 36889999999999 9999987755 6899999311 0 112356788877776
Q ss_pred CCCCc--ceEEEEEEeC------------------CEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 000715 54 DHPNV--LRFYSWYETS------------------AHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLH 113 (1335)
Q Consensus 54 ~HPNI--VrL~dvfeds------------------~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLH 113 (1335)
.+.++ ++.++|..-. ....||.||.+... .++..+ +.+|.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 44556 9999987322 12468888876544 233333 456777788899
Q ss_pred HCCCcccCCCCCCeEECCCCCeeecccccc
Q 000715 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLA 143 (1335)
Q Consensus 114 skGIVHRDIKPENILIDedG~VKLiDFGLA 143 (1335)
..||+-+|+++.|.. +| ||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---CC--EEEecccC
Confidence 999999999999986 33 89999864
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0033 Score=71.69 Aligned_cols=75 Identities=16% Similarity=0.065 Sum_probs=55.9
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCch-hHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCEEEEEEeecC
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-QKSKVLQEVRMLHSLDH---PNVLRFYSWYET---SAHLWLVLEYCV 79 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-~~e~LlrEIqILkkL~H---PNIVrL~dvfed---s~~lyLVMEY~e 79 (1335)
.+.||.|..+.||.....+ + .+++|..... ....+..|...++.+.. -.+.++++++.. .+..++|||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQ-G-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCC-C-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 5679999999999986443 2 3777885442 45678899999998843 357778877654 366899999999
Q ss_pred CCCH
Q 000715 80 GGDL 83 (1335)
Q Consensus 80 GGSL 83 (1335)
|.++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0077 Score=68.18 Aligned_cols=135 Identities=14% Similarity=0.171 Sum_probs=77.0
Q ss_pred EEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCCCCC--cceEEE------EEEeCCEEEEEEeecC
Q 000715 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPN--VLRFYS------WYETSAHLWLVLEYCV 79 (1335)
Q Consensus 8 K~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HPN--IVrL~d------vfeds~~lyLVMEY~e 79 (1335)
+.|+.|....+|+..... | .|++|++.......+..|+.++..|...+ +.+++. +....+..+++++|++
T Consensus 28 ~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~ 105 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQ-G-EYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE 105 (319)
T ss_pred chhccccccceEEEEeCC-C-cEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence 456677778899887543 3 58899886434455666666666653222 333332 2234567899999999
Q ss_pred CCCHH-----------HHHHh----CCCC--------CH---HH------------HHHHHHHHH-HHHHHHH-------
Q 000715 80 GGDLM-----------SLLRQ----DNQL--------PE---DS------------IRDLAQDLV-RALQYLH------- 113 (1335)
Q Consensus 80 GGSL~-----------dlIkq----~~~L--------SE---eq------------Ir~I~rQIL-sGLkYLH------- 113 (1335)
|..+. ..+.+ ...+ .. .+ ....+.+.+ ..+..+.
T Consensus 106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l 185 (319)
T PRK05231 106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL 185 (319)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence 87531 11111 0001 00 00 011111111 1122222
Q ss_pred HCCCcccCCCCCCeEECCCCCeeeccccccc
Q 000715 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 114 skGIVHRDIKPENILIDedG~VKLiDFGLAr 144 (1335)
..|++|+|++|.||+++.+...-++||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2389999999999999866556899999763
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.006 Score=69.10 Aligned_cols=135 Identities=19% Similarity=0.275 Sum_probs=81.0
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCch-hHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEEEEEEee
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-QKSKVLQEVRMLHSLDHPN--VLRFYSW------YETSAHLWLVLEY 77 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe-~~e~LlrEIqILkkL~HPN--IVrL~dv------feds~~lyLVMEY 77 (1335)
.+.++.|....+|+... .+| .|++|+.... ....+..|.+++..|...+ +.+++.. ....+..+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 55677787789998864 344 4778987553 2455667777777773322 3343331 1234667999999
Q ss_pred cCCCCHH-----------HHHHh----CCCCC--------HHH-----HH----------HHHHHHHHHHHHHHH-----
Q 000715 78 CVGGDLM-----------SLLRQ----DNQLP--------EDS-----IR----------DLAQDLVRALQYLHS----- 114 (1335)
Q Consensus 78 ~eGGSL~-----------dlIkq----~~~LS--------Eeq-----Ir----------~I~rQILsGLkYLHs----- 114 (1335)
++|..+. ..+.+ ...++ ... .. .....+...+.++..
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9986532 11110 00110 000 00 001122334555542
Q ss_pred --CCCcccCCCCCCeEECCCCCeeecccccc
Q 000715 115 --KGIIYCDLKPSNILLDENGRTKLCDFGLA 143 (1335)
Q Consensus 115 --kGIVHRDIKPENILIDedG~VKLiDFGLA 143 (1335)
.+++|+|+++.||+++.++.+.++||+.+
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 68999999999999998887789999965
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0043 Score=69.68 Aligned_cols=74 Identities=16% Similarity=0.186 Sum_probs=50.1
Q ss_pred EEEEeccCcEEEEEEEECC------CCeEEEEEEcCch--hHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEee
Q 000715 7 YEAIGRGKYSTVYKGRKKK------TIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNV-LRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~------TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HPNI-VrL~dvfeds~~lyLVMEY 77 (1335)
++.+..|-...+|+..... +++.|++|+.... ......+|.+++..+...++ .+++..+. . .+|+||
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 4567777778999987654 3578999997654 22356788888888854333 34454443 2 358999
Q ss_pred cCCCCHH
Q 000715 78 CVGGDLM 84 (1335)
Q Consensus 78 ~eGGSL~ 84 (1335)
++|..+.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9987764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0037 Score=67.22 Aligned_cols=99 Identities=25% Similarity=0.326 Sum_probs=78.6
Q ss_pred HHHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeecCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 000715 44 LQEVRMLHSLDH-PNVLRFYSWYETSAHLWLVLEYCVGGDLMSL---LRQDNQLPEDSIRDLAQDLVRALQYLHS---KG 116 (1335)
Q Consensus 44 lrEIqILkkL~H-PNIVrL~dvfeds~~lyLVMEY~eGGSL~dl---Ikq~~~LSEeqIr~I~rQILsGLkYLHs---kG 116 (1335)
..|.-+++.+.+ +++.++++++- + ++|.||...+++... +.+--.-++.++.+++.++++.+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG---~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG---R-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC---C-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888866 68999999872 2 669999877666421 2222345789999999999999999998 45
Q ss_pred CcccCCCCCCeEECCCCCeeeccccccccc
Q 000715 117 IIYCDLKPSNILLDENGRTKLCDFGLARKL 146 (1335)
Q Consensus 117 IVHRDIKPENILIDedG~VKLiDFGLAr~l 146 (1335)
+.-.|++|+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777999999999999999999999976554
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.02 Score=67.80 Aligned_cols=136 Identities=24% Similarity=0.280 Sum_probs=95.8
Q ss_pred EEEEEeccCcEEEEEEEECCCCeEEEEEEcCch------------------------hHH-----HHHHHHHHHHhCCCC
Q 000715 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------------------------QKS-----KVLQEVRMLHSLDHP 56 (1335)
Q Consensus 6 LlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe------------------------~~e-----~LlrEIqILkkL~HP 56 (1335)
+-.+|..|.-+.||.|.... |..+|||++..+ +.. -..+|++-|+++..-
T Consensus 148 inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 45678899999999988655 566999986321 001 135788888888655
Q ss_pred CcceEEEEEEeCCEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCCCeEECCCCCe
Q 000715 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL-HSKGIIYCDLKPSNILLDENGRT 135 (1335)
Q Consensus 57 NIVrL~dvfeds~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYL-HskGIVHRDIKPENILIDedG~V 135 (1335)
.|.-.--+... .-++||+|+.+..-.--.-++-.++...++.+-.|++.-+.-| |..++||.||.-=|+|+ .+|.+
T Consensus 227 GIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l 303 (520)
T KOG2270|consen 227 GIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL 303 (520)
T ss_pred CCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence 54332222222 2378999985333222222345688889999999999888877 56799999999999999 67899
Q ss_pred eecccccccc
Q 000715 136 KLCDFGLARK 145 (1335)
Q Consensus 136 KLiDFGLAr~ 145 (1335)
.++|-+-+..
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 9999986653
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.0044 Score=72.24 Aligned_cols=130 Identities=19% Similarity=0.232 Sum_probs=95.2
Q ss_pred EEEEEEEeccCcEEEEEEEECCCCeEEEEEEcCc---------hh----------------HHHHHHHHHHHHhCC-CC-
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK---------SQ----------------KSKVLQEVRMLHSLD-HP- 56 (1335)
Q Consensus 4 YeLlK~LGeGgFGtVYkArdk~TGk~VAIKiIdK---------e~----------------~e~LlrEIqILkkL~-HP- 56 (1335)
|.++..||-|.-+.||.+-+.. |+++++|+=.- .. +-...+|+..|+.|. |.
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4578899999999999988765 57788885210 00 012457888888873 22
Q ss_pred CcceEEEEEEeCCEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCCeEECCCCCee
Q 000715 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTK 136 (1335)
Q Consensus 57 NIVrL~dvfeds~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIVHRDIKPENILIDedG~VK 136 (1335)
-+.+.++ .+..++|||++.|..|...-. ...+..+...++.-+--|-.+|+||+|..--||++++++.++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 2344443 455689999999988876432 223456677777788889999999999999999999999999
Q ss_pred eccccccc
Q 000715 137 LCDFGLAR 144 (1335)
Q Consensus 137 LiDFGLAr 144 (1335)
++||--..
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99997544
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.046 Score=62.78 Aligned_cols=74 Identities=20% Similarity=0.287 Sum_probs=51.3
Q ss_pred EEEEEeccCcEEEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEeecCCC
Q 000715 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSL---DHPNVLRFYSWYETSAHLWLVLEYCVGG 81 (1335)
Q Consensus 6 LlK~LGeGgFGtVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL---~HPNIVrL~dvfeds~~lyLVMEY~eGG 81 (1335)
-.+.+|.|....+|+.. .+++.|.+|.-.......+..|..-|+.| ..-.+.+++.+....+..|+||||++.+
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 45678999999999877 66788999998876677788899988888 3345778888888877779999999877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.083 Score=62.81 Aligned_cols=77 Identities=16% Similarity=0.094 Sum_probs=49.1
Q ss_pred EEeccCcEEEEEEEECCCCeEEEEEEcCc----------hhHHHHHHHHHHHHhCC--CCC-cceEEEEEEeCCEEEEEE
Q 000715 9 AIGRGKYSTVYKGRKKKTIEYFAIKSVDK----------SQKSKVLQEVRMLHSLD--HPN-VLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 9 ~LGeGgFGtVYkArdk~TGk~VAIKiIdK----------e~~e~LlrEIqILkkL~--HPN-IVrL~dvfeds~~lyLVM 75 (1335)
.||.|....||++....+++.++||.-.. -..++..-|...|+... -|. +.++|. .+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 58999999999999865557899996521 12345566777776652 343 444443 3344456899
Q ss_pred eecCCCC-HHHHH
Q 000715 76 EYCVGGD-LMSLL 87 (1335)
Q Consensus 76 EY~eGGS-L~dlI 87 (1335)
|+++... |.+.+
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 9985433 33444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.035 Score=67.97 Aligned_cols=163 Identities=20% Similarity=0.286 Sum_probs=107.6
Q ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEeC-CEEEEEEeecCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 000715 40 KSKVLQEVRMLHSLDHPNVLRFYSWYETS-AHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118 (1335)
Q Consensus 40 ~e~LlrEIqILkkL~HPNIVrL~dvfeds-~~lyLVMEY~eGGSL~dlIkq~~~LSEeqIr~I~rQILsGLkYLHskGIV 118 (1335)
..++....++++.+.|+|...++++-... ....+|||++ +.++.+....+. +-..... .+|+.
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~ 89 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVL 89 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccc
Confidence 34567788899999999999998876554 4578999998 789999887654 2222111 12222
Q ss_pred ccCCCCCCeEECCCCCeeeccccccccccCCCCCCCCCCCCCccCCCCCCCcchhccCCCCCchhhHHHHHHHHHHHHhC
Q 000715 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAG 198 (1335)
Q Consensus 119 HRDIKPENILIDedG~VKLiDFGLAr~l~e~~~~~ss~l~~t~~GTp~YmAPEVL~~~~~yS~kSDIWSLGVILYELLTG 198 (1335)
|- | ..+.+| -++ .. | |-. .++++||||+|.++.++.-|
T Consensus 90 ~~-----~-------~~~~td-~~~----t~-----------------~--~~~------~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 90 HL-----N-------IIYITD-HFL----TK-----------------Y--PSP------IGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred ee-----h-------hhhccc-ccc----cc-----------------C--CCC------CCcchhhhhHHHHHHHHHHh
Confidence 21 1 222333 000 00 0 111 12499999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhcCCCCCC-----------CCCCChhHHHHHHHhcccCCCCCCCHHHHhcCcccccc
Q 000715 199 RPPFVGREFTQLVKSILSDPSPPL-----------PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 199 rpPF~g~d~~eLikkIl~~~~~pi-----------p~~iS~eL~DLIkkcLqkDPsKRPTAeEILkHPfFq~~ 260 (1335)
...|......+....+.+-...+. -...+....++.++|+...|..||...++.+++-|.+.
T Consensus 128 ~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 128 ISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred hHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 888777666666555543221111 11235667789999999999999999999999988765
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.19 Score=56.42 Aligned_cols=64 Identities=16% Similarity=0.245 Sum_probs=39.3
Q ss_pred EEEEEEECCCCeEEEEEEcCchhHHHHHHHHHHHHhCCCC--CcceEEEE------EEeCCEEEEEEeecCCCCH
Q 000715 17 TVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHP--NVLRFYSW------YETSAHLWLVLEYCVGGDL 83 (1335)
Q Consensus 17 tVYkArdk~TGk~VAIKiIdKe~~e~LlrEIqILkkL~HP--NIVrL~dv------feds~~lyLVMEY~eGGSL 83 (1335)
.||++... .| .+++|.+... ...+..|+..+..|... .+.+++.. ...++..|.++||++|..+
T Consensus 11 ~v~~v~t~-~g-~~~LK~~~~~-~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETD-SG-NKCLKKINYP-PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeC-CC-CeEEEEcCCC-HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 48887643 33 5889988643 33455566666665322 33444422 2345678999999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.48 E-value=0.072 Score=60.49 Aligned_cols=29 Identities=38% Similarity=0.629 Sum_probs=24.6
Q ss_pred CCcccCCCCCCeEECCCCCe-eeccccccc
Q 000715 116 GIIYCDLKPSNILLDENGRT-KLCDFGLAR 144 (1335)
Q Consensus 116 GIVHRDIKPENILIDedG~V-KLiDFGLAr 144 (1335)
.++|+|++|.||++++++.+ -|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 48999999999999875654 699999764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.085 Score=61.65 Aligned_cols=134 Identities=16% Similarity=0.207 Sum_probs=81.2
Q ss_pred EEEEeccCcEEEEEEEECC----CCeEEEEEEcCchhHH--HHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEeecC
Q 000715 7 YEAIGRGKYSTVYKGRKKK----TIEYFAIKSVDKSQKS--KVLQEVRMLHSLDHPNVL-RFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~----TGk~VAIKiIdKe~~e--~LlrEIqILkkL~HPNIV-rL~dvfeds~~lyLVMEY~e 79 (1335)
.+.|..|-...+|++.... +++.|++|+....... .-.+|..+++.+..-++- ++++.+.. + .|.||++
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 4456568888999987543 3467999988654211 125788888888554443 45555433 2 5899998
Q ss_pred CCCHHHH--------------HHh---CC------CCCHHHHHHHHHHHH-----------------HHHHHH----H--
Q 000715 80 GGDLMSL--------------LRQ---DN------QLPEDSIRDLAQDLV-----------------RALQYL----H-- 113 (1335)
Q Consensus 80 GGSL~dl--------------Ikq---~~------~LSEeqIr~I~rQIL-----------------sGLkYL----H-- 113 (1335)
|.++... +.+ -. ....+++..|+.++. ..+..| .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 111 00 111234444443321 111122 1
Q ss_pred --HCCCcccCCCCCCeEECC-CCCeeeccccccc
Q 000715 114 --SKGIIYCDLKPSNILLDE-NGRTKLCDFGLAR 144 (1335)
Q Consensus 114 --skGIVHRDIKPENILIDe-dG~VKLiDFGLAr 144 (1335)
...++|+|+++.||++++ ++.+.++||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 235899999999999986 4789999998764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.083 Score=61.76 Aligned_cols=138 Identities=17% Similarity=0.264 Sum_probs=78.4
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEE----cCchhHHHHHHHHHHHHhCCCCC--cceEEEEEEeCC--EEEEEEeec
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKS----VDKSQKSKVLQEVRMLHSLDHPN--VLRFYSWYETSA--HLWLVLEYC 78 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKi----IdKe~~e~LlrEIqILkkL~HPN--IVrL~dvfeds~--~lyLVMEY~ 78 (1335)
.+.+..|-...+|..... ++.+++.. -......+..+|+++++.+.--- +-..+..+.+.. ..|.||+|+
T Consensus 30 v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 344433433355555444 67777771 12234456678888888874322 333444444444 679999999
Q ss_pred CCCCHHH------------------HHHhC--------------CCCCHHHHHHHHHHH--------------HHHHHHH
Q 000715 79 VGGDLMS------------------LLRQD--------------NQLPEDSIRDLAQDL--------------VRALQYL 112 (1335)
Q Consensus 79 eGGSL~d------------------lIkq~--------------~~LSEeqIr~I~rQI--------------LsGLkYL 112 (1335)
+|..+.+ .+..- +.+...++..+..+. ..-..++
T Consensus 108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 9843221 11110 001111222222222 2223444
Q ss_pred HHC--------CCcccCCCCCCeEECCCCCeeeccccccccc
Q 000715 113 HSK--------GIIYCDLKPSNILLDENGRTKLCDFGLARKL 146 (1335)
Q Consensus 113 Hsk--------GIVHRDIKPENILIDedG~VKLiDFGLAr~l 146 (1335)
+.+ .++|+|+++.|++++.++-+-++||+++..-
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 433 4899999999999999888999999987643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.17 Score=61.08 Aligned_cols=71 Identities=18% Similarity=0.202 Sum_probs=49.2
Q ss_pred EEEEEeccCcEEEEEEEECCCCeEEEEEEcC-----c-----hhHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEE
Q 000715 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-----K-----SQKSKVLQEVRMLHSLD---HPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 6 LlK~LGeGgFGtVYkArdk~TGk~VAIKiId-----K-----e~~e~LlrEIqILkkL~---HPNIVrL~dvfeds~~ly 72 (1335)
..+.||.|....||+..+. +..|+||.-. . ....+...|...|+.+. ..++.+++.+.. ...+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3568899999999998874 3458899764 1 13344455677776653 346777887766 3457
Q ss_pred EEEeecCC
Q 000715 73 LVLEYCVG 80 (1335)
Q Consensus 73 LVMEY~eG 80 (1335)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >cd00020 ARM Armadillo/beta-catenin-like repeats | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.043 Score=51.96 Aligned_cols=114 Identities=16% Similarity=0.099 Sum_probs=85.0
Q ss_pred hhHHHHHHHhcccCCchHHHHHHHHHHHHhhcccccccccccchhhhhhhhhhhhHHHHHHHHHHHhhhhheeeeeecCC
Q 000715 573 PIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLRDKQEKVRRFSMAALGELLFYISTQNE 652 (1335)
Q Consensus 573 ~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ge~~~~~~~q~~ 652 (1335)
-+.+.+++++.. .+|++|..+.+.+|-++.+.-...+..-..+++-.|.+.+.+.+.+||+..+.+|+.+...-..
T Consensus 7 ~~i~~l~~~l~~-~~~~~~~~a~~~l~~l~~~~~~~~~~~~~~~~i~~l~~~l~~~~~~v~~~a~~~L~~l~~~~~~--- 82 (120)
T cd00020 7 GGLPALVSLLSS-SDENVQREAAWALSNLSAGNNDNIQAVVEAGGLPALVQLLKSEDEEVVKAALWALRNLAAGPED--- 82 (120)
T ss_pred CChHHHHHHHHc-CCHHHHHHHHHHHHHHhcCCHHHHHHHHHCCChHHHHHHHhCCCHHHHHHHHHHHHHHccCcHH---
Confidence 366778888874 4699999999999999998655555555569999999999999999999999999999532110
Q ss_pred ccCCCCCCCCCCcCcccccccccchhHHHHHHHHHhcCcchhhHHHHHHHHHhhhc
Q 000715 653 HARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTIENICS 708 (1335)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 708 (1335)
.. -..+...++..+..+|..+. .-++-+++.++.|||+
T Consensus 83 ---------------~~--~~~~~~g~l~~l~~~l~~~~-~~~~~~a~~~l~~l~~ 120 (120)
T cd00020 83 ---------------NK--LIVLEAGGVPKLVNLLDSSN-EDIQKNATGALSNLAS 120 (120)
T ss_pred ---------------HH--HHHHHCCChHHHHHHHhcCC-HHHHHHHHHHHHHhhC
Confidence 00 11123446677788886664 4455689999999985
|
An approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity gene armadillo; these repeats were also found in the mammalian armadillo homolog beta-catenin, the junctional plaque protein plakoglobin, the adenomatous polyposis coli (APC) tumor suppressor protein, and a number of other proteins. ARM has been implicated in mediating protein-protein interactions, but no common features among the target proteins recognized by the ARM repeats have been identified; related to the HEAT domain; three consecutive copies of the repeat are represented by this alignment model. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.13 Score=61.99 Aligned_cols=73 Identities=18% Similarity=0.209 Sum_probs=49.0
Q ss_pred EEEEeccCcEEEEEEEECCCCeEEEEEEcCc---------hhHHHHHHHHHHHHhCC--CCC-cceEEEEEEeCCEEEEE
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK---------SQKSKVLQEVRMLHSLD--HPN-VLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TGk~VAIKiIdK---------e~~e~LlrEIqILkkL~--HPN-IVrL~dvfeds~~lyLV 74 (1335)
.+.||.|.-..||++.+...++.++||.-.. -..++..-|.++|+... -|. +.++|. .+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 5789999999999999854456799996421 13456667777777652 343 444554 334445789
Q ss_pred EeecCCC
Q 000715 75 LEYCVGG 81 (1335)
Q Consensus 75 MEY~eGG 81 (1335)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9988543
|
|
| >cd00020 ARM Armadillo/beta-catenin-like repeats | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.094 Score=49.64 Aligned_cols=110 Identities=14% Similarity=0.114 Sum_probs=91.6
Q ss_pred HHHHHHHhhcCCcchhhhhhHHHHHHHhcCc-cchhhHhhcchhHHHHHHHhcccCCchHHHHHHHHHHHHhhccccccc
Q 000715 532 LNARILAVLNGNSSIGEKQNVIRYLEMLSSN-ADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDD 610 (1335)
Q Consensus 532 f~~~~~~~~~~~~~~~~k~n~~~yl~~v~~~-~~~a~~~~~~~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~ 610 (1335)
.++.++..+..+. .+.|.+.+.-|..+|.+ .+..+.++....++.+++.+.. +++.+|..+++.+|-++.+.....+
T Consensus 8 ~i~~l~~~l~~~~-~~~~~~a~~~l~~l~~~~~~~~~~~~~~~~i~~l~~~l~~-~~~~v~~~a~~~L~~l~~~~~~~~~ 85 (120)
T cd00020 8 GLPALVSLLSSSD-ENVQREAAWALSNLSAGNNDNIQAVVEAGGLPALVQLLKS-EDEEVVKAALWALRNLAAGPEDNKL 85 (120)
T ss_pred ChHHHHHHHHcCC-HHHHHHHHHHHHHHhcCCHHHHHHHHHCCChHHHHHHHhC-CCHHHHHHHHHHHHHHccCcHHHHH
Confidence 3455566665443 67778888888888888 7888888988999999999997 6899999999999999988766666
Q ss_pred ccccchhhhhhhhhhhhHHHHHHHHHHHhhhhh
Q 000715 611 DLANSGILGSLTDGLRDKQEKVRRFSMAALGEL 643 (1335)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ge~ 643 (1335)
..-..|++..|.+.+.+.+.++|+....+|+.+
T Consensus 86 ~~~~~g~l~~l~~~l~~~~~~~~~~a~~~l~~l 118 (120)
T cd00020 86 IVLEAGGVPKLVNLLDSSNEDIQKNATGALSNL 118 (120)
T ss_pred HHHHCCChHHHHHHHhcCCHHHHHHHHHHHHHh
Confidence 666678999999999999999999999998865
|
An approximately 40 amino acid long tandemly repeated sequence motif first identified in the Drosophila segment polarity gene armadillo; these repeats were also found in the mammalian armadillo homolog beta-catenin, the junctional plaque protein plakoglobin, the adenomatous polyposis coli (APC) tumor suppressor protein, and a number of other proteins. ARM has been implicated in mediating protein-protein interactions, but no common features among the target proteins recognized by the ARM repeats have been identified; related to the HEAT domain; three consecutive copies of the repeat are represented by this alignment model. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.11 Score=60.22 Aligned_cols=134 Identities=14% Similarity=0.188 Sum_probs=78.8
Q ss_pred EEEEeccCcEEEEEEEECCC---CeEEEEEEcCchhH--HHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEeecCC
Q 000715 7 YEAIGRGKYSTVYKGRKKKT---IEYFAIKSVDKSQK--SKVLQEVRMLHSLDHPNVL-RFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~T---Gk~VAIKiIdKe~~--e~LlrEIqILkkL~HPNIV-rL~dvfeds~~lyLVMEY~eG 80 (1335)
.+.|..|=...+|+....+. +..|++|+...... -+-.+|..+++.+..-++- ++++++. .+ +|.+|++|
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 44565577778998875432 34788998755321 1235788888888655553 4555442 22 58999988
Q ss_pred CCHHH----------HH----Hh--CCC------C-CHHHHHHHHHHHH----------------------HHHHHHHH-
Q 000715 81 GDLMS----------LL----RQ--DNQ------L-PEDSIRDLAQDLV----------------------RALQYLHS- 114 (1335)
Q Consensus 81 GSL~d----------lI----kq--~~~------L-SEeqIr~I~rQIL----------------------sGLkYLHs- 114 (1335)
..+.. .+ ++ ... . -...+..|+.++- .-+..+.+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 76521 11 11 001 1 1233334433321 11222221
Q ss_pred ---CC----CcccCCCCCCeEECC-CCCeeeccccccc
Q 000715 115 ---KG----IIYCDLKPSNILLDE-NGRTKLCDFGLAR 144 (1335)
Q Consensus 115 ---kG----IVHRDIKPENILIDe-dG~VKLiDFGLAr 144 (1335)
.+ ++|.|+.+.||++++ ++.++++||..|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 12 799999999999974 5789999999763
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.19 Score=57.39 Aligned_cols=29 Identities=24% Similarity=0.256 Sum_probs=26.8
Q ss_pred CCcccCCCCCCeEECCCCCeeeccccccc
Q 000715 116 GIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 116 GIVHRDIKPENILIDedG~VKLiDFGLAr 144 (1335)
+++|+|+.+.||+++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF13646 HEAT_2: HEAT repeats; PDB: 1OYZ_A 3FGA_A 2PF4_C 2IAE_A 3B2A_A | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.29 Score=44.87 Aligned_cols=86 Identities=22% Similarity=0.393 Sum_probs=68.4
Q ss_pred HHHHHHhcccCCchHHHHHHHHHHHHhhcccccccccccchhhhhhhhhhhhHHHHHHHHHHHhhhhheeeeeecCCccC
Q 000715 576 LVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLRDKQEKVRRFSMAALGELLFYISTQNEHAR 655 (1335)
Q Consensus 576 ~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ge~~~~~~~q~~~~~ 655 (1335)
+.|++.|...++|.+|..++.++| .+ ..-+++..|.+.+.|++..||+-+.-+||++ | .
T Consensus 2 ~~L~~~l~~~~~~~vr~~a~~~L~-------~~----~~~~~~~~L~~~l~d~~~~vr~~a~~aL~~i--------~-~- 60 (88)
T PF13646_consen 2 PALLQLLQNDPDPQVRAEAARALG-------EL----GDPEAIPALIELLKDEDPMVRRAAARALGRI--------G-D- 60 (88)
T ss_dssp HHHHHHHHTSSSHHHHHHHHHHHH-------CC----THHHHHHHHHHHHTSSSHHHHHHHHHHHHCC--------H-H-
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHH-------Hc----CCHhHHHHHHHHHcCCCHHHHHHHHHHHHHh--------C-C-
Confidence 468899978999999999999999 22 2236788889999999999999999999986 2 1
Q ss_pred CCCCCCCCCcCcccccccccchhHHHHHHHHHhcCcchhhHHHHHHHH
Q 000715 656 DSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTI 703 (1335)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 703 (1335)
|. .+..+...+..+.++++++-|++++
T Consensus 61 --------------------~~-~~~~L~~~l~~~~~~~vr~~a~~aL 87 (88)
T PF13646_consen 61 --------------------PE-AIPALIKLLQDDDDEVVREAAAEAL 87 (88)
T ss_dssp --------------------HH-THHHHHHHHTC-SSHHHHHHHHHHH
T ss_pred --------------------HH-HHHHHHHHHcCCCcHHHHHHHHhhc
Confidence 11 3446777888888888899888875
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.80 E-value=0.18 Score=54.17 Aligned_cols=29 Identities=41% Similarity=0.641 Sum_probs=20.8
Q ss_pred CCcccCCCCCCeEE-CCCCCeeeccccccc
Q 000715 116 GIIYCDLKPSNILL-DENGRTKLCDFGLAR 144 (1335)
Q Consensus 116 GIVHRDIKPENILI-DedG~VKLiDFGLAr 144 (1335)
-++|+|+.|.||++ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 888999999999764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.67 E-value=2.1 Score=49.67 Aligned_cols=68 Identities=13% Similarity=0.077 Sum_probs=41.8
Q ss_pred CcEEEEEEEECCCCeEEEEEEcCch--hHHHHHHHHHHHHhCCCC--CcceEE---E--EEEeCCEEEEEEeecCCCC
Q 000715 14 KYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHP--NVLRFY---S--WYETSAHLWLVLEYCVGGD 82 (1335)
Q Consensus 14 gFGtVYkArdk~TGk~VAIKiIdKe--~~e~LlrEIqILkkL~HP--NIVrL~---d--vfeds~~lyLVMEY~eGGS 82 (1335)
.-..||+.... +|..|++|+.... ....+..|++.+..|... .++... + +...++..+.++++++|..
T Consensus 37 ~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 34578887653 3456999988643 456677888887766321 122211 1 2233567888999998764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.89 E-value=0.99 Score=54.07 Aligned_cols=74 Identities=12% Similarity=0.154 Sum_probs=45.6
Q ss_pred EEEEeccCcEEEEEEEECCCC-e-----EEEEEEcCchh--HHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEee
Q 000715 7 YEAIGRGKYSTVYKGRKKKTI-E-----YFAIKSVDKSQ--KSKVLQEVRMLHSLDHPNVL-RFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 7 lK~LGeGgFGtVYkArdk~TG-k-----~VAIKiIdKe~--~e~LlrEIqILkkL~HPNIV-rL~dvfeds~~lyLVMEY 77 (1335)
.+.|..|=...+|++...... . .|.+....... .-+-.+|+++++.+...++- ++++.+.. ++|.||
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 456666888899999754431 2 24444432211 11225789999999665554 45555532 689999
Q ss_pred cCCCCHH
Q 000715 78 CVGGDLM 84 (1335)
Q Consensus 78 ~eGGSL~ 84 (1335)
++|..+.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9988764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1335 | ||||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-34 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-33 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-33 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-33 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-33 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-33 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-32 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-32 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-32 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-32 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-32 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-32 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-32 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-32 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-32 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-32 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-32 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-32 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-32 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-32 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-32 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-32 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-32 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-32 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-32 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-32 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-32 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-32 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-32 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-32 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-32 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-32 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-32 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-32 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-32 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-32 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-32 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-32 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-32 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-32 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-32 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-32 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-32 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-32 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-32 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-31 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-31 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-31 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-31 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-31 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-31 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-31 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-31 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-31 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-31 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-31 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-31 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-31 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-31 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-31 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-31 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-30 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-30 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-30 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-30 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-30 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-30 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-30 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-30 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-30 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-30 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-30 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-30 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-30 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-30 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-30 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-30 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-30 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-30 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-30 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-30 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-30 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-30 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-30 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-30 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-30 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-30 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-30 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-30 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-30 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-30 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-30 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-30 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-30 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-30 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-30 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-30 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-30 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-30 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-30 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-29 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-29 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-29 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-29 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-29 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-29 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-29 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-29 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-29 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-29 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-29 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-29 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-29 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-29 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-29 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-29 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-29 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-29 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-29 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-29 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-29 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-29 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-29 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-29 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-29 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-29 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-29 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-29 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-29 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-29 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-29 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-29 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-29 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-29 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-29 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-29 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-29 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-29 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-29 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-29 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-29 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-29 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-29 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-29 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-29 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-29 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-29 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-29 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-29 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-29 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-29 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-29 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-29 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-29 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-29 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-29 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-29 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-28 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-28 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-28 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-28 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-28 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-28 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-28 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-28 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-28 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-28 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-28 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-28 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-27 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-27 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-27 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-27 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-27 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-27 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-27 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-27 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-27 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-27 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-27 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-27 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-27 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-27 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-27 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-27 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-27 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-27 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-27 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-27 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-27 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-27 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-27 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-27 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-27 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-27 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-27 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-27 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-27 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-26 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-26 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-26 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-26 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-26 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-26 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-26 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-26 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-26 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-26 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-26 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-26 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-26 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-26 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-26 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-26 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-26 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-26 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-26 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-26 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-25 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-25 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-25 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-25 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-25 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-25 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-25 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-25 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-25 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-25 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-25 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-25 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-25 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-25 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-25 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-25 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-25 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-25 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-25 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-25 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-25 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-25 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-25 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-25 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-25 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-25 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 9e-25 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-24 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-24 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-24 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-24 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-24 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-24 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-24 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-24 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-24 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-24 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-24 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-24 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-24 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-24 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-24 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-24 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-24 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-24 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-24 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-24 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-24 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-24 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-24 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-24 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-24 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-24 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-24 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-24 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-24 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-24 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-24 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-23 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-23 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-23 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-23 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-23 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-23 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-23 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-23 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-23 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-23 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-23 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-23 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-23 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-23 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-23 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-23 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-23 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-23 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-23 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-23 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-23 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-23 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-23 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-23 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-23 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-23 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-23 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-22 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-22 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-22 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-22 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-22 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-22 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-22 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-22 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-22 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-22 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-22 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-22 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-22 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-22 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-22 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-22 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-22 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-22 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-22 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-22 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-21 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-21 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-21 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-21 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-21 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-21 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-21 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-21 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-21 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-21 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-21 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-21 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-21 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-21 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-21 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-21 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-21 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-21 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-21 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-21 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-21 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-20 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-20 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-20 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-20 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-20 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-20 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-20 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-20 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-20 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-20 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-20 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-19 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-19 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-19 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-19 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-19 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-19 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-19 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-19 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-19 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-19 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-19 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-19 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-19 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-19 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-19 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-19 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-19 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-19 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-19 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-19 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-19 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-19 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-19 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-19 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-19 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-19 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-19 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-19 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-19 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-19 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-19 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-19 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-19 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-19 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-19 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-19 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-19 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-19 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-19 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-19 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-19 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-19 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-19 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-19 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-19 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-19 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-19 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-19 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-19 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-19 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-19 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-19 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-19 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 5e-19 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-19 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-19 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-19 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-19 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-19 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-19 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-19 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-19 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-19 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-19 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-19 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-19 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-19 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-19 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-19 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-19 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-19 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-19 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-19 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-19 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-19 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-19 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-19 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-19 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-19 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-19 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-19 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-19 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-19 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-19 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-19 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-18 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-18 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-18 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-18 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-18 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-18 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-18 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-18 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-18 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-18 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-18 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-18 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-18 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-18 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-18 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-17 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-17 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-17 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-17 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-17 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 7e-17 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-17 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-17 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-17 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-17 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-16 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-16 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-16 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-16 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-16 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-16 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-16 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-16 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-16 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-16 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-16 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-16 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-15 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-15 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-15 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-14 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-14 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-14 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-14 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-14 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-14 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-14 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-14 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-14 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-14 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-14 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-14 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-14 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-14 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-14 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-14 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-14 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-13 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-13 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-13 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-13 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-13 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 8e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-13 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-13 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-12 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-12 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-12 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-12 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 7e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-11 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-11 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-11 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-11 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-11 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-11 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-11 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 5e-11 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-11 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 6e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-11 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 8e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-10 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-10 |
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1335 | |||
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 7e-88 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-82 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-81 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 7e-81 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-80 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 9e-80 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-79 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 6e-78 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 7e-76 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 8e-76 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-74 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-72 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-71 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 6e-71 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-69 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-69 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-68 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-67 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-67 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-67 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-64 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-64 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 4e-63 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-63 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 7e-63 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-62 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-62 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-62 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-62 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-62 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 5e-62 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 7e-62 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 7e-62 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 7e-62 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 8e-62 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 8e-62 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-61 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 2e-61 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-61 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-61 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 4e-61 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 6e-61 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 8e-61 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-60 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-60 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-60 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-60 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-60 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-60 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 4e-60 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 5e-60 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 7e-60 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 9e-60 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 9e-60 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-59 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-59 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-59 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-59 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-59 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-59 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-59 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-59 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 5e-59 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 6e-59 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 8e-59 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-58 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-58 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-58 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-58 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-58 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 4e-58 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 4e-58 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 8e-58 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 8e-58 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 9e-58 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-57 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-57 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-57 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-57 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-57 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-57 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 4e-57 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 6e-57 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-57 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 8e-57 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-56 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-56 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 2e-56 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-56 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 3e-56 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-55 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-55 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-55 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-55 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-55 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 3e-55 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-55 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-55 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 5e-55 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-55 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 7e-55 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-55 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 9e-55 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-54 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-54 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-54 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 5e-54 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 8e-54 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 9e-54 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 1e-53 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-53 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-53 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 6e-53 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-52 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-52 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-52 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-51 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-51 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-51 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-51 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 8e-51 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-50 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 2e-50 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-47 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 5e-47 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 8e-47 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-46 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 5e-46 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 6e-46 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 8e-46 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-45 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-45 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 4e-45 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 4e-45 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-44 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-44 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-44 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-44 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 9e-43 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-42 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-42 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 4e-42 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 6e-42 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 9e-42 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-41 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-41 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 7e-41 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 7e-40 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-39 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-38 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-38 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 7e-38 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-37 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 6e-37 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 2e-36 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 7e-36 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-35 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 3e-35 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 6e-35 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 7e-35 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-34 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-34 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-33 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-33 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-33 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 9e-33 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-31 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-30 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-29 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-29 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 3e-29 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-29 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-29 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-28 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-28 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 3e-28 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-28 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-28 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-28 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 7e-28 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 8e-28 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-27 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-27 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-27 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-27 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-27 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 5e-27 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 6e-27 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 6e-27 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 9e-27 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-26 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-26 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-26 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-26 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-26 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 5e-26 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 5e-26 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-26 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-26 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-26 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 7e-26 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 8e-26 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 9e-26 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-25 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-25 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-25 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-25 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-25 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-25 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-24 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-24 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-23 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-23 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-22 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-22 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-22 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-22 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 4e-22 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-22 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 6e-22 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 9e-22 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-21 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 5e-21 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-21 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 6e-21 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 6e-21 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-20 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-19 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-18 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-18 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 3e-17 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-16 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 8e-15 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-12 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 2e-12 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-12 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-10 | |
| 2jdq_A | 450 | Importin alpha-1 subunit; transport, PB2 subunit, | 1e-06 | |
| 2z6h_A | 644 | Catenin beta-1, beta-catenin; C-terminal domain, a | 8e-05 | |
| 1jdh_A | 529 | Beta-catenin; beta-catenin, protein-protein comple | 8e-05 | |
| 1xqr_A | 296 | HSPBP1 protein; armadillo repeat, superhelical twi | 8e-05 | |
| 2z6g_A | 780 | B-catenin; FULL-length, beta-catenin, cell adhesio | 1e-04 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 2e-04 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 4e-04 |
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 7e-88
Identities = 79/332 (23%), Positives = 143/332 (43%), Gaps = 14/332 (4%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDH 55
M +Y + IG G + + + + IK ++ S+ S +EV +L ++ H
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLH 113
PN++++ +E + L++V++YC GGDL + ED I D + AL+++H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
+ I++ D+K NI L ++G +L DFG+AR L+ + + GTP Y++PE+
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-----IGTPYYLSPEIC 197
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233
E ++ SD+W LGCVLYE + F LV I+S PP+ + S +L
Sbjct: 198 ENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL 256
Query: 234 INSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKGAVRQDENSMLGSTPVR 293
++ L ++P R + + F ++ L PQ + S
Sbjct: 257 VSQLFKRNPRDRPSVNSILEKGFIAKRIEKF-LSPQLIAEEFCLKTFSKFGSQPIPAKRP 315
Query: 294 VTPSGRKTQTKTSGRVFEEKQKDPSGTTRQVN 325
+ + + ++
Sbjct: 316 ASGQNSISVMPAQKITKPAAKYGIPLAYKKYG 347
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 272 bits (697), Expect = 1e-82
Identities = 73/262 (27%), Positives = 109/262 (41%), Gaps = 20/262 (7%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSL-DHP 56
+ +G G Y V+K R K+ +A+K + L EV + HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLHSK 115
+R +E L+L E C G L LPE + +D + AL +LHS+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
G+++ D+KP+NI L GR KL DFGL +L A + + G P YMAPEL +
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG------EVQEGDPRYMAPELLQG 230
Query: 176 GGVHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
+ A+D++ LG + E P G + QL + L P S +++
Sbjct: 231 S--YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL---PPEFTAGLSSELRSVL 285
Query: 235 NSLLVKDPAQRLHWSDLCGHAF 256
+L DP R L
Sbjct: 286 VMMLEPDPKLRATAEALLALPV 307
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 2e-81
Identities = 81/339 (23%), Positives = 155/339 (45%), Gaps = 31/339 (9%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDHP 56
Y I + IG G S V++ +K + +AIK V+ + E+ L+ L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 57 N--VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
+ ++R Y + T ++++V+E C DL S L++ + + ++++ A+ +H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
GI++ DLKP+N L+ +G KL DFG+A ++ + S++ ++ GT YM PE +
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT---SVVKDSQVGTVNYMPPEAIK 182
Query: 175 EGGV----------HSYASDLWGLGCVLYECYAGRPPFVGRE--FTQLVKSILSDPSPPL 222
+ S SD+W LGC+LY G+ PF ++L I +
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 242
Query: 223 PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKGAVRQD 282
P P + +++ L +DP QR+ +L H + + + P+ + + +K + Q
Sbjct: 243 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQL 302
Query: 283 EN------SMLGSTPVRVTPSGRKTQTKTSGRVFEEKQK 315
+ + + SG ++ +S + FE+K+
Sbjct: 303 VGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 341
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 7e-81
Identities = 87/280 (31%), Positives = 140/280 (50%), Gaps = 19/280 (6%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD----KSQKSK--VLQEVRMLHSLD 54
+ + I + IGRG++S VY+ A+K V K++ ++E+ +L L+
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLL----RQDNQLPEDSIRDLAQDLVRALQ 110
HPNV+++Y+ + L +VLE GDL ++ +Q +PE ++ L AL+
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 111 YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAP 170
++HS+ +++ D+KP+N+ + G KL D GL R S + A S+ GTP YM+P
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-----VGTPYYMSP 205
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT--QLVKSILSDPSPPLPGNP-S 227
E E G +++ SD+W LGC+LYE A + PF G + L K I PPLP + S
Sbjct: 206 ERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264
Query: 228 RPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLP 267
L+N + DP +R + + A T L
Sbjct: 265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 1e-80
Identities = 79/272 (29%), Positives = 123/272 (45%), Gaps = 22/272 (8%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-----KVLQEVRMLHSLDH 55
Y + IG G Y K R+K + K +D + ++ EV +L L H
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 56 PNVLRFYSWY--ETSAHLWLVLEYCVGGDLMSLLRQDNQ----LPEDSIRDLAQDLVRAL 109
PN++R+Y T+ L++V+EYC GGDL S++ + + L E+ + + L AL
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 110 QYLHSKG-----IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGT 164
+ H + +++ DLKP+N+ LD KL DFGLAR L+ + + GT
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-----VGT 179
Query: 165 PCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPG 224
P YM+PE ++ SD+W LGC+LYE A PPF +L I +P
Sbjct: 180 PYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 238
Query: 225 NPSRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
S +I +L R ++ +
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPL 270
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 9e-80
Identities = 73/290 (25%), Positives = 135/290 (46%), Gaps = 25/290 (8%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDH 55
Y I + IG G S V++ +K + +AIK V+ + E+ L+ L
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 56 PN--VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLH 113
+ ++R Y + T ++++V+E C DL S L++ + + ++++ A+ +H
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
GI++ DLKP+N L+ +G KL DFG+A ++ + S++ ++ GT YM PE
Sbjct: 145 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT---SVVKDSQVGTVNYMPPEAI 200
Query: 174 EEGGV----------HSYASDLWGLGCVLYECYAGRPPFVGRE--FTQLVKSILSDPSPP 221
++ S SD+W LGC+LY G+ PF ++L I +
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260
Query: 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPA 271
P P + +++ L +DP QR+ +L H + + + P+ +
Sbjct: 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 310
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 262 bits (671), Expect = 2e-79
Identities = 69/280 (24%), Positives = 115/280 (41%), Gaps = 33/280 (11%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
+ E IG G + V+K + + + + IK V K +EV+ L LDH N++
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY-NNEKAEREVKALAKLDHVNIVH 68
Query: 61 FY-SWYE---------------TSAHLWLVLEYCVGGDLMSLL--RQDNQLPEDSIRDLA 102
+ W + L++ +E+C G L + R+ +L + +L
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 103 QDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC 162
+ + + + Y+HSK +I DLKPSNI L + + K+ DFGL L + K S
Sbjct: 129 EQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS------K 182
Query: 163 GTPCYMAPELFEEGGVHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKSILSDPSPP 221
GT YM+PE + DL+ LG +L E + F E ++ +
Sbjct: 183 GTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAF---ETSKFFTDL---RDGI 235
Query: 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261
+ + L+ LL K P R + S++ K
Sbjct: 236 ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 262 bits (670), Expect = 6e-78
Identities = 83/340 (24%), Positives = 157/340 (46%), Gaps = 31/340 (9%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDH 55
Y I + IG G S V++ +K + +AIK V+ + E+ L+ L
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLNEKK-QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 56 PN--VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLH 113
+ ++R Y + T ++++V+E C DL S L++ + + ++++ A+ +H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
GI++ DLKP+N L+ +G KL DFG+A ++ + S++ ++ G YM PE
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT---SVVKDSQVGAVNYMPPEAI 228
Query: 174 EEGGV----------HSYASDLWGLGCVLYECYAGRPPFVGRE--FTQLVKSILSDPSPP 221
++ S SD+W LGC+LY G+ PF ++L I +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288
Query: 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKGAVRQ 281
P P + +++ L +DP QR+ +L H + + + P+ + + +K + Q
Sbjct: 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQ 348
Query: 282 -----DENSML-GSTPVRVTPSGRKTQTKTSGRVFEEKQK 315
NS+L + + SG ++ +S + FE+K+
Sbjct: 349 LVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 388
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 7e-76
Identities = 64/294 (21%), Positives = 125/294 (42%), Gaps = 31/294 (10%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHP 56
+ + + +GRG + V++ + K +AIK + + KV++EV+ L L+HP
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63
Query: 57 NVLRFY-SWYE-----------TSAHLWLVLEYCVGGDLMSLLRQDNQL---PEDSIRDL 101
++R++ +W E +L++ ++ C +L + + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 102 AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSD-------ASKAPS 154
+ A+++LHSKG+++ DLKPSNI + K+ DFGL + + P+
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKS 213
+ GT YM+PE +S+ D++ LG +L+E Y P E + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQMERVRTLTD 239
Query: 214 ILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLP 267
+ + PPL ++ +L P +R ++ +A + P
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTV 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 253 bits (647), Expect = 8e-76
Identities = 78/284 (27%), Positives = 130/284 (45%), Gaps = 32/284 (11%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK--SKVLQEVRMLHSLDHPNVL 59
+ + +G+G + V K R Y+AIK + +++ S +L EV +L SL+H V+
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 60 RFY-SWYE------------TSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDL 105
R+Y +W E + L++ +EYC G L L+ +N D L + +
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125
Query: 106 VRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA----- 160
+ AL Y+HS+GII+ DLKP NI +DE+ K+ DFGLA+ + +
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 161 ----KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKSIL 215
GT Y+A E+ + G ++ D++ LG + +E Y P G E ++K +
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLR 242
Query: 216 S---DPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
S + P N + +I L+ DP +R L +
Sbjct: 243 SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 2e-74
Identities = 77/287 (26%), Positives = 122/287 (42%), Gaps = 23/287 (8%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV---DKSQKSKVLQEVRMLHSLDHPNVL 59
Y + +G G +S V ++A+K + ++ + + +E M +HPN+L
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 60 RFYSWY----ETSAHLWLVLEYCVGGDLMSLLRQDNQ----LPEDSIRDLAQDLVRALQY 111
R ++ WL+L + G L + + + L ED I L + R L+
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQ----AKCGTPCY 167
+H+KG + DLKP+NILL + G+ L D G + + L A+ T Y
Sbjct: 150 IHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 168 MAPELFEE--GGVHSYASDLWGLGCVLYECYAGRPPF--VGREFTQLVKSILSDPSPPLP 223
APELF V +D+W LGCVLY G P+ V ++ + ++ + S P
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS 269
Query: 224 GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQP 270
S L+NS++ DP QR H L + P P Q
Sbjct: 270 PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL-EALQ---PPAPGQH 312
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 5e-72
Identities = 66/284 (23%), Positives = 115/284 (40%), Gaps = 41/284 (14%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-----KVLQEVRMLHSL-DH 55
++H E IG G++ +V+K K+ +AIK K L+EV L H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ----LPEDSIRDLAQDLVRALQY 111
+V+R++S + H+ + EYC GG L + ++ + E ++DL + R L+Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 112 LHSKGIIYCDLKPSNILLDENGRT-------------------KLCDFGLARKLSDASKA 152
+HS +++ D+KPSNI + K+ D G ++S
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS---- 186
Query: 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVK 212
PQ + G ++A E+ +E H +D++ L + P
Sbjct: 187 -----PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWH 238
Query: 213 SILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
I P +P S+ F L+ ++ DP +R L H+
Sbjct: 239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-71
Identities = 81/272 (29%), Positives = 134/272 (49%), Gaps = 13/272 (4%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHP 56
+Y +G+G ++ ++ T E FA K V KS + K+ E+ + SL H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
+V+ F+ ++E + +++VLE C L+ L ++ L E R + +V QYLH
Sbjct: 76 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
+I+ DLK N+ L+E+ K+ DFGLA K+ + + CGTP Y+APE+ +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV----EYDGERK-KVLCGTPNYIAPEVLSKK 190
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
G HS+ D+W +GC++Y G+PPF + I +P + + A+LI
Sbjct: 191 G-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-KKNEYSIPKHINPVAASLIQK 248
Query: 237 LLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPP 268
+L DP R ++L F+ + P LP
Sbjct: 249 MLQTDPTARPTINELLNDEFFTSGYIPARLPI 280
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 6e-71
Identities = 81/272 (29%), Positives = 135/272 (49%), Gaps = 13/272 (4%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHP 56
+Y +G+G ++ ++ T E FA K V KS + K+ E+ + SL H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
+V+ F+ ++E + +++VLE C L+ L ++ L E R + +V QYLH
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
+I+ DLK N+ L+E+ K+ DFGLA K+ + + CGTP Y+APE+ +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV----EYDGERK-KVLCGTPNYIAPEVLSKK 216
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
G HS+ D+W +GC++Y G+PPF + I + +P + + A+LI
Sbjct: 217 G-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSIPKHINPVAASLIQK 274
Query: 237 LLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPP 268
+L DP R ++L F+ + P LP
Sbjct: 275 MLQTDPTARPTINELLNDEFFTSGYIPARLPI 306
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 2e-69
Identities = 83/281 (29%), Positives = 135/281 (48%), Gaps = 26/281 (9%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLD 54
+ + I +G+GK+ VY R+K++ A+K + K+Q + ++ +EV + L
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HPN+LR Y ++ + ++L+LEY G + L++ ++ E +L AL Y HS
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK----CGTPCYMAP 170
K +I+ D+KP N+LL G K+ DFG S P ++ CGT Y+ P
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGW-----------SVHAPSSRRTDLCGTLDYLPP 176
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPSPPLPGNPSRP 229
E+ E H DLW LG + YE G+PPF + + K I + + P +
Sbjct: 177 EMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEG 233
Query: 230 FANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQP 270
+LI+ LL +P+QR ++ H W T + P Q
Sbjct: 234 ARDLISRLLKHNPSQRPMLREVLEHP-WITANSSKPSNCQN 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 3e-69
Identities = 83/280 (29%), Positives = 128/280 (45%), Gaps = 24/280 (8%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQ----EVRMLHSLD 54
++ + I +G+GK+ VY R+K+ A+K + KSQ K V E+ + L
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HPN+LR Y+++ ++L+LE+ G+L L++ + E ++L AL Y H
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK----CGTPCYMAP 170
+ +I+ D+KP N+L+ G K+ DFG S P + CGT Y+ P
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGW-----------SVHAPSLRRRTMCGTLDYLPP 181
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPF 230
E+ E H DLW G + YE G PPF T+ + I++ P S
Sbjct: 182 EMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD-LKFPPFLSDGS 239
Query: 231 ANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQP 270
+LI+ LL P QRL + H W + LPP
Sbjct: 240 KDLISKLLRYHPPQRLPLKGVMEHP-WVKANSRRVLPPVY 278
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-68
Identities = 87/264 (32%), Positives = 133/264 (50%), Gaps = 21/264 (7%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLHSLDHPNVLRFYS 63
+G G +STV R+ T +AIK ++K +++KV +E ++ LDHP ++ Y
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
++ L+ L Y G+L+ +R+ E R ++V AL+YLH KGII+ DLK
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 157
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAP--SSMLPQAKCGTPCYMAPELFEEGGVHSY 181
P NILL+E+ ++ DFG A+ LS SK +S GT Y++PEL E
Sbjct: 158 PENILLNEDMHIQITDFGTAKVLSPESKQARANSF-----VGTAQYVSPELLTEKS-ACK 211
Query: 182 ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKD 241
+SDLW LGC++Y+ AG PPF + + I+ P +L+ LLV D
Sbjct: 212 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKLLVLD 270
Query: 242 PAQRL------HWSDLCGHAFWRT 259
+RL + L H F+ +
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFFES 294
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-67
Identities = 85/271 (31%), Positives = 133/271 (49%), Gaps = 16/271 (5%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLD 54
+ + + +G+G ++ VY+ T AIK +DK +V EV++ L
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLH 113
HP++L Y+++E S +++LVLE C G++ L+ + E+ R ++ + YLH
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
S GI++ DL SN+LL N K+ DFGLA +L K P CGTP Y++PE+
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL----KMPHEKH-YTLCGTPNYISPEIA 184
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPSPPLPGNPSRPFAN 232
H SD+W LGC+ Y GRPPF + ++ D +P S +
Sbjct: 185 TRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE--MPSFLSIEAKD 241
Query: 233 LINSLLVKDPAQRLHWSDLCGHAFWRTKLTP 263
LI+ LL ++PA RL S + H F +
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 1e-67
Identities = 79/268 (29%), Positives = 140/268 (52%), Gaps = 19/268 (7%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSK----VLQEVRMLHSLD 54
+ + I AIG+G + V +K T + +A+K ++K + + V +E++++ L+
Sbjct: 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HP ++ + ++ +++V++ +GGDL L+Q+ E++++ +LV AL YL +
Sbjct: 74 HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF- 173
+ II+ D+KP NILLDE+G + DF +A L ++ + GT YMAPE+F
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT------MAGTKPYMAPEMFS 187
Query: 174 -EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT---QLVKSILSDPSPPLPGNPSRP 229
+G +S+A D W LG YE GR P+ R T ++V + + P S+
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-VTYPSAWSQE 246
Query: 230 FANLINSLLVKDPAQRL-HWSDLCGHAF 256
+L+ LL +P QR SD+ +
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPY 274
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-67
Identities = 68/307 (22%), Positives = 124/307 (40%), Gaps = 55/307 (17%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK----VLQEVRMLHSLDHPN 57
+ + + + +G+G + V++GR KKT + FAIK + + ++E +L L+H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 58 VLRFYSWYE--TSAHLWLVLEYCVGGDLMSLLRQ---DNQLPEDSIRDLAQDLVRALQYL 112
+++ ++ E T+ H L++E+C G L ++L + LPE + +D+V + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 113 HSKGIIYCDLKPSNILL----DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
GI++ ++KP NI+ D KL DFG AR+L D + S GT Y+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL------YGTEEYL 182
Query: 169 APELFEEGGV-------HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL------ 215
P+++E + + DLW +G Y G PF E + K ++
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 216 ----------------------SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253
S L ++ ++L D + +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 254 HAFWRTK 260
Sbjct: 303 ET-SDIL 308
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 3e-64
Identities = 66/263 (25%), Positives = 107/263 (40%), Gaps = 6/263 (2%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
++ +GRG + V++ + K+T A+K V +E+ L P ++
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--EELVACAGLSSPRIVP 114
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
Y + + +E GG L L++Q LPED + L+YLH++ I++
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHG 174
Query: 121 DLKPSNILLDENG-RTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
D+K N+LL +G R LCDFG A L S + GT +MAPE+
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 233
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD--PSPPLPGNPSRPFANLINSL 237
D+W C++ G P+ L I S+ P +P + + A I
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEG 293
Query: 238 LVKDPAQRLHWSDLCGHAFWRTK 260
L K+P R +L +
Sbjct: 294 LRKEPVHRASAMELRRKVGKALQ 316
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 222 bits (566), Expect = 7e-64
Identities = 68/298 (22%), Positives = 124/298 (41%), Gaps = 54/298 (18%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK----VLQEVRMLHSLDHPN 57
+ + + + +G+G + V++GR KKT + FAIK + + ++E +L L+H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 58 VLRFYSWYE--TSAHLWLVLEYCVGGDLMSLLRQ---DNQLPEDSIRDLAQDLVRALQYL 112
+++ ++ E T+ H L++E+C G L ++L + LPE + +D+V + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 113 HSKGIIYCDLKPSNILL----DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
GI++ ++KP NI+ D KL DFG AR+L D + S GT Y+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL------YGTEEYL 182
Query: 169 APELFEEGGV-------HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL------ 215
P+++E + + DLW +G Y G PF E + K ++
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 216 ----------------------SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDL 251
S L ++ ++L D + +
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 4e-63
Identities = 65/270 (24%), Positives = 106/270 (39%), Gaps = 16/270 (5%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLD-HPNVLRF 61
+ + +G G T+ R A+K + S +EV++L D HPNV+R+
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRY 83
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
+ + ++ +E C L + Q D L Q L +LHS I++
Sbjct: 84 FCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHR 142
Query: 121 DLKPSNILLDENG-----RTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
DLKP NIL+ + + DFGL +KL+ + S GT ++APE+ E
Sbjct: 143 DLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR--SGVPGTEGWIAPEMLSE 200
Query: 176 GGVHSY--ASDLWGLGCVLYECYA-GRPPFVGREFTQL--VKSILSDPSPPLPGNPSRPF 230
+ D++ GCV Y + G PF Q + S +
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIA 260
Query: 231 ANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260
LI ++ DP +R + H F+ +
Sbjct: 261 RELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 7e-63
Identities = 72/314 (22%), Positives = 127/314 (40%), Gaps = 30/314 (9%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV---DKSQKSKVLQEVRMLHSL-DHPNV 58
+ + + G ++ VY+ + + +A+K + ++ + ++QEV + L HPN+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 59 LRFYSWYETSAH--------LWLVLEYCVGG--DLMSLLRQDNQLPEDSIRDLAQDLVRA 108
++F S L+ E C G + + + L D++ + RA
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 109 LQYLHSKG--IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA------ 160
+Q++H + II+ DLK N+LL G KLCDFG A +S S +A
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 161 -KCGTPCYMAPELFEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD 217
+ TP Y PE+ + D+W LGC+LY + PF ++V S
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSI 268
Query: 218 PSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKG 277
P F +LI ++L +P +RL +++ P P + L+
Sbjct: 269 PPHD---TQYTVFHSLIRAMLQVNPEERLSIAEVVHQL-QEIAAARNVNPKSPITELLEQ 324
Query: 278 AVRQDENSMLGSTP 291
++ L P
Sbjct: 325 NGGY-GSATLSRGP 337
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 7e-63
Identities = 80/275 (29%), Positives = 131/275 (47%), Gaps = 27/275 (9%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIK----SVDKSQKSKVLQEVRMLHSL-DH 55
+N +G G V+K R +KT A+K S +K + ++L ++ ++ D
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDC 83
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
P +++ + + T+ +++ +E R +PE + + +V+AL YL K
Sbjct: 84 PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 116 -GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC---GTPCYMAPE 171
G+I+ D+KPSNILLDE G+ KLCDFG++ +L D AK G YMAPE
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD------DK---AKDRSAGCAAYMAPE 194
Query: 172 ----LFEEGGVHSYASDLWGLGCVLYECYAGRPPF--VGREFTQLVKSILSDPSPPLPGN 225
+ +D+W LG L E G+ P+ +F L K +L + P LPG+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK-VLQEEPPLLPGH 253
Query: 226 P--SRPFANLINSLLVKDPAQRLHWSDLCGHAFWR 258
S F + + L KD +R ++ L H+F +
Sbjct: 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK 288
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-62
Identities = 69/272 (25%), Positives = 123/272 (45%), Gaps = 19/272 (6%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKV---LQEVRMLHSLDHPNVLRFYSWYE 66
+G+G Y VY GR AIK + + +E+ + L H N++++ +
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 67 TSAHLWLVLEYCVGGDLMSLLRQDN---QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
+ + + +E GG L +LLR + E +I + ++ L+YLH I++ D+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 124 PSNILLD-ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV-HSY 181
N+L++ +G K+ DFG +++L+ + + GT YMAPE+ ++G +
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-----TGTLQYMAPEIIDKGPRGYGK 204
Query: 182 ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL----SDPSPPLPGNPSRPFANLINSL 237
A+D+W LGC + E G+PPF E + ++ P +P + S I
Sbjct: 205 AADIWSLGCTIIEMATGKPPFY--ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKC 262
Query: 238 LVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQ 269
DP +R +DL F + P+
Sbjct: 263 FEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-62
Identities = 70/258 (27%), Positives = 122/258 (47%), Gaps = 22/258 (8%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDH 55
++Y +G+G + V + K T + A+K + K Q K +L+EV++L LDH
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
PN+++ Y ++E + +LV E GG+L + + E + + ++ + Y+H
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 116 GIIYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
I++ DLKP N+LL ++ ++ DFGL+ + K + K GT Y+APE+
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM------KDKIGTAYYIAPEV 199
Query: 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----PSPPLPGNPSR 228
G + D+W G +LY +G PPF G ++K + P S
Sbjct: 200 LH--GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK-KVSE 256
Query: 229 PFANLINSLLVKDPAQRL 246
+LI +L P+ R+
Sbjct: 257 SAKDLIRKMLTYVPSMRI 274
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 2e-62
Identities = 74/257 (28%), Positives = 125/257 (48%), Gaps = 21/257 (8%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHP 56
Y + +G G Y V R K T AIK + K+ SK+L+EV +L LDHP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
N+++ Y ++E + +LV+E GG+L + + E + + ++ + YLH
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 117 IIYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
I++ DLKP N+LL +++ K+ DFGL+ + K + + GT Y+APE+
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM------KERLGTAYYIAPEVL 210
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----PSPPLPGNPSRP 229
+ D+W +G +L+ AG PPF G+ ++++ + SP N S
Sbjct: 211 R--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK-NVSEG 267
Query: 230 FANLINSLLVKDPAQRL 246
+LI +L D +R+
Sbjct: 268 AKDLIKQMLQFDSQRRI 284
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-62
Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 18/261 (6%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLHSLDHPNVLRFYS 63
+G+G + V R+K T Y+A+K + K K +V + E R+L + HP +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
++T L V+EY GG+L L ++ E+ R ++V AL+YLHS+ ++Y D+K
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 132
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYAS 183
N++LD++G K+ DFGL ++ + CGTP Y+APE+ E+ + A
Sbjct: 133 LENLMLDKDGHIKITDFGLCKEGISDGATMKTF-----CGTPEYLAPEVLEDND-YGRAV 186
Query: 184 DLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPA 243
D WGLG V+YE GR PF ++ +L + IL + P S +L+ LL KDP
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLLAGLLKKDPK 245
Query: 244 QRL-----HWSDLCGHAFWRT 259
QRL ++ H F+ +
Sbjct: 246 QRLGGGPSDAKEVMEHRFFLS 266
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 5e-62
Identities = 76/265 (28%), Positives = 125/265 (47%), Gaps = 29/265 (10%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----------KSKVLQEVRMLH 51
+Y + + +G G V ++KT + AI+ + K + V E+ +L
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 52 SLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
L+HP +++ ++++ ++VLE GG+L + + +L E + + ++ A+QY
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 112 LHSKGIIYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
LH GII+ DLKP N+LL +E+ K+ DFG ++ L + S L + CGTP Y+
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS------LMRTLCGTPTYL 308
Query: 169 APELFEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGRE-----FTQLVKSILSDPSPP 221
APE+ G Y A D W LG +L+ C +G PPF Q+ +
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 368
Query: 222 LPGNPSRPFANLINSLLVKDPAQRL 246
S +L+ LLV DP R
Sbjct: 369 WA-EVSEKALDLVKKLLVVDPKARF 392
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 5e-62
Identities = 77/252 (30%), Positives = 137/252 (54%), Gaps = 16/252 (6%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSK----VLQEVRMLHSLD 54
++Q+ + +G G + V + K++ ++A+K +DK + K K L E R+L +++
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
P +++ ++ +++L++V+EY GG++ S LR+ + E R A +V +YLHS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
+IY DLKP N+L+D+ G ++ DFG A+++ + CGTP +APE+
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL--------CGTPEALAPEIIL 211
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
G ++ A D W LG ++YE AG PPF + Q+ + I+S P + S +L+
Sbjct: 212 SKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLL 269
Query: 235 NSLLVKDPAQRL 246
+LL D +R
Sbjct: 270 RNLLQVDLTKRF 281
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 7e-62
Identities = 79/252 (31%), Positives = 133/252 (52%), Gaps = 16/252 (6%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSK----VLQEVRMLHSLD 54
+ + I +G G + V+ R + Y+A+K + K + K E ML +
Sbjct: 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HP ++R + ++ + ++++++Y GG+L SLLR+ + P + A ++ AL+YLHS
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
K IIY DLKP NILLD+NG K+ DFG A+ + D + ++ CGTP Y+APE+
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY---TL-----CGTPDYIAPEVVS 176
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
++ + D W G ++YE AG PF + + IL+ P + +L+
Sbjct: 177 TKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLL 234
Query: 235 NSLLVKDPAQRL 246
+ L+ +D +QRL
Sbjct: 235 SRLITRDLSQRL 246
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 7e-62
Identities = 69/257 (26%), Positives = 126/257 (49%), Gaps = 21/257 (8%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHP 56
+Y+I +G+G + V K + + T + +A+K ++K+ S +L+EV +L LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
N+++ + E S+ ++V E GG+L + + + E + + + + Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 117 IIYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
I++ DLKP NILL +++ K+ DFGL+ +K + + GT Y+APE+
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM------KDRIGTAYYIAPEVL 195
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----PSPPLPGNPSRP 229
+ D+W G +LY +G PPF G+ ++K + + P S
Sbjct: 196 RGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-TISDD 252
Query: 230 FANLINSLLVKDPAQRL 246
+LI +L P+ R+
Sbjct: 253 AKDLIRKMLTFHPSLRI 269
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 7e-62
Identities = 65/317 (20%), Positives = 115/317 (36%), Gaps = 59/317 (18%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------------------ 42
+N Y I + +GK++ + K +++A+K +KS K
Sbjct: 30 INDYRIIRTLNQGKFNKIILCEKDN--KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 43 --VLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQL------- 93
E++++ + + L ++++ EY ++ L
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 94 -PEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151
P I+ + + ++ + Y+H+ K I + D+KPSNIL+D+NGR KL DFG +
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE------SEY 201
Query: 152 APSSMLPQAKCGTPCYMAPELFE-EGGVHSYASDLWGLGCVLYECYAGRPPFVG-REFTQ 209
+ + GT +M PE F E + D+W LG LY + PF +
Sbjct: 202 MVDKKI-KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260
Query: 210 LVKSILSD----PSPPLPGNPSRPFA--------------NLINSLLVKDPAQRLHWSDL 251
L +I + P + + L K+PA+R+ D
Sbjct: 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
Query: 252 CGHAFWRTKLTPMPLPP 268
H W L
Sbjct: 321 LKHE-WLADTNIEDLRE 336
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 8e-62
Identities = 74/254 (29%), Positives = 124/254 (48%), Gaps = 19/254 (7%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK---VLQEVRMLHSLDHPNVL 59
+ E +G G +S V+ +++ T + FA+K + KS + + E+ +L + H N++
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
YE++ H +LV++ GG+L + + E + Q ++ A++YLH GI++
Sbjct: 70 TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVH 129
Query: 120 CDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
DLKP N+L +EN + + DFGL++ M CGTP Y+APE+ +
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKMEQ-----NGIM--STACGTPGYVAPEVLAQK 182
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----PSPPLPGNPSRPFAN 232
+S A D W +G + Y G PPF ++L + I SP + S +
Sbjct: 183 P-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD-DISESAKD 240
Query: 233 LINSLLVKDPAQRL 246
I LL KDP +R
Sbjct: 241 FICHLLEKDPNERY 254
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 8e-62
Identities = 73/257 (28%), Positives = 125/257 (48%), Gaps = 20/257 (7%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-----KVLQEVRMLHSLDHP 56
+ Y + E +G+G +S V + K T FA K ++ + S K+ +E R+ L HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
N++R + + + +LV + GG+L + E Q ++ ++ Y HS G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 117 IIYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
I++ +LKP N+LL + KL DFGLA +++D+ GTP Y++PE+
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW------HGFAGTPGYLSPEVL 179
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----PSPPLPGNPSRP 229
++ +S D+W G +LY G PPF + +L I + PSP +
Sbjct: 180 KKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD-TVTPE 237
Query: 230 FANLINSLLVKDPAQRL 246
+LI+S+L +P +R+
Sbjct: 238 AKSLIDSMLTVNPKKRI 254
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-61
Identities = 70/257 (27%), Positives = 127/257 (49%), Gaps = 21/257 (8%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHP 56
+Y+I +G+G + V K + + T + +A+K ++K+ S +L+EV +L LDHP
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP 81
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
N+++ + E S+ ++V E GG+L + + + E + + + + Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 117 IIYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
I++ DLKP NILL +++ K+ DFGL+ +K + + GT Y+APE+
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM------KDRIGTAYYIAPEVL 195
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----PSPPLPGNPSRP 229
G + D+W G +LY +G PPF G+ ++K + + P S
Sbjct: 196 R--GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR-TISDD 252
Query: 230 FANLINSLLVKDPAQRL 246
+LI +L P+ R+
Sbjct: 253 AKDLIRKMLTFHPSLRI 269
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-61
Identities = 80/289 (27%), Positives = 130/289 (44%), Gaps = 30/289 (10%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------------KSKVLQEVRM 49
Y E +GRG S V + K T + +A+K +D + + L+EV +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 50 LHSLD-HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRA 108
L + HPN+++ YET+ +LV + G+L L + L E R + + L+
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 109 LQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
+ LH I++ DLKP NILLD++ KL DFG + +L K + CGTP Y+
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL------REVCGTPSYL 190
Query: 169 APELFEEGGV-----HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----PS 219
APE+ E + D+W G ++Y AG PPF R+ +++ I+S S
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250
Query: 220 PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPP 268
P + S +L++ LV P +R + H + + +
Sbjct: 251 PEWD-DYSDTVKDLVSRFLVVQPQKRYTAEEALAHP-FFQQYVVEEVRH 297
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-61
Identities = 82/273 (30%), Positives = 132/273 (48%), Gaps = 12/273 (4%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-----KVLQEVRMLHSLDHPN 57
Y + + IG+G ++ V R T AIK +DK+Q + K+ +EVR++ L+HPN
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+++ + ET L+L++EY GG++ L ++ E R + +V A+QY H K I
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRI 135
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
++ DLK N+LLD + K+ DFG + + + K + CG P Y APELF+
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF------CGAPPYAAPELFQGKK 189
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237
D+W LG +LY +G PF G+ +L + +L +P S NL+
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR-GKYRIPFYMSTDCENLLKRF 248
Query: 238 LVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQP 270
LV +P +R + + L P
Sbjct: 249 LVLNPIKRGTLEQIMKDRWINAGHEEDELKPFV 281
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-61
Identities = 75/253 (29%), Positives = 116/253 (45%), Gaps = 19/253 (7%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---KSKVLQEVRMLHSLDHPNVLR 60
Y + IGRG + V +K T A K + K + QE+ ++ SLDHPN++R
Sbjct: 11 YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
Y +E + ++LV+E C GG+L + E + +D++ A+ Y H + +
Sbjct: 71 LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 130
Query: 121 DLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
DLKP N L + KL DFGLA + + K GTP Y++P++ E G
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM------RTKVGTPYYVSPQVLE--G 182
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----PSPPLPGNPSRPFANL 233
++ D W G ++Y G PPF ++++ I P N S +L
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL-NVSPQAESL 241
Query: 234 INSLLVKDPAQRL 246
I LL K P QR+
Sbjct: 242 IRRLLTKSPKQRI 254
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 4e-61
Identities = 67/256 (26%), Positives = 123/256 (48%), Gaps = 21/256 (8%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVL 59
+ +G G + V+ ++ + IK+++K + ++ E+ +L SLDHPN++
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 60 RFYSWYETSAHLWLVLEYCVGGDL----MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
+ + +E ++++V+E C GG+L +S + L E + +L + ++ AL Y HS+
Sbjct: 84 KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 116 GIIYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
+++ DLKP NIL + K+ DFGLA + GT YMAPE+
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS------TNAAGTALYMAPEV 197
Query: 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPS-PPLPGNPSRPF 230
F+ ++ D+W G V+Y G PF G ++ + +P+ +
Sbjct: 198 FK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 231 ANLINSLLVKDPAQRL 246
+L+ +L KDP +R
Sbjct: 256 VDLLKQMLTKDPERRP 271
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 6e-61
Identities = 83/258 (32%), Positives = 138/258 (53%), Gaps = 15/258 (5%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRML-HSLDHPNVLRFY 62
+G+G + V+ KKT ++FAIK++ K V + E R+L + +HP + +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
++T +L+ V+EY GGDLM ++ ++ A +++ LQ+LHSKGI+Y DL
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
K NILLD++G K+ DFG+ ++ ++ CGTP Y+APE+ ++++
Sbjct: 145 KLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-----CGTPDYIAPEILLGQK-YNHS 198
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDP 242
D W G +LYE G+ PF G++ +L SI D P P + +L+ L V++P
Sbjct: 199 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDLLVKLFVREP 257
Query: 243 AQRL-HWSDLCGHAFWRT 259
+RL D+ H +R
Sbjct: 258 EKRLGVRGDIRQHPLFRE 275
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 8e-61
Identities = 72/256 (28%), Positives = 123/256 (48%), Gaps = 20/256 (7%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDHPN 57
Y + E +G+G +S V + K T FA K ++ + K+ +E R+ L HPN
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
++R + + + +LV + GG+L + E Q ++ ++ Y HS GI
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 149
Query: 118 IYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
++ +LKP N+LL + KL DFGLA +++D+ GTP Y++PE+ +
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW------HGFAGTPGYLSPEVLK 203
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----PSPPLPGNPSRPF 230
+ +S D+W G +LY G PPF + +L I + PSP +
Sbjct: 204 KDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD-TVTPEA 261
Query: 231 ANLINSLLVKDPAQRL 246
+LI+S+L +P +R+
Sbjct: 262 KSLIDSMLTVNPKKRI 277
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 1e-60
Identities = 69/268 (25%), Positives = 117/268 (43%), Gaps = 32/268 (11%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----------------KSKVLQ 45
Y +G G Y V ++K AIK + KSQ ++
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 46 EVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDL 105
E+ +L SLDHPN+++ + +E + +LV E+ GG+L + ++ E ++ + +
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 106 VRALQYLHSKGIIYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKC 162
+ + YLH I++ D+KP NILL + K+ DFGL+ S K + +
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK------LRDRL 209
Query: 163 GTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----P 218
GT Y+APE+ + ++ D+W G ++Y G PPF G+ ++K +
Sbjct: 210 GTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267
Query: 219 SPPLPGNPSRPFANLINSLLVKDPAQRL 246
N S LI +L D +R
Sbjct: 268 FNDWK-NISDEAKELIKLMLTYDYNKRC 294
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-60
Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 28/276 (10%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRM-----LHSLDH 55
+ +GRG Y V K R + + A+K + + S+ + + M + ++D
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGG---DLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
P + FY +W+ +E ++ + +PED + +A +V+AL++L
Sbjct: 66 PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 113 HSKG-IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC---GTPCYM 168
HSK +I+ D+KPSN+L++ G+ K+CDFG++ L D + AK G YM
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD------DV---AKDIDAGCKPYM 176
Query: 169 APE---LFEEGGVHSYASDLWGLGCVLYECYAGRPPF--VGREFTQLVKSILSDPSPPLP 223
APE +S SD+W LG + E R P+ G F QL + ++ +PSP LP
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ-VVEEPSPQLP 235
Query: 224 GNP-SRPFANLINSLLVKDPAQRLHWSDLCGHAFWR 258
+ S F + + L K+ +R + +L H F+
Sbjct: 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-60
Identities = 83/263 (31%), Positives = 139/263 (52%), Gaps = 20/263 (7%)
Query: 10 IGRGKYSTVYKGRK---KKTIEYFAIKSVDKS---QKSKV--LQEVRMLHSLDHPNVLRF 61
+G+G + V+ +K + +A+K + K+ + +V E +L ++HP +++
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
+ ++T L+L+L++ GGDL + L ++ E+ ++ +L AL +LHS GIIY D
Sbjct: 92 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRD 151
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSY 181
LKP NILLDE G KL DFGL+++ D K S CGT YMAPE+ G H+
Sbjct: 152 LKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-----CGTVEYMAPEVVNRRG-HTQ 205
Query: 182 ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKD 241
++D W G +++E G PF G++ + + IL +P S +L+ L ++
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK-LGMPQFLSPEAQSLLRMLFKRN 264
Query: 242 PAQRL-----HWSDLCGHAFWRT 259
PA RL ++ H+F+ T
Sbjct: 265 PANRLGAGPDGVEEIKRHSFFST 287
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-60
Identities = 84/299 (28%), Positives = 141/299 (47%), Gaps = 24/299 (8%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVR-MLHSLDHPNVLRF 61
Y + E IG G YS + K T FA+K +DKS K +E+ +L HPN++
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS-KRDPTEEIEILLRYGQHPNIITL 81
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
Y+ ++++V E GG+L+ + + E + + + ++YLH++G+++ D
Sbjct: 82 KDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 122 LKPSNILL---DENGRT-KLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
LKPSNIL N + ++CDFG A++L +A + +L C T ++APE+ E G
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQL----RAENGLL-MTPCYTANFVAPEVLERQG 196
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGRE-------FTQLVKSILSDPSPPLPGNPSRPF 230
+ A D+W LG +LY G PF ++ S + S
Sbjct: 197 -YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN-SVSDTA 254
Query: 231 ANLINSLLVKDPAQRLHWSDLCGHAFW---RTKLTPMPLPPQPAFDSLKGAVRQDENSM 286
+L++ +L DP QRL + + H W +L L Q A +KGA+ +++
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHP-WIVHWDQLPQYQLNRQDAPHLVKGAMAATYSAL 312
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-60
Identities = 77/297 (25%), Positives = 125/297 (42%), Gaps = 34/297 (11%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLHSLD 54
+ + + +GRG + V+ + K T + +A K ++K ++ + E ++L +
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ----LPEDSIRDLAQDLVRALQ 110
++ +ET L LV+ GGD+ + ++ E +V L+
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 111 YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAP 170
+LH + IIY DLKP N+LLD++G ++ D GLA +L GTP +MAP
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-----AGTPGFMAP 358
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR----EFTQLVKSILSDPSPPLPGNP 226
EL + ++ D + LG LYE A R PF R E +L + +L P
Sbjct: 359 ELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-VTYPDKF 416
Query: 227 SRPFANLINSLLVKDPAQRL-----HWSDLCGHAFWRT--------KLTPMPLPPQP 270
S + +LL KDP +RL L H +R + P P
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDS 473
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-60
Identities = 85/265 (32%), Positives = 131/265 (49%), Gaps = 22/265 (8%)
Query: 10 IGRGKYSTVYKGRK---KKTIEYFAIKSVDKS---QKSK----VLQEVRMLHSLDHPNVL 59
+G+G Y V++ RK T + FA+K + K+ + +K E +L + HP ++
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
++T L+L+LEY GG+L L ++ ED+ ++ AL +LH KGIIY
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIY 144
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
DLKP NI+L+ G KL DFGL ++ + CGT YMAPE+ G H
Sbjct: 145 RDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF-----CGTIEYMAPEILMRSG-H 198
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLV 239
+ A D W LG ++Y+ G PPF G + + IL LP ++ +L+ LL
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-LNLPPYLTQEARDLLKKLLK 257
Query: 240 KDPAQRL-----HWSDLCGHAFWRT 259
++ A RL ++ H F+R
Sbjct: 258 RNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 4e-60
Identities = 81/258 (31%), Positives = 134/258 (51%), Gaps = 11/258 (4%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD----KSQKSKVLQEVRMLHSLDHPNV 58
+ E IG+G + V+KG +T + AIK +D + + + QE+ +L D P V
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
++Y Y LW+++EY GG + LL L E I + +++++ L YLHS+ I
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKI 141
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
+ D+K +N+LL E+G KL DFG+A +L+D ++ + GTP +MAPE+ ++
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVIKQSA- 195
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLL 238
+ +D+W LG E G PP +++ I + P L GN S+P + + L
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 255
Query: 239 VKDPAQRLHWSDLCGHAF 256
K+P+ R +L H F
Sbjct: 256 NKEPSFRPTAKELLKHKF 273
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 5e-60
Identities = 79/300 (26%), Positives = 136/300 (45%), Gaps = 29/300 (9%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----------KSKVLQEVRMLH 51
+Y + + +G G V ++KT + AIK + K + V E+ +L
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 52 SLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
L+HP +++ ++++ + ++VLE GG+L + + +L E + + ++ A+QY
Sbjct: 71 KLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 112 LHSKGIIYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
LH GII+ DLKP N+LL +E+ K+ DFG ++ L + S + CGTP Y+
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM------RTLCGTPTYL 183
Query: 169 APELFEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGRE-----FTQLVKSILSDPSPP 221
APE+ G Y A D W LG +L+ C +G PPF Q+ +
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV 243
Query: 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKGAVRQ 281
S +L+ LLV DP R + H + + + + ++ A+ Q
Sbjct: 244 WA-EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENESTALPQ 302
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 7e-60
Identities = 82/295 (27%), Positives = 132/295 (44%), Gaps = 33/295 (11%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLHSLD 54
N + Y +G+G + V + + T + +A K ++K ++ L E ++L ++
Sbjct: 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYL 112
V+ YET L LVL GGDL + Q PE A ++ L+ L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
H + I+Y DLKP NILLD++G ++ D GLA + + GT YMAPE+
Sbjct: 303 HRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR------VGTVGYMAPEV 356
Query: 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR----EFTQLVKSILSDPSPPLPGNPSR 228
+ ++++ D W LGC+LYE AG+ PF R + ++ + + P S
Sbjct: 357 VKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP-EEYSERFSP 414
Query: 229 PFANLINSLLVKDPAQRL-----HWSDLCGHAFWRT--------KLTPMPLPPQP 270
+L + LL KDPA+RL ++ H ++ + P P P
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP 469
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 9e-60
Identities = 67/256 (26%), Positives = 120/256 (46%), Gaps = 19/256 (7%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-----KVLQEVRMLHSLDHPN 57
+Y ++E +G+G +S V + K + +A ++ + S K+ +E R+ L HPN
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
++R + H +L+ + GG+L + E Q ++ A+ + H G+
Sbjct: 72 IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131
Query: 118 IYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
++ +LKP N+LL + KL DFGLA ++ + GTP Y++PE+
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEV----EGEQQAW-FGFAGTPGYLSPEVLR 186
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----PSPPLPGNPSRPF 230
+ + DLW G +LY G PPF + +L + I + PSP +
Sbjct: 187 KDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD-TVTPEA 244
Query: 231 ANLINSLLVKDPAQRL 246
+LIN +L +P++R+
Sbjct: 245 KDLINKMLTINPSKRI 260
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 218 bits (555), Expect = 9e-60
Identities = 91/417 (21%), Positives = 152/417 (36%), Gaps = 43/417 (10%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK----SQKSKVLQEVRMLHSLDHPNV 58
+ + E +G G + V + + T E AIK + + + E++++ L+HPNV
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 59 LRFYSWYETSAHL------WLVLEYCVGGDLMSLLRQ---DNQLPEDSIRDLAQDLVRAL 109
+ + L L +EYC GGDL L Q L E IR L D+ AL
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRT---KLCDFGLARKLSDASKAPSSMLPQAKCGTPC 166
+YLH II+ DLKP NI+L + K+ D G A++L GT
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF------VGTLQ 188
Query: 167 YMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP 226
Y+APEL E ++ D W G + +EC G PF+ + + S
Sbjct: 189 YLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 227 SRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMP--------LPPQPAFDSLKGA 278
+ S ++ P + + L P F +L
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307
Query: 279 VRQDENSMLGSTPVRVTPSGRKTQTKTSGRVFEEKQKDPSGTTRQVNLLRLSRIVKSNLQ 338
+ S++ RV T+ + + Q+D + LL+ S + ++
Sbjct: 308 LSLKLLSVMNMVSGRVHTY-PVTENENLQNLKSWLQQDTGIPEEEQELLQASGLALNS-- 364
Query: 339 RENDKENYRRPLPNGSENDSEVKIENNDMELDFN-ENTEDETNDEPDGPDNPNCASE 394
+PL + + + + +L F +N + + P +P S
Sbjct: 365 --------AQPLTQYVIDCTVIDGRQGEGDLIFLFDNRKTVYEPQISLPAHPESVSI 413
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-59
Identities = 79/278 (28%), Positives = 121/278 (43%), Gaps = 32/278 (11%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRM-----LHSLDH 55
IGRG Y +V K K + + A+K + + K +++ M + S D
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDC 80
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLR-----QDNQLPEDSIRDLAQDLVRALQ 110
P +++FY W+ +E + D+ +PE+ + + V+AL
Sbjct: 81 PYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 111 YLHSKG-IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC---GTPC 166
+L II+ D+KPSNILLD +G KLCDFG++ +L D S+ AK G
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD------SI---AKTRDAGCRP 190
Query: 167 YMAPE---LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-FTQLVKSILSDPSPPL 222
YMAPE + SD+W LG LYE GR P+ + ++ P L
Sbjct: 191 YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250
Query: 223 PGNP----SRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
+ S F N +N L KD ++R + +L H F
Sbjct: 251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF 288
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-59
Identities = 89/271 (32%), Positives = 138/271 (50%), Gaps = 19/271 (7%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLHSLD 54
MN++ + +G+G + V ++K T Y+A+K + K K +V L E R+L +
Sbjct: 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HP + ++T L V+EY GG+L L ++ ED R ++V AL YLHS
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 115 -KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
K ++Y DLK N++LD++G K+ DFGL ++ + CGTP Y+APE+
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-----CGTPEYLAPEVL 321
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233
E+ + A D WGLG V+YE GR PF ++ +L + IL + P +L
Sbjct: 322 EDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTLGPEAKSL 379
Query: 234 INSLLVKDPAQRL-----HWSDLCGHAFWRT 259
++ LL KDP QRL ++ H F+
Sbjct: 380 LSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 1e-59
Identities = 68/261 (26%), Positives = 120/261 (45%), Gaps = 25/261 (9%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--------KSKVLQEVRMLHSLDH 55
Y + E IG+G +S V + ++T + FA+K VD ++ + +E + H L H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDL----MSLLRQDNQLPEDSIRDLAQDLVRALQY 111
P+++ Y + L++V E+ G DL + E + ++ AL+Y
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 112 LHSKGIIYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
H II+ D+KP +LL + + KL FG+A +L ++ GTP +M
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-----VGTPHFM 200
Query: 169 APELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE---FTQLVKSILSDPSPPLPGN 225
APE+ + + D+WG G +L+ +G PF G + F ++K +
Sbjct: 201 APEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWS-H 258
Query: 226 PSRPFANLINSLLVKDPAQRL 246
S +L+ +L+ DPA+R+
Sbjct: 259 ISESAKDLVRRMLMLDPAERI 279
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-59
Identities = 76/301 (25%), Positives = 125/301 (41%), Gaps = 59/301 (19%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--------KSKVLQEVRMLHSL 53
+YH+ AIG+G Y V + +T AIK ++K++ ++ EVR++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 54 DHPNVLRFYSWYETSAHLWLVLEYCVGGDL------------------------------ 83
HPN+ R Y YE ++ LV+E C GG L
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 84 ----------MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILL--DE 131
D E I ++ + + AL YLH++GI + D+KP N L ++
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 132 NGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSY--ASDLWGLG 189
+ KL DFGL+++ + + K GTP ++APE+ SY D W G
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGM-TTKAGTPYFVAPEVL-NTTNESYGPKCDAWSAG 263
Query: 190 CVLYECYAGRPPFVGREFTQLVKSILSD----PSPPLPGNPSRPFANLINSLLVKDPAQR 245
+L+ G PF G + +L+ +P S +L+++LL ++ +R
Sbjct: 264 VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYN-VLSPLARDLLSNLLNRNVDER 322
Query: 246 L 246
Sbjct: 323 F 323
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 217 bits (553), Expect = 3e-59
Identities = 89/304 (29%), Positives = 143/304 (47%), Gaps = 35/304 (11%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRML---H 51
MN + ++ IGRG + VY RK T + +A+K +DK K L E ML
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247
Query: 52 SLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
+ D P ++ + T L +L+ GGDL L Q E +R A +++ L++
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
+H++ ++Y DLKP+NILLDE+G ++ D GLA S P A GT YMAPE
Sbjct: 308 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPE 360
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF---TQLVKSILSDPSPPLPGNPSR 228
+ ++G + ++D + LGC+L++ G PF + ++ + L+ LP + S
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-VELPDSFSP 419
Query: 229 PFANLINSLLVKDPAQRL-----HWSDLCGHAFWRT---------KLTPMPLPPQPAFDS 274
+L+ LL +D +RL ++ F+R+ K P PL P +
Sbjct: 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP-PLIPPRGEVN 478
Query: 275 LKGA 278
A
Sbjct: 479 AADA 482
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-59
Identities = 81/264 (30%), Positives = 133/264 (50%), Gaps = 22/264 (8%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRML-HSLDHPNVLRFY 62
+G+G + V R K+T + +A+K + K Q V + E R+L + +HP + + +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
++T L+ V+E+ GGDLM +++ + E R A +++ AL +LH KGIIY DL
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDL 150
Query: 123 KPSNILLDENGRTKLCDFGLARK-LSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSY 181
K N+LLD G KL DFG+ ++ + + ++ CGTP Y+APE+ +E +
Sbjct: 151 KLDNVLLDHEGHCKLADFGMCKEGICNGVTT-ATF-----CGTPDYIAPEILQEML-YGP 203
Query: 182 ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKD 241
A D W +G +LYE G PF L ++IL+D P ++ S + K+
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLHEDATGILKSFMTKN 262
Query: 242 PAQRL------HWSDLCGHAFWRT 259
P RL + H F++
Sbjct: 263 PTMRLGSLTQGGEHAILRHPFFKE 286
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 4e-59
Identities = 76/268 (28%), Positives = 125/268 (46%), Gaps = 37/268 (13%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---------KSKVLQEVRMLHS 52
+ Y I E +G G+++ V K R+K T +A K + K Q + ++ +EV +L
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 53 LDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
+ H NV+ + YE + L+LE GG+L L Q L E+ + ++ + YL
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 113 HSKGIIYCDLKPSNILL----DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
H+K I + DLKP NI+L KL DFGLA ++ D + + GTP ++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF------KNIFGTPEFV 185
Query: 169 APELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN--- 225
APE+ + +D+W +G + Y +G PF+G + + +I S +
Sbjct: 186 APEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITS-------VSYDF 237
Query: 226 PSRPFAN-------LINSLLVKDPAQRL 246
F++ I LLVK+ +RL
Sbjct: 238 DEEFFSHTSELAKDFIRKLLVKETRKRL 265
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 5e-59
Identities = 85/261 (32%), Positives = 133/261 (50%), Gaps = 18/261 (6%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRML-HSLDHPNVLRFY 62
IG+G + V R K ++A+K + K +K + + E +L ++ HP ++ +
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
++T+ L+ VL+Y GG+L L+++ E R A ++ AL YLHS I+Y DL
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 165
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
KP NILLD G L DFGL ++ + + S+ CGTP Y+APE+ + +
Sbjct: 166 KPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF-----CGTPEYLAPEVLHKQP-YDRT 219
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDP 242
D W LG VLYE G PPF R ++ +IL+ P L N + +L+ LL KD
Sbjct: 220 VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNITNSARHLLEGLLQKDR 278
Query: 243 AQRL----HWSDLCGHAFWRT 259
+RL + ++ H F+
Sbjct: 279 TKRLGAKDDFMEIKSHVFFSL 299
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 6e-59
Identities = 82/262 (31%), Positives = 128/262 (48%), Gaps = 19/262 (7%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRML-HSLDHPNVLRFY 62
+G+G + V +K T E +A+K + K Q V + E R+L P + + +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
S ++T L+ V+EY GGDLM ++Q + E A ++ L +L SKGIIY DL
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 147
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
K N++LD G K+ DFG+ ++ + CGTP Y+APE+ + +
Sbjct: 148 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-----CGTPDYIAPEIIAYQP-YGKS 201
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDP 242
D W G +LYE AG+ PF G + +L +SI+ P + S+ + L+ K P
Sbjct: 202 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHP 260
Query: 243 AQRLH-----WSDLCGHAFWRT 259
+RL D+ HAF+R
Sbjct: 261 GKRLGCGPEGERDIKEHAFFRY 282
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 8e-59
Identities = 90/272 (33%), Positives = 140/272 (51%), Gaps = 29/272 (10%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRML-HSLDHPNVLRFY 62
IGRG Y+ V R KKT +A+K V K + E + + +HP ++ +
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
S ++T + L+ V+EY GGDLM +++ +LPE+ R + ++ AL YLH +GIIY DL
Sbjct: 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 136
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
K N+LLD G KL D+G+ ++ S+ CGTP Y+APE+ + ++
Sbjct: 137 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-----CGTPNYIAPEILRGED-YGFS 190
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFT---------QLVKSILSDPSPPLPGNPSRPFANL 233
D W LG +++E AGR PF + L + IL +P + S A++
Sbjct: 191 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRIPRSLSVKAASV 249
Query: 234 INSLLVKDPAQRL------HWSDLCGHAFWRT 259
+ S L KDP +RL ++D+ GH F+R
Sbjct: 250 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 1e-58
Identities = 78/266 (29%), Positives = 126/266 (47%), Gaps = 28/266 (10%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----------KSKVLQEVRML 50
+Y + IGRG S V + + T FA+K ++ + + +E +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 51 HSL-DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRAL 109
+ HP+++ YE+S+ ++LV + G+L L + L E R + + L+ A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
+LH+ I++ DLKP NILLD+N + +L DFG + L K + CGTP Y+A
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL------RELCGTPGYLA 267
Query: 170 PELFEEGGV-----HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----PSP 220
PE+ + + DLW G +L+ AG PPF R +++ I+ SP
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327
Query: 221 PLPGNPSRPFANLINSLLVKDPAQRL 246
+ S +LI+ LL DP RL
Sbjct: 328 EWD-DRSSTVKDLISRLLQVDPEARL 352
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 1e-58
Identities = 81/299 (27%), Positives = 136/299 (45%), Gaps = 29/299 (9%)
Query: 3 QYHIY---EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLD-HPNV 58
Y + + +G G +S K KK+ + FA+K + K ++ +E+ L + HPN+
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNI 68
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
++ + + H +LV+E GG+L +++ E + + LV A+ ++H G++
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVV 128
Query: 119 YCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
+ DLKP N+L ++N K+ DFG AR ++ + C T Y APEL +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-----CFTLHYAAPELLNQ 183
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVG-------REFTQLVKSILSD----PSPPLPG 224
G + + DLW LG +LY +G+ PF +++K I
Sbjct: 184 NG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK- 241
Query: 225 NPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW---RTKLTPMPLPPQPAFDSLKGAVR 280
N S+ +LI LL DP +RL S L + W ++L+ PL S AV
Sbjct: 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE-WLQDGSQLSSNPLMTPDILGSSGAAVH 299
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 1e-58
Identities = 77/268 (28%), Positives = 129/268 (48%), Gaps = 37/268 (13%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---------KSKVLQEVRMLHS 52
+ Y + E +G G+++ V K R+K T + +A K + K + + ++ +EV +L
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 53 LDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
+ HPN++ + +E + L+LE GG+L L + L ED + ++ + YL
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 113 HSKGIIYCDLKPSNILL----DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
HSK I + DLKP NI+L N R KL DFG+A K+ + + GTP ++
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-----AGNEF-KNIFGTPEFV 178
Query: 169 APELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN--- 225
APE+ + +D+W +G + Y +G PF+G + + +I + N
Sbjct: 179 APEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISA-------VNYDF 230
Query: 226 PSRPFAN-------LINSLLVKDPAQRL 246
F+N I LLVKDP +R+
Sbjct: 231 DEEYFSNTSELAKDFIRRLLVKDPKRRM 258
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-58
Identities = 80/287 (27%), Positives = 128/287 (44%), Gaps = 33/287 (11%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLHSLDHPNVLRFYS 63
IGRG +S V + K+T + +A+K ++K ++ +V +E +L + D + + +
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 64 WYETSAHLWLVLEYCVGGDLMSLL-RQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
++ +L+LV+EY VGGDL++LL + ++P + R ++V A+ +H G ++ D+
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDI 188
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV---- 178
KP NILLD G +L DFG KL S + GTP Y++PE+ + G
Sbjct: 189 KPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA----VGTPDYLSPEILQAVGGGPGT 244
Query: 179 --HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD----PSPPLPGNPSRPFAN 232
+ D W LG YE + G+ PF + I+ P + +
Sbjct: 245 GSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARD 304
Query: 233 LINSLLVKDPAQRL---HWSDLCGHAF-----WRT--KLTPMPLPPQ 269
I LL P RL D H F W P P P
Sbjct: 305 FIQRLL-CPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVP-PFTPD 349
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 3e-58
Identities = 84/295 (28%), Positives = 132/295 (44%), Gaps = 43/295 (14%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--------------------- 39
+NQY + + IG+G Y V + Y+A+K + K +
Sbjct: 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 40 --------KSKVLQEVRMLHSLDHPNVLRFYSWYE--TSAHLWLVLEYCVGGDLMSLLRQ 89
+V QE+ +L LDHPNV++ + HL++V E G +M +
Sbjct: 72 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-T 130
Query: 90 DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA 149
L ED R QDL++ ++YLH + II+ D+KPSN+L+ E+G K+ DFG++ +
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG- 189
Query: 150 SKAPSSMLPQAKCGTPCYMAPELFEEG--GVHSYASDLWGLGCVLYECYAGRPPFVGREF 207
++L GTP +MAPE E A D+W +G LY G+ PF+
Sbjct: 190 ---SDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 208 TQLVKSILSDPSPPLPGNP--SRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260
L I S P P + +LI +L K+P R+ ++ H W T+
Sbjct: 246 MCLHSKIKSQA-LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHP-WVTR 298
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 4e-58
Identities = 64/260 (24%), Positives = 118/260 (45%), Gaps = 29/260 (11%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--VLQEVRMLHSLDHPNVL 59
+Y I E +GRG++ V++ + + + + K V + V +E+ +L+ H N+L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLM-SLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ +E+ L ++ E+ G D+ + +L E I + ALQ+LHS I
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 119 YCDLKPSNILL--DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
+ D++P NI+ + K+ +FG AR+L + P Y APE+ +
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF------RLLFTAPEYYAPEVHQHD 178
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN---PSRPFAN- 232
V S A+D+W LG ++Y +G PF+ Q++++I++ F
Sbjct: 179 VV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN-------AEYTFDEEAFKEI 230
Query: 233 ------LINSLLVKDPAQRL 246
++ LLVK+ R+
Sbjct: 231 SIEAMDFVDRLLVKERKSRM 250
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 4e-58
Identities = 75/268 (27%), Positives = 125/268 (46%), Gaps = 37/268 (13%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---------KSKVLQEVRMLHS 52
+ Y I E +G G+++ V K R+K T +A K + K Q + ++ +EV +L
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 53 LDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
+ HPN++ + YE + L+LE GG+L L Q L E+ + ++ + YL
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 113 HSKGIIYCDLKPSNILL----DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
H+K I + DLKP NI+L KL DFGLA ++ D + + GTP ++
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF------KNIFGTPEFV 185
Query: 169 APELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN--- 225
APE+ + +D+W +G + Y +G PF+G + + +I + +
Sbjct: 186 APEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITA-------VSYDF 237
Query: 226 PSRPFAN-------LINSLLVKDPAQRL 246
F+ I LLVK+ +RL
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRL 265
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 8e-58
Identities = 78/262 (29%), Positives = 126/262 (48%), Gaps = 21/262 (8%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLHSLDHPNVLRFYS 63
IGRG + V R K T + +A+K + K ++S +E ++ + P V++ +
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
++ +L++V+EY GGDL++L+ +PE R ++V AL +HS G I+ D+K
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195
Query: 124 PSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE-EGGVHSY- 181
P N+LLD++G KL DFG K++ GTP Y++PE+ + +GG Y
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA----VGTPDYISPEVLKSQGGDGYYG 251
Query: 182 -ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP-PLPGNP--SRPFANLINSL 237
D W +G LYE G PF I++ + P + S+ NLI +
Sbjct: 252 RECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAF 311
Query: 238 LVKDPAQRLHW---SDLCGHAF 256
L D RL ++ H F
Sbjct: 312 L-TDREVRLGRNGVEEIKRHLF 332
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 8e-58
Identities = 62/261 (23%), Positives = 121/261 (46%), Gaps = 30/261 (11%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNV 58
+ Y I E +G G + V++ +K T F K ++ K V E+ +++ L HP +
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLM-SLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+ + +E + L+LE+ GG+L + +D ++ E + + + L+++H I
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 118 IYCDLKPSNILL--DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
++ D+KP NI+ + K+ DFGLA KL+ + T + APE+ +
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV------KVTTATAEFAAPEIVDR 224
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN---PSRPFAN 232
V + +D+W +G + Y +G PF G + + ++++ + F++
Sbjct: 225 EPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR-------CDWEFDEDAFSS 276
Query: 233 -------LINSLLVKDPAQRL 246
I +LL K+P +RL
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRL 297
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 9e-58
Identities = 74/274 (27%), Positives = 118/274 (43%), Gaps = 9/274 (3%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQ----EVRMLHSLDHP 56
+ + + + +G G Y V + T E A+K VD + + E+ + L+H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
NV++FY +L LEYC GG+L + D +PE + L+ + YLH G
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
I + D+KP N+LLDE K+ DFGLA ++ +L CGT Y+APEL +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--ERLL-NKMCGTLPYVAPELLKRR 182
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPF--VGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
H+ D+W G VL AG P+ + L+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 235 NSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPP 268
+ +LV++P+ R+ D+ ++ L P
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 1e-57
Identities = 75/276 (27%), Positives = 131/276 (47%), Gaps = 21/276 (7%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD--KSQKSK--VLQEVRMLHSLDHPN 57
+ Y + E IG G + V E AIK ++ K Q S +L+E++ + HPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 58 VLRFYSWYETSAHLWLVLEYCVGG---DLMSLLRQD-----NQLPEDSIRDLAQDLVRAL 109
++ +Y+ + LWLV++ GG D++ + L E +I + ++++ L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
+YLH G I+ D+K NILL E+G ++ DFG++ L+ + + + GTPC+MA
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 170 PELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP--- 226
PE+ E+ + + +D+W G E G P+ +++ L + P L
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDK 254
Query: 227 ------SRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
+ F +I+ L KDP +R ++L H F
Sbjct: 255 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-57
Identities = 89/272 (32%), Positives = 140/272 (51%), Gaps = 29/272 (10%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRML-HSLDHPNVLRFY 62
IGRG Y+ V R KKT +A++ V K + E + + +HP ++ +
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
S ++T + L+ V+EY GGDLM +++ +LPE+ R + ++ AL YLH +GIIY DL
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 179
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
K N+LLD G KL D+G+ ++ S+ CGTP Y+APE+ + ++
Sbjct: 180 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-----CGTPNYIAPEILRGED-YGFS 233
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFT---------QLVKSILSDPSPPLPGNPSRPFANL 233
D W LG +++E AGR PF + L + IL +P + S A++
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-IRIPRSLSVKAASV 292
Query: 234 INSLLVKDPAQRL------HWSDLCGHAFWRT 259
+ S L KDP +RL ++D+ GH F+R
Sbjct: 293 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 1e-57
Identities = 78/304 (25%), Positives = 137/304 (45%), Gaps = 56/304 (18%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHP 56
+ + +G G V+K K + A K + + ++++++E+++LH + P
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
++ FY + + + + +E+ GG L +L++ ++PE + ++ +++ L YL K
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 117 -IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I++ D+KPSNIL++ G KLCDFG++ +L D S A S GT YM+PE +
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANS------FVGTRSYMSPERLQG 204
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPF--------------------------------- 202
+S SD+W +G L E GR P
Sbjct: 205 TH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 203 ---------VGREFTQLVKSILSDPSPPLPGNP-SRPFANLINSLLVKDPAQRLHWSDLC 252
+L+ I+++P P LP S F + +N L+K+PA+R L
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 323
Query: 253 GHAF 256
HAF
Sbjct: 324 VHAF 327
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 1e-57
Identities = 76/275 (27%), Positives = 129/275 (46%), Gaps = 14/275 (5%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLD 54
+ Y + + +G G + V G + T A+K +++ + K+ +E++ L
Sbjct: 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HP++++ Y T ++V+EY GG+L + + ++ E R L Q ++ A+ Y H
Sbjct: 70 HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
+++ DLKP N+LLD + K+ DFGL+ +SD +S CG+P Y APE+
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS------CGSPNYAAPEVIS 183
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
D+W G +LY G PF L K I +P +R A L+
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG-VFYIPEYLNRSVATLL 242
Query: 235 NSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQ 269
+L DP +R D+ H +++ L P L P+
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDL-PSYLFPE 276
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-57
Identities = 73/253 (28%), Positives = 119/253 (47%), Gaps = 17/253 (6%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-VLQEVRMLHSLDHPNVLRF 61
+ + +GRG S VY+ ++K T + +A+K + K+ K V E+ +L L HPN+++
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
+ET + LVLE GG+L + + E D + ++ A+ YLH GI++ D
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRD 173
Query: 122 LKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
LKP N+L + K+ DFGL++ + + CGTP Y APE+
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM------KTVCGTPGYCAPEILRGCA- 226
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVGRE-----FTQLVKSILSDPSPPLPGNPSRPFANL 233
+ D+W +G + Y G PF F +++ SP S +L
Sbjct: 227 YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWD-EVSLNAKDL 285
Query: 234 INSLLVKDPAQRL 246
+ L+V DP +RL
Sbjct: 286 VRKLIVLDPKKRL 298
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-57
Identities = 78/301 (25%), Positives = 125/301 (41%), Gaps = 12/301 (3%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQ----EVRMLHSLDHP 56
+ + + + +G G Y V + T E A+K VD + + E+ + L+H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
NV++FY +L LEYC GG+L + D +PE + L+ + YLH G
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
I + D+KP N+LLDE K+ DFGLA ++ L CGT Y+APEL +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR---ERLLNKMCGTLPYVAPELLKRR 182
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPF--VGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
H+ D+W G VL AG P+ + L+
Sbjct: 183 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242
Query: 235 NSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLK---GAVRQDENSMLGSTP 291
+ +LV++P+ R+ D+ ++ L P+ + + S L +P
Sbjct: 243 HKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSP 302
Query: 292 V 292
V
Sbjct: 303 V 303
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 210 bits (535), Expect = 4e-57
Identities = 82/262 (31%), Positives = 128/262 (48%), Gaps = 19/262 (7%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRML-HSLDHPNVLRFY 62
+G+G + V +K T E +A+K + K Q V + E R+L P + + +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
S ++T L+ V+EY GGDLM ++Q + E A ++ L +L SKGIIY DL
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
K N++LD G K+ DFG+ ++ + CGTP Y+APE+ + +
Sbjct: 469 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF-----CGTPDYIAPEIIAYQP-YGKS 522
Query: 183 SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDP 242
D W G +LYE AG+ PF G + +L +SI+ P + S+ + L+ K P
Sbjct: 523 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHP 581
Query: 243 AQRL-----HWSDLCGHAFWRT 259
+RL D+ HAF+R
Sbjct: 582 GKRLGCGPEGERDIKEHAFFRY 603
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 6e-57
Identities = 75/266 (28%), Positives = 125/266 (46%), Gaps = 37/266 (13%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---------KSKVLQEVRMLHSLD 54
Y E +G G+++ V K R+K T +A K + K + + + +EV +L +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HPNV+ + YE + L+LE GG+L L + L E+ + + ++ + YLHS
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 115 KGIIYCDLKPSNILL----DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAP 170
I + DLKP NI+L R K+ DFGLA K+ ++ + GTP ++AP
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF------KNIFGTPEFVAP 186
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN---PS 227
E+ + +D+W +G + Y +G PF+G + + ++ + N
Sbjct: 187 EIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA-------VNYEFED 238
Query: 228 RPFAN-------LINSLLVKDPAQRL 246
F+N I LLVKDP +R+
Sbjct: 239 EYFSNTSALAKDFIRRLLVKDPKKRM 264
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 6e-57
Identities = 93/390 (23%), Positives = 155/390 (39%), Gaps = 44/390 (11%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRML-HSLDHPNVLR 60
N + +G G TV + A+K + L E+++L S DHPNV+R
Sbjct: 15 NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIR 73
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQ-------DNQLPEDSIRDLAQDLVRALQYLH 113
+Y T L++ LE C +L L+ E + L + + + +LH
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 114 SKGIIYCDLKPSNILLD-------------ENGRTKLCDFGLARKLSDASKAPSSMLPQA 160
S II+ DLKP NIL+ EN R + DFGL +KL + + L
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL-NN 191
Query: 161 KCGTPCYMAPELFEEGGVH------SYASDLWGLGCVLYECY-AGRPPFVGREFTQ--LV 211
GT + APEL EE + + D++ +GCV Y G+ PF + + ++
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
Query: 212 KSILSDPSPPLPGNP--SRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQ 269
+ I S + +LI+ ++ DP +R + H + K +
Sbjct: 252 RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEF-LL 310
Query: 270 PAFDSLKGAVRQDENSMLG---STPVRVTPSGRKTQTKTSGRVFEEKQKDPSGTTRQV-N 325
D L+ R +++L + V PSG T K + ++ + ++ +
Sbjct: 311 KVSDRLEIENRDPPSALLMKFDAGSDFVIPSGDWTV-KFDKTFMDNLERYRKYHSSKLMD 369
Query: 326 LLRLSRIVKSNLQRE--NDKENYRRPLPNG 353
LLR R K + + D P+P+G
Sbjct: 370 LLRALR-NKYHHFMDLPEDIAELMGPVPDG 398
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 8e-57
Identities = 83/270 (30%), Positives = 123/270 (45%), Gaps = 31/270 (11%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---KSKVLQEVRMLHSL-DHPNVLRFYS 63
+ +G G ++ V T + +A+K ++K +S+V +EV ML+ H NVL
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
++E +LV E GG ++S + + E + QD+ AL +LH+KGI + DLK
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138
Query: 124 PSNILL---DENGRTKLCDFGLAR--KLSDASKAPSSMLPQAKCGTPCYMAPELFE--EG 176
P NIL ++ K+CDF L KL+ S+ CG+ YMAPE+ E
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
Query: 177 GVHSY--ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN--------- 225
Y DLW LG +LY +G PPFVGR +
Sbjct: 199 EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY 258
Query: 226 --PSRPFAN-------LINSLLVKDPAQRL 246
P + +A+ LI+ LLV+D QRL
Sbjct: 259 EFPDKDWAHISCAAKDLISKLLVRDAKQRL 288
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 1e-56
Identities = 76/271 (28%), Positives = 133/271 (49%), Gaps = 12/271 (4%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD---KSQKSKVLQEVRMLHSLDHPNVL 59
+Y +E IG+G TVY T + AI+ ++ + +K ++ E+ ++ +PN++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ Y LW+V+EY GG L ++ + + E I + ++ ++AL++LHS +I+
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
D+K NILL +G KL DFG +++ S+M+ GTP +MAPE+ +
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAPEVVTRKA-Y 193
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGNPSRPFANLINSL 237
D+W LG + E G PP++ + + I ++ +P L P S F + +N
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 238 LVKDPAQRLHWSDLCGHAFWRTKLTPMPLPP 268
L D +R +L H F + L P
Sbjct: 254 LEMDVEKRGSAKELLQHQFLKIAKPLSSLTP 284
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-56
Identities = 71/267 (26%), Positives = 121/267 (45%), Gaps = 23/267 (8%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVD-----KSQKSKVLQEVRMLHSLDHPNVLRFY 62
IGRG + TVYKG +T A + KS++ + +E ML L HPN++RFY
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 63 -SWYETS---AHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG-- 116
SW T + LV E G L + L++ + +R + +++ LQ+LH++
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 117 IIYCDLKPSNILLD-ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
II+ DLK NI + G K+ D GLA + +++ GTP +MAPE++EE
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVI-----GTPEFMAPEMYEE 204
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP--LPGNPSRPFANL 233
+ + D++ G + E P+ + + ++ P +
Sbjct: 205 K--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262
Query: 234 INSLLVKDPAQRLHWSDLCGHAFWRTK 260
I + ++ +R DL HAF++ +
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-56
Identities = 84/308 (27%), Positives = 136/308 (44%), Gaps = 17/308 (5%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSLDHPNV 58
++Y + IG G + R K T E A+K +++ V +E+ SL HPN+
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI 78
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+RF T HL +++EY GG+L + + ED R Q L+ + Y HS I
Sbjct: 79 VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138
Query: 119 YCDLKPSNILLDEN--GRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
+ DLK N LLD + R K+CDFG ++ S P++ GTP Y+APE+
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS------QPKSTVGTPAYIAPEVLLRQ 192
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPF----VGREFTQLVKSILS-DPSPPLPGNPSRPFA 231
+D+W G LY G PF R++ + ++ ILS S P S
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECC 252
Query: 232 NLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLK--GAVRQDENSMLGS 289
+LI+ + V DPA R+ ++ H+++ L + + Q ++++
Sbjct: 253 HLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQI 312
Query: 290 TPVRVTPS 297
P+
Sbjct: 313 ISEATIPA 320
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-56
Identities = 78/285 (27%), Positives = 130/285 (45%), Gaps = 31/285 (10%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKV---LQEVRMLHSLDHPNVLRFYS 63
IGRG + V + K + FA+K ++K ++++ +E +L + D + +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 64 WYETSAHLWLVLEYCVGGDLMSLL-RQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
++ +L+LV++Y VGGDL++LL + +++LPE+ R ++V A+ +H ++ D+
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDI 201
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE----GGV 178
KP NIL+D NG +L DFG KL + SS+ GTP Y++PE+ + G
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA----VGTPDYISPEILQAMEGGKGR 257
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS----PPLPGNPSRPFANLI 234
+ D W LG +YE G PF + I++ P + S +LI
Sbjct: 258 YGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLI 317
Query: 235 NSLLVKDPAQRL---HWSDLCGHAF-----WRT--KLTPMPLPPQ 269
L+ RL D H F W P P+
Sbjct: 318 RRLI-CSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEA-PYIPE 360
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 3e-56
Identities = 49/342 (14%), Positives = 97/342 (28%), Gaps = 59/342 (17%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------------------------- 42
+G+ + ++T E F + +++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 43 VLQEVRMLHSLD---HPNVLRFYSWYETSAHLWLVLEYCV-----------GGDLMSLLR 88
+R + D P + +W++ + + G L+S
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 89 QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSD 148
L + L ++R L LH G+++ L+P +I+LD+ G L F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263
Query: 149 ASKAPSSMLPQAKCGTPCYMAPELF----EEGGVHSYASDLWGLGCVLYECYAGRPPFVG 204
++ +P P A + + ++A D W LG +Y + P
Sbjct: 264 SAVSPIGRG----FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319
Query: 205 REFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPM 264
+ I N +P L+ L RL + +L
Sbjct: 320 DAALGGSEWIFRSCK-----NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE-QLRTE 373
Query: 265 PLPPQPAFDSLKGAVRQDENSMLGSTPVRVTPSGRKTQTKTS 306
P + + E + G P T + +
Sbjct: 374 LSAALPLYQT------DGEPTREGGAPPSGTSQPDEAGAAEA 409
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 1e-55
Identities = 80/270 (29%), Positives = 132/270 (48%), Gaps = 12/270 (4%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD---KSQKSKVLQEVRMLHSLDHPNVLR 60
Y IG G V R+K + A+K +D + ++ + EV ++ H NV+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
Y Y LW+++E+ GG L ++ Q +L E+ I + + +++AL YLH++G+I+
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHR 165
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
D+K +ILL +GR KL DFG ++S S++ GTP +MAPE+ ++
Sbjct: 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRSL-YA 219
Query: 181 YASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP--SRPFANLINSLL 238
D+W LG ++ E G PP+ Q +K + P P L + S + + +L
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279
Query: 239 VKDPAQRLHWSDLCGHAFWRTKLTPMPLPP 268
V+DP +R +L H F P L P
Sbjct: 280 VRDPQERATAQELLDHPFLLQTGLPECLVP 309
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-55
Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 19/260 (7%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIK-----SVDKSQKSKVLQEVRMLHSLDH 55
Q I E IG+G++ VY GR + AI+ ++ Q +EV H
Sbjct: 32 FEQLEIGELIGKGRFGQVYHGRWHGEV---AIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHS 114
NV+ F + HL ++ C G L S++R L + R +AQ++V+ + YLH+
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF- 173
KGI++ DLK N+ D NG+ + DFGL + + G C++APE+
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 174 -------EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLP-GN 225
E+ S SD++ LG + YE +A PF + ++ + + P L
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG 267
Query: 226 PSRPFANLINSLLVKDPAQR 245
+ ++++ + +R
Sbjct: 268 MGKEISDILLFCWAFEQEER 287
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-55
Identities = 87/272 (31%), Positives = 136/272 (50%), Gaps = 28/272 (10%)
Query: 10 IGRGKYSTVYKGRK---KKTIEYFAIKSVDKS---QKSK----VLQEVRMLHSLDH-PNV 58
+G G Y V+ RK T + +A+K + K+ QK+K E ++L + P +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ + ++T L L+L+Y GG+L + L Q + E ++ ++V AL++LH GII
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGII 181
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARK-LSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
Y D+K NILLD NG L DFGL+++ ++D ++ CGT YMAP++ G
Sbjct: 182 YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF-----CGTIEYMAPDIVRGGD 236
Query: 178 V-HSYASDLWGLGCVLYECYAGRPPFVG----REFTQLVKSILSDPSPPLPGNPSRPFAN 232
H A D W LG ++YE G PF ++ + IL PP P S +
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-PPYPQEMSALAKD 295
Query: 233 LINSLLVKDPAQRL-----HWSDLCGHAFWRT 259
LI LL+KDP +RL ++ H F++
Sbjct: 296 LIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-55
Identities = 76/267 (28%), Positives = 129/267 (48%), Gaps = 36/267 (13%)
Query: 2 NQYHIY-EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDH 55
N Y + + +GRGK++ V + K T + +A K + K ++ + +L E+ +L
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 56 -PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLL--RQDNQLPEDSIRDLAQDLVRALQYL 112
P V+ + YE ++ + L+LEY GG++ SL + E+ + L + ++ + YL
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 113 HSKGIIYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
H I++ DLKP NILL G K+ DFG++RK+ + L + GTP Y+A
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-----HACEL-REIMGTPEYLA 201
Query: 170 PELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN---P 226
PE+ + + A+D+W +G + Y PFVG + + +I N
Sbjct: 202 PEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ-------VNVDYS 253
Query: 227 SRPFAN-------LINSLLVKDPAQRL 246
F++ I SLLVK+P +R
Sbjct: 254 EETFSSVSQLATDFIQSLLVKNPEKRP 280
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-55
Identities = 81/274 (29%), Positives = 127/274 (46%), Gaps = 15/274 (5%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLDHP 56
Y I E +G G + V KT + A+K + + +V +E+ L L HP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
++++ Y T + +V+EY GG+L + + ++ ED R Q ++ A++Y H
Sbjct: 70 HIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
I++ DLKP N+LLD+N K+ DFGL+ ++D + +S CG+P Y APE+
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS------CGSPNYAAPEVINGK 182
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
D+W G VLY GR PF L K + S +P S +LI
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSC-VYVMPDFLSPGAQSLIRR 241
Query: 237 LLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQP 270
++V DP QR+ ++ W P L P
Sbjct: 242 MIVADPMQRITIQEIRRDP-WFNVNLPDYLRPME 274
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-55
Identities = 69/253 (27%), Positives = 121/253 (47%), Gaps = 21/253 (8%)
Query: 5 HIYEAIGRGKYSTVYKGR-KKKTIEYFAIK-----SVDKSQKSKVLQEVRMLHSLDHPNV 58
+I E IG G + TV++ + A+K + ++ L+EV ++ L HPN+
Sbjct: 40 NIKEKIGAGSFGTVHRAEWHGSDV---AVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDN---QLPEDSIRDLAQDLVRALQYLHSK 115
+ F +L +V EY G L LL + QL E +A D+ + + YLH++
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 116 G--IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
I++ +LK N+L+D+ K+CDFGL+R KA + + ++ GTP +MAPE+
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-----LKASTFLSSKSAAGTPEWMAPEVL 211
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPSPPLPGNPSRPFAN 232
+ SD++ G +L+E + P+ Q+V ++ +P N + A
Sbjct: 212 -RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAA 270
Query: 233 LINSLLVKDPAQR 245
+I +P +R
Sbjct: 271 IIEGCWTNEPWKR 283
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 4e-55
Identities = 71/257 (27%), Positives = 118/257 (45%), Gaps = 29/257 (11%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVR-MLHSLDHPNVLRFYSWYE 66
+ +G G V + ++T + A+K + S K++ QEV + P+++ YE
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR--QEVDHHWQASGGPHIVCILDVYE 92
Query: 67 TSAH----LWLVLEYCVGGDLMS--LLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
H L +++E GG+L S R D E ++ +D+ A+Q+LHS I +
Sbjct: 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHR 152
Query: 121 DLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
D+KP N+L +++ KL DFG A++ + +++ Q C TP Y+APE+
Sbjct: 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETT-----QNAL--QTPCYTPYYVAPEVLGPEK 205
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVG----REFTQLVKSILSD----PSPPLPGNPSRP 229
+ + D+W LG ++Y G PPF + + I P+P S
Sbjct: 206 -YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS-EVSED 263
Query: 230 FANLINSLLVKDPAQRL 246
LI LL DP +RL
Sbjct: 264 AKQLIRLLLKTDPTERL 280
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-55
Identities = 77/275 (28%), Positives = 129/275 (46%), Gaps = 15/275 (5%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK---VLQEVRMLHSLDHPNVLR 60
+ I +G G + VYK + K+T A K ++ + + + E+ +L + DHP +++
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
Y LW+++E+C GG + +++ + D L E I+ + + ++ AL +LHSK II+
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 140
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE--LFEEGG 177
DLK N+L+ G +L DFG++ K + S + GTP +MAPE + E
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETMK 195
Query: 178 VHSY--ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGNPSRPFANL 233
Y +D+W LG L E PP +++ I P L P S F +
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255
Query: 234 INSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPP 268
+ L K+P R + L H F + + L
Sbjct: 256 LKIALDKNPETRPSAAQLLEHPFVSSITSNKALRE 290
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-55
Identities = 67/255 (26%), Positives = 122/255 (47%), Gaps = 30/255 (11%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---KSKVLQEVRMLHSLDHPNVLRFYSW 64
E +G G++ V+K + T A K + K +V E+ +++ LDH N+++ Y
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 65 YETSAHLWLVLEYCVGGDLM-SLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
+E+ + LV+EY GG+L ++ + L E + + ++++H I++ DLK
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLK 214
Query: 124 PSNILL--DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSY 181
P NIL + + K+ DFGLAR+ K + GTP ++APE+ V S+
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARRYKPREKL------KVNFGTPEFLAPEVVNYDFV-SF 267
Query: 182 ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN---PSRPFAN------ 232
+D+W +G + Y +G PF+G + + +IL+ F +
Sbjct: 268 PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA-------CRWDLEDEEFQDISEEAK 320
Query: 233 -LINSLLVKDPAQRL 246
I+ LL+K+ + R+
Sbjct: 321 EFISKLLIKEKSWRI 335
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 7e-55
Identities = 76/288 (26%), Positives = 141/288 (48%), Gaps = 25/288 (8%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-------KSKVLQEVRMLHSL 53
+ +Y + + +G G Y V + +T+ A+K + K + ++ V +E+++L L
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 54 DHPNVLRFYS--WYETSAHLWLVLEYCVGG--DLMSLLRQDNQLPEDSIRDLAQDLVRAL 109
H NV++ + E +++V+EYCV G +++ + + + P L+ L
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGL 122
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
+YLHS+GI++ D+KP N+LL G K+ G+A L A + G+P +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH--PFAADDTCRTS-QGSPAFQP 179
Query: 170 PELFEEGGVHSYA---SDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP 226
PE+ G+ +++ D+W G LY G PF G +L ++I +PG+
Sbjct: 180 PEIAN--GLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-YAIPGDC 236
Query: 227 SRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLT----PMPLPPQP 270
P ++L+ +L +PA+R + H+++R K P+P+PP P
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSP 284
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 7e-55
Identities = 49/270 (18%), Positives = 92/270 (34%), Gaps = 35/270 (12%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKK-----KTIEYFAIKSVDKSQKSK---VLQEVRMLHSL 53
+++ +G G ++ VY+ + K + F +K + + Q + L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124
Query: 54 DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-----DNQLPEDSIRDLAQDLVRA 108
++FYS + LV E G L++ + + +P+ + A ++
Sbjct: 125 MQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYM 184
Query: 109 LQYLHSKGIIYCDLKPSNILL-----------DENGRTKLCDFGLARKLSDASKAPSSML 157
++ +H II+ D+KP N +L D + L D G + D P +
Sbjct: 185 IEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI---DMKLFPKGTI 241
Query: 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD 217
AKC T + E+ +Y D +G+ +Y G V E +
Sbjct: 242 FTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------K 294
Query: 218 PSPPLPGNPSRPF-ANLINSLLVKDPAQRL 246
P P + +L L
Sbjct: 295 PEGLFRRLPHLDMWNEFFHVMLNIPDCHHL 324
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 9e-55
Identities = 46/319 (14%), Positives = 86/319 (26%), Gaps = 64/319 (20%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-------------------- 42
+G+ + ++T E F + +++
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 43 -----VLQEVRMLHSLD------HPNVLRFYSWYETSAHLWLVLEY--------CVGGDL 83
+R + D ++R L Y G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 84 MSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143
+S L + L ++R L LH G+++ L+P +I+LD+ G L F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 144 RKLSDASKAPSSMLPQAKCGTPCYMAPELF----------EEGGVHSYASDLWGLGCVLY 193
+ + + + PEL + + +++ D W LG V+Y
Sbjct: 254 VRDGARVVS---------SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 194 ECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253
+ P + I N +P L+ L RL
Sbjct: 305 WIWCADLPITKDAALGGSEWIFRSCK-----NIPQPVRALLEGFLRYPKEDRLLPLQAME 359
Query: 254 HAFWRTKLTPMPLPPQPAF 272
+L P +
Sbjct: 360 TP-EYEQLRTELSAALPLY 377
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 200 bits (509), Expect = 2e-54
Identities = 64/259 (24%), Positives = 115/259 (44%), Gaps = 30/259 (11%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---KSKVLQEVRMLHSLDHPNVLR 60
Y I+E +G G + V++ ++ T FA K V K V +E++ + L HP ++
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMS-LLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ +E + ++ E+ GG+L + + N++ ED + + + + L ++H ++
Sbjct: 219 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 278
Query: 120 CDLKPSNILL--DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
DLKP NI+ + KL DFGL L + GT + APE+ E
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV------KVTTGTAEFAAPEVAEGKP 332
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN---PSRPFAN-- 232
V Y +D+W +G + Y +G PF G + ++++ S + F+
Sbjct: 333 V-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS-------CDWNMDDSAFSGIS 384
Query: 233 -----LINSLLVKDPAQRL 246
I LL+ DP R+
Sbjct: 385 EDGKDFIRKLLLADPNTRM 403
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-54
Identities = 88/272 (32%), Positives = 143/272 (52%), Gaps = 14/272 (5%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-KSQKSKVLQEVRMLHSLDHPNVLRFY 62
+ + E +G G Y +VYK K+T + AIK V +S ++++E+ ++ D P+V+++Y
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 63 SWYETSAHLWLVLEYCVGG---DLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
Y + LW+V+EYC G D++ L + L ED I + Q ++ L+YLH I+
Sbjct: 91 GSYFKNTDLWIVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMRKIH 148
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
D+K NILL+ G KL DFG+A +L+D ++++ GTP +MAPE+ +E G +
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEVIQEIG-Y 202
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGNPSRPFANLINSL 237
+ +D+W LG E G+PP+ + + I ++P P P S F + +
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC 262
Query: 238 LVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQ 269
LVK P QR + L H F R+ L
Sbjct: 263 LVKSPEQRATATQLLQHPFVRSAKGVSILRDL 294
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 4e-54
Identities = 74/286 (25%), Positives = 119/286 (41%), Gaps = 29/286 (10%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---------KSKVLQEVRMLH 51
+Y + +G+G + TV+ G + AIK + +++ EV +L
Sbjct: 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 52 SLD----HPNVLRFYSWYETSAHLWLVLEYCV-GGDLMSLLRQDNQLPEDSIRDLAQDLV 106
+ HP V+R W+ET LVLE + DL + + L E R +V
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149
Query: 107 RALQYLHSKGIIYCDLKPSNILLD-ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTP 165
A+Q+ HS+G+++ D+K NIL+D G KL DFG L D GT
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD------EPYTDF-DGTR 202
Query: 166 CYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGN 225
Y PE H+ + +W LG +LY+ G PF + +++++ L P +
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--EILEAELH-----FPAH 255
Query: 226 PSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPA 271
S LI L P+ R ++ + +T +PL P
Sbjct: 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKG 301
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 5e-54
Identities = 68/282 (24%), Positives = 113/282 (40%), Gaps = 26/282 (9%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----------KSKVLQEVRM 49
+Y +G G + V+ K+ + +K + K + KV E+ +
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 50 LHSLDHPNVLRFYSWYETSAHLWLVLEYCV-GGDLMSLLRQDNQLPEDSIRDLAQDLVRA 108
L ++H N+++ +E LV+E G DL + + + +L E + + LV A
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 109 LQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
+ YL K II+ D+K NI++ E+ KL DFG A L + CGT Y
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF------CGTIEYC 196
Query: 169 APELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSR 228
APE+ ++W LG LY PF E + V++ + P S+
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF--CELEETVEAAIHPPYL-----VSK 249
Query: 229 PFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQP 270
+L++ LL P +R L W T+ +
Sbjct: 250 ELMSLVSGLLQPVPERRTTLEKLVTDP-WVTQPVNLADYTWE 290
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 8e-54
Identities = 74/280 (26%), Positives = 131/280 (46%), Gaps = 13/280 (4%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQEVRMLHSLD 54
+ Y + + +G G + V G+ + T A+K +++ + K+ +E++ L
Sbjct: 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HP++++ Y T + +++V+EY GG+L + ++ +L E R L Q ++ + Y H
Sbjct: 75 HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR 134
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
+++ DLKP N+LLD + K+ DFGL+ +SD +S CG+P Y APE+
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS------CGSPNYAAPEVIS 188
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
D+W G +LY G PF L K I P + +L+
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG-IFYTPQYLNPSVISLL 247
Query: 235 NSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDS 274
+L DP +R D+ H +++ L P P++ S
Sbjct: 248 KHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSS 287
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 9e-54
Identities = 47/317 (14%), Positives = 82/317 (25%), Gaps = 56/317 (17%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS------KVLQEVRMLHSLDHP 56
+ + E + G S V+ R + +E FA+K ++ ++ + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 57 NVLRFYSWY--------------------------ETSAHLWLVLEYCVG--GDLMSLLR 88
+ A+ L++ L S L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 89 ----QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLAR 144
++ L L+R L SKG+++ P N+ + +GR L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 145 KLSDASKAPSSMLPQAKCGTPCYMAPELFE-EGGVHSYASDLWGLGCVLYECYAGRPPFV 203
K+ A Y E ++A + W LG +Y + PF
Sbjct: 243 KVGTRGPAS--------SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 204 GREF--------TQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHA 255
L + LI L D +RL +
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354
Query: 256 FWRTKLTPMPLPPQPAF 272
+L
Sbjct: 355 -EFLQLQNEISSSLSTG 370
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-53
Identities = 90/283 (31%), Positives = 136/283 (48%), Gaps = 23/283 (8%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIK--SVDKSQKSKVLQEVRMLHSL-DHPNVLR 60
+ + E +G G Y VYKGR KT + AIK V ++ ++ QE+ ML H N+
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 61 FY------SWYETSAHLWLVLEYCVGG---DLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
+Y + LWLV+E+C G DL+ + N L E+ I + ++++R L +
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSH 144
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
LH +I+ D+K N+LL EN KL DFG++ +L ++ + GTP +MAPE
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPE 199
Query: 172 --LFEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL-PGNP 226
+E +Y SDLW LG E G PP + + I +P+P L
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 259
Query: 227 SRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQ 269
S+ F + I S LVK+ +QR L H F R + + Q
Sbjct: 260 SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQ 302
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 2e-53
Identities = 75/255 (29%), Positives = 123/255 (48%), Gaps = 23/255 (9%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-DKSQKSKVLQEVRMLHSLDHPNVL 59
+ + E +GRG + V K + + AIK + +S++ + E+R L ++HPN++
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAKWRAKD--VAIKQIESESERKAFIVELRQLSRVNHPNIV 64
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIR---DLAQDLVRALQYLHS-- 114
+ Y + LV+EY GG L ++L LP + + + YLHS
Sbjct: 65 KLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 115 -KGIIYCDLKPSNILLDENGRT-KLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
K +I+ DLKP N+LL G K+CDFG A + + M G+ +MAPE+
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ------THMT--NNKGSAAWMAPEV 174
Query: 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT--QLVKSILSDPSPPLPGNPSRPF 230
F EG +S D++ G +L+E R PF +++ ++ + PPL N +P
Sbjct: 175 F-EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 231 ANLINSLLVKDPAQR 245
+L+ KDP+QR
Sbjct: 234 ESLMTRCWSKDPSQR 248
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-53
Identities = 59/313 (18%), Positives = 115/313 (36%), Gaps = 59/313 (18%)
Query: 2 NQYHIYEAIGRG--KYSTVYKGRKKKTIEYFAIKSVD-----KSQKSKVLQEVRMLHSLD 54
Y + IG+G TV R K T EY ++ ++ + + E+ + +
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYL 112
HPN++ + + + LW+V + G L+ + + E +I + Q +++AL Y+
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM--LPQAKCGTPCYMAP 170
H G ++ +K S+IL+ +G+ L + + + P+ +++P
Sbjct: 145 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 171 ELFEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP-- 226
E+ ++ + Y SD++ +G E G PF TQ++ L+ P L
Sbjct: 205 EVLQQ-NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263
Query: 227 -------------------------------------------SRPFANLINSLLVKDPA 243
S F + + L ++P
Sbjct: 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD 323
Query: 244 QRLHWSDLCGHAF 256
R S L H+F
Sbjct: 324 ARPSASTLLNHSF 336
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 6e-53
Identities = 72/258 (27%), Positives = 116/258 (44%), Gaps = 20/258 (7%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIK-----SVDKSQKSKVLQEVRMLHSLDH 55
Q + + IG G + TVYKG+ + A+K + Q EV +L H
Sbjct: 23 DGQITVGQRIGSGSFGTVYKGKWHGDV---AVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHS 114
N+L F + T+ L +V ++C G L L + + + D+A+ R + YLH+
Sbjct: 80 VNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF- 173
K II+ DLK +NI L E+ K+ DFGLA + S S + G+ +MAPE+
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE---QLSGSILWMAPEVIR 195
Query: 174 -EEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-----FTQLVKSILSDPSPPLPGNPS 227
++ +S+ SD++ G VLYE G+ P+ + + LS + N
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 228 RPFANLINSLLVKDPAQR 245
+ L+ L K +R
Sbjct: 256 KRMKRLMAECLKKKRDER 273
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-52
Identities = 70/283 (24%), Positives = 118/283 (41%), Gaps = 27/283 (9%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---------KSKVLQEVRMLH 51
+QY + +G G + +VY G + AIK V+K + ++V EV +L
Sbjct: 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 101
Query: 52 SLDH--PNVLRFYSWYETSAHLWLVLEYCVG-GDLMSLLRQDNQLPEDSIRDLAQDLVRA 108
+ V+R W+E L+LE DL + + L E+ R ++ A
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161
Query: 109 LQYLHSKGIIYCDLKPSNILLDEN-GRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCY 167
+++ H+ G+++ D+K NIL+D N G KL DFG L D ++ GT Y
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD------TVY-TDFDGTRVY 214
Query: 168 MAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPS 227
PE H ++ +W LG +LY+ G PF E ++++ + S
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--EIIRGQVF-----FRQRVS 267
Query: 228 RPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQP 270
+LI L P+ R + ++ H + + L P
Sbjct: 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 310
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-52
Identities = 73/283 (25%), Positives = 112/283 (39%), Gaps = 18/283 (6%)
Query: 5 HIYEAIGRGKYSTVYKGRKKKTIEYFAIK---SVDKSQKSKVLQEVRMLHSLDHPNVLRF 61
E +G+G + K ++T E +K D+ + L+EV+++ L+HPNVL+F
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF 72
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
L + EY GG L +++ D+Q P A+D+ + YLHS II+
Sbjct: 73 IGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR 132
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSD---------ASKAPSSMLPQAKCGTPCYMAPE 171
DL N L+ EN + DFGLAR + D + K P G P +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLV--KSILSDPSPPLPGNPSRP 229
+ G + D++ G VL E + ++ P N
Sbjct: 193 MI-NGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPS 251
Query: 230 FANLINSLLVKDPAQRLHWSDLCGH--AFWRTKLTPMPLPPQP 270
F + DP +R + L +PL PQ
Sbjct: 252 FFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQL 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 3e-52
Identities = 62/330 (18%), Positives = 121/330 (36%), Gaps = 76/330 (23%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS----KVLQEVRMLHSLDHP 56
+ + + +GRG + V++ + K +AIK + + KV++EV+ L L+HP
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 64
Query: 57 NVLRFYS--------WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSI---------- 98
++R+++ ++ + + L S D +
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 99 ---------------------RDLAQ---------------------DLVRALQYLHSKG 116
+L + A+++LHSKG
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK-------CGTPCYMA 169
+++ DLKPSNI + K+ DFGL + + + + P GT YM+
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 170 PELFEEGGVHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSR 228
PE G +S+ D++ LG +L+E Y E +++ + + P L
Sbjct: 245 PEQI-HGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKYP 300
Query: 229 PFANLINSLLVKDPAQRLHWSDLCGHAFWR 258
++ +L P +R +D+ +A +
Sbjct: 301 QEHMMVQDMLSPSPTERPEATDIIENAIFE 330
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 1e-51
Identities = 69/250 (27%), Positives = 109/250 (43%), Gaps = 13/250 (5%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIK------SVDKSQKSKVLQEVRMLHSLDHPN 57
Y + +GRG VY+ A+K S D ++++ +E R L P+
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
V+ + + E L++ + G DL ++LR+ L + + + AL H+ G
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
+ D+KP NIL+ + L DFG+A +D GT YMAPE F
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV----GTLYYMAPERF-SES 210
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRP--FANLIN 235
+Y +D++ L CVLYEC G PP+ G + + + I P P P F +I
Sbjct: 211 HATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIA 270
Query: 236 SLLVKDPAQR 245
+ K+P R
Sbjct: 271 RGMAKNPEDR 280
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-51
Identities = 46/260 (17%), Positives = 94/260 (36%), Gaps = 28/260 (10%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGR-KKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLD 54
Q + + ++KGR + I +K + S +E L
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRWQGNDI---VVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 55 HPNVLRFY--SWYETSAHLWLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQ 110
HPNVL + H L+ + G L ++L + + + A D+ R +
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 111 YLHSKG--IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
+LH+ I L ++++DE+ ++ + + P ++
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----------PGRMYAPAWV 175
Query: 169 APELFEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPSPPLPGN 225
APE ++ + ++D+W +L+E PF ++ + P +P
Sbjct: 176 APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG 235
Query: 226 PSRPFANLINSLLVKDPAQR 245
S + L+ + +DPA+R
Sbjct: 236 ISPHVSKLMKICMNEDPAKR 255
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-51
Identities = 72/260 (27%), Positives = 111/260 (42%), Gaps = 30/260 (11%)
Query: 5 HIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-------KVLQEVRMLHSLDHPN 57
+ E IG G + VY+ A+K+ V QE ++ L HPN
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG- 116
++ +L LV+E+ GG L +L ++P D + + A + R + YLH +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 117 --IIYCDLKPSNILLDENGRT--------KLCDFGLARKLSDASKAPSSMLPQAKCGTPC 166
II+ DLK SNIL+ + K+ DFGLAR+ +K + G
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-------MSAAGAYA 179
Query: 167 YMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPSPPLPGN 225
+MAPE+ + S SD+W G +L+E G PF G + + + + P+P
Sbjct: 180 WMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238
Query: 226 PSRPFANLINSLLVKDPAQR 245
PFA L+ DP R
Sbjct: 239 CPEPFAKLMEDCWNPDPHSR 258
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 3e-51
Identities = 88/276 (31%), Positives = 124/276 (44%), Gaps = 22/276 (7%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHPN 57
+ IG G + VY R + E AIK + S K +++EVR L L HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 58 VLRFYSWYETSAHLWLVLEYCVGG--DLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
+++ Y WLV+EYC+G DL+ + L E I + ++ L YLHS
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE--LF 173
+I+ D+K NILL E G KL DFG A ++ A +S + GTP +MAPE L
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFV-----GTPYWMAPEVILA 224
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL-PGNPSRPFAN 232
+ G + D+W LG E +PP + I + SP L G+ S F N
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 284
Query: 233 LINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPP 268
++S L K P R L H F + P +
Sbjct: 285 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 320
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 8e-51
Identities = 72/257 (28%), Positives = 113/257 (43%), Gaps = 28/257 (10%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVR-MLHSLDHPNVLRFYSWYE 66
+ +G G V + K+T E FA+K + K +EV + P+++R YE
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--ARREVELHWRASQCPHIVRIVDVYE 125
Query: 67 TSA----HLWLVLEYCVGGDLMS--LLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
L +V+E GG+L S R D E ++ + + A+QYLHS I +
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 185
Query: 121 DLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
D+KP N+L N KL DFG A++ + +S+ C TP Y+APE+
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKET----TSHNSL--TTPCYTPYYVAPEVLGPEK 239
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD--------PSPPLPGNPSRP 229
+ + D+W LG ++Y G PPF + + + P+P S
Sbjct: 240 -YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS-EVSEE 297
Query: 230 FANLINSLLVKDPAQRL 246
LI +LL +P QR+
Sbjct: 298 VKMLIRNLLKTEPTQRM 314
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-50
Identities = 58/262 (22%), Positives = 104/262 (39%), Gaps = 32/262 (12%)
Query: 6 IYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK----------VLQEVRMLHSLDH 55
+ IG+G + V+KGR K AIKS+ +EV ++ +L+H
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHS 114
PN+++ Y +V+E+ GDL L + + + L D+ ++Y+ +
Sbjct: 83 PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 115 KG--IIYCDLKPSNILLDENGRT-----KLCDFGLARKLSDASKAPSSMLPQAKCGTPCY 167
+ I++ DL+ NI L K+ DFGL+++ + G +
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS--------GLLGNFQW 192
Query: 168 MAPELFE-EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ---LVKSILSDPSPPLP 223
MAPE E ++ +D + +LY G PF + + + P +P
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP 252
Query: 224 GNPSRPFANLINSLLVKDPAQR 245
+ N+I DP +R
Sbjct: 253 EDCPPRLRNVIELCWSGDPKKR 274
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-47
Identities = 69/254 (27%), Positives = 109/254 (42%), Gaps = 15/254 (5%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIK------SVDKSQKSKVLQEVRMLHSLDH 55
+Y I + +G G STVY AIK + + +EV L H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
N++ E +LV+EY G L + L D+ + ++ +++ H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
I++ D+KP NIL+D N K+ DFG+A+ LS+ S ++ + GT Y +PE +
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV----LGTVQYFSPEQ-AK 185
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPG--NPSRP--FA 231
G +D++ +G VLYE G PPF G + + D P + P +
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245
Query: 232 NLINSLLVKDPAQR 245
N+I KD A R
Sbjct: 246 NVILRATEKDKANR 259
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 8e-47
Identities = 84/311 (27%), Positives = 124/311 (39%), Gaps = 48/311 (15%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-----KSKVLQEVRMLHSLDH 55
M +Y IG G Y V+K R + T + AIK +S+ K L+E+RML L H
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLL-RQDNQLPEDSIRDLAQDLVRALQYLHS 114
PN++ + L LV EYC ++ L R +PE ++ + ++A+ + H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE-LF 173
I+ D+KP NIL+ ++ KLCDFG AR L+ S + T Y +PE L
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD-----EVATRWYRSPELLV 175
Query: 174 EEGGVHSYAS--DLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDPSPP-LPG--- 224
G Y D+W +GCV E +G P + G+ + QL L D P
Sbjct: 176 ---GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232
Query: 225 ------------NPSRPFA-----------NLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261
P L+ L DP +RL L H ++
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292
Query: 262 TPMPLPPQPAF 272
L +
Sbjct: 293 EIEDLAKEHDK 303
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-46
Identities = 72/322 (22%), Positives = 120/322 (37%), Gaps = 38/322 (11%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKK-TIEYFAIK----SVDKSQKSKVLQEVRMLHSLDHP 56
QY + I G +Y + +K S D ++ + E + L + HP
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHP 139
Query: 57 NVLRFYSWYETSAH-----LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
++++ +++ E + ++V+EY G L Q +LP +++ AL Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSY 197
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
LHS G++Y DLKP NI+L E KL D G +++ GTP + APE
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFG---------YLYGTPGFQAPE 247
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFA 231
+ + A+D++ +G L P GR L + P L S +
Sbjct: 248 IVR--TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----LPEDDPVLKTYDS--YG 298
Query: 232 NLINSLLVKDPAQRLH-----WSDLCGHAFWRTKLTPMPLPPQPAFDSLKGAVRQDENSM 286
L+ + DP QR + L R + P+P ++ R
Sbjct: 299 RLLRRAIDPDPRQRFTTAEEMSAQL--TGVLREVVAQDTGVPRPGLSTIFSPSRSTFGVD 356
Query: 287 LGSTPVRVTPSGRKTQTKTSGR 308
L V G+ K +
Sbjct: 357 LLVAHTDVYLDGQVHAEKLTAN 378
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-46
Identities = 83/322 (25%), Positives = 129/322 (40%), Gaps = 57/322 (17%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSLDH 55
+++Y IG+G + V+K R +KT + A+K V + L+E+++L L H
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 56 PNVLRFY--------SWYETSAHLWLVLEYCVGGDLMSLL-RQDNQLPEDSIRDLAQDLV 106
NV+ + ++LV ++C DL LL + I+ + Q L+
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 107 RALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC 166
L Y+H I++ D+K +N+L+ +G KL DFGLAR S A + + T
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY------TNR 188
Query: 167 -----YMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDP 218
Y PEL + DLWG GC++ E + P G E QL +
Sbjct: 189 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248
Query: 219 SP---------------PLPGNPSRPFA-------------NLINSLLVKDPAQRLHWSD 250
+P L R +LI+ LLV DPAQR+ D
Sbjct: 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 308
Query: 251 LCGHAFWRTKLTPMPLPPQPAF 272
H F+ + P L +
Sbjct: 309 ALNHDFFWSDPMPSDLKGMLST 330
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 8e-46
Identities = 79/314 (25%), Positives = 122/314 (38%), Gaps = 42/314 (13%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----DKSQKSKVLQEVRMLHSLDH 55
M +Y +G G Y V K R K T AIK DK K ++E+++L L H
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLL-RQDNQLPEDSIRDLAQDLVRALQYLHS 114
N++ + +LV E+ ++ L N L ++ ++ + + HS
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS 142
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
II+ D+KP NIL+ ++G KLCDFG AR L+ + + T Y APEL
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD-----EVATRWYRAPELLV 197
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDPSP---P----LPG 224
+ A D+W +GC++ E + G P F G + QL L + P P
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257
Query: 225 ---------NPSRPFA-----------NLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPM 264
P +L L DP +R ++L H F++
Sbjct: 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAE 317
Query: 265 PLPPQPAFDSLKGA 278
+ K A
Sbjct: 318 RFSQELQLKVQKDA 331
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-45
Identities = 70/284 (24%), Positives = 114/284 (40%), Gaps = 44/284 (15%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQE--VRMLHSLDHPNVLR 60
+ E+IG+G++ V++G+ + E A+K ++ +E + L H N+L
Sbjct: 43 TIVLQESIGKGRFGEVWRGKWRG--EEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 100
Query: 61 FY----SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK- 115
F T LWLV +Y G L L + + + + LA L +LH +
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 116 -------GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
I + DLK NIL+ +NG + D GLA + D++ + P + GT YM
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH-DSATDTIDIAPNHRVGTKRYM 218
Query: 169 APELFEEGGVHSY-----ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL--SDPS-- 219
APE+ ++ + +D++ +G V +E E QL L SDPS
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 220 ------------PPLPGNPS-----RPFANLINSLLVKDPAQRL 246
P +P R A ++ + A RL
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-45
Identities = 68/282 (24%), Positives = 107/282 (37%), Gaps = 44/282 (15%)
Query: 5 HIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQE--VRMLHSLDHPNVLRFY 62
+ E +G+G+Y V++G + E A+K + +E + L H N+L F
Sbjct: 11 TLLECVGKGRYGEVWRGSWQG--ENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 63 SWYETSAH----LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK--- 115
+ TS H LWL+ Y G L L+ L S + + L +LH +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 116 -----GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAP 170
I + DLK NIL+ +NG+ + D GLA S + + GT YMAP
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMH-SQSTNQLDVGNNPRVGTKRYMAP 186
Query: 171 ELFE-----EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL--SDPS---- 219
E+ + + D+W G VL+E E + + +DPS
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246
Query: 220 ----------PPLPGNPS-----RPFANLINSLLVKDPAQRL 246
P +P A L+ ++P+ RL
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-45
Identities = 69/260 (26%), Positives = 121/260 (46%), Gaps = 22/260 (8%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIK------SVDKSQKSKVLQEVRMLHSLDH 55
++Y + E +G G S V+ R + A+K + D S + +E + +L+H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 56 PNVLRFYSWYETSAHL----WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
P ++ Y E ++V+EY G L ++ + + ++ D +AL +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA---PSSMLPQAKCGTPCYM 168
H GII+ D+KP+NI++ K+ DFG+AR ++D+ + ++++ GT Y+
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-----GTAQYL 186
Query: 169 APELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-FTQLVKSILSDPSPPLPGNPS 227
+PE G SD++ LGCVLYE G PPF G + + + DP PP +
Sbjct: 187 SPEQ-ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 245
Query: 228 RP--FANLINSLLVKDPAQR 245
++ L K+P R
Sbjct: 246 LSADLDAVVLKALAKNPENR 265
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-45
Identities = 83/347 (23%), Positives = 143/347 (41%), Gaps = 56/347 (16%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSK------VLQEVRMLHS 52
+Y + +G G+++TVYK R K T + AIK + ++K L+E+++L
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 53 LDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQY 111
L HPN++ + +++ LV ++ DL +++ ++ L I+ ++ L+Y
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEY 127
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC----- 166
LH I++ DLKP+N+LLDENG KL DFGLA+ ++ + T
Sbjct: 128 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR---AY-------THQVVTRW 177
Query: 167 YMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDPSP--- 220
Y APEL ++ D+W +GC+L E P G + QL + L P+
Sbjct: 178 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237
Query: 221 ----------PLPGNPSRPFA-----------NLINSLLVKDPAQRLHWSDLCGHAFWRT 259
P P +LI L + +P R+ + ++
Sbjct: 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297
Query: 260 KLTPMPLPPQ--PAFDSLKGAVRQDENSMLGSTPVRVTPSGRKTQTK 304
+ P P P P + +++ N L R + K
Sbjct: 298 R--PGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPK 342
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 79/315 (25%), Positives = 126/315 (40%), Gaps = 49/315 (15%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK----SKVLQEVRMLHSLDHP 56
+Q+ E +G G Y+TVYKG K T Y A+K V + S ++E+ ++ L H
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHE 63
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ------LPEDSIRDLAQDLVRALQ 110
N++R Y T L LV E+ DL + L + ++ L++ L
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 111 YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAP 170
+ H I++ DLKP N+L+++ G+ KL DFGLAR SS + T Y AP
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS-----EVVTLWYRAP 177
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK----------------S 213
++ +S + D+W GC+L E G+P F G + QL +
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237
Query: 214 ILSDPSPPLPGNPSRPFAN----------------LINSLLVKDPAQRLHWSDLCGHAFW 257
L +P + P R ++ LL +P RL H ++
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297
Query: 258 RTKLTPMPLPPQPAF 272
+ +
Sbjct: 298 AEYYHHASMGGSRSH 312
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-44
Identities = 83/309 (26%), Positives = 127/309 (41%), Gaps = 42/309 (13%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQK----SKVLQEVRMLHSLDHP 56
M Y + +G G Y+TVYKG+ K T A+K + + ++EV +L L H
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLHSK 115
N++ + T L LV EY DL L + +++ L+R L Y H +
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
+++ DLKP N+L++E G KL DFGLAR S +K + + T Y P++
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN-----EVVTLWYRPPDILLG 174
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDPSP------------ 220
+S D+WG+GC+ YE GRP F G QL IL P+
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234
Query: 221 ---PLPGNPSRPFAN-----------LINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPL 266
P + + L+ LL + R+ D H F+ + +
Sbjct: 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL--GERI 292
Query: 267 PPQPAFDSL 275
P S+
Sbjct: 293 HKLPDTTSI 301
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-44
Identities = 72/284 (25%), Positives = 115/284 (40%), Gaps = 44/284 (15%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQE--VRMLHSLDHPNVLR 60
Q + + IG+G+Y V+ G+ + E A+K ++++ +E + + H N+L
Sbjct: 38 QIQMVKQIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEASWFRETEIYQTVLMRHENILG 95
Query: 61 FY----SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK- 115
F + L+L+ +Y G L L+ L S+ LA V L +LH++
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 116 -------GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
I + DLK NIL+ +NG + D GLA K + + P + GT YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF-ISDTNEVDIPPNTRVGTKRYM 213
Query: 169 APELFEEGGVHSY-----ASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL--SDPS-- 219
PE+ +E ++ +D++ G +L+E E QL L SDPS
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 220 ------------PPLPGNPS-----RPFANLINSLLVKDPAQRL 246
P P S R L+ +PA RL
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL 317
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 66/261 (25%), Positives = 102/261 (39%), Gaps = 49/261 (18%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVR-MLHSLDHPNVLRFY 62
+ +G G V + K+T E FA+K + K++ +EV + P+++R
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--REVELHWRASQCPHIVRIV 77
Query: 63 SWYETSA----HLWLVLEYCVGGDLMS--LLRQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
YE L +V+E GG+L S R D E ++ + + A+QYLHS
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 117 IIYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
I + D+KP N+L N KL DFG A E
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------------AKETT 171
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD--------PSPPLPGN 225
E + + D+W LG ++Y G PPF + + + P+P
Sbjct: 172 GEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS-E 228
Query: 226 PSRPFANLINSLLVKDPAQRL 246
S LI +LL +P QR+
Sbjct: 229 VSEEVKMLIRNLLKTEPTQRM 249
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-43
Identities = 77/291 (26%), Positives = 122/291 (41%), Gaps = 43/291 (14%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLD 54
M +YH E IG G Y VYK + E FA+K + + +K ++E+ +L L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELK 58
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLH 113
H N+++ Y T L LV E+ DL LL L + + L+ + Y H
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
+ +++ DLKP N+L++ G K+ DFGLAR + + + T Y AP++
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-----EIVTLWYRAPDVL 172
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK----------------SILS 216
+S D+W +GC+ E G P F G E QL++ + L
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 217 DPSPPLPGNPSRPFAN-----------LINSLLVKDPAQRLHWSDLCGHAF 256
P P+ + L++ +L DP QR+ HA+
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-42
Identities = 87/320 (27%), Positives = 132/320 (41%), Gaps = 70/320 (21%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKV----LQEV---RM 49
++Y IG G Y TVYK R + + A+KSV + ++EV R
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 50 LHSLDHPNVLRFY-----SWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLA 102
L + +HPNV+R S + + LV E+ DL + L + LP ++I+DL
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 103 QDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC 162
+ +R L +LH+ I++ DLKP NIL+ G KL DFGLAR S ++
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY----QMAL------ 176
Query: 163 GTPC-----YMAPE-LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK--S 213
TP Y APE L ++ D+W +GC+ E + +P F G E QL K
Sbjct: 177 -TPVVVTLWYRAPEVLL--QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233
Query: 214 ILSDPS---------------PPLPGNPSRPF--------ANLINSLLVKDPAQRLHWSD 250
++ P PP P + A L+ +L +P +R+
Sbjct: 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFR 293
Query: 251 LCGHAFWRTKLTPMPLPPQP 270
H++ P
Sbjct: 294 ALQHSYLHK------DEGNP 307
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 80/301 (26%), Positives = 129/301 (42%), Gaps = 45/301 (14%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLD 54
M +Y E IG G Y TV+K + ++T E A+K V + L+E+ +L L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELK 59
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLH 113
H N++R + + L LV E+C DL N L + ++ L++ L + H
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
S+ +++ DLKP N+L++ NG KL +FGLAR + S+ + T Y P++
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-----EVVTLWYRPPDVL 173
Query: 174 EEGGVHSYASDLWGLGCVLYE-CYAGRPPFVGR-EFTQLVK----------------SIL 215
++S + D+W GC+ E AGRP F G QL + + L
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 216 SD----PSPPLPGNPSRPFAN-------LINSLLVKDPAQRLHWSDLCGHAFWRTKLTPM 264
D P P + L+ +LL +P QR+ + H ++
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF--CP 291
Query: 265 P 265
P
Sbjct: 292 P 292
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-42
Identities = 70/308 (22%), Positives = 117/308 (37%), Gaps = 51/308 (16%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLD 54
+++Y +G G Y VYK T E AIK + + + + ++EV +L L
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQ 91
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
H N++ S + L L+ EY DL + ++ + I+ L+ + + HS
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 115 KGIIYCDLKPSNILLD-----ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
+ ++ DLKP N+LL E K+ DFGLAR + + + T Y
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH-----EIITLWYRP 205
Query: 170 PELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK---------------- 212
PE+ +S + D+W + C+ E P F G E QL K
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGV 265
Query: 213 SILSDPSPPLPGNPSRPFAN------------LINSLLVKDPAQRLHWSDLCGHAFWRTK 260
+ L D P + L+ ++L DP +R+ + H ++
Sbjct: 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH- 324
Query: 261 LTPMPLPP 268
P
Sbjct: 325 ---NDFDP 329
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 6e-42
Identities = 66/287 (22%), Positives = 103/287 (35%), Gaps = 48/287 (16%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVL--QEVRMLHSLDHPNVL 59
+ E RG++ V+K + EY A+K K EV L + H N+L
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 60 RFYSW----YETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
+F LWL+ + G L L+ N + + + +A+ + R L YLH
Sbjct: 82 QFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHED 140
Query: 116 ----------GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTP 165
I + D+K N+LL N + DFGLA K A + + GT
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH---GQVGTR 197
Query: 166 CYMAPELFEEGGVHSY----ASDLWGLGCVLYECYAGRPPFVGREFTQLV---KSILSDP 218
YMAPE+ E D++ +G VL+E + G ++ + I P
Sbjct: 198 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257
Query: 219 S--------------PPLPGN-PSRPFANLINSLLVK----DPAQRL 246
S P L ++ + + D RL
Sbjct: 258 SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-42
Identities = 66/296 (22%), Positives = 105/296 (35%), Gaps = 53/296 (17%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQE--VRMLHSLDHPNV 58
++ + E IGRG+Y VYKG + A+K + + + E + + ++H N+
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSFANRQNFINEKNIYRVPLMEHDNI 69
Query: 59 LRFY-----SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLH 113
RF + LV+EY G L L + S LA + R L YLH
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLH 128
Query: 114 S---------KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA---K 161
+ I + DL N+L+ +G + DFGL+ +L+ A +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 162 CGTPCYMAPELFEEG------GVHSYASDLWGLGCVLYECYAG---RPPFVGREFTQLV- 211
GT YMAPE+ E D++ LG + +E + P Q+
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248
Query: 212 -KSILSDPS--------------PPLPGNPS------RPFANLINSLLVKDPAQRL 246
+ + P+ P P R I +D RL
Sbjct: 249 QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 75/292 (25%), Positives = 128/292 (43%), Gaps = 44/292 (15%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLD 54
M +Y E +G G Y VYK + A+K + + ++E+ +L L
Sbjct: 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAEDEGIPSTAIREISLLKELH 77
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLH 113
HPN++ + L LV E+ DL +L ++ L + I+ L+R + + H
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
I++ DLKP N+L++ +G KL DFGLAR ++ + + T Y AP++
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH-----EVVTLWYRAPDVL 191
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDPSP---------- 220
+S + D+W +GC+ E G+P F G + QL K SIL P+P
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251
Query: 221 -----PLPGNPSRPFAN-----------LINSLLVKDPAQRLHWSDLCGHAF 256
+P+++ L++++L DP +R+ D H +
Sbjct: 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 84/319 (26%), Positives = 132/319 (41%), Gaps = 66/319 (20%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGR-KKKTIEYFAIKSVDKSQKSK------VLQEV---RML 50
QY IG G Y V+K R K + A+K V + Q + ++EV R L
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHL 68
Query: 51 HSLDHPNVLRFY-----SWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQ 103
+ +HPNV+R + S + L LV E+ DL + L + + +P ++I+D+
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMF 127
Query: 104 DLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCG 163
L+R L +LHS +++ DLKP NIL+ +G+ KL DFGLAR S ++
Sbjct: 128 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF----QMAL------- 176
Query: 164 TPC-----YMAPE-LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SI 214
T Y APE L ++ DLW +GC+ E + +P F G + QL K +
Sbjct: 177 TSVVVTLWYRAPEVLL--QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234
Query: 215 LSDPS---------------PPLPGNPSRPF--------ANLINSLLVKDPAQRLHWSDL 251
+ P P F +L+ L +PA+R+
Sbjct: 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294
Query: 252 CGHAFWRTKLTPMPLPPQP 270
H +++
Sbjct: 295 LSHPYFQDL--ERCKENLD 311
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-41
Identities = 100/377 (26%), Positives = 151/377 (40%), Gaps = 69/377 (18%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR-- 60
Y + IG G + VY+ + + E AIK V + ++ K +E++++ LDH N++R
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLR 113
Query: 61 --FYSWYETS--AHLWLVLEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYL 112
FYS E +L LVL+Y V + + R LP ++ L R+L Y+
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDY-VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 113 HSKGIIYCDLKPSNILLDEN-GRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
HS GI + D+KP N+LLD + KLCDFG A++L C + Y APE
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-----RGEPNVSYIC-SRYYRAPE 226
Query: 172 L-FEEGGVHSYAS--DLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDPSP----- 220
L F G Y S D+W GCVL E G+P F G QLV+ +L P+
Sbjct: 227 LIF---GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283
Query: 221 --------PLPGNPSRPFA------------NLINSLLVKDPAQRLHWSDLCGHAF---W 257
P + P+ L + LL P RL + C H+F
Sbjct: 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343
Query: 258 RTKLTPMP----LPPQPAFDSLKGAVRQDENSML---------GSTPVRVTPSGRKTQTK 304
R +P P F + + + ++L ++ + T
Sbjct: 344 RDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTG 403
Query: 305 TSGRVFEEKQKDPSGTT 321
G+ S +T
Sbjct: 404 DRGQTNNAASASASNST 420
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 7e-40
Identities = 93/330 (28%), Positives = 142/330 (43%), Gaps = 68/330 (20%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSKVLQEVRMLHSLDHPNV 58
M+++ + G+G + TV G++K T AIK V D +++ LQ ++ L L HPN+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI 81
Query: 59 LR----FYSWYETSAH---LWLVLEYCVGGDLMSLLR----QDNQLPEDSIRDLAQDLVR 107
++ FY+ E L +V+EY V L R + P I+ L+R
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEY-VPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 108 ALQYLH--SKGIIYCDLKPSNILLD-ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGT 164
++ LH S + + D+KP N+L++ +G KLCDFG A+KLS PS C +
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-----PSEPNVAYIC-S 194
Query: 165 PCYMAPEL-FEEGGVHSY--ASDLWGLGCVLYECYAGRPPFVGREFT-QLVK--SILSDP 218
Y APEL F G Y A D+W +GC+ E G P F G QL + +L P
Sbjct: 195 RYYRAPELIF---GNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251
Query: 219 SP-------------PLPGNPSRPFAN---------------LINSLLVKDPAQRLHWSD 250
S L + P++N L+++LL P +R+ +
Sbjct: 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311
Query: 251 LCGHAF---WRTKLTPMP----LPPQPAFD 273
H + T +P LP F
Sbjct: 312 ALCHPYFDELHDPATKLPNNKDLPEDL-FR 340
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-39
Identities = 69/287 (24%), Positives = 120/287 (41%), Gaps = 50/287 (17%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSL-DHPNVL 59
+ Y + +GRGKYS V++ E +K + +K K+ +E+++L +L PN++
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 94
Query: 60 RFYS--WYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
S LV E+ D L + L + IR ++++AL Y HS GI
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGI 151
Query: 118 IYCDLKPSNILLD-ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
++ D+KP N+++D E+ + +L D+GLA P + + + PEL +
Sbjct: 152 MHRDVKPHNVMIDHEHRKLRLIDWGLAE-----FYHPGQEY-NVRVASRYFKGPELLVDY 205
Query: 177 GVHSYASDLWGLGCVLYECYAGRPP-FVGR-EFTQLVK--------------SILSDPSP 220
++ Y+ D+W LGC+L + P F G + QLV+ +
Sbjct: 206 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265
Query: 221 P-----LPGNPSRPFANLINS----------------LLVKDPAQRL 246
P L + + + ++S LL D RL
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-38
Identities = 80/375 (21%), Positives = 139/375 (37%), Gaps = 77/375 (20%)
Query: 10 IGRGKYSTVYKGRKK--KTIEYFAIKSVDK-SQKSKVLQEVRMLHSLDHPNVLRFYS--W 64
+GRG Y VYK ++K K + +A+K ++ +E+ +L L HPNV+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 65 YETSAHLWLVLEYCVGGDLMSLL---------RQDNQLPEDSIRDLAQDLVRALQYLHSK 115
+WL+ +Y DL ++ ++ QLP ++ L ++ + YLH+
Sbjct: 89 SHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 116 GIIYCDLKPSNILL----DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
+++ DLKP+NIL+ E GR K+ D G AR + K + + P T Y APE
Sbjct: 148 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--TFWYRAPE 205
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE----------FTQLVK--SILSDPS 219
L ++ A D+W +GC+ E P F R+ QL + +++ P+
Sbjct: 206 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPA 265
Query: 220 -----------------PPLPGNPSRPFA-----------------NLINSLLVKDPAQR 245
N + +L+ LL DP +R
Sbjct: 266 DKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR 325
Query: 246 LHWSDLCGHAFWRTKLTPMPLPPQPAFDSLKG------AVRQDENSMLGSTPVRVTPSGR 299
+ ++ PLP F + + ++E G + G
Sbjct: 326 ITSEQAMQDPYFLED----PLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKKNQQQQQGN 381
Query: 300 KTQTKTSGRVFEEKQ 314
T ++
Sbjct: 382 NHTNGTGHPGNQDSS 396
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-38
Identities = 101/341 (29%), Positives = 145/341 (42%), Gaps = 71/341 (20%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
Y + IG G + V++ + ++ E AIK V + ++ K +E++++ + HPNV+
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK-NRELQIMRIVKHPNVVD 96
Query: 61 ----FYSWYETS--AHLWLVLEYCVGGDLMSLLR----QDNQLPEDSIRDLAQDLVRALQ 110
FYS + L LVLEY V + R +P I+ L+R+L
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEY-VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 111 YLHSKGIIYCDLKPSNILLDEN-GRTKLCDFGLARKLSDASKAPSSMLPQAK-----CGT 164
Y+HS GI + D+KP N+LLD G KL DFG A+ L C +
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI----------AGEPNVSYIC-S 204
Query: 165 PCYMAPEL-FEEGGVHSYAS--DLWGLGCVLYECYAGRPPFVGR-EFTQLVK--SILSDP 218
Y APEL F G +Y + D+W GCV+ E G+P F G QLV+ +L P
Sbjct: 205 RYYRAPELIF---GATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 219 S-------------PPLPGNPSRPFA------------NLINSLLVKDPAQRLHWSDLCG 253
S P PF+ +LI+ LL P+ RL +
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 254 HAF---WRTKLTPMP----LPPQPAFDSLKGAVRQDENSML 287
H F RT MP LPP + + +VR D S L
Sbjct: 322 HPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRL 362
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 7e-38
Identities = 78/290 (26%), Positives = 129/290 (44%), Gaps = 47/290 (16%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS----KVLQEVRMLHSLDHPN 57
+ + + +G G Y V K T E AIK ++ K + L+E+++L H N
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHEN 70
Query: 58 VLRFY-----SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
++ + +E ++++ E + DL ++ L +D I+ +RA++ L
Sbjct: 71 IITIFNIQRPDSFENFNEVYIIQEL-MQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVL 128
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC-----Y 167
H +I+ DLKPSN+L++ N K+CDFGLAR + +++ S Q Y
Sbjct: 129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 168 MAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT-QLVK--SILSDPSPP--- 221
APE+ +S A D+W GC+L E + RP F GR++ QL+ I+ P
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDL 248
Query: 222 --------------LPGNPSRPFAN-----------LINSLLVKDPAQRL 246
LP P+ P L+ +LV DPA+R+
Sbjct: 249 RCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI 298
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-37
Identities = 68/284 (23%), Positives = 118/284 (41%), Gaps = 52/284 (18%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSK-VLQEVRMLHSLDHPNV 58
Y +G G Y +V K++ E AIK + +K +E+ +L + H NV
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 59 LRFY------SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
+ S +LV+ + + DL ++ + E+ I+ L +++ L+Y+
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPF-MQTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYI 142
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
HS G+++ DLKP N+ ++E+ K+ DFGLAR M T Y APE+
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA------EMTGY--VVTRWYRAPEV 194
Query: 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT-QLVK--SILSDPSPP-------- 221
++ D+W +GC++ E G+ F G+++ QL + + P
Sbjct: 195 ILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 222 --------LPGNPSRPFAN-----------LINSLLVKDPAQRL 246
LP P + F L+ +L D +RL
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL 298
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-37
Identities = 72/284 (25%), Positives = 116/284 (40%), Gaps = 43/284 (15%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS----KVLQEVRMLHSLDHPN 57
+Y IG G Y V AIK + + + L+E+++L H N
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 58 VLRFY-----SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
++ E +++V + + DL LL+ L D I ++R L+Y+
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDL-METDLYKLLKT-QHLSNDHICYFLYQILRGLKYI 144
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
HS +++ DLKPSN+LL+ K+CDFGLAR + T Y APE+
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV--ATRWYRAPEI 202
Query: 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREF-TQLVK--SILSDPSPP-------- 221
++ + D+W +GC+L E + RP F G+ + QL IL PS
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 222 --------LPGNPSRPFAN-----------LINSLLVKDPAQRL 246
LP P+ L++ +L +P +R+
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 64/292 (21%), Positives = 113/292 (38%), Gaps = 51/292 (17%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSK-VLQEVRMLHSLDHPNV 58
++Y + +G G V+ + AIK + Q K L+E++++ LDH N+
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI 70
Query: 59 LRFY--------------SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQD 104
++ + +++V EY + DL ++L Q L E+ R
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDLANVLEQ-GPLLEEHARLFMYQ 128
Query: 105 LVRALQYLHSKGIIYCDLKPSNILLD-ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCG 163
L+R L+Y+HS +++ DLKP+N+ ++ E+ K+ DFGLAR + +
Sbjct: 129 LLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG--LV 186
Query: 164 TPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT-QLVK--SILSDPSP 220
T Y +P L ++ A D+W GC+ E G+ F G Q+ +
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246
Query: 221 P---------------LPGNPSRPFA-----------NLINSLLVKDPAQRL 246
P +P + + +L P RL
Sbjct: 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL 298
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-36
Identities = 75/286 (26%), Positives = 122/286 (42%), Gaps = 51/286 (17%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSK-VLQEVRMLHSLDHP 56
+Y +G G Y +V KT A+K + +K +E+R+L + H
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 57 NVLRFY------SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQ 110
NV+ E ++LV +G DL ++++ +L +D ++ L ++R L+
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKC-QKLTDDHVQFLIYQILRGLK 146
Query: 111 YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAP 170
Y+HS II+ DLKPSN+ ++E+ K+ DFGLAR +D M T Y AP
Sbjct: 147 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE------MTGYV--ATRWYRAP 198
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT-QLVK--SILSDPSPP------ 221
E+ ++ D+W +GC++ E GR F G + QL ++ P
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 222 ----------LPGNPSRPFAN-----------LINSLLVKDPAQRL 246
L P FAN L+ +LV D +R+
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 304
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 41/254 (16%), Positives = 65/254 (25%), Gaps = 47/254 (18%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIK------SVDKSQKSKVLQEVRMLHSLDHPN 57
Y + G ++ A+ + + L L +D P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
V R T A +V E+ GG L + + P +IR Q L A H G+
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-TSPSPVGAIR-AMQSLAAAADAAHRAGV 150
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
PS + + +G L M
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA-------------------------TMPDA------ 179
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGREFTQ----LVKSILSDPSPPLPGNPSRP--FA 231
+ D+ G+G LY R P + P P + P +
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237
Query: 232 NLINSLLVKDPAQR 245
+ + D R
Sbjct: 238 AVAARSVQGDGGIR 251
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-35
Identities = 73/284 (25%), Positives = 121/284 (42%), Gaps = 51/284 (17%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSK-VLQEVRMLHSLDHPNV 58
Y + +G G Y V +T AIK + +K +E+R+L + H NV
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 59 LRFY------SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
+ + +LV+ + +G DL L++ +L ED I+ L +++ L+Y+
Sbjct: 87 IGLLDVFTPDETLDDFTDFYLVMPF-MGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYI 144
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
H+ GII+ DLKP N+ ++E+ K+ DFGLAR+ M T Y APE+
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS------EMTGYV--VTRWYRAPEV 196
Query: 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT-QLVK--SILSDPSPP-------- 221
++ D+W +GC++ E G+ F G + QL + + P
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 222 --------LPGNPSRPFAN-----------LINSLLVKDPAQRL 246
LP + FA+ L+ +LV D QR+
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-35
Identities = 62/292 (21%), Positives = 112/292 (38%), Gaps = 31/292 (10%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSK-VLQEVRMLHSLDH 55
+ +Y + IG G V AIK + +K +E+ ++ ++H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 56 PNVLRFY------SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRAL 109
N++ E +++V+E + +L +++ + L + + L ++ +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMSYLLYQMLCGI 140
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
++LHS GII+ DLKPSNI++ + K+ DFGLAR + M P T Y A
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYV--VTRYYRA 194
Query: 170 PELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRP 229
PE+ G + D+W +GC++ E G F G + ++ G P
Sbjct: 195 PEVI-LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIE-----QLGTPCPE 248
Query: 230 FANLINS-----LLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLK 276
F + + + + L + L A D L
Sbjct: 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS 300
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-35
Identities = 69/280 (24%), Positives = 113/280 (40%), Gaps = 44/280 (15%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKV-----LQEVRMLHSLDHP 56
++Y I IG G Y V + K AIK + + + + L+E+ +L+ L+H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 57 NVLRFY-----SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
+V++ E L++VLE D L R L E I+ L +L+ ++Y
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEI-ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC----- 166
+HS GI++ DLKP+N L++++ K+CDFGLAR + S + +
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 167 -----------------YMAPELFEEGGVHSYASDLWGLGCVLYE-----------CYAG 198
Y APEL ++ A D+W +GC+ E
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291
Query: 199 RPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLL 238
P F G L + +R N+I ++L
Sbjct: 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNIL 331
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-34
Identities = 74/327 (22%), Positives = 135/327 (41%), Gaps = 79/327 (24%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLR 60
+Y + + +G G + V + ++ + FA+K V + + K +E+ ++ LDH N+++
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-NRELDIMKVLDHVNIIK 64
Query: 61 ----FYSWYETSAH----------------------------------LWLVLEYCVGGD 82
FY+ + L +++EY V
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY-VPDT 123
Query: 83 LMSLLR----QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLD-ENGRTKL 137
L +L+ +P + I L RA+ ++HS GI + D+KP N+L++ ++ KL
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKL 183
Query: 138 CDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA 197
CDFG A+KL + + + + C + Y APEL ++ + DLW +GCV E
Sbjct: 184 CDFGSAKKLIPSEPSVAYI-----C-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 198 GRPPFVGREFT-QLVK--SILSDPSPP-------------LPGNPSRPFAN--------- 232
G+P F G QLV+ I+ P+ P ++ +
Sbjct: 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSL 297
Query: 233 ---LINSLLVKDPAQRLHWSDLCGHAF 256
L+ +L +P R++ + H F
Sbjct: 298 AIDLLEQILRYEPDLRINPYEAMAHPF 324
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-34
Identities = 71/296 (23%), Positives = 110/296 (37%), Gaps = 59/296 (19%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--------------VLQEV 47
+ Y + I G Y V G + AIK V + VL+E+
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDSEG-IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 48 RMLHSLDHPNVLRFY-----SWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDL 101
R+L+ HPN+L L+LV E + DL ++ Q + I+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDLAQVIHDQRIVISPQHIQYF 139
Query: 102 AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAK 161
++ L LH G+++ DL P NILL +N +CDF LAR+ + +
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT-----ADANKTH-Y 193
Query: 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT-QLVK--SILSDP 218
Y APEL + + D+W GCV+ E + + F G F QL K ++ P
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 219 SP-----------------PLPGNPSRPFAN-----------LINSLLVKDPAQRL 246
L P+R + LI +L +P +R+
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-33
Identities = 64/290 (22%), Positives = 114/290 (39%), Gaps = 33/290 (11%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSK-VLQEVRMLHSLDHPNV 58
Y + IG G V AIK + +K +E+ ++ ++H N+
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 59 LRFY------SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
+ E ++LV+E + +L +++ + L + + L ++ +++L
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQME--LDHERMSYLLYQMLCGIKHL 180
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
HS GII+ DLKPSNI++ + K+ DFGLAR + M P T Y APE+
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYV--VTRYYRAPEV 234
Query: 173 FEEGGVH-SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFA 231
G+ D+W +GC++ E + F GR++ ++ G P F
Sbjct: 235 I--LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE-----QLGTPCPEFM 287
Query: 232 NLINS-----LLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLK 276
+ + + L + L + + L A D L
Sbjct: 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS 337
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-33
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 25/223 (11%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQ---EVRMLHSL----- 53
+Y + + IG+G + V K K ++ A+K + +++K Q E+R+L L
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALK-MVRNEKRFHRQAAEEIRILEHLRKQDK 155
Query: 54 -DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQ 110
+ NV+ + H+ + E + +L L++++ +R A +++ L
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFE-LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 111 YLHSKGIIYCDLKPSNILLDENGRT--KLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
LH II+CDLKP NILL + GR+ K+ DFG + + + + Q + Y
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYI-Q----SRFYR 266
Query: 169 APELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQL 210
APE+ G + D+W LGC+L E G P G E QL
Sbjct: 267 APEVI-LGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL 308
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-33
Identities = 77/303 (25%), Positives = 138/303 (45%), Gaps = 31/303 (10%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSK-VLQEVRMLHSL-DHP 56
+Y + + +G+G Y V+K ++T E A+K + S ++ +E+ +L L H
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 57 NVLRFYSWY--ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
N++ + + ++LV +Y + DL +++R N L + + L++ ++YLHS
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDY-METDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHS 127
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC-------- 166
G+++ D+KPSNILL+ K+ DFGL+R + + +++ T
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 167 --------YMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT-QLVK--SIL 215
Y APE+ ++ D+W LGC+L E G+P F G QL + ++
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI 247
Query: 216 SDPSPPLPGNPSRPFA-NLINSLLVKDPAQRLHWSDLC-GHAFWRTKLTPMPLPPQPAFD 273
PS + PFA +I SL K ++ + D+ K+ P + A D
Sbjct: 248 DFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALD 307
Query: 274 SLK 276
L
Sbjct: 308 LLD 310
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-33
Identities = 76/330 (23%), Positives = 118/330 (35%), Gaps = 86/330 (26%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSK-VLQEVRMLHSLDHP 56
+ Y I IGRG Y VY K T + AIK V + K +L+E+ +L+ L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 57 NVLRFY-----SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
++R Y L++VLE DL L + L E+ I+ + +L+ +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEI-ADSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC----- 166
+H GII+ DLKP+N LL+++ K+CDFGLAR ++ +
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 167 ------------YMAPELFEEGGVHSYASDLWGLGCVLYECYAG-----------RPPFV 203
Y APEL ++ + D+W GC+ E P F
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264
Query: 204 GREFT------------------QLVK--SILSDPSPP----------------LPGNPS 227
G QL +I+ P+ P
Sbjct: 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP 324
Query: 228 RPFA-----------NLINSLLVKDPAQRL 246
NL+ S+L +P +R+
Sbjct: 325 INLKQKYPSISDDGINLLESMLKFNPNKRI 354
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 68/225 (30%), Positives = 105/225 (46%), Gaps = 27/225 (12%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQ---EVRMLHSL----- 53
++Y I IG+G + V K + E+ AIK + K++K+ + Q EVR+L +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-IIKNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 54 -DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQ 110
++ + HL LV E + +L LLR N + + R AQ + AL
Sbjct: 113 EMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 111 YLHSK--GIIYCDLKPSNILLDENGRT--KLCDFGLARKLSDASKAPSSMLPQAKCGTPC 166
+L + II+CDLKP NILL R+ K+ DFG + + + Q +
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYI-Q----SRF 223
Query: 167 YMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EFTQL 210
Y +PE+ + A D+W LGC+L E + G P F G E Q+
Sbjct: 224 YRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM 267
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-30
Identities = 65/229 (28%), Positives = 106/229 (46%), Gaps = 19/229 (8%)
Query: 5 HIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNVLR 60
+ E IGRG + V+ GR + A+KS K+K LQE R+L HPN++R
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+++V+E GGD ++ LR + +L ++ + D ++YL SK I+
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDA---SKAPSSMLPQAKCGTPCYMAPELFEEG 176
DL N L+ E K+ DFG++R+ +D + +P K + APE
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP-VK-----WTAPEALNY- 289
Query: 177 GVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
G +S SD+W G +L+E ++ G P+ Q + + P P
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPE 338
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 64/233 (27%), Positives = 100/233 (42%), Gaps = 23/233 (9%)
Query: 5 HIYEAIGRGKYSTVYKGRKKKTIEYF---AIKSV----DKSQKSKVLQEVRMLHSLDHPN 57
HI + IG G V GR + + AIK++ + Q+ L E ++ DHPN
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPN 111
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKG 116
++R +V EY G L + LR D Q + + + + ++YL G
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSD----ASKAPSSMLPQAKCGTPCYMAPEL 172
++ DL N+L+D N K+ DFGL+R L D A +P + + APE
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP-IR-----WTAPEA 225
Query: 173 FEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
S ASD+W G V++E A G P+ ++ S+ P+P
Sbjct: 226 IAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPM 277
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 47/239 (19%), Positives = 100/239 (41%), Gaps = 38/239 (15%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS---KVLQEVRMLHSL----- 53
+Y + +G G +STV+ + + A+K + + K E+++L +
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 54 ------DHPNVLRFYSWYE----TSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDL 101
++L+ + H+ +V E +G +L++L+++ +P ++ +
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 102 AQDLVRALQYLHSK-GIIYCDLKPSNILLDENGRT------KLCDFGLARKLSDASKAPS 154
++ L+ L Y+H + GII+ D+KP N+L++ K+ D G A + +
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYT 193
Query: 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKS 213
+ + T Y +PE+ +D+W C+++E G F E K
Sbjct: 194 NSIQ-----TREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-29
Identities = 59/245 (24%), Positives = 110/245 (44%), Gaps = 14/245 (5%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
+G G+Y VY+G KK A+K++ D + + L+E ++ + HPN+++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
+++ E+ G+L+ LR+ N ++ + +A + A++YL K I+ +L
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345
Query: 124 PSNILLDENGRTKLCDFGLARKLSDAS--KAPSSMLPQAKCGTPCYMAPELFEEGGVHSY 181
N L+ EN K+ DFGL+R ++ + + P APE S
Sbjct: 346 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW------TAPESLAY-NKFSI 398
Query: 182 ASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
SD+W G +L+E G P+ G + +Q+ + + D P L+ +
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 458
Query: 241 DPAQR 245
+P+ R
Sbjct: 459 NPSDR 463
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 54/223 (24%), Positives = 102/223 (45%), Gaps = 17/223 (7%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
+ IG G++ V+ G + AIK++ + ++E ++ L HP +++ Y
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKP 124
A + LV E+ G L LR +++ + D+ + YL +I+ DL
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA 132
Query: 125 SNILLDENGRTKLCDFGLARKLSDAS--KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
N L+ EN K+ DFG+ R + D + + P K + +PE+F +S
Sbjct: 133 RNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP-VK-----WASPEVFSF-SRYSSK 185
Query: 183 SDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
SD+W G +++E ++ G+ P+ R +++V+ I + P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR 228
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 53/223 (23%), Positives = 102/223 (45%), Gaps = 17/223 (7%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
+ +G G++ V G+ K + A+K + + + QE + + L HP +++FY
Sbjct: 14 KELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKP 124
+++V EY G L++ LR L + ++ D+ + +L S I+ DL
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAA 132
Query: 125 SNILLDENGRTKLCDFGLARKLSDAS--KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
N L+D + K+ DFG+ R + D + + P K + APE+F +S
Sbjct: 133 RNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP-VK-----WSAPEVFHY-FKYSSK 185
Query: 183 SDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
SD+W G +++E ++ G+ P+ +++V + P
Sbjct: 186 SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH 228
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 59/269 (21%), Positives = 112/269 (41%), Gaps = 43/269 (15%)
Query: 8 EAIGRGKYSTVYKGR-----KKKTIEYFAIK----SVDKSQKSKVLQEVRMLHSLDHPNV 58
+ +G G + TVYKG +K I AIK + ++L E ++ S+D+P+V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGI 117
R ++ + L+ + G L+ +R+ + + + + + + + YL + +
Sbjct: 80 CRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSMLPQAKCGTPCYMAPELFE 174
++ DL N+L+ K+ DFGLA+ L A +P +MA E
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK------WMALESIL 192
Query: 175 EGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPPL-PG----- 224
++++ SD+W G ++E G P+ G +++ + P PP+
Sbjct: 193 H-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251
Query: 225 -------NPS-RP-FANLINSL--LVKDP 242
+ RP F LI + +DP
Sbjct: 252 MRKCWMIDADSRPKFRELIIEFSKMARDP 280
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 10 IGRGKYSTVYKGR---KKKTIEYFAIK-----SVDKSQKSKVLQEVRMLHSLDHPNVLRF 61
+G G + TV KG KK A+K + D + K ++L E ++ LD+P ++R
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKT-VAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
+ LV+E G L L+Q+ + + +I +L + ++YL ++ D
Sbjct: 84 IG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 142
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDAS----KAPSSMLPQAKCGTPCYMAPELFEEGG 177
L N+LL K+ DFGL++ L P + APE
Sbjct: 143 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK------WYAPECINY-Y 195
Query: 178 VHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
S SD+W G +++E ++ G+ P+ G + +++ +
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 17/224 (7%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
+G G+Y VY+G KK A+K++ D + + L+E ++ + HPN+++
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
+++ E+ G+L+ LR+ N ++ + +A + A++YL K I+ DL
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 124 PSNILLDENGRTKLCDFGLARKLSDA--SKAPSSMLPQAKCGTPCYMAPELFEEGGVHSY 181
N L+ EN K+ DFGL+R ++ + + P K + APE S
Sbjct: 139 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-IK-----WTAPESLAY-NKFSI 191
Query: 182 ASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
SD+W G +L+E G P+ G + +Q+ + + D P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 235
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 6 IYEAIGRGKYSTVYKGRKKKTIEYF---AIKSV----DKSQKSKVLQEVRMLHSLDHPNV 58
I + +G G++ V GR K + AIK++ + Q+ L E ++ DHPN+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+R S + +V EY G L S LR+ D Q + + + + ++YL G
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSD----ASKAPSSMLPQAKCGTPCYMAPELF 173
++ DL NIL++ N K+ DFGL R L D A +P + + +PE
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP-IR-----WTSPEAI 222
Query: 174 EEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
+ ASD+W G VL+E + G P+ ++K++ P P
Sbjct: 223 AY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPM 273
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 50/226 (22%), Positives = 108/226 (47%), Gaps = 17/226 (7%)
Query: 5 HIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSKVLQEVRMLHSLDHPNVLRFY 62
+ +G G++ V G+ + + AIK + + + ++E +++ +L H +++ Y
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
++++ EY G L++ LR+ ++ + ++ +D+ A++YL SK ++ D
Sbjct: 86 GVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRD 145
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDA--SKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
L N L+++ G K+ DFGL+R + D + + S P + + PE+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-VR-----WSPPEVLMY-SKF 198
Query: 180 SYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
S SD+W G +++E Y+ G+ P+ ++ + I P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 244
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 22/230 (9%)
Query: 6 IYEAIGRGKYSTVYKGR---KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNV 58
+ IG G++ V++G + AIK+ S + K LQE + DHP++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGI 117
++ T +W+++E C G+L S L+ L S+ A L AL YL SK
Sbjct: 79 VKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 137
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKL--SDASKAPSSMLPQAKCGTPCYMAPELFEE 175
++ D+ N+L+ N KL DFGL+R + S KA LP K +MAPE
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP-IK-----WMAPESINF 191
Query: 176 GGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
+ ASD+W G ++E G PF G + ++ I + P PP
Sbjct: 192 -RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 240
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-28
Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 49/246 (19%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQ---EVRMLHSL----- 53
N + + +G G + V + +Y+A+K V ++ K E +L +
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVK-VVRNIKKYTRSAKIEADILKKIQNDDI 93
Query: 54 DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQY 111
++ N+++++ + H+ L+ E +G L ++ ++N + I+ ++++AL Y
Sbjct: 94 NNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 112 LHSKGIIYCDLKPSNILLDENGRT-------------------------KLCDFGLARKL 146
L + + DLKP NILLD+ KL DFG A
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--- 209
Query: 147 SDASKAPSSMLPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR 205
+ S S++ T Y APE + G +SD+W GCVL E Y G F
Sbjct: 210 TFKSDYHGSII-N----TRQYRAPEVILNLG--WDVSSDMWSFGCVLAELYTGSLLFRTH 262
Query: 206 -EFTQL 210
L
Sbjct: 263 EHMEHL 268
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 54/266 (20%), Positives = 104/266 (39%), Gaps = 41/266 (15%)
Query: 5 HIYEAIGRGKYSTVYKGRKKKTIEYF-------AIKSVDK---SQKSKVLQEVRMLHSLD 54
E++G+G ++ ++KG +++ +Y +K +DK + + M+ L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLH 113
H +++ Y LV E+ G L + L++ N + ++A+ L A+ +L
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE 130
Query: 114 SKGIIYCDLKPSNILLDENGRT--------KLCDFGLARKLSDAS--KAPSSMLPQAKCG 163
+I+ ++ NILL KL D G++ + +
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER------IP-- 182
Query: 164 TPCYMAPELFEEGGVHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKSILSD---PS 219
++ PE E + A+D W G L+E C G P + + ++ P+
Sbjct: 183 ---WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA 239
Query: 220 PPLPGNPSRPFANLINSLLVKDPAQR 245
P ANLIN+ + +P R
Sbjct: 240 PKAA-----ELANLINNCMDYEPDHR 260
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 24/233 (10%)
Query: 6 IYEAIGRGKYSTVYKGRKKKTIEYF----AIKSV----DKSQKSKVLQEVRMLHSLDHPN 57
+ IG G++ VYKG K + AIK++ + Q+ L E ++ H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKG 116
++R + ++ EY G L LR+ D + + + + + ++YL +
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS----KAPSSMLPQAKCGTPCYMAPEL 172
++ DL NIL++ N K+ DFGL+R L D +P + + APE
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP-IR-----WTAPEA 221
Query: 173 FEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
+ ASD+W G V++E G P+ +++K+I P+P
Sbjct: 222 ISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM 273
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 25/235 (10%)
Query: 5 HIYEAIGRGKYSTVYKGR---KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPN 57
H E IGRG + VY G + A+KS+ D + S+ L E ++ HPN
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 58 VLRFY-SWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSK 115
VL + +VL Y GDL + +R + + + + ++YL SK
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK 147
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSD-----ASKAPSSMLPQAKCGTPCYMAP 170
++ DL N +LDE K+ DFGLAR + D + LP K +MA
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP-VK-----WMAL 201
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
E + + SD+W G +L+E G PP+ + +L P
Sbjct: 202 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 255
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 60/245 (24%), Positives = 106/245 (43%), Gaps = 16/245 (6%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
+G+G + V+ G T AIK++ LQE +++ L H +++ Y+
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-V 247
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
+ +++V EY G L+ L+ + L + D+A + + Y+ ++ DL+
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 307
Query: 124 PSNILLDENGRTKLCDFGLARKLSDAS--KAPSSMLPQAKCGTPCYMAPELFEEGGVHSY 181
+NIL+ EN K+ DFGLAR + D + P + APE G +
Sbjct: 308 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALY-GRFTI 360
Query: 182 ASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
SD+W G +L E GR P+ G +++ + P P +L+ K
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 420
Query: 241 DPAQR 245
+P +R
Sbjct: 421 EPEER 425
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 29/230 (12%)
Query: 10 IGRGKYSTVYKGR---KKKTIEYFAIKS----VDKSQKSKVLQEVRMLHSLDHPNVLRFY 62
+G G + +V +G +KK I+ AIK +K+ ++++E +++H LD+P ++R
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
+ A L LV+E GG L L ++P ++ +L + ++YL K ++ D
Sbjct: 77 GVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDAS----KAPSSMLPQAKCGTPCYMAPE--LFEE 175
L N+LL K+ DFGL++ L + P + APE F
Sbjct: 136 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK------WYAPECINF-- 187
Query: 176 GGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
S SD+W G ++E + G+ P+ + +++ I PP
Sbjct: 188 -RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 236
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 52/236 (22%), Positives = 101/236 (42%), Gaps = 31/236 (13%)
Query: 5 HIYEAIGRGKYSTVYKGRKKKTIEYF---AIKSV-----DKSQKSKVLQEVRMLHSLDHP 56
+ +G+G++ +V + + K+ F A+K + S + L+E + DHP
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85
Query: 57 NVLRFY------SWYETSAHLWLVLEYCVGGDLMSLLR------QDNQLPEDSIRDLAQD 104
+V + ++L + GDL + L LP ++ D
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 105 LVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSMLPQAK 161
+ ++YL S+ I+ DL N +L E+ + DFGL+RK+ + +S LP K
Sbjct: 146 IACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLP-VK 204
Query: 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILS 216
++A E + +++ SD+W G ++E G+ P+ G E ++ ++
Sbjct: 205 -----WLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 22/231 (9%)
Query: 5 HIYEAIGRGKYSTVYKGR---KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPN 57
+ +G G + VY+G K A+K+ K K + E ++ +LDHP+
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKG 116
+++ W+++E G+L L + N L ++ + + +A+ YL S
Sbjct: 75 IVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKL--SDASKAPSSMLPQAKCGTPCYMAPELFE 174
++ D+ NIL+ KL DFGL+R + D KA + LP +M+PE
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------WMSPESIN 187
Query: 175 EGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
+ ASD+W ++E + G+ PF E ++ + P P
Sbjct: 188 F-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPD 237
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-27
Identities = 46/235 (19%), Positives = 100/235 (42%), Gaps = 30/235 (12%)
Query: 5 HIYEAIGRGKYSTVYKGRKKKTIEYF---AIKSV-----DKSQKSKVLQEVRMLHSLDHP 56
+ + +G G++ +V +G K+ A+K++ + + + L E + HP
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 57 NVLRFY-----SWYETSAHLWLVLEYCVGGDLMSLLR------QDNQLPEDSIRDLAQDL 105
NV+R + ++L + GDL + L +P ++ D+
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 106 VRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSMLPQAKC 162
++YL ++ ++ DL N +L ++ + DFGL++K+ + + +P K
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMP-VK- 214
Query: 163 GTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILS 216
++A E + V++ SD+W G ++E G P+ G + ++ +L
Sbjct: 215 ----WIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 54/227 (23%), Positives = 103/227 (45%), Gaps = 19/227 (8%)
Query: 5 HIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSKVLQEVRMLHSLDHPNVLRFY 62
+ E +G G++ V+ G + A+KS+ L E ++ L H ++R Y
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
+ T ++++ EY G L+ L+ + +L + + D+A + + ++ + I+
Sbjct: 75 A-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDA--SKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
DL+ +NIL+ + K+ DFGLAR + D + + P K + APE G
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP-IK-----WTAPEAINY-GT 186
Query: 179 HSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
+ SD+W G +L E GR P+ G ++++++ P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-27
Identities = 62/235 (26%), Positives = 96/235 (40%), Gaps = 25/235 (10%)
Query: 5 HIYEAIGRGKYSTVYKGR---KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPN 57
H E IGRG + VY G + A+KS+ D + S+ L E ++ HPN
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 58 VLRFY-SWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSK 115
VL + +VL Y GDL + +R + + + + +++L SK
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS-----KAPSSMLPQAKCGTPCYMAP 170
++ DL N +LDE K+ DFGLAR + D + LP K +MA
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP-VK-----WMAL 265
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
E + + SD+W G +L+E G PP+ + +L P
Sbjct: 266 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 319
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 51/243 (20%), Positives = 94/243 (38%), Gaps = 47/243 (19%)
Query: 2 NQYHIYEAIGRGKYSTVYKGR-KKKTIEYFAIK---SVDKSQKSKVLQEVRMLHSL---- 53
+Y I +G G + V + + A+K +V K +++ E+ +L +
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA-ARLEINVLKKIKEKD 77
Query: 54 --DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRAL 109
+ + W+ H+ + E +G + L+++N P +R +A L AL
Sbjct: 78 KENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRT-------------------KLCDFGLARKLSDAS 150
++LH + + DLKP NIL + ++ DFG A +
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---TFDH 193
Query: 151 KAPSSMLPQAKCGTPCYMAPE--LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EF 207
+ ++++ T Y PE L + D+W +GC+L+E Y G F
Sbjct: 194 EHHTTIV-A----TRHYRPPEVIL---ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245
Query: 208 TQL 210
L
Sbjct: 246 EHL 248
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-26
Identities = 68/230 (29%), Positives = 106/230 (46%), Gaps = 22/230 (9%)
Query: 6 IYEAIGRGKYSTVYKGR---KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNV 58
+ IG G++ V++G + AIK+ S + K LQE + DHP++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGI 117
++ T +W+++E C G+L S L+ L S+ A L AL YL SK
Sbjct: 454 VKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDAS--KAPSSMLPQAKCGTPCYMAPELFEE 175
++ D+ N+L+ N KL DFGL+R + D++ KA LP +MAPE
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAPESINF 566
Query: 176 GGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
+ ASD+W G ++E G PF G + ++ I + P PP
Sbjct: 567 -RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 615
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 57/243 (23%), Positives = 99/243 (40%), Gaps = 47/243 (19%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKT-IEYFAIK---SVDKSQKSKVLQEVRMLHSL---- 53
+Y I + +G G + V + K + A+K +VD+ ++ E+++L L
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEA-ARSEIQVLEHLNTTD 72
Query: 54 --DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRAL 109
++ W+E H+ +V E G ++++ D IR +A + +++
Sbjct: 73 PNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRT-------------------KLCDFGLARKLSDAS 150
+LHS + + DLKP NIL ++ T K+ DFG A +
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA---TYDD 188
Query: 151 KAPSSMLPQAKCGTPCYMAPE--LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR-EF 207
+ S+++ T Y APE L S D+W +GC+L E Y G F
Sbjct: 189 EHHSTLV-S----TRHYRAPEVIL---ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 208 TQL 210
L
Sbjct: 241 EHL 243
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 60/245 (24%), Positives = 106/245 (43%), Gaps = 16/245 (6%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
+G+G + V+ G T AIK++ LQE +++ L H +++ Y+
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-V 330
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
+ +++V EY G L+ L+ + L + D+A + + Y+ ++ DL+
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 390
Query: 124 PSNILLDENGRTKLCDFGLARKLSDAS--KAPSSMLPQAKCGTPCYMAPELFEEGGVHSY 181
+NIL+ EN K+ DFGLAR + D + P + APE G +
Sbjct: 391 AANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTAPEAALY-GRFTI 443
Query: 182 ASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVK 240
SD+W G +L E GR P+ G +++ + P P +L+ K
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 503
Query: 241 DPAQR 245
+P +R
Sbjct: 504 EPEER 508
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV-DKSQKSKVLQEVRMLHSLDHPNVLRFY---S 63
+ IG+G++ V G + A+K + + + L E ++ L H N+++
Sbjct: 27 QTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 64 WYETSAHLWLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
E L++V EY G L+ LR L D + + D+ A++YL ++ D
Sbjct: 85 --EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 142
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSY 181
L N+L+ E+ K+ DFGL ++ S + LP K + APE E S
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLP-VK-----WTAPEALRE-KKFST 193
Query: 182 ASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
SD+W G +L+E Y+ GR P+ +V + +P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 237
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-26
Identities = 52/231 (22%), Positives = 101/231 (43%), Gaps = 26/231 (11%)
Query: 8 EAIGRGKYSTVYKGR-----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNV 58
+ +G G + TVYKG +K I AIK + ++L E ++ S+D+P+V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIP-VAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGI 117
R ++ + L+ + G L+ +R+ + + + + + + + YL + +
Sbjct: 80 CRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSMLPQAKCGTPCYMAPELFE 174
++ DL N+L+ K+ DFGLA+ L A +P +MA E
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK------WMALESIL 192
Query: 175 EGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
++++ SD+W G ++E G P+ G +++ + P PP
Sbjct: 193 H-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPP 242
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 57/213 (26%), Positives = 84/213 (39%), Gaps = 37/213 (17%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQ-------EVRMLHSLDHPNVLRFY 62
+G G + VYKG T A+K + + E++++ H N++
Sbjct: 39 MGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 63 SWYETSAHLWLVLEYCVGGDLMS-LLRQDNQLPED-SIR-DLAQDLVRALQYLHSKGIIY 119
+ L LV Y G L+ L D P +R +AQ + +LH I+
Sbjct: 97 GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS---MLPQAKCGTPCYMAPELFEEG 176
D+K +NILLDE K+ DFGLAR ++ + + GT YMAPE
Sbjct: 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV------GTTAYMAPE----- 205
Query: 177 GVHSYA-------SDLWGLGCVLYECYAGRPPF 202
SD++ G VL E G P
Sbjct: 206 ----ALRGEITPKSDIYSFGVVLLEIITGLPAV 234
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 46/230 (20%), Positives = 87/230 (37%), Gaps = 27/230 (11%)
Query: 10 IGRGKYSTVYKGR----KKKTIEYFAIKS----VDKSQKSKVLQEVRMLHSLDHPNVLRF 61
+G G + V R T E A+KS + + + +E+ +L +L H N++++
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 62 Y--SWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ + L++E+ G L L + N++ A + + + YL S+ +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYV 148
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDAS----KAPSSMLPQAKCGTPCYMAPELFE 174
+ DL N+L++ + K+ DFGL + + P + APE
Sbjct: 149 HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF------WYAPECLM 202
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPG 224
+ ASD+W G L+E + + L P
Sbjct: 203 Q-SKFYIASDVWSFGVTLHELLT-----YCDSDSSPMALFLKMIGPTHGQ 246
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 55/229 (24%), Positives = 89/229 (38%), Gaps = 27/229 (11%)
Query: 10 IGRGKYSTVYKGR----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNVLRF 61
+G G + V T E A+K++ +S QE+ +L +L H +++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 62 Y--SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+A L LV+EY G L L + + + + AQ + + YLH++ I+
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIH 157
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDAS----KAPSSMLPQAKCGTPCYMAPELFEE 175
DL N+LLD + K+ DFGLA+ + + P + APE +E
Sbjct: 158 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF------WYAPECLKE 211
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPG 224
YASD+W G LYE L
Sbjct: 212 -YKFYYASDVWSFGVTLYELLT-----HCDSSQSPPTKFLELIGIAQGQ 254
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 29/237 (12%)
Query: 5 HIYEAIGRGKYSTVYKGR----KKKTIEYFAIKSV------DKSQKSKVLQEVRMLHSLD 54
+ E +G G + V +G KT+ A+K + ++EV +HSLD
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVS-VAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLH 113
H N++R Y + + +V E G L+ LR+ ++ A + + YL
Sbjct: 80 HRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS----KAPSSMLPQAKCGTPCYMA 169
SK I+ DL N+LL K+ DFGL R L +P A + A
Sbjct: 139 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA------WCA 192
Query: 170 PELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD----PSPP 221
PE + S+ASD W G L+E + G+ P++G +Q++ I + P P
Sbjct: 193 PESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE 248
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 8 EAIGRGKYSTVYKGR----KKKTIEYFAIKSV---DKSQKSKVLQEVRMLHSLDHPNVLR 60
+ +G+G + +V R + T E A+K + + +E+ +L SL H N+++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 61 FY--SWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+ + +L L++EY G L L++ ++ + + + ++YL +K
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDAS----KAPSSMLPQAKCGTPCYMAPELF 173
I+ DL NIL++ R K+ DFGL + L P + APE
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF------WYAPESL 220
Query: 174 EEGGVHSYASDLWGLGCVLYE 194
E S ASD+W G VLYE
Sbjct: 221 TE-SKFSVASDVWSFGVVLYE 240
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-26
Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 22/212 (10%)
Query: 8 EAIGRGKYSTVYKGR----KKKTIEYFAIKSV---DKSQKSKVLQEVRMLHSLDHPNVLR 60
+G+G + +V R T A+K + Q+ +E+++L +L +++
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 61 FY--SWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+ S+ L LV+EY G L L++ +L + + + + ++YL S+
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC 148
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDAS----KAPSSMLPQAKCGTPCYMAPELF 173
++ DL NIL++ K+ DFGLA+ L P + APE
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF------WYAPESL 202
Query: 174 EEGGVHSYASDLWGLGCVLYECYA-GRPPFVG 204
+ + S SD+W G VLYE +
Sbjct: 203 SD-NIFSRQSDVWSFGVVLYELFTYCDKSCSP 233
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-26
Identities = 51/233 (21%), Positives = 91/233 (39%), Gaps = 24/233 (10%)
Query: 5 HIYEAIGRGKYSTVYKGRKKKTIEYF----AIK----SVDKSQKSKVLQEVRMLHSLDHP 56
+ +G G + TV+KG E IK + V + + SLDH
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSK 115
+++R + L LV +Y G L+ +RQ L + + + + + YL
Sbjct: 76 HIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSD---ASKAPSSMLPQAKCGTPCYMAPEL 172
G+++ +L N+LL + ++ DFG+A L + P K +MA E
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP-IK-----WMALES 188
Query: 173 FEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
G +++ SD+W G ++E G P+ G ++ + P
Sbjct: 189 IHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ 240
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-25
Identities = 55/228 (24%), Positives = 102/228 (44%), Gaps = 25/228 (10%)
Query: 10 IGRGKYSTVYKGR---KKKTIEYFAIKS----VDKSQKSKVLQEVRMLHSLDHPNVLRFY 62
+G G + +V +G +KK I+ AIK +K+ ++++E +++H LD+P ++R
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCD 121
+ L LV+E GG L L ++P ++ +L + ++YL K ++ +
Sbjct: 403 G-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461
Query: 122 LKPSNILLDENGRTKLCDFGLARKLSDAS----KAPSSMLPQAKCGTPCYMAPELFEEGG 177
L N+LL K+ DFGL++ L + P + APE
Sbjct: 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK------WYAPECINF-R 514
Query: 178 VHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
S SD+W G ++E + G+ P+ + +++ I PP
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPP 562
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 8 EAIGRGKYSTVYKGR----KKKTIEYFAIKSV---DKSQKSKVLQEVRMLHSLDHPNVLR 60
+ +G+G + +V R + T E A+K + + +E+ +L SL H N+++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 61 FY--SWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+ + +L L++EY G L L++ ++ + + + ++YL +K
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDAS----KAPSSMLPQAKCGTPCYMAPELF 173
I+ DL NIL++ R K+ DFGL + L P + APE
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF------WYAPESL 189
Query: 174 EEGGVHSYASDLWGLGCVLYE 194
E S ASD+W G VLYE
Sbjct: 190 TE-SKFSVASDVWSFGVVLYE 209
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 22/225 (9%)
Query: 5 HIYEAIGRGKYSTVYKGRKKKTIEYF---AIKSV----DKSQKSKVLQEVRMLHSLDHPN 57
H IG+G + VY G + AIKS+ + Q L+E ++ L+HPN
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 58 VLRFYSW-YETSAHLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSK 115
VL ++L Y GDL+ +R + + R ++YL +
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ 143
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSD-----ASKAPSSMLPQAKCGTPCYMAP 170
++ DL N +LDE+ K+ DFGLAR + D + + LP K + A
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP-VK-----WTAL 197
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
E + + SD+W G +L+E G PP+ + L +
Sbjct: 198 ESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 48/214 (22%), Positives = 100/214 (46%), Gaps = 16/214 (7%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSV--DKSQKSKVLQEVRMLHSLDHPNVLRFYSWY 65
+ +G G++ V+ K + A+K++ L E ++ +L H +++ ++
Sbjct: 194 KKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-V 251
Query: 66 ETSAHLWLVLEYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLK 123
T ++++ E+ G L+ L+ D ++ P + D + + + ++ + I+ DL+
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311
Query: 124 PSNILLDENGRTKLCDFGLARKLSDAS--KAPSSMLPQAKCGTPCYMAPELFEEGGVHSY 181
+NIL+ + K+ DFGLAR + D + P K + APE G +
Sbjct: 312 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP-IK-----WTAPEAINF-GSFTI 364
Query: 182 ASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
SD+W G +L E GR P+ G ++++++
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 25/225 (11%)
Query: 8 EAIGRGKYSTVYKGR-KKKTIEYFAIKSV-DKSQKSKVLQEVRMLHSLDHPNVLRFY--- 62
+ IG+G++ V G + + A+K + + + L E ++ L H N+++
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKV---AVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
E L++V EY G L+ LR L D + + D+ A++YL ++
Sbjct: 256 V--EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313
Query: 121 DLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHS 180
DL N+L+ E+ K+ DFGL ++ S + LP K + APE E S
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLP-VK-----WTAPEALRE-KKFS 364
Query: 181 YASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD---PSPP 221
SD+W G +L+E Y+ GR P+ +V + +P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 409
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 54/233 (23%), Positives = 103/233 (44%), Gaps = 32/233 (13%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYF-----AIKSV----DKSQKSKVLQEVRMLHSLDHPNV 58
+G+G + VY+G K ++ AIK+V ++ + L E ++ + +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLR-------QDNQLPEDSIRDL---AQDLVRA 108
+R +++E GDL S LR + L S+ + A ++
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 109 LQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSMLPQAKCGTP 165
+ YL++ ++ DL N ++ E+ K+ DFG+ R + + K +LP +
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP-VR---- 205
Query: 166 CYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILS 216
+M+PE L + GV + SD+W G VL+E P+ G Q+++ ++
Sbjct: 206 -WMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 30/233 (12%)
Query: 5 HIYEAIGRGKYSTVYKGR-----KKKTIEYFAIKSVDK----SQKSKVLQEVRMLHSLDH 55
+ +G G + VY+G+ + A+K++ + + L E ++ +H
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLR-------QDNQLPEDSIRDLAQDLVRA 108
N++R S ++++E GGDL S LR Q + L + +A+D+
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 109 LQYLHSKGIIYCDLKPSNILLDENG--RT-KLCDFGLARKLSDAS---KAPSSMLPQAKC 162
QYL I+ D+ N LL G R K+ DFG+AR + AS K +MLP
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV--- 209
Query: 163 GTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
+M PE F E G+ + +D W G +L+E ++ G P+ + ++++ +
Sbjct: 210 ---KWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 30/233 (12%)
Query: 5 HIYEAIGRGKYSTVYKGR-----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDH 55
+ +G G + VY+G+ + A+K++ + + L E ++ +H
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLR-------QDNQLPEDSIRDLAQDLVRA 108
N++R S +++LE GGDL S LR Q + L + +A+D+
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 109 LQYLHSKGIIYCDLKPSNILLDENGRT---KLCDFGLARKLSDAS---KAPSSMLPQAKC 162
QYL I+ D+ N LL G K+ DFG+AR + A K +MLP
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV--- 250
Query: 163 GTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
+M PE F E G+ + +D W G +L+E ++ G P+ + ++++ +
Sbjct: 251 ---KWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 70/205 (34%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 10 IGRGKYSTVYKGR-KKKTIEYFAIK--SVDKSQKSKV--LQEVRMLHSLDHPNVLRFYSW 64
+GRG + VYKGR T+ A+K +++Q ++ EV M+ H N+LR +
Sbjct: 38 LGRGGFGKVYKGRLADGTL--VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95
Query: 65 YETSAHLWLVLEYCVGGDLMSLL--RQDNQLPED-SIR-DLAQDLVRALQYLHSKG---I 117
T LV Y G + S L R ++Q P D R +A R L YLH I
Sbjct: 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
I+ D+K +NILLDE + DFGLA KL D + + A GT ++APE G
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLA-KLMDYKD---THVTTAVRGTIGHIAPEYLSTGK 211
Query: 178 VHSYASDLWGLGCVLYECYAGRPPF 202
S +D++G G +L E G+ F
Sbjct: 212 S-SEKTDVFGYGVMLLELITGQRAF 235
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 52/237 (21%), Positives = 92/237 (38%), Gaps = 34/237 (14%)
Query: 5 HIYEAIGRGKYSTVYKGR-----KKKTIEYFAIKSV---DKSQKSKVLQEVRMLHSLDHP 56
+ +G G + V+ ++ A+K++ +S + +E +L L H
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ------------DNQLPEDSIRDL--- 101
+++RF+ L +V EY GDL LR D + L
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 102 AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA---SKAPSSMLP 158
A + + YL ++ DL N L+ + K+ DFG++R + +MLP
Sbjct: 164 ASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
+ +M PE + SD+W G VL+E + G+ P+ T+ + I
Sbjct: 224 -IR-----WMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-22
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 34/210 (16%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIK--SVDKSQKSKVLQ-EVRMLHSLDHPNVLRFYSWYE 66
IG G + VYKG + + A+K + + SQ + + E+ L HP+++ + +
Sbjct: 47 IGHGVFGKVYKGVLRDGAK-VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 67 TSAHLWLVLEYCVGGDLMSLL--RQDNQLPED-SIR-DLAQDLVRALQYLHSKGIIYCDL 122
+ L+ +Y G+L L + R ++ R L YLH++ II+ D+
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDV 165
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSS---MLPQAKCGTPCYMAPELFEEGGVH 179
K NILLDEN K+ DFG+++K ++ + S GT Y+ PE
Sbjct: 166 KSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK------GTLGYIDPE-------- 211
Query: 180 SYA--------SDLWGLGCVLYECYAGRPP 201
Y SD++ G VL+E R
Sbjct: 212 -YFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 60/249 (24%), Positives = 99/249 (39%), Gaps = 39/249 (15%)
Query: 5 HIYEAIGRGKYSTVYKGR-----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDH 55
E +G ++ VYKG + + AIK++ + + + E + L H
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ----------------DNQLPEDSIR 99
PNV+ L ++ YC GDL L + L
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 100 DLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSM 156
L + ++YL S +++ DL N+L+ + K+ D GL R++ A +S+
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSIL 215
LP + +MAPE G S SD+W G VL+E ++ G P+ G +V+ I
Sbjct: 192 LP-IR-----WMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 244
Query: 216 SD---PSPP 221
+ P P
Sbjct: 245 NRQVLPCPD 253
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 52/235 (22%), Positives = 95/235 (40%), Gaps = 35/235 (14%)
Query: 8 EAIGRGKYSTVYKGR-----KKKTIEYFAIKSV---DKSQKSKVLQEVRMLHSLDHPNVL 59
+G G + V+ K A+K++ + + +E +L +L H +++
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLR----------------QDNQLPEDSIRDLAQ 103
+FY L +V EY GDL LR +L + +A
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 104 DLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA---SKAPSSMLPQA 160
+ + YL S+ ++ DL N L+ N K+ DFG++R + +MLP
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP-I 199
Query: 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSI 214
+ +M PE + SD+W G +L+E + G+ P+ T++++ I
Sbjct: 200 R-----WMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 248
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-22
Identities = 53/251 (21%), Positives = 97/251 (38%), Gaps = 46/251 (18%)
Query: 2 NQYHIYEAIGRGKYSTVYKGR-----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHS 52
N IG G + V++ R + A+K + ++ +E ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 53 LDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ---------------------DN 91
D+PN+++ + L+ EY GDL LR
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 92 QLPEDSIRDL---AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSD 148
P S + A+ + + YL + ++ DL N L+ EN K+ DFGL+R +
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 149 AS---KAPSSMLPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFV 203
A + +P + +M PE +F ++ SD+W G VL+E ++ G P+
Sbjct: 227 ADYYKADGNDAIP-IR-----WMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPYY 278
Query: 204 GREFTQLVKSI 214
G +++ +
Sbjct: 279 GMAHEEVIYYV 289
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-22
Identities = 63/219 (28%), Positives = 91/219 (41%), Gaps = 34/219 (15%)
Query: 8 EAIGRGKYSTVYKGR--KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSL-DHPNVLR 60
+ IG G + V K R K AIK + K E+ +L L HPN++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLLRQ----------------DNQLPEDSIRDLAQD 104
E +L+L +EY G+L+ LR+ + L + A D
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 105 LVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGT 164
+ R + YL K I+ DL NIL+ EN K+ DFGL+R K LP +
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP-VR--- 206
Query: 165 PCYMAPE-LFEEGGVHSYASDLWGLGCVLYEC--YAGRP 200
+MA E L V++ SD+W G +L+E G P
Sbjct: 207 --WMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-22
Identities = 62/242 (25%), Positives = 111/242 (45%), Gaps = 44/242 (18%)
Query: 8 EAIGRGKYSTVYKGR-----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLD-HPN 57
+ +GRG + V + K T A+K + S+ ++ E+++L + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 58 VLRFYSW-YETSAHLWLVLEYCVGGDLMSLLR-------------QDNQLPEDSIRDL-- 101
V+ + L +++E+C G+L + LR +D ++ L
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 102 -AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSML 157
+ + + +++L S+ I+ DL NILL E K+CDFGLAR + + + L
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 158 PQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVG----REFTQLV 211
P K +MAPE +F+ V++ SD+W G +L+E ++ G P+ G EF + +
Sbjct: 213 P-LK-----WMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264
Query: 212 KS 213
K
Sbjct: 265 KE 266
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-22
Identities = 66/245 (26%), Positives = 110/245 (44%), Gaps = 49/245 (20%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYF-----AIKSV----DKSQKSKVLQEVRMLHSL-DHPN 57
+ +G G + V + I+ A+K + +++ ++ E+++L L +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLR----------QDNQLPEDSIRDL-AQDLV 106
++ ++ EYC GDL++ LR + ED L +DL+
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 107 R-ALQ------YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSM 156
+ Q +L SK I+ DL NILL TK+CDFGLAR + + S ++
Sbjct: 149 SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 157 LPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYEC-------YAGRPPFVGREFT 208
LP K +MAPE +F V+++ SD+W G L+E Y G P V +F
Sbjct: 209 LP-VK-----WMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP--VDSKFY 258
Query: 209 QLVKS 213
+++K
Sbjct: 259 KMIKE 263
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 9e-22
Identities = 59/247 (23%), Positives = 105/247 (42%), Gaps = 49/247 (19%)
Query: 8 EAIGRGKYSTVYKGR-----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLDHPNV 58
+ +G G++ V K + A+K + S+ +L E +L ++HP+V
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPED---------------------S 97
++ Y L L++EY G L LR+ ++ +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 98 IRDL---AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---K 151
+ DL A + + +QYL +++ DL NIL+ E + K+ DFGL+R + + K
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK 208
Query: 152 APSSMLPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVG---RE 206
+P K +MA E LF+ +++ SD+W G +L+E G P+ G
Sbjct: 209 RSQGRIP-VK-----WMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260
Query: 207 FTQLVKS 213
L+K+
Sbjct: 261 LFNLLKT 267
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 62/241 (25%), Positives = 111/241 (46%), Gaps = 45/241 (18%)
Query: 8 EAIGRGKYSTVYKG-----RKKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLD-HPN 57
+ +G G + V + K+ + A+K + +K ++ E++++ L H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPED-----------SIRDL---AQ 103
++ + ++ EYC GDL++ LR+ +++ E S RDL +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 104 DLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSMLPQA 160
+ + + +L SK I+ D+ N+LL K+ DFGLAR + + S ++ LP
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP-V 230
Query: 161 KCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYEC-------YAGRPPFVGREFTQLVK 212
K +MAPE +F+ V++ SD+W G +L+E Y G V +F +LVK
Sbjct: 231 K-----WMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGIL--VNSKFYKLVK 281
Query: 213 S 213
Sbjct: 282 D 282
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-21
Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 8 EAIGRGKYSTVYKGR-------KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSL-DH 55
+ +G G + V K K A+K + + S ++ E+ M+ + H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-----------DNQLPEDSI--RDL- 101
N++ L++++EY G+L LR N++PE+ + +DL
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 102 --AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSM 156
L R ++YL S+ I+ DL N+L+ EN K+ DFGLAR +++ K +
Sbjct: 207 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266
Query: 157 LPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVG---REFTQLV 211
LP K +MAPE LF+ V+++ SD+W G +++E + G P+ G E +L+
Sbjct: 267 LP-VK-----WMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 318
Query: 212 KS 213
K
Sbjct: 319 KE 320
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-21
Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 44/242 (18%)
Query: 8 EAIGRGKYSTVYKGR-------KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSL-DH 55
+ +G G + V K K A+K + + S ++ E+ M+ + H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-----------DNQLPEDSI--RDL- 101
N++ L++++EY G+L LR N++PE+ + +DL
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 102 --AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSM 156
L R ++YL S+ I+ DL N+L+ EN K+ DFGLAR +++ K +
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 157 LPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVG---REFTQLV 211
LP K +MAPE LF+ V+++ SD+W G +++E + G P+ G E +L+
Sbjct: 221 LP-VK-----WMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL 272
Query: 212 KS 213
K
Sbjct: 273 KE 274
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 6e-21
Identities = 55/271 (20%), Positives = 97/271 (35%), Gaps = 76/271 (28%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIK--SVDKSQKSKVLQEVRMLHSL-----D 54
+YH+ +G G +STV+ + ++ A+K + L E+R+L S+ +
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 55 HPN---VLRFYSWYETS----AHLWLVLEYCVGGDLMSLLRQ--DNQLPEDSIRDLAQDL 105
PN V++ ++ S H+ +V E G L+ + + LP ++ + Q +
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQV 155
Query: 106 VRALQYLHSK-GIIYCDLKPSNILL----------------------------------- 129
++ L YLH+K II+ D+KP NILL
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 130 --------------DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
E + K+ D G A + T Y + E+
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--------FTEDIQTRQYRSLEVLIG 267
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGRE 206
G + +D+W C+ +E G F
Sbjct: 268 SGY-NTPADIWSTACMAFELATGDYLFEPHS 297
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-21
Identities = 61/242 (25%), Positives = 106/242 (43%), Gaps = 44/242 (18%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYF-------AIKSV----DKSQKSKVLQEVRMLHSL-DH 55
+ +G G + V + A+K + + S ++ E+ M+ + H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLR-------------QDNQLPEDSIRDL- 101
N++ L++++EY G+L L+ N + S +DL
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 102 --AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---KAPSSM 156
A + R ++YL SK I+ DL N+L+ E+ K+ DFGLAR + K +
Sbjct: 195 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254
Query: 157 LPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVG---REFTQLV 211
LP K +MAPE LF+ ++++ SD+W G +L+E + G P+ G E +L+
Sbjct: 255 LP-VK-----WMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
Query: 212 KS 213
K
Sbjct: 307 KE 308
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-20
Identities = 68/250 (27%), Positives = 111/250 (44%), Gaps = 54/250 (21%)
Query: 8 EAIGRGKYSTVYKGR-----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSL-DHPN 57
+ +G G + V K A+K + D S++ ++ E++M+ L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLR---------------QDNQLPEDSIRDL- 101
++ S ++L+ EYC GDL++ LR Q E+ + L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 102 AQDLVR-ALQ------YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS---K 151
+DL+ A Q +L K ++ DL N+L+ K+CDFGLAR + S
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 230
Query: 152 APSSMLPQAKCGTPCYMAPE-LFEEGGVHSYASDLWGLGCVLYEC-------YAGRPPFV 203
++ LP K +MAPE LFE G+++ SD+W G +L+E Y G P V
Sbjct: 231 RGNARLP-VK-----WMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP--V 280
Query: 204 GREFTQLVKS 213
F +L+++
Sbjct: 281 DANFYKLIQN 290
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 53/211 (25%), Positives = 79/211 (37%), Gaps = 16/211 (7%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQ-EVRMLHSLDH-PNVL 59
N+Y + IG G + +Y G E AIK K L E ++ + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ +V+E G L L + ++ LA ++ ++Y+HSK I
Sbjct: 69 TIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 127
Query: 119 YCDLKPSNILLDENGRTK---LCDFGLARKLSDASKAPSSMLPQAK--CGTPCYM---AP 170
+ D+KP N L+ + + DFGLA+K DA + K GT Y
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 187
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPP 201
E S DL LG VL G P
Sbjct: 188 LGIE----QSRRDDLESLGYVLMYFNLGSLP 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 49/212 (23%), Positives = 79/212 (37%), Gaps = 16/212 (7%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQ-EVRMLHSLDH-PNVL 59
Y + IG G + +++G + AIK + + L+ E R L +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGII 118
Y + + H LV++ G L LL + ++ A+ ++ +Q +H K ++
Sbjct: 70 NVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 128
Query: 119 YCDLKPSNILLDENGRTK-----LCDFGLARKLSDASKAPSSMLPQAK--CGTPCYM--A 169
Y D+KP N L+ + DFG+ + D + K GT YM
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 188
Query: 170 PELFEEGGVHSYASDLWGLGCVLYECYAGRPP 201
L E S DL LG V G P
Sbjct: 189 THLGRE---QSRRDDLEALGHVFMYFLRGSLP 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 16/212 (7%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVL-QEVRMLHSLDH-PNVL 59
+ + + IG G + + G+ T EY AIK ++ L E R L +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ Y + + +VLE G L L D ++ +A L+ ++Y+HSK +I
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLI 127
Query: 119 YCDLKPSNILLDENGRTK-----LCDFGLARKLSDASKAPSSMLPQAK--CGTPCYM--A 169
Y D+KP N L+ G + DF LA++ D + K GT YM
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSIN 187
Query: 170 PELFEEGGVHSYASDLWGLGCVLYECYAGRPP 201
L +E S DL LG + G P
Sbjct: 188 THLGKE---QSRRDDLEALGHMFMYFLRGSLP 216
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 3e-17
Identities = 42/232 (18%), Positives = 85/232 (36%), Gaps = 41/232 (17%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIK--SVDKSQKSKVLQEVRMLHSLDHPNVL 59
NQ+ + + IG G + +Y E A V+ + + E++ + + +
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 60 RFYSWYETSAHL-------------------WLVLEYCVGGDLMSLLRQDNQLPEDSIRD 100
+ + + +L ++V+E G DL + Q+ + ++
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQ 155
Query: 101 LAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTK--LCDFGLARKLSDASK------A 152
L ++ L+Y+H ++ D+K +N+LL + L D+GL+ +
Sbjct: 156 LGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 153 PSSMLPQAKCGTPCYM---APELFEEGGVHSYASDLWGLGCVLYECYAGRPP 201
P GT + A +G S SD+ LG + G+ P
Sbjct: 216 PRKGH----NGTIEFTSLDA----HKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 1e-16
Identities = 54/211 (25%), Positives = 85/211 (40%), Gaps = 16/211 (7%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQ-EVRMLHSL-DHPNVL 59
N++ + IG G + +Y G +T E AIK + K L E ++ L +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ + LV++ +G L L +L ++ LA ++ ++++HSK +
Sbjct: 67 NVRWFGVEGDYNVLVMDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
Query: 119 YCDLKPSNILLDENGRTK---LCDFGLARKLSDASKAPSSMLPQAK--CGTPCYM---AP 170
+ D+KP N L+ R + DFGLA+K D S + K GT Y
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTH 185
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPP 201
E S DL LG VL G P
Sbjct: 186 LGIE----QSRRDDLESLGYVLMYFLRGSLP 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 8e-15
Identities = 44/233 (18%), Positives = 85/233 (36%), Gaps = 40/233 (17%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTI--------EYFAIK-------------SVDKSQK 40
Q+ + R +Y+ T+ + F++K ++ K
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 41 SKVLQEVRMLHSLDHPNVLRFYSWY--ETSAHLWLVLEYCVGGDLMSLLRQDN--QLPED 96
+ + + L+S + + + +LVL G L S L L E
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCM-GFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSER 159
Query: 97 SIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTK--LCDFGLARKLSDASK--- 151
S+ +A L+ AL++LH ++ ++ NI +D +++ L +G A + + K
Sbjct: 160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219
Query: 152 ---APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPP 201
S G +++ +L +G S SDL LG + + G P
Sbjct: 220 YVEGSRSPH----EGDLEFISMDL-HKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 6e-13
Identities = 37/128 (28%), Positives = 64/128 (50%), Gaps = 18/128 (14%)
Query: 97 SIRDL---AQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS--- 150
++ L + + + +++L S+ I+ DL NILL E K+CDFGLAR +
Sbjct: 191 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250
Query: 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPF----VGR 205
+ + LP +MAPE + V++ SD+W G +L+E ++ G P+ +
Sbjct: 251 RKGDARLPL------KWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 303
Query: 206 EFTQLVKS 213
EF + +K
Sbjct: 304 EFCRRLKE 311
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 31/149 (20%), Positives = 55/149 (36%), Gaps = 15/149 (10%)
Query: 10 IGRGKYSTVYKGR-----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHSLD-HPNVL 59
+GRG + V + K T A+K + S+ ++ E+++L + H NV+
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 60 RFYSWY-ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ L +++E+C G+L + LR R Q G I
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN----EFVPYKTKGARFRQGKDYVGAI 145
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLS 147
DLK + + + F + LS
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLS 174
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 1e-12
Identities = 35/246 (14%), Positives = 65/246 (26%), Gaps = 66/246 (26%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV-----------DKSQKSKVLQEVRML 50
+ E IG G + V++ T AIK + + ++L E+ +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 51 HSL---------DHPNVLRFYSWY------------------------------ETSAHL 71
L + S + L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 72 WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK-GIIYCDLKPSNILLD 130
++VLE+ GG + + + + + L +L + + DL N+LL
Sbjct: 138 FIVLEFEFGGIDL-EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 131 ENGRTKLCDFGLARKLSDASK----------APSSMLPQAKCGTPCYMAPELFEEGGVHS 180
+ KL + + S M +LF G
Sbjct: 197 KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT--GDGD 254
Query: 181 YASDLW 186
Y D++
Sbjct: 255 YQFDIY 260
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 39/233 (16%), Positives = 81/233 (34%), Gaps = 40/233 (17%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKK-----TIEYFAIKSVDKSQKSKVLQEVRMLHSLDHP 56
+ + IG+G + +Y + +K V+ S + E++ P
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVK-VEPSDNGPLFTELKFYQRAAKP 93
Query: 57 NVLRFYSWYETSAHL-------------------WLVLEYCVGGDLMSLLR-QDNQLPED 96
++ + +L +++++ G DL + +
Sbjct: 94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRK 152
Query: 97 SIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTK--LCDFGLARKLSDASK--- 151
++ L+ ++ L+Y+H ++ D+K SN+LL+ + L D+GLA +
Sbjct: 153 TVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 152 ---APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPP 201
P GT + + + G S DL LG + + G P
Sbjct: 213 YAADPKRCH----DGTIEFTSIDA-HNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 69.1 bits (168), Expect = 8e-12
Identities = 94/713 (13%), Positives = 192/713 (26%), Gaps = 240/713 (33%)
Query: 469 LDSESSRSSNSLSQVLWH-----PSDLSV-------RPVMPSRKADKVSEVFPS------ 510
+D E+ +L + + ++ + D +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMS-KDAVSGTL 65
Query: 511 LPFEAL--KASDFVKMSKEQLDALNARILAVLNGNSSIGEKQNVIRYLEMLSSNADAANI 568
F L K + V+ E++ +N + L Y+E +
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD------RL 119
Query: 569 LTSGPIMLVLVKM--LRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGS----LT 622
V K RL LR L L R + + G+LGS +
Sbjct: 120 YNDNQ---VFAKYNVSRLQPYLKLRQALLEL-----RPAKNV----LIDGVLGSGKTWVA 167
Query: 623 -DGLRD-KQEKVRRFSM--AALG------------ELLFYISTQNEHARDSNPPESP--- 663
D K + F + L + L Y N +R +
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 664 ----SKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTIENIC-------SQGGH 712
++ R N L+ VL ++ A C +
Sbjct: 228 HSIQAELRRLLKSKPYENCLL-----VL----LNVQNAKAWNAFNLSCKILLTTRFKQ-- 276
Query: 713 WVARFTSQDVISNLCYIYRATG--KQESMRLTAGSCLVRLVRFNAPSMQSVMDKLSIKDI 770
V F S +++ + + E L L +D+
Sbjct: 277 -VTDFLSAATTTHISLDHHSMTLTPDEVKSLLL-KYL----------------DCRPQDL 318
Query: 771 ASSLIKGSPREQQISLNLLNLAMLGSQMCTNIGRNLLPLVEDKNLVPSLVSLTEQGSEVL 830
++ +P L+++ E +
Sbjct: 319 PREVLTTNP---------RRLSIIA--------------------------------ESI 337
Query: 831 RGKALVFVSLLCKNGRRW--LLHFFCN--SRLL-SSVDRLGKEKDSFLQQCLEAF----- 880
R W H C+ + ++ SS++ L + + ++ +
Sbjct: 338 RDGLA-----------TWDNWKHVNCDKLTTIIESSLNVL---EPAEYRKMFDRLSVFPP 383
Query: 881 -VHVVASIIPGL-LDIITGDIQQMMGG--RRHGQISAITSRAAPKTNVHLFPVVLHLLGS 936
H+ ++ + D+I D+ ++ + S + + T + + +
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLHKY----SLVEKQPKEST------ISIPSI-Y 432
Query: 937 SSFKNRVVSPPVLQQLANLCKVVETQFQGRDDFQITLLRILESISEESNVILGNPE---I 993
K ++ + L + +V+ + F +S+ ++
Sbjct: 433 LELKVKLENEYALHR-----SIVD-HYNIPKTF-------------DSDDLIPPYLDQYF 473
Query: 994 FFH-----------EILPSLTVLYKGNKDGDARFLCLKILSDVMIILLNEPVEDEQRLQD 1042
+ H E + +++ D RFL KI D + + + LQ
Sbjct: 474 YSHIGHHLKNIEHPERMTLFRMVFL-----DFRFLEQKIRHDSTAWNASGSILNT--LQQ 526
Query: 1043 LKS----ISNSHFLPLYPTLIED-EDPIPMYAQKVLVMLIESGYIKISDILHL 1090
LK I ++ P Y L+ D +P + LI S K +D+L +
Sbjct: 527 LKFYKPYICDND--PKYERLVNAILDFLPKIEEN----LICS---KYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.5 bits (156), Expect = 2e-10
Identities = 104/673 (15%), Positives = 185/673 (27%), Gaps = 223/673 (33%)
Query: 757 SMQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGSQMCTNIGRNLLPLVEDKNLV 816
+S++ K I I I L + K
Sbjct: 41 MPKSILSKEEIDHI----IMSKDAVSGT-------------------LRLFWTLLSKQ-- 75
Query: 817 PSLVSLTEQGSEVLRGKALVFVSLLCKNGRRWL---LHFFCNSRLL------SSVDRLGK 867
E+ + FV + + ++L + + DRL
Sbjct: 76 -------EEMVQK-------FVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN 121
Query: 868 EKDSF-------------LQQCLEAFVHVVASIIPGLLDIITGDIQQMMGGRRHGQISAI 914
+ F L+Q L + P +I G + G G+ + +
Sbjct: 122 DNQVFAKYNVSRLQPYLKLRQALL-------ELRPAKNVLIDG-----VLG--SGK-TWV 166
Query: 915 TSRAAPKTNVHL-FPVVLHLLGSSSFKNRVVSPPVLQQLANLCKVVETQFQGRDDFQITL 973
V + L + KN VL+ L L ++ + R D +
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWL---NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 974 LRILESISEESNVILGNPEIFFHEILP-SLTVLYKGNKDG--DARFL------CLKIL-- 1022
+ SI E + + L VL +A+ C KIL
Sbjct: 224 KLRIHSIQAELR------RLLKSKPYENCLLVL-----LNVQNAKAWNAFNLSC-KILLT 271
Query: 1023 ------SDVMI------ILLNEPV----EDE----------QRLQDL----KSISNSHFL 1052
+D + I L+ DE R QDL + +
Sbjct: 272 TRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN----- 326
Query: 1053 PLYPTLI----EDE----DPIPMYAQKVLVMLIESGYIKISDILHLKTVSQCFEFLLGDL 1104
P ++I D D L +IES ++L + F+ L
Sbjct: 327 PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL----NVLEPAEYRKMFD----RL 378
Query: 1105 S----SANVSNVKLCLALASAPE-----MESKLLSQLKVVRRIGNL------LELVYAKD 1149
S SA++ + L L + + +KL V ++ + L
Sbjct: 379 SVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK 438
Query: 1150 MEDFLEPTLGLCRAFLLRSVSSRKGFNYTKEPALLGDCSAEY-----GTAIDQQQSIRDI 1204
+E+ E L ++ + K F+ D +Y G + + +
Sbjct: 439 LEN--EYAL---HRSIVDHYNIPKTFDSDDLIPPYLD---QYFYSHIGHHLKNIEHPERM 490
Query: 1205 MDFSGNVGVFLKLSCSQEANVADVASECVVLLLKAAPREGTTGFLTNLAKVTAILESWRR 1264
F VFL FL K+ +W
Sbjct: 491 TLFR---MVFLDFR-----------------------------FLE--QKIRHDSTAWNA 516
Query: 1265 GTSHL-ILQRVLHALGYSCRQYLSHAMILSISINEISRIEAIISEMKTSSTTTLA----D 1319
S L LQ++ Y C + +++ ++ + +IE + K + +A D
Sbjct: 517 SGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAED 576
Query: 1320 AALL--AASELQR 1330
A+ A ++QR
Sbjct: 577 EAIFEEAHKQVQR 589
|
| >2jdq_A Importin alpha-1 subunit; transport, PB2 subunit, nuclear protein, protein transport, armadillo repeats; 2.2A {Homo sapiens} PDB: 3tj3_A Length = 450 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 37/288 (12%), Positives = 87/288 (30%), Gaps = 29/288 (10%)
Query: 558 MLSSNADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGI 617
+ + + + I+ L+++ + + R + + S
Sbjct: 134 IAGDSTMCRDYVLDCNILPPLLQLFSKQNRLTMTRNAVWALSNLCRGKSPPPEFAKVSPC 193
Query: 618 LGSLTDGLRDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPN 677
L L+ L V + AL L + + + D+ V
Sbjct: 194 LNVLSWLLFVSDTDVLADACWALSYLSDGPNDKIQAVIDAG----------------VCR 237
Query: 678 SLISLVSSVLRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQE 737
L+ L+ D ALR + NI + + + +L ++ +E
Sbjct: 238 RLVELLMH-----NDYKVVSPALRAVGNIVTGDDIQTQVILNCSALQSLLHLLS--SPKE 290
Query: 738 SMRLTAGSCLVRLVRFNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGSQ 797
S++ A + + N +Q+V+D + S L R ++ + + +
Sbjct: 291 SIKKEACWTISNITAGNRAQIQTVIDANIFPALISILQTAEFRTRKEAAWAI------TN 344
Query: 798 MCTNIGRNLLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNG 845
+ + + + + L L + AL + + + G
Sbjct: 345 ATSGGSAEQIKYLVELGCIKPLCDLLTVMDSKIVQVALNGLENILRLG 392
|
| >2z6h_A Catenin beta-1, beta-catenin; C-terminal domain, activator, alternative splicing, cell adhesion, cytoplasm, cytoskeleton, disease mutation, nucleus; 2.20A {Homo sapiens} Length = 644 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 8e-05
Identities = 42/282 (14%), Positives = 82/282 (29%), Gaps = 38/282 (13%)
Query: 568 ILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLRD 627
IL SG LV ++R L + ++ + S+ + +G + +L L D
Sbjct: 178 ILASGGPQA-LVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPA-IVEAGGMQALGLHLTD 235
Query: 628 KQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQ-VPNSLISLVSSV 686
+++ + + L L S G + + +L+ L+ S
Sbjct: 236 PSQRLVQNCLWTLRNL--------------------SDAATKQEGMEGLLGTLVQLLGS- 274
Query: 687 LRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESMRLTAGSC 746
+D A + N+ I L G +E + A
Sbjct: 275 ----DDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICA 330
Query: 747 LVRLV---RFNAPSMQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGSQMCTNIG 803
L L + + +V + + L S + L +
Sbjct: 331 LRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGL------IRNLALCP 384
Query: 804 RNLLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNG 845
N PL E +P LV L + + + + + +
Sbjct: 385 ANHAPLREQ-GAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVE 425
|
| >1jdh_A Beta-catenin; beta-catenin, protein-protein complex, transcription; 1.90A {Homo sapiens} SCOP: a.118.1.1 PDB: 1qz7_A 1g3j_A 1th1_A* 1i7w_A* 1i7x_A 1jpp_A 1m1e_A 1v18_A* 3oux_A 3ouw_A 1jpw_A 3tx7_A* 2gl7_A 1t08_A 1luj_A 2bct_A 3bct_A* 3ifq_A* 3sla_A 3sl9_A Length = 529 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 8e-05
Identities = 39/289 (13%), Positives = 85/289 (29%), Gaps = 35/289 (12%)
Query: 560 SSNADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILG 619
N ++ I+ + LV ++R L + ++ + S+ + +G +
Sbjct: 172 YGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPA-IVEAGGMQ 230
Query: 620 SLTDGLRDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSL 679
+L L D +++ + + L L S + + + +L
Sbjct: 231 ALGLHLTDPSQRLVQNCLWTLRNL------------------SDAATKQEGMEGLLG-TL 271
Query: 680 ISLVSSVLRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESM 739
+ L+ S +D A + N+ I L G +E +
Sbjct: 272 VQLLGS-----DDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDI 326
Query: 740 RLTAGSCLVRLVRFNAPS---MQSVMDKLSIKDIASSLIKGSPREQQISLNLLNLAMLGS 796
A L L + + +V + + L S + L
Sbjct: 327 TEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGL------I 380
Query: 797 QMCTNIGRNLLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNG 845
+ N PL E + +P LV L + + + + + +
Sbjct: 381 RNLALCPANHAPLRE-QGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVE 428
|
| >1xqr_A HSPBP1 protein; armadillo repeat, superhelical twist, chaperone; 2.10A {Homo sapiens} SCOP: a.118.1.21 PDB: 1xqs_A* Length = 296 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 24/194 (12%), Positives = 58/194 (29%), Gaps = 28/194 (14%)
Query: 518 ASDFVKMSKEQLDALNARILAVLNGNSSIGEKQNVIRYLEMLSS-NADAANILTSGPIML 576
A+DF ++S ++ ++ + G + + + S A + +
Sbjct: 74 AADFCQLS-----GMHL-LVGRYLEAGAAGLRWRAAQLIGTCSQNVAAIQEQVLGLGALR 127
Query: 577 VLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLRDKQEKVRRFS 636
L+++L +RV+ I +R L ++ + +K++ S
Sbjct: 128 KLLRLLDRDACDTVRVKALFAISCLVREQEAGLLQFLRLDGFSVLMRAMQQQVQKLKVKS 187
Query: 637 MAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQ 696
L LL + L++LV + E
Sbjct: 188 AFLLQNLLVGHPEHKGTLCSMG----------------MVQQLVALVRT-----EHSPFH 226
Query: 697 LYALRTIENICSQG 710
+ L + ++ +
Sbjct: 227 EHVLGALCSLVTDF 240
|
| >2z6g_A B-catenin; FULL-length, beta-catenin, cell adhesion; 3.40A {Danio rerio} Length = 780 | Back alignment and structure |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 62/495 (12%), Positives = 128/495 (25%), Gaps = 76/495 (15%)
Query: 414 GNHSGTPSAEGMPVSDESRKQDRESSPERVEVAATPPT-----VSPQLKTTR-------- 460
G + PS G ++ ++ + + Q TR
Sbjct: 38 GATTTAPSLSGKGNPEDDDVDNQVLYEWEQGFNQSFNQEQVADIDGQYAMTRAQRVRAAM 97
Query: 461 ----IREGSGPPLDSESSRSSNSLSQVLWHPS----DLSVRPVMPSRKADKVSEVFPSL- 511
+ EG P ++ + + Q L PS V + A+ + P L
Sbjct: 98 FPETLDEGMQIPS-TQFDSAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPELT 156
Query: 512 ----------PFEALKA-SDFVKMSKEQLDALN-----ARILAVLNGNSSIGEKQNVIRY 555
+A K + + + I+ + + + +
Sbjct: 157 KLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTSGT 216
Query: 556 LEMLSSNADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANS 615
L LS + + + + LV ML S ++ + + + H + +
Sbjct: 217 LHNLSHHREGLLAIFKSGGIPALVNMLG-SPVDSVLFHAITTLHNLLLHQEGAKMAVRLA 275
Query: 616 GILGSLTDGLRDKQEKVRRFSMAALGELLFYISTQNEHARDSN--PP-----ESPSKDNR 668
G L + L K + L L + S + + +
Sbjct: 276 GGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKL 335
Query: 669 TASGWQVPNSL---------------ISLVSSVLRKGEDDMTQLYALRTIENICSQGGHW 713
+ +V L + + L + L T+ N+
Sbjct: 336 LWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRL-VQNCLWTLRNLSDAA--- 391
Query: 714 VARFTSQDVISNLCYIYRATGKQESMRLTAGSCLVRLVRFNAPSMQSVMDKLSIKDIASS 773
+ + ++ L + ++ A L L N + V I+ + +
Sbjct: 392 TKQEGMEGLLGTLVQL--LGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRT 449
Query: 774 LIKGSPREQ---QISLNLLNLAMLGSQMCTNIGRNLLPLVEDKNLVPSLVSLTEQGSEVL 830
+++ RE L +L V +P +V L S
Sbjct: 450 VLRAGDREDITEPAICALRHLTSRHQDAEMAQN-----AVRLHYGLPVVVKLLHPPSHWP 504
Query: 831 RGKALVFVSLLCKNG 845
KA V +
Sbjct: 505 LIKATVGLIRNLALC 519
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 27/131 (20%), Positives = 53/131 (40%), Gaps = 14/131 (10%)
Query: 15 YSTVYKGRKKKTIEYFAIKSVD-KSQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73
+ + K R KK + + +D +KS+ +E R L + + Y + + +
Sbjct: 360 FDVIIKERVKKG---YRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416
Query: 74 VLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG 133
++ Y G ++ + D+A + + LH +I+ DL SN + D
Sbjct: 417 MMSYINGKLAKDVI--------EDNLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD--K 466
Query: 134 RTKLCDFGLAR 144
+ DFGL +
Sbjct: 467 DLYIIDFGLGK 477
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 27/161 (16%), Positives = 56/161 (34%), Gaps = 34/161 (21%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS---------------------K 42
I + +G GK S V+ +K E +K S
Sbjct: 92 DAIGKLMGEGKESAVFNCYSEKFGEC-VVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 43 VLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLA 102
E R L L V + Y+W + +++E +L ++ ++ ++
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAWEGNA----VLMELIDAKEL-------YRVRVENPDEVL 199
Query: 103 QDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLA 143
++ + + +GI++ DL N+L+ + DF +
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQS 239
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1335 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-75 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-74 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-74 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-74 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-73 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-73 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-72 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-71 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-70 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-70 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-69 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-69 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-68 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-67 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-67 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-64 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-64 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-64 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-63 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-62 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-62 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-61 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-60 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-60 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-59 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-59 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-57 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-57 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-56 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-56 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-56 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-55 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-55 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-54 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-54 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-52 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-51 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-20 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (636), Expect = 2e-75
Identities = 79/262 (30%), Positives = 129/262 (49%), Gaps = 15/262 (5%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLD 54
+ + I +G+GK+ VY R+K++ A+K + K+Q K + +EV + L
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HPN+LR Y ++ + ++L+LEY G + L++ ++ E +L AL Y HS
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
K +I+ D+KP N+LL G K+ DFG + + + CGT Y+ PE+
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-------TTLCGTLDYLPPEMI- 176
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
EG +H DLW LG + YE G+PPF + + K I P + +LI
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLI 235
Query: 235 NSLLVKDPAQRLHWSDLCGHAF 256
+ LL +P+QR ++ H +
Sbjct: 236 SRLLKHNPSQRPMLREVLEHPW 257
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 248 bits (635), Expect = 1e-74
Identities = 87/284 (30%), Positives = 124/284 (43%), Gaps = 20/284 (7%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHPN 57
+ IG G + VY R + E AIK + S K +++EVR L L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+++ Y WLV+EYC+G L L E I + ++ L YLHS +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE--E 175
I+ D+K NILL E G KL DFG A ++ A+ GTP +MAPE+ +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS---------FVGTPYWMAPEVILAMD 187
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL-PGNPSRPFANLI 234
G + D+W LG E +PP + I + SP L G+ S F N +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 235 NSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPP--QPAFDSLK 276
+S L K P R L H F + P + Q D+++
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVR 291
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (632), Expect = 1e-74
Identities = 77/263 (29%), Positives = 125/263 (47%), Gaps = 15/263 (5%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKV---LQEVRMLHSLDHPNVLR 60
+ I +G G + VYK + K+T A K +D + ++ + E+ +L S DHPN+++
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 61 FYSWYETSAHLWLVLEYCVGGDLMSLL-RQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ +LW+++E+C GG + +++ + L E I+ + + + AL YLH II+
Sbjct: 74 LLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIH 133
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF----EE 175
DLK NIL +G KL DFG++ K + + S GTP +MAPE+ +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-----IGTPYWMAPEVVMCETSK 188
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPL--PGNPSRPFANL 233
+ Y +D+W LG L E PP +++ I P L P S F +
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDF 248
Query: 234 INSLLVKDPAQRLHWSDLCGHAF 256
+ L K+ R S L H F
Sbjct: 249 LKKCLEKNVDARWTTSQLLQHPF 271
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 249 bits (637), Expect = 2e-74
Identities = 71/337 (21%), Positives = 131/337 (38%), Gaps = 26/337 (7%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK---SQKSKVLQEVRMLHSLDHPN 57
++ Y I+E +G G + V++ ++ T FA K V S K V +E++ + L HP
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 84
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLL-RQDNQLPEDSIRDLAQDLVRALQYLHSKG 116
++ + +E + ++ E+ GG+L + + N++ ED + + + + L ++H
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 117 IIYCDLKPSNILL--DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
++ DLKP NI+ + KL DFGL L + GT + APE+
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT------TGTAEFAAPEVA- 197
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS---DPSPPLPGNPSRPFA 231
EG Y +D+W +G + Y +G PF G + ++++ S + S
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 232 NLINSLLVKDPAQRLHWSDLCGHAF-----WRTKLTPMPLPPQPAFDSLKGAVRQDENSM 286
+ I LL+ DP R+ H + + + +P
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEP 317
Query: 287 LGSTPVRVTPSGRKTQTKTSGRVFEEKQKDPSGTTRQ 323
L S + E +D +
Sbjct: 318 LPPLGRISNYSSLRKHRPQ-----EYSIRDAFWDRSE 349
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (622), Expect = 4e-73
Identities = 78/280 (27%), Positives = 136/280 (48%), Gaps = 17/280 (6%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK---VLQEVRMLHSLDHPNV 58
+Y +E IG+G TVY T + AI+ ++ Q+ K ++ E+ ++ +PN+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ + Y LW+V+EY GG L ++ + + E I + ++ ++AL++LHS +I
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
+ D+K NILL +G KL DFG +++ S+M GTP +MAPE+
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-----VGTPYWMAPEVV-TRKA 192
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP--SRPFANLINS 236
+ D+W LG + E G PP++ + + I ++ +P L S F + +N
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 237 LLVKDPAQRLHWSDLCGHAFWR-----TKLTPMPLPPQPA 271
L D +R +L H F + + LTP+ + A
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEA 292
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (618), Expect = 5e-73
Identities = 75/266 (28%), Positives = 119/266 (44%), Gaps = 9/266 (3%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK----VLQEVRMLHSLDHPN 57
+ + + +G G Y V + T E A+K VD + + +E+ + L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
V++FY +L LEYC GG+L + D +PE + L+ + YLH GI
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
+ D+KP N+LLDE K+ DFGLA ++ L CGT Y+APEL +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNR---ERLLNKMCGTLPYVAPELLKRRE 181
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNP--SRPFANLIN 235
H+ D+W G VL AG P+ + S + L L++
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 236 SLLVKDPAQRLHWSDLCGHAFWRTKL 261
+LV++P+ R+ D+ ++ L
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPL 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (610), Expect = 6e-72
Identities = 80/269 (29%), Positives = 124/269 (46%), Gaps = 22/269 (8%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNV 58
Y + IG G Y K R+K + K +D +K ++ EV +L L HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 59 LRFYSWY--ETSAHLWLVLEYCVGGDLMSLLRQDNQ----LPEDSIRDLAQDLVRALQYL 112
+R+Y T+ L++V+EYC GGDL S++ + + L E+ + + L AL+
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 113 HSKG-----IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCY 167
H + +++ DLKP+N+ LD KL DFGLAR L+ + + GTP Y
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-----VGTPYY 180
Query: 168 MAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPS 227
M+PE ++ SD+W LGC+LYE A PPF +L I +P S
Sbjct: 181 MSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 239
Query: 228 RPFANLINSLLVKDPAQRLHWSDLCGHAF 256
+I +L R ++ +
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 237 bits (606), Expect = 2e-71
Identities = 80/277 (28%), Positives = 128/277 (46%), Gaps = 27/277 (9%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------------VLQEVRML 50
Y E +GRG S V + K T + +A+K +D + L+EV +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 51 HSL-DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRAL 109
+ HPN+++ YET+ +LV + G+L L + L E R + + L+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
LH I++ DLKP NILLD++ KL DFG + +L K + CGTP Y+A
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL------REVCGTPSYLA 177
Query: 170 PELFEEG-----GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS---DPSPP 221
PE+ E + D+W G ++Y AG PPF R+ +++ I+S P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWR 258
+ S +L++ LV P +R + H F++
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 7e-71
Identities = 78/305 (25%), Positives = 138/305 (45%), Gaps = 56/305 (18%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK----VLQEVRMLHSLDHPN 57
+ + +G G V+K K + A K + K +++E+++LH + P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK-G 116
++ FY + + + + +E+ GG L +L++ ++PE + ++ +++ L YL K
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
I++ D+KPSNIL++ G KLCDFG++ +L D+ + + GT YM+PE +G
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------MANSFVGTRSYMSPERL-QG 177
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVGRE------------------------------ 206
+S SD+W +G L E GR P +
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237
Query: 207 ------------FTQLVKSILSDPSPPLP-GNPSRPFANLINSLLVKDPAQRLHWSDLCG 253
+L+ I+++P P LP G S F + +N L+K+PA+R L
Sbjct: 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
Query: 254 HAFWR 258
HAF +
Sbjct: 298 HAFIK 302
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 238 bits (607), Expect = 2e-70
Identities = 69/327 (21%), Positives = 141/327 (43%), Gaps = 21/327 (6%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNV 58
+ Y I E +G G + V++ +K T F K ++ K V E+ +++ L HP +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 59 LRFYSWYETSAHLWLVLEYCVGGDLMSLL-RQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+ + +E + L+LE+ GG+L + +D ++ E + + + L+++H I
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 118 IYCDLKPSNILLD--ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
++ D+KP NI+ + + K+ DFGLA KL+ + T + APE+ +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT------TATAEFAAPEIV-D 201
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS---DPSPPLPGNPSRPFAN 232
+ +D+W +G + Y +G PF G + + ++++ + + S +
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261
Query: 233 LINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLP-PQPAFDSLKGAVRQDENSMLGSTP 291
I +LL K+P +RL D H + + + + P ++ + RQ P
Sbjct: 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKI----RQKIKEKYADWP 317
Query: 292 VRVTPSGRKTQTKTSGRVFEEKQKDPS 318
GR + + ++ +
Sbjct: 318 APQPAIGRIANFSSLRKHRPQEYQIYD 344
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 9e-70
Identities = 88/284 (30%), Positives = 134/284 (47%), Gaps = 21/284 (7%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLDHPN 57
+ + +G G +STV R+ T +AIK ++K K V +E ++ LDHP
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
++ Y ++ L+ L Y G+L+ +R+ E R ++V AL+YLH KGI
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
I+ DLKP NILL+E+ ++ DFG A+ LS SK + GT Y++PEL
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESK---QARANSFVGTAQYVSPELL-TEK 185
Query: 178 VHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237
+SDLW LGC++Y+ AG PPF + + I+ P +L+ L
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVEKL 244
Query: 238 LVKDPAQRLHWSDLCG------HAFWRT----KLTPMPLPPQPA 271
LV D +RL ++ G H F+ + L P A
Sbjct: 245 LVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTA 288
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 232 bits (593), Expect = 4e-69
Identities = 78/285 (27%), Positives = 130/285 (45%), Gaps = 17/285 (5%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPN 57
+ Y + +G G +S V K+T + AIK + K ++ + E+ +LH + HPN
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68
Query: 58 VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
++ YE+ HL+L+++ GG+L + + E L ++ A++YLH GI
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128
Query: 118 IYCDLKPSNILL---DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
++ DLKP N+L DE+ + + DFGL++ S + CGTP Y+APE+
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST------ACGTPGYVAPEVLA 182
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS---DPSPPLPGNPSRPFA 231
+ +S A D W +G + Y G PPF +L + IL + P + S
Sbjct: 183 QKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241
Query: 232 NLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLK 276
+ I L+ KDP +R H + Q + +K
Sbjct: 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIK 286
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 4e-69
Identities = 73/320 (22%), Positives = 144/320 (45%), Gaps = 24/320 (7%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--VLQEVRMLHSLDHPNVLRF 61
Y I E +GRG++ V++ + + + + K V + V +E+ +L+ H N+L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 62 YSWYETSAHLWLVLEYCVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYC 120
+ +E+ L ++ E+ G D+ + +L E I + ALQ+LHS I +
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126
Query: 121 DLKPSNILLD--ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
D++P NI+ + K+ +FG AR+L P Y APE+ + V
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL------FTAPEYYAPEVH-QHDV 179
Query: 179 HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS---DPSPPLPGNPSRPFANLIN 235
S A+D+W LG ++Y +G PF+ Q++++I++ S + ++
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239
Query: 236 SLLVKDPAQRLHWSDLCGHAFWRTKLTPMP------LPPQPAFDSLKGAVRQDENSMLGS 289
LLVK+ R+ S+ H + + K+ + L + + +L ++D N ++ +
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLI---KKDLNMVVSA 296
Query: 290 TPVRVTPSGRKTQTKTSGRV 309
+ + R + + +V
Sbjct: 297 ARISCGGAIRSQKGVSVAKV 316
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 1e-68
Identities = 71/269 (26%), Positives = 120/269 (44%), Gaps = 23/269 (8%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDHPNV 58
IGRG + TVYKG +T A + + +K +E ML L HPN+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 59 LRFYSWYETSA----HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
+RFY +E++ + LV E G L + L++ + +R + +++ LQ+LH+
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 115 KG--IIYCDLKPSNILL-DENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
+ II+ DLK NI + G K+ D GLA + +A GTP +MAPE
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-------FAKAVIGTPEFMAPE 183
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVG-REFTQLVKSILSDPSPP-LPGNPSRP 229
++EE + + D++ G + E P+ + Q+ + + S P
Sbjct: 184 MYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241
Query: 230 FANLINSLLVKDPAQRLHWSDLCGHAFWR 258
+I + ++ +R DL HAF++
Sbjct: 242 VKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 1e-67
Identities = 71/266 (26%), Positives = 119/266 (44%), Gaps = 20/266 (7%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDHP 56
Q + + IG G + TVYKG+ A+K ++ + + EV +L H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 57 NVLRFYSWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSK 115
N+L F Y T+ L +V ++C G L L + + + D+A+ + + YLH+K
Sbjct: 65 NILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF-- 173
II+ DLK +NI L E+ K+ DFGLA S S + + G+ +MAPE+
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF---EQLSGSILWMAPEVIRM 180
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-----FTQLVKSILSDPSPPLPGNPSR 228
++ +S+ SD++ G VLYE G+ P+ + + LS + N +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240
Query: 229 PFANLINSLLVKDPAQRLHWSDLCGH 254
L+ L K +R + +
Sbjct: 241 AMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 1e-67
Identities = 83/266 (31%), Positives = 143/266 (53%), Gaps = 15/266 (5%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRML-HSL 53
+ + +++ +G+G + V+ KKT ++FAIK++ K + E R+L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 54 DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLH 113
+HP + + ++T +L+ V+EY GGDLM ++ ++ A +++ LQ+LH
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
SKGI+Y DLK NILLD++G K+ DFG+ ++ ++ CGTP Y+APE+
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-----CGTPDYIAPEIL 175
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233
G ++++ D W G +LYE G+ PF G++ +L SI D P P + +L
Sbjct: 176 -LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDL 233
Query: 234 INSLLVKDPAQRLH-WSDLCGHAFWR 258
+ L V++P +RL D+ H +R
Sbjct: 234 LVKLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 223 bits (569), Expect = 3e-65
Identities = 81/294 (27%), Positives = 138/294 (46%), Gaps = 31/294 (10%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS---------KVLQEVRMLH 51
MN + ++ IGRG + VY RK T + +A+K +DK + + ++
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 52 SLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
+ D P ++ + T L +L+ GGDL L Q E +R A +++ L++
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
+H++ ++Y DLKP+NILLDE+G ++ D GLA S P A GT YMAPE
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPE 175
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGR--EFTQLVKSILSDPSPPLPGNPSRP 229
+ ++G + ++D + LGC+L++ G PF + + + + LP + S
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235
Query: 230 FANLINSLLVKDPAQRLHW-----SDLCGHAFWRT--------KLTPMPLPPQP 270
+L+ LL +D +RL ++ F+R+ + P PL P
Sbjct: 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPR 289
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 1e-64
Identities = 59/259 (22%), Positives = 104/259 (40%), Gaps = 16/259 (6%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-VLQEVRMLHSLDHPNVL 59
M + + + IG+G++ V G + A+K + ++ L E ++ L H N++
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQLRHSNLV 63
Query: 60 RFY-SWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHSKG 116
+ E L++V EY G L+ LR + L D + + D+ A++YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123
Query: 117 IIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
++ DL N+L+ E+ K+ DFGL ++ S + APE
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--------TGKLPVKWTAPEAL-RE 174
Query: 177 GVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235
S SD+W G +L+E Y+ GR P+ +V + P ++
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 236 SLLVKDPAQRLHWSDLCGH 254
+ D A R + L
Sbjct: 235 NCWHLDAAMRPSFLQLREQ 253
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 2e-64
Identities = 81/291 (27%), Positives = 136/291 (46%), Gaps = 26/291 (8%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---------KSKVLQEVRMLHS 52
+ Y E +G G+++ V K R+K T +A K + K + + + +EV +L
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 53 LDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYL 112
+ HPNV+ + YE + L+LE GG+L L + L E+ + + ++ + YL
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 113 HSKGIIYCDLKPSNILLDENG----RTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
HS I + DLKP NI+L + R K+ DFGLA K+ ++ + GTP ++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF------KNIFGTPEFV 183
Query: 169 APELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS---DPSPPLPGN 225
APE+ +D+W +G + Y +G PF+G + + ++ + + N
Sbjct: 184 APEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242
Query: 226 PSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQ---PAFD 273
S + I LLVKDP +R+ D H + + K T L P F+
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQFE 293
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (559), Expect = 3e-64
Identities = 89/284 (31%), Positives = 141/284 (49%), Gaps = 23/284 (8%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLD 54
MN + + +G+G + V R+K T Y+A+K + K + + + E R+L +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HP + ++T L V+EY GG+L L ++ E+ R ++V AL+YLHS
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
+ ++Y D+K N++LD++G K+ DFGL ++ + CGTP Y+APE+
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-----DGATMKTFCGTPEYLAPEVL- 177
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
E + A D WGLG V+YE GR PF ++ +L + IL + P S +L+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLL 236
Query: 235 NSLLVKDPAQRLHW-----SDLCGHAF-----WRTKLTPMPLPP 268
LL KDP QRL ++ H F W+ + LPP
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 280
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 9e-64
Identities = 59/250 (23%), Positives = 110/250 (44%), Gaps = 12/250 (4%)
Query: 10 IGRGKYSTVYKG--RKKKTIEYFAIK-----SVDKSQKSKVLQEVRMLHSLDHPNVLRFY 62
+G G + TV KG + KK ++ A+K + D + K ++L E ++ LD+P ++R
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDL 122
E LV+E G L L+Q+ + + +I +L + ++YL ++ DL
Sbjct: 75 GICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 133
Query: 123 KPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYA 182
N+LL K+ DFGL++ L + + APE S
Sbjct: 134 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--THGKWPVKWYAPECI-NYYKFSSK 190
Query: 183 SDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLVKD 241
SD+W G +++E ++ G+ P+ G + +++ + P R +L+N D
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD 250
Query: 242 PAQRLHWSDL 251
R ++ +
Sbjct: 251 VENRPGFAAV 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 216 bits (552), Expect = 2e-63
Identities = 81/269 (30%), Positives = 136/269 (50%), Gaps = 21/269 (7%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLD 54
+ + I +G G + V+ R + Y+A+K + K Q E ML +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
HP ++R + ++ + ++++++Y GG+L SLLR+ + P + A ++ AL+YLHS
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
K IIY DLKP NILLD+NG K+ DFG A+ + D + CGTP Y+APE+
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--------VTYTLCGTPDYIAPEVV- 173
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
++ + D W G ++YE AG PF + + IL+ P + +L+
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLL 232
Query: 235 NSLLVKDPAQRLH-----WSDLCGHAFWR 258
+ L+ +D +QRL D+ H +++
Sbjct: 233 SRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 4e-63
Identities = 77/294 (26%), Positives = 129/294 (43%), Gaps = 28/294 (9%)
Query: 1 MNQYHIY-EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVR-MLHSLDHPNV 58
++ Y + + +G G V + K+T E FA+K + K++ +EV + P++
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--REVELHWRASQCPHI 67
Query: 59 LRFYSWYETSA----HLWLVLEYCVGGDLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYL 112
+R YE L +V+E GG+L S ++ D E ++ + + A+QYL
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 113 HSKGIIYCDLKPSNILLD---ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
HS I + D+KP N+L N KL DFG A++ + + + C TP Y+A
Sbjct: 128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP------CYTPYYVA 181
Query: 170 PELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-------DPSPPL 222
PE+ + + D+W LG ++Y G PPF + + + + P
Sbjct: 182 PEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 223 PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPAFDSLK 276
S LI +LL +P QR+ ++ H W + T +P P LK
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP-WIMQSTKVPQTPLHTSRVLK 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 5e-63
Identities = 54/257 (21%), Positives = 114/257 (44%), Gaps = 10/257 (3%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--VLQEVRMLHSLDHPNVL 59
+ +G G++ V G+ + + AIK + + S+ ++E +++ +L H ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSKGII 118
+ Y ++++ EY G L++ LR ++ + ++ +D+ A++YL SK +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
+ DL N L+++ G K+ DFGL+R + D S + PE+
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS----KFPVRWSPPEVL-MYSK 177
Query: 179 HSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237
S SD+W G +++E Y+ G+ P+ ++ + I P S ++ S
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237
Query: 238 LVKDPAQRLHWSDLCGH 254
+ +R + L +
Sbjct: 238 WHEKADERPTFKILLSN 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 2e-62
Identities = 72/279 (25%), Positives = 112/279 (40%), Gaps = 27/279 (9%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK---------VLQEVRMLHS 52
+QY + +G G + +VY G + AIK V+K + S V EV +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 53 LD--HPNVLRFYSWYETSAHLWLVLEYCVGG-DLMSLLRQDNQLPEDSIRDLAQDLVRAL 109
+ V+R W+E L+LE DL + + L E+ R ++ A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 110 QYLHSKGIIYCDLKPSNILLDEN-GRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYM 168
++ H+ G+++ D+K NIL+D N G KL DFG L D GT Y
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-------TDFDGTRVYS 176
Query: 169 APELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSR 228
PE H ++ +W LG +LY+ G PF E I+ S
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQ-VFFRQRVSS 229
Query: 229 PFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLP 267
+LI L P+ R + ++ H + + L P
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETA 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 3e-62
Identities = 75/298 (25%), Positives = 124/298 (41%), Gaps = 40/298 (13%)
Query: 8 EAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--------VLQEVRMLHSLDHPNVL 59
+ +G G+++TVYK R K T + AIK + +S+ L+E+++L L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
+ +++ LV ++ + + L I+ ++ L+YLH I++
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123
Query: 120 CDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVH 179
DLKP+N+LLDENG KL DFGLA+ ++A + T Y APEL ++
Sbjct: 124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ-----VVTRWYRAPELLFGARMY 178
Query: 180 SYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP------------------ 221
D+W +GC+L E P G + I P
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 222 -LPGNP--------SRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQP 270
PG P +LI L + +P R+ + ++ + P P P
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP 296
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 7e-62
Identities = 58/255 (22%), Positives = 110/255 (43%), Gaps = 12/255 (4%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--VLQEVRMLHSLDHPNVL 59
+ E +G G++ V+ G + A+KS+ + S L E ++ L H ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGI 117
R Y+ T ++++ EY G L+ L+ + +L + + D+A + + ++ +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
I+ DL+ +NIL+ + K+ DFGLAR + D + + APE G
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDN----EYTAREGAKFPIKWTAPE-AINYG 185
Query: 178 VHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
+ SD+W G +L E GR P+ G ++++++ P N L+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 237 LLVKDPAQRLHWSDL 251
+ P R + L
Sbjct: 246 CWKERPEDRPTFDYL 260
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 210 bits (535), Expect = 1e-61
Identities = 71/257 (27%), Positives = 119/257 (46%), Gaps = 16/257 (6%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSV------DKSQKSKVLQEVRMLHSLDH 55
++Y + E +G G S V+ R + A+K + D S + +E + +L+H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 56 PNVLRFYSWYETSAH----LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
P ++ Y E ++V+EY G L ++ + + ++ D +AL +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
H GII+ D+KP+NI++ K+ DFG+AR ++D+ + + A GT Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT--AAVIGTAQYLSPE 184
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS-DPSPPLPGNP--SR 228
G SD++ LGCVLYE G PPF G + + DP PP + S
Sbjct: 185 QA-RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243
Query: 229 PFANLINSLLVKDPAQR 245
++ L K+P R
Sbjct: 244 DLDAVVLKALAKNPENR 260
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 4e-61
Identities = 57/259 (22%), Positives = 110/259 (42%), Gaps = 13/259 (5%)
Query: 2 NQYHIYEA-IGRGKYSTVYKG--RKKKTIEYFAIK----SVDKSQKSKVLQEVRMLHSLD 54
+ I + +G G + +V +G R +K AIK +K+ ++++E +++H LD
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLH 113
+P ++R + L LV+E GG L L + +P ++ +L + ++YL
Sbjct: 68 NPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 126
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
K ++ DL N+LL K+ DFGL++ L ++ A + APE
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECI 184
Query: 174 EEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232
S SD+W G ++E + G+ P+ + +++ I P
Sbjct: 185 -NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243
Query: 233 LINSLLVKDPAQRLHWSDL 251
L++ + R + +
Sbjct: 244 LMSDCWIYKWEDRPDFLTV 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 209 bits (533), Expect = 4e-61
Identities = 64/261 (24%), Positives = 110/261 (42%), Gaps = 10/261 (3%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIE---YFAIKSVDKS----QKSKVLQEVRMLHSL 53
++ I + IG G++ V G K + + AIK++ Q+ L E ++
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84
Query: 54 DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYL 112
DHPNV+ S + ++ E+ G L S LRQ+ Q + + + + ++YL
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
++ DL NIL++ N K+ DFGL+R L D + P+ + APE
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204
Query: 173 FEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFA 231
+ ASD+W G V++E + G P+ ++ +I D P P +
Sbjct: 205 IQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH 263
Query: 232 NLINSLLVKDPAQRLHWSDLC 252
L+ KD R + +
Sbjct: 264 QLMLDCWQKDRNHRPKFGQIV 284
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 8e-61
Identities = 60/257 (23%), Positives = 113/257 (43%), Gaps = 10/257 (3%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--VLQEVRMLHSLDHPNVL 59
++ + IG G++ V+ G + AIK++ + S+ ++E ++ L HP ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQL-PEDSIRDLAQDLVRALQYLHSKGII 118
+ Y A + LV E+ G L LR L +++ + D+ + YL +I
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 123
Query: 119 YCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGV 178
+ DL N L+ EN K+ DFG+ R + D + +PE+F
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKFPVKWASPEVF-SFSR 178
Query: 179 HSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237
+S SD+W G +++E ++ G+ P+ R +++V+ I + P S ++N
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238
Query: 238 LVKDPAQRLHWSDLCGH 254
+ P R +S L
Sbjct: 239 WKERPEDRPAFSRLLRQ 255
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 2e-60
Identities = 78/314 (24%), Positives = 124/314 (39%), Gaps = 49/314 (15%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDH 55
+++Y IG+G + V+K R +KT + A+K V + + L+E+++L L H
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68
Query: 56 PNVLRFYSWYETSA--------HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVR 107
NV+ T A ++LV ++C L + I+ + Q L+
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 108 ALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCY 167
L Y+H I++ D+K +N+L+ +G KL DFGLAR S A + + + T Y
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR-YTNRVVTLWY 187
Query: 168 MAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPG--- 224
PEL + DLWG GC++ E + P G + I P
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 225 ----------------------------NPSRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
+LI+ LLV DPAQR+ D H F
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307
Query: 257 WRTKLTPMPLPPQP 270
+ + P+P
Sbjct: 308 FWSD----PMPSDL 317
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-60
Identities = 71/308 (23%), Positives = 115/308 (37%), Gaps = 41/308 (13%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK----VLQEVRMLHSLDHPN 57
+Y IG G Y V AIK + + L+E+++L H N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 58 VLRFYSWYETSAH----LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLH 113
++ ++ + +G DL LL+ L D I ++R L+Y+H
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIH 126
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
S +++ DLKPSN+LL+ K+CDFGLAR + T Y APE+
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL--TEYVATRWYRAPEIM 184
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP------------ 221
++ + D+W +GC+L E + RP F G+ + + IL P
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 222 ------------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTP 263
L N +L++ +L +P +R+ H + P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304
Query: 264 MPLPPQPA 271
P A
Sbjct: 305 SDEPIAEA 312
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 206 bits (524), Expect = 4e-60
Identities = 69/291 (23%), Positives = 114/291 (39%), Gaps = 39/291 (13%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDH 55
M +YH E IG G Y VYK + E FA+K + ++ + ++E+ +L L H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
N+++ Y T L LV E+ L + L + + L+ + Y H +
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
+++ DLKP N+L++ G K+ DFGLAR + + T Y AP++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE-----IVTLWYRAPDVLMG 174
Query: 176 GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL-------------------- 215
+S D+W +GC+ E G P F G + I
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 216 --------SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWR 258
P +L++ +L DP QR+ HA+++
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-59
Identities = 65/275 (23%), Positives = 111/275 (40%), Gaps = 14/275 (5%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK--VLQEVRMLHSLDHPNVL 59
+ +G+G + V+ G T AIK++ S LQE +++ L H ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLP--EDSIRDLAQDLVRALQYLHSKGI 117
+ Y+ +++V EY G L+ L+ + + D+A + + Y+
Sbjct: 76 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
++ DL+ +NIL+ EN K+ DFGLAR + D + APE G
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA----KFPIKWTAPEAA-LYG 189
Query: 178 VHSYASDLWGLGCVLYEC-YAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
+ SD+W G +L E GR P+ G +++ + P P +L+
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249
Query: 237 LLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQPA 271
K+P +R + L AF T QP
Sbjct: 250 CWRKEPEERPTFEYL--QAFLEDYFTSTEPQYQPG 282
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 9e-59
Identities = 74/299 (24%), Positives = 119/299 (39%), Gaps = 39/299 (13%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDH 55
M + E IG G Y VYK R K T E A+K + +++ ++E+ +L L+H
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLVRALQYLHS 114
PN+++ T L+LV E+ + +P I+ L++ L + HS
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
+++ DLKP N+L++ G KL DFGLAR + + T Y APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE-----VVTLWYRAPEILL 175
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP------------- 221
+S A D+W LGC+ E R F G + I P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 222 ---------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMP 265
+ +L++ +L DP +R+ H F++ P+P
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (517), Expect = 2e-58
Identities = 79/270 (29%), Positives = 142/270 (52%), Gaps = 21/270 (7%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK------VLQEVRMLHSLD 54
++Q+ + +G G + V + K++ ++A+K +DK + K L E R+L +++
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
P +++ ++ +++L++V+EY GG++ S LR+ + E R A +V +YLHS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
+IY DLKP N+L+D+ G ++ DFG A+++ CGTP +APE+
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--------TWTLCGTPEALAPEIIL 211
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234
G ++ A D W LG ++YE AG PPF + Q+ + I+S P + S +L+
Sbjct: 212 SKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLL 269
Query: 235 NSLLVKDPAQRLHW-----SDLCGHAFWRT 259
+LL D +R +D+ H ++ T
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (510), Expect = 3e-58
Identities = 58/255 (22%), Positives = 115/255 (45%), Gaps = 10/255 (3%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVL 59
+ +G G+Y VY+G KK A+K++ + + + L+E ++ + HPN++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ--LPEDSIRDLAQDLVRALQYLHSKGI 117
+ +++ E+ G+L+ LR+ N+ + + +A + A++YL K
Sbjct: 77 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 136
Query: 118 IYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGG 177
I+ DL N L+ EN K+ DFGL+R ++ + + + APE
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK----FPIKWTAPESL-AYN 191
Query: 178 VHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236
S SD+W G +L+E G P+ G + +Q+ + + D P L+ +
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 237 LLVKDPAQRLHWSDL 251
+P+ R ++++
Sbjct: 252 CWQWNPSDRPSFAEI 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 4e-58
Identities = 59/288 (20%), Positives = 114/288 (39%), Gaps = 39/288 (13%)
Query: 2 NQYHIYEAIGRGKYSTVYKGR-----KKKTIEYFAIKSV----DKSQKSKVLQEVRMLHS 52
+ +G G + V K A+K + D S++ ++ E++M+
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 53 L-DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ------------------- 92
L H N++ S ++L+ EYC GDL++ LR +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 93 ----LPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSD 148
L + + A + + +++L K ++ DL N+L+ K+CDFGLAR +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 149 ASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREF 207
S + ++ +MAPE G+++ SD+W G +L+E ++ G P+ G
Sbjct: 217 DS---NYVVRGNARLPVKWMAPESL-FEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 208 TQLVKSIL-SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254
++ + P + ++ S D +R + +L
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-57
Identities = 63/260 (24%), Positives = 107/260 (41%), Gaps = 16/260 (6%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKT---IEYFAIKSVDKSQKSK------VLQEVRMLHSLD 54
+ E +G G + V +G A+K + S+ ++EV +HSLD
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSL-LRQDNQLPEDSIRDLAQDLVRALQYLH 113
H N++R Y T + +V E G L+ + ++ A + + YL
Sbjct: 70 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
SK I+ DL N+LL K+ DFGL R L ++ + + + APE
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD--HYVMQEHRKVPFAWCAPESL 186
Query: 174 EEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD-PSPPLPGNPSRPFA 231
+ S+ASD W G L+E + G+ P++G +Q++ I + P P + +
Sbjct: 187 -KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY 245
Query: 232 NLINSLLVKDPAQRLHWSDL 251
N++ P R + L
Sbjct: 246 NVMVQCWAHKPEDRPTFVAL 265
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-57
Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 39/290 (13%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDH 55
M +Y E IG G Y TV+K + ++T E A+K V + L+E+ +L L H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 56 PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSK 115
N++R + + L LV E+C + L + ++ L++ L + HS+
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 116 GIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEE 175
+++ DLKP N+L++ NG KL +FGLAR + S+ T Y P++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-----VVTLWYRPPDVLFG 175
Query: 176 GGVHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKSILSDPSPP------------- 221
++S + D+W GC+ E AGRP F G + +K I P
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 222 ---------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAF 256
+ + +L+ +LL +P QR+ + H +
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-57
Identities = 70/262 (26%), Positives = 116/262 (44%), Gaps = 15/262 (5%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKT---IEYFAIKSVDK----SQKSKVLQEVRMLHSLD 54
+ + IG G++ V++G AIK+ S + K LQE + D
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLL-RQDNQLPEDSIRDLAQDLVRALQYLH 113
HP++++ T +W+++E C G+L S L + L S+ A L AL YL
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 114 SKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
SK ++ D+ N+L+ N KL DFGL+R + D++ +S +MAPE
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG----KLPIKWMAPESI 181
Query: 174 EEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232
ASD+W G ++E G PF G + ++ I + P+P N +
Sbjct: 182 NFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 233 LINSLLVKDPAQRLHWSDLCGH 254
L+ DP++R +++L
Sbjct: 241 LMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (500), Expect = 9e-57
Identities = 58/284 (20%), Positives = 103/284 (36%), Gaps = 38/284 (13%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKK-----KTIEYFAIKSVDKS----QKSKVLQEVRMLHS 52
N IG G + V++ R + A+K + + ++ +E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 53 LDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ----------------------- 89
D+PN+++ + L+ EY GDL LR
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 90 -DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSD 148
L +A+ + + YL + ++ DL N L+ EN K+ DFGL+R +
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 192
Query: 149 ASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREF 207
A + +M PE ++ SD+W G VL+E ++ G P+ G
Sbjct: 193 ADYYKADG---NDAIPIRWMPPESI-FYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 208 TQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDL 251
+++ + P N NL+ K PA R + +
Sbjct: 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 197 bits (502), Expect = 1e-56
Identities = 65/300 (21%), Positives = 119/300 (39%), Gaps = 50/300 (16%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSL-DHPNVL 59
+ Y + +GRGKYS V++ E +K + +K K+ +E+++L +L PN++
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 93
Query: 60 RFYSWYE--TSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGI 117
+ S LV E+ D L + L + IR ++++AL Y HS GI
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGI 150
Query: 118 IYCDLKPSNILLD-ENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEG 176
++ D+KP N+++D E+ + +L D+GLA + + + + PEL +
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE------YNVRVASRYFKGPELLVDY 204
Query: 177 GVHSYASDLWGLGCVLYECYAGRPPFVG----REFTQLVKSILSDP-------------- 218
++ Y+ D+W LGC+L + PF + + +L
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 219 -------------------SPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRT 259
S + ++ LL D RL + H ++ T
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-56
Identities = 86/297 (28%), Positives = 133/297 (44%), Gaps = 32/297 (10%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRK---KKTIEYFAIKSVDKSQKSK-------VLQEVRML 50
+ + + + +G G Y V+ RK T + +A+K + K+ + E ++L
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 51 HSLDH-PNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRAL 109
+ P ++ + ++T L L+L+Y GG+L + L Q + E ++ ++V AL
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
++LH GIIY D+K NILLD NG L DFGL+++ + CGT YMA
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD----FCGTIEYMA 198
Query: 170 PELFEEGGV-HSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS---DPSPPLPGN 225
P++ G H A D W LG ++YE G PF I PP P
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258
Query: 226 PSRPFANLINSLLVKDPAQRLHW-----SDLCGHAFWR--------TKLTPMPLPPQ 269
S +LI LL+KDP +RL ++ H F++ K P P P
Sbjct: 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV 315
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-56
Identities = 88/335 (26%), Positives = 138/335 (41%), Gaps = 46/335 (13%)
Query: 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYS 63
Y + IG G + VY+ + + E AIK V + ++ K +E++++ LDH N++R
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-NRELQIMRKLDHCNIVRLRY 80
Query: 64 WYETSA------HLWLVLEYCVGGDLMSLL---RQDNQLPEDSIRDLAQDLVRALQYLHS 114
++ +S +L LVL+Y R LP ++ L R+L Y+HS
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 115 KGIIYCDLKPSNILLDENGR-TKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELF 173
GI + D+KP N+LLD + KLCDFG A++L S + Y APEL
Sbjct: 141 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS------YICSRYYRAPELI 194
Query: 174 EEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP------------ 221
++ + D+W GCVL E G+P F G + I+ P
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 222 ----LPGNPSRPFA------------NLINSLLVKDPAQRLHWSDLCGHAFWRTKLTP-M 264
P + P+ L + LL P RL + C H+F+ P +
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 314
Query: 265 PLPPQPAFDSLKGAVRQDENSMLGSTPVRVTPSGR 299
LP +L Q+ +S + + P R
Sbjct: 315 KLPNGRDTPALFNFTTQELSSNPPLATILIPPHAR 349
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 8e-56
Identities = 68/278 (24%), Positives = 106/278 (38%), Gaps = 31/278 (11%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYF--AIKSVDKS----QKSKVLQEVRMLHSL- 53
N + IG G + V K R KK AIK + + E+ +L L
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 54 DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDN----------------QLPEDS 97
HPN++ E +L+L +EY G+L+ LR+ L
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 98 IRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157
+ A D+ R + YL K I+ DL NIL+ EN K+ DFGL+R K
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG-- 186
Query: 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYE-CYAGRPPFVGREFTQLVKSILS 216
+MA E V++ SD+W G +L+E G P+ G +L + +
Sbjct: 187 ----RLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
Query: 217 DPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254
P N +L+ + P +R ++ +
Sbjct: 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-55
Identities = 74/314 (23%), Positives = 127/314 (40%), Gaps = 51/314 (16%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDHP 56
Y + +G G Y V +T AIK + + +S+ +E+R+L + H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 57 NVLRFYSWYETS------AHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQ 110
NV+ + +LV+ + G + L + +L ED I+ L +++ L+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 111 YLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAP 170
Y+H+ GII+ DLKP N+ ++E+ K+ DFGLAR+ T Y AP
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY--------VVTRWYRAP 187
Query: 171 ELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP--------- 221
E+ ++ D+W +GC++ E G+ F G + +K I+ P
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 222 ----------LPGNPSRPFA-----------NLINSLLVKDPAQRLHWSDLCGHAFWRTK 260
LP + FA NL+ +LV D QR+ + H ++ +
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307
Query: 261 LTPMPLPPQPAFDS 274
P +D
Sbjct: 308 HDTEDEPQVQKYDD 321
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-55
Identities = 52/277 (18%), Positives = 103/277 (37%), Gaps = 13/277 (4%)
Query: 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIK--------SVDKSQKSKVLQEVRMLHSLD 54
++ + +G G + TVYKG E I + ++L E ++ S+D
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 55 HPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS 114
+P+V R TS + G L + + + + + + + + YL
Sbjct: 70 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
+ +++ DL N+L+ K+ DFGLA+ L K + +MA E
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---GGKVPIKWMALESI- 185
Query: 175 EGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233
++++ SD+W G ++E G P+ G +++ + P P + +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 245
Query: 234 INSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPLPPQP 270
+ + D R + +L + L Q
Sbjct: 246 MVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-55
Identities = 76/298 (25%), Positives = 119/298 (39%), Gaps = 48/298 (16%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTI-EYFAIKSVDKSQKSKV--------LQEVRMLHS 52
QY IG G Y V+K R K + A+K V + + +R L +
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 53 LDHPNVLRFYSWYETSA-----HLWLVLEYCVGGDLMSLLRQDNQ-LPEDSIRDLAQDLV 106
+HPNV+R + S L LV E+ L + +P ++I+D+ L+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 107 RALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPC 166
R L +LHS +++ DLKP NIL+ +G+ KL DFGLAR S S T
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV------VVTLW 180
Query: 167 YMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSIL----------- 215
Y APE+ ++ DLW +GC+ E + +P F G + IL
Sbjct: 181 YRAPEVL-LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 216 ---------------SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWR 258
+ P + +L+ L +PA+R+ H +++
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (484), Expect = 1e-54
Identities = 60/264 (22%), Positives = 97/264 (36%), Gaps = 15/264 (5%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVD-KSQKSKVLQEVRMLHSLDHPNVLR 60
N+Y + IG G + +Y G E AIK K++ ++ E ++ + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 61 FYSWY-ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
W + +V+E + ++ LA ++ ++Y+HSK I+
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 126
Query: 120 CDLKPSNILLDENGRTKLC---DFGLARKLSDASKAPSSMLPQAK--CGTPCYMAPELFE 174
D+KP N L+ + L DFGLA+K DA + K GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH- 185
Query: 175 EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSI-------LSDPSPPLPGNPS 227
G S DL LG VL G P+ G + + +S P L
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 228 RPFANLINSLLVKDPAQRLHWSDL 251
FA +N + +S L
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYL 269
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-54
Identities = 60/280 (21%), Positives = 116/280 (41%), Gaps = 34/280 (12%)
Query: 2 NQYHIYEAIGRGKYSTVYKGR-----KKKTIEYFAIKSVDKS----QKSKVLQEVRMLHS 52
N+ + +G G + V + K A+K + S ++ ++ E+++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 53 L-DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ------------------DNQL 93
L +H N++ ++ EYC GDL++ LR+ + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 94 PEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153
+ + + + + + +L SK I+ DL NILL TK+CDFGLAR + + S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS--- 199
Query: 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVK 212
+ ++ +MAPE V+++ SD+W G L+E ++ G P+ G
Sbjct: 200 NYVVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 213 SIL-SDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDL 251
++ P + +++ + DP +R + +
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 189 bits (481), Expect = 2e-54
Identities = 50/266 (18%), Positives = 90/266 (33%), Gaps = 17/266 (6%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-VLQEVRMLHSLDH-PNVL 59
Y + IG G + +++G + AIK + + + E R L +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 60 RFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIY 119
Y + + H LV++ L + ++ A+ ++ +Q +H K ++Y
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 120 CDLKPSNILLDE-----NGRTKLCDFGLARKLSDASKAPSSMLPQAK--CGTPCYMAPEL 172
D+KP N L+ + DFG+ + D + K GT YM+
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 173 FEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-------FTQLVKSILSDPSPPLPGN 225
G S DL LG V G P+ G + + ++ + S P L
Sbjct: 185 H-LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 226 PSRPFANLINSLLVKDPAQRLHWSDL 251
F ++ + L
Sbjct: 244 FPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 4e-54
Identities = 59/260 (22%), Positives = 109/260 (41%), Gaps = 13/260 (5%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIE----YFAIKSVDKS----QKSKVLQEVRMLHSL 53
+ + IG G++ VYKG K + AIK++ Q+ L E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 54 DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSL-LRQDNQLPEDSIRDLAQDLVRALQYL 112
H N++R + ++ EY G L +D + + + + + ++YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 113 HSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPEL 172
+ ++ DL NIL++ N K+ DFGL+R L D +A + + APE
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT--SGGKIPIRWTAPEA 184
Query: 173 FEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFA 231
+ ASD+W G V++E G P+ +++K+I P P +
Sbjct: 185 I-SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243
Query: 232 NLINSLLVKDPAQRLHWSDL 251
L+ ++ A+R ++D+
Sbjct: 244 QLMMQCWQQERARRPKFADI 263
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 5e-54
Identities = 58/279 (20%), Positives = 109/279 (39%), Gaps = 33/279 (11%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKT-------IEYFAIKSVDKSQKSK----VLQEVRML 50
++ + + +G G + V + A+K + K ++ E+ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 51 HSL-DHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQ----------------DNQL 93
+ H N++ L++++EY G+L L+ + QL
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 94 PEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153
+ A + R ++YL SK I+ DL N+L+ E+ K+ DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVK 212
+ +MAPE ++++ SD+W G +L+E + G P+ G +L K
Sbjct: 193 KTT---NGRLPVKWMAPEAL-FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 213 SILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDL 251
+ P N + ++ P+QR + L
Sbjct: 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 5e-54
Identities = 64/261 (24%), Positives = 104/261 (39%), Gaps = 12/261 (4%)
Query: 4 YHIYEAIGRGKYSTVYKGR---KKKTIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHP 56
H E IGRG + VY G + A+KS+++ + S+ L E ++ HP
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88
Query: 57 NVLRFY-SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLP-EDSIRDLAQDLVRALQYLHS 114
NVL + +VL Y GDL + +R + P + + + +++L S
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 115 KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFE 174
K ++ DL N +LDE K+ DFGLAR + D + S +MA E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD-KEFDSVHNKTGAKLPVKWMALESL- 206
Query: 175 EGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233
+ + SD+W G +L+E G PP+ + +L P P +
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266
Query: 234 INSLLVKDPAQRLHWSDLCGH 254
+ R +S+L
Sbjct: 267 MLKCWHPKAEMRPSFSELVSR 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-52
Identities = 53/270 (19%), Positives = 106/270 (39%), Gaps = 24/270 (8%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTI-----EYFAIKSVDKSQKSK----VLQEVRMLHS 52
+ + +G+G + VY+G K + AIK+V+++ + L E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 53 LDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ----------LPEDSIRDLA 102
+ +V+R +++E GDL S LR + +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 103 QDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKC 162
++ + YL++ ++ DL N ++ E+ K+ DFG+ R + +
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG---KGL 196
Query: 163 GTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAG-RPPFVGREFTQLVKSILSDPSPP 221
+M+PE + GV + SD+W G VL+E P+ G Q+++ ++
Sbjct: 197 LPVRWMSPESL-KDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255
Query: 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDL 251
P N L+ +P R + ++
Sbjct: 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 8e-52
Identities = 77/312 (24%), Positives = 131/312 (41%), Gaps = 49/312 (15%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS-----KVLQEVRMLHSLDHP 56
+Y +G G Y +V KT A+K + + +S + +E+R+L + H
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 57 NVLRFYSWYETSAHLW-----LVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQY 111
NV+ + + L ++ + +G DL ++++ +L +D ++ L ++R L+Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136
Query: 112 LHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPE 171
+HS II+ DLKPSN+ ++E+ K+ DFGLAR T Y APE
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--------DEMTGYVATRWYRAPE 188
Query: 172 LFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP---------- 221
+ ++ D+W +GC++ E GR F G + +K IL P
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 222 ---------LPGNPSRPFAN-----------LINSLLVKDPAQRLHWSDLCGHAFWRTKL 261
L P FAN L+ +LV D +R+ + HA++
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
Query: 262 TPMPLPPQPAFD 273
P P +D
Sbjct: 309 DPDDEPVADPYD 320
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 5e-51
Identities = 65/290 (22%), Positives = 108/290 (37%), Gaps = 44/290 (15%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQ--EVRMLHSLDHPNVL 59
+ E+IG+G++ V++G+ + A+K ++ + E+ L H N+L
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 60 RFYSWYE----TSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS- 114
F + T LWLV +Y G L L + + + + LA L +LH
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHME 119
Query: 115 -------KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCY 167
I + DLK NIL+ +NG + D GLA + A+ + P + GT Y
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD-TIDIAPNHRVGTKRY 178
Query: 168 MAPELFEEG-----GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS--- 219
MAPE+ ++ +D++ +G V +E E QL L
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 220 -------------PPLPGNPS-----RPFANLINSLLVKDPAQRLHWSDL 251
P +P R A ++ + A RL +
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-48
Identities = 64/324 (19%), Positives = 120/324 (37%), Gaps = 62/324 (19%)
Query: 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSK-----VLQEVRMLHSLDH 55
+ +Y + IG G V AIK + + +++ +E+ ++ ++H
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 56 PNVLRFYSWY------ETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRAL 109
N++ + + E ++LV+E + + + + L ++ +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGI 132
Query: 110 QYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMA 169
++LHS GII+ DLKPSNI++ + K+ DFGLAR S + T Y A
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT------SFMMTPYVVTRYYRA 186
Query: 170 PELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLP------ 223
PE+ G + D+W +GC++ E + F GR++ ++ P P
Sbjct: 187 PEVI-LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 224 -----------------------------------GNPSRPFANLINSLLVKDPAQRLHW 248
+ +L++ +LV DPA+R+
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 249 SDLCGHAFWRTKLTPMPLPPQPAF 272
D H + P + P
Sbjct: 306 DDALQHPYINVWYDPAEVEAPPPQ 329
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-48
Identities = 61/282 (21%), Positives = 117/282 (41%), Gaps = 33/282 (11%)
Query: 2 NQYHIYEAIGRGKYSTVYKGR-----KKKTIEYFAIKSVDKS----QKSKVLQEVRMLHS 52
++ + + +GRG + V + K T A+K + + + ++ E+++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 53 LDHPN--VLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQ----------------LP 94
+ H V + + L +++E+C G+L + LR L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 95 EDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154
+ + + + + +++L S+ I+ DL NILL E K+CDFGLAR + K P
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI---YKDPD 189
Query: 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAG-RPPFVGREFTQLVKS 213
+ +MAPE V++ SD+W G +L+E ++ P+ G + +
Sbjct: 190 YVRKGDARLPLKWMAPETI-FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 214 ILSD-PSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254
L + P + + +P+QR +S+L H
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (369), Expect = 1e-38
Identities = 54/342 (15%), Positives = 116/342 (33%), Gaps = 73/342 (21%)
Query: 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSLDHPNVL 59
+Y + +G G +STV+ + + A+K V + E+++L ++ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 60 R---------------FYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQL-PEDSIRDLAQ 103
+ F H+ +V E L + + +++ P ++ +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 104 DLVRALQYLHSK-GIIYCDLKPSNILLDENGRT-KLCDFGLARKLSDASKAPSSMLPQAK 161
L+ L Y+H + GII+ D+KP N+L++ L +A +
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT---NS 189
Query: 162 CGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT-------QLVKSI 214
T Y +PE+ G +D+W C+++E G F E + + I
Sbjct: 190 IQTREYRSPEVL-LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 215 LSDPSPP----------------------------------------LPGNPSRPFANLI 234
P + ++ ++ +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 235 NSLLVKDPAQRLHWSDLCGHAFWRTKLT--PMPLPPQPAFDS 274
+ +L DP +R L H + + L + +P + + S
Sbjct: 309 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGS 350
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.9 bits (217), Expect = 3e-20
Identities = 27/159 (16%), Positives = 56/159 (35%), Gaps = 34/159 (21%)
Query: 10 IGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKS---------------------KVLQEVR 48
+G GK S V+ +K E +K S E R
Sbjct: 8 MGEGKESAVFNCYSEKFGEC-VVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 49 MLHSLDHPNVLRFYSWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRA 108
L L V + Y+W +++E + ++ ++ ++ ++
Sbjct: 67 ALQKLQGLAVPKVYAWEGN----AVLMELIDAK-------ELYRVRVENPDEVLDMILEE 115
Query: 109 LQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLS 147
+ + +GI++ DL N+L+ E G + DF + ++
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1335 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.41 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.15 | |
| d1jdha_ | 529 | beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} | 98.1 | |
| d1xm9a1 | 457 | Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} | 97.9 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.83 | |
| d1q1sc_ | 434 | Importin alpha {Mouse (Mus musculus) [TaxId: 10090 | 97.67 | |
| d1xqra1 | 264 | Hsp70-binding protein 1 (HspBP1) {Human (Homo sapi | 97.59 | |
| d1wa5b_ | 503 | Karyopherin alpha {Baker's yeast (Saccharomyces ce | 97.49 | |
| d1wa5b_ | 503 | Karyopherin alpha {Baker's yeast (Saccharomyces ce | 97.48 | |
| d1xqra1 | 264 | Hsp70-binding protein 1 (HspBP1) {Human (Homo sapi | 97.21 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.04 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.78 | |
| d1q1sc_ | 434 | Importin alpha {Mouse (Mus musculus) [TaxId: 10090 | 96.64 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.55 | |
| d1b3ua_ | 588 | Constant regulatory domain of protein phosphatase | 96.08 | |
| d1b3ua_ | 588 | Constant regulatory domain of protein phosphatase | 95.98 | |
| d1jdha_ | 529 | beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} | 95.78 | |
| d1u6gc_ | 1207 | Cullin-associated NEDD8-dissociated protein 1 (Tip | 95.06 | |
| d1qbkb_ | 888 | Karyopherin beta2 {Human (Homo sapiens) [TaxId: 96 | 89.92 | |
| d1ibrb_ | 458 | Importin beta {Human (Homo sapiens) [TaxId: 9606]} | 83.39 | |
| d1xm9a1 | 457 | Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} | 83.16 | |
| d1te4a_ | 111 | MTH187 {Archaeon Methanobacterium thermoautotrophi | 80.46 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=419.72 Aligned_cols=253 Identities=34% Similarity=0.609 Sum_probs=231.7
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH------HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 98589997870169579999999788709999981711------079999999999918999800489999828979999
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs------q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLV 74 (1335)
|++|++++.||+|+||.||+|+++.+++.||+|++.+. ....+.+|+.++++++||||+++++++++.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 96048999789998389999999999999999999999987970147899974777999755403562100357899989
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 75 MEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~s 154 (1335)
|||++||+|.+++.+.+.+++..++.|+.|++.||.|||++||+||||||+||+++.+|.+||+|||+|+........
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~-- 161 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-- 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC--
T ss_pred EECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCCCC--
T ss_conf 003579860555532567759999999999965211343159622464777847658998888205652003567862--
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Q ss_conf 88888756999879950000279999402499999999999809999999978999999835999999999995699999
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 155 s~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~DLI 234 (1335)
....+||+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.+..++.+.+.... ..+|..+++++.+||
T Consensus 162 ---~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dli 236 (337)
T d1o6la_ 162 ---MKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IRFPRTLSPEAKSLL 236 (337)
T ss_dssp ---BCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHH
T ss_pred ---CCCCEECHHHHHHHHCCC-CCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCHHHHHHH
T ss_conf ---055100889966665048-988833310223067889987899999969999999985289-989866899999999
Q ss_pred HHHCCCCCCCCCC-----HHHHHCCCCCCCC
Q ss_conf 9831259899999-----9889629232365
Q 000715 235 NSLLVKDPAQRLH-----WSDLCGHAFWRTK 260 (1335)
Q Consensus 235 kkLLskDPekRPT-----AeEILkHPFFq~~ 260 (1335)
.+||++||.+|++ ++++++||||++.
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHCCCCCHHHCCCCCCCHHHHHCCCCCCCC
T ss_conf 8666389344225652349999729150369
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=419.98 Aligned_cols=251 Identities=30% Similarity=0.571 Sum_probs=229.3
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH------HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 98589997870169579999999788709999981711------079999999999918999800489999828979999
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs------q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLV 74 (1335)
+++|++.+.||+|+||.||+|+++.+++.||+|++.+. ....+.+|++++++++||||+++++++.+.+.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 53769988985177858999999899949999998168856768999999999999856888888599999989998999
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 96048999789998389999999999999999999999987970147899974777999755403562100357899989
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 75 MEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~s 154 (1335)
|||++||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~---- 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---- 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----
T ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECCCCC----
T ss_conf 8504798589887504899999999999999999999998894652202344146689987115556335448885----
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Q ss_conf 88888756999879950000279999402499999999999809999999978999999835999999999995699999
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 155 s~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~DLI 234 (1335)
....+||+.|+|||++.+ ..|+.++||||+||++|+|++|+.||.+.+..++...+.... ..+|..+++++.+||
T Consensus 161 ---~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 235 (263)
T d2j4za1 161 ---RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-FTFPDFVTEGARDLI 235 (263)
T ss_dssp ---CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-CCCCTTSCHHHHHHH
T ss_pred ---CCCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCHHHHHHH
T ss_conf ---235578876349999758-998931440467599999832999988899999999997189-999866899999999
Q ss_pred HHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 98312598999999889629232365
Q 000715 235 NSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 235 kkLLskDPekRPTAeEILkHPFFq~~ 260 (1335)
.+||++||.+|||++|+++||||+..
T Consensus 236 ~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 236 SRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 99764797689099999719070783
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=422.73 Aligned_cols=257 Identities=28% Similarity=0.480 Sum_probs=223.5
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCHH----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 985899978701695799999997887099999817110----7999999999991899980048999982897999996
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq----~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVME 76 (1335)
+++|++.+.||+|+||+||+|+++.+++.||+|++.+.. .+.+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 04899978999838999999999999999999999998797014789997477799975540356210035789998988
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 77 yieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss~ 156 (1335)
|++||+|.+++..++.+++.+++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+........ .
T Consensus 84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~---~ 160 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE---R 160 (271)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE---C
T ss_pred CCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC---C
T ss_conf 4589808999753799999999999999999999999759835754689978878998798323142240468865---3
Q ss_pred CCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHC-CCCCCCCCCCCHHHHHHH
Q ss_conf 88875699987995000027999940249999999999980999999997899-9999835-999999999995699999
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQ-LVKSILS-DPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 157 l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~e-LikkIl~-~~~~plp~~iS~eL~DLI 234 (1335)
.....+||+.|+|||++.+..+++.++||||+||++|+|++|++||....... ....+.. ......+..+++++.+||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred CCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHH
T ss_conf 11132557474287286189999971016173799999982997888898599999998638887886446999999999
Q ss_pred HHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 98312598999999889629232365
Q 000715 235 NSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 235 kkLLskDPekRPTAeEILkHPFFq~~ 260 (1335)
.+||+.||++|||++|+++||||++.
T Consensus 241 ~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 241 HKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 99767996689099999619845859
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=415.01 Aligned_cols=255 Identities=25% Similarity=0.457 Sum_probs=226.1
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH---HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEE
Q ss_conf 98589997870169579999999788709999981711---079999999999918999800489999828979999960
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs---q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVMEy 77 (1335)
+++|++.+.||+|+||.||+|+++.+|+.||+|++.+. ..+.+.+|++++++++||||+++++++.+.+.+|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC--CCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 48999789998-3899999999999999999999999879701478999747779--99755403562100357899989
Q 000715 78 CVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE--NGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 78 ieGGSL~dlIk-k~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDe--dG~IKLiDFGLAr~l~~~~~~~s 154 (1335)
++||+|.+++. ..+.+++.+++.|+.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.......
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~--- 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--- 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC---
T ss_pred CCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCCCC---
T ss_conf 79988999997623789999999999999999999975697600015467364168898699954521044256543---
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC---CCCCCCCHHHH
Q ss_conf 888887569998799500002799994024999999999998099999999789999998359999---99999995699
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP---PLPGNPSRPFA 231 (1335)
Q Consensus 155 s~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~---plp~~iS~eL~ 231 (1335)
....+||+.|+|||++. +..|+.++||||+||++|+|++|+.||.+.+..+++..+...... ..+..+++++.
T Consensus 182 ---~~~~~gT~~Y~aPEv~~-~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 257 (350)
T d1koaa2 182 ---VKVTTGTAEFAAPEVAE-GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 257 (350)
T ss_dssp ---EEEECSCTTTCCHHHHH-TCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred ---CCEECCCCCCCCHHHHC-CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHH
T ss_conf ---20006862421889975-89987267655465999999859899899799999999984788989422358999999
Q ss_pred HHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 9999831259899999988962923236579
Q 000715 232 NLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 232 DLIkkLLskDPekRPTAeEILkHPFFq~~l~ 262 (1335)
+||.+||..||.+|||++|+++||||+....
T Consensus 258 ~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHCCCCHHHCCCHHHHHCCCCCCCCCC
T ss_conf 9999975689667908999862913288988
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=414.03 Aligned_cols=252 Identities=28% Similarity=0.515 Sum_probs=224.4
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH---HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEEC
Q ss_conf 8589997870169579999999788709999981711---0799999999999189998004899998289799999604
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs---q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVMEyi 78 (1335)
++|++.+.||+|+||+||+|+++.+++.||+|++... ..+.+.+|++++++++||||+++++++.+.+.+|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 89997899983899999999999999999999999879701478999747779997554035621003578999898888
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 79 eGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss~l~ 158 (1335)
+||+|.+++.+ +.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+...... .
T Consensus 100 ~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-----~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-----R 173 (293)
T ss_dssp TTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-----B
T ss_pred CCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC-----C
T ss_conf 79808988641-59999999999999999999999879722677688868878996864251564132136664-----4
Q ss_pred CCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--CCCCCCCCCHHHHHHHHH
Q ss_conf 875699987995000027999940249999999999980999999997899999983599--999999999569999998
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP--SPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 159 ~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~--~~plp~~iS~eL~DLIkk 236 (1335)
...+||+.|+|||++.+ ..|+.++||||+||++|+|++|++||.+.+..+....+.... ..+.+..+++.+.+||.+
T Consensus 174 ~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHCC-CCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH
T ss_conf 44444777368266447-99880120313729999980488998997999999999857999888855379999999999
Q ss_pred HCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 312598999999889629232365
Q 000715 237 LLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 237 LLskDPekRPTAeEILkHPFFq~~ 260 (1335)
||..||.+|||+.|+++||||+..
T Consensus 253 ~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 253 CLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp HTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 866996689099999649965778
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=414.41 Aligned_cols=255 Identities=33% Similarity=0.559 Sum_probs=230.0
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH------HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 8589997870169579999999788709999981711------0799999999999189998004899998289799999
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs------q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVM 75 (1335)
++|++.+.||+|+||.||+|+++.+++.||+|++.+. ..+.+.+|++++++++||||+++++++.+.+.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 60489997899983899999999999999999999999879701478999747779997554035621003578999898
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss 155 (1335)
||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+.+.......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~-- 165 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-- 165 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred ECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCCCC--
T ss_conf 704898777765315999999999999999999976216508847677412366888538860321024225677643--
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Q ss_conf 88887569998799500002799994024999999999998099999999789999998359999999999956999999
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 156 ~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~DLIk 235 (1335)
.....+||+.|+|||++. +..|+.++||||+||++|+|++|+.||.+.+..++..++.... ..+|..+++++.+||.
T Consensus 166 -~~~~~~GT~~Y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 242 (288)
T d1uu3a_ 166 -RANSFVGTAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVE 242 (288)
T ss_dssp -----CCCCGGGCCHHHHH-TCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-CCCCTTCCHHHHHHHH
T ss_pred -CCCCCCCCCCCCCCEEEC-CCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCHHHHHHHH
T ss_conf -335556775525844002-6898966623045699999803889989959999999997189-9998547999999999
Q ss_pred HHCCCCCCCCCCHHH------HHCCCCCCCCC
Q ss_conf 831259899999988------96292323657
Q 000715 236 SLLVKDPAQRLHWSD------LCGHAFWRTKL 261 (1335)
Q Consensus 236 kLLskDPekRPTAeE------ILkHPFFq~~l 261 (1335)
+||+.||.+|||++| +++||||++..
T Consensus 243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp TTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCC
T ss_conf 98557976891978973778987697647899
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=412.23 Aligned_cols=250 Identities=31% Similarity=0.587 Sum_probs=229.3
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH------HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 98589997870169579999999788709999981711------079999999999918999800489999828979999
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs------q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLV 74 (1335)
|++|++++.||+|+||.||+|+++.+++.||+|++.+. ..+.+.+|+++++.++||||+++++++.+...+|+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCC
T ss_conf 23708988961176808999999899989999998267745889999999999999974877274034444322222322
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 96048999789998389999999999999999999999987970147899974777999755403562100357899989
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 75 MEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~s 154 (1335)
|||+.||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~---- 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---- 195 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB----
T ss_pred CCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCCC----
T ss_conf 2233466226667515898999999999999998999985998617679999360778978861010333225666----
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Q ss_conf 88888756999879950000279999402499999999999809999999978999999835999999999995699999
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 155 s~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~DLI 234 (1335)
...+||+.|+|||++. +..|+.++||||+||++|+|++|++||.+.+...++..+.... ...+..+++++.+||
T Consensus 196 ----~~~~Gt~~Y~APE~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 269 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK-VRFPSHFSSDLKDLL 269 (350)
T ss_dssp ----CCCEECGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTCCHHHHHHH
T ss_pred ----CCCCCCCCCCCHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCHHHHHHH
T ss_conf ----4336763567889971-7998853311450078999975889989959999999986179-889766899999999
Q ss_pred HHHCCCCCCCCC-----CHHHHHCCCCCCCC
Q ss_conf 983125989999-----99889629232365
Q 000715 235 NSLLVKDPAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 235 kkLLskDPekRP-----TAeEILkHPFFq~~ 260 (1335)
.+||.+||.+|+ |++++++||||++.
T Consensus 270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHHCHHHCCCCCCCCHHHHHCCCCCCCC
T ss_conf 9983409986065534549999719051589
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=410.28 Aligned_cols=252 Identities=31% Similarity=0.548 Sum_probs=220.8
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCHH------HHHHHH---HHHHHHHCCCCCCCEEEEEEEECCEE
Q ss_conf 985899978701695799999997887099999817110------799999---99999918999800489999828979
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ------KSKVLQ---EVRMLHSLDHPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq------~eeIlr---EIkILkkLkHPNIVkLlevfed~~~L 71 (1335)
|++|++.+.||+|+||.||+|+++.+++.||+|++.+.. ...+.+ ++++++.++||||+++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCC
Q ss_conf 99996048999789998389999999999999999999999987970147899974777999755403562100357899
Q 000715 72 WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 72 yLVMEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~ 151 (1335)
|+||||++||+|.+++.+++.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~- 161 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 161 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-
T ss_pred EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECCCCC-
T ss_conf 9999914898389998732553278999999999999999997796220444221678588967982201023337886-
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHCCCCCCCCCCCCH
Q ss_conf 989888887569998799500002799994024999999999998099999999789---99999835999999999995
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT---QLVKSILSDPSPPLPGNPSR 228 (1335)
Q Consensus 152 ~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~---eLikkIl~~~~~plp~~iS~ 228 (1335)
....+||+.|+|||++..+..|+.++||||+||++|+|++|+.||.+.... .+...+ ......++..+++
T Consensus 162 ------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~ 234 (364)
T d1omwa3 162 ------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-LTMAVELPDSFSP 234 (364)
T ss_dssp ------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS-SSCCCCCCSSSCH
T ss_pred ------CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC-CCCCCCCCCCCCH
T ss_conf ------433113455421687603899984410467789999998599988889989999999860-4688878877899
Q ss_pred HHHHHHHHHCCCCCCCCCC-----HHHHHCCCCCCCC
Q ss_conf 6999999831259899999-----9889629232365
Q 000715 229 PFANLINSLLVKDPAQRLH-----WSDLCGHAFWRTK 260 (1335)
Q Consensus 229 eL~DLIkkLLskDPekRPT-----AeEILkHPFFq~~ 260 (1335)
++.+||.+||.+||.+||| ++++++||||++.
T Consensus 235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCC
T ss_conf 9999999985669888088743579999749102378
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=414.45 Aligned_cols=252 Identities=30% Similarity=0.551 Sum_probs=226.2
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCHH----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEE
Q ss_conf 85899978701695799999997887099999817110----79999999999918999800489999828979999960
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq----~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVMEy 77 (1335)
++|++.+.||+|+||+||+|+++.+++.||+|.+.+.. ...+.+|++++++++||||+++++++.+.+.+|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 66699889940658399999999999899999981577312899999999999867998999198999989988898852
Q ss_pred CCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC---CCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 48999789998389999999999999999999999987970147899974777---999755403562100357899989
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLD---ENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 78 ieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILID---edG~IKLiDFGLAr~l~~~~~~~s 154 (1335)
|+||+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+||++. .++.+||+|||+++.......
T Consensus 89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~--- 165 (307)
T d1a06a_ 89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--- 165 (307)
T ss_dssp CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------------
T ss_pred CCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCCCE---
T ss_conf 68984888653036788789999999999998752413055687046300110468882499831543587258970---
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHHH
Q ss_conf 88888756999879950000279999402499999999999809999999978999999835999---999999995699
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS---PPLPGNPSRPFA 231 (1335)
Q Consensus 155 s~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~---~plp~~iS~eL~ 231 (1335)
....+||+.|+|||++. +..|+.++||||+||++|+|++|++||.+....++...+..... .+.+..+++++.
T Consensus 166 ---~~~~~GT~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 166 ---LSTACGTPGYVAPEVLA-QKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp ----------CTTSCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred ---EEEEEECCCCCCCHHHC-CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHH
T ss_conf ---44003284225918873-79998078734515999999859799999899999999861687778766667899999
Q ss_pred HHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 99998312598999999889629232365
Q 000715 232 NLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 232 DLIkkLLskDPekRPTAeEILkHPFFq~~ 260 (1335)
+||.+||.+||++|||+.|+++||||++.
T Consensus 242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 99999760897579189998629844799
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=412.51 Aligned_cols=255 Identities=24% Similarity=0.463 Sum_probs=226.6
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH---HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEE
Q ss_conf 98589997870169579999999788709999981711---079999999999918999800489999828979999960
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs---q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVMEy 77 (1335)
+++|++.+.||+|+||.||+|+++.+++.||+|++.+. ....+.+|++++++++||||++++++|.+.+.+|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC--CCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 48999789998389-999999999999999999999987970147899974777--999755403562100357899989
Q 000715 78 CVGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLD--ENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 78 ieGGSL~dlIkk~g-~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILID--edG~IKLiDFGLAr~l~~~~~~~s 154 (1335)
|+||+|.+++...+ ++++.+++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+|........
T Consensus 108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~--- 184 (352)
T d1koba_ 108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI--- 184 (352)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---
T ss_pred CCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCCC---
T ss_conf 89980888898638998999999999999999999997792651314455311346788489952563034378872---
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHHH
Q ss_conf 88888756999879950000279999402499999999999809999999978999999835999---999999995699
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS---PPLPGNPSRPFA 231 (1335)
Q Consensus 155 s~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~---~plp~~iS~eL~ 231 (1335)
....+|++.|+|||++. +..|+.++||||+||++|+|++|++||.+.+..++...+..... ...+..+++++.
T Consensus 185 ---~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 260 (352)
T d1koba_ 185 ---VKVTTATAEFAAPEIVD-REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260 (352)
T ss_dssp ---EEEECSSGGGCCHHHHT-TCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred ---EEECCCCCCCCCHHHHC-CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHH
T ss_conf ---01004764534899974-79989763338989999999968899899799999999984788989300247999999
Q ss_pred HHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 9999831259899999988962923236579
Q 000715 232 NLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 232 DLIkkLLskDPekRPTAeEILkHPFFq~~l~ 262 (1335)
+||.+||++||.+|||+.|+++||||+....
T Consensus 261 ~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 9999975699668918999960973488820
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=415.13 Aligned_cols=251 Identities=30% Similarity=0.564 Sum_probs=217.7
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCC----HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEE
Q ss_conf 858999787016957999999978870999998171----1079999999999918999800489999828979999960
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdK----sq~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVMEy 77 (1335)
++|++.+.||+|+||+||+|+++.+++.||+|.+.+ .....+.+|++++++++||||++++++|.+.+.+|+||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 68889789712778099999998999699999987540978999999999999867999999499999989999999976
Q ss_pred CCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 4899978999838999999999999999999999998-797014789997477799975540356210035789998988
Q 000715 78 CVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 78 ieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHs-kGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss~ 156 (1335)
++||+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+......
T Consensus 86 ~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~------ 159 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM------ 159 (322)
T ss_dssp CTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT------
T ss_pred CCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCCCC------
T ss_conf 79986899874249999999999999999999999985999714457799468789989995487762567886------
Q ss_pred CCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--------------------------
Q ss_conf 888756999879950000279999402499999999999809999999978999--------------------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQL-------------------------- 210 (1335)
Q Consensus 157 l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eL-------------------------- 210 (1335)
....+||++|+|||++.+ ..|+.++||||+||++|||++|+.||.+.+..+.
T Consensus 160 -~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 160 -ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp -C---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred -CCCCCCCCCCCCCHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf -211137714119468758-998948889989999999998889989988789999998875177545774212333221
Q ss_pred ----------------HHHHHCCCCCCCC-CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf ----------------9998359999999-9999569999998312598999999889629232365
Q 000715 211 ----------------VKSILSDPSPPLP-GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 211 ----------------ikkIl~~~~~plp-~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~ 260 (1335)
...+.....+..+ ...+.++.+||.+||..||.+|||++|+++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf 1112223541347788766502687667644489999999999868994679089999609864769
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=408.62 Aligned_cols=250 Identities=32% Similarity=0.619 Sum_probs=230.1
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH------HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 98589997870169579999999788709999981711------079999999999918999800489999828979999
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs------q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLV 74 (1335)
|++|++.+.||+|+||+||+|+++.+++.||+|++.+. ..+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf 54708888972076808999999899979999998457754889999999999999863696753303568528800567
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 96048999789998389999999999999999999999987970147899974777999755403562100357899989
Q 000715 75 LEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 75 MEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~s 154 (1335)
|||++||++..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~---- 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---- 158 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB----
T ss_pred EEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEECCCC----
T ss_conf 6503786322343222211100799999999876554124767705568105038689988983175216712456----
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Q ss_conf 88888756999879950000279999402499999999999809999999978999999835999999999995699999
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLI 234 (1335)
Q Consensus 155 s~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~DLI 234 (1335)
...+||+.|+|||++. +..|+.++||||+||++|+|++|+.||.+.+..++..++.... ..+|..+++++.+++
T Consensus 159 ----~~~~Gt~~Y~APE~l~-~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 232 (316)
T d1fota_ 159 ----YTLCGTPDYIAPEVVS-TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-LRFPPFFNEDVKDLL 232 (316)
T ss_dssp ----CCCCSCTTTCCHHHHT-TCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHHH
T ss_pred ----CCCCCCCCCCCHHHHC-CCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCHHHHHHH
T ss_conf ----4345763435999983-8999804304653336899975989999969999999997089-889977899999999
Q ss_pred HHHCCCCCCCCC-----CHHHHHCCCCCCCC
Q ss_conf 983125989999-----99889629232365
Q 000715 235 NSLLVKDPAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 235 kkLLskDPekRP-----TAeEILkHPFFq~~ 260 (1335)
.+||.+||.+|+ |++++++||||++.
T Consensus 233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHHCHHHCCCCCHHHHHHHHCCCCCCCC
T ss_conf 9995449976664310219999819351467
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=410.77 Aligned_cols=249 Identities=33% Similarity=0.517 Sum_probs=224.0
Q ss_pred CEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH------HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 589997870169579999999788709999981711------07999999999991899980048999982897999996
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 3 kYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs------q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVME 76 (1335)
.|++++.||+|+||.||+|+++.+++.||+|.+.+. ..+.+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 04899978999838999999999999999999999998797014789997477799975540356210035789998988
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 77 yieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss~ 156 (1335)
||.+|++..++..++++++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------
T ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCCCC-------
T ss_conf 0699945789973799999999999999999999998689766678842179879997898443653346778-------
Q ss_pred CCCCCCCCCCCCCCCHHCC--CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC-CCCCCCHHHHHH
Q ss_conf 8887569998799500002--7999940249999999999980999999997899999983599999-999999569999
Q 000715 157 LPQAKCGTPCYMAPELFEE--GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP-LPGNPSRPFANL 233 (1335)
Q Consensus 157 l~~t~vGTp~YlAPEVL~~--~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~p-lp~~iS~eL~DL 233 (1335)
...+||+.|+|||++.+ .+.|+.++||||+||++|+|++|..||.+.+..+....+.....+. .+..+++.+.+|
T Consensus 169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (309)
T ss_dssp --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred --CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHH
T ss_conf --731347663688998346788867214545589999999878899999799999999982899988878889999999
Q ss_pred HHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 998312598999999889629232365
Q 000715 234 INSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 234 IkkLLskDPekRPTAeEILkHPFFq~~ 260 (1335)
|.+||+.||.+|||++++++||||.+.
T Consensus 247 i~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 247 VDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf 999773796579189999719975378
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=411.37 Aligned_cols=254 Identities=30% Similarity=0.526 Sum_probs=224.4
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH---HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEEC
Q ss_conf 8589997870169579999999788709999981711---0799999999999189998004899998289799999604
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs---q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVMEyi 78 (1335)
+.|++.+.||+|+||.||+|+++.+++.||+|++.+. ..+.+.+|++++++++||||+++++++.+.+.+|+||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 89997899983-89999999999999999999999987970147899974777999755403562100357899989888
Q 000715 79 VGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 79 eGGSL~dlIkk-~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss~l 157 (1335)
+||+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~----- 166 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR----- 166 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHH-----
T ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCCCCC-----
T ss_conf 998188999862899999999999999999999999889887140700314878999899716123035778641-----
Q ss_pred CCCCCCCCCCCCCCHHC----CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC--CCCCCCCHHHH
Q ss_conf 88756999879950000----2799994024999999999998099999999789999998359999--99999995699
Q 000715 158 PQAKCGTPCYMAPELFE----EGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP--PLPGNPSRPFA 231 (1335)
Q Consensus 158 ~~t~vGTp~YlAPEVL~----~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~--plp~~iS~eL~ 231 (1335)
....+||+.|+|||++. .+..|+.++||||+||++|+|++|++||.+.+..+....+.....+ ..+..+++++.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 246 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHH
T ss_conf 00102562647999983202578888806657878999999820889999989999999997079987776566999999
Q ss_pred HHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 99998312598999999889629232365
Q 000715 232 NLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 232 DLIkkLLskDPekRPTAeEILkHPFFq~~ 260 (1335)
+||.+||+.||.+|||+.|+++||||+..
T Consensus 247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 247 DFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 99999766996689199999629231889
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=408.75 Aligned_cols=251 Identities=32% Similarity=0.541 Sum_probs=226.4
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH-----HHHHHHHHHHHHHHCCCCCCCEEEEEEEE--CCEEEE
Q ss_conf 98589997870169579999999788709999981711-----07999999999991899980048999982--897999
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYET--SAHLWL 73 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs-----q~eeIlrEIkILkkLkHPNIVkLlevfed--~~~LyL 73 (1335)
.++|++.+.||+|+||.||+|+++.+++.||+|.+.+. ..+.+.+|++++++++||||+++++++.+ .+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEEECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 9960489997899983----899999999999999999999999879-----7014789997477799975540356210
Q 000715 74 VLEYCVGGDLMSLLRQ----DNQLPEDSIRDLAQDLVRALQYLHSKG-----IIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 74 VMEyieGGSL~dlIkk----~g~LSEeeIr~IL~QILeALkYLHskG-----IVHRDIKPeNILIDedG~IKLiDFGLAr 144 (1335)
|||||+||+|.+++.+ ++.+++..++.++.|++.||.|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCC
Q ss_conf 03578999898888875699987995000027999940249999999999980999999997899999983599999999
Q 000715 145 KLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPG 224 (1335)
Q Consensus 145 ~l~~~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~plp~ 224 (1335)
........ ....+||+.|+|||++. +..|+.++||||+||++|+|++|++||.+.+..++...+..+...+++.
T Consensus 163 ~~~~~~~~-----~~~~~gt~~Y~APE~l~-~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 236 (269)
T d2java1 163 ILNHDTSF-----AKAFVGTPYYMSPEQMN-RMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY 236 (269)
T ss_dssp HC----------------CCCSCCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCT
T ss_pred ECCCCCCC-----CCCCCCCCCCCCHHHHC-CCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCC
T ss_conf 22457775-----56677882327999983-9999938988752789999801889989989999999997189988974
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCC
Q ss_conf 999569999998312598999999889629232
Q 000715 225 NPSRPFANLINSLLVKDPAQRLHWSDLCGHAFW 257 (1335)
Q Consensus 225 ~iS~eL~DLIkkLLskDPekRPTAeEILkHPFF 257 (1335)
.+++++.+||.+||+.||.+|||++|+++|||.
T Consensus 237 ~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 237 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf 359999999999767995579189999729819
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=404.01 Aligned_cols=253 Identities=30% Similarity=0.525 Sum_probs=226.8
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH---------HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 8589997870169579999999788709999981711---------0799999999999189998004899998289799
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs---------q~eeIlrEIkILkkLkHPNIVkLlevfed~~~Ly 72 (1335)
++|++.+.||+|+||+||+|+++.+++.||+|++.+. ..+.+.+|++++++++||||+++++++.+.+.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 67798279811789599999999999899999987566321340689999999999998679989993889999799899
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC----CEEECCCCCCCCCCC
Q ss_conf 9996048999789998389999999999999999999999987970147899974777999----755403562100357
Q 000715 73 LVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG----RTKLCDFGLARKLSD 148 (1335)
Q Consensus 73 LVMEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG----~IKLiDFGLAr~l~~ 148 (1335)
+|||||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++ .+|++|||++.....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHHCCC
T ss_conf 99986778643100103564215578999999999987666254221133301279825898666469643344210577
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC---CCCC
Q ss_conf 8999898888875699987995000027999940249999999999980999999997899999983599999---9999
Q 000715 149 ASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP---LPGN 225 (1335)
Q Consensus 149 ~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~p---lp~~ 225 (1335)
.... ....|++.|+|||++. +..++.++||||+||++|+|++|+.||.+.+..+....+....... .+..
T Consensus 170 ~~~~------~~~~~t~~y~APE~~~-~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (293)
T d1jksa_ 170 GNEF------KNIFGTPEFVAPEIVN-YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242 (293)
T ss_dssp SCBC------SCCCCCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred CCCC------CCCCCCCCCCCHHHHC-CCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCHHCCC
T ss_conf 7631------2247777430999981-89999766522140999999708899889999999999981688887010478
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 995699999983125989999998896292323657
Q 000715 226 PSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 226 iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~l 261 (1335)
++..+.+||.+||..||.+|||++|+++||||+...
T Consensus 243 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf 899999999998638966891999996190418887
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=403.63 Aligned_cols=253 Identities=33% Similarity=0.615 Sum_probs=227.9
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH------HHHHHHHHHHHHH-HCCCCCCCEEEEEEEECCEEEE
Q ss_conf 98589997870169579999999788709999981711------0799999999999-1899980048999982897999
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLH-SLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs------q~eeIlrEIkILk-kLkHPNIVkLlevfed~~~LyL 73 (1335)
|++|++.+.||+|+||+||+|+++.+++.||+|++.+. ..+.+.+|..++. .++||||+++++++.+.+.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEE
T ss_conf 99718865894087828999999999989999998055533848999999999999984799968789889704983167
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 99604899978999838999999999999999999999998797014789997477799975540356210035789998
Q 000715 74 VLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 74 VMEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ 153 (1335)
||||++||+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++........
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~- 159 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK- 159 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC-
T ss_pred EEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCCCCC-
T ss_conf 7750379808998640478999999999999999999998689340347654044448996301555302323566533-
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Q ss_conf 98888875699987995000027999940249999999999980999999997899999983599999999999569999
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANL 233 (1335)
Q Consensus 154 ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~DL 233 (1335)
....+||+.|+|||++. +..|+.++||||+||++|+|++|+.||.+.+..++...+..+. +.+|..+++++.+|
T Consensus 160 ----~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~p~~~s~~~~dl 233 (320)
T d1xjda_ 160 ----TNTFCGTPDYIAPEILL-GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-PFYPRWLEKEAKDL 233 (320)
T ss_dssp ----BCCCCSCGGGCCHHHHT-TCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCCCTTSCHHHHHH
T ss_pred ----CCCCCCCCCCCCHHHHC-CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCHHHHHH
T ss_conf ----45457877768999982-7998832320112278989873889999989999999997189-98975679999999
Q ss_pred HHHHCCCCCCCCCCHH-HHHCCCCCCCC
Q ss_conf 9983125989999998-89629232365
Q 000715 234 INSLLVKDPAQRLHWS-DLCGHAFWRTK 260 (1335)
Q Consensus 234 IkkLLskDPekRPTAe-EILkHPFFq~~ 260 (1335)
|.+||.+||.+||++. ++++||||++.
T Consensus 234 i~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 234 LVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHCCCCCCCCCCHHHHHHHCCHHCCC
T ss_conf 9996544898783889999809013158
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=404.49 Aligned_cols=255 Identities=26% Similarity=0.452 Sum_probs=226.4
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCHH--HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEEC
Q ss_conf 985899978701695799999997887099999817110--799999999999189998004899998289799999604
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYC 78 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq--~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVMEyi 78 (1335)
+++|++.+.||+|+||.||+|.++.+++.||+|.+.+.. ...+.+|+++++.++||||+++++++++.+.+|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 01058878983177839999999899969999997578665999999999998579979890989998899889999538
Q ss_pred CCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC--CCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 8999789998389-99999999999999999999998797014789997477799--97554035621003578999898
Q 000715 79 VGGDLMSLLRQDN-QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN--GRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 79 eGGSL~dlIkk~g-~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDed--G~IKLiDFGLAr~l~~~~~~~ss 155 (1335)
+||+|.+++...+ .+++.+++.|+.||+.||.|||++||+||||||+||+++.+ +.+||+|||+++.......
T Consensus 84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~---- 159 (321)
T d1tkia_ 84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---- 159 (321)
T ss_dssp CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE----
T ss_pred CCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCCC----
T ss_conf 9980889987538999999999999999999999987699751355444344378851899764411100346775----
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCHHHHH
Q ss_conf 888875699987995000027999940249999999999980999999997899999983599999---99999956999
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP---LPGNPSRPFAN 232 (1335)
Q Consensus 156 ~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~p---lp~~iS~eL~D 232 (1335)
....+|++.|+|||++. +..|+.++||||+||++|+|++|.+||.+.+..+++..+....... .+..+++++.+
T Consensus 160 --~~~~~~t~~y~ape~~~-~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 236 (321)
T d1tkia_ 160 --FRLLFTAPEYYAPEVHQ-HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236 (321)
T ss_dssp --EEEEESCGGGSCHHHHT-TCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred --CCCCCCCCCCCCCHHCC-CCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHCCCCCHHHHH
T ss_conf --32122332223402104-877784011302799999998289999998999999999838999880223678999999
Q ss_pred HHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf 999831259899999988962923236579
Q 000715 233 LINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 233 LIkkLLskDPekRPTAeEILkHPFFq~~l~ 262 (1335)
||.+||.+||.+|||++|+++||||++...
T Consensus 237 li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 266 (321)
T d1tkia_ 237 FVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 999986699668909999963996566753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=399.25 Aligned_cols=248 Identities=28% Similarity=0.492 Sum_probs=215.9
Q ss_pred CCE-EEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH-----HHHHHHHHHHHHHHCCCCCCCEEEEEEEE----CCEE
Q ss_conf 858-9997870169579999999788709999981711-----07999999999991899980048999982----8979
Q 000715 2 NQY-HIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYET----SAHL 71 (1335)
Q Consensus 2 ekY-eIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs-----q~eeIlrEIkILkkLkHPNIVkLlevfed----~~~L 71 (1335)
++| ++.+.||+|+||+||+|.++.+++.||+|.+... ..+.+.+|++++++++||||+++++++.+ ...+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEE
T ss_conf 87788516970082849999999999959999998512279899999999999998579998506999984033458889
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCCEEEC-CCCCEEECCCCCCCCCCC
Q ss_conf 999960489997899983899999999999999999999999879--70147899974777-999755403562100357
Q 000715 72 WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKG--IIYCDLKPSNILLD-ENGRTKLCDFGLARKLSD 148 (1335)
Q Consensus 72 yLVMEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskG--IVHRDIKPeNILID-edG~IKLiDFGLAr~l~~ 148 (1335)
|+||||+++|+|.+++.+.+.+++..++.|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++....
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC
T ss_conf 99995789894899975135546999999999999999999978997996876743511667999889800576542368
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHCCCCC-CCCCCC
Q ss_conf 8999898888875699987995000027999940249999999999980999999997-89999998359999-999999
Q 000715 149 ASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-FTQLVKSILSDPSP-PLPGNP 226 (1335)
Q Consensus 149 ~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d-~~eLikkIl~~~~~-plp~~i 226 (1335)
.. ....+||+.|+|||++. +.++.++||||+||++|+|++|+.||.+.. ...+...+..+..+ .++...
T Consensus 168 ~~-------~~~~~GT~~Y~aPE~~~--~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (270)
T d1t4ha_ 168 SF-------AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238 (270)
T ss_dssp TS-------BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred CC-------CCCCCCCCCCCCHHHHC--CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
T ss_conf 76-------67755381300898847--8999867110079999999878899987655999999997389986567557
Q ss_pred CHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCC
Q ss_conf 95699999983125989999998896292323
Q 000715 227 SRPFANLINSLLVKDPAQRLHWSDLCGHAFWR 258 (1335)
Q Consensus 227 S~eL~DLIkkLLskDPekRPTAeEILkHPFFq 258 (1335)
++++.++|.+||.+||++|||++|+++||||+
T Consensus 239 ~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 89999999997637975892999996775409
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=404.05 Aligned_cols=257 Identities=27% Similarity=0.478 Sum_probs=222.4
Q ss_pred EEEEEEECCCCEEEEEEEECCCCEEEEEEECCCHH--------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 99978701695799999997887099999817110--------7999999999991899980048999982897999996
Q 000715 5 HIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--------KSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 5 eIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq--------~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVME 76 (1335)
+.++.||+|+||+||+|+++.+++.||+|++.... ...+.+|++++++++||||+++++++.+.+++|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHH
T ss_conf 95638512728299999999999699999984202124567999999999999986799998689854225874022045
Q ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 04899978999838999999999999999999999998797014789997477799975540356210035789998988
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 77 yieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss~ 156 (1335)
|+.++++..+......+++..++.|++||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~---- 156 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---- 156 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC----
T ss_pred HHCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC----
T ss_conf 5345077655412667789999999999999998863163550357762588537784114657610005787554----
Q ss_pred CCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC---------------
Q ss_conf 88875699987995000027999940249999999999980999999997899999983599999---------------
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP--------------- 221 (1335)
Q Consensus 157 l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~p--------------- 221 (1335)
....+||++|+|||++.....|+.++||||+||++|+|++|.+||.+.+..++...+......+
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred -CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHH
T ss_conf -3302047333639997267788805643630428999985969999999999999999851899725452100021344
Q ss_pred ------------CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCCCCC
Q ss_conf ------------999999569999998312598999999889629232365799999
Q 000715 222 ------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPMPL 266 (1335)
Q Consensus 222 ------------lp~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~l~~~p~ 266 (1335)
.....++.+.+||.+||+.||++|||++|+++||||++.+.+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~ 292 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred HHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCCCC
T ss_conf 303478988678565689999999999763894569089999679965789999898
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=396.03 Aligned_cols=254 Identities=31% Similarity=0.552 Sum_probs=226.9
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH------------HHHHHHHHHHHHHHCC-CCCCCEEEEEEEE
Q ss_conf 98589997870169579999999788709999981711------------0799999999999189-9980048999982
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------------QKSKVLQEVRMLHSLD-HPNVLRFYSWYET 67 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs------------q~eeIlrEIkILkkLk-HPNIVkLlevfed 67 (1335)
.++|++.+.||+|+||+||+|+++.+++.||+|++.+. ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCC
Q ss_conf 89799999604899978999838999999999999999999999998797014789997477799975540356210035
Q 000715 68 SAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLS 147 (1335)
Q Consensus 68 ~~~LyLVMEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~ 147 (1335)
.+.+|+||||++||+|.+++...+.+++.+++.|+.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEEECC
T ss_conf 76059999768986689999865999999999999999999999987599432346254898689983871240316726
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHCC-----CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---
Q ss_conf 7899989888887569998799500002-----79999402499999999999809999999978999999835999---
Q 000715 148 DASKAPSSMLPQAKCGTPCYMAPELFEE-----GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS--- 219 (1335)
Q Consensus 148 ~~~~~~ss~l~~t~vGTp~YlAPEVL~~-----~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~--- 219 (1335)
.... ....+||+.|+|||++.. ...++.++||||+||++|+|++|+.||.+.+.......+..+..
T Consensus 162 ~~~~------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~ 235 (277)
T d1phka_ 162 PGEK------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 235 (277)
T ss_dssp TTCC------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred CCCC------EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 8872------1345246788898886053445678899233185656023103228889889999999999981898889
Q ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 99999999569999998312598999999889629232365
Q 000715 220 PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 220 ~plp~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~ 260 (1335)
.+.+..+|+++.+|+.+||+.||.+|||++|+++||||++.
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHHH
T ss_conf 85434689999999999765896689199999739787975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=394.10 Aligned_cols=259 Identities=29% Similarity=0.466 Sum_probs=220.5
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH-----HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 98589997870169579999999788709999981711-----0799999999999189998004899998289799999
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs-----q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVM 75 (1335)
|++|++++.||+|+||+||+|+++.+++.||+|++... ....+.+|++++++++||||+++++++.+.+.+|+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 99977651772376809999999999979999998022257589999999999998679983887445332243203788
Q ss_pred EECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 60489997899983-89999999999999999999999987970147899974777999755403562100357899989
Q 000715 76 EYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 76 EyieGGSL~dlIkk-~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~s 154 (1335)
||+.++.+...... ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~-- 158 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT-- 158 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC--
T ss_pred EECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCCCC--
T ss_conf 623774455544202568888999999999999999865288992135711401134676210357861343688641--
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC---CCC-----------
Q ss_conf 888887569998799500002799994024999999999998099999999789999998359---999-----------
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD---PSP----------- 220 (1335)
Q Consensus 155 s~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~---~~~----------- 220 (1335)
....+|++.|+|||++....+++.++||||+||++|+|++|+.||.+.+..+....+... +..
T Consensus 159 ---~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 159 ---YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp ---TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ---CEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCC
T ss_conf ---00103652154112213665777422103333134279668799898899999999998328983331444222421
Q ss_pred ---CC-----------CCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCCCC
Q ss_conf ---99-----------999995699999983125989999998896292323657999
Q 000715 221 ---PL-----------PGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLTPM 264 (1335)
Q Consensus 221 ---pl-----------p~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~l~~~ 264 (1335)
.. ....+.++.+|+.+||+.||++|||++|+++||||++...|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~ 293 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCCCC
T ss_conf 2434543222204441667899999999997639955791899996787014699999
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=395.85 Aligned_cols=251 Identities=28% Similarity=0.496 Sum_probs=212.1
Q ss_pred CCCEEEEE-EEECCCCEEEEEEEECCCCEEEEEEECCCHHHHHHHHHHHHHHH-CCCCCCCEEEEEEEE----CCEEEEE
Q ss_conf 98589997-87016957999999978870999998171107999999999991-899980048999982----8979999
Q 000715 1 MNQYHIYE-AIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHS-LDHPNVLRFYSWYET----SAHLWLV 74 (1335)
Q Consensus 1 IekYeIlK-~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq~eeIlrEIkILkk-LkHPNIVkLlevfed----~~~LyLV 74 (1335)
+++|++.+ .||+|+||.||+|+++.+++.||+|++.+. ..+.+|+.++.+ .+||||++++++|++ ...+|+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC--HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEEE
T ss_conf 148798107965454869999998899989999998974--779999999998669999782989995034689789999
Q ss_pred EEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC---CCCEEECCCCCCCCCCCC
Q ss_conf 9604899978999838--99999999999999999999999879701478999747779---997554035621003578
Q 000715 75 LEYCVGGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE---NGRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 75 MEyieGGSL~dlIkk~--g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDe---dG~IKLiDFGLAr~l~~~ 149 (1335)
||||+||+|.+++.+. ..+++.+++.|+.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.....
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred EECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCC
T ss_conf 97789984999998627877579999999999999999999769864441002201135555663113545512333688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC---CCCCCC---
Q ss_conf 99989888887569998799500002799994024999999999998099999999789999998359---999999---
Q 000715 150 SKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD---PSPPLP--- 223 (1335)
Q Consensus 150 ~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~---~~~plp--- 223 (1335)
... ...+||+.|+|||++. +..|+.++||||+||++|+|++|++||.+.+.......+... ....++
T Consensus 168 ~~~------~~~~gt~~y~aPE~~~-~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~ 240 (335)
T d2ozaa1 168 NSL------TTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240 (335)
T ss_dssp CCC------CCCSCCCSSCCCCCCC-GGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTH
T ss_pred CCC------CCCCCCCCCCCCHHHC-CCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 864------3226775637927774-898888888876451677886588998898877889999999853888889854
Q ss_pred -CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf -9999569999998312598999999889629232365
Q 000715 224 -GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 224 -~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~ 260 (1335)
..+++++.+||.+||++||++|||+.++++||||.+.
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCC
T ss_conf 34699999999999756996579099999709876178
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=385.68 Aligned_cols=253 Identities=28% Similarity=0.462 Sum_probs=221.6
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH-----HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 98589997870169579999999788709999981711-----0799999999999189998004899998289799999
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs-----q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVM 75 (1335)
|++|++.+.||+|+||+||+|+++ +++.||+|++... ..+.+.+|+.++++++||||+++++++.+.+..|+++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEE
T ss_conf 999634318722778189999968-9999999998123268589999999999998679986876601204677315899
Q ss_pred EECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 60489997899983899999999999999999999999879701478999747779997554035621003578999898
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss 155 (1335)
|++.++.+..+....+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+|++|||.+.........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--- 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--- 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCCC---
T ss_conf 74004567899860477514456899999999999860574882678775056868997873236643011467654---
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCC---CC-------------
Q ss_conf 88887569998799500002799994024999999999998099999999789999998359---99-------------
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSD---PS------------- 219 (1335)
Q Consensus 156 ~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~---~~------------- 219 (1335)
.....|++.|+|||++.+..+++.++||||+||++|+|++|++||.+.+..+...++... +.
T Consensus 157 --~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 157 --YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred --CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf --101024311013788717888884100211175899997797998988989999999986389971104212333221
Q ss_pred ------------CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf ------------9999999956999999831259899999988962923236
Q 000715 220 ------------PPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 220 ------------~plp~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~ 259 (1335)
.......++.+.+||++||+.||++|||++|+++||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf 4333335676466651258999999999986689668909999856922074
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=384.72 Aligned_cols=252 Identities=25% Similarity=0.412 Sum_probs=223.4
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCE---EEEEEECCC----HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 858999787016957999999978870---999998171----1079999999999918999800489999828979999
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIE---YFAIKSVDK----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk---~VAIKiIdK----sq~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLV 74 (1335)
++|++.+.||+|+||+||+|+++.+++ .||+|.+.. ...+.+.+|++++++++||||+++++++.+.+.+|+|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 9604899978999838-999999999999999999999998797014789997477799975540356210035789998
Q 000715 75 LEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 75 MEyieGGSL~dlIkk~-g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ 153 (1335)
|||+++|+|.+++... +.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~ 185 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------------
T ss_pred EEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEECCCCCCCC
T ss_conf 97227985300210456799999999999999998898852798357615044898899919988844315756777765
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Q ss_conf 98888875699987995000027999940249999999999980-99999999789999998359999999999956999
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 154 ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~D 232 (1335)
.........|++.|+|||++. ++.++.++|||||||++|||++ |++||.+....++...+..+..++.+..++..+.+
T Consensus 186 ~~~~~~~~~~t~~y~aPE~~~-~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~ 264 (299)
T d1jpaa_ 186 TYTSALGGKIPIRWTAPEAIQ-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264 (299)
T ss_dssp ----------CGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred EEEECCCCCCCCCCCCHHHHH-CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHH
T ss_conf 365025666883003878883-6997861214453578999986799999999999999999737889997422699999
Q ss_pred HHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 9998312598999999889629
Q 000715 233 LINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 233 LIkkLLskDPekRPTAeEILkH 254 (1335)
++.+||+.||.+|||+.+++++
T Consensus 265 li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 265 LMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999758797689299999999
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.01 Aligned_cols=260 Identities=29% Similarity=0.444 Sum_probs=218.8
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH-----HHHHHHHHHHHHHHCCCCCCCEEEEEEEE--------
Q ss_conf 98589997870169579999999788709999981711-----07999999999991899980048999982--------
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYET-------- 67 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs-----q~eeIlrEIkILkkLkHPNIVkLlevfed-------- 67 (1335)
+++|++.+.||+|+||+||+|+++.+++.||+|++.+. ...++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCC
Q ss_conf 89799999604899978999838999999999999999999999998797014789997477799975540356210035
Q 000715 68 SAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLS 147 (1335)
Q Consensus 68 ~~~LyLVMEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~ 147 (1335)
...+|+||||+.++.+.........+++..++.++.|++.||.|||++||+||||||+||+++.++.+|++|||++....
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CCEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCEEEECC
T ss_conf 76389998535787410122203443308999999999999988522998856767222036689968763135002235
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHC---CCCCCCCC
Q ss_conf 789998988888756999879950000279999402499999999999809999999978999999835---99999999
Q 000715 148 DASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILS---DPSPPLPG 224 (1335)
Q Consensus 148 ~~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~---~~~~plp~ 224 (1335)
........ .....+||++|+|||++.+...|+.++||||+||++|+|++|++||.+.+.......+.. .+......
T Consensus 169 ~~~~~~~~-~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 169 LAKNSQPN-RYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp C-----CC-CCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred CCCCCCCC-CCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCC
T ss_conf 54443211-35660249787428997079998917870067864661744879989989999999999841899825534
Q ss_pred ----------------------------CCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf ----------------------------9995699999983125989999998896292323657
Q 000715 225 ----------------------------NPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 225 ----------------------------~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~l 261 (1335)
..++.+.|||.+||+.||++|||++|+++||||++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred CCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 43203444332013344555033404445998999999998738965890999997495015699
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=388.22 Aligned_cols=246 Identities=28% Similarity=0.468 Sum_probs=215.6
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCHH---------HHHHHHHHHHHHHCC--CCCCCEEEEEEEECCE
Q ss_conf 85899978701695799999997887099999817110---------799999999999189--9980048999982897
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---------KSKVLQEVRMLHSLD--HPNVLRFYSWYETSAH 70 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq---------~eeIlrEIkILkkLk--HPNIVkLlevfed~~~ 70 (1335)
++|++.+.||+|+||.||+|+++.+++.||+|.+.+.. ..++.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC-CCEEECCCCCCCCCCC
Q ss_conf 9999960489-9978999838999999999999999999999998797014789997477799-9755403562100357
Q 000715 71 LWLVLEYCVG-GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDEN-GRTKLCDFGLARKLSD 148 (1335)
Q Consensus 71 LyLVMEyieG-GSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDed-G~IKLiDFGLAr~l~~ 148 (1335)
+|+||||+.+ +++.+++.+++.+++.+++.++.|++.||.|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCEECCC
T ss_conf 89999833686228999861589999999999999999999998779755667611147744788489775465353244
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Q ss_conf 89998988888756999879950000279999402499999999999809999999978999999835999999999995
Q 000715 149 ASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPPLPGNPSR 228 (1335)
Q Consensus 149 ~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~plp~~iS~ 228 (1335)
.. ....+||+.|+|||++.+..+++.++||||+||++|+|++|+.||.+.+ .+... ...++..+++
T Consensus 164 ~~-------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~-~~~~~~~~s~ 229 (273)
T d1xwsa_ 164 TV-------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-QVFFRQRVSS 229 (273)
T ss_dssp SC-------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-CCCCSSCCCH
T ss_pred CC-------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH------HHHHC-CCCCCCCCCH
T ss_conf 45-------5665658774799998489978865332554034536756889988736------77615-4477877999
Q ss_pred HHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 699999983125989999998896292323657
Q 000715 229 PFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 229 eL~DLIkkLLskDPekRPTAeEILkHPFFq~~l 261 (1335)
++.+||.+||..||.+|||++|+++||||++..
T Consensus 230 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 999999997608975893999985398667887
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.49 Aligned_cols=253 Identities=30% Similarity=0.432 Sum_probs=211.9
Q ss_pred CEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEC------CEEEEEEE
Q ss_conf 589997870169579999999788709999981711079999999999918999800489999828------97999996
Q 000715 3 QYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLDHPNVLRFYSWYETS------AHLWLVLE 76 (1335)
Q Consensus 3 kYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq~eeIlrEIkILkkLkHPNIVkLlevfed~------~~LyLVME 76 (1335)
+|...+.||+|+||+||+|+++.+++.||+|++.+.. ....+|++++++++||||++++++|... .++|+|||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCC-HHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEEEEE
T ss_conf 7675169821768399999999999799999988160-689999999986689898738789974476577318999984
Q ss_pred ECCCCCHHHH---HHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC-CEEECCCCCCCCCCCCCCC
Q ss_conf 0489997899---98389999999999999999999999987970147899974777999-7554035621003578999
Q 000715 77 YCVGGDLMSL---LRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG-RTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 77 yieGGSL~dl---Ikk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG-~IKLiDFGLAr~l~~~~~~ 152 (1335)
|++++.+..+ ......+++.+++.|++|++.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~- 178 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP- 178 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC-
T ss_pred CCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECCCCHHHCCCCCC-
T ss_conf 1688607888863103689999999999999999999998668764578860378735897116733660544047765-
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--------------
Q ss_conf 898888875699987995000027999940249999999999980999999997899999983599--------------
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP-------------- 218 (1335)
Q Consensus 153 ~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~-------------- 218 (1335)
....+|++.|+|||++.+...|+.++||||+||++|||++|++||.+.+..+.+..+....
T Consensus 179 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 253 (350)
T d1q5ka_ 179 -----NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253 (350)
T ss_dssp -----CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred -----CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHCCC
T ss_conf -----320025555568277640468882100024652778550287998987999999999997489817765430621
Q ss_pred --CC------------CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf --99------------999999956999999831259899999988962923236579
Q 000715 219 --SP------------PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 219 --~~------------plp~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~l~ 262 (1335)
.. ......++++.+||.+||.+||.+|||+.|+++||||++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 0110355445674444315689999999999976589557929999966984524667
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.90 Aligned_cols=250 Identities=28% Similarity=0.494 Sum_probs=216.0
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH-----HHHHHHHHHHHHHHCCCCCCCEEEEEEEECC------E
Q ss_conf 8589997870169579999999788709999981711-----0799999999999189998004899998289------7
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSA------H 70 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs-----q~eeIlrEIkILkkLkHPNIVkLlevfed~~------~ 70 (1335)
++|++.+.||+|+||+||+|.++.+++.||+|++.+. ..+.+.+|++++++++||||++++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCE
T ss_conf 71899889801778199999999999899999985222596999999999999986689875479998635765555415
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCC
Q ss_conf 99999604899978999838999999999999999999999998797014789997477799975540356210035789
Q 000715 71 LWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDAS 150 (1335)
Q Consensus 71 LyLVMEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~ 150 (1335)
+|+||||+ +.+|..+++ ++.+++..++.++.||+.||.|||++||+||||||+||+++.++.+|++|||+++......
T Consensus 98 ~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~ 175 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 175 (346)
T ss_dssp CEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC
T ss_pred EEEEEECC-CCCHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEECCCCCC
T ss_conf 99998405-521899987-4022699999999999999999873787645668511112100122113431022068763
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC------------
Q ss_conf 99898888875699987995000027999940249999999999980999999997899999983599------------
Q 000715 151 KAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP------------ 218 (1335)
Q Consensus 151 ~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~------------ 218 (1335)
...+|++.|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+....
T Consensus 176 --------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 176 --------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp --------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred --------CCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHC
T ss_conf --------102455333588998178789965010300389999997869988897689999998503788488886530
Q ss_pred ------------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf ------------------9999999995699999983125989999998896292323657
Q 000715 219 ------------------SPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 219 ------------------~~plp~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~l 261 (1335)
........++.+.+||.+||..||.+|||+.|+++||||++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 0034433115786665566775568999999999997729955792999996396237587
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.30 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=215.3
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCE-----EEEEEECCCH----HHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCEE
Q ss_conf 858999787016957999999978870-----9999981711----079999999999918-999800489999828979
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIE-----YFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk-----~VAIKiIdKs----q~eeIlrEIkILkkL-kHPNIVkLlevfed~~~L 71 (1335)
++|++.+.||+|+||.||+|+++.+++ .||+|.+... ....+.+|+.++.++ +||||+++++++.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
T ss_conf 99397019830788199999985788554204999999663358789999999999999715899686877888629958
Q ss_pred EEEEEECCCCCHHHHHHHC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 9999604899978999838-----------------------99999999999999999999999879701478999747
Q 000715 72 WLVLEYCVGGDLMSLLRQD-----------------------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNIL 128 (1335)
Q Consensus 72 yLVMEyieGGSL~dlIkk~-----------------------g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNIL 128 (1335)
|+|||||++|+|.+++... +.+++..++.|+.|++.||.|||++||+||||||+||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHCCC
T ss_conf 99997279995999998625777510221000012220012577899999999999999999997399050527032144
Q ss_pred ECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCH
Q ss_conf 779997554035621003578999898888875699987995000027999940249999999999980-9999999978
Q 000715 129 LDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREF 207 (1335)
Q Consensus 129 IDedG~IKLiDFGLAr~l~~~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~ 207 (1335)
++.++.+||+|||+|+......... ......||+.|+|||++. ++.++.++||||+||++|||++ |.+||.+.+.
T Consensus 197 l~~~~~~Kl~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 197 VTHGKVVKICDFGLARDIMSDSNYV---VRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp EETTTEEEECCCGGGSCGGGCTTSE---EETTEEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred CCCCCEEEEEECCCCCCCCCCCCEE---EECCCCCCCCCCCHHHHC-CCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 3459828985142222045778615---623435787657838872-799996330300039999998389999999898
Q ss_pred HHHH-HHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 9999-9983599999999999569999998312598999999889629
Q 000715 208 TQLV-KSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 208 ~eLi-kkIl~~~~~plp~~iS~eL~DLIkkLLskDPekRPTAeEILkH 254 (1335)
...+ ..+..+..++.|..+++.+.+||.+||+.||++|||++++++|
T Consensus 273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 999999985699899887678999999999758896689399999999
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.23 Aligned_cols=252 Identities=30% Similarity=0.470 Sum_probs=209.9
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCC-CEEEEEEECCCH-----HHHHHHHHHHHHHHC---CCCCCCEEEEEEEE-----
Q ss_conf 8589997870169579999999788-709999981711-----079999999999918---99980048999982-----
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKT-IEYFAIKSVDKS-----QKSKVLQEVRMLHSL---DHPNVLRFYSWYET----- 67 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~T-Gk~VAIKiIdKs-----q~eeIlrEIkILkkL---kHPNIVkLlevfed----- 67 (1335)
++|++++.||+|+||+||+|++..+ ++.||+|++... ....+.+|+.+++.+ +||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCC
T ss_conf 89798889921558699999998889989999998023245167999999999999874258988023663221466666
Q ss_pred CCEEEEEEEECCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCC
Q ss_conf 897999996048999789998-3899999999999999999999999879701478999747779997554035621003
Q 000715 68 SAHLWLVLEYCVGGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKL 146 (1335)
Q Consensus 68 ~~~LyLVMEyieGGSL~dlIk-k~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l 146 (1335)
...+|++||++.++.+..... ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCHHHHHHH
T ss_conf 74699999740587144444303789998999999999999999997588983579862789858997542100010110
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC--------
Q ss_conf 578999898888875699987995000027999940249999999999980999999997899999983599--------
Q 000715 147 SDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDP-------- 218 (1335)
Q Consensus 147 ~~~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~-------- 218 (1335)
..... ....+||+.|+|||++. +..|+.++||||+||++|+|++|++||.+.+..+....+....
T Consensus 167 ~~~~~------~~~~~gT~~Y~APE~~~-~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 167 SFQMA------LTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CGGGG------GCCCCCCCTTCCHHHHT-TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred CCCCC------CCCCCCCHHHCCCCHHC-CCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHCC
T ss_conf 02345------77765485114831001-798881110003289999998787998998989999999984079961105
Q ss_pred ------------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf ------------------999999999569999998312598999999889629232365
Q 000715 219 ------------------SPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTK 260 (1335)
Q Consensus 219 ------------------~~plp~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~ 260 (1335)
...++...++.+.+||.+||.+||++|||+.|+++||||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred CCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 321111033302234564544044589999999999874896679189999669634075
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.60 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=221.7
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH-----HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
Q ss_conf 98589997870169579999999788709999981711-----0799999999999189998004899998289799999
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVL 75 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs-----q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVM 75 (1335)
|++|++++.||+|+||+||+|+++.+++.||+|++... ....+.+|+.+++.++||||+++++++.+....++|+
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 99978626971286819999999999969999998032178689999999999998567578882135444443115886
Q ss_pred EECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 60489997899983899999999999999999999999879701478999747779997554035621003578999898
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 76 EyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss 155 (1335)
+++.++++..++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||.+..........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~-- 158 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-- 158 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC--
T ss_pred EECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCCCCC--
T ss_conf 302332221121235654036789999999999877433998600146761211337826652046011046887510--
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHHCCC----------------
Q ss_conf 88887569998799500002799994024999999999998099999-9997899999983599----------------
Q 000715 156 MLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPF-VGREFTQLVKSILSDP---------------- 218 (1335)
Q Consensus 156 ~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF-~g~d~~eLikkIl~~~---------------- 218 (1335)
....+++.|+|||++.....++.++||||+||++|+|++|+.|| .+.+..+....+....
T Consensus 159 ---~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
T d1unla_ 159 ---SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp ---CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred ---EEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCC
T ss_conf ---01034431014667506988880444026541889985189999889999999999986118997355134432221
Q ss_pred ------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf ------------9999999995699999983125989999998896292323657
Q 000715 219 ------------SPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 219 ------------~~plp~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~l 261 (1335)
........++.+.+||.+||+.||.+|||++|+++||||++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred CCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 1334445443104330656899999999998649966890999996495340798
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=379.62 Aligned_cols=251 Identities=23% Similarity=0.402 Sum_probs=221.2
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH--HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEECC
Q ss_conf 8589997870169579999999788709999981711--07999999999991899980048999982897999996048
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs--q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVMEyie 79 (1335)
++|++.+.||+|+||.||+|.++.+++.||+|.+.+. ..+++.+|++++++++||||+++++++.+.+.+|+||||++
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEECCC
T ss_conf 99398659820888089999999999699999977761039999999999986799988267752745785478763146
Q ss_pred CCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 99978999838--9999999999999999999999987970147899974777999755403562100357899989888
Q 000715 80 GGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 80 GGSL~dlIkk~--g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss~l 157 (1335)
+|+|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 97 ~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~---- 172 (287)
T d1opja_ 97 YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA---- 172 (287)
T ss_dssp TCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE----
T ss_pred CCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCCEE----
T ss_conf 7606777530355415799999999999997888987893057604576899899928983244546537887221----
Q ss_pred CCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 88756999879950000279999402499999999999809-99999997899999983599999999999569999998
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAG-RPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTG-kpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~DLIkk 236 (1335)
.....|++.|+|||++.+ ..|+.++||||+||++|||++| .+||.+.+...+...+..+..++.+..+++.+.+|+.+
T Consensus 173 ~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 251 (287)
T d1opja_ 173 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251 (287)
T ss_dssp ETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ECCCCCCCCCCCHHHHCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
T ss_conf 035566546669278727-9998104302178999999867998877425999999985588888874330999999999
Q ss_pred HCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 31259899999988962923236
Q 000715 237 LLVKDPAQRLHWSDLCGHAFWRT 259 (1335)
Q Consensus 237 LLskDPekRPTAeEILkHPFFq~ 259 (1335)
||+.||++|||++++++ +|+.
T Consensus 252 cl~~dP~~Rps~~ei~~--~L~~ 272 (287)
T d1opja_ 252 CWQWNPSDRPSFAEIHQ--AFET 272 (287)
T ss_dssp HTCSSGGGSCCHHHHHH--HHHH
T ss_pred HCCCCHHHCCCHHHHHH--HHHH
T ss_conf 75779768939999999--9999
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.86 Aligned_cols=257 Identities=27% Similarity=0.477 Sum_probs=214.9
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCHH----HHHHHHHHHHHHHCCCCCCCEEEEEEEECC-----EEE
Q ss_conf 85899978701695799999997887099999817110----799999999999189998004899998289-----799
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ----KSKVLQEVRMLHSLDHPNVLRFYSWYETSA-----HLW 72 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq----~eeIlrEIkILkkLkHPNIVkLlevfed~~-----~Ly 72 (1335)
++|++++.||+|+||+||+|+++.+++.||+|++.+.. .+.+.+|+.++++++||||+++++++.... .+|
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 98599789940648099999999999499999980310958999999999999976898988588899505645541499
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 99960489997899983899999999999999999999999879701478999747779997554035621003578999
Q 000715 73 LVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 73 LVMEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~ 152 (1335)
++++ +.|++|.+++..+ .+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 88 l~~~-~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 88 LVTH-LMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp EEEE-CCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEE-ECCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCCC
T ss_conf 9996-2598656644058-9999999999999999999999789867778764378879997787545705650477764
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC-------------
Q ss_conf 8988888756999879950000279999402499999999999809999999978999999835999-------------
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPS------------- 219 (1335)
Q Consensus 153 ~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~------------- 219 (1335)
.. .....+|++.|+|||++.....++.++||||+||++|+|++|++||.+.+..+..........
T Consensus 166 ~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 166 TG--FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CC--TTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CE--EECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHH
T ss_conf 10--1011026520003878604788874101004670133776697997888889999987652069975664234332
Q ss_pred --------------C---CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf --------------9---999999956999999831259899999988962923236579
Q 000715 220 --------------P---PLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 220 --------------~---plp~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~l~ 262 (1335)
. ......+..+.+|+.+||..||.+|||++++++||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 222024467755778777837899999999999976489567908999861986555889
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=374.05 Aligned_cols=251 Identities=25% Similarity=0.436 Sum_probs=212.6
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEEC--CEEEEEEEEC
Q ss_conf 8589997870169579999999788709999981711079999999999918-999800489999828--9799999604
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSL-DHPNVLRFYSWYETS--AHLWLVLEYC 78 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq~eeIlrEIkILkkL-kHPNIVkLlevfed~--~~LyLVMEyi 78 (1335)
++|++++.||+|+||+||+|+++.+++.||+|++.+...+++.+|+++++++ .||||+++++++... ..+++||||+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEEEEC
T ss_conf 67189789831748199999988999799999988899999999999998515799876799999816877126888631
Q ss_pred CCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC-CEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 8999789998389999999999999999999999987970147899974777999-755403562100357899989888
Q 000715 79 VGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG-RTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 79 eGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG-~IKLiDFGLAr~l~~~~~~~ss~l 157 (1335)
.+++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 115 ~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~------ 185 (328)
T d3bqca1 115 NNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE------ 185 (328)
T ss_dssp CSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC------
T ss_pred CCCCHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECCCCCC------
T ss_conf 798589974---68999999999999999998876433443456441237748998366415654266468874------
Q ss_pred CCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHC----------------C---
Q ss_conf 8875699987995000027999940249999999999980999999997-8999999835----------------9---
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE-FTQLVKSILS----------------D--- 217 (1335)
Q Consensus 158 ~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d-~~eLikkIl~----------------~--- 217 (1335)
....+||+.|+|||++.+...++.++||||+||++|+|++|+.||.... ..+....+.. .
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 265 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCCCCCC
T ss_conf 44322486424761026888888452323354555876048899988760189999999987884155555422544474
Q ss_pred -----------------CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf -----------------99999999995699999983125989999998896292323657
Q 000715 218 -----------------PSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 218 -----------------~~~plp~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~l 261 (1335)
........+++++.+||++||.+||.+|||++|+++||||++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred CCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf 3000003334331121155211244899999999998669956890899996493558879
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.08 Aligned_cols=253 Identities=21% Similarity=0.376 Sum_probs=220.3
Q ss_pred CCEEEEEE-EECCCCEEEEEEEECC--CCEEEEEEECCC----HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 85899978-7016957999999978--870999998171----1079999999999918999800489999828979999
Q 000715 2 NQYHIYEA-IGRGKYSTVYKGRKKK--TIEYFAIKSVDK----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 ekYeIlK~-LGkGsFGtVYkAkdk~--TGk~VAIKiIdK----sq~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLV 74 (1335)
++|.+.+. ||+|+||.||+|.++. ++..||+|.+.+ ...+.+.+|++++++++||||+++++++.+ +.+|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 4718878487306080999999960897689999998820397899999999999986799888068656036-807999
Q ss_pred EEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 960489997899983-8999999999999999999999998797014789997477799975540356210035789998
Q 000715 75 LEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 75 MEyieGGSL~dlIkk-~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ 153 (1335)
|||+++|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCCCCCCC
T ss_conf 98078996899752125699999999999999998789986881057676466045468854203313421155434321
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Q ss_conf 98888875699987995000027999940249999999999980-99999999789999998359999999999956999
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 154 ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~D 232 (1335)
. ......||+.|+|||++.. +.++.++||||+||++|||++ |+.||.+.+..++...+..+.+++.|..+++++.+
T Consensus 167 ~--~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 167 T--ARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp C--CCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred C--CCCCCCCCCCCCCHHHHHC-CCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
T ss_conf 1--3562113743358688727-999954123220178999993899999997999999999818999999767899999
Q ss_pred HHHHHCCCCCCCCCCHHHH---HCCCCCC
Q ss_conf 9998312598999999889---6292323
Q 000715 233 LINSLLVKDPAQRLHWSDL---CGHAFWR 258 (1335)
Q Consensus 233 LIkkLLskDPekRPTAeEI---LkHPFFq 258 (1335)
++.+||..||++|||+.++ ++|+|+.
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 99997577976890999999999999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.22 Aligned_cols=247 Identities=23% Similarity=0.405 Sum_probs=216.3
Q ss_pred EEEECCCCEEEEEEEEC--CCCEEEEEEECCCH-----HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEECCC
Q ss_conf 78701695799999997--88709999981711-----079999999999918999800489999828979999960489
Q 000715 8 EAIGRGKYSTVYKGRKK--KTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCVG 80 (1335)
Q Consensus 8 K~LGkGsFGtVYkAkdk--~TGk~VAIKiIdKs-----q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVMEyieG 80 (1335)
++||+|+||.||+|.++ .+++.||+|.+... ..+.+.+|++++++++||||+++++++.++ ..|+||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC-CEEEEEECCCC
T ss_conf 78345878299999981697385999999880108989999999999999867998985277775059-77999974788
Q ss_pred CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99789998389999999999999999999999987970147899974777999755403562100357899989888887
Q 000715 81 GDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLPQA 160 (1335)
Q Consensus 81 GSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss~l~~t 160 (1335)
|+|.+++.+...+++..+..|+.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......... ....
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~--~~~~ 169 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTH 169 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE--C---
T ss_pred CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCC--CCCC
T ss_conf 96899975225789999999999999997668747955677761131023567512341345331343234432--2445
Q ss_pred CCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 5699987995000027999940249999999999980-999999997899999983599999999999569999998312
Q 000715 161 KCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSLLV 239 (1335)
Q Consensus 161 ~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~DLIkkLLs 239 (1335)
..||+.|+|||++.. ..++.++|||||||++|||++ |++||.+.+..++...+..+.+++.|..+++++.+++.+||+
T Consensus 170 ~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~ 248 (277)
T d1xbba_ 170 GKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 248 (277)
T ss_dssp -CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCCEECCCHHHCC-CCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCC
T ss_conf 677842039166537-9998434430340313289658999999989999999998289999986567999999999758
Q ss_pred CCCCCCCCHHHH---HCCCCCC
Q ss_conf 598999999889---6292323
Q 000715 240 KDPAQRLHWSDL---CGHAFWR 258 (1335)
Q Consensus 240 kDPekRPTAeEI---LkHPFFq 258 (1335)
.||.+|||++++ |+|+|+.
T Consensus 249 ~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 249 YDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp SSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCHHHCCCHHHHHHHHHCHHHH
T ss_conf 8976890989999985288750
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.52 Aligned_cols=247 Identities=23% Similarity=0.408 Sum_probs=221.2
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH--HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEECC
Q ss_conf 8589997870169579999999788709999981711--07999999999991899980048999982897999996048
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs--q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVMEyie 79 (1335)
++|++.+.||+|+||.||+|+++. +..||+|.+.+. ..+++.+|++++++++||||+++++++.+.+.+|+||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECC-CCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 995888898208882999999889-9999999987886768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99978999838-99999999999999999999999879701478999747779997554035621003578999898888
Q 000715 80 GGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 80 GGSL~dlIkk~-g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss~l~ 158 (1335)
+|+|.+++... ..+++..+..++.|++.||.|+|+++|+||||||+||+++.++.+||+|||+++......... .
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~----~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS----S 159 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEE----E
T ss_conf 991899752013478899999999999998776531643104431532666688776865532100236887335----0
Q ss_pred CCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 875699987995000027999940249999999999980-9999999978999999835999999999995699999983
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 159 ~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~DLIkkL 237 (1335)
....||+.|+|||++. +..|+.++||||+|+++|||++ |.+||...+..++...+..+.....|..+++.+.+++.+|
T Consensus 160 ~~~~gt~~y~aPE~l~-~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 238 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFS-FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238 (263)
T ss_dssp -----CTTSCCHHHHT-TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHH
T ss_pred CCEECCCCCCCHHHHC-CCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
T ss_conf 4300176667857860-799984033210599999998789888778999999999980688899543679999999997
Q ss_pred CCCCCCCCCCHHHHHCC
Q ss_conf 12598999999889629
Q 000715 238 LVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 238 LskDPekRPTAeEILkH 254 (1335)
|+.||++|||++++++|
T Consensus 239 l~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 239 WKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHCCCHHHHHHH
T ss_conf 65797689199999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.16 Aligned_cols=256 Identities=32% Similarity=0.566 Sum_probs=220.2
Q ss_pred CCCEEEEEEEECCCCEEEEEEEE---CCCCEEEEEEECCCH-------HHHHHHHHHHHHHHCCC-CCCCEEEEEEEECC
Q ss_conf 98589997870169579999999---788709999981711-------07999999999991899-98004899998289
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRK---KKTIEYFAIKSVDKS-------QKSKVLQEVRMLHSLDH-PNVLRFYSWYETSA 69 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkd---k~TGk~VAIKiIdKs-------q~eeIlrEIkILkkLkH-PNIVkLlevfed~~ 69 (1335)
+++|++++.||+|+||+||+|++ +.+++.||+|.+.+. ..+.+.+|++++++++| |||+++++++++..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 10259998983287839999998765887948999998367721016899999999999986467983999620002487
Q ss_pred EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCC
Q ss_conf 79999960489997899983899999999999999999999999879701478999747779997554035621003578
Q 000715 70 HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 70 ~LyLVMEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~ 149 (1335)
.+|++|||+.+|+|.+++...+.+++..++.++.|++.||.|+|++||+||||||+||+++.+|.+||+|||++..+...
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred CEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHHHCCC
T ss_conf 30012312341179999873045437888888999999998851499896547732012469998887413202220344
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH---HHHCCCCCCCCCC
Q ss_conf 999898888875699987995000027-999940249999999999980999999997899999---9835999999999
Q 000715 150 SKAPSSMLPQAKCGTPCYMAPELFEEG-GVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVK---SILSDPSPPLPGN 225 (1335)
Q Consensus 150 ~~~~ss~l~~t~vGTp~YlAPEVL~~~-~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLik---kIl~~~~~plp~~ 225 (1335)
... ......|++.|+|||.+... ..++.++||||+||++|+|++|+.||.+.+..+... .......++++..
T Consensus 183 ~~~----~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (322)
T d1vzoa_ 183 ETE----RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 258 (322)
T ss_dssp GGG----GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred CCC----CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCC
T ss_conf 443----2212223333310687605776887132517777999999768999888877779999998335689988654
Q ss_pred CCHHHHHHHHHHCCCCCCCCC-----CHHHHHCCCCCCCC
Q ss_conf 995699999983125989999-----99889629232365
Q 000715 226 PSRPFANLINSLLVKDPAQRL-----HWSDLCGHAFWRTK 260 (1335)
Q Consensus 226 iS~eL~DLIkkLLskDPekRP-----TAeEILkHPFFq~~ 260 (1335)
.++.+.+||.+||.+||.+|| |++|+++||||++.
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCC
T ss_conf 7999999999974458988199974509999749723489
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=373.75 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=218.2
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH------HHHHHHHHHHHHHHCCCCCCCEEEEEEEECC----EE
Q ss_conf 8589997870169579999999788709999981711------0799999999999189998004899998289----79
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSA----HL 71 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs------q~eeIlrEIkILkkLkHPNIVkLlevfed~~----~L 71 (1335)
++|++.+.||+|+||.||+|+++.+++.||+|++.+. ....+.+|+++++.++||||+++++++.... .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEE
T ss_conf 20698689960899299999999999899999985566469899999999999998569998873114354326887669
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCC
Q ss_conf 99996048999789998389999999999999999999999987970147899974777999755403562100357899
Q 000715 72 WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 72 yLVMEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~ 151 (1335)
|+||||++|++|.+++...+.+++.+++.++.|++.||.|||++||+||||||+||+++.++..+++|||.+........
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCCCCC
T ss_conf 99997788987101120358999999999999999999999857952763467556657543201003444322123544
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC---CCCCCCCH
Q ss_conf 989888887569998799500002799994024999999999998099999999789999998359999---99999995
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSP---PLPGNPSR 228 (1335)
Q Consensus 152 ~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~---plp~~iS~ 228 (1335)
.. ......+||+.|+|||++. +..++.++||||+||++|+|++|++||.+.+..+...++...... ..+..+++
T Consensus 167 ~~--~~~~~~~Gt~~Y~aPE~~~-~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 243 (277)
T d1o6ya_ 167 SV--TQTAAVIGTAQYLSPEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA 243 (277)
T ss_dssp --------------TTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred CC--CCCCCCCCCCCCCCHHHHC-CCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCHHCCCCCH
T ss_conf 33--3346425762436999983-99999663202652899999769799899699999999984699997100347899
Q ss_pred HHHHHHHHHCCCCCCCCCCHHHHHCCCCCC
Q ss_conf 699999983125989999998896292323
Q 000715 229 PFANLINSLLVKDPAQRLHWSDLCGHAFWR 258 (1335)
Q Consensus 229 eL~DLIkkLLskDPekRPTAeEILkHPFFq 258 (1335)
.+.++|.+||.+||.+||+..+.+.|+|.+
T Consensus 244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 244 DLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCHHHCHHHHHHHHHHHHH
T ss_conf 999999998667976777399999999999
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.19 Aligned_cols=252 Identities=27% Similarity=0.466 Sum_probs=215.5
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH-----HHHHHHHHHHHHHHCCCCCCCEEEEEEEEC-----CEE
Q ss_conf 8589997870169579999999788709999981711-----079999999999918999800489999828-----979
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-----QKSKVLQEVRMLHSLDHPNVLRFYSWYETS-----AHL 71 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs-----q~eeIlrEIkILkkLkHPNIVkLlevfed~-----~~L 71 (1335)
++|++.+.||+|+||+||+|+++.+++.||+|++.+. ..+.+.+|++++++++||||+++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCE
T ss_conf 87188889831788399999999999799999988200286899999999999986689874259999963464566864
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCC
Q ss_conf 99996048999789998389999999999999999999999987970147899974777999755403562100357899
Q 000715 72 WLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 72 yLVMEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~ 151 (1335)
+++++++.||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+||+++.+|.+|++|||++.......
T Consensus 98 ~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~- 175 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM- 175 (348)
T ss_dssp CEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGGG-
T ss_pred EEEEEEECCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCC-
T ss_conf 999996258862320022-453099999999999999999973887651667763345543220013210001257544-
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC----------
Q ss_conf 9898888875699987995000027999940249999999999980999999997899999983599999----------
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP---------- 221 (1335)
Q Consensus 152 ~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~p---------- 221 (1335)
....|++.|+|||++.+...++.++||||+||++|+|++|++||.+.+.......+......+
T Consensus 176 -------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 176 -------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp -------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred -------CCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHCCC
T ss_conf -------4434543555835533775678551243205899999768899788988999999997307997577320010
Q ss_pred --------------------CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCCC
Q ss_conf --------------------99999956999999831259899999988962923236579
Q 000715 222 --------------------LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKLT 262 (1335)
Q Consensus 222 --------------------lp~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~l~ 262 (1335)
.....++.+.+||.+||..||.+|||+.|+++||||++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 2445444303557875556626789999999999977588345938999855995487999
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.99 Aligned_cols=251 Identities=23% Similarity=0.436 Sum_probs=220.3
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH--HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEECC
Q ss_conf 8589997870169579999999788709999981711--07999999999991899980048999982897999996048
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs--q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVMEyie 79 (1335)
++|++.+.||+|+||.||+|.++. +..||+|.+.+. ..+.+.+|++++++++||||+++++++.+ +.+|+||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHEEEEEEEECCCCCEEEEEEECC-CCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEECC
T ss_conf 993886798107982899999999-9999999986476888999999999986799988578731045-97699999578
Q ss_pred CCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 99978999838--9999999999999999999999987970147899974777999755403562100357899989888
Q 000715 80 GGDLMSLLRQD--NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 80 GGSL~dlIkk~--g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss~l 157 (1335)
+|+|.+++... ..+++.++..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+|+.........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~---- 166 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA---- 166 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC----
T ss_pred CCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCCC----
T ss_conf 9828888751478988788999999999999999974895467564225156202440423410147735886442----
Q ss_pred CCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 8875699987995000027999940249999999999980-999999997899999983599999999999569999998
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~DLIkk 236 (1335)
.....|++.|+|||++.. +.++.++||||+||++|||++ |.+||...+..++...+..+..++.|..+++++.+|+.+
T Consensus 167 ~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 245 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245 (272)
T ss_dssp CTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
T ss_conf 035677444458289837-9998245645257999999968988888889999999997068888965571999999999
Q ss_pred HCCCCCCCCCCHHHHHC--CCCCCC
Q ss_conf 31259899999988962--923236
Q 000715 237 LLVKDPAQRLHWSDLCG--HAFWRT 259 (1335)
Q Consensus 237 LLskDPekRPTAeEILk--HPFFq~ 259 (1335)
||+.||++|||++++++ |+||..
T Consensus 246 cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 246 CWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 7588976893999999986113213
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.92 Aligned_cols=247 Identities=21% Similarity=0.407 Sum_probs=222.9
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH--HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEECC
Q ss_conf 8589997870169579999999788709999981711--07999999999991899980048999982897999996048
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs--q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVMEyie 79 (1335)
++|++.++||+|+||+||+|+++ +++.||+|.+.+. ..+.+.+|+.++.+++||||+++++++.+++.+|+||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 99799689820788399999988-99899999987475778999999999996689860158899850781699997048
Q ss_pred CCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 9997899983-899999999999999999999999879701478999747779997554035621003578999898888
Q 000715 80 GGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSMLP 158 (1335)
Q Consensus 80 GGSL~dlIkk-~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss~l~ 158 (1335)
+|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......... .
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~----~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS----S 158 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC----C
T ss_pred CCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEE----E
T ss_conf 993888641024677689999999999999998754684346654135887699847988614420235787225----2
Q ss_pred CCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 875699987995000027999940249999999999980-9999999978999999835999999999995699999983
Q 000715 159 QAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINSL 237 (1335)
Q Consensus 159 ~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~DLIkkL 237 (1335)
....|++.|+|||++.. ..++.++||||+|+++|||++ |+.||.+.+..++...+..+.+.+.|...++.+.+|+.+|
T Consensus 159 ~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~c 237 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSC 237 (258)
T ss_dssp CCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHT
T ss_pred CCCCCCCCCCCCHHHCC-CCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
T ss_conf 46578877578078637-99885210336432467397559999889999999999980797899654659999999997
Q ss_pred CCCCCCCCCCHHHHHCC
Q ss_conf 12598999999889629
Q 000715 238 LVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 238 LskDPekRPTAeEILkH 254 (1335)
|+.||++|||++++++|
T Consensus 238 l~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 238 WHEKADERPTFKILLSN 254 (258)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHCCCHHHHHHH
T ss_conf 66897689399999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.45 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=218.6
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCC----EEEEEEECCCH----HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 85899978701695799999997887----09999981711----07999999999991899980048999982897999
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTI----EYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TG----k~VAIKiIdKs----q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyL 73 (1335)
+.|++.+.||+|+||.||+|.++.++ ..||+|.+... ....+.+|++++++++||||+++++++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 99604899978999838-99999999999999999999999879701478999747779997554035621003578999
Q 000715 74 VLEYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 74 VMEyieGGSL~dlIkk~-g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~ 152 (1335)
||||+.++++.+++... +.+++.++..++.|++.|+.|||+++|+||||||+|||++.++.+||+|||+++........
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred EEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHCCCCCCCC
T ss_conf 99721357402221023454208999999999998541212123425765644278889984998455103003578765
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Q ss_conf 898888875699987995000027999940249999999999980-9999999978999999835999999999995699
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFA 231 (1335)
Q Consensus 153 ~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~ 231 (1335)
.. ......||+.|+|||++. ++.++.++|||||||++|||++ |.+||.+.+..++...+..+.+++.+..++..+.
T Consensus 167 ~~--~~~~~~gt~~Y~APE~l~-~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 243 (283)
T d1mqba_ 167 TY--TTSGGKIPIRWTAPEAIS-YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 243 (283)
T ss_dssp ---------CCCGGGSCHHHHH-SCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred CE--EECCCCCCCCCCCHHHHC-CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHH
T ss_conf 26--742677773434888870-499997355634489899999679886556899999999863578998504579999
Q ss_pred HHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 9999831259899999988962
Q 000715 232 NLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 232 DLIkkLLskDPekRPTAeEILk 253 (1335)
+++.+||+.||++|||+.++++
T Consensus 244 ~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 244 QLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999977679768939999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.40 Aligned_cols=251 Identities=24% Similarity=0.414 Sum_probs=211.0
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCC-----HHHHHHHHHHHHHHHCCCCCCCEEEEEEEE------CC
Q ss_conf 9858999787016957999999978870999998171-----107999999999991899980048999982------89
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK-----SQKSKVLQEVRMLHSLDHPNVLRFYSWYET------SA 69 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdK-----sq~eeIlrEIkILkkLkHPNIVkLlevfed------~~ 69 (1335)
+++|++.+.||+|+||+||+|+++.+++.||+|++.+ ....++.+|+.++++++||||++++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCC
Q ss_conf 79999960489997899983899999999999999999999999879701478999747779997554035621003578
Q 000715 70 HLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDA 149 (1335)
Q Consensus 70 ~LyLVMEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~ 149 (1335)
++|+||||+.++. .+.+ ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+|++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~l-~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANL-CQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEH-HHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEEEEECCCHHH-HHHH--HCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECHHHHHCCCCC
T ss_conf 2699984144677-8765--038999999999999999998865221124567763211365443132010232114666
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC--------
Q ss_conf 999898888875699987995000027999940249999999999980999999997899999983599999--------
Q 000715 150 SKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKSILSDPSPP-------- 221 (1335)
Q Consensus 150 ~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikkIl~~~~~p-------- 221 (1335)
.. ....+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+......++......+
T Consensus 173 ~~------~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 173 FM------MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp --------------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred CC------CCCCCCCCCCCCHHHHCC-CCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHH
T ss_conf 55------332214655558133147-77787743335662578986598998889778899999972058987999876
Q ss_pred -------------C--------------C------CCCCHHHHHHHHHHCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf -------------9--------------9------99995699999983125989999998896292323657
Q 000715 222 -------------L--------------P------GNPSRPFANLINSLLVKDPAQRLHWSDLCGHAFWRTKL 261 (1335)
Q Consensus 222 -------------l--------------p------~~iS~eL~DLIkkLLskDPekRPTAeEILkHPFFq~~l 261 (1335)
. + ...++++.+||.+||..||++|||++|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf 5667777641754356664212643335432101333799999999998769945790899996694208788
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.88 Aligned_cols=247 Identities=28% Similarity=0.409 Sum_probs=207.8
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCC-----HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
Q ss_conf 858999787016957999999978870999998171-----107999999999991899980048999982897999996
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK-----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdK-----sq~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVME 76 (1335)
++|++.+.||+|+||.||+|+.+. .||+|.+.. ...+.+.+|+.++++++||||+++++++. ...+|+|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECC---EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEEEEE
T ss_conf 518998898307885899999999---8999999734699899999999999998479987864567971-558999996
Q ss_pred ECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 04899978999838-99999999999999999999999879701478999747779997554035621003578999898
Q 000715 77 YCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSS 155 (1335)
Q Consensus 77 yieGGSL~dlIkk~-g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss 155 (1335)
|+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~-- 161 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH-- 161 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCCC--
T ss_conf 589988899985235789999999999999999888750999516147899798189978875002213335567763--
Q ss_pred CCCCCCCCCCCCCCCCHHCC--CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHCCCCC----CCCCCCCH
Q ss_conf 88887569998799500002--799994024999999999998099999999789999-998359999----99999995
Q 000715 156 MLPQAKCGTPCYMAPELFEE--GGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLV-KSILSDPSP----PLPGNPSR 228 (1335)
Q Consensus 156 ~l~~t~vGTp~YlAPEVL~~--~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLi-kkIl~~~~~----plp~~iS~ 228 (1335)
......||+.|+|||++.. ...|+.++||||+||++|||++|+.||.+.+..... ..+..+... ..+..+++
T Consensus 162 -~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 240 (276)
T d1uwha_ 162 -QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPK 240 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCH
T ss_pred -CCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCHHCCCCCHH
T ss_conf -1256655743179999950568999953151635999999997889989989699999999658889860003655549
Q ss_pred HHHHHHHHHCCCCCCCCCCHHHHHCCC
Q ss_conf 699999983125989999998896292
Q 000715 229 PFANLINSLLVKDPAQRLHWSDLCGHA 255 (1335)
Q Consensus 229 eL~DLIkkLLskDPekRPTAeEILkHP 255 (1335)
.+.+++.+||..||++|||+.+++++-
T Consensus 241 ~l~~li~~cl~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 241 AMKRLMAECLKKKRDERPLFPQILASI 267 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 999999997588976892999999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.60 Aligned_cols=252 Identities=24% Similarity=0.416 Sum_probs=220.8
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH--HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEECC
Q ss_conf 8589997870169579999999788709999981711--07999999999991899980048999982897999996048
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs--q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLVMEyie 79 (1335)
++|++.+.||+|+||.||+|+++.+ ..||+|.+... ..+.+.+|+.++++++||||+++++++.+ +.+|+||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEECC
T ss_conf 9979846993079809999999999-999999988044888999999999986666788689999823-97599999447
Q ss_pred CCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 9997899983--89999999999999999999999987970147899974777999755403562100357899989888
Q 000715 80 GGDLMSLLRQ--DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSML 157 (1335)
Q Consensus 80 GGSL~dlIkk--~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss~l 157 (1335)
+|+|..++.. .+.+++.++..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~---- 170 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA---- 170 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCEE----
T ss_conf 9943542000035530599999999999999998754114335312307999899929984425554256887335----
Q ss_pred CCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 8875699987995000027999940249999999999980-999999997899999983599999999999569999998
Q 000715 158 PQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLINS 236 (1335)
Q Consensus 158 ~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~DLIkk 236 (1335)
.....|++.|+|||++. .+.++.++||||+|+++|||++ |.+||.+....++...+..+...+.+..+++++.++|.+
T Consensus 171 ~~~~~gt~~y~aPE~~~-~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~ 249 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249 (285)
T ss_dssp -----CCGGGSCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred ECCCCCCCCCCCHHHHH-CCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
T ss_conf 24545566545808983-79989177413235899999868999998888999999998268999983237999999999
Q ss_pred HCCCCCCCCCCHHHHHC--CCCCCCC
Q ss_conf 31259899999988962--9232365
Q 000715 237 LLVKDPAQRLHWSDLCG--HAFWRTK 260 (1335)
Q Consensus 237 LLskDPekRPTAeEILk--HPFFq~~ 260 (1335)
||+.||++||+++++++ ++||...
T Consensus 250 cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 250 CWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf 75669758919999999876662389
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.70 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=218.7
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCE----EEEEEECCC----HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
Q ss_conf 858999787016957999999978870----999998171----107999999999991899980048999982897999
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIE----YFAIKSVDK----SQKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk----~VAIKiIdK----sq~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyL 73 (1335)
++|++.+.||+|+||+||+|.+..+++ .||+|.+.. ...+.+.+|++++++++||||+++++++.+.. .++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC-EEE
T ss_conf 9997831982089929999999589988989999999651349799999999999998679988815899996198-369
Q ss_pred EEEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 9960489997899983-899999999999999999999999879701478999747779997554035621003578999
Q 000715 74 VLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKA 152 (1335)
Q Consensus 74 VMEyieGGSL~dlIkk-~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~ 152 (1335)
++|++.+++|.+.+.. ...+++..++.|+.|++.||.|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~ 167 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC-
T ss_pred EEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCCCCCC
T ss_conf 99842687401011133457999999999999999999998769504762120311679987586025522233544453
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Q ss_conf 898888875699987995000027999940249999999999980-9999999978999999835999999999995699
Q 000715 153 PSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFA 231 (1335)
Q Consensus 153 ~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~ 231 (1335)
.. .....||+.|+|||++.+ +.++.++|||||||++|||++ |.+||.+.+..++...+..+.+++.|..+++.+.
T Consensus 168 ~~---~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~ 243 (317)
T d1xkka_ 168 YH---AEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 243 (317)
T ss_dssp ----------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHH
T ss_pred CC---CCCCCCCCCCCCHHHHHC-CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
T ss_conf 22---365105864467088746-99983565440799999999779999999998999999975998999855689999
Q ss_pred HHHHHHCCCCCCCCCCHHHHHCCCC
Q ss_conf 9999831259899999988962923
Q 000715 232 NLINSLLVKDPAQRLHWSDLCGHAF 256 (1335)
Q Consensus 232 DLIkkLLskDPekRPTAeEILkHPF 256 (1335)
+++.+||..||.+|||+.+++.|..
T Consensus 244 ~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 244 MIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 9999847899346919999999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.42 Aligned_cols=247 Identities=27% Similarity=0.446 Sum_probs=218.6
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCC---CEEEEEEECCCH----HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
Q ss_conf 8589997870169579999999788---709999981711----079999999999918999800489999828979999
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKT---IEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLWLV 74 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~T---Gk~VAIKiIdKs----q~eeIlrEIkILkkLkHPNIVkLlevfed~~~LyLV 74 (1335)
++|++.+.||+|+||.||+|.+..+ +..||+|.+... ..+.+.+|++++++++||||+++++++. .+.+|+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEEE
T ss_conf 996987799307882999999936996449999999365668799999999999998689999856988995-3747999
Q ss_pred EEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 960489997899983-8999999999999999999999998797014789997477799975540356210035789998
Q 000715 75 LEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 75 MEyieGGSL~dlIkk-~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ 153 (1335)
|||+++|++.+++.. .+.+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.........
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~ 165 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 165 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------------
T ss_pred EEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHEECCCCCCEE
T ss_conf 98406980776542247899999999999999877523022674414102655320678967876503421336776233
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Q ss_conf 98888875699987995000027999940249999999999980-99999999789999998359999999999956999
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFAN 232 (1335)
Q Consensus 154 ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~D 232 (1335)
.....||+.|+|||++. +..++.++||||+||++|||++ |.+||.+.+..++...+..+..++.+..+++.+.+
T Consensus 166 ----~~~~~gt~~y~apE~l~-~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 166 ----ASKGKLPIKWMAPESIN-FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240 (273)
T ss_dssp ---------CCGGGCCHHHHH-HCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ----CCCEECCCCCCHHHHHC-CCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
T ss_conf ----05400583103266751-6998874524442478999982699998889999999999818999898777999999
Q ss_pred HHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 9998312598999999889629
Q 000715 233 LINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 233 LIkkLLskDPekRPTAeEILkH 254 (1335)
||.+||..||++|||+.++++|
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9999768797689299999999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.77 Aligned_cols=247 Identities=27% Similarity=0.412 Sum_probs=220.7
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEE--EEEEECCC----HHHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCEEEE
Q ss_conf 98589997870169579999999788709--99998171----1079999999999918-99980048999982897999
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEY--FAIKSVDK----SQKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~--VAIKiIdK----sq~eeIlrEIkILkkL-kHPNIVkLlevfed~~~LyL 73 (1335)
+++|++.+.||+|+||.||+|+++.++.. ||+|.+.. ...+.+.+|++++.++ +||||+++++++.+.+.+|+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
T ss_conf 79968877982078828999999899969999999978233857999999999999862289988367888841873699
Q ss_pred EEEECCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEE
Q ss_conf 99604899978999838----------------99999999999999999999999879701478999747779997554
Q 000715 74 VLEYCVGGDLMSLLRQD----------------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKL 137 (1335)
Q Consensus 74 VMEyieGGSL~dlIkk~----------------g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKL 137 (1335)
||||+++|+|.+++... ..+++.++..++.|++.|+.|+|+++++||||||+|||++.++.+||
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCEEE
T ss_conf 99802898699998640355555123101234578999999999999999987663089545550520489868876387
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHHC
Q ss_conf 0356210035789998988888756999879950000279999402499999999999809-999999978999999835
Q 000715 138 CDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAG-RPPFVGREFTQLVKSILS 216 (1335)
Q Consensus 138 iDFGLAr~l~~~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTG-kpPF~g~d~~eLikkIl~ 216 (1335)
+|||+++........ ....||+.|+|||.+.+ +.++.++||||||+++|||++| .+||.+.+..++...+..
T Consensus 169 ~DfG~a~~~~~~~~~------~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~ 241 (309)
T d1fvra_ 169 ADFGLSRGQEVYVKK------TMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241 (309)
T ss_dssp CCTTCEESSCEECCC----------CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG
T ss_pred CCCCCCCCCCCCCCC------CCEECCCCCCCHHHHCC-CCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
T ss_conf 434432244422345------53013775555387526-99996221531388999998368999999999999999982
Q ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 99999999999569999998312598999999889629
Q 000715 217 DPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 217 ~~~~plp~~iS~eL~DLIkkLLskDPekRPTAeEILkH 254 (1335)
+.+++.+..+++++.+||.+||+.||++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 242 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 68888876678999999999767896689499999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=360.60 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=220.2
Q ss_pred CCEEEEEEEECCCCEEEEEEEECC-----CCEEEEEEECCCH----HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 858999787016957999999978-----8709999981711----0799999999999189998004899998289799
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-----TIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~-----TGk~VAIKiIdKs----q~eeIlrEIkILkkLkHPNIVkLlevfed~~~Ly 72 (1335)
++|++.+.||+|+||+||+|++++ ++..||+|.+... ..+++.+|++++++++||||+++++++.+....+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCCEE
T ss_conf 89388679820788399999988876577882999999882108579999999999999668997655246660598038
Q ss_pred EEEEECCCCCHHHHHHHCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 9996048999789998389------------------------9999999999999999999999879701478999747
Q 000715 73 LVLEYCVGGDLMSLLRQDN------------------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNIL 128 (1335)
Q Consensus 73 LVMEyieGGSL~dlIkk~g------------------------~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNIL 128 (1335)
+||||+++|+|.+++.... .+++..+..++.|++.|+.|||+++++||||||+||+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NIL 172 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCL 172 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEECCCCEE
T ss_conf 99981589929999985275542100001110012103467889899999999999999855413578685488401168
Q ss_pred ECCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCH
Q ss_conf 7799975540356210035789998988888756999879950000279999402499999999999809-999999978
Q 000715 129 LDENGRTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAG-RPPFVGREF 207 (1335)
Q Consensus 129 IDedG~IKLiDFGLAr~l~~~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTG-kpPF~g~d~ 207 (1335)
++.++.+||+|||+++......... ......|++.|+|||++. +..|+.++|||||||++|||++| .+||.+.+.
T Consensus 173 ld~~~~~Kl~DFGls~~~~~~~~~~---~~~~~~~~~~y~aPE~~~-~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 173 VGENMVVKIADFGLSRNIYSADYYK---ADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCBC-------CCBCGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ECCCCCEEECCCHHHEECCCCCCCC---CCCCCCCCCCCCCHHHHC-CCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCCH
T ss_conf 9899928983314421136776411---157777676767989972-688980563025236299998068999999899
Q ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 9999998359999999999956999999831259899999988962
Q 000715 208 TQLVKSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 208 ~eLikkIl~~~~~plp~~iS~eL~DLIkkLLskDPekRPTAeEILk 253 (1335)
.++...+..+..++.+..+++.+.+++.+||+.||++|||+.++.+
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999999739978887325299999999974889657939999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.94 Aligned_cols=248 Identities=23% Similarity=0.408 Sum_probs=221.2
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCC-------EEEEEEECCCH----HHHHHHHHHHHHHHC-CCCCCCEEEEEEEECC
Q ss_conf 85899978701695799999997887-------09999981711----079999999999918-9998004899998289
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTI-------EYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSA 69 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TG-------k~VAIKiIdKs----q~eeIlrEIkILkkL-kHPNIVkLlevfed~~ 69 (1335)
++|++++.||+|+||.||+|++..++ ..||+|.+.+. ...++.+|...+.++ +||||+++++++.+..
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCC
T ss_conf 99697009851678289999985787555667549999998811286889999999999998139996973465220188
Q ss_pred EEEEEEEECCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC
Q ss_conf 799999604899978999838----------------9999999999999999999999987970147899974777999
Q 000715 70 HLWLVLEYCVGGDLMSLLRQD----------------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG 133 (1335)
Q Consensus 70 ~LyLVMEyieGGSL~dlIkk~----------------g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG 133 (1335)
.+|+||||+++|+|.+++... ..+++.+++.++.||+.||.|||+++|+||||||+|||++.++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~ 172 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN 172 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred EEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCEEECCCC
T ss_conf 68999973699909999986067764322233457434679999999999999999876637978630221022454789
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHH
Q ss_conf 7554035621003578999898888875699987995000027999940249999999999980-999999997899999
Q 000715 134 RTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVK 212 (1335)
Q Consensus 134 ~IKLiDFGLAr~l~~~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLik 212 (1335)
.+||+|||+++.......... .....|++.|+|||++.+ +.|+.++||||||+++|||++ |.+||.+.+..++..
T Consensus 173 ~~kl~dfg~~~~~~~~~~~~~---~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 173 VMKIADFGLARDIHHIDYYKK---TTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CEEECSTTCCCCGGGCCTTCC---CTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CEEECCCHHHCCCCCCCCCCC---CCCCCCCHHHHHHHHHCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHH
T ss_conf 767622111011355555431---466788846632667517-9888255547758888874017989899999999999
Q ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 98359999999999956999999831259899999988962
Q 000715 213 SILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 213 kIl~~~~~plp~~iS~eL~DLIkkLLskDPekRPTAeEILk 253 (1335)
.+..+..++.|..+++.+.+||.+||+.||.+|||+.|+++
T Consensus 249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99728888987435299999999976679767939999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.79 Aligned_cols=249 Identities=23% Similarity=0.426 Sum_probs=210.5
Q ss_pred CCEEEEEEEECCCCEEEEEEEECC-----CCEEEEEEECCCH----HHHHHHHHHHHHHHC-CCCCCCEEEEEEEEC-CE
Q ss_conf 858999787016957999999978-----8709999981711----079999999999918-999800489999828-97
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-----TIEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETS-AH 70 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~-----TGk~VAIKiIdKs----q~eeIlrEIkILkkL-kHPNIVkLlevfed~-~~ 70 (1335)
++|++.+.||+|+||.||+|++.. +++.||+|.+... ..+.+.+|...+.++ +|+||+.+++++... ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCE
T ss_conf 99798449841678399999986777555783999999860017178999999999988614998499741154047975
Q ss_pred EEEEEEECCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCC
Q ss_conf 99999604899978999838----------------99999999999999999999999879701478999747779997
Q 000715 71 LWLVLEYCVGGDLMSLLRQD----------------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGR 134 (1335)
Q Consensus 71 LyLVMEyieGGSL~dlIkk~----------------g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~ 134 (1335)
+++|||||++|+|.+++... ..+++.+++.|+.|++.||.|||++||+||||||+||+++.++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~ 172 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV 172 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCC
T ss_conf 79999845899299999853666665322202332146899999999999999999887379717867731065779982
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCHH-HHHH
Q ss_conf 5540356210035789998988888756999879950000279999402499999999999809-9999999789-9999
Q 000715 135 TKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAG-RPPFVGREFT-QLVK 212 (1335)
Q Consensus 135 IKLiDFGLAr~l~~~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTG-kpPF~g~d~~-eLik 212 (1335)
+||+|||+|+......... .....+||+.|+|||++.+ ..++.++||||+||++|||++| .+||.+.... ....
T Consensus 173 ~Kl~DFGla~~~~~~~~~~---~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 173 VKICDFGLARDIYKDPDYV---RKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp EEECC------CCSCTTSC---CTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred EEECCCCCHHHCCCCCCCC---CCCCEEECCCCCCHHHHHC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 8984575200113566522---2475166721020368646-88996632213678999998688999989998999999
Q ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 983599999999999569999998312598999999889629
Q 000715 213 SILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 213 kIl~~~~~plp~~iS~eL~DLIkkLLskDPekRPTAeEILkH 254 (1335)
.+..+..++.+..+++.+.+++.+||+.||++|||++++++|
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 996389888886578999999999767796679199999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.29 Aligned_cols=243 Identities=24% Similarity=0.433 Sum_probs=218.3
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCHH-HHHHHHHHHHHHHCCCCCCCEEEEEEEE-CCEEEEEEEEC
Q ss_conf 985899978701695799999997887099999817110-7999999999991899980048999982-89799999604
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ-KSKVLQEVRMLHSLDHPNVLRFYSWYET-SAHLWLVLEYC 78 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq-~eeIlrEIkILkkLkHPNIVkLlevfed-~~~LyLVMEyi 78 (1335)
+++|++.+.||+|+||.||+|+++ +..||+|.+.++. .+.+.+|++++++++||||+++++++.+ .+.+|+||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf 899488579820798089999999--909999998857779999999999986789898549878872389289999636
Q ss_pred CCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 8999789998389--99999999999999999999998797014789997477799975540356210035789998988
Q 000715 79 VGGDLMSLLRQDN--QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPSSM 156 (1335)
Q Consensus 79 eGGSL~dlIkk~g--~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~ss~ 156 (1335)
++|+|.+++.+.+ .+++..++.++.|++.|+.|||+++|+||||||+||+++.++.+|++|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~------ 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------ 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEECCCCC------
T ss_conf 99989999874578888999999999999852321133765536665676014689977632456003447877------
Q ss_pred CCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Q ss_conf 88875699987995000027999940249999999999980-99999999789999998359999999999956999999
Q 000715 157 LPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSDPSPPLPGNPSRPFANLIN 235 (1335)
Q Consensus 157 l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLikkIl~~~~~plp~~iS~eL~DLIk 235 (1335)
....+++.|+|||++.+ +.++.++||||||+++|||++ |++||...+..++...+..+.+++++...++.+.++|.
T Consensus 158 --~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 234 (262)
T d1byga_ 158 --DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234 (262)
T ss_dssp ------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred --CCCCCCCCCCCHHHHHC-CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
T ss_conf --65566646778178727-988858877757999999997899999999999999999808999997657999999999
Q ss_pred HHCCCCCCCCCCHHHHHCC
Q ss_conf 8312598999999889629
Q 000715 236 SLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 236 kLLskDPekRPTAeEILkH 254 (1335)
+||..||.+|||+.+++++
T Consensus 235 ~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 235 NCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCHHHCCCHHHHHHH
T ss_conf 9756697689399999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.51 Aligned_cols=249 Identities=21% Similarity=0.371 Sum_probs=219.8
Q ss_pred CCEEEEEEEECCCCEEEEEEEECC-----CCEEEEEEECCCH----HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 858999787016957999999978-----8709999981711----0799999999999189998004899998289799
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKK-----TIEYFAIKSVDKS----QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~-----TGk~VAIKiIdKs----q~eeIlrEIkILkkLkHPNIVkLlevfed~~~Ly 72 (1335)
++|++.+.||+|+||.||+|.++. ++..||+|.+.+. ....+.+|++++++++||||+++++++......+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 99188359820788189999987864477896899999870128689999999999999769998841254784288106
Q ss_pred EEEEECCCCCHHHHHHHC----------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCC
Q ss_conf 999604899978999838----------9999999999999999999999987970147899974777999755403562
Q 000715 73 LVLEYCVGGDLMSLLRQD----------NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGL 142 (1335)
Q Consensus 73 LVMEyieGGSL~dlIkk~----------g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGL 142 (1335)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGl 179 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTC
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCCCEEEEEECCC
T ss_conf 77760489988999875033211344468879999999999999999987647965432867754035996499942454
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 10035789998988888756999879950000279999402499999999999809-99999997899999983599999
Q 000715 143 ARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAG-RPPFVGREFTQLVKSILSDPSPP 221 (1335)
Q Consensus 143 Ar~l~~~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTG-kpPF~g~d~~eLikkIl~~~~~p 221 (1335)
++......... ......|++.|+|||.+. +..++.++||||+|+++|||++| .+||.+.+..+.+..+..+..++
T Consensus 180 a~~~~~~~~~~---~~~~~~~t~~y~aPe~l~-~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 180 TRDIYETDYYR---KGGKGLLPVRWMSPESLK-DGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp CCGGGGGGCEE---GGGSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred CEECCCCCCEE---ECCCEECCCCCCCHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 20235776303---134023163237888873-69988333444378999999968999999989999999998088888
Q ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 999999569999998312598999999889629
Q 000715 222 LPGNPSRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 222 lp~~iS~eL~DLIkkLLskDPekRPTAeEILkH 254 (1335)
.+..+++.+.+++.+||+.||++|||+.+++++
T Consensus 256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 863353999999999757796589399999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.92 Aligned_cols=248 Identities=25% Similarity=0.447 Sum_probs=214.6
Q ss_pred CCEEEEEEEECCCCEEEEEEEEC-----CCCEEEEEEECCCH----HHHHHHHHHHHHHHC-CCCCCCEEEEEEEECCEE
Q ss_conf 85899978701695799999997-----88709999981711----079999999999918-999800489999828979
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKK-----KTIEYFAIKSVDKS----QKSKVLQEVRMLHSL-DHPNVLRFYSWYETSAHL 71 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk-----~TGk~VAIKiIdKs----q~eeIlrEIkILkkL-kHPNIVkLlevfed~~~L 71 (1335)
++|++.+.||+|+||.||+|+++ .+++.||+|.+.+. ....+.+|+.+++++ +||||+++++++.+...+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 99698549820688299999980664477886999999874248779999999999987626999887899898319978
Q ss_pred EEEEEECCCCCHHHHHHHCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCC
Q ss_conf 99996048999789998389------------------999999999999999999999987970147899974777999
Q 000715 72 WLVLEYCVGGDLMSLLRQDN------------------QLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENG 133 (1335)
Q Consensus 72 yLVMEyieGGSL~dlIkk~g------------------~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG 133 (1335)
|+||||+++|+|.+++.... .+++..+..|+.||+.|+.|||+++++||||||+||+++.++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~ 182 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR 182 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCC
T ss_conf 99997379987999998535665444445332223345889999999999999999988757926662410210000257
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHH-
Q ss_conf 7554035621003578999898888875699987995000027999940249999999999980-99999999789999-
Q 000715 134 RTKLCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLV- 211 (1335)
Q Consensus 134 ~IKLiDFGLAr~l~~~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLi- 211 (1335)
.+|++|||.++........ ......+|++.|+|||++. ++.++.++||||||+++|||++ |.+||.+.+..+.+
T Consensus 183 ~~ki~DfG~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 183 ITKICDFGLARDIKNDSNY---VVKGNARLPVKWMAPESIF-NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp EEEECCCGGGSCTTSCTTS---EECSSSEECGGGCCHHHHH-HCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCCCCCHHEECCCCCCC---EEEEECCCCHHHCCHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 5210234010233678861---5862013596876778861-79999740010258999999858998877899899999
Q ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 998359999999999956999999831259899999988962
Q 000715 212 KSILSDPSPPLPGNPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 212 kkIl~~~~~plp~~iS~eL~DLIkkLLskDPekRPTAeEILk 253 (1335)
..+..+.++..+...+..+.+||.+||+.||.+|||+.++++
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 998668988985436599999999975779657929999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.40 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=211.3
Q ss_pred EEEEEEEECCCCEEEEEEEECCCC---EEEEEEECCC----HHHHHHHHHHHHHHHCCCCCCCEEEEEEEE-CCEEEEEE
Q ss_conf 899978701695799999997887---0999998171----107999999999991899980048999982-89799999
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTI---EYFAIKSVDK----SQKSKVLQEVRMLHSLDHPNVLRFYSWYET-SAHLWLVL 75 (1335)
Q Consensus 4 YeIlK~LGkGsFGtVYkAkdk~TG---k~VAIKiIdK----sq~eeIlrEIkILkkLkHPNIVkLlevfed-~~~LyLVM 75 (1335)
+.+.+.||+|+||+||+|++..++ ..||+|.+++ ...+++.+|++++++++||||+++++++.. +..+++||
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 52666981368809999999779987999999998843697899999999999986789998678678980699438999
Q ss_pred EECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 604899978999838-9999999999999999999999987970147899974777999755403562100357899989
Q 000715 76 EYCVGGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASKAPS 154 (1335)
Q Consensus 76 EyieGGSL~dlIkk~-g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~~~s 154 (1335)
||+++++|.+++... ..+++..+..++.|++.|+.|+|+.+|+||||||+|||+++++.+||+|||+++..........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCCCC
T ss_conf 87406741442101345404899999999988765200336762577668757677999889910652322556655531
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Q ss_conf 8888875699987995000027999940249999999999980999999-997899999983599999999999569999
Q 000715 155 SMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFV-GREFTQLVKSILSDPSPPLPGNPSRPFANL 233 (1335)
Q Consensus 155 s~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~-g~d~~eLikkIl~~~~~plp~~iS~eL~DL 233 (1335)
.......|++.|+|||++.. ..++.++||||||+++|||++|..||. ..+..++...+..+.++..|..+++.+.++
T Consensus 189 -~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 189 -HNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp -TCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred -EECCCCCCCCCCCCHHHHHC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
T ss_conf -00256555645567688743-7999745746619999999978999988899999999998089889964475999999
Q ss_pred HHHHCCCCCCCCCCHHHHHCC
Q ss_conf 998312598999999889629
Q 000715 234 INSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 234 IkkLLskDPekRPTAeEILkH 254 (1335)
+.+||..||++||++.|+++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCCHHHCCCHHHHHHH
T ss_conf 999768897689399999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.47 Aligned_cols=248 Identities=26% Similarity=0.431 Sum_probs=213.5
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCC-C--EEEEEEECCCH------HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
Q ss_conf 8589997870169579999999788-7--09999981711------0799999999999189998004899998289799
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKT-I--EYFAIKSVDKS------QKSKVLQEVRMLHSLDHPNVLRFYSWYETSAHLW 72 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~T-G--k~VAIKiIdKs------q~eeIlrEIkILkkLkHPNIVkLlevfed~~~Ly 72 (1335)
++|++.+.||+|+||.||+|++... + ..||+|.+.+. ..+.+.+|++++++++||||+++++++.+ ..++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCCCCCCCCCCC
Q ss_conf 99960489997899983-89999999999999999999999987970147899974777999755403562100357899
Q 000715 73 LVLEYCVGGDLMSLLRQ-DNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGLARKLSDASK 151 (1335)
Q Consensus 73 LVMEyieGGSL~dlIkk-~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~~~~~ 151 (1335)
+||||+++|++.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred EEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCCCCC
T ss_conf 14654238612544421268999999999999999999875217875205668881565565433256115553035887
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHH
Q ss_conf 9898888875699987995000027999940249999999999980-99999999789999998359-999999999956
Q 000715 152 APSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYA-GRPPFVGREFTQLVKSILSD-PSPPLPGNPSRP 229 (1335)
Q Consensus 152 ~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLT-GkpPF~g~d~~eLikkIl~~-~~~plp~~iS~e 229 (1335)
.. .......|+..|+|||++.+ ..++.++||||||+++|||++ |.+||.+.+..+....+... ..++.+..++..
T Consensus 167 ~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (273)
T d1u46a_ 167 HY--VMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243 (273)
T ss_dssp EE--EC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred CC--EECCCCCCCCCCCCHHHHHC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHH
T ss_conf 52--65476325731079999837-9999421566148999999968999999969999999998479999985445399
Q ss_pred HHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 999999831259899999988962
Q 000715 230 FANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 230 L~DLIkkLLskDPekRPTAeEILk 253 (1335)
+.+++.+||..||++|||+.++.+
T Consensus 244 l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 999999976889667929999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=335.77 Aligned_cols=257 Identities=24% Similarity=0.292 Sum_probs=205.7
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH-HHHHHHHHHHHHHHCCCCC-CCEEEEEEEECCEEEEEEEECC
Q ss_conf 8589997870169579999999788709999981711-0799999999999189998-0048999982897999996048
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-QKSKVLQEVRMLHSLDHPN-VLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs-q~eeIlrEIkILkkLkHPN-IVkLlevfed~~~LyLVMEyie 79 (1335)
++|++.+.||+|+||.||+|+++.+++.||+|++... ....+.+|+++++.++|++ |+.+++++.+....++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEEC-
T ss_conf 8899968985078809999999889989999997210058889999999997038996017999995198778999873-
Q ss_pred CCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC---CCCEEECCCCCCCCCCCCCCCC--
Q ss_conf 999789998-3899999999999999999999999879701478999747779---9975540356210035789998--
Q 000715 80 GGDLMSLLR-QDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE---NGRTKLCDFGLARKLSDASKAP-- 153 (1335)
Q Consensus 80 GGSL~dlIk-k~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDe---dG~IKLiDFGLAr~l~~~~~~~-- 153 (1335)
++++.+.+. ..+.+++..+..++.|++.||.|||++||+||||||+||+++. +..+||+|||+|+.+.......
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~ 165 (299)
T d1ckia_ 86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165 (299)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBC
T ss_pred CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCCCCCCE
T ss_conf 87133324430688768999999999999999999799442667876606433577761565046751342554455410
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-------HHCCCCCCCCCCC
Q ss_conf 988888756999879950000279999402499999999999809999999978999999-------8359999999999
Q 000715 154 SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFTQLVKS-------ILSDPSPPLPGNP 226 (1335)
Q Consensus 154 ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~eLikk-------Il~~~~~plp~~i 226 (1335)
........+||+.|+|||++. +..++.++||||+||++|||++|..||.+......... ....+.+.....+
T Consensus 166 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
T d1ckia_ 166 PYRENKNLTGTARYASINTHL-GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGY 244 (299)
T ss_dssp CCCBCCSCCCCSSSCCHHHHT-TBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTS
T ss_pred ECCCCCCCCCCCCCCCHHHHH-CCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHHHCCCC
T ss_conf 001357767873532999991-8998983218861778999984987665530577999999852356789835753478
Q ss_pred CHHHHHHHHHHCCCCCCCCCCHH---HHHCCCCCCCC
Q ss_conf 95699999983125989999998---89629232365
Q 000715 227 SRPFANLINSLLVKDPAQRLHWS---DLCGHAFWRTK 260 (1335)
Q Consensus 227 S~eL~DLIkkLLskDPekRPTAe---EILkHPFFq~~ 260 (1335)
++++.+++.+||+.||++||+++ ++++|+|.+..
T Consensus 245 p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 245 PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCC
T ss_conf 8999999999843995579199999999999999769
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.2e-45 Score=326.90 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=207.1
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH-HHHHHHHHHHHHHHCCC-CCCCEEEEEEEECCEEEEEEEECC
Q ss_conf 8589997870169579999999788709999981711-07999999999991899-980048999982897999996048
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-QKSKVLQEVRMLHSLDH-PNVLRFYSWYETSAHLWLVLEYCV 79 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs-q~eeIlrEIkILkkLkH-PNIVkLlevfed~~~LyLVMEyie 79 (1335)
++|++.+.||+|+||.||+|+++.+++.||+|++... ....+.+|++.++.++| +|++.+++++......|+||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEC-
T ss_conf 8069979984178829999999889979999997502582999999999999648999877999960188117999964-
Q ss_pred CCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC-----CCCEEECCCCCCCCCCCCCCCC
Q ss_conf 99978999838-99999999999999999999999879701478999747779-----9975540356210035789998
Q 000715 80 GGDLMSLLRQD-NQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDE-----NGRTKLCDFGLARKLSDASKAP 153 (1335)
Q Consensus 80 GGSL~dlIkk~-g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDe-----dG~IKLiDFGLAr~l~~~~~~~ 153 (1335)
+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||+++.+.......
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 163 (293)
T d1csna_ 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 163 (293)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCC
T ss_pred CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCCCCCCC
T ss_conf 88879999752031106899999999999999999779662667713152347543447956872366057714676654
Q ss_pred --CCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHH----CCCCCCCCC
Q ss_conf --98888875699987995000027999940249999999999980999999997---899999983----599999999
Q 000715 154 --SSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGRE---FTQLVKSIL----SDPSPPLPG 224 (1335)
Q Consensus 154 --ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d---~~eLikkIl----~~~~~plp~ 224 (1335)
........+||+.|+|||++. +..++.++||||+|+++|+|++|..||.+.. .......+. ..+......
T Consensus 164 ~~~~~~~~~~~GT~~y~aPE~~~-~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (293)
T d1csna_ 164 HIPYREKKNLSGTARYMSINTHL-GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242 (293)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHT-TCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTT
T ss_pred CEEECCCCCEEECHHHCCHHHHC-CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHCC
T ss_conf 11102467627751026798964-88888699989831999999869876788530219999999970567999589657
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCHHHHHC
Q ss_conf 99956999999831259899999988962
Q 000715 225 NPSRPFANLINSLLVKDPAQRLHWSDLCG 253 (1335)
Q Consensus 225 ~iS~eL~DLIkkLLskDPekRPTAeEILk 253 (1335)
.+++++.+++..|+..+|++||+++.+.+
T Consensus 243 ~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 243 GFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp TSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCCHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 99899999999984399300859999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=328.46 Aligned_cols=249 Identities=25% Similarity=0.382 Sum_probs=197.7
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCHHHHHHHHHHHH--HHHCCCCCCCEEEEEEEECC----EEEEEE
Q ss_conf 858999787016957999999978870999998171107999999999--99189998004899998289----799999
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRM--LHSLDHPNVLRFYSWYETSA----HLWLVL 75 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq~eeIlrEIkI--LkkLkHPNIVkLlevfed~~----~LyLVM 75 (1335)
++|.+.+.||+|+||.||+|++ +++.||+|.+.........+|.++ +.+++||||+++++++.+.+ .+|+||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE--CCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf 6899988982078819999999--99899999987200467999999999962799868326889983798604899999
Q ss_pred EECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH--------CCCCCCCCCCCCEEECCCCCEEECCCCCCCCCC
Q ss_conf 604899978999838999999999999999999999998--------797014789997477799975540356210035
Q 000715 76 EYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHS--------KGIIYCDLKPSNILLDENGRTKLCDFGLARKLS 147 (1335)
Q Consensus 76 EyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHs--------kGIVHRDIKPeNILIDedG~IKLiDFGLAr~l~ 147 (1335)
||+++|+|.+++++. .+++.++..++.|++.|+.|+|. +||+||||||+||+++.++.+||+|||++....
T Consensus 81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred ECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCC
T ss_conf 646698989998658-9998999999999999999988766520468986615317313578688776887638662346
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHCCCC-----CCCCHHHHHHHHHHHHHHHHCCCCCCCC---------------CH
Q ss_conf 789998988888756999879950000279-----9994024999999999998099999999---------------78
Q 000715 148 DASKAPSSMLPQAKCGTPCYMAPELFEEGG-----VHSYASDLWGLGCVLYECYAGRPPFVGR---------------EF 207 (1335)
Q Consensus 148 ~~~~~~ss~l~~t~vGTp~YlAPEVL~~~~-----~yS~KSDIWSLGVILYELLTGkpPF~g~---------------d~ 207 (1335)
....... ......+||+.|+|||++.... .++.++|||||||++|||++|.+||... ..
T Consensus 160 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 160 SATDTID-IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp TTTTEEC-C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred CCCCCEE-CCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCCHH
T ss_conf 7776200-135525035476782210565454677767501220159999999628998876631124101225564309
Q ss_pred HHHHHHHHC-CCCCCCCCCC-----CHHHHHHHHHHCCCCCCCCCCHHHHHCC
Q ss_conf 999999835-9999999999-----9569999998312598999999889629
Q 000715 208 TQLVKSILS-DPSPPLPGNP-----SRPFANLINSLLVKDPAQRLHWSDLCGH 254 (1335)
Q Consensus 208 ~eLikkIl~-~~~~plp~~i-----S~eL~DLIkkLLskDPekRPTAeEILkH 254 (1335)
......... ..++.++... ...+.+++.+||+.||.+|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 99999875024688877655776899999999999760698589599999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-44 Score=320.66 Aligned_cols=252 Identities=20% Similarity=0.411 Sum_probs=197.1
Q ss_pred CCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCHH--HHHHHHHHHHHHHCC-----------CCCCCEEEEEEEE-
Q ss_conf 85899978701695799999997887099999817110--799999999999189-----------9980048999982-
Q 000715 2 NQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ--KSKVLQEVRMLHSLD-----------HPNVLRFYSWYET- 67 (1335)
Q Consensus 2 ekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq--~eeIlrEIkILkkLk-----------HPNIVkLlevfed- 67 (1335)
++|++++.||+|+||+||+|+++.+++.||+|++.+.. .+.+.+|+++++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 85799899750778189999999999799999983431336899999999998401455555422767647899876312
Q ss_pred -CCEEEEEEEECCCCCHHHH-H--HHCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCCEEECCCC------CEE
Q ss_conf -8979999960489997899-9--838999999999999999999999998-7970147899974777999------755
Q 000715 68 -SAHLWLVLEYCVGGDLMSL-L--RQDNQLPEDSIRDLAQDLVRALQYLHS-KGIIYCDLKPSNILLDENG------RTK 136 (1335)
Q Consensus 68 -~~~LyLVMEyieGGSL~dl-I--kk~g~LSEeeIr~IL~QILeALkYLHs-kGIVHRDIKPeNILIDedG------~IK 136 (1335)
....+++++++..+..... . .....+++..++.++.|++.|+.|||+ .||+||||||+|||++.++ .++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred CCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCCCCCCEEE
T ss_conf 56520234320003542000001223467868999999999999988876405864656770570563057656443056
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH------HH
Q ss_conf 403562100357899989888887569998799500002799994024999999999998099999999789------99
Q 000715 137 LCDFGLARKLSDASKAPSSMLPQAKCGTPCYMAPELFEEGGVHSYASDLWGLGCVLYECYAGRPPFVGREFT------QL 210 (1335)
Q Consensus 137 LiDFGLAr~l~~~~~~~ss~l~~t~vGTp~YlAPEVL~~~~~yS~KSDIWSLGVILYELLTGkpPF~g~d~~------eL 210 (1335)
++|||.+....... ...+|++.|+|||++.. ..++.++||||+||++++|++|+.||...+.. +.
T Consensus 173 l~dfg~s~~~~~~~--------~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 173 IADLGNACWYDEHY--------TNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp ECCCTTCEETTBCC--------CSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred EEECCCCCCCCCCC--------CCCCCCCCCCCHHHCCC-CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHH
T ss_conf 75314421234454--------22366521057132146-6777643201237899999878899898755432102689
Q ss_pred HHH---HHCC--------------------C------------------CCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH
Q ss_conf 999---8359--------------------9------------------9999999995699999983125989999998
Q 000715 211 VKS---ILSD--------------------P------------------SPPLPGNPSRPFANLINSLLVKDPAQRLHWS 249 (1335)
Q Consensus 211 ikk---Il~~--------------------~------------------~~plp~~iS~eL~DLIkkLLskDPekRPTAe 249 (1335)
... +... . ....+...++.+.+||.+||.+||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 99999983799878862453220001320122024323577644421000156743589999999998779945790899
Q ss_pred HHHCCCCCCCCCC
Q ss_conf 8962923236579
Q 000715 250 DLCGHAFWRTKLT 262 (1335)
Q Consensus 250 EILkHPFFq~~l~ 262 (1335)
|+|+||||++...
T Consensus 324 e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 324 GLVNHPWLKDTLG 336 (362)
T ss_dssp HHHTCGGGTTCTT
T ss_pred HHHCCCCCCCCCC
T ss_conf 9966934078987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=2.3e-22 Score=169.25 Aligned_cols=161 Identities=17% Similarity=0.216 Sum_probs=120.5
Q ss_pred EEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH---------------------HHHHHHHHHHHHHHCCCCCCCEEE
Q ss_conf 89997870169579999999788709999981711---------------------079999999999918999800489
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS---------------------QKSKVLQEVRMLHSLDHPNVLRFY 62 (1335)
Q Consensus 4 YeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs---------------------q~eeIlrEIkILkkLkHPNIVkLl 62 (1335)
|.+++.||+|+||.||+|.+. +|+.||+|++... ......+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 022778024856599999979-9999999998604434666556563000888999999778999999981699914499
Q ss_pred EEEEECCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEECCCCC
Q ss_conf 99982897999996048999789998389999999999999999999999987970147899974777999755403562
Q 000715 63 SWYETSAHLWLVLEYCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLHSKGIIYCDLKPSNILLDENGRTKLCDFGL 142 (1335)
Q Consensus 63 evfed~~~LyLVMEyieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLHskGIVHRDIKPeNILIDedG~IKLiDFGL 142 (1335)
++.. .+++|||+++..+.+ ++...+..++.|++.++.|||++||+||||||+||+++++ .++|+|||.
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EECC----CEEEEEEECCCCCCC-------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-CEEEEECCC
T ss_conf 8628----889999504565420-------0157899999999999999826888983689036114289-899987788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC------CHHCCCCCCCCHHHHHHHHHHH
Q ss_conf 1003578999898888875699987995------0000279999402499999999
Q 000715 143 ARKLSDASKAPSSMLPQAKCGTPCYMAP------ELFEEGGVHSYASDLWGLGCVL 192 (1335)
Q Consensus 143 Ar~l~~~~~~~ss~l~~t~vGTp~YlAP------EVL~~~~~yS~KSDIWSLGVIL 192 (1335)
|.....+.. ..|... +.+ .+.|+.++|+||+.--+
T Consensus 149 a~~~~~~~~-------------~~~l~rd~~~~~~~f--~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 149 SVEVGEEGW-------------REILERDVRNIITYF--SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CEETTSTTH-------------HHHHHHHHHHHHHHH--HHHHCCCCCHHHHHHHH
T ss_pred CCCCCCCCC-------------HHHHHHHHHHHHHHH--CCCCCCCCCHHHHHHHH
T ss_conf 430899870-------------999987799999997--57899844689999987
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.41 E-value=1.6e-06 Score=59.44 Aligned_cols=137 Identities=17% Similarity=0.170 Sum_probs=89.0
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCHH---HHHHHHHHHHHHHCC-CCCCCEEEEEEEECCEEEEEEE
Q ss_conf 985899978701695799999997887099999817110---799999999999189-9980048999982897999996
Q 000715 1 MNQYHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKSQ---KSKVLQEVRMLHSLD-HPNVLRFYSWYETSAHLWLVLE 76 (1335)
Q Consensus 1 IekYeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKsq---~eeIlrEIkILkkLk-HPNIVkLlevfed~~~LyLVME 76 (1335)
+++|+..+..+.++.+.||+... .+..+.+|...... ...+.+|...+..+. +--+.+++.+..+.+..|+||+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HHCEEEEECCCCCCCCCEEEEEE--CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEE
T ss_conf 13527997678998771899990--8986999984887653255699999999987606998728999750896499998
Q ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q ss_conf 0489997899983899999999999999999999999-------------------------------------------
Q 000715 77 YCVGGDLMSLLRQDNQLPEDSIRDLAQDLVRALQYLH------------------------------------------- 113 (1335)
Q Consensus 77 yieGGSL~dlIkk~g~LSEeeIr~IL~QILeALkYLH------------------------------------------- 113 (1335)
+++|..+.+...... ....+..++...+..+|
T Consensus 91 ~l~G~~~~~~~~~~~-----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 91 EADGVLCSEEYEDEQ-----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHTTTCS-----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred ECCCCCCCCCCCCCC-----CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCH
T ss_conf 604334354334402-----699999989999999855684214357644656555778998776555543033232005
Q ss_pred ----------HC------CCCCCCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf ----------87------97014789997477799975540356210
Q 000715 114 ----------SK------GIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 114 ----------sk------GIVHRDIKPeNILIDedG~IKLiDFGLAr 144 (1335)
+. .++|+|+.|.||++++++...++||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf 79999999984498678178986004764236499659996023144
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.15 E-value=9.9e-06 Score=53.87 Aligned_cols=75 Identities=17% Similarity=0.124 Sum_probs=51.4
Q ss_pred EEEEECCCCEEEEEEEECCCCEEEEEEECCC----------HHHHHHHHHHHHHHHC-CC--CCCCEEEEEEEECCEEEE
Q ss_conf 9787016957999999978870999998171----------1079999999999918-99--980048999982897999
Q 000715 7 YEAIGRGKYSTVYKGRKKKTIEYFAIKSVDK----------SQKSKVLQEVRMLHSL-DH--PNVLRFYSWYETSAHLWL 73 (1335)
Q Consensus 7 lK~LGkGsFGtVYkAkdk~TGk~VAIKiIdK----------sq~eeIlrEIkILkkL-kH--PNIVkLlevfed~~~LyL 73 (1335)
.+.+|.|....||+.....+++.+++|.-.. ....+...|...++.+ .+ ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCH
Q ss_conf 9960489997
Q 000715 74 VLEYCVGGDL 83 (1335)
Q Consensus 74 VMEyieGGSL 83 (1335)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.10 E-value=4.1e-05 Score=49.63 Aligned_cols=115 Identities=12% Similarity=0.174 Sum_probs=64.9
Q ss_pred HHHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHHEEEEEECCCC
Q ss_conf 99999984003780379999999989751123232221111036654444455-78999999999632120235613775
Q 000715 575 MLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLRD-KQEKVRRFSMAALGELLFYISTQNEH 653 (1335)
Q Consensus 575 ~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ge~~~~~~~q~~~ 653 (1335)
++.|+++|+ .....+|-+++.+++-+++|....+.=.-..+++..|.+.++. .+..+++....+|..+- .+..
T Consensus 19 ip~L~~lL~-~~~~~v~~~A~~~l~~l~~~~~~~~~~~~~~~~v~~l~~~L~~~~~~~~~~~a~~~L~~l~-----~~~~ 92 (529)
T d1jdha_ 19 IPELTKLLN-DEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLS-----HHRE 92 (529)
T ss_dssp HHHHHHHHT-CSCHHHHHHHHHHHHHHHTSHHHHHHHHTCHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHT-----TSHH
T ss_pred HHHHHHHHC-CCCHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHH-----CCCH
T ss_conf 999999872-9999999999999999984557789998713399999999847999999999999999995-----8916
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCCC
Q ss_conf 68899999998675552354356148999999872495125677877789854204880
Q 000715 654 ARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTIENICSQGGH 712 (1335)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (1335)
... +-+-...+..+-.+| +..|.-++.++++++-|+|.....
T Consensus 93 --------------~~~--~i~~~g~i~~Li~lL-~~~~~~v~~~a~~aL~~l~~~~~~ 134 (529)
T d1jdha_ 93 --------------GLL--AIFKSGGIPALVKML-GSPVDSVLFYAITTLHNLLLHQEG 134 (529)
T ss_dssp --------------HHH--HHHHTTHHHHHHHHT-TCSCHHHHHHHHHHHHHHHHHCTT
T ss_pred --------------HHH--HHHHCCCHHHHHHHH-CCCCHHHHHHHHHHHHHHHCCCCH
T ss_conf --------------699--999879899999985-797989999999999986513201
|
| >d1xm9a1 a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Plakophilin 1 helical region domain: Plakophilin 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.90 E-value=1.7e-05 Score=52.21 Aligned_cols=119 Identities=20% Similarity=0.158 Sum_probs=94.0
Q ss_pred CHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHEEEEEECC
Q ss_conf 00499999984003780379999999989751123232221111036654444455789999999996321202356137
Q 000715 572 GPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLRDKQEKVRRFSMAALGELLFYISTQN 651 (1335)
Q Consensus 572 ~~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ge~~~~~~~q~ 651 (1335)
|..+|-|||+|+ ..+++.+..+|+.||-|.....+..+.....|++..|.+.+++.+.++|.-...+|+.+.+ .+
T Consensus 1 ~~~ip~lv~~L~-~~~~~~~~~a~~~l~~l~~~~~~~~~~i~~~g~i~~Lv~lL~~~~~~v~~~a~~aL~~L~~----~~ 75 (457)
T d1xm9a1 1 GLTIPKAVQYLS-SQDEKYQAIGAYYIQHTCFQDESAKQQVYQLGGICKLVDLLRSPNQNVQQAAAGALRNLVF----RS 75 (457)
T ss_dssp CCCHHHHHHHHH-SSCTHHHHHHHHHHHHHTSSCSSHHHHHHHTTHHHHHHHHTTSSCHHHHHHHHHHHHHHHS----SC
T ss_pred CCCHHHHHHHHC-CCCHHHHHHHHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHCCCCHHHHHHHHHHHHHHHC----CC
T ss_conf 997899999857-9999999999999999984999999999988859999998779998999999999999974----99
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCC
Q ss_conf 756889999999867555235435614899999987249512567787778985420488
Q 000715 652 EHARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTIENICSQGG 711 (1335)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 711 (1335)
... ++.-...| .+..+..+++...+..++..+..++.|+++-..
T Consensus 76 ~~~----------~~~i~~~g------~v~~li~~l~~~~~~~~~~~a~~~l~~l~~~~~ 119 (457)
T d1xm9a1 76 TTN----------KLETRRQN------GIREAVSLLRRTGNAEIQKQLTGLLWNLSSTDE 119 (457)
T ss_dssp HHH----------HHHHHHTT------CHHHHHHHHTTCCCHHHHHHHHHHHHHHHTSSS
T ss_pred HHH----------HHHHHHCC------CHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 888----------99999879------828999998433738899999999999986413
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.83 E-value=4.1e-05 Score=49.58 Aligned_cols=136 Identities=15% Similarity=0.165 Sum_probs=84.7
Q ss_pred EEEECCCC-EEEEEEEECCCCEEEEEEECCCHHHHHHHHHHHHHHHCC--CCCCCEEEEEEEECCEEEEEEEECCCCCHH
Q ss_conf 78701695-799999997887099999817110799999999999189--998004899998289799999604899978
Q 000715 8 EAIGRGKY-STVYKGRKKKTIEYFAIKSVDKSQKSKVLQEVRMLHSLD--HPNVLRFYSWYETSAHLWLVLEYCVGGDLM 84 (1335)
Q Consensus 8 K~LGkGsF-GtVYkAkdk~TGk~VAIKiIdKsq~eeIlrEIkILkkLk--HPNIVkLlevfed~~~LyLVMEyieGGSL~ 84 (1335)
+.+..|.. +.||+..... +..+.+|.........+.+|...++.+. .-.+.+++.+..+.+..|+||++++|.++.
T Consensus 16 ~~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 16 AQQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp EECSCTTSSCEEEEEECTT-SCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred EECCCCCCCCEEEEEEECC-CCEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCCC
T ss_conf 8767865477589999389-878999958966776899999999999865999886132224566159998744135543
Q ss_pred HH--------------HHH-C------CCCC--HHH-HHH----H---------------HHHHHHHHHHHHHC------
Q ss_conf 99--------------983-8------9999--999-999----9---------------99999999999987------
Q 000715 85 SL--------------LRQ-D------NQLP--EDS-IRD----L---------------AQDLVRALQYLHSK------ 115 (1335)
Q Consensus 85 dl--------------Ikk-~------g~LS--Eee-Ir~----I---------------L~QILeALkYLHsk------ 115 (1335)
+. +.+ + .++. ... ... + .......+..+.+.
T Consensus 95 ~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 174 (255)
T d1nd4a_ 95 SSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGED 174 (255)
T ss_dssp TSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCC
T ss_pred CCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 22126899999999999987368854488755412468899999987541101134011213799999999871876579
Q ss_pred -CCCCCCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf -97014789997477799975540356210
Q 000715 116 -GIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 116 -GIVHRDIKPeNILIDedG~IKLiDFGLAr 144 (1335)
.++|+|+.|.||+++.++.+-++||+.+.
T Consensus 175 ~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 175 LVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 567867888763577379658999853326
|
| >d1q1sc_ a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin alpha species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.67 E-value=1.4e-05 Score=52.85 Aligned_cols=109 Identities=12% Similarity=0.162 Sum_probs=77.6
Q ss_pred HHHHHHCCCCCHHHHHHHHHHHHHH---CCCCCHHHHHHCCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 9998512875412113477789774---1760013576120049999998400378037999999998975112323222
Q 000715 535 RILAVLNGNSSIGEKQNVIRYLEML---SSNADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDD 611 (1335)
Q Consensus 535 ~~~~~~~~~~~~~~k~n~~~yl~~v---~~~~~~a~~~~~~~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~ 611 (1335)
.+...+.|. ..+.+.+-+..++-. ..+..+ ..++.+-+++.|++.++...++++|..+++.++-++++..+..+-
T Consensus 17 ~lv~~l~s~-~~~~~~~a~~~l~~l~s~~~~~~~-~~i~~~g~i~~Lv~lL~~~~~~~v~~~a~~~L~~la~~~~~~~~~ 94 (434)
T d1q1sc_ 17 DIVKGINSN-NLESQLQATQAARKLLSREKQPPI-DNIIRAGLIPKFVSFLGKTDCSPIQFESAWALTNIASGTSEQTKA 94 (434)
T ss_dssp HHHHHHTSS-CHHHHHHHHHHHHHHHHSSSCCCH-HHHHHTTCHHHHHHHTTCGGGHHHHHHHHHHHHHHHTSCHHHHHH
T ss_pred HHHHHHCCC-CHHHHHHHHHHHHHHHCCCCCCHH-HHHHHCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCHHHHHH
T ss_conf 999987698-999999999999998637998329-999988899999998746998899999999999986398551047
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHEE
Q ss_conf 1111036654444455789999999996321202
Q 000715 612 LANSGILGSLTDGLRDKQEKVRRFSMAALGELLF 645 (1335)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ge~~~ 645 (1335)
....|++-.+.+.++..+..+++.++.+|+.+..
T Consensus 95 i~~~~~i~~l~~~L~~~~~~~~~~a~~~L~nl~~ 128 (434)
T d1q1sc_ 95 VVDGGAIPAFISLLASPHAHISEQAVWALGNIAG 128 (434)
T ss_dssp HHHTTHHHHHHHHTTCSCHHHHHHHHHHHHHHHT
T ss_pred HHHCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHC
T ss_conf 6644631566640356879999999999998850
|
| >d1xqra1 a.118.1.21 (A:87-350) Hsp70-binding protein 1 (HspBP1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HspBP1 domain domain: Hsp70-binding protein 1 (HspBP1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.59 E-value=2e-05 Score=51.71 Aligned_cols=165 Identities=18% Similarity=0.144 Sum_probs=120.0
Q ss_pred CHHHHHHHHHHHHHHCCCCCHHHHHHCCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 41211347778977417600135761200499999984003780379999999989751123232221111036654444
Q 000715 545 SIGEKQNVIRYLEMLSSNADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDG 624 (1335)
Q Consensus 545 ~~~~k~n~~~yl~~v~~~~~~a~~~~~~~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~~~~~~~~~~~~~~ 624 (1335)
....+.+.+-.|...|-+.|-|+.+..---++.++..+-..+++++|.+++++||-++++....++.....+++..|...
T Consensus 30 ~~~~~~~Al~~L~~L~~~~d~a~~l~~~gg~~~ll~~ll~s~~~~vr~~A~~~L~~l~~~~~~~~~~~~~~~~i~~Lv~l 109 (264)
T d1xqra1 30 DQQEREGALELLADLCENMDNAADFCQLSGMHLLVGRYLEAGAAGLRWRAAQLIGTCSQNVAAIQEQVLGLGALRKLLRL 109 (264)
T ss_dssp HHHHHHHHHHHHHHHHTSHHHHHHHHHTTHHHHHHHTTTTCSSHHHHHHHHHHHHHHHTTCHHHHHHHHHTTHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHCCHHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHH
T ss_conf 99999999999999976978899999869999999998379999999999999999998888888999972763799999
Q ss_pred HH-HHHHHHHHHHHHHHHHHEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHHHHHH
Q ss_conf 45-57899999999963212023561377568899999998675552354356148999999872495125677877789
Q 000715 625 LR-DKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTI 703 (1335)
Q Consensus 625 ~~-~~~~~~~~~~~~~~ge~~~~~~~q~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 703 (1335)
+. +....+|+....+++.+...- ....-.-+....+.++...|+. .+..++.+++.+|
T Consensus 110 L~~~~~~~v~~~a~~aL~~l~~~~--------------------~~~~~~~~~~~gi~~L~~lL~~-~~~~~~~~a~~~L 168 (264)
T d1xqra1 110 LDRDACDTVRVKALFAISCLVREQ--------------------EAGLLQFLRLDGFSVLMRAMQQ-QVQKLKVKSAFLL 168 (264)
T ss_dssp HHHCSCHHHHHHHHHHHHHHHTTC--------------------HHHHHHHHHTTHHHHHHHHHHS-SCHHHHHHHHHHH
T ss_pred HHCCCCHHHHHHHHHHHHHHHCCC--------------------HHHHHHHHHHHHHHHHHHHHHC-CCHHHHHHHHHHH
T ss_conf 604998999999999999874244--------------------0267899872012688998805-8657889999999
Q ss_pred HHHHCCCCCEEEEEEHHHHCCCCEEEE
Q ss_conf 854204880256520132101201225
Q 000715 704 ENICSQGGHWVARFTSQDVISNLCYIY 730 (1335)
Q Consensus 704 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (1335)
-|+++...+-...+...+++.-|+-..
T Consensus 169 ~~l~~~~~~~~~~~~~~~~v~~L~~lL 195 (264)
T d1xqra1 169 QNLLVGHPEHKGTLCSMGMVQQLVALV 195 (264)
T ss_dssp HHHHHHCGGGHHHHHHTTHHHHHHHHH
T ss_pred HHHHHCCHHHHHHHHHHHHHHHHHHHH
T ss_conf 998744577888888764689999997
|
| >d1wa5b_ a.118.1.1 (B:) Karyopherin alpha {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Karyopherin alpha species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.49 E-value=0.00015 Score=45.63 Aligned_cols=145 Identities=12% Similarity=0.130 Sum_probs=88.9
Q ss_pred HHHHHHHHHHHHCC--CCCHHHHHHCCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 11347778977417--6001357612004999999840037803799999999897511232322211110366544444
Q 000715 548 EKQNVIRYLEMLSS--NADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGL 625 (1335)
Q Consensus 548 ~k~n~~~yl~~v~~--~~~~a~~~~~~~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~~~~~~~~~~~~~~~ 625 (1335)
..++-+..++-+.. +..-...++.+-+++.|++.++...++.++..++++++-++++...........|++-.+.+.+
T Consensus 92 ~~~~a~~~~r~~ls~~~~~~i~~ii~~g~i~~Lv~~l~~~~~~~iq~~a~~~L~ni~~~~~~~~~~~~~~g~i~~l~~lL 171 (503)
T d1wa5b_ 92 EQLSATVKFRQILSREHRPPIDVVIQAGVVPRLVEFMRENQPEMLQLEAAWALTNIASGTSAQTKVVVDADAVPLFIQLL 171 (503)
T ss_dssp HHHHHHHHHHHHTCCSSSCSHHHHHHTTCHHHHHHTTSTTSCHHHHHHHHHHHHHHTTSCHHHHHHHHHTTCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCHHHHHHHCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHH
T ss_conf 99999999999974078843999998798499999871799999999999999999749888779999678747899985
Q ss_pred HHHHHHHHHHHHHHHHHHEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHHHHHHHH
Q ss_conf 55789999999996321202356137756889999999867555235435614899999987249512567787778985
Q 000715 626 RDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTIEN 705 (1335)
Q Consensus 626 ~~~~~~~~~~~~~~~ge~~~~~~~q~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 705 (1335)
...+.+++..++.+||.+.. .+... ++ ..... ..+..+...+... +.-++..+..++-|
T Consensus 172 ~s~~~~i~~~a~~~L~nia~----~~~~~----------r~-~l~~~-----~~~~~L~~ll~~~-~~~~~~~~~~~l~n 230 (503)
T d1wa5b_ 172 YTGSVEVKEQAIWALGNVAG----DSTDY----------RD-YVLQC-----NAMEPILGLFNSN-KPSLIRTATWTLSN 230 (503)
T ss_dssp HHCCHHHHHHHHHHHHHHHT----TCHHH----------HH-HHHHT-----TCHHHHHHGGGSC-CHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHH----HHHHH----------HH-HHHHH-----CCCCCCHHHCCCC-CHHHHHHHHHHHHH
T ss_conf 59971589999999999854----11899----------99-88741-----3556301204568-88999999999999
Q ss_pred HHCCCCCE
Q ss_conf 42048802
Q 000715 706 ICSQGGHW 713 (1335)
Q Consensus 706 ~~~~~~~~ 713 (1335)
+|+.....
T Consensus 231 l~~~~~~~ 238 (503)
T d1wa5b_ 231 LCRGKKPQ 238 (503)
T ss_dssp HHCCSSSC
T ss_pred HHCCCCCC
T ss_conf 84687420
|
| >d1wa5b_ a.118.1.1 (B:) Karyopherin alpha {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Karyopherin alpha species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.48 E-value=7.6e-05 Score=47.73 Aligned_cols=174 Identities=11% Similarity=0.101 Sum_probs=109.8
Q ss_pred HHHHHHHHCCCCCH---HHHHHHHHHHHHHCCCCCHHHHHHCCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 99999851287541---211347778977417600135761200499999984003780379999999989751123232
Q 000715 533 NARILAVLNGNSSI---GEKQNVIRYLEMLSSNADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFID 609 (1335)
Q Consensus 533 ~~~~~~~~~~~~~~---~~k~n~~~yl~~v~~~~~~a~~~~~~~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~ 609 (1335)
+..+...+..+... .+-..+|++++ ++..+....++...+.+.+++++. ..+.+++..+++.+|-++.......
T Consensus 121 i~~Lv~~l~~~~~~~iq~~a~~~L~ni~--~~~~~~~~~~~~~g~i~~l~~lL~-s~~~~i~~~a~~~L~nia~~~~~~r 197 (503)
T d1wa5b_ 121 VPRLVEFMRENQPEMLQLEAAWALTNIA--SGTSAQTKVVVDADAVPLFIQLLY-TGSVEVKEQAIWALGNVAGDSTDYR 197 (503)
T ss_dssp HHHHHHTTSTTSCHHHHHHHHHHHHHHT--TSCHHHHHHHHHTTCHHHHHHHHH-HCCHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHCCCCCHHHHHHHHHHHHHHH--CCCHHHHHHHHHCCCHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHHH
T ss_conf 4999998717999999999999999997--498887799996787478999855-9971589999999999854118999
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 22111103665444445578999999999632120235613775688999999986755523543561489999998724
Q 000715 610 DDLANSGILGSLTDGLRDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRK 689 (1335)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ge~~~~~~~q~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~ 689 (1335)
+-....|++..|...+.+....+++.++.++.-+...- . . .+.. -.+. .....+...+ +
T Consensus 198 ~~l~~~~~~~~L~~ll~~~~~~~~~~~~~~l~nl~~~~----~--------~------~~~~-~~~~-~~l~~l~~~l-~ 256 (503)
T d1wa5b_ 198 DYVLQCNAMEPILGLFNSNKPSLIRTATWTLSNLCRGK----K--------P------QPDW-SVVS-QALPTLAKLI-Y 256 (503)
T ss_dssp HHHHHTTCHHHHHHGGGSCCHHHHHHHHHHHHHHHCCS----S--------S------CCCH-HHHG-GGHHHHHHHT-T
T ss_pred HHHHHHCCCCCCHHHCCCCCHHHHHHHHHHHHHHHCCC----C--------C------CHHH-HHHH-HHHHHHHHHH-C
T ss_conf 98874135563012045688899999999999984687----4--------2------0479-9999-9999999872-3
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCEEEEEEHHHHCCCCEEEE
Q ss_conf 95125677877789854204880256520132101201225
Q 000715 690 GEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIY 730 (1335)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 730 (1335)
..|.-+..+++.++-+++....+....+...+++..+....
T Consensus 257 ~~d~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~l~~ll 297 (503)
T d1wa5b_ 257 SMDTETLVDACWAISYLSDGPQEAIQAVIDVRIPKRLVELL 297 (503)
T ss_dssp CCCHHHHHHHHHHHHHHHSSCHHHHHHHHHTTCHHHHHHGG
T ss_pred CCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHCC
T ss_conf 56389999999998753227711110011223311101102
|
| >d1xqra1 a.118.1.21 (A:87-350) Hsp70-binding protein 1 (HspBP1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HspBP1 domain domain: Hsp70-binding protein 1 (HspBP1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.21 E-value=0.0011 Score=39.79 Aligned_cols=148 Identities=12% Similarity=0.107 Sum_probs=113.3
Q ss_pred CCCHHHHHHHHHHHHHHCCC-CCHHHHHHCCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHH
Q ss_conf 75412113477789774176-00135761200499999984003780379999999989751123232221111036654
Q 000715 543 NSSIGEKQNVIRYLEMLSSN-ADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSL 621 (1335)
Q Consensus 543 ~~~~~~k~n~~~yl~~v~~~-~~~a~~~~~~~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~~~~~~~~~~~ 621 (1335)
++...-+......+..+|.+ ...-..+.....++.|++.+.....+.+|..+++.++-+++|...-.......|.+..|
T Consensus 70 s~~~~vr~~A~~~L~~l~~~~~~~~~~~~~~~~i~~Lv~lL~~~~~~~v~~~a~~aL~~l~~~~~~~~~~~~~~~gi~~L 149 (264)
T d1xqra1 70 AGAAGLRWRAAQLIGTCSQNVAAIQEQVLGLGALRKLLRLLDRDACDTVRVKALFAISCLVREQEAGLLQFLRLDGFSVL 149 (264)
T ss_dssp CSSHHHHHHHHHHHHHHHTTCHHHHHHHHHTTHHHHHHHHHHHCSCHHHHHHHHHHHHHHHTTCHHHHHHHHHTTHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHH
T ss_conf 99999999999999999988888889999727637999996049989999999999998742440267899872012688
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHHHH
Q ss_conf 44445578999999999632120235613775688999999986755523543561489999998724951256778777
Q 000715 622 TDGLRDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALR 701 (1335)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~ge~~~~~~~q~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 701 (1335)
.+.++..++++++..+.+++.++.. +... +... +-...+..+...| +..|..++.+++.
T Consensus 150 ~~lL~~~~~~~~~~a~~~L~~l~~~----~~~~-------------~~~~---~~~~~v~~L~~lL-~~~~~~~~~~a~~ 208 (264)
T d1xqra1 150 MRAMQQQVQKLKVKSAFLLQNLLVG----HPEH-------------KGTL---CSMGMVQQLVALV-RTEHSPFHEHVLG 208 (264)
T ss_dssp HHHHHSSCHHHHHHHHHHHHHHHHH----CGGG-------------HHHH---HHTTHHHHHHHHH-TSCCSTHHHHHHH
T ss_pred HHHHHCCCHHHHHHHHHHHHHHHHC----CHHH-------------HHHH---HHHHHHHHHHHHH-CCCCHHHHHHHHH
T ss_conf 9988058657889999999998744----5778-------------8888---8764689999997-3999899999999
Q ss_pred HHHHHHCCCC
Q ss_conf 8985420488
Q 000715 702 TIENICSQGG 711 (1335)
Q Consensus 702 ~~~~~~~~~~ 711 (1335)
++.|++....
T Consensus 209 aL~~L~~~~~ 218 (264)
T d1xqra1 209 ALCSLVTDFP 218 (264)
T ss_dssp HHHHHHTTCH
T ss_pred HHHHHHHCCH
T ss_conf 9999986488
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.04 E-value=0.0032 Score=36.48 Aligned_cols=73 Identities=14% Similarity=0.144 Sum_probs=49.6
Q ss_pred EEEEECCCCEEEEEEEECC-------CCEEEEEEECCCH-HHHHHHHHHHHHHHCC-CCCCCEEEEEEEECCEEEEEEEE
Q ss_conf 9787016957999999978-------8709999981711-0799999999999189-99800489999828979999960
Q 000715 7 YEAIGRGKYSTVYKGRKKK-------TIEYFAIKSVDKS-QKSKVLQEVRMLHSLD-HPNVLRFYSWYETSAHLWLVLEY 77 (1335)
Q Consensus 7 lK~LGkGsFGtVYkAkdk~-------TGk~VAIKiIdKs-q~eeIlrEIkILkkLk-HPNIVkLlevfed~~~LyLVMEy 77 (1335)
.+.|+.|-.-.+|++.... ..+.|.+++.... ..-...+|..+++.+. +.-..++++++.+ ++|+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEEE
T ss_conf 9991785334348999688775445789817999659961165899999999999757999808998189----569997
Q ss_pred CCCCCH
Q ss_conf 489997
Q 000715 78 CVGGDL 83 (1335)
Q Consensus 78 ieGGSL 83 (1335)
++|..+
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred ECCCCC
T ss_conf 345548
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.78 E-value=0.0036 Score=36.08 Aligned_cols=126 Identities=17% Similarity=0.203 Sum_probs=72.2
Q ss_pred EEEEEEEECCCCEEEEEEECCCH--HHHHHHHHHHHHHHCCCCCC--CEEE-----EEEEECCEEEEEEEECCCCCHH--
Q ss_conf 79999999788709999981711--07999999999991899980--0489-----9998289799999604899978--
Q 000715 16 STVYKGRKKKTIEYFAIKSVDKS--QKSKVLQEVRMLHSLDHPNV--LRFY-----SWYETSAHLWLVLEYCVGGDLM-- 84 (1335)
Q Consensus 16 GtVYkAkdk~TGk~VAIKiIdKs--q~eeIlrEIkILkkLkHPNI--VkLl-----evfed~~~LyLVMEyieGGSL~-- 84 (1335)
-.||++... +|..|++|+.... ..+++..|...+..|....+ .... ..+......+.++++.+|..+.
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred CEEEEEECC-CCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCC
T ss_conf 026999838-9997999984787788999999999999998559987875206898056653479999865277688999
Q ss_pred ---HHH------H---H----------------------------CCCCCHHH---HHHHHHHHHHHHHHHH----HCCC
Q ss_conf ---999------8---3----------------------------89999999---9999999999999999----8797
Q 000715 85 ---SLL------R---Q----------------------------DNQLPEDS---IRDLAQDLVRALQYLH----SKGI 117 (1335)
Q Consensus 85 ---dlI------k---k----------------------------~g~LSEee---Ir~IL~QILeALkYLH----skGI 117 (1335)
.+. . . ...++... ....+.++...+.-.- ..++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCEE
T ss_conf 99999998999999886303578655677897887665689998747699889899999999999999984545687120
Q ss_pred CCCCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 014789997477799975540356210
Q 000715 118 IYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 118 VHRDIKPeNILIDedG~IKLiDFGLAr 144 (1335)
+|+|+.+.||+++++ ..++||+.+.
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ECCCCCCCCEEEECC--CEEEECHHCC
T ss_conf 247888042878389--3588652014
|
| >d1q1sc_ a.118.1.1 (C:) Importin alpha {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin alpha species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.64 E-value=0.00035 Score=43.15 Aligned_cols=67 Identities=13% Similarity=0.098 Sum_probs=29.9
Q ss_pred HHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHH
Q ss_conf 999998400378037999999998975112323-2221111036654444455-7899999999963212
Q 000715 576 LVLVKMLRLSKTSALRVQLASLIGLFIRHSTFI-DDDLANSGILGSLTDGLRD-KQEKVRRFSMAALGEL 643 (1335)
Q Consensus 576 ~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ge~ 643 (1335)
..+|+++.-. |++.+.+++..+.=+.+..+.- -+.....|++..|.+.+.. ....+++-...+|+.+
T Consensus 16 ~~lv~~l~s~-~~~~~~~a~~~l~~l~s~~~~~~~~~i~~~g~i~~Lv~lL~~~~~~~v~~~a~~~L~~l 84 (434)
T d1q1sc_ 16 EDIVKGINSN-NLESQLQATQAARKLLSREKQPPIDNIIRAGLIPKFVSFLGKTDCSPIQFESAWALTNI 84 (434)
T ss_dssp HHHHHHHTSS-CHHHHHHHHHHHHHHHHSSSCCCHHHHHHTTCHHHHHHHTTCGGGHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCC-CHHHHHHHHHHHHHHHCCCCCCHHHHHHHCCCHHHHHHHHCCCCCHHHHHHHHHHHHHH
T ss_conf 9999987698-99999999999999863799832999998889999999874699889999999999998
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.55 E-value=0.0054 Score=34.91 Aligned_cols=139 Identities=19% Similarity=0.166 Sum_probs=76.8
Q ss_pred EEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCH-HHHHHHHHHHHHHHCCC-----CCCCEEE---EEEEECCEEEEE
Q ss_conf 89997870169579999999788709999981711-07999999999991899-----9800489---999828979999
Q 000715 4 YHIYEAIGRGKYSTVYKGRKKKTIEYFAIKSVDKS-QKSKVLQEVRMLHSLDH-----PNVLRFY---SWYETSAHLWLV 74 (1335)
Q Consensus 4 YeIlK~LGkGsFGtVYkAkdk~TGk~VAIKiIdKs-q~eeIlrEIkILkkLkH-----PNIVkLl---evfed~~~LyLV 74 (1335)
..-.+.|..|---+.|+..... + .|++|++.+. ....+..|.+++..+.. |..+... .+.......+.+
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~ 97 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 97 (316)
T ss_dssp EEEEEEECC---EEEEEEEESS-C-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred CEEEECCCCCCCCCEEEEEECC-C-CEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEECCCCEE
T ss_conf 5685237888526738999789-7-2899980789998899999999875430255545564104897621341255024
Q ss_pred EEECCCCCHHH-----H------H---HH-CC--------C------------------CCHHHHHHHHHHHHHHHHHHH
Q ss_conf 96048999789-----9------9---83-89--------9------------------999999999999999999999
Q 000715 75 LEYCVGGDLMS-----L------L---RQ-DN--------Q------------------LPEDSIRDLAQDLVRALQYLH 113 (1335)
Q Consensus 75 MEyieGGSL~d-----l------I---kk-~g--------~------------------LSEeeIr~IL~QILeALkYLH 113 (1335)
+.+..|..... . + .. .. . .........+......+...+
T Consensus 98 ~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 177 (316)
T d2ppqa1 98 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 177 (316)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHCCC
T ss_conf 53114655333204678888899876454443202453101110120024567777653114127999999987642048
Q ss_pred H----CCCCCCCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 8----797014789997477799975540356210
Q 000715 114 S----KGIIYCDLKPSNILLDENGRTKLCDFGLAR 144 (1335)
Q Consensus 114 s----kGIVHRDIKPeNILIDedG~IKLiDFGLAr 144 (1335)
. .|++|+|+.++||+++++...-++||+.+.
T Consensus 178 ~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 178 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf 55454503337863656402045412674222123
|
| >d1b3ua_ a.118.1.2 (A:) Constant regulatory domain of protein phosphatase 2a, pr65alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HEAT repeat domain: Constant regulatory domain of protein phosphatase 2a, pr65alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.08 E-value=0.0056 Score=34.77 Aligned_cols=107 Identities=19% Similarity=0.207 Sum_probs=66.5
Q ss_pred HHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHEEEEEECCCCCC
Q ss_conf 99999840037803799999999897511232322211110366544444557899999999963212023561377568
Q 000715 576 LVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLRDKQEKVRRFSMAALGELLFYISTQNEHAR 655 (1335)
Q Consensus 576 ~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ge~~~~~~~q~~~~~ 655 (1335)
..|+..|+. .++..|..+++.+|.++..- ..+-...+++-.|++++.|+. .|+..+.-.||++.-++ |+.
T Consensus 13 ~~l~~~l~~-~~~~~R~~a~~~l~~ia~~l---g~~~~~~~lip~l~~~~~~~~-ev~~~~~~~l~~~~~~~----~~~- 82 (588)
T d1b3ua_ 13 AVLIDELRN-EDVQLRLNSIKKLSTIALAL---GVERTRSELLPFLTDTIYDED-EVLLALAEQLGTFTTLV----GGP- 82 (588)
T ss_dssp HHHHHHTTC-SCHHHHHHHHHTHHHHHHHS---CHHHHHHTHHHHHHHTCCCCH-HHHHHHHHHHTTCSGGG----TSG-
T ss_pred HHHHHHHCC-CCHHHHHHHHHHHHHHHHHH---CCHHHHHHHHHHHHHHHCCCH-HHHHHHHHHHHHHHHHC----CCH-
T ss_conf 999998669-99899999999999999984---917459999999999865868-99999999999999874----874-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCC
Q ss_conf 89999999867555235435614899999987249512567787778985420488
Q 000715 656 DSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTIENICSQGG 711 (1335)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 711 (1335)
+.-..++..+...+ ..+|..++..|.+++..|+..-+
T Consensus 83 ------------------~~~~~ll~~l~~l~-~~~~~~Vr~~a~~~l~~i~~~~~ 119 (588)
T d1b3ua_ 83 ------------------EYVHCLLPPLESLA-TVEETVVRDKAVESLRAISHEHS 119 (588)
T ss_dssp ------------------GGGGGGHHHHHHHT-TSSCHHHHHHHHHHHHHHHTTSC
T ss_pred ------------------HHHHHHHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHCC
T ss_conf ------------------68999999999980-69988999999999999998679
|
| >d1b3ua_ a.118.1.2 (A:) Constant regulatory domain of protein phosphatase 2a, pr65alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HEAT repeat domain: Constant regulatory domain of protein phosphatase 2a, pr65alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.98 E-value=0.00089 Score=40.31 Aligned_cols=56 Identities=16% Similarity=0.161 Sum_probs=23.4
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHE
Q ss_conf 378037999999998975112323222111103665444445578999999999632120
Q 000715 585 SKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLRDKQEKVRRFSMAALGELL 644 (1335)
Q Consensus 585 ~~~~~~r~~~a~~~g~~~~h~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ge~~ 644 (1335)
...+..|..++.+++.++.+...- -..+++-.+.+.+.|++..||+.+..++|++.
T Consensus 137 ~~~~~~r~~a~~ll~~~~~~~~~~----~~~~l~~~~~~l~~D~~~~VR~~a~~~l~~~~ 192 (588)
T d1b3ua_ 137 GDWFTSRTSACGLFSVCYPRVSSA----VKAELRQYFRNLCSDDTPMVRRAAASKLGEFA 192 (588)
T ss_dssp CSSHHHHHHHGGGHHHHTTTSCHH----HHHHHHHHHHHHHTCSCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHH----HHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_conf 631479999999999999986189----99999999999851699899999999999899
|
| >d1jdha_ a.118.1.1 (A:) beta-Catenin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: beta-Catenin species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.78 E-value=0.047 Score=28.40 Aligned_cols=276 Identities=15% Similarity=0.095 Sum_probs=115.4
Q ss_pred HHHHHCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHC-CHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 998512875412113477789774176001357612-0049999998400378037999999998975112323222111
Q 000715 536 ILAVLNGNSSIGEKQNVIRYLEMLSSNADAANILTS-GPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLAN 614 (1335)
Q Consensus 536 ~~~~~~~~~~~~~k~n~~~yl~~v~~~~~~a~~~~~-~~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~~~~ 614 (1335)
+...+++ +....+.+-.+.++.++.+...-..++. +.++..+++.|+...+.+.+..+++.++-+..|... .+..-.
T Consensus 22 L~~lL~~-~~~~v~~~A~~~l~~l~~~~~~~~~~~~~~~~v~~l~~~L~~~~~~~~~~~a~~~L~~l~~~~~~-~~~i~~ 99 (529)
T d1jdha_ 22 LTKLLND-EDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREG-LLAIFK 99 (529)
T ss_dssp HHHHHTC-SCHHHHHHHHHHHHHHHTSHHHHHHHHTCHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHTTSHHH-HHHHHH
T ss_pred HHHHHCC-CCHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHCCCHH-HHHHHH
T ss_conf 9998729-99999999999999998455778999871339999999984799999999999999999589166-999998
Q ss_pred CHHHHHHHHHHHHHHHHHHHHHHHHHHHHEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHH
Q ss_conf 10366544444557899999999963212023561377568899999998675552354356148999999872495125
Q 000715 615 SGILGSLTDGLRDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDM 694 (1335)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~ge~~~~~~~q~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~~~~~~ 694 (1335)
.|.+-.|.+.+++.+++++.....+|+.+.+. ++.. ++ ..+ -...+..+...| +..+.-
T Consensus 100 ~g~i~~Li~lL~~~~~~v~~~a~~aL~~l~~~----~~~~----------~~-~~~-----~~g~i~~Lv~lL-~~~~~~ 158 (529)
T d1jdha_ 100 SGGIPALVKMLGSPVDSVLFYAITTLHNLLLH----QEGA----------KM-AVR-----LAGGLQKMVALL-NKTNVK 158 (529)
T ss_dssp TTHHHHHHHHTTCSCHHHHHHHHHHHHHHHHH----CTTH----------HH-HHH-----HHTHHHHHHHGG-GCCCHH
T ss_pred CCCHHHHHHHHCCCCHHHHHHHHHHHHHHHCC----CCHH----------HH-HHH-----HCCCCHHHHHHH-HCCCHH
T ss_conf 79899999985797989999999999986513----2011----------36-787-----658814899988-705768
Q ss_pred HHHHHHHHHHHHHCCCCCEEEEEEHHHHCCCCEEEEECCCCCCEEECCCCCEEEEEEECCCCHHHHHHHHCCHHHHHHHH
Q ss_conf 67787778985420488025652013210120122541574210002346416888612886068997430298999753
Q 000715 695 TQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESMRLTAGSCLVRLVRFNAPSMQSVMDKLSIKDIASSL 774 (1335)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 774 (1335)
++..+..++.+++....+...-+.....+..|..+++...... ++..+..++-.+ -.++.....+.+.-.++-+..-+
T Consensus 159 ~~~~a~~~L~~l~~~~~~~~~~~~~~~~~~~L~~ll~~~~~~~-~~~~~~~~l~~l-s~~~~~~~~~~~~g~~~~L~~ll 236 (529)
T d1jdha_ 159 FLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEK-LLWTTSRVLKVL-SVCSSNKPAIVEAGGMQALGLHL 236 (529)
T ss_dssp HHHHHHHHHHHHHTTCHHHHHHHHHTTHHHHHHHHHHHCCCHH-HHHHHHHHHHHH-TTSTTHHHHHHHTTHHHHHHTTT
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHCCCCHHHHHHHHHHHHHH-HHHHHHHHHHHH-HCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 8888899998876300478888876056368999998610489-999999987511-01332330456543334699986
Q ss_pred HCCCCCCHHHHHHHH-HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHCCCCE
Q ss_conf 049921100555455-6886443320111224433332356302367762026322145046899987203740
Q 000715 775 IKGSPREQQISLNLL-NLAMLGSQMCTNIGRNLLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNGRR 847 (1335)
Q Consensus 775 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (1335)
-.++.+.+.-.+..+ |++ +..++. ......+|.|+.+++.+..-.+..|.-..+.||.++..
T Consensus 237 ~~~~~~~~~~a~~~l~~ls--------~~~~~~---~~~~~~i~~Lv~ll~~~~~~~~~~a~~~L~~l~~~~~~ 299 (529)
T d1jdha_ 237 TDPSQRLVQNCLWTLRNLS--------DAATKQ---EGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYK 299 (529)
T ss_dssp TSSCHHHHHHHHHHHHHHH--------TTCTTC---SCCHHHHHHHHHHTTCSCHHHHHHHHHHHHHHTTTCHH
T ss_pred CCCCHHHHHHHHHHHHHCC--------CCCCCH---HHHHHCCHHHHHHCCCCCHHHHHHHHHHHHHHCCCHHH
T ss_conf 2540155530156777504--------321102---56640101445412454288999999988750122037
|
| >d1u6gc_ a.118.1.2 (C:) Cullin-associated NEDD8-dissociated protein 1 (Tip120) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: HEAT repeat domain: Cullin-associated NEDD8-dissociated protein 1 (Tip120) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.06 E-value=0.079 Score=26.80 Aligned_cols=286 Identities=13% Similarity=0.089 Sum_probs=123.5
Q ss_pred HHHHHHHHHHCCCC--CHHHHHHHHHHHHHHCCCCCHHHHHHCCHHHHHHHHHHCCCCCC-HHHHHHHHHHHHHHHCCC-
Q ss_conf 99999998512875--41211347778977417600135761200499999984003780-379999999989751123-
Q 000715 531 ALNARILAVLNGNS--SIGEKQNVIRYLEMLSSNADAANILTSGPIMLVLVKMLRLSKTS-ALRVQLASLIGLFIRHST- 606 (1335)
Q Consensus 531 ~f~~~~~~~~~~~~--~~~~k~n~~~yl~~v~~~~~~a~~~~~~~~~~lli~~l~~~~~~-~~r~~~a~~~g~~~~h~t- 606 (1335)
..++.+...+.+.. .-.+-..++..+..+... .....+ .++++.+++.+...... .+|..+.+.++-++....
T Consensus 431 ~i~~~l~~~l~~~~~~~r~~~~~~l~~l~~~~~~-~l~~~l--~~~~~~i~~~l~~~~~~~~~~~~al~~l~~l~~~~~~ 507 (1207)
T d1u6gc_ 431 NIVKALHKQMKEKSVKTRQCCFNMLTELVNVLPG-ALTQHI--PVLVPGIIFSLNDKSSSSNLKIDALSCLYVILCNHSP 507 (1207)
T ss_dssp HHHHHHHHHTTCSCHHHHHHHHHHHHHHHHHSTT-TTGGGH--HHHHHHHHHHTTCSSSCHHHHHHHHHHHHHHHHSSCG
T ss_pred HHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHCCH-HHHHHH--HHHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHCCH
T ss_conf 9999999986488656788899999999997225-777766--7567899999760264168889999999999872267
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 23222111103665444445578999999999632120235613775688999999986755523543561489999998
Q 000715 607 FIDDDLANSGILGSLTDGLRDKQEKVRRFSMAALGELLFYISTQNEHARDSNPPESPSKDNRTASGWQVPNSLISLVSSV 686 (1335)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ge~~~~~~~q~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 686 (1335)
..-. -....+...+.+.+.++..+++..+..+++++...+....... ... ....+..-...+...+
T Consensus 508 ~~~~-~~~~~l~~~~~~~~~~~~~~i~~~al~~~~~l~~~l~~~~~~~----------~~~---~~~~~~~l~~~~~~~l 573 (1207)
T d1u6gc_ 508 QVFH-PHVQALVPPVVACVGDPFYKITSEALLVTQQLVKVIRPLDQPS----------SFD---ATPYIKDLFTCTIKRL 573 (1207)
T ss_dssp GGGH-HHHTTTHHHHHHHHTCSSHHHHHHHHHHHHHHHHHHCCSSSCC----------CCC---CHHHHHHHHHHHHHHH
T ss_pred HHHH-HHHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHHCCCH----------HHH---HHHHHHHHHHHHHHHH
T ss_conf 8899-9987633468888712308899999999998898750001102----------554---4788999999999998
Q ss_pred HHCCCCHHHHHHHHHHHHHHHCCCCCEEEEEEHHHHCCCCEEEEECCCCCCEEECCCCCEEEEEEECC-CCHHHHHHHHC
Q ss_conf 72495125677877789854204880256520132101201225415742100023464168886128-86068997430
Q 000715 687 LRKGEDDMTQLYALRTIENICSQGGHWVARFTSQDVISNLCYIYRATGKQESMRLTAGSCLVRLVRFN-APSMQSVMDKL 765 (1335)
Q Consensus 687 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 765 (1335)
.....|.-++..++..+..+.+..|....... ...+..+ -..-+.|..|..+...+..+.... ...++.++..+
T Consensus 574 ~~~~~~~e~~~~al~~l~~l~~~~~~~~~~~~-~~~l~~l----~~~l~~~~~r~~a~~~l~~i~~~~~~~~~~~~l~~~ 648 (1207)
T d1u6gc_ 574 KAADIDQEVKERAISCMGQIICNLGDNLGSDL-PNTLQIF----LERLKNEITRLTTVKALTLIAGSPLKIDLRPVLGEG 648 (1207)
T ss_dssp SCSSSCHHHHHHHHHHHHHHHHHTGGGCCTHH-HHHHHHH----HHHTTSSSHHHHHHHHHHHHTTCSSCCCCHHHHHHH
T ss_pred HHCCCCHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHH----HHHHCCHHHHHHHHHHHHHHHHHCCCHHHHHHHHHH
T ss_conf 73131017889899999989887655658888-8887778----887423045799999999998731321478999888
Q ss_pred CHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 29899975304992110055545568864433201112244333323563023677620263221450468999872037
Q 000715 766 SIKDIASSLIKGSPREQQISLNLLNLAMLGSQMCTNIGRNLLPLVEDKNLVPSLVSLTEQGSEVLRGKALVFVSLLCKNG 845 (1335)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (1335)
+..+...+-+.....++.++..|..- +.+.+..+..-.- ..+++.+..++.....-++..++.+.+.+++..
T Consensus 649 -~~~l~~~l~~~~~~~r~~al~~L~~l------~~~~~~~~~~~~~-~~~l~~l~~ll~~~d~~v~~~~l~~l~~l~~~~ 720 (1207)
T d1u6gc_ 649 -VPILASFLRKNQRALKLGTLSALDIL------IKNYSDSLTAAMI-DAVLDELPPLISESDMHVSQMAISFLTTLAKVY 720 (1207)
T ss_dssp -HHHHHHHTTSCCHHHHHHHHHHHHHH------HHHCCTTCCHHHH-HHHHTTCGGGSCTTCHHHHHHHHHHHHHHTTSC
T ss_pred -HHHHHHHCCCCHHHHHHHHHHHHHHH------HHHCCCCCHHHHH-HHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHC
T ss_conf -88987750144388999999999999------9845421006777-667776324443440788999999988888626
Q ss_pred C
Q ss_conf 4
Q 000715 846 R 846 (1335)
Q Consensus 846 ~ 846 (1335)
.
T Consensus 721 ~ 721 (1207)
T d1u6gc_ 721 P 721 (1207)
T ss_dssp G
T ss_pred C
T ss_conf 3
|
| >d1qbkb_ a.118.1.1 (B:) Karyopherin beta2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Karyopherin beta2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.92 E-value=0.4 Score=21.90 Aligned_cols=117 Identities=13% Similarity=0.137 Sum_probs=72.7
Q ss_pred HHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHEEEEEECC
Q ss_conf 04999999840037803799999999897511232-32221111036654444455789999999996321202356137
Q 000715 573 PIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTF-IDDDLANSGILGSLTDGLRDKQEKVRRFSMAALGELLFYISTQN 651 (1335)
Q Consensus 573 ~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ge~~~~~~~q~ 651 (1335)
.+++.+.+++. .++|..|-.+...+|-++..... +.+. ..+++..|...+.|.+..||.-.+-++|.+.-++..+.
T Consensus 395 ~~l~~l~~~l~-s~~~~~reaa~~alg~i~eg~~~~~~~~--l~~li~~l~~~l~d~~~~Vr~~a~~~l~~~~~~~~~~~ 471 (888)
T d1qbkb_ 395 HILPLLKELLF-HHEWVVKESGILVLGAIAEGCMQGMIPY--LPELIPHLIQCLSDKKALVRSITCWTLSRYAHWVVSQP 471 (888)
T ss_dssp HHHHHHHHTTT-SSSHHHHHHHHHHHHHHTTTSHHHHTTT--HHHHHHHHHHHTTSSCHHHHHHHHHHHHHTHHHHHSSC
T ss_pred HHHHHHHHHHC-CCHHHHHHHHHHHHHHHHHHHHHHHCCC--CHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_conf 99999887512-2056899999998643555578774212--03556799984269989999999999999999866541
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHHHHHHHHHHCCCCCE
Q ss_conf 75688999999986755523543561489999998724951256778777898542048802
Q 000715 652 EHARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTIENICSQGGHW 713 (1335)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (1335)
. ..+ .+.....++..+ .+.+..++..+..++.+++...+.-
T Consensus 472 ~------------------~~~-~~~~l~~ll~~l--~d~~~~V~~~a~~al~~l~~~~~~~ 512 (888)
T d1qbkb_ 472 P------------------DTY-LKPLMTELLKRI--LDSNKRVQEAACSAFATLEEEACTE 512 (888)
T ss_dssp H------------------HHH-TTTHHHHHHHHH--SSSCHHHHHHHHHHHHHHHHHHTTS
T ss_pred H------------------HHH-HHHHHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHH
T ss_conf 5------------------655-455589999884--2898789998999999999875531
|
| >d1ibrb_ a.118.1.1 (B:) Importin beta {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Armadillo repeat domain: Importin beta species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.39 E-value=0.89 Score=19.50 Aligned_cols=15 Identities=27% Similarity=0.118 Sum_probs=4.9
Q ss_pred CCCCCHHHHHHHHHH
Q ss_conf 877612441355789
Q 000715 1219 CSQEANVADVASECV 1233 (1335)
Q Consensus 1219 ~~~~~~i~~~as~c~ 1233 (1335)
.++++.|-..|..|+
T Consensus 417 ~d~~~~VR~~a~~~l 431 (458)
T d1ibrb_ 417 KDPSVVVRDTAAWTV 431 (458)
T ss_dssp GCSCHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHH
T ss_conf 899899999999999
|
| >d1xm9a1 a.118.1.24 (A:244-700) Plakophilin 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: Plakophilin 1 helical region domain: Plakophilin 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.16 E-value=0.91 Score=19.44 Aligned_cols=110 Identities=14% Similarity=0.063 Sum_probs=86.1
Q ss_pred HHHHHHHHCCCCCHHHHHHHHHHHHHHCC-CCCHHHHHHCCHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 99999851287541211347778977417-60013576120049999998400378037999999998975112323222
Q 000715 533 NARILAVLNGNSSIGEKQNVIRYLEMLSS-NADAANILTSGPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDD 611 (1335)
Q Consensus 533 ~~~~~~~~~~~~~~~~k~n~~~yl~~v~~-~~~~a~~~~~~~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~ 611 (1335)
+..+.+.+++. ...-+..-..||.-+|. +.+....+...-..+.|+++++ .+++++|..+++.++-|+.+..+.+.-
T Consensus 4 ip~lv~~L~~~-~~~~~~~a~~~l~~l~~~~~~~~~~i~~~g~i~~Lv~lL~-~~~~~v~~~a~~aL~~L~~~~~~~~~~ 81 (457)
T d1xm9a1 4 IPKAVQYLSSQ-DEKYQAIGAYYIQHTCFQDESAKQQVYQLGGICKLVDLLR-SPNQNVQQAAAGALRNLVFRSTTNKLE 81 (457)
T ss_dssp HHHHHHHHHSS-CTHHHHHHHHHHHHHTSSCSSHHHHHHHTTHHHHHHHHTT-SSCHHHHHHHHHHHHHHHSSCHHHHHH
T ss_pred HHHHHHHHCCC-CHHHHHHHHHHHHHHHCCCHHHHHHHHHCCCHHHHHHHHC-CCCHHHHHHHHHHHHHHHCCCHHHHHH
T ss_conf 89999985799-9999999999999998499999999998885999999877-999899999999999997499888999
Q ss_pred CCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHHE
Q ss_conf 1111036654444455-78999999999632120
Q 000715 612 LANSGILGSLTDGLRD-KQEKVRRFSMAALGELL 644 (1335)
Q Consensus 612 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ge~~ 644 (1335)
....|++-.+.+.++. ....+|.-...+++.+.
T Consensus 82 i~~~g~v~~li~~l~~~~~~~~~~~a~~~l~~l~ 115 (457)
T d1xm9a1 82 TRRQNGIREAVSLLRRTGNAEIQKQLTGLLWNLS 115 (457)
T ss_dssp HHHTTCHHHHHHHHTTCCCHHHHHHHHHHHHHHH
T ss_pred HHHCCCHHHHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_conf 9987982899999843373889999999999998
|
| >d1te4a_ a.118.1.16 (A:) MTH187 {Archaeon Methanobacterium thermoautotrophicum [TaxId: 145262]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: alpha-alpha superhelix superfamily: ARM repeat family: PBS lyase HEAT-like repeat domain: MTH187 species: Archaeon Methanobacterium thermoautotrophicum [TaxId: 145262]
Probab=80.46 E-value=1.1 Score=18.79 Aligned_cols=90 Identities=17% Similarity=0.190 Sum_probs=65.9
Q ss_pred CHHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHEEEEEECC
Q ss_conf 00499999984003780379999999989751123232221111036654444455789999999996321202356137
Q 000715 572 GPIMLVLVKMLRLSKTSALRVQLASLIGLFIRHSTFIDDDLANSGILGSLTDGLRDKQEKVRRFSMAALGELLFYISTQN 651 (1335)
Q Consensus 572 ~~~~~lli~~l~~~~~~~~r~~~a~~~g~~~~h~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ge~~~~~~~q~ 651 (1335)
.+-+..|++.+. .++|.+|..+++.+|-+- ..+++..|.+.+.|++..||+...-+||++
T Consensus 21 ~~~~~~L~~~l~-d~~~~vR~~a~~~L~~~~-----------~~~~~~~L~~~l~d~~~~VR~~a~~aL~~i-------- 80 (111)
T d1te4a_ 21 DEAFEPLLESLS-NEDWRIRGAAAWIIGNFQ-----------DERAVEPLIKLLEDDSGFVRSGAARSLEQI-------- 80 (111)
T ss_dssp STTHHHHHHGGG-CSCHHHHHHHHHHHGGGC-----------SHHHHHHHHHHHHHCCTHHHHHHHHHHHHH--------
T ss_pred HHHHHHHHHHHC-CCCHHHHHHHHHHHHHCC-----------HHHHHHHHHHHHCCCHHHHHHHHHHHHHHH--------
T ss_conf 789999999974-998789999999987610-----------123279987330230337999999999986--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHHHHHHHHH
Q ss_conf 756889999999867555235435614899999987249512567787778985
Q 000715 652 EHARDSNPPESPSKDNRTASGWQVPNSLISLVSSVLRKGEDDMTQLYALRTIEN 705 (1335)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 705 (1335)
| . ...+..+...+ +++|..++.-|+++++.
T Consensus 81 ~-~----------------------~~~~~~L~~ll-~d~~~~vr~~A~~aL~t 110 (111)
T d1te4a_ 81 G-G----------------------ERVRAAMEKLA-ETGTGFARKVAVNYLET 110 (111)
T ss_dssp C-S----------------------HHHHHHHHHHT-TSCCTHHHHHHHHHGGG
T ss_pred C-C----------------------CCHHHHHHHHH-CCCCHHHHHHHHHHHHC
T ss_conf 7-6----------------------11499999988-29989999999999876
|